<SEC-DOCUMENT>0001628280-20-016036.txt : 20201109
<SEC-HEADER>0001628280-20-016036.hdr.sgml : 20201109
<ACCEPTANCE-DATETIME>20201109080404
ACCESSION NUMBER:		0001628280-20-016036
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		88
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201109
DATE AS OF CHANGE:		20201109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		201296184

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mygn-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:e951f29c-a210-45d5-8fef-ac7c87c1a1f9,g:048ed3a0-61ad-4824-a735-4ab2d7ea0155,d:35df2622b3a0423e9f409ac2173a31c8--><html xmlns:mygn="http://www.myriad.com/20200930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mygn-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl80LTEtMS0xLTA_27ba3252-2eed-4d4b-855c-c470f2786d8b">false</ix:nonNumeric><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl8yLTEtMS0xLTE4OTQ_704f36f7-ce2b-4eef-86a0-eebe2d76b1e1">0000899923</ix:nonNumeric><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl8zLTEtMS0xLTE4OTQ_aa287260-4a8a-41e9-a565-6348d760de34">--06-30</ix:nonNumeric><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl82LTEtMS0xLTA_52a3bffe-c351-497b-b8dc-f05ca92c386e">2021</ix:nonNumeric><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl83LTEtMS0xLTA_170ab23a-d57b-45a6-bb6c-1e3832a8ac02">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:RevenuePracticalExpedientRemainingPerformanceObligation" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80My9mcmFnOjE2NTYyOGI1Y2FlYTRjZTRiMzk4MTIzYWU2OTliNTI3L3RhYmxlOjcxODc0M2NiYmJjYjRlYTg5NjZjZGE4Njg2ZTRiYThmL3RhYmxlcmFuZ2U6NzE4NzQzY2JiYmNiNGVhODk2NmNkYTg2ODZlNGJhOGZfNC0xLTEtMS0w_6c879270-2c34-41b1-a8b1-fbea23bd7625">true</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mygn-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i912f7c983e734c25aaf08678ad9b5ec8_I20201102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5fe991d524ac4629ab0f930806f7c992_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i0afd5266f1674cd890c5e822e8608051_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60c68c3b6a064506b03ca32fad5428a0_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5f2e721cba4626be7e73ae2f98f5be_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i645c55a2b3c240cc83b60c6876b52044_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i139906c1954e43c39560efe073ca515b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e44f0801a764c629e60704da55af897_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74aa2b09d6d7450b992f13f174e86815_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0dc32b94684fb9a72074a4467ddbb3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac1b61b427d34cd1aee1ba7384109a9d_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i091efe167f3c4e1da67fb808d46a17cf_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacae5069b54f4a67b0357cd8ef5efb1a_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25198efed29e4e92b99f0262f821c2d3_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61a8af6463ab4c92ba4435534752e1a2_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ccc458b8fab4e1aaf73e23ed8876645_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1b31638ad944d72af7bea5c92686dee_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i005afd72b0d346de9ebc794edf8af44d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3201828072042f8be79031422bab5b1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8725d74790d48458cfdfa6233888a31_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82a7856a26e14144a676ceba1c64446a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaedb6702dab54acfb883a731f04b482f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2efecfeca2f34c238cfefcdb778c6425_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i160b5ebaf0a348a6bf32eaa61276f655_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877b14486ab2428ba1f01ad23fccb179_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64095d8f93a94fbeb281e9c293c679a9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055da3a2d6c44d7597f0360c7843f5ff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1795c5c48c34f16b22b8ae598cdd22a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id178ba580c6f4185bc51f217377478d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcedbfd8cc754e8492395b6e8c733e64_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bfb911643b349c899f841b445e06512_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422deb02b92f488ca820658db810b31a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i401a6d1f82534405a2c00ba1f907da60_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb347fa85ae744768f8361fb2ca325eb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i200b85a83c6a46bbabdea8dcc39d8562_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic51c9413854143499e5aaf57989d7eb7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3348c1dccc754570a3090cd6065878a9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7687ee73ec6a4a2fb7d9c3c95f5ed679_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08483a8a185e4dfb9ae69070970276d7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951685b4432940a2b6070e5ae3bd49a5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6744579210784fdeb06463912c24a193_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd0de429b834c25b696cffe376cd572_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8769527161654967b1c9d612b500e5bf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a7219c652fa40129553545f083b6ffd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45fc867c897b4386aeaf67795c276626_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fad8fd2ba87493e8cae157d3442bae9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bfa2d578a84425184f03060039d64fd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2742d972b9a4d7fbbde1e0bbed5c74e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74596ec49a7a4ebe83e5358874b6f8b1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3644e7dfea0400597ac774c4595f9c1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3668121649b4395acd610e7f38044b8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62e373c9cfa4d13b74004a4f087e81d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af57be3ac8745b59d1c5c8f835c759c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca7cd2a9ed64068a730c3d0940649c7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2228b67d6e046568399abed69752b24_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0b089eccab490aa3d7e32307f073dc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cc249590a16407aa43f1bcdf46a5e5c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dad84e61a5648f68b1f50c0b983bede_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7033a2b43a11471a8ee110193d73fa2b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d3d58394a04580baac5d76d025fa35_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bf5e0d1693441a18f30a9d95fe4163b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67246cad5fa34d69b25bfc809dd1c777_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i567a2a9416d34f3c92557d9422f0348b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ebbd429b95f49139bb9281a342136de_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i484f743506ee4902aef30c20d43aa898_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280ce449a5d6421ca8511c92eeddca0a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i605a9571af9c4c29b51405c5fa8a5180_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8720515f7754cf1bb2ae4218d464c2a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59e287da7a7c4198b40966eba2b62146_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285edd982b994ad2b3b7a0af7f283e6b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51fd75ee62c145e2952ac446346d9b7c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4121b8b21d442e292a4ed42bdb30d70_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29558741c2674b39926f43730a6b171b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1bb8d1c57184d4f94dc2c42b00f8a29_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef0215658fa4d7c85eef815a3644861_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd11d9c02bce445fa4341df9cbdb8482_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i378ad67948644fae91e1885f07d8b2c2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6600cdbac0c2465bb71dca2e44416ef6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ede0c04f58f4611b03fdd8721157941_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia52c822bff2e4272a00b3a632878266f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba547eb3ac564cf5bc3176aceeb2d680_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if78ac333a8f347ea8edf5c2f08bf8df0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8835dd209114523bb9e8a64833ef8ff_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47d31e10974947898926c5dcd4c0a95a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec7def734f4846fea024f404d1b6f52f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a8093dea57344778918ad7b5f751bce_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a611ec025e4fe6ac0191daf64556af_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4464ac83ed924822929712315bbc20be_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9a31395d02b44be398a13e91e3f5d44b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0632e32f05f944ccbf27e6259c5b238b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic645e61b77c341fab940f4bbab5081e8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb745cf587b4aee882556505e97108b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i363e9516fa95448388f9372a48406019_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c6e2f5995484ce7b6fa8a39920efa01_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i283089fe02a54c5b92e07efd341a571b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044fc58634da4848b1552fffbacd4a03_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic47a7731c378469ba7051e67d843a0e0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b0749afe2864e698e44179a9a3109aa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia50d0d8131d5462795581f189d2f1d14_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b12526fbc2445095fb01cac8a0200e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ca61745af34a4892fb24f02df51ce3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4cd1faa18234928a9a39c3bbf242061_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbd1f3cce2e5428eb21ef3b840688e1a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54e3cdbd09e6474bad78d5f7ae7c8d95_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4fbe575c144479f93f88f70cd2f64f0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbadb5bbe9c24d9aacd4015398fe5cb0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72a3a4c04f3d40f5a2832e1afe743ff6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4e8d24654e407fa0d279355277f975_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b08211082a3454893716f0969068c16_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95e73f78d584d03824f89f24d888618_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3996efae676460a9efe08f0472b97ac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefcec8bb3032434d9fab30ffede5b08b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08f528c9e5845f9a07f73e22be9e0d6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18fd7203ded848c0a6062cace377683e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5db99cba11444b8bdf61c2da7e49565_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b57287f98834cbca2dae9554a148b7c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d6b05ed9dff446597fbac8b9a5c2d2d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadafeb4cc83d4d8f830a67adc9b80fc3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02975ce7a7184746bad04769367d2d8a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89284fd7a0a14425a733d40a934ae931_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab197615130e49f98518a5172359cd51_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e11187b43e04a0093140e12fee973c1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd13afd135f940fbbf70581c789f8cf3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c502380d0d43a88063a06a16530a3e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0daf004372944a1bac9f844e1eef37d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60c105243a44ff2b52cb830ca3f0612_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9169f553a75d40ea8601058742b6ce6b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17529a19c854ba3a5b3782a119a6641_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e7fa915fa440fba6edada1d950d356_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6cbaca5036438d8e4b5fc144239335_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i469e373b8c0c43c2a5d70d03cf8bbd0f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ffbeab905e44cf92eeca09b81182f1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97e8d8a8b99d42c2827899164b67f836_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57248bec235b477e86c27bec023182d8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc90dd9b027a488592fd2345f76e07b8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06989fe731e041ec9c47378d113e9ba4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c91e9de9334c18b4886936541914c8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8924bcae1bc14f7ea6e74dd68cf95dbc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if285d2c4c39b48fea6ad28b9de16c7ef_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f53f70b2fc74581bf96fa47b43ca738_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0b0e9caa9844859a83f02b58ec38d1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa131e48ae9f404b915d24c15ada4467_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd593b0b41a4e759514f092f1f9e3ec_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6e717c6e6cf4c1cacf0ce093a7d1b51_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a3c6b6633454ca5abeba426ba6e1898_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i116991c09d6949c597cc44e8be8f1a92_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i977c59e776264b9e898cb3877c491df2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44895c20478e407d8960b3da61962bfd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f595a1c9de24b2d8b457b7d67db72dc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedc11b500619497e955129438d050806_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3b56267b5884c6b82c4eba0a047ea30_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd37b997bb634ad6af913ee6c81e67d4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id401e6b7bcfc481bb6f8a4e878338fe9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd87820edea446099b7bfa0e8c2239a6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69e12ae53554f31b7c4a41249056530_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605e7ce6614b44f98a3ad36551642783_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131e53046dba42e784ea6b9c4a34ebb0_D20180731-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-31</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e77d4115af8402f8e7c73bf41aa6d84_I20161223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799a546ec5224cf79c846d48840419b5_I20200501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39160baa532a49a3a841ba3506e61d34_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f213a904c342bc9d88379906d18608_D20200331-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i817593bab77d4c76bee489fbd71601e8_D20200331-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f336dee21354bffb60cdbdea5421626_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd85ff567e346758c47e5bf8e86f56e_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3c8e67aaa446f9b27da019f00dc7c7_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac78c7144eeb42a297b36f757e868180_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mygn:EighthShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f9212ac2aa140f8a16748ce2ea8a434_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfa07cb7aed64763a7a9f6f9ebf99038_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8531ebcd74e04283a1b94b983fa04b07_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mygn:NonEmployeeDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e56313342974e7382a91c90b4089dd6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe25ff804ef6473c900712207237104f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedAfterDecemberFiveTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8426764c4bf94a13a8f122cbaf9d20f2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedPriorToDecemberFiveTwentyTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d168ccbb6474a0bbbe80bbe0520d013_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7b2b333937b4d8ab126f4324d951eb8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc4477be5174638b6d2d9c390dc35df_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03913453337a4247aeed7aa0ba49835a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9ebc3017dbc42c68c8b36d9f7808984_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i935d96454093413f9b4072fbc7472673_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a60af6e087f4872829727b5a4666fd3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i692152fef23148a68888c9f3d749a1ac_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713e3bcca2f747c69452acd15600fa56_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica96d2399231445fa8ea26045d7379d9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7029214bab44cbb90983534da0be3e1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89373e9be2a0449893aabbe615c8f4d4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie481d4259b1e43cb9c6b7ea0cea96d16_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5e1f249221245de8a6c79eb95cdc6de_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3457c831a65d4dc386d66b85605c73bf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:MassachusettsDepartmentOfRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590b46ab6f6241c0854149f1703f3040_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b0b4b7980a4b0bae0e190d4c2adc80_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:MassachusettsDepartmentOfRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic84b54586f924efeb788832bba77a03a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c12ff8b2c1b4feca4bfe7d6b0767522_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia11bd3e88b394e2aaacc3f17950ab8a0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a4299d589f945d99e682d367f4fde51_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mygn:segment</xbrli:measure></xbrli:unit><xbrli:context id="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd70072490624e738ef4b03b84386198_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i35df2622b3a0423e9f409ac2173a31c8_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk1_fc8ba804-65d1-495d-abf8-08f4320c5c8a">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6YzA5NzA3NTA4Y2NhNDQxNzhiYTM1ZWVkNmIzOGEzOTQvdGFibGVyYW5nZTpjMDk3MDc1MDhjY2E0NDE3OGJhMzVlZWQ2YjM4YTM5NF8wLTAtMS0xLTA_919fe7c0-7b16-4527-b1e5-3f20262453a6">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl84MjQ2MzM3MjEwODkw_d166c704-1d40-4255-a426-a5c9bbed1180">September 30, 2020</ix:nonNumeric></span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6NGRkMWM5NzU5MzcwNDI5ODg4Y2NkNDMxYTU1OWY4NDEvdGFibGVyYW5nZTo0ZGQxYzk3NTkzNzA0Mjk4ODhjY2Q0MzFhNTU5Zjg0MV8wLTAtMS0xLTA_cb4dbfb0-ab2b-442a-83bd-26a88f640854">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number:&#160;&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAx_179d10ec-e7ad-4939-b9d4-21c1e2fb25af">0-26642</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk2_537d3f85-4a66-4a72-8e9c-cad1f92f9ab1">MYRIAD GENETICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________________________</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk3_bfcd3ec7-dc7a-4fff-a2b2-0eed75cc12a4">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of incorporation or organization)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAy_37ebfafa-3d44-423c-a4e1-a8166f517169">320 Wakara Way</ix:nonNumeric>, <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA2_bfe7b8e8-0488-47a9-93e0-0ccdbbecf668">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk4_2a62cb12-9dc6-4cf6-88db-9719b0bd2aa9">UT</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAz_98e0092c-cc1e-4e30-999e-9e33c174e54a">87-0494517</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(I.R.S. Employer Identification No.)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA0_e8dd6945-28ad-4a41-89cf-10da2b30be81">84108</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Zip Code)</span></div></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA3_5ffffa17-fd7c-4e6d-ae03-f57ab68a770e">801</ix:nonNumeric>) <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAw_16545646-c257-422b-bcf3-0f092cb63400">584-3600</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________________________</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6M2FmN2U3NDI0YzI5NGI3NmIxYWE3ODYzYjhhMDRmZTQvdGFibGVyYW5nZTozYWY3ZTc0MjRjMjk0Yjc2YjFhYTc4NjNiOGEwNGZlNF8xLTAtMS0xLTA_3ea1c8bd-d972-46f6-9f55-44f80ca56605">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6M2FmN2U3NDI0YzI5NGI3NmIxYWE3ODYzYjhhMDRmZTQvdGFibGVyYW5nZTozYWY3ZTc0MjRjMjk0Yjc2YjFhYTc4NjNiOGEwNGZlNF8xLTItMS0xLTA_ccaa2b88-6023-46d8-bb92-f4adefb9001b">MYGN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6M2FmN2U3NDI0YzI5NGI3NmIxYWE3ODYzYjhhMDRmZTQvdGFibGVyYW5nZTozYWY3ZTc0MjRjMjk0Yjc2YjFhYTc4NjNiOGEwNGZlNF8xLTQtMS0xLTA_03b2d4a2-10c5-4d0d-a031-5ef79da63dd5">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA4_f12edfc7-8b88-4720-aa8f-8f45a4e1ef02">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk5_fd7599ad-5aad-44c8-822f-a47ad807a0cd">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6Y2I1NGE1Yzk3YzAyNGExNmE4ZGMyYzA3NWVkZDgyOTYvdGFibGVyYW5nZTpjYjU0YTVjOTdjMDI0YTE2YThkYzJjMDc1ZWRkODI5Nl8wLTAtMS0xLTE4MzQ_45720c77-45c3-460a-8d73-2210acc9eea0">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6Y2I1NGE1Yzk3YzAyNGExNmE4ZGMyYzA3NWVkZDgyOTYvdGFibGVyYW5nZTpjYjU0YTVjOTdjMDI0YTE2YThkYzJjMDc1ZWRkODI5Nl8xLTMtMS0xLTA_4b495518-dcf8-4ff6-abc8-1389dd633cd7">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6Y2I1NGE1Yzk3YzAyNGExNmE4ZGMyYzA3NWVkZDgyOTYvdGFibGVyYW5nZTpjYjU0YTVjOTdjMDI0YTE2YThkYzJjMDc1ZWRkODI5Nl8yLTQtMS0xLTc2NjM_448b4b50-de63-408b-b436-aff0d4123b3f">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl84MjQ2MzM3MjEwOTE1_b4eb4cb5-d767-41f5-beb9-ea39549ce306">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of November&#160;2, 2020, the registrant had <ix:nonFraction unitRef="shares" contextRef="i912f7c983e734c25aaf08678ad9b5ec8_I20201102" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl82MDQ3MzEzOTU1Mjkx_9451f239-fb1f-4bea-8d86-b274dab82944">75,210,480</ix:nonFraction> shares of $0.01 par value common stock outstanding.</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:8.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_10">PART I - Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16">Condensed Consolidated Balance Sheets</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16"> as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16">September 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16">, 2020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16"> (Unaudited)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16">and June 30, </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_16">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_16">3</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_22">Condensed Consolidated Statements of Operations </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_22">for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_22">September 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_22">, 2020 and 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_22">(Unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_22">4</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25">Condensed Consolidated Statements of Comprehensive</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25">Loss</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25"> for the three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25">September 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25">, 2020 and 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_25">(Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_25">5</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28">Condensed Consolidated Statements of Stockholders&#8217; Equity</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28"> for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28">, 2020 and 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_28"> (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_28">6</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31">Condensed Consolidated Statements of Cash Flows</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31"> for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31">, 2020 and 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_31"> (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_31">7</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_34">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_34">8</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_121">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_121">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_121">21</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_145">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_145">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_145">27</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_148">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_148">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_148">27</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_151">PART II - Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_154">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_154">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_154">28</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_157">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_157">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_157">28</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_160">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_160">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_160">29</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_163">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_163">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_163">29</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_166">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_166">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_166">30</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_169">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_169">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_169">30</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_172">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_172">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_172">30</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_175">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i35df2622b3a0423e9f409ac2173a31c8_175">31</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_13"></div><div><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMi0xLTEtMS0w_ebea7f58-7fe8-44b9-80af-c52e654d629f">118.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMi0zLTEtMS0w_eb4352d6-7f13-4e44-897e-1e1e85ded5d5">163.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable investment securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMy0xLTEtMS0w_1bb2ad43-0a5a-4e21-9de7-13f53855e13a">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMy0zLTEtMS0w_1753ae01-1669-4e3d-b74f-5beffc798dca">54.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNC0xLTEtMS0w_9985f199-cc8b-4b5e-bc0f-6492d11d3378">12.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNC0zLTEtMS0w_5c342c66-2d45-4f4a-a065-8e21106ebc65">13.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNS0xLTEtMS0w_48e88af2-0592-4bbb-9e09-dff3138ca5ee">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNS0zLTEtMS0w_474ef2f1-7f0c-4f78-a9a4-904b7200fbbc">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNi0xLTEtMS0w_a8cd2459-3eff-4c10-ab61-9b60fd878060">85.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNi0zLTEtMS0w_155158d9-3df6-4131-88ea-1067d117c088">68.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0xLTEtMS01Njky_a9dd5bed-43f4-41a5-acd4-f8e17e33c20f">107.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0zLTEtMS01Njk1_96eeca0a-7f98-4e53-b114-1cf14b8d33b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0xLTEtMS0w_d5c4b1e6-7c31-4dbb-a4b3-293b06dab62f">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0zLTEtMS0w_08e807b9-9c9a-4a29-b1ae-5e13ca8038af">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOS0xLTEtMS0w_bf00166c-fe27-4841-93fe-0676cdc5eeb2">394.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOS0zLTEtMS0w_0ed34614-207e-4fd5-8bf5-a6eaaa54934f">331.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTAtMS0xLTEtMA_aec3f1c9-03c6-430f-b9d9-ad62e655f529">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTAtMy0xLTEtMA_4f1541d4-dbf8-4aac-9118-2d52b66b46ea">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTEtMS0xLTEtMA_b850a53a-80b9-4611-b21b-36c710c40319">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTEtMy0xLTEtMA_ec1fda17-7ed9-412b-9f90-f1c72a971b69">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term marketable investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTItMS0xLTEtMA_b6b320b9-4a43-4cbd-bfe2-280a6a74c2e6">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTItMy0xLTEtMA_020a7e2d-a940-497b-ab75-9093c56b2f00">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTMtMS0xLTEtMA_ed7e10c0-bd9e-4404-ad01-75147c78de1b">590.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTMtMy0xLTEtMA_a5390655-44e7-45cd-ad8c-fddd6d31ce0a">605.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTQtMS0xLTEtMA_b2681238-5a28-4381-9e3b-3f21ff47e988">328.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTQtMy0xLTEtMA_fd81f306-f800-41e0-aa75-1a1d42f1eb65">327.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTUtMS0xLTEtMjY5MQ_da02a5af-9e1d-4348-a93f-6a520e7bd866">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTQtMy0xLTEtMjg0NQ_fcd37adb-25e6-4403-9e31-deabf89c8b89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTUtMS0xLTEtMA_7927ce78-19a3-4a99-9d2e-1a488f498ed3">1,444.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTUtMy0xLTEtMA_9080f26e-02cb-4fda-b50b-01e1853d68be">1,404.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTgtMS0xLTEtMA_076a38a9-83eb-46b9-81b3-cc4bd4a650e7">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTgtMy0xLTEtMA_e75846bd-666d-4dd7-b5ba-7bbbf4f3d58a">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTktMS0xLTEtMA_098f9ed8-8fca-4b68-a55e-27ea23df8dea">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTktMy0xLTEtMA_aa8a34db-2ea2-4112-bee3-24209c7dffc4">75.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current maturities of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjAtMS0xLTEtMA_807bb62d-dbb8-42e5-a76a-a33142fcd94d">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjAtMy0xLTEtMA_b68c80b2-d438-4fa5-ac01-fb468f285c59">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjEtMS0xLTEtMA_a5f7e12d-7f9d-4fab-b8bf-b3805a97c6c5">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjEtMy0xLTEtMA_2ba6642d-c960-42ee-b118-911ed45cbedb">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjItMS0xLTEtMA_026e9220-2d0c-4966-bbf9-e2b29cf559a1">32.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjItMy0xLTEtMA_d23cbda7-4883-405f-b59f-d521d11a4604">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjMtMS0xLTEtMA_d28b9019-9343-434e-a404-488e76dc48d3">133.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjMtMy0xLTEtMA_2c39ef2a-2bb5-46c3-8b7d-d7c26439836f">147.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjQtMS0xLTEtMA_80eaaa75-c860-42d5-89db-746ed64c1a83">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjQtMy0xLTEtMA_dcb31311-7fcd-48a5-9156-bc12929cedc4">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjUtMS0xLTEtNDk1Mw_4cb14504-5cd9-4425-b08e-81a8fa33719e">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjUtMy0xLTEtNDk1Mw_ee69b618-83b6-4aba-93d8-cf8b6fd0e8ce">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjgtMS0xLTEtMA_f003ce32-bb93-4d87-b6bb-ab2429a3a232">224.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjgtMy0xLTEtMA_512a8573-a5f8-4bde-a127-77b0e30a66e9">224.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncurrent operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjktMS0xLTEtMA_fea75a61-cecd-42f8-a87c-a6b0ea1fce10">53.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjktMy0xLTEtMA_d5a9f356-1361-47e3-ad25-6384132555ae">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMS0xLTEtNDk3Mg_2b6a1ed3-2d08-4f38-855a-cbe2f385846b">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMy0xLTEtNDk3Mg_1783f457-a5df-408c-9168-e60ffcdce1e6">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMS0xLTEtMA_7b5dc410-78ef-43e4-b44a-d40ce91a81cb">535.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMy0xLTEtMA_8178ea18-2401-4567-8f72-e2339d83db72">486.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzEtMS0xLTEtMA_0c9619df-3f18-4878-8406-80b10275a52e"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzEtMy0xLTEtMA_0edb2cc3-be0b-4c8b-98eb-a8f18a2d9f82"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, <ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMC0xLTEtMjkyMy90ZXh0cmVnaW9uOmM3NzcwOGIxZTQ1YjQzMWM4YTk3ZTIxOWUyZmRiY2Y5XzgyNDYzMzcyMDg0Mjc_3a27fb3b-ba99-4827-9496-aa0608d3188e">75.2</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMC0xLTEtMjkyMy90ZXh0cmVnaW9uOmM3NzcwOGIxZTQ1YjQzMWM4YTk3ZTIxOWUyZmRiY2Y5XzgyNDYzMzcyMDg0MzQ_e97c5a82-896f-480f-99a4-bcc6c689d98c">74.7</ix:nonFraction> shares outstanding at September 30, 2020 and June 30, 2020 respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMS0xLTEtMA_dc07247b-cfbf-4efb-8528-62d737ec5c87">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMy0xLTEtMA_7f3983c7-20ba-4f4d-8f95-827f1b41a7b7">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzQtMS0xLTEtMA_b7812de2-0333-47cc-b49b-c463286fedf3">1,101.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzQtMy0xLTEtMA_c68d4f5b-75c5-4376-abf4-753321ef03ce">1,096.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzUtMS0xLTEtMA_785b2f39-ce65-4538-825d-066f6caff453">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzUtMy0xLTEtMA_b30f6e7f-1394-4879-bd02-94410cb10185">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzYtMS0xLTEtMA_f7c81c37-637f-4611-a176-67a8c2067143">189.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzYtMy0xLTEtMA_2a19c152-6062-43e3-8432-27dd02c02e4f">173.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Myriad Genetics, Inc. stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzctMS0xLTEtMA_1f06f8b7-43c2-47eb-8b1c-9343dbf83aaa">909.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzctMy0xLTEtMA_5e783edd-5ab4-496b-99de-a17094b9382f">918.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzgtMS0xLTEtMA_e841b8b8-6e0a-4ac0-88cf-0daf3998e09f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzgtMy0xLTEtMA_70f55906-fbca-4e50-b59e-76a722b00808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzktMS0xLTEtMA_c9432184-0846-49db-a997-a5f58c083535">909.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzktMy0xLTEtMA_cef37cc4-051b-4265-8ca5-4124a7e50f1f">918.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNDAtMS0xLTEtMA_a2fdbb48-975d-4877-8c6d-fbc06c360319">1,444.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNDAtMy0xLTEtMA_05d109df-1ddb-48c5-a4c2-8429af4f6fc7">1,404.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Operations (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:76.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMi0xLTEtMS0w_43f9dab0-3eb7-4123-9316-1b9be521a754">135.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMi0zLTEtMS0w_37fdb709-5013-436d-a3fb-b3e8bcfad59e">172.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMy0xLTEtMS0w_3e3213f0-a21b-4d75-8ac9-aa79cccf48a4">9.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMy0zLTEtMS0w_f23baebc-8aba-4dc7-9a3e-3eff4b5bc9b4">14.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 54pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNC0xLTEtMS0w_4ab76a58-a3ae-4e58-adb9-67ee12276af3">145.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNC0zLTEtMS0w_a32e1f7b-f6af-4e2c-ab8a-04ef149a6c95">186.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs and expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of molecular diagnostic testing</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNi0xLTEtMS0w_d2fb2c6e-c5cf-4d57-b534-14bc54fb17fe">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNi0zLTEtMS0w_75b2ca28-a604-4152-b220-ce061c38a257">41.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNy0xLTEtMS0w_14a0ce61-fb9f-437b-a670-bef637afabeb">4.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNy0zLTEtMS0w_e4f0f4da-6a9c-42b7-8d7b-dc4df694904b">8.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOC0xLTEtMS0w_d65087f9-71d4-4645-98e9-5b7016dd471a">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOC0zLTEtMS0w_3f4b179f-bb1d-4b87-a58e-11f2b420ba42">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in the fair value of contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOS0xLTEtMS0w_1b9fda2a-c0fb-4270-90fb-fa0f750c7bd6">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOS0zLTEtMS0w_747fe2ce-d110-4d20-bfdd-18cdbf88a2ce">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTAtMS0xLTEtMA_4e7fbb3e-833d-4626-b2cf-6c9f93372b5e">124.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTAtMy0xLTEtMA_c080f326-3d0e-42c2-b4f7-f64ecb3b42d2">135.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 42.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTItMS0xLTEtMA_c23e392a-3c12-4385-9ef5-19a698268f28">184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTItMy0xLTEtMA_b90fd22d-2b0a-41ac-b042-0a3c1d3ace2a">207.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 42.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTMtMS0xLTEtMA_0ece6648-794c-40ff-9146-6e132ce8f3bf">39.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTMtMy0xLTEtMA_13aab9dc-a359-4831-a2b9-e916e89136be">20.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTUtMS0xLTEtMA_520ef652-189b-4d3a-8a6f-8810e9b8ea7e">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTUtMy0xLTEtMA_f81c4fd1-d2f9-41ba-b27d-3cfbe0c83e3e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTYtMS0xLTEtMA_350e288f-a2b1-4273-89ee-f8d4e4b201e2">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTYtMy0xLTEtMA_555d3df2-204b-4916-9e02-e7e974735b98">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTctMS0xLTEtMA_5d09fa39-292f-493f-b37f-d3bd5d92054a">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTctMy0xLTEtMA_3fe3c814-d537-4782-a3f3-beb8f2f3be91">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTgtMS0xLTEtMA_ac8d926a-b37c-4760-85eb-c56f623dd851">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTgtMy0xLTEtMA_946f4325-a50d-44e1-bc50-0e764f9d71a7">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 42.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTktMS0xLTEtMA_85ffb759-c275-4f6a-a2d0-02aa7bc1d226">43.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTktMy0xLTEtMA_6150a651-3ed4-4502-b515-4224105f8831">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjAtMS0xLTEtMA_71316029-bf41-4b46-99b9-f2a96e620026">28.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjAtMy0xLTEtMA_cf2c0810-eb38-405f-a85d-6dbc115cc1c7">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjEtMS0xLTEtMA_5d096ba7-06b1-4d79-b573-68d26a52f794">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjEtMy0xLTEtMA_881e54a1-d2d0-410c-9089-7e3eeec78779">20.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjItMS0xLTEtMA_ce8395dd-ea92-4dd8-9a71-cc950e43813d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjItMy0xLTEtMA_d0c2de83-ffdc-4148-98d3-5ede0cacbe06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics, Inc. stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjMtMS0xLTEtMA_38623ca0-f9c4-4bcf-aa3f-e1a091ff26ef">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjMtMy0xLTEtMA_02c6d265-9b68-4ae1-a8e4-11ab5a371a0d">20.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjUtMS0xLTEtMA_b50845bd-f9dc-4e9e-b799-493d9c970226">0.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjUtMy0xLTEtMA_43ac0a91-c804-4ec0-ab6c-ca1ad278f5eb">0.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjgtMS0xLTEtMA_de120159-b4b1-4546-af80-e89a75c3b1b4">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjgtMy0xLTEtMA_d9cee638-351e-49ce-8cb4-230c4d054df7">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:76.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.717%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics, Inc. stockholders</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMi0xLTEtMS0w_3e0b0bd6-7ce9-4c4e-849d-7d9fa2acaa12">15.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMi0zLTEtMS0w_b0422e9d-166b-45ac-a044-5311f68827a3">20.6</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on available-for-sale debt securities, net of tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMy0xLTEtMS0w_d838ef3a-d9da-4c1c-a753-7a09383c9a24">0.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMy0zLTEtMS0w_193e097f-ee1b-476b-a496-dd0fe6990924">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in foreign currency translation adjustment, net of tax</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNC0xLTEtMS0w_2c904c32-58d2-4a41-a0fb-34965d2002d0">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNC0zLTEtMS0w_7a22d8d4-ee58-4313-8f76-c4d75b1074eb">2.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNS0xLTEtMS0w_19b49658-c611-4cd1-8ad1-60a3a069e07e">13.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNS0zLTEtMS0w_cd0ce758-7020-4e88-a2e5-34ae9e34688d">22.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNi0xLTEtMS0w_1cde374c-fcad-4988-8612-f1b3b197bd41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNi0zLTEtMS0w_deffc74e-7de0-4c25-9e1d-a6f2657a6b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss attributable to Myriad Genetics, Inc. shareholders</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNy0xLTEtMS0w_19d47660-86bf-499b-a7ac-b8a513796d2d">13.6</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNy0zLTEtMS0w_ffa3323f-b2d4-4088-89a4-661086d17663">22.8</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:34.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common<br/>stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Retained<br/>earnings<br/>(accumulated<br/>deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Myriad<br/>Genetics, Inc.<br/>Stockholders&#8217;<br/>equity</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BALANCES AT JUNE 30, 2019</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0afd5266f1674cd890c5e822e8608051_I20190630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS0xLTEtMS0w_06c4d5df-d788-42eb-ad3d-9cf12b45a61a">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i60c68c3b6a064506b03ca32fad5428a0_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS0zLTEtMS0w_7969d6d7-b6b2-4aa0-bac2-cf504205fae1">1,068.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6b5f2e721cba4626be7e73ae2f98f5be_I20190630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS01LTEtMS0w_afffb658-d670-4d7c-a642-6ef483ee19e2">5.4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i645c55a2b3c240cc83b60c6876b52044_I20190630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS03LTEtMS0w_b001151e-45ac-46f6-b714-7c5b95cc9be4">25.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i139906c1954e43c39560efe073ca515b_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS0xMS0xLTEtMA_46dc51f2-343d-4e51-b692-3f50c21ffb78">1,088.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0e44f0801a764c629e60704da55af897_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMi0zLTEtMS0w_16ef7d04-5e4f-4422-bdaf-cf57fb9462d4">0.5</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMi0xMS0xLTEtMA_8755ec5b-9277-41c9-8394-e87738ea8148">0.5</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based payment expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e44f0801a764c629e60704da55af897_D20190701-20190930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMy0zLTEtMS05MQ_8948ba4f-e697-444e-ae38-60c4dceed572">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMy0xMS0xLTEtOTE_e217d5ae-e3fb-48e2-9749-f081e38742a6">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i74aa2b09d6d7450b992f13f174e86815_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNS03LTEtMS0w_0570061d-07e4-4fe6-b86e-b0d5edac43ac">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNS0xMS0xLTEtMA_35a4771a-ec1a-4c73-8817-fffcb2d800e0">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5c0dc32b94684fb9a72074a4467ddbb3_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNi01LTEtMS0w_331cf889-6340-471c-b912-0925cb32ac73">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNi0xMS0xLTEtMA_433bf0ad-3df6-4bce-b866-884aee0023a6">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BALANCES AT SEPTEMBER 30, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iac1b61b427d34cd1aee1ba7384109a9d_I20190930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy0xLTEtMS0w_a9cd8610-4e7a-451c-b674-f0203b4fd344">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i091efe167f3c4e1da67fb808d46a17cf_I20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy0zLTEtMS0w_86e6890e-f880-49dc-8ce3-8dc496f2a268">1,076.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iacae5069b54f4a67b0357cd8ef5efb1a_I20190930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy01LTEtMS0w_f987a6e3-d480-46e2-a0cc-ad5fb7dc47ff">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i25198efed29e4e92b99f0262f821c2d3_I20190930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy03LTEtMS0w_8031fcae-9d02-4fb3-85e2-b0e68278efa5">5.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61a8af6463ab4c92ba4435534752e1a2_I20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy0xMS0xLTEtMA_5fbac2ae-0106-4a28-9f3e-f841b957b1d5">1,074.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BALANCES AT JUNE 30, 2020</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7ccc458b8fab4e1aaf73e23ed8876645_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtMS0xLTEtMA_c646620a-370d-4ca3-9863-a977573dd123">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib1b31638ad944d72af7bea5c92686dee_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtMy0xLTEtMA_2e48c2d3-10c4-49e5-9657-ce9755842c23">1,096.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i005afd72b0d346de9ebc794edf8af44d_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtNS0xLTEtMA_e13fd696-debb-491f-8d81-7090cf8eeaf6">5.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if3201828072042f8be79031422bab5b1_I20200630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtNy0xLTEtMA_5fe86b3d-f4d0-4ca1-9bae-342af6fa5373">173.9</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtMTEtMS0xLTA_dc7b3844-9ec0-47ba-9c3e-9595858ce17a">918.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8725d74790d48458cfdfa6233888a31_D20200701-20200930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjEtMS0xLTEtMA_1b295d6d-309b-43c4-9434-3fe9e0b3ebf2">0.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i82a7856a26e14144a676ceba1c64446a_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjEtMy0xLTEtMA_232e6c5f-ae63-4f78-bf79-c6408a9856aa">3.8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjEtMTEtMS0xLTA_4a55ea71-ddab-488d-b751-efc02b9d394f">3.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based payment expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i82a7856a26e14144a676ceba1c64446a_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjItMy0xLTEtMA_1c476a60-e0e4-4166-96f2-93e33138993c">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjItMTEtMS0xLTA_07d07afb-ca38-4007-9b23-71092f1b43a8">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iaedb6702dab54acfb883a731f04b482f_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjMtNy0xLTEtMA_5790a06d-bdf9-4110-8e98-976736729c0b">15.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjMtMTEtMS0xLTA_c49d69d8-75fd-4199-a448-e3c98cf1dfc5">15.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2efecfeca2f34c238cfefcdb778c6425_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjQtNS0xLTEtMA_f3f44ec3-3449-4159-8e3c-524ee7528d06">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjQtMTEtMS0xLTA_20c1d2e9-29b6-499f-8a73-681b2108fd41">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BALANCES AT SEPTEMBER 30, 2020</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i160b5ebaf0a348a6bf32eaa61276f655_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtMS0xLTEtMA_9f51c9c0-96a7-402e-9f4c-a6c9ecb71639">0.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i877b14486ab2428ba1f01ad23fccb179_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtMy0xLTEtMA_6eae638d-b0cd-4813-843d-10bfb2be3399">1,101.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i64095d8f93a94fbeb281e9c293c679a9_I20200930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtNS0xLTEtMA_c55de458-e2fb-4fc2-94b1-4cc09cef291b">3.6</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i055da3a2d6c44d7597f0360c7843f5ff_I20200930" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtNy0xLTEtMA_23bc42a2-baff-477a-bb3f-9992cf3819ef">189.1</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtMTEtMS0xLTA_8ee7c9a1-3b19-4491-b91b-f3b466d4a2cc">909.3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics, Inc. stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMy0xLTEtMS0w_45f693fc-c05a-4346-9efe-e3556ae8cdba">15.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMy0zLTEtMS0w_f9a19f35-5e08-4d9b-bbbf-c766f56f8795">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNS0xLTEtMS0w_a366ccf3-fab0-4fe5-be1f-9f30ce44a67b">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNS0zLTEtMS0w_25a71d41-3bd1-4310-b2dc-289cf5912e7f">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="mygn:NonCashInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNi0xLTEtMS0w_04826be0-4a26-4172-9ad8-29e10d44adc4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="mygn:NonCashInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNi0zLTEtMS0w_d0e1b5b5-1acf-45cc-8f86-77c5d38cb7ad">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNy0xLTEtMS03MzE4_00ffe859-2a57-479f-8924-2d91d385b934">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNy0zLTEtMS03MzE4_55ab2992-d696-48c5-9bfc-e3a57ef374ff">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Loss (gain) on disposition of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOC0xLTEtMS0w_e89dcf40-8fff-4c9d-a3d4-9ecbbb6e614d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOC0zLTEtMS0w_1fc7a18c-d745-4525-97c4-e7d452833307">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOS0xLTEtMS0w_46d1a360-70fb-416d-9a4c-2f760293b3d8">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOS0zLTEtMS0w_57823db0-93a5-4ada-900c-22e7af8d86f7">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTAtMS0xLTEtMA_da29d64d-35bc-440b-837c-72fb80595c8e">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTAtMy0xLTEtMA_8dbc841e-3cda-449c-bd5a-6dc224d0ec24">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="mygn:IncreaseDecreaseInUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTEtMS0xLTEtMA_d366cb51-a4b8-468b-b9f1-258836619377">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="mygn:IncreaseDecreaseInUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTEtMy0xLTEtMA_3d6a04f0-6ec2-49de-8e84-76584648e41b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="mygn:ChangeInFairValueOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTMtMS0xLTEtMA_f43b0864-18c5-40ef-abe2-9c7ce0b26255">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="mygn:ChangeInFairValueOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTMtMy0xLTEtMA_40f6a15f-6570-4c63-be1b-38bf7396655f">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTYtMS0xLTEtMA_e37965db-2436-4915-b266-74db76aed60c">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTYtMy0xLTEtMA_73a2e2bc-a7dc-4d42-905a-51d01530e57c">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTctMS0xLTEtMA_2701956f-a351-4c35-a381-072bc9cbba92">17.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTctMy0xLTEtMA_fea84b84-1935-4d62-9c0f-5fbbfa890a84">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMS0xLTEtMA_71a04dc4-e40e-40eb-b77a-07d5c204233f">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMy0xLTEtMA_67238a9b-c844-43d4-a170-64a6c19e8269">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTktMS0xLTEtMA_e528259f-ac66-46c3-921d-2ff035aaec44">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTktMy0xLTEtMA_2ab04ffd-f7e0-4289-a490-b0cbe2b54f4e">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepaid taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjAtMS0xLTEtMA_c8a6a200-1d90-4006-8967-09233564e74d">107.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjAtMy0xLTEtMA_ec873007-0cbd-429c-a15b-953f5a44bf2e">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMS0xLTEtMzgzOA_0c2584b4-c6e4-4777-9029-cab85875085a">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMy0xLTEtMzkwNg_50c59fc4-18cd-45d2-a198-d249ab52c1b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjEtMS0xLTEtMA_df689fcf-395c-4a62-85d9-cc62bbcd4d01">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjEtMy0xLTEtMA_862479a7-ae4d-48e9-8697-eea36ac47de2">9.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjItMS0xLTEtMA_1b99930f-e6ef-4022-b4a2-ff773e72edb5">9.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjItMy0xLTEtMA_caee9b80-6a78-490c-9ad1-8fe9ede03966">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjMtMS0xLTEtMA_09d145dd-982e-435c-8552-a27083f99a38">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjMtMy0xLTEtMA_cedf02bb-636f-4286-b310-26e5ed4e85fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjQtMS0xLTEtMA_4714a8d0-0599-4aad-bebf-968f4a37cc25">59.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjQtMy0xLTEtMA_7304f4f4-ae84-43d2-941d-bcc41339a166">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjYtMS0xLTEtMA_1cc42304-0bd5-4cb3-a2e9-16453e1f9ffc">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjYtMy0xLTEtMA_79b5a4bf-a48b-4265-abe6-85650a0313ed">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchases of marketable investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjktMS0xLTEtMA_578fca73-883b-4eda-ba99-6ef9a418a31e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjktMy0xLTEtMA_6f37040e-a931-4f2b-8b6b-38933c62cb4d">23.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from maturities and sales of marketable investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzAtMS0xLTEtMA_a7a051b5-1b19-4620-994f-49c6d0ac4eb6">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzAtMy0xLTEtMA_356cd64f-b697-448f-8fc3-3307f16a3f3a">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzEtMS0xLTEtMA_cb39a64d-925d-401d-8289-a1635b2bad79">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzEtMy0xLTEtMA_016e6c7c-a4c8-4304-8f7d-565c08a924a6">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payment for tax withholding for common stock issued under share-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzMtMS0xLTEtMA_a5c8da4a-662f-41cd-8a8f-70293c17e98f">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzMtMy0xLTEtMA_08b2f09c-9f6d-4609-a0b0-49f1068e3d93">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payment of contingent consideration recognized at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzQtMS0xLTEtMA_e187c4fe-0ed2-465d-a9eb-f55ffd45da4c">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzQtMy0xLTEtMA_890383c9-70c9-4ff2-9377-4ebcd1226647">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Repayment of revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzYtMS0xLTEtMA_28baf386-8661-496a-80da-9f6c29690c88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzYtMy0xLTEtMA_131fa92a-d418-4018-9473-3fd9f735a499">8.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzktMS0xLTEtMA_051771e6-fc86-4a42-a5b5-2ac476d434ed">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzktMy0xLTEtMA_d7d0752d-7e29-4771-bd1d-35dddd04bf98">12.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of foreign exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDAtMS0xLTEtMA_111fdaf6-e2aa-4fe2-bc8c-0e58b1fd39ad">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDAtMy0xLTEtMA_66c488b8-eb76-498b-b564-1ba60ac8f0aa">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDEtMS0xLTEtMA_88a9a847-1063-4407-a60a-7e75acd0d0f8">45.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDEtMy0xLTEtMA_cff7a99a-ce8b-4221-82e2-3f91d1c07fc4">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents at beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDItMS0xLTEtMA_ddc2bd66-2450-4f9a-9d56-9778556a2963">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i139906c1954e43c39560efe073ca515b_I20190630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDItMy0xLTEtMA_d518b4e3-25c8-4192-bb8f-a56aee4b8ecd">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents at end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDMtMS0xLTEtMA_c76feb09-a267-4842-b724-e0c91f3d8aa2">118.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61a8af6463ab4c92ba4435534752e1a2_I20190930" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDMtMy0xLTEtMA_dbdb9f36-dc86-44fb-a983-848848f35142">89.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_37"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zNy9mcmFnOjZlZDE3NWI4Yzc0MTQ2NDZhOTJkN2Y3ZmJkZTY2ZGIxL3RleHRyZWdpb246NmVkMTc1YjhjNzQxNDY0NmE5MmQ3ZjdmYmRlNjZkYjFfOTk3Ng_c0d04fa1-fa8c-437d-9119-9a0a4addee15" continuedAt="ic73754f83d7e46cbb10419dd35cb1518" escape="true"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zNy9mcmFnOjZlZDE3NWI4Yzc0MTQ2NDZhOTJkN2Y3ZmJkZTY2ZGIxL3RleHRyZWdpb246NmVkMTc1YjhjNzQxNDY0NmE5MmQ3ZjdmYmRlNjZkYjFfOTk3Nw_a50e16cb-a3a6-4abe-acdc-b54e52ebdf77" continuedAt="ie78e5a8b8bc947429706203fd3e10085" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ic73754f83d7e46cbb10419dd35cb1518" continuedAt="i03ba288eb6d04b3a86593381035c10d0"><ix:continuation id="ie78e5a8b8bc947429706203fd3e10085"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements for Myriad Genetics, Inc. and subsidiaries (the &#8220;Company&#8221; or &#8220;Myriad&#8221;) have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). &#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Operating results for the three months ended September&#160;30, 2020 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full impact of the COVID-19 outbreak continues to evolve and its future impact remains highly uncertain and unpredictable. As such, it is uncertain as to the full magnitude of the effect that the pandemic will have on the Company's financial condition, liquidity, and future results of operations. Management is actively monitoring the impact of the global situation on the Company's financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evaluation of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced seasonality in our testing business. The volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, the quarter ending March 31 is typically negatively impacted by the annual reset of patient deductibles. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders&#8217; equity, cash flows from operations, or net loss for the period.</span></div></ix:continuation><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zNy9mcmFnOjZlZDE3NWI4Yzc0MTQ2NDZhOTJkN2Y3ZmJkZTY2ZGIxL3RleHRyZWdpb246NmVkMTc1YjhjNzQxNDY0NmE5MmQ3ZjdmYmRlNjZkYjFfODI0NjMzNzIzODgxMg_9dd6f685-4193-433e-a9f9-e922937a0273" continuedAt="i62981f47c751431c97965b87bad3c710" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Standards</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (the "FASB") issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326) (&#8220;ASU 2016-13&#8221;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company is required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are also recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, Intangibles &#8211; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU 2018-15&#8221;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="i03ba288eb6d04b3a86593381035c10d0"><ix:continuation id="i62981f47c751431c97965b87bad3c710"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements as of September 30, 2020. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of the other assets financial statement line item in the consolidated balance sheets.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards Effective in Future Years and Not Yet Adopted</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact this new standard will have on the consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i35df2622b3a0423e9f409ac2173a31c8_40"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIxMTg1Nw_e92e3f5d-91df-40d4-b13c-6432ae080b66" continuedAt="i59b0bc696e2848be850e9f7718189acb" escape="true">REVENUE</ix:nonNumeric></span></div><ix:continuation id="i59b0bc696e2848be850e9f7718189acb" continuedAt="i7a444608f06f433e94b61ab4b08e4535"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated amount of consideration to be received. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.</span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMzUwNA_c79ee56d-6d2b-4703-b903-16db87c85688" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents detail regarding the composition of our total revenue by product and by U.S. versus rest of world, &#8220;RoW&#8221;:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:31.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RoW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RoW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie1795c5c48c34f16b22b8ae598cdd22a_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC0xLTEtMS0w_c217d711-1f54-442e-981b-6e2dae32405b">72.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id178ba580c6f4185bc51f217377478d5_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC0zLTEtMS0w_c74e9516-2679-4862-ba11-ea4f8bcad575">8.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifcedbfd8cc754e8492395b6e8c733e64_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC01LTEtMS0w_2efdc777-bf6d-470a-adc1-c75cb94cea5c">80.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9bfb911643b349c899f841b445e06512_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC03LTEtMS0w_273286c1-c7fb-4153-af41-224c86d6c2c0">100.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i422deb02b92f488ca820658db810b31a_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC05LTEtMS0w_4a46845e-e412-444a-b58f-295191f0c105">3.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i401a6d1f82534405a2c00ba1f907da60_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC0xMS0xLTEtMA_9ec210f3-dbe8-4ddc-a73c-1aa58d278c78">104.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb347fa85ae744768f8361fb2ca325eb_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xLTEtMS01OTMy_885921f5-0d37-404d-9a8b-d3e38c6fa962">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i200b85a83c6a46bbabdea8dcc39d8562_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0zLTEtMS01OTMy_94426a0e-bbff-4304-9a9d-278c26d59db8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic51c9413854143499e5aaf57989d7eb7_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS01LTEtMS01OTMy_ac60ee18-6d7f-4b07-a663-3eeb666bee0f">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3348c1dccc754570a3090cd6065878a9_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS03LTEtMS01OTMy_fa435c10-ec37-4203-a968-c1f9f3e46c53">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7687ee73ec6a4a2fb7d9c3c95f5ed679_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS05LTEtMS01OTMy_d37c40b9-2793-4140-b32f-129653507f64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08483a8a185e4dfb9ae69070970276d7_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xMS0xLTEtNTkzMg_2c469acb-737e-4156-9e89-b271e338b18a">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeneSight</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i951685b4432940a2b6070e5ae3bd49a5_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xLTEtMS0w_1ee750ec-8f51-46c9-b051-72031c467905">11.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6744579210784fdeb06463912c24a193_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0zLTEtMS0w_0ed729f9-77c0-4c7e-9c00-ff448fcfb3b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7fd0de429b834c25b696cffe376cd572_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS01LTEtMS0w_0cada45a-8e82-4e13-8be6-23072a0d901c">11.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8769527161654967b1c9d612b500e5bf_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS03LTEtMS0w_0e97af6b-e5a4-42ff-ba24-91065c09cc8c">22.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7219c652fa40129553545f083b6ffd_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS05LTEtMS0w_dbeea1fd-a210-4281-afb7-b8ccbf5eaf6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i45fc867c897b4386aeaf67795c276626_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xMS0xLTEtMA_5aa08e81-e405-45ae-a022-da0dd5ad0576">22.7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vectra</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9fad8fd2ba87493e8cae157d3442bae9_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy0xLTEtMS0w_1594ad78-3466-4a80-a39d-a357c81990c7">9.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfa2d578a84425184f03060039d64fd_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy0zLTEtMS0w_99d80845-1d23-4414-aadf-aa4faf97e5ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic2742d972b9a4d7fbbde1e0bbed5c74e_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy01LTEtMS0w_46edc309-107f-4ce7-93ed-4edfc0b66f6d">9.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74596ec49a7a4ebe83e5358874b6f8b1_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy03LTEtMS0w_27932156-c7f3-4f04-97db-e5d327b53667">11.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3644e7dfea0400597ac774c4595f9c1_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy05LTEtMS0w_7e55b564-2519-4b62-835b-6ea70a11bd4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia3668121649b4395acd610e7f38044b8_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy0xMS0xLTEtMA_2ff13c18-bed4-49ea-85f0-78b44efddbde">11.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">myChoice CDx</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id62e373c9cfa4d13b74004a4f087e81d_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xLTEtMS02OTM3_b4099d60-e04d-4075-a150-c51889b16ca0">7.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af57be3ac8745b59d1c5c8f835c759c_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0zLTEtMS02OTM3_46ee6a1d-40fd-4b82-b7c2-efc7604a68a5">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibca7cd2a9ed64068a730c3d0940649c7_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC01LTEtMS02OTM3_d843d940-fec6-4b1e-9f7e-d72e65989dc5">7.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if2228b67d6e046568399abed69752b24_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC03LTEtMS02OTM3_0f12cce3-1c16-4876-ae93-432dfb08d33c">1.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0b089eccab490aa3d7e32307f073dc_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC05LTEtMS02OTM3_3a9b09a4-cd60-453d-9292-c294e1b07e6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7cc249590a16407aa43f1bcdf46a5e5c_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xMS0xLTEtNjkzNw_0261e9b0-f196-4a86-81ec-a49b4d2e4f7d">1.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prolaris</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5dad84e61a5648f68b1f50c0b983bede_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xLTEtMS0w_8d2a1f6f-baa1-46bd-a9da-5e9105501178">6.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7033a2b43a11471a8ee110193d73fa2b_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0zLTEtMS0w_7c35304e-964f-4011-a0a9-31a3c7c16f67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i22d3d58394a04580baac5d76d025fa35_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC01LTEtMS0w_a9ff9555-d44b-48f1-9137-2b0e6addc71b">6.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2bf5e0d1693441a18f30a9d95fe4163b_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC03LTEtMS0w_831b4407-dce0-4bc3-9e79-4afe1b0b854e">6.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67246cad5fa34d69b25bfc809dd1c777_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC05LTEtMS0w_c040bb99-fcd9-4b67-942a-011f2772eeff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i567a2a9416d34f3c92557d9422f0348b_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xMS0xLTEtMA_0593ec18-8790-4bc8-9403-e4437b4ddf59">6.5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoPredict</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8ebbd429b95f49139bb9281a342136de_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS0xLTEtMS0w_85abee2e-8a0f-4cb7-a28b-e03216981c54">0.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i484f743506ee4902aef30c20d43aa898_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS0zLTEtMS0w_34479753-4231-4c4f-b47a-0105dc153ceb">2.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i280ce449a5d6421ca8511c92eeddca0a_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS01LTEtMS0w_ecfd8ee5-423a-47c0-abd0-615f05075278">2.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i605a9571af9c4c29b51405c5fa8a5180_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS03LTEtMS0w_83982864-5e85-4d2d-ae54-d4d96792fc9c">0.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8720515f7754cf1bb2ae4218d464c2a_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS05LTEtMS0w_6c22d4ce-3982-4783-a4b2-a0e26209162a">1.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i59e287da7a7c4198b40966eba2b62146_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS0xMS0xLTEtMA_ee97d30c-8a62-4157-bba2-54cc708a9841">2.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i285edd982b994ad2b3b7a0af7f283e6b_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtMS0xLTEtMA_a22751b3-710d-4a58-af53-5651d4b41609">0.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i51fd75ee62c145e2952ac446346d9b7c_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtMy0xLTEtMA_3e3067d1-f3d5-4a89-81ac-4c47dbabe4e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia4121b8b21d442e292a4ed42bdb30d70_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtNS0xLTEtMA_0a6ef48f-6021-434e-880e-d04bda9f750e">0.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i29558741c2674b39926f43730a6b171b_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtNy0xLTEtMA_2ee52ab7-10c0-4e57-9160-b78f84d63bf9">0.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id1bb8d1c57184d4f94dc2c42b00f8a29_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtOS0xLTEtMA_59a18b3e-5032-49a2-a52d-3baa2deeb873">0.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3ef0215658fa4d7c85eef815a3644861_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtMTEtMS0xLTA_6ff186ee-fa1a-4f49-a311-28c02537948d">0.2</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total molecular diagnostic revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd11d9c02bce445fa4341df9cbdb8482_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtMS0xLTEtMA_34993b3a-c35f-4aff-b356-4e3407c89990">124.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i378ad67948644fae91e1885f07d8b2c2_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtMy0xLTEtMA_dff981c9-9149-4af9-bff2-38a7257831be">11.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtNS0xLTEtMA_28d1c80b-4897-4538-aa08-f0c1484eeb1c">135.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6600cdbac0c2465bb71dca2e44416ef6_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtNy0xLTEtMA_5594203a-0ce9-4fbe-98b6-8d3fccc958b3">166.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9ede0c04f58f4611b03fdd8721157941_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtOS0xLTEtMA_c4455b95-6c7c-47b1-8435-3c4dfc989148">5.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtMTEtMS0xLTA_4b5366be-caae-4bc9-aa64-a15477c9bdc7">172.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia52c822bff2e4272a00b3a632878266f_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItMS0xLTEtMA_6a9edc95-6dc8-49cb-9c0b-ad7651059467">9.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iba547eb3ac564cf5bc3176aceeb2d680_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItMy0xLTEtMA_1264e765-0310-443b-984d-c5f0efaa5730">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItNS0xLTEtMA_66524662-6144-4c6c-9a5f-7cfd66f6a011">9.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if78ac333a8f347ea8edf5c2f08bf8df0_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItNy0xLTEtMA_3d8a9ed4-0a4b-4e0f-a210-d485d28f9383">8.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8835dd209114523bb9e8a64833ef8ff_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItOS0xLTEtMA_3c178b8f-29d6-47f5-a71a-6447a9f37336">5.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItMTEtMS0xLTA_94c54db3-9377-4222-a2fb-698701f47e07">14.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i47d31e10974947898926c5dcd4c0a95a_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtMS0xLTEtMA_fb749246-1cf6-47a7-b3fe-e68b82d7bb4f">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec7def734f4846fea024f404d1b6f52f_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtMy0xLTEtMA_f0886364-819c-4f51-922e-9c4745d56499">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtNS0xLTEtMA_1f4e3c7b-890f-4c0c-b3bd-0f86a1c591bf">145.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a8093dea57344778918ad7b5f751bce_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtNy0xLTEtMA_5af4c4a7-0824-47b0-bf3f-e5405909420f">174.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if2a611ec025e4fe6ac0191daf64556af_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtOS0xLTEtMA_a64673b5-8f8e-4ac0-825f-2c4319aa0c99">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtMTEtMS0xLTA_b39ff4b6-05c1-44b6-99d9-a990206f341e">186.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets. Occasionally, customers make payments prior to the Company's performance of its contractual obligations. When this occurs, the Company records a contract liability as deferred revenue. During fiscal year 2020, the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="i4464ac83ed924822929712315bbc20be_D20190701-20200630" decimals="-5" name="mygn:CARESActOf2020MedicarePaymentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMjc0ODc3OTA3MzAzOQ_3b9246a4-2283-4da0-ab72-e6ed6f74dba1">29.7</ix:nonFraction> in advance Medicare payments to provide relief from the economic impacts of COVID-19 on the Company. The advance Medicare payments are included in the beginning and ending balance of deferred revenue. <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMzUwNQ_c89d686c-0d12-4ed8-bdb1-4d6b9ae64df2" continuedAt="ic5f16890ff034c9783b87b0e31463552" escape="true">A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="i7a444608f06f433e94b61ab4b08e4535"><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="ic5f16890ff034c9783b87b0e31463552"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:77.010%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - beginning balance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMi0xLTEtMS0w_af807977-a281-4087-8f74-97b654f6d5ec">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i139906c1954e43c39560efe073ca515b_I20190630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMi0zLTEtMS0w_6a08d997-4cf0-4dfb-bf09-3232f25030f8">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMy0xLTEtMS0w_91263365-0446-4eab-aeab-1b4e56899299">2.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMy0zLTEtMS0w_57a35f30-15b4-45dd-b8b4-1c448a349551">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="mygn:ContractWithCustomerLiabilityPrepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNC0xLTEtMS0w_53c1d5b1-dad3-45df-8ac0-5f27ed7cbe09">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="mygn:ContractWithCustomerLiabilityPrepayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNC0zLTEtMS0w_7de3f257-86a6-4aa9-b365-53dde9aee0d7">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNS0xLTEtMS0w_790ed98e-b056-4d96-b63d-efce4e1abb5c">32.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61a8af6463ab4c92ba4435534752e1a2_I20190930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNS0zLTEtMS0w_6e420c2d-42a9-4ceb-88c4-0cce13fc24ce">2.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:RevenuePracticalExpedientRemainingPerformanceObligationDescription" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMTI1Nw_9624b43f-8b87-4b1a-8846-ba82bdb43550">In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#8217;s right to payment is in an amount that directly corresponds with the value of Company&#8217;s performance to date. However, the Company periodically enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations.</ix:nonNumeric> As of September&#160;30, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfNjA0NzMxMzk2MTkwNQ_9e1c72b3-e78c-4c87-a404-ec6e81425a6e">2.8</ix:nonFraction>.&#160;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may provide discounts to its customers. In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. The Company applies the expected value method for sales where the Company has a large number of contracts with similar characteristics.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. The Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. The Company excludes from the measurement of transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer. for example, sales tax, value added tax, etc. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in accrued liabilities on the balance sheet in anticipation of requests for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the consolidated statements of operations and comprehensive loss. As of September 30, 2020, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIyNTczMw_1ae2c5d7-c155-468d-86ce-a5adbb5ae579">2.2</ix:nonFraction> accrued liability and corresponding reduction in revenues for future refund of payments. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates our estimate of the amounts to be recognized for previously delivered tests, the impact of which was not material to our consolidated statements of operations for the three months ended September 30, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" format="ixt:booleantrue" name="us-gaap:RevenuePracticalExpedientIncrementalCostOfObtainingContract" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIxMTg1NQ_ed09cbc0-c6fa-42ac-b558-fe45f14a2e47">practical expedient</ix:nonNumeric> related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CapitalizedContractCostGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMjc3OA_ad1311a2-e410-43d8-bb6b-e85b81dc0cba">no</ix:nonFraction> costs incurred to obtain or fulfill a contract have been capitalized. The Company also applies the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and the vast majority of payment terms have a payback period of less than one year. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#8217;s accounts receivable are with companies in the healthcare industry, U.S. and state governmental agencies that make payments on the customer's behalf, and with individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare represented approximately <ix:nonFraction unitRef="number" contextRef="i9a31395d02b44be398a13e91e3f5d44b_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIyNTc0Mw_676bc2ce-7a12-4324-af33-24f37f7797a0">16</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0632e32f05f944ccbf27e6259c5b238b_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIyNTc0OA_9049cc77-ae8d-4130-bb55-2d4a682ff129">14</ix:nonFraction>% of total revenue for the three months ended September 30, 2020 and 2019, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many geographic regions. No payor accounted for more than 10% of accounts receivable at September&#160;30, 2020 or 2019. The Company does not require collateral from its customers.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_52"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RleHRyZWdpb246Y2EzMGY4OTFlYzZlNDMwMTkxMmI3NTU0OTk1MGRkNDRfOTgx_97bbd86d-fe27-48ec-b5d9-6d4fcf393246" continuedAt="i1e847005c14e4010bc26ba63bfafa613" escape="true">MARKETABLE INVESTMENT SECURITIES</ix:nonNumeric></span></div><ix:continuation id="i1e847005c14e4010bc26ba63bfafa613" continuedAt="ie55747b401634dd58423b09e49713f7d"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its debt investment securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#8217;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RleHRyZWdpb246Y2EzMGY4OTFlYzZlNDMwMTkxMmI3NTU0OTk1MGRkNDRfOTgy_34ea6c23-7860-4a3f-9e2b-27a04d44f451" continuedAt="iea8b930de556453d9de2b81ec3ed880f" escape="true">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at September&#160;30, 2020 and June&#160;30, 2020 were as follows:</ix:nonNumeric></span></div><ix:continuation id="iea8b930de556453d9de2b81ec3ed880f"><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:46.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMy0xLTEtMS0w_93a688c4-e0de-4302-9a5c-b8f9d35cdfc6">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMy03LTEtMS0w_fe1802ff-4a44-47a2-9baf-13a8f61310f1">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNC0xLTEtMS0w_9e28ee66-b1d8-4669-9188-97c31189c705">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNC03LTEtMS0w_e338ab33-ec66-46f5-893b-894c3a9b7ae1">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNS0xLTEtMS0w_62515226-cdbd-49dd-b507-4502ffa99914">118.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNS03LTEtMS0w_e6478b40-f39e-4f06-aba6-a896829e899a">118.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy0xLTEtMS0w_35e996be-5e14-4e74-acb1-1559ef148642">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy0zLTEtMS0w_6ed08b01-1aac-4f34-97a0-bf0d8622fa5a">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy01LTEtMS0w_47d7bf1c-005f-4e65-beec-bda6ebec7dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy03LTEtMS0w_b77c3cd7-1d18-49c3-a102-46007c04ac2d">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC0xLTEtMS0w_bbd43bb4-6a39-490f-8b0b-f95264ad7bdd">12.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC0zLTEtMS0w_a806b9ae-3cd3-44e3-a4bf-f696bd8f3a00">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC01LTEtMS0w_4b965ef1-4705-48fa-8884-1977f5d886f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC03LTEtMS0w_f5712bca-bdc0-45e2-84b1-1858c135d680">12.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS0xLTEtMS0w_e461e56d-2987-41e6-8f91-3ddd42ce4f84">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS0zLTEtMS0w_acbd976f-d851-4d53-9679-7f3e15ecb009">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS01LTEtMS0w_17111fc7-2862-4d96-87c9-7736deb94abc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS03LTEtMS0w_cf951eed-4b06-4865-91d1-a9ef687d84e3">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6fb745cf587b4aee882556505e97108b_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtMS0xLTEtMA_24323b6a-1e82-4ae5-8e8f-856c50ecd9f2">14.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6fb745cf587b4aee882556505e97108b_I20200930" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtMy0xLTEtMA_d112fe01-73fb-433c-8c82-a809fdded3e4">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6fb745cf587b4aee882556505e97108b_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtNS0xLTEtMA_1a4fc41b-c098-432e-a4b2-dd3b83072fb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6fb745cf587b4aee882556505e97108b_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtNy0xLTEtMA_0f45022d-e6f7-4d6b-9969-746d6a5e03c9">14.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="mygn:InvestmentsAndCashAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtMS0xLTEtMA_1a8787f0-e496-450d-b390-444ce6d50756">189.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtMy0xLTEtMA_d088563c-fe9a-4180-9a5d-30438d33760f">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:zerodash" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtNS0xLTEtMA_da4fb94a-e09e-4999-a52e-f08a6887573a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtNy0xLTEtMA_26b17904-f98b-459b-a409-dcc52adaa1be">190.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:46.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i363e9516fa95448388f9372a48406019_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMy0xLTEtMS0w_277686e7-157b-4750-b808-500292c93773">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i363e9516fa95448388f9372a48406019_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMy03LTEtMS0w_f54d7348-c1fb-4bea-ae4f-185f3b1e40a0">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6c6e2f5995484ce7b6fa8a39920efa01_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNC0xLTEtMS0w_08c5e4eb-37b9-4dbf-b7bf-0b701698c66b">30.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6c6e2f5995484ce7b6fa8a39920efa01_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNC03LTEtMS0w_43c8638b-1a06-4075-8c73-71c49dfce243">30.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNS0xLTEtMS0w_57025004-f566-444e-b54d-9ef0df9c77ba">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNS03LTEtMS0w_a82dac2e-abd6-487f-9942-712d329a743d">163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy0xLTEtMS0w_68a86af1-255b-481f-abd7-d511ed92b3cf">50.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy0zLTEtMS0w_56f44aba-79c0-4769-9190-c028098edd89">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy01LTEtMS0w_a743f76a-9f4b-4e9d-9ae3-9851e35861ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy03LTEtMS0w_d6ec8d41-d215-45b2-bd8d-9b0e1d6d0da6">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC0xLTEtMS0w_60f7b4fe-c1f0-4d5e-abfa-3763aa20287d">17.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC0zLTEtMS0w_f0b87e5e-bea2-4326-be5b-b14ae289e5e1">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC01LTEtMS0w_e2d159e6-4b40-46ab-a3a7-fc2f2344d310">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC03LTEtMS0w_9624b335-f006-4459-a841-2b0db2e9ad3a">18.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS0xLTEtMS0w_a4a76fa3-2aed-4978-846d-b2804cc7551f">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS0zLTEtMS0w_9fea4c94-caef-4a58-a489-4e8fefd1d530">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS01LTEtMS0w_422c6593-3848-46ec-a515-ee87ba6d7dad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS03LTEtMS0w_b4ea4632-a8e4-4c7f-a087-3a243bf5390d">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtMS0xLTEtMA_c007a34d-f295-4e19-a0a3-fece7744c55e">16.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtMy0xLTEtMA_7884eae6-5e59-4bfc-a3dd-31a60bbf5004">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtNS0xLTEtMA_51417622-70c9-4ef7-9307-e33f475dc5e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtNy0xLTEtMA_c3102dda-1a10-4743-8146-f772f9ea9e19">16.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="mygn:InvestmentsAndCashAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtMS0xLTEtMA_8f4f4f39-8e48-4216-a5e0-8c0b671bd8c7">253.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtMy0xLTEtMA_37580ba9-92df-425d-8483-c19203f310d8">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" format="ixt:zerodash" name="mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtNS0xLTEtMA_23d3dea2-02c5-4384-834d-23b2cec360de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtNy0xLTEtMA_6c8ba303-9eef-44cb-8895-7cc74858f773">254.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the adoption of ASC 2016-13, the Company assesses any unrealized loss positions for available-for-sale debt securities for which an allowance for credit losses has not been recorded. The aggregate amount of unrealized losses of these securities was not significant, and the impact of the securities in a continuous loss position to the condensed consolidated statements of operations and comprehensive loss were not material as of September&#160;30, 2020.</span></div></ix:continuation><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="ie55747b401634dd58423b09e49713f7d"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RleHRyZWdpb246Y2EzMGY4OTFlYzZlNDMwMTkxMmI3NTU0OTk1MGRkNDRfOTgz_dc863b18-ad7a-4066-991e-8717201547fe" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at September&#160;30, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMS0xLTEtMS0w_485ca50f-464e-411e-bac8-b32eec622f92">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMS0zLTEtMS0w_f855555a-05ee-4ffe-aed8-e906a88d0c4a">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMi0xLTEtMS0w_6d1e40d3-9645-4232-95de-fb2035407d7a">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMi0zLTEtMS0w_b17acbdd-8fe9-4931-b9ce-55d852ee9359">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due within one year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNC0xLTEtMS0w_e38ba9cb-ac7e-4781-b5aa-009078eb3e46">41.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNC0zLTEtMS0w_92d35407-9d62-4521-ba81-fc6ffadd35f1">42.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNS0xLTEtMS0w_4ade2128-ffee-4a48-a9be-00ae48af2a7c">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNS0zLTEtMS0w_863a740c-2c89-454f-a23b-b0e9a2cc7b94">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due after five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNi0xLTEtMS0w_823c5ab7-45a5-4a1a-8378-b3af2d034cd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNi0zLTEtMS0w_42841f56-10ea-4758-9b01-430225b00de7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_94"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNDM1MQ_9117339c-57c1-4933-b788-dc29b1f8d0fe" continuedAt="i892c4794e48a4982a5dbbaa8af56f934" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i892c4794e48a4982a5dbbaa8af56f934" continuedAt="i44529f51c0524370abf8149634359172"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:</span></div><div style="margin-top:6pt;padding-left:76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1&#8212;quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2&#8212;observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;&#160;Some of the Company&#8217;s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.</span></div><div style="margin-top:6pt;padding-left:76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#8212;unobservable inputs.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s financial instruments are valued using quoted prices in active markets or based on other observable inputs.&#160;&#160;For Level 2 securities, the Company uses a third party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information. The fair value of contingent consideration related to the Sividon Diagnostics GmbH ("Sividon") acquisition in fiscal year 2016 as well as long-term debt are categorized as Level 3 liabilities, as the measurement amount is based primarily on significant inputs not observable in the market. &#160;For Level 3 contingent consideration, the Company reassesses the fair value of expected contingent consideration and the corresponding liability each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected earn out liability.&#160;This fair value measurement is considered a Level 3 measurement because the Company estimates projections during the expected measurement period of approximately <ix:nonNumeric contextRef="i6b0749afe2864e698e44179a9a3109aa_D20200701-20200930" format="ixt-sec:duryear" name="mygn:BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfODI0NjMzNzIxNDMyMA_8a98adf4-618b-4baa-aee9-464bfcacf20d">9.25</ix:nonNumeric> years, utilizing various potential pay-out scenarios.&#160;&#160;Probabilities were applied to each potential scenario and the resulting values were discounted using a rate that considers weighted average cost of capital as well as a specific risk premium associated with the riskiness of the earn-out itself, the related projections, and the overall business.&#160;The contingent earn-out liabilities are classified as a component of long-term and short-term contingent consideration in the Company&#8217;s consolidated balance sheets.&#160;&#160;Changes to the earn-out liabilities are reflected in change in the fair value of contingent consideration in our consolidated statements of operations. Changes to the unobservable inputs could have a material impact on the Company&#8217;s financial statements.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term debt, which we consider a Level 3 measurement, is estimated using discounted cash flow analyses, based on the Company&#8217;s current estimated incremental borrowing rates for similar borrowing arrangements.&#160;&#160;The fair value of long-term debt is estimated to be $<ix:nonFraction unitRef="usd" contextRef="ia50d0d8131d5462795581f189d2f1d14_I20200930" decimals="-5" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNzE0NjgyNTU4NTkwNg_bc083e1d-70b5-4ddd-9ecf-9771e81868e2">226.5</ix:nonFraction> at September&#160;30, 2020.</span></div></ix:continuation><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="i44529f51c0524370abf8149634359172" continuedAt="i5c6fd26e387648f380f5625c97ee2495"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNDM0OQ_42936dae-5e8f-4ad4-8dd6-9aebb1cca4d0" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the fair value of the financial assets and liabilities that the Company re-measures on a regular basis:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:46.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03b12526fbc2445095fb01cac8a0200e_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi0xLTEtMS0w_371a6c94-391b-4c77-9d09-0d17e835dcab">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib9ca61745af34a4892fb24f02df51ce3_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi0zLTEtMS0w_452cdc52-3909-4f4a-8e98-680a3222c088">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4cd1faa18234928a9a39c3bbf242061_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi01LTEtMS0w_56f1af5f-2a04-4bfc-9c27-309fd28ba8d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icbd1f3cce2e5428eb21ef3b840688e1a_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi03LTEtMS0w_a27220d7-95a6-4b08-b64e-636307bbfa24">50.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i54e3cdbd09e6474bad78d5f7ae7c8d95_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy0xLTEtMS0w_51aabf0b-5f81-439a-b355-8d9369aa3466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if4fbe575c144479f93f88f70cd2f64f0_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy0zLTEtMS0w_54175dd3-00fe-48eb-9028-5ed70468a661">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbadb5bbe9c24d9aacd4015398fe5cb0_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy01LTEtMS0w_9be7b8b0-61db-4874-9de2-4d356eee07fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy03LTEtMS0w_5e2e0d6a-93f1-466c-b3e2-1f597b2ac68b">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i72a3a4c04f3d40f5a2832e1afe743ff6_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC0xLTEtMS0w_60a2737c-848f-4d7c-b6db-e6320902f37d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf4e8d24654e407fa0d279355277f975_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC0zLTEtMS0w_c2c0389b-65da-42b5-96f5-eeaddef3eb2e">12.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b08211082a3454893716f0969068c16_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC01LTEtMS0w_b8c30287-6de2-45dd-a1ce-b524072aa28b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC03LTEtMS0w_41ee3364-e963-4509-bbdc-c1e7393e96dd">12.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib95e73f78d584d03824f89f24d888618_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS0xLTEtMS0w_485cf3ae-2976-45b8-a320-921577d4dea3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic3996efae676460a9efe08f0472b97ac_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS0zLTEtMS0w_63d689c4-d759-4ef1-90b7-dfbad5ab37d7">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iefcec8bb3032434d9fab30ffede5b08b_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS01LTEtMS0w_d5089823-188d-4c59-830d-566ebc5a1984">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS03LTEtMS0w_bcf696ea-746c-4a19-95e5-490ab2ec4607">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id08f528c9e5845f9a07f73e22be9e0d6_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi0xLTEtMS0w_9dd6bb03-34ee-4e61-bf65-3a1a31b9353a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18fd7203ded848c0a6062cace377683e_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi0zLTEtMS0w_c92d02ea-8057-4065-8be1-3a4577f9a85e">14.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if5db99cba11444b8bdf61c2da7e49565_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi01LTEtMS0w_839d1224-ace0-4aa1-99a9-866c0a763a19">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6fb745cf587b4aee882556505e97108b_I20200930" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi03LTEtMS0w_9ab49877-78fa-43d7-9641-1264040d670d">14.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b57287f98834cbca2dae9554a148b7c_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy0xLTEtMS0w_4fea1136-60b1-4430-a040-cf8f87a6412e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5d6b05ed9dff446597fbac8b9a5c2d2d_I20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy0zLTEtMS0w_c29b2da9-8487-414a-8be1-47f2f2f4ce5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadafeb4cc83d4d8f830a67adc9b80fc3_I20200930" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy01LTEtMS0w_60fd87d3-c515-45f2-a805-80ebebb695e4">5.9</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i02975ce7a7184746bad04769367d2d8a_I20200930" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy03LTEtMS0w_fbb57bab-4a15-4054-9e71-a3f6323b2d0f">5.9</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i89284fd7a0a14425a733d40a934ae931_I20200930" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC0xLTEtMS0w_c3443c75-5944-4150-aec9-fc351452bdc8">50.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iab197615130e49f98518a5172359cd51_I20200930" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC0zLTEtMS0w_29806da2-5d4d-4e7f-a443-09927c61c5ab">72.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia50d0d8131d5462795581f189d2f1d14_I20200930" decimals="-5" sign="-" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC01LTEtMS0w_0542d926-955a-4cac-b40e-b709e762c27b">5.9</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC03LTEtMS0w_f2f811b1-92b8-491c-8fd7-459995e581c2">116.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:46.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e11187b43e04a0093140e12fee973c1_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi0xLTEtMS0w_1987fa30-98a1-452c-bb48-ea6918f19519">30.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idd13afd135f940fbbf70581c789f8cf3_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi0zLTEtMS0w_a318845d-7780-44b8-b104-71b5b6858f1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i56c502380d0d43a88063a06a16530a3e_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi01LTEtMS0w_609b0b7b-553d-4d1b-9c61-462b74ee2bb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie0daf004372944a1bac9f844e1eef37d_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi03LTEtMS0w_b2e4cd20-02d4-4d98-9835-acf2816e9345">30.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib60c105243a44ff2b52cb830ca3f0612_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy0xLTEtMS0w_15423b3b-d11e-4c0e-a6b8-a948a3c18e70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9169f553a75d40ea8601058742b6ce6b_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy0zLTEtMS0w_f8a60df4-eceb-4545-b583-413a197c7801">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia17529a19c854ba3a5b3782a119a6641_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy01LTEtMS0w_dad2fc6f-5bc1-449c-a838-27ca08463fd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy03LTEtMS0w_da2c198f-2156-47e9-9dd1-e66ad6e6b4d8">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i51e7fa915fa440fba6edada1d950d356_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC0xLTEtMS0w_4ccee3ff-12cd-40dc-be7f-f478bc8997e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idc6cbaca5036438d8e4b5fc144239335_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC0zLTEtMS0w_b29d8487-88df-4709-842f-58a7d2c0e393">18.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i469e373b8c0c43c2a5d70d03cf8bbd0f_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC01LTEtMS0w_dea267f5-7fde-48ab-8ba8-eecd447d9b37">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC03LTEtMS0w_b91815ad-5f35-4a76-842d-25b88c4a1f49">18.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia7ffbeab905e44cf92eeca09b81182f1_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS0xLTEtMS0w_81d5443e-d007-432b-872e-ce8169b9b174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i97e8d8a8b99d42c2827899164b67f836_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS0zLTEtMS0w_bf4bb817-d385-4f77-9731-35f539fde197">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57248bec235b477e86c27bec023182d8_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS01LTEtMS0w_cf97d5f9-be92-4393-a7cd-8b1ea0e7bc15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS03LTEtMS0w_38271925-64fa-46a7-bbee-e22e7a617e09">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc90dd9b027a488592fd2345f76e07b8_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi0xLTEtMS0w_6407f1f1-07a0-48f3-bd39-528214772eb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i06989fe731e041ec9c47378d113e9ba4_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi0zLTEtMS0w_08424bde-6c94-4047-b217-825106bc8234">16.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia3c91e9de9334c18b4886936541914c8_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi01LTEtMS0w_ee6c93b7-5bba-42bf-bc7f-cce4afb8c428">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi03LTEtMS0w_12773bc4-900b-4b16-8c20-383ca000a984">16.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8924bcae1bc14f7ea6e74dd68cf95dbc_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy0xLTEtMS0w_f64123ac-e29d-4d84-a51c-399683ff9b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if285d2c4c39b48fea6ad28b9de16c7ef_I20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy0zLTEtMS0w_81fc7585-7c10-44bc-b64c-e18c9de4210d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3f53f70b2fc74581bf96fa47b43ca738_I20200630" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy01LTEtMS0w_2556d7a6-ca79-4e77-9364-8a7a0fd9c4c6">6.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7e0b0e9caa9844859a83f02b58ec38d1_I20200630" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy03LTEtMS0w_cb2ebf89-2302-4a36-888e-382cedb00fed">6.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa131e48ae9f404b915d24c15ada4467_I20200630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC0xLTEtMS0w_619f4c68-e7b6-4830-888c-e2d68ac145ee">30.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2cd593b0b41a4e759514f092f1f9e3ec_I20200630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC0zLTEtMS0w_0c247f39-49ca-4324-b2c9-669ffe8f2759">91.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if6e717c6e6cf4c1cacf0ce093a7d1b51_I20200630" decimals="-5" sign="-" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC01LTEtMS0w_f98300af-b4d7-4fe9-97cd-55bca0bf566c">6.8</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:FairValueNetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC03LTEtMS0w_a8da6b08-eb5a-43a1-ae12-7c7373382149">115.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNDM1MA_78156d8d-ccfe-4160-9b3d-56a4b8a9adc2" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the change in the fair value of the contingent consideration during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:86.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance June 30, 2020</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfMS0xLTEtMS0w_ea234309-7b0b-4424-8379-68f8c2e03d7e">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfMi0xLTEtMS0w_22eeabfb-41c0-4908-bcd7-e95c9eda70e1">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value recognized in the income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfMy0xLTEtMS0w_d9ab9c8d-eaf0-47f3-93b2-084c2a8cb2a9">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Translation adjustments recognized in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfNC0xLTEtMS0w_da0c604c-ac39-4d68-9901-8e3feb519327">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfNS0xLTEtMS0w_85f4863b-7ca1-4929-910e-c8a8ac85e7f4">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5c6fd26e387648f380f5625c97ee2495">The fair value of contingent consideration for the three months ended September&#160;30, 2020 decreased compared to the same period in the prior year due to changes in timing of expected cash payments associated with the contingent consideration related to the Sividon acquisition.</ix:continuation>&#160;&#160;</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_58"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RleHRyZWdpb246NTE0MWQwNTU1Yzc4NDcwYjllNDg2Y2MzNjAwYWY0ZjhfMjg1_d87ac4cf-9851-437e-aaf0-2ec5837f6940" continuedAt="i99386442c5094ce1a763f0d4382cb54b" escape="true">PROPERTY, PLANT AND EQUIPMENT, NET</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i99386442c5094ce1a763f0d4382cb54b" continuedAt="i1bdc3140f4cf42f5a94c98407da27960"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RleHRyZWdpb246NTE0MWQwNTU1Yzc4NDcwYjllNDg2Y2MzNjAwYWY0ZjhfMjg2_38c9c257-f693-4dbd-9d53-5e0e829ea5b2" continuedAt="i8f511edd57a244a8ba58405f52b31619" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfMy0xLTEtMS0w_6d06834f-2d82-4996-b527-084398fc60dc">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfMy0zLTEtMS0w_25777c05-f841-4fab-b488-2c89a21c9719">31.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNC0xLTEtMS0w_96fc37e6-06e5-4a2f-93c0-b437254d4014">114.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNC0zLTEtMS0w_367b7bf7-7722-434d-9a19-6dde9eb339fa">112.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNS0xLTEtMS0w_bf17d030-b25e-4ee5-982f-8675a175b460">146.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNS0zLTEtMS0w_66aad824-a262-42fd-bb17-d0fb5a96568d">143.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNi0xLTEtMS0w_be190e6d-83ca-425f-8c35-f9e40381c7e7">110.0</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNi0zLTEtMS0w_d23eb5f6-60f7-43c4-b0a9-17ddff37da60">106.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNy0xLTEtMS0w_22add731-81da-4c71-aa0e-59e66faf6eac">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNy0zLTEtMS0w_6c4618e1-77f9-410d-997b-826f02b27800">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i1bdc3140f4cf42f5a94c98407da27960"><ix:continuation id="i8f511edd57a244a8ba58405f52b31619"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:72.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmZjY2IxM2JkNjExYTQwMTFiNmUxNzQxYmNmN2Y2Njg4L3RhYmxlcmFuZ2U6ZmNjYjEzYmQ2MTFhNDAxMWI2ZTE3NDFiY2Y3ZjY2ODhfMi0xLTEtMS0w_55037c02-8a2b-42b2-86c6-8ed27ee6381a">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmZjY2IxM2JkNjExYTQwMTFiNmUxNzQxYmNmN2Y2Njg4L3RhYmxlcmFuZ2U6ZmNjYjEzYmQ2MTFhNDAxMWI2ZTE3NDFiY2Y3ZjY2ODhfMi0zLTEtMS0w_0b9a892a-82f0-4608-99aa-26a0ad2dd4b3">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr></table></ix:continuation></ix:continuation></div><div style="padding-left:36pt"><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_61"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMg_7f60be4c-8af2-4162-bb95-173a226b5b68" continuedAt="i4f087432a87c4905bb5a034602ef60ac" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i4f087432a87c4905bb5a034602ef60ac" continuedAt="i64f5e6bb3b934110b254b6d56d371691"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzQ5OQ_a9a18da8-8655-412d-98fd-3ebbbb7e71b8" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended September&#160;30, 2020, are as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:38.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3c6b6633454ca5abeba426ba6e1898_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMS0xLTEtMS0zMTg2_30fde889-73e6-45ac-90c9-fe9270ead817">270.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i116991c09d6949c597cc44e8be8f1a92_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMS0zLTEtMS0zMjM0_e484675f-955b-4113-a7c8-cd4a7eefdf16">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMS01LTEtMS0zMjM2_8b6bc619-2fe6-4a4a-baa5-5c6b4a3b1061">327.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMi0xLTEtMS0zMTg4_82abc67f-68cf-42ed-b3a4-45d68ff81f9b">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMi0zLTEtMS0zMjM0_82cfe3b9-3783-401e-804d-5afd0fd54200">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMi01LTEtMS0zMjM2_79e57c3a-315e-4be8-8c67-eac58a8d7af7">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44895c20478e407d8960b3da61962bfd_I20200930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMy0xLTEtMS0zMjMy_9ed83e68-15d3-4f0a-9dd5-f4a62f97307b">271.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f595a1c9de24b2d8b457b7d67db72dc_I20200930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMy0zLTEtMS0zMjM0_d8766b6f-282e-4beb-960e-51ed40659502">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMy01LTEtMS0zMjM2_2daccf4e-3487-46e6-a3ca-5d9c07ba907f">328.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company will perform its annual goodwill impairment testing during the quarter ended December 31, 2020 as a result of its change in fiscal year end (see Note 16). The upcoming annual assessment may result in impairment charges if there is deterioration in business conditions, negative changes in market factors, or changes in the strategic priorities of the Company and its reporting units.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and trade names as well as non-amortizable intangible assets of in-process technologies and research and development.&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMA_ce8f7b5a-3a5d-4633-9ee5-f5d160945b70" continuedAt="i1441bb8f8f37449b88d6c6ece6bba92d" escape="true"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMA_f23e1d5e-1f11-4f41-9bb5-7ea21c04fd09" continuedAt="i035233a5a6424da3b101489064b557a1" escape="true">The following summarizes the amounts reported as intangible assets:</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i1441bb8f8f37449b88d6c6ece6bba92d"><ix:continuation id="i035233a5a6424da3b101489064b557a1"><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:59.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iedc11b500619497e955129438d050806_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMi0xLTEtMS0w_0f8ba39e-f59f-4590-b3e7-97e82778a72e">816.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iedc11b500619497e955129438d050806_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMi0zLTEtMS0w_165e68bc-059d-4771-bfdc-d97679fe162d">232.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iedc11b500619497e955129438d050806_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMi01LTEtMS0w_e61c2204-4b33-4eae-a01c-14beff19076f">584.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3b56267b5884c6b82c4eba0a047ea30_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMy0xLTEtMS0w_630fc415-264f-4fdf-9af9-f01bc2f3df9a">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3b56267b5884c6b82c4eba0a047ea30_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMy0zLTEtMS0w_6dfa2b0c-b182-4ac8-9caf-b0cc98485bb9">4.4</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3b56267b5884c6b82c4eba0a047ea30_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMy01LTEtMS0w_63554ab4-06df-4c34-acdc-309355fa17d5">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd37b997bb634ad6af913ee6c81e67d4_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNC0xLTEtMS0w_1f342004-d66c-497c-8249-aefa5a2e6fe0">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ibd37b997bb634ad6af913ee6c81e67d4_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNC0zLTEtMS0w_cd8cb5d4-030c-4f3b-9008-cd5aab8f913c">1.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd37b997bb634ad6af913ee6c81e67d4_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNC01LTEtMS0w_224f4cad-095f-411e-9619-8efc2b31f926">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNS0xLTEtMS0w_650547f6-182f-4de0-bff8-807ff21531ff">824.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNS0zLTEtMS0w_92df2b8e-75f5-4627-9fc0-3bc7c304712c">238.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNS01LTEtMS0w_1f3dce96-21e2-4f82-ac64-c42ab968bde3">586.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id401e6b7bcfc481bb6f8a4e878338fe9_I20200930" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNi0xLTEtMS0w_6260650c-9fae-414e-babb-2b04601812f1">4.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id401e6b7bcfc481bb6f8a4e878338fe9_I20200930" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNi01LTEtMS0w_1ad645b1-6ada-41d3-a3ed-b257fb365c66">4.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNy0xLTEtMS0w_6b02c681-a00f-46f2-ae50-6215e4e0f0c0">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNy01LTEtMS0w_233e9cdf-a6de-49a5-9b77-2a3656d6c71d">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfOC0xLTEtMS0w_97b8457b-4598-40a0-aa36-0406e965438a">829.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfOC0zLTEtMS0w_4b211b0c-c78d-40c9-8f92-efd2c3f5987c">238.2</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfOC01LTEtMS0w_142d4f87-b312-476f-9a84-3b8a23fe4ee3">590.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:59.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMi0xLTEtMS0w_439d52c9-575f-4428-8dc6-083736771b33">815.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMi0zLTEtMS0w_4c51ec64-c7b3-49b2-8d51-60b520e02ffd">217.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMi01LTEtMS0w_18560861-c1bd-4f3f-a9f7-4e68b82f44a9">598.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd87820edea446099b7bfa0e8c2239a6_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMy0xLTEtMS0w_c95d4fa2-836d-411a-8521-fe47311d3ee0">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ibd87820edea446099b7bfa0e8c2239a6_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMy0zLTEtMS0w_3cdf2e53-6504-4fa7-bbc8-66b08835d030">4.2</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd87820edea446099b7bfa0e8c2239a6_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMy01LTEtMS0w_5a50cbd3-f9cf-427d-8d84-f28f4244287c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id69e12ae53554f31b7c4a41249056530_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNC0xLTEtMS0w_bf4b115c-7209-40f9-82ed-2a1b81ae5c53">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id69e12ae53554f31b7c4a41249056530_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNC0zLTEtMS0w_e554d434-a070-4e5c-a4fb-83957d35e0ec">1.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id69e12ae53554f31b7c4a41249056530_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNC01LTEtMS0w_a7e5c35e-e2a4-4bf6-aed5-fd102dce7f62">1.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNS0xLTEtMS0w_4358aec3-feef-458e-bf4e-ffc41360adb6">823.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNS0zLTEtMS0w_ad506f99-4959-4936-b659-3f6737489cff">222.7</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNS01LTEtMS0w_5704dabf-aece-4626-a971-878084b2d7a4">600.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i605e7ce6614b44f98a3ad36551642783_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNi0xLTEtMS0w_f118a791-7b68-40a7-ac5a-2525d5812ff0">4.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i605e7ce6614b44f98a3ad36551642783_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNi01LTEtMS0w_ad4ad003-def2-4d71-82f7-bef3a7f06e98">4.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNy0xLTEtMS0w_74c160d9-5db2-41f6-8a10-636d6395fccb">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNy01LTEtMS0w_a0423fb1-cd6d-4596-a5f9-de6af493e619">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfOC0xLTEtMS0w_6abec92f-5355-4e71-b281-073617fdb525">828.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfOC0zLTEtMS0w_c85a0d3f-6b06-46ba-8812-b9e6b1aa7562">222.7</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfOC01LTEtMS0w_853a5a56-8c8d-4950-9c62-ad8d3f0f118e">605.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="i64f5e6bb3b934110b254b6d56d371691"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMQ_ea9dd61d-abe3-40fb-8e92-d6c7a8373938" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense during the respective periods for these intangible assets as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"></td><td style="width:62.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjgzMWMzYjAxOTQ3MTQwNmM5NTA5OWE1YWU3MWQ1ZTAyL3RhYmxlcmFuZ2U6ODMxYzNiMDE5NDcxNDA2Yzk1MDk5YTVhZTcxZDVlMDJfMi0xLTEtMS0w_a6cd529a-f12d-45f3-87c2-b450285a7e01">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjgzMWMzYjAxOTQ3MTQwNmM5NTA5OWE1YWU3MWQ1ZTAyL3RhYmxlcmFuZ2U6ODMxYzNiMDE5NDcxNDA2Yzk1MDk5YTVhZTcxZDVlMDJfMi0zLTEtMS0w_454aa34b-9956-420a-86eb-9ccd8f485357">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i35df2622b3a0423e9f409ac2173a31c8_64"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RleHRyZWdpb246MWRiYmEyNjhjNzE1NGFiOGIxZGExYTJiY2FlOTZhZmVfMjc_4f694915-7e37-48a0-b0c9-fae64cd15cd5" continuedAt="i2bc6390d04774e16a6c50d386f76ac01" escape="true">ACCRUED LIABILITIES</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i2bc6390d04774e16a6c50d386f76ac01"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RleHRyZWdpb246MWRiYmEyNjhjNzE1NGFiOGIxZGExYTJiY2FlOTZhZmVfMjg_034b91f8-616d-436e-9a58-ca000d4ba0f1" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee compensation and benefits</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMS0xLTEtMS0w_88d238d8-bdb7-46b5-86d5-5d3307265c00">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMS0zLTEtMS0w_7c9f9d1c-4be1-4a6f-b33d-0a2510e7461f">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMi0xLTEtMS0w_9c4bc3e9-19fe-4dd0-9bdb-730ffd919652">3.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMi0zLTEtMS0w_ce1338d0-0ca4-4b58-adcc-4dcbb5797ce1">6.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNC0xLTEtMS0w_41538b66-76bb-4fb5-a3e3-e48a78be2577">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNC0zLTEtMS0w_ef0f4716-a14c-4f9f-a925-bed26c465253">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNS0xLTEtMS0w_b052fa7d-b4f6-47f7-8d3a-90faf8468152">65.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNS0zLTEtMS0w_0a70e09c-1944-434f-96af-1f58e91ae0c8">75.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i35df2622b3a0423e9f409ac2173a31c8_67"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMjk0OA_52e4c096-72f6-46c2-a9c0-a7b1a8632b65" continuedAt="i59dbd762cc73408186a769420582c1e3" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="i59dbd762cc73408186a769420582c1e3" continuedAt="iaa2bb7c757ea4890abdba044985e3a65"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2016, the Company entered into a senior secured revolving credit facility (the &#8220;Facility&#8221;) by and among Myriad, as borrower, and the lenders from time to time party thereto. On July 31, 2018, the Company entered into Amendment No. 1 which effected an &#8220;amend and extend&#8221; transaction with respect to the Facility by which the maturity date thereof was extended to <ix:nonNumeric contextRef="i131e53046dba42e784ea6b9c4a34ebb0_D20180731-20180731" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxMzA3Nw_f8edcd15-01b5-40f5-abc7-2f965318bd1f">July 31, 2023</ix:nonNumeric> and the maximum aggregate principal commitment was increased from $<ix:nonFraction unitRef="usd" contextRef="i3e77d4115af8402f8e7c73bf41aa6d84_I20161223" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNTA0_59fb2bf9-d6a0-4de8-b868-3c2aec326791">300.0</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNTEw_ea6c7e22-2a1d-4982-91b9-b1786278f382">350.0</ix:nonFraction>.&#160;On May 1, 2020, the Company entered into Amendment No. 2 (the &#8220;Amended Facility&#8221;), which waived the Company's compliance with certain covenants and modified the interest rate and other terms during the Amendment Period from March 31, 2020 through June 30, 2021 (the "Amendment Period"). Both amendments were accounted for as modifications pursuant to guidance in ASC 470-50.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended Facility, the Company borrowed revolving loans in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNjkz_415637ed-e50a-43f1-83ef-1000edfef75c">300.0</ix:nonFraction> with $<ix:nonFraction unitRef="usd" contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNzAx_81041247-a563-485a-84cb-86e45ffabcde">1.8</ix:nonFraction> in upfront fees and $<ix:nonFraction unitRef="usd" contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731" decimals="-5" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNzI0_43ef6334-9ca4-4703-b6f9-34d768eb75c3">0.3</ix:nonFraction> debt issuance costs recorded as a debt discount to be amortized over the term of the Amended Facility. The Company incurred an additional $<ix:nonFraction unitRef="usd" contextRef="i799a546ec5224cf79c846d48840419b5_I20200501" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMTY0OTI2NzQ0NTI0MQ_8123d196-3345-4bb0-9e50-18347791a061">1.0</ix:nonFraction> in upfront fees as a result of Amendment No. 2, which was also recorded as a debt discount that will be amortized over the term of the Amended Facility. The current balance of the net long-term debt is $<ix:nonFraction unitRef="usd" contextRef="i39160baa532a49a3a841ba3506e61d34_I20200930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODc5_6ea4cf70-dbba-4e85-9677-7307e6102a2e">224.6</ix:nonFraction>. There are <ix:nonFraction unitRef="usd" contextRef="i39160baa532a49a3a841ba3506e61d34_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODkz_20420f07-4c5b-40fd-b250-77b139391aa2">no</ix:nonFraction> scheduled principal payments of the Amended Facility prior to its maturity date.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility contains customary loan terms, interest rates, representations and warranties, affirmative and negative covenants, in each case, subject to customary limitations, exceptions and exclusions. The Amended Facility also contains certain customary events of default. Amendment No. 2 modified the Facility to increase the interest rate to be fixed at a spread of LIBOR plus <ix:nonFraction unitRef="number" contextRef="ib9f213a904c342bc9d88379906d18608_D20200331-20210630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc2OQ_68d394a4-6a16-41ad-b459-18ee37e36195">350</ix:nonFraction> basis points on drawn balance and the undrawn fee was increased to <ix:nonFraction unitRef="number" contextRef="i817593bab77d4c76bee489fbd71601e8_D20200331-20210630" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc3NA_7bfdc2ed-46a4-4c6d-b4ab-abdc788fa0dd">50</ix:nonFraction> basis points during the Amendment Period. At the end of the Amendment Period, interest rates return to the previous pricing of <ix:nonFraction unitRef="number" contextRef="i0f336dee21354bffb60cdbdea5421626_D20210701-20210701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc3OA_aa72235f-b000-417f-88cb-089a29a2c73e">200</ix:nonFraction> basis points on drawn balances and an undrawn fee ranging from <ix:nonFraction unitRef="number" contextRef="i7dd85ff567e346758c47e5bf8e86f56e_D20210701-20210701" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc4Mw_586ec45b-4920-4f61-a089-2c4b59acb3ec">25</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i9a3c8e67aaa446f9b27da019f00dc7c7_D20210701-20210701" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc4Nw_eb66cfb4-d912-433e-9844-376be7d686ec">45</ix:nonFraction> basis points based on the Company's leverage ratio. The LIBOR floor was also increased to <ix:nonFraction unitRef="number" contextRef="i817593bab77d4c76bee489fbd71601e8_D20200331-20210630" decimals="INF" name="mygn:DebtInstrumentLIBORFloorPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc5MQ_a88195c6-ddd5-4d9c-8b85-f7c99d52b1ba">1.0</ix:nonFraction>% during the Amendment Period. The interest rate as of September&#160;30, 2020 was <ix:nonFraction unitRef="number" contextRef="i39160baa532a49a3a841ba3506e61d34_I20200930" decimals="3" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMTY0OTI2NzQ0NTQ3OQ_8e964603-b00d-4890-8114-a5103f56c7f1">4.5</ix:nonFraction>%.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covenants in the Amended Facility impose operating and financial restrictions on the Company. These restrictions may prohibit or place limitations on, among other things, the Company&#8217;s ability to incur additional indebtedness, create certain types of liens, and complete mergers, consolidations, or complete change in control transactions. The Amended Facility may also prohibit or place limitations on the Company&#8217;s ability to sell assets, pay dividends or provide other distributions to shareholders. The Company must maintain specified leverage and interest ratios measured as of the end of each quarter as a financial covenant in the Amended Facility. Amendment No. 2 modified the Amended Facility's compliance with the leverage covenant and the interest coverage ratio covenant, which were waived through March 31, 2021. A minimum liquidity covenant was added for the period beginning May 2020 until March 2021, and a minimum EBITDA covenant was added for the quarters ending December 31, 2020 and March 31, 2021. Amendment No. 2 also revised certain negative covenants of the Amended Facility during the Amendment Period. The Company was in compliance with all financial covenants at September&#160;30, 2020. Based on the continued uncertainty regarding the impact of COVID-19 on the Company&#8217;s future operations, it is possible that the Company could be in violation of certain financial covenants contained in the Amended Facility within the Amendment Period, which runs through June 30, 2021. The Company may seek waivers or amendments from the lenders in order to avoid a future potential covenant violation, in addition to taking other potential actions. If the Company were unable to comply with the covenants in the future, it could result in an increase in the rate of interest and limits on the Company's ability to incur certain additional indebtedness and it could potentially cause the loan repayment to be </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="iaa2bb7c757ea4890abdba044985e3a65"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated, any of which could have a material adverse impact on the Company&#8217;s operations and liquidity. The Company has and continues to take actions to mitigate the risk of an event of default under the Amended Facility, however there is no assurance it will be successful in doing so.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility is secured by a first-lien security interest in substantially all of the assets of Myriad and certain of its domestic subsidiaries and each such domestic subsidiary of Myriad has guaranteed the repayment of the Amended Facility. <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMjk0OQ_5e1855db-79a9-435c-8928-92044f15cb41" continuedAt="i9b1f0cb2593044369fc35100153fa696" escape="true">Amounts outstanding under the Amended Facility and Facility were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i9b1f0cb2593044369fc35100153fa696"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMS0xLTEtMS0w_1c221326-1e78-4937-967f-0cdf1c10d12b">226.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMS0zLTEtMS0w_188fbd3b-be1a-4ccc-9fe3-1690bdf9dafd">226.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMi0xLTEtMS0w_022b09b6-dc31-4808-a04a-ae1f09b0b6ca">2.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMi0zLTEtMS0w_20dab4f0-8ef8-47f3-8f86-cb8b75a873ee">2.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net long-term debt</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMy0xLTEtMS0w_a64f35c6-b12a-44d2-b635-ecb025f7a4b2">224.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMy0zLTEtMS0w_b2b6c77b-a620-4793-aca2-232e2e284d00">224.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_73"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RleHRyZWdpb246Y2EwNWM3MDk2MzljNDExN2FhMmQ2OGVkOWZkYzQ5Y2VfMzM0_207105cc-81d9-473b-9e2d-236170befba4" continuedAt="i86207bb2614e48eb9e6ebafd554919dd" escape="true">OTHER LONG-TERM LIABILITIES</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i86207bb2614e48eb9e6ebafd554919dd" continuedAt="id0ed56493f5c498097b675d1c00f531b"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RleHRyZWdpb246Y2EwNWM3MDk2MzljNDExN2FhMmQ2OGVkOWZkYzQ5Y2VfODI0NjMzNzIwOTI3OA_d0691cca-d29b-4c1c-baec-58a8cb50bc64" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMS0xLTEtMS03ODE2_d0477c02-6ee3-4de5-98df-05ae58e4245c">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMS0zLTEtMS03ODE2_6a538f46-8770-4bc9-aac4-45f80dbf1071">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMi0xLTEtMS03ODE2_b04508c0-5d03-4a5a-a1d9-295e78881908">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMi0zLTEtMS03ODE2_45809435-4a27-43ad-b265-3e45af6a5ab7">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMy0xLTEtMS03ODE2_ec1efadc-f04d-42d6-9601-b48a0737408e">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMy0zLTEtMS03ODE2_f0eacd87-c609-4738-8bbe-e6cf5d9a4c29">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:5pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id0ed56493f5c498097b675d1c00f531b">The Company's balance of other long-term liabilities as of September&#160;30, 2020 and June&#160;30, 2020 consists of the Company's portion of social security taxes that have been deferred under the CARES Act that do not have to be deposited until December 2021 and December 2022.</ix:continuation> </span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_76"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMA_6cf9d3f0-135c-49fa-99f6-00fcbfcf639e" continuedAt="i8d0d4c1d05c94d31bb33cd60ce67e3d9" escape="true">PREFERRED AND COMMON STOCKHOLDERS' EQUITY</ix:nonNumeric></span></div><ix:continuation id="i8d0d4c1d05c94d31bb33cd60ce67e3d9" continuedAt="i57a377ca6e784419b27b13c9f363aa93"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfODk_451adb13-433c-475f-ba47-3ab1718077a2">5.0</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTI5_b5f1d999-e71a-45f1-8ef0-4a2315941035">0.01</ix:nonFraction> per share.&#160;&#160;There were <ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTU1_a867c78a-47e5-4f85-a999-c53772bd68fc">no</ix:nonFraction> preferred shares outstanding at September&#160;30, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjM1_74875659-4356-44c5-ae45-a5c421020733">150.0</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjcy_4ba458be-adf7-406b-8988-88ef5df60753">0.01</ix:nonFraction> per share. There were <ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjk3_0b8cd940-e2f2-46bd-b4c1-94774b9090d8"><ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjk3_7536603f-9408-4d53-be7e-c2e63cc11b06">75.2</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2020.</span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMQ_815624d3-05fe-44d8-800c-7de0c559e56e" escape="true"><div style="margin-top:18pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common shares issued and outstanding</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning common stock issued and outstanding</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0xLTEtMS0w_c3591340-6e36-46da-bffe-edda042e1e85"><ix:nonFraction unitRef="shares" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0xLTEtMS0w_e01acc2a-7852-4d76-9c2c-87ccfceee9af">74.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i139906c1954e43c39560efe073ca515b_I20190630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0zLTEtMS0w_17907dad-4629-45dc-9d50-5d647fe5d0a3"><ix:nonFraction unitRef="shares" contextRef="i139906c1954e43c39560efe073ca515b_I20190630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0zLTEtMS0w_2eea4978-72c9-4e0e-9a76-ac3f15ba41fc">73.5</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMy0xLTEtMS0w_ad97ff8b-316c-4af3-b009-274ff00328ca">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4464ac83ed924822929712315bbc20be_D20190701-20200630" decimals="-5" name="mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMy0zLTEtMS0w_81e4e9c7-7de2-45c8-9670-b43a210442f3">1.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued and outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0xLTEtMS0w_3ad5291c-23b3-47a3-bb71-28fddc87520a"><ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0xLTEtMS0w_bdb2ab0a-181d-4014-9ca8-050cab3f7217">75.2</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0zLTEtMS0w_304de0d2-4945-4f36-b6e2-79bc7233b0bd"><ix:nonFraction unitRef="shares" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0zLTEtMS0w_7dc50812-8833-48b3-a313-a9197a2a074c">74.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.&#160;&#160;In periods when the Company has a net loss, stock awards are excluded from the calculation of diluted net loss per share as their inclusion would have an antidilutive effect.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="i57a377ca6e784419b27b13c9f363aa93"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMg_8e3566db-dd3b-448f-8b2d-567df45c4ecb" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share (&#8220;EPS&#8221;) computations:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:80.994%"><tr><td style="width:1.0%"></td><td style="width:68.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.340%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.340%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfMy0xLTEtMS0w_a15dc247-7ac1-412a-8aea-cc73066c07fb">74.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfMy0zLTEtMS0w_d18301a1-2549-4240-936d-f094e9724d1a">73.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive shares</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNC0xLTEtMS0w_0d71f9dd-bbb0-4320-a4cc-68332aa37ed1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNC0zLTEtMS0w_b0aceec3-b1ed-4b4f-ab5d-71ab5b405f62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNS0xLTEtMS0w_d08ddf75-b377-4526-b394-a74b06673648">74.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNS0zLTEtMS0w_b6d4ef68-e971-434c-b427-3e478ed70e4c">73.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain outstanding options and restricted stock units (&#8220;RSUs&#8221;) were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. <ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMw_79f1fdc0-d0ce-4350-85b3-c37be6b70d14" continuedAt="i4fd6f2267efe4a57b7cd7430ecdb134f" escape="true">These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><ix:continuation id="i4fd6f2267efe4a57b7cd7430ecdb134f"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"></td><td style="width:62.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjhhOWE1MTIyZmI0OTRmYmU5NzEyMzdmYzUxNjViMTUxL3RhYmxlcmFuZ2U6OGE5YTUxMjJmYjQ5NGZiZTk3MTIzN2ZjNTE2NWIxNTFfMi0xLTEtMS0w_1e88fdd9-fe29-4771-8df3-3e6065372a7a">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjhhOWE1MTIyZmI0OTRmYmU5NzEyMzdmYzUxNjViMTUxL3RhYmxlcmFuZ2U6OGE5YTUxMjJmYjQ5NGZiZTk3MTIzN2ZjNTE2NWIxNTFfMi0zLTEtMS0w_8fa2e5f1-34fc-4d43-9aa6-c19133108634">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:18pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Company&#8217;s Board of Directors authorized a share repurchase program of $<ix:nonFraction unitRef="usd" contextRef="iac78c7144eeb42a297b36f757e868180_I20170630" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTM4MQ_4b816d2c-6963-4be3-a337-279103352e85">200.0</ix:nonFraction> of the Company&#8217;s outstanding common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company's management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of September&#160;30, 2020, the Company is authorized to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTg0NA_b57cda13-1a44-4eff-990c-8b821701e3aa">110.7</ix:nonFraction> of shares under this authorization. <ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfOTM0NTg0ODgzOTMzNw_745abdd2-8c8a-4e2c-93e8-9506915a1008"><ix:nonFraction unitRef="shares" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfOTM0NTg0ODgzOTMzNw_e977a306-247f-417d-8952-3e43ef1c6276">No</ix:nonFraction></ix:nonFraction> shares were repurchased during the three months ended September 30, 2020 or 2019.</span></div></ix:continuation><div id="i35df2622b3a0423e9f409ac2173a31c8_88"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAyOQ_20a61b7e-f9a3-4027-b2f8-77958e1f8880" continuedAt="i7a6646eea2be469db2c15c510e96ebd7" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i7a6646eea2be469db2c15c510e96ebd7" continuedAt="idaa89fdb3e814c74816ae54f964fdb22"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2017, the Company&#8217;s shareholders approved the adoption of the 2017 Employee, Director and Consultant Equity Incentive Plan (as amended, the &#8220;2017 Plan&#8221;).&#160;On November 29, 2018 and December 5, 2019, the shareholders approved amendments to the 2017 Plan increasing the shares available to grant. The 2017 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of restricted and unrestricted stock awards to employees, consultants and directors. As of September&#160;30, 2020, the Company may grant additional shares of common stock under the 2017 Plan with respect to the <ix:nonFraction unitRef="shares" contextRef="i0f9212ac2aa140f8a16748ce2ea8a434_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfNjI2_43bf4114-9958-4620-8e1a-3c9a50f52bd1">0.1</ix:nonFraction> options outstanding under our 2003 Plan and <ix:nonFraction unitRef="shares" contextRef="icfa07cb7aed64763a7a9f6f9ebf99038_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfNjcz_d5bbc467-d85f-4548-bd3d-d62ee8169401">4.8</ix:nonFraction> options and restricted stock units outstanding under our 2010 Plan, to the extent that those options and restricted stock units expire or are cancelled without delivery of shares of common stock. If an RSU awarded under the 2017 Plan is cancelled or forfeited without the issuance of shares of common stock, the unissued or reacquired shares, which were subject to the RSU, shall again be available for issuance pursuant to the 2017 Plan.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares, terms, and vesting periods are determined by the Company&#8217;s Board of Directors or a committee thereof on an award-by-award basis. RSUs granted to employees generally vest ratably over <ix:nonNumeric contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTg2OTE2OTc2ODQyNTc_c426ea6f-c420-48ef-b61b-937603aaf569">four years</ix:nonNumeric> on the anniversary date of the designated day of the last week of the month in which the RSUs are granted. The number of RSUs awarded to certain executive officers may be increased or reduced based on certain additional performance metrics. Options and RSUs granted to our non-employee directors vest in full upon completion of <ix:nonNumeric contextRef="i8531ebcd74e04283a1b94b983fa04b07_D20200701-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfODI0NjMzNzIyMjA0NA_9b407daa-6ea5-4955-b40c-c0d199cf410a">one year</ix:nonNumeric> of service on the anniversary following the date of the grant. Options generally vest ratably over service periods of <ix:nonNumeric contextRef="i6e56313342974e7382a91c90b4089dd6_D20200701-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTI2OA_c25632ef-a1ab-40c5-9ff7-4f8f7dd28766">four years</ix:nonNumeric>.&#160;&#160;Options granted after December 5, 2012 expire <ix:nonNumeric contextRef="ibe25ff804ef6473c900712207237104f_D20200701-20200930" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTMxOQ_7f6b0976-e904-4b97-ae43-f3233af70300">eight years</ix:nonNumeric> from the date of grant, and options granted prior to that date generally expire <ix:nonNumeric contextRef="i8426764c4bf94a13a8f122cbaf9d20f2_D20200701-20200930" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTQwMg_42aaf289-8c95-48d6-87de-f3913fa7f97a">ten years</ix:nonNumeric> from the date of grant. In September 2014, the Company began generally issuing RSUs in lieu of stock options.&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, the Company granted stock-based awards to the Company's new President and Chief Executive Officer as an inducement material to his commencement of employment and entry into an employment agreement with the Company. The inducement awards were made in accordance with Nasdaq Stock Market rules and were not made under the Company's existing equity plans; the inducement awards are included in the tables below.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="idaa89fdb3e814c74816ae54f964fdb22"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAzMA_77ca416d-f72b-4995-aa43-77b075189bc6" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the stock option activity under the Company&#8217;s equity plans, including the Company's inducement awards, for the three months ended September&#160;30, 2020 is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMS0xLTEtMS0w_4a8f3b0f-ca9c-4451-8c8e-60b8cb679285">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMS0zLTEtMS0w_857b4fdc-84da-425f-a6ff-6b5ede5038ec">24.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMi0xLTEtMS0w_b61b11b7-1a12-4958-9bfc-bca3c5f60498">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMi0zLTEtMS0w_c1d2733d-869c-45d0-9cf4-010eaf2d0f36">13.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNC0xLTEtMS0w_7d8f2d1c-ca92-4338-b0d0-09e7fcb1143e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNC0zLTEtMS0w_d186889b-27c5-4f38-aeeb-c113ccd7b954">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options canceled or expired</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNS0xLTEtMS0w_090c066a-17f2-4280-aaeb-1a3ab8b4dcf7">0.1</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNS0zLTEtMS0w_e8450a15-0f11-44d6-97bc-241bbc3e3c00">16.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding at September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNi0xLTEtMS0w_ccb37482-4342-4a6b-9493-42b75d68dd4a">5.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNi0zLTEtMS0w_54611494-f3ec-4585-93c3-44b81a15c4a5">23.19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercisable at September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNy0xLTEtMS0w_7babca29-1a07-4975-a75b-2dee4242953f">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNy0zLTEtMS0w_680d77c7-5f08-4e66-8592-2ddc29fc1ef1">24.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTY0OTI2NzQ1MTA5NQ_d7c368c9-f2de-4ebc-9164-037f4ef82227">5.2</ix:nonFraction> of unrecognized share-based compensation expense related to the inducement stock options that will be recognized over a weighted-average period of <ix:nonNumeric contextRef="i6e56313342974e7382a91c90b4089dd6_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTY0OTI2NzQ1MzUxNQ_fc07a7de-b24d-4380-a033-8b1d6a64ef3d">2.8</ix:nonNumeric> years. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAzMQ_6ca96d5b-2ab8-47b3-a983-f04d6ba67721" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the RSU activity under the Company&#8217;s plans, including the Company's inducement awards and RSU awards with performance metrics, for the three months ended September&#160;30, 2020 is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4d168ccbb6474a0bbbe80bbe0520d013_I20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMS0xLTEtMS0w_444ca0d8-184b-4ba8-8156-f885290f6467">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4d168ccbb6474a0bbbe80bbe0520d013_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMS0zLTEtMS0w_94c0642d-d9fe-4018-85c8-85a831dcae66">32.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMi0xLTEtMS0w_c009e68e-a520-4cbd-aad1-0d9e631e3bb1">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMi0zLTEtMS0w_079d3c6e-701b-4bbb-8a8c-cd2dc6babf66">13.24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNC0xLTEtMS0w_d91012eb-4ee5-437a-a999-1abb1774cf80">0.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNC0zLTEtMS0w_42334a15-5e43-447f-97f9-89ab5054bb4a">33.07</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs canceled</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNS0xLTEtMS0w_c305ef7f-5d5c-4282-8756-e97d8c89a108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNS0zLTEtMS0w_06142471-390d-4f6b-8f79-0446f6a7224b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs outstanding at September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id7b2b333937b4d8ab126f4324d951eb8_I20200930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNi0xLTEtMS0w_5f12c8f7-9b47-4df6-9345-bc4b86f0ab8e">1.9</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7b2b333937b4d8ab126f4324d951eb8_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNi0zLTEtMS0w_9167597c-d669-4f5a-9b8c-76abe851c63b">27.70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="id7b2b333937b4d8ab126f4324d951eb8_I20200930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjE4OQ_398a7824-3fa4-4e74-99d6-9c2166f2ef72">44.1</ix:nonFraction> of total unrecognized share-based compensation expense related to RSUs that will be recognized over a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted-average period of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjMyMQ_60cd228f-5aac-471b-95d5-659646fb42f6">2.5</ix:nonNumeric> years.&#160;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has an Employee Stock Purchase Plan that was approved by shareholders in 2012 (the &#8220;2012 Purchase Plan&#8221;), under which <ix:nonFraction unitRef="shares" contextRef="ibbc4477be5174638b6d2d9c390dc35df_I20200930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjU4Mg_02b89827-474a-4f30-8b30-3293abd12682">2.0</ix:nonFraction> shares of common stock have been authorized.&#160;&#160;Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period.&#160;&#160;As of September&#160;30, 2020, approximately <ix:nonFraction unitRef="shares" contextRef="ibbc4477be5174638b6d2d9c390dc35df_I20200930" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjc1Mg_821ca18c-bf14-4186-88f5-e8d433569721">0.3</ix:nonFraction> shares of common stock are available for issuance under the 2012 Purchase Plan.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation Expense</span></div><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAyOA_da35329a-b396-4d0b-8969-094a989bd022" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense recognized and included in the condensed consolidated statements of operations and comprehensive loss was allocated as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"></td><td style="width:62.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03913453337a4247aeed7aa0ba49835a_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMi0xLTEtMS0w_c98db239-7699-42a8-9eb0-c4f1b3777fec">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9ebc3017dbc42c68c8b36d9f7808984_D20190701-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMi0zLTEtMS0w_7e00dfc0-645c-4e9c-98ce-b29886ed45f4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i935d96454093413f9b4072fbc7472673_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMy0xLTEtMS0w_e512e823-a379-4e16-95d8-b9fefa53dfca">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2a60af6e087f4872829727b5a4666fd3_D20190701-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMy0zLTEtMS0w_436adf1e-8302-4f4b-8cf3-f9a8d0884009">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i692152fef23148a68888c9f3d749a1ac_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNC0xLTEtMS0w_736a6e3d-21a0-477b-ab32-09a797e6ccea">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i713e3bcca2f747c69452acd15600fa56_D20190701-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNC0zLTEtMS0w_82598f44-1cf5-4a84-9243-4598ab758337">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ica96d2399231445fa8ea26045d7379d9_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNS0xLTEtMS0w_72b1bca4-7467-47e0-aef7-dd6b615bd250">6.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7029214bab44cbb90983534da0be3e1_D20190701-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNS0zLTEtMS0w_5bd280ce-08f7-4be0-b20d-b3e61de9c6e9">7.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total share-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNi0xLTEtMS0w_ff454610-5f90-4115-9c73-668d66c9b3d6">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNi0zLTEtMS0w_e4eaf33f-06d3-462e-947f-de52ab198430">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAzNQ_44f840d6-400f-4f07-8c0a-f91211d63c72" continuedAt="i96dbece6833048cab40cad63d75b1778" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i96dbece6833048cab40cad63d75b1778"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine the Company&#8217;s quarterly provision for income taxes, the Company used an estimated annual effective tax rate that is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates.&#160;Under the Tax Cuts and Jobs Act, the federal corporate tax rate is 21% for calendar year 2020.&#160;Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rate from quarter to quarter.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the three months ended September&#160;30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNjIy_21eb1d33-1b0a-4f21-97c6-7082f8401eec">28.5</ix:nonFraction>, or approximately <ix:nonFraction unitRef="number" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNjQz_775970c8-1225-4a35-901e-c98526b32081">65.2</ix:nonFraction>% of pre-tax loss compared to an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNjk4_889c5502-554e-458e-a0e3-124b05313722">1.7</ix:nonFraction>, or approximately <ix:nonFraction unitRef="number" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNzE5_627ae494-fbb1-4cce-bbb4-a481ec317445">7.6</ix:nonFraction>% of pre-tax loss, for the three months ended September&#160;30, 2019.&#160;&#160;Income tax benefit for the three months ended September&#160;30, 2020 is based on the Company&#8217;s estimated annualized effective tax rate for the six-month transition period ending December 31, 2020, adjusted by discrete items recognized during the period.&#160;&#160;For the three months ended September&#160;30, 2020, the Company&#8217;s recognized effective tax rate differs from the U.S. federal statutory rate primarily due to carrying back net operating losses due to the CARES Act.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES&#8221;) was enacted.&#160;&#160;CARES impacted several provisions to the U.S. tax code that have affected our six-month transition period ending December 31, 2020, including, but not limited to, (1) NOL carry-back and carry-forward provisions, (2) deductibility of interest, (3) acceleration of corporate AMT credits, and (4) classification of qualified improvement property.&#160;&#160;As of the quarter ended September&#160;30, 2020, the Company recognized an income tax net benefit of $<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="mygn:IncomeTaxExpenseBenefitCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMzM5OQ_15f08f15-9d2b-4f6e-8dbb-d26e8a4359ca">20.0</ix:nonFraction> related to the CARES Act, which included an increase in the uncertain tax benefit accrual of $<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="mygn:UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMzQwOQ_604aa783-8574-453a-9828-40b040f00fc9">14.3</ix:nonFraction>, related to carrying back net operating losses to tax years with higher corporate tax rates than the year the net operating loss originated. The Company will continue to evaluate the application of any and all provisions through the remainder of the six-month transition period ending December 31, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S., foreign and state income tax returns in jurisdictions with various statutes of limitations.&#160;&#160;The Company is currently under audit by the state of New Jersey for the fiscal years June 30, <ix:nonNumeric contextRef="i89373e9be2a0449893aabbe615c8f4d4_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjE3NQ_171a958f-f64b-4edd-beb1-1d0898d3e609">2013</ix:nonNumeric> through <ix:nonNumeric contextRef="ie481d4259b1e43cb9c6b7ea0cea96d16_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjE4Ng_7a185bf1-adb7-4acd-9c8d-9fd146f16e33">2017</ix:nonNumeric>; the state of New York and Massachusetts for the fiscal years June 30, <ix:nonNumeric contextRef="ia5e1f249221245de8a6c79eb95cdc6de_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjI2MA_3bdd2771-27bc-4300-9fe8-a98da7fdca52"><ix:nonNumeric contextRef="i3457c831a65d4dc386d66b85605c73bf_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjI2MA_ef426461-9748-4254-9a85-2a8fc1bc72b5">2014</ix:nonNumeric></ix:nonNumeric> through <ix:nonNumeric contextRef="i590b46ab6f6241c0854149f1703f3040_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAyNA_2b074be8-6451-49f6-a516-4d0685f5ec19"><ix:nonNumeric contextRef="ic9b0b4b7980a4b0bae0e190d4c2adc80_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAyNA_a7111a80-da90-435a-b1eb-1d5f663b97ef">2016</ix:nonNumeric></ix:nonNumeric>; Germany for the fiscal years June 30, <ix:nonNumeric contextRef="ic84b54586f924efeb788832bba77a03a_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMDk4MQ_96827056-dea6-409c-849e-78c169572a82">2013</ix:nonNumeric> through <ix:nonNumeric contextRef="i6c12ff8b2c1b4feca4bfe7d6b0767522_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAwNw_2859cc0a-89ce-4a17-9c7a-65cdf0156f62">2015</ix:nonNumeric>; and Switzerland for the fiscal years June 30, <ix:nonNumeric contextRef="ia11bd3e88b394e2aaacc3f17950ab8a0_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjM3NA_b012e5b2-239f-4097-8805-4e083c4d133e">2015</ix:nonNumeric> through <ix:nonNumeric contextRef="i9a4299d589f945d99e682d367f4fde51_D20200701-20200930" name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjM4NQ_6a99e886-6315-402f-87ba-58431c95321a">2016</ix:nonNumeric>. Annual and interim tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued.</span></div></ix:continuation><div id="i35df2622b3a0423e9f409ac2173a31c8_100"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDAvZnJhZzowYWYzYWVmN2Y0MGE0OTIwYWE1Y2Q3NDYyZmYzYWVkYS90ZXh0cmVnaW9uOjBhZjNhZWY3ZjQwYTQ5MjBhYTVjZDc0NjJmZjNhZWRhXzIyNzA_2da330f2-fbed-41e2-9121-ce2550ea990d" continuedAt="i87a64cabbfff4d3a8ecbf16c6cc94fc9" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87a64cabbfff4d3a8ecbf16c6cc94fc9" continuedAt="i1b7b1b80042f4ed79594355aa0a3a3fc">The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of September&#160;30, 2020, the management of the Company believes any reasonably possible liability that may result from the resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated financial position, operating results, or cash flows.</ix:continuation></span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b7b1b80042f4ed79594355aa0a3a3fc">From time to time, the Company receives recoupment requests from third-party payors for alleged overpayments. The Company disagrees with the contentions of the pending requests or has recorded an estimated reserve for the alleged overpayments.</ix:continuation> </span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_106"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14) &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90ZXh0cmVnaW9uOmJhMTI2MGY4YzAwNDQ4MzZhZmU1ZjJlMTRjYWMwYzdmXzEwMjY_c8b6ae58-9851-4eff-8fc7-e90b8850338a" continuedAt="i5b0f1848479d414389fc1e27600f88a2" escape="true">SEGMENT AND RELATED INFORMATION</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5b0f1848479d414389fc1e27600f88a2" continuedAt="i96cfd1d842344f368a8c81510c9fc196">The Company&#8217;s business is aligned with how the chief operating decision maker reviews performance and makes decisions in managing the Company.&#160;&#160;The business units have been aggregated into <ix:nonFraction unitRef="segment" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90ZXh0cmVnaW9uOmJhMTI2MGY4YzAwNDQ4MzZhZmU1ZjJlMTRjYWMwYzdmXzIyNw_fc041cd7-f0db-4cda-abf7-20a2d63742f5">two</ix:nonFraction> reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual&#8217;s risk for developing disease later in life, identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment, or assess a patient&#8217;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology.</ix:continuation></span></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">Table of Conten</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i35df2622b3a0423e9f409ac2173a31c8_7">s</a></span></div></div><ix:continuation id="i96cfd1d842344f368a8c81510c9fc196"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90ZXh0cmVnaW9uOmJhMTI2MGY4YzAwNDQ4MzZhZmU1ZjJlMTRjYWMwYzdmXzEwMjc_843fc99b-c231-4cfb-9927-ee1a47f0c603" escape="true"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment revenue and operating income (loss) were as follows during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:59.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzItMS0xLTEtMA_637de77c-b5cc-465e-9edf-12a5df4850a7">130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzItMy0xLTEtMA_cb1e7afb-4614-4ad3-b5e3-00b945c3ddff">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzItNS0xLTEtMA_35266f98-c0c1-489a-89da-8134defbee4a">145.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzMtMS0xLTEtMA_13dac44c-9a85-483f-9e80-98e42b8747d5">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzMtMy0xLTEtMA_a2d430db-1bfa-4b1b-b41c-ea054b0c0308">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzMtNS0xLTEtMA_c9e6b3c7-4c75-4e20-a431-b527c54303a0">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzQtMS0xLTEtMA_392489ad-538b-450a-a1a6-dbb95a760d85">0.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzQtMy0xLTEtMA_f3994d1f-32a6-4c59-ba53-e047fc02b568">39.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzQtNS0xLTEtMA_40b35972-4651-4ef2-9bf1-fce31d7b707f">39.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended September 30, 2019</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzYtMS0xLTEtMA_edc1a573-24fd-4c45-8deb-c2e323e5c6e3">170.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifd70072490624e738ef4b03b84386198_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzYtMy0xLTEtMA_4ace4837-7b5f-4f6f-8b0b-9facbd9b4281">15.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzYtNS0xLTEtMA_bd2bf7b0-7b65-40f3-a783-262061c21c1c">186.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzctMS0xLTEtMA_ca4c73bc-f08f-4535-afe0-71f1df2740cc">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifd70072490624e738ef4b03b84386198_D20190701-20190930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzctMy0xLTEtMA_ef2f4fce-d2e0-4c97-a1db-2ba9b3b283f0">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzctNS0xLTEtMA_d09be67c-49c8-4357-a165-27065373dee6">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzgtMS0xLTEtMA_26a1082b-6d00-420f-9ac5-dbf9d8297a06">17.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifd70072490624e738ef4b03b84386198_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzgtMy0xLTEtMA_8f31830d-e424-49d8-9abc-421c78a24a80">38.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzgtNS0xLTEtMA_f5cccec1-57bf-471c-90b6-e1955916a0fc">20.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"></td><td style="width:68.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.314%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.314%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating loss for reportable segments</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzItMS0xLTEtMA_efc7563d-6a47-465e-b023-c858c8c171fc">39.6</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzItMy0xLTEtMA_8bf36d73-a4d6-47f9-ac1e-b64055ac0a51">20.9</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated amounts:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzQtMS0xLTEtMA_ef963e0f-b90c-48c4-94a1-77a247ed9e6d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzQtMy0xLTEtMA_590c765e-81b4-4b4a-85d5-85bc9fd0a927">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzUtMS0xLTEtMA_adbd1130-27a1-439b-ad98-e666bdbbccaa">2.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzUtMy0xLTEtMA_00868869-4fd8-4625-bf16-63dad9c9e05c">2.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzYtMS0xLTEtMA_56977aec-4c96-404f-b4b0-c9e2fbfe218a">1.6</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzYtMy0xLTEtMA_af6a6828-90dd-4652-a0cf-c596cfd44620">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations before income taxes</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzctMS0xLTEtMA_e679e00f-4d24-4c71-a44f-ca255b0f2bad">43.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzctMy0xLTEtMA_31013ce6-eac9-4f8c-99fa-73f320ea2c46">22.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzgtMS0xLTEtMA_9100b7c2-0558-426d-97fc-7cef485990c8">28.5</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzgtMy0xLTEtMA_a35d3114-f537-47f2-a251-4801807d4110">1.7</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzktMS0xLTEtMA_863666aa-d712-4550-b3e8-8f7733dbe762">15.2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzktMy0xLTEtMA_fd47f1c9-6e0c-477f-89b0-c5085febd076">20.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzEwLTEtMS0xLTA_f7b1dc9c-806a-4081-bf64-2d5b104cfe06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzEwLTMtMS0xLTA_eda8dc85-80f3-4f71-ab68-005ff9daabb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics, Inc. stockholders</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzExLTEtMS0xLTA_565799ef-c77b-4828-8a3d-e0a272938c2a">15.2</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzExLTMtMS0xLTA_a1ffbaa7-38b6-4d58-98a3-f232cd8d9a9f">20.6</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_109"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90ZXh0cmVnaW9uOjYwNWFmNTQ2NzA2ZDQ5ODRiODQ0ODBjYjlkZmQ1NDQ2XzQy_4c9339e8-ebc6-4af2-b354-8797e4c1766c" continuedAt="i6113c25479ca4c8390242daca214e929" escape="true">SUPPLEMENTAL CASH FLOW INFORMATION</ix:nonNumeric></span></div><div style="margin-top:5pt;padding-left:36pt"><ix:continuation id="i6113c25479ca4c8390242daca214e929"><ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90ZXh0cmVnaW9uOjYwNWFmNTQ2NzA2ZDQ5ODRiODQ0ODBjYjlkZmQ1NDQ2XzQz_9ff1957b-c0eb-4dd7-b074-79269e1865c4" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:72.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid during the period for income taxes</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzItMS0xLTEtMA_d63d810a-4b39-4b97-b6bd-2888104af3a0">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzItMy0xLTEtMA_0aeaea6b-53a7-40f5-a69a-1914f4221a85">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzMtMS0xLTEtMA_5d4838b8-e286-4676-a8a7-1951f6551ad0">2.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzMtMy0xLTEtMA_bcca9a22-d7f3-495a-984a-40fe28e5756b">2.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishment of operating lease right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzUtMy0xLTEtMA_872e8c6a-f498-4177-9b85-3fd8a64eabde">74.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930" decimals="-5" name="mygn:OperatingLeaseLiabilityEstablished" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzYtMy0xLTEtMA_beb2ae74-3290-4831-bd8c-803153312906">78.8</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities and other long-term liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzctMy0xLTEtMA_3b8b3985-afe1-44bf-9f48-ef916d40e263">4.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="padding-left:36pt"><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_115"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16) &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMTUvZnJhZzplYTMyNzcyNmM5NWU0MzhjYTU2ZWU2NTg1NGZhNzg2MS90ZXh0cmVnaW9uOmVhMzI3NzI2Yzk1ZTQzOGNhNTZlZTY1ODU0ZmE3ODYxXzI5MjA_fddae262-32f6-44aa-a749-bc45fc17f768" continuedAt="i7e62e7681eee4730ab53ee7cf488af7b" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="i7e62e7681eee4730ab53ee7cf488af7b"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Fiscal Year</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 9, 2020, the Company&#8217;s Board of Directors approved a change in the Company&#8217;s fiscal year from a fiscal year ending on the last day of June of each year to a calendar fiscal year ending on the last day of December of each year, effective January 1, 2021. Accordingly, the Company will be issuing financial statements for a six-month transition period ending December 31, 2020 and calendar year financial statements thereafter.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-align:center;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_142"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company&#8217;s future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q contains such &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995.</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Words such as &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seek,&#8221; &#8220;could,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; &#8220;will,&#8221; &#8220;strategy&#8221;, &#8220;goal&#8221; and words and terms of similar substance used in connection with any discussion of future operating or financial performance, identify forward-looking statements. All forward-looking statements are management&#8217;s present expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to: uncertainties associated with COVID-19, including its possible effects on our operations and the demand for our products and services; our ability to efficiently and flexibly manage our business amid uncertainties related to COVID-19; the risk that sales and profit margins of our existing molecular diagnostic tests and pharmaceutical and clinical services may decline or will not continue to increase at historical rates; risks related to our ability to successfully transition from our existing product portfolio to our new tests; risks related to changes in governmental or private insurers&#8217; coverage and reimbursement levels for our tests or our ability to obtain reimbursement for our new tests at comparable levels to our existing tests; risks related to increased competition and the development of new competing tests and services; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services tests and any future tests are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with operating our laboratory testing facilities; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; risks related to our projections about the potential market opportunity for our products; the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents; risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services and patents or enforcement in the United States and foreign countries, such as the Supreme Court decisions in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mayo Collab. Servs. v. Prometheus Labs., Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 566 U.S. 66 (2012), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ass&#8217;n for Molecular Pathology v. Myriad Genetics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 569 U.S. 576 (2013), and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alice Corp. v. CLS Bank Int&#8217;l</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 573 U.S. 208 (2014); risks of new, changing and competitive technologies and regulations in the United States and internationally; the risk that we may be unable to comply with financial operating covenants under our credit or lending agreements; the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements; and other factors discussed under the heading &#8220;Risk Factors&#8221; contained in Item 1A of our Annual report on Form 10-K for the fiscal year ended June 30, 2020, which has been filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q (including Item 1A below in this report) or Current Reports on Form 8-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this Quarterly Report or in any document incorporated by reference might not occur. Stockholders are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this Quarterly Report. We are not under any obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements attributable to us or to any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.</span></div><div><span><br/></span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_124"></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading precision medicine company acting as a trusted advisor to transform patient lives through pioneering molecular diagnostics.&#160;Through our proprietary technologies, we believe we are positioned to identify important disease genes, the proteins they produce, and the biological pathways in which such genes and proteins are involved to better understand the molecular basis of certain human diseases. We believe that identifying these biomarkers (i.e., DNA, RNA and proteins) will enable us to develop novel molecular diagnostic tests that can provide important information to solve unmet medical needs. During the three months ended September 30, 2020, we reported total revenues of $145.2 and net loss of $(15.2) resulting in $(0.20) net loss per share.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business units have been aligned with how the chief operating decision maker reviews performance and makes decisions in managing the Company.&#160;The business units have been aggregated into two reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual&#8217;s risk for developing disease later in life, identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment, or assess a patient&#8217;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_127"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Updates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the quarter ended September 30, 2020, we continued to see improvement in business fundamentals, including test volumes, for our diagnostic products which have been affected by the COVID-19 pandemic. Total test volumes reached 90 percent of pre-pandemic levels by the end of the quarter compared to 75 percent of pre-pandemic levels at the end of the prior quarter ended June 30, 2020. We have also made the following recent announcements:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Appointed Paul J. Diaz as President and Chief Executive Officer, effective August 13, 2020.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The American College of Obstetricians and Gynecologists recently issued guidelines recommending prenatal testing for average risk patients. These guidelines have led to new medical policy guidelines for payors covering average risk testing incorporating 24 million covered lives to date. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;padding-left:13.8pt">Received a local coverage determination ("LCD") for Prolaris for unfavorable intermediate and high-risk patients from Palmetto GBA and CGS Administrators, LLC, two of the administrative contractors for the Centers for Medicare &amp; Medicaid Services. The final LCD becomes effective December 6, 2020. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;padding-left:14.5pt">The final LCD for pharmacogenomic (PGx) testing became effective during the quarter, which expanded coverage for patients to all healthcare providers licensed and qualified to diagnose the condition and prescribe relevant medications (either independently or in an arrangement). </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Received coverage from the German Federal Joint Committee (G-BA) for the EndoPredict&#174; breast cancer prognostic test. The positive decision means that EndoPredict&#174; is now available to all patients with statutory health insurance in Germany without restrictions as a benefit of the statutory health insurance scheme (GKV).</span></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Change in Fiscal Year</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 9, 2020, our Board of Directors approved a change in our fiscal year from a fiscal year ending on the last day of June of each year to a calendar fiscal year ending on the last day of December of each year, effective January 1, 2021. Accordingly, we will be issuing financial statements for a six-month transition period ending as of December 31, 2020, and calendar year financial statements thereafter.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_130"></div><div style="margin-top:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the Three Months Ended September 30, 2020 and 2019</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues for the three months ended September 30, 2020 continued to be impacted by factors related to the COVID-19 pandemic, including patients incurring obstacles to access healthcare professionals, which resulted in testing volumes declining compared to the prior year across the majority of the products. In addition, the average expected reimbursement per test decreased due to a variety of factors such as negotiating new contracts with payors and the impact of a $2.2 million reduction in revenues for estimated future refunds across the Company's products.  Hereditary Cancer Testing revenues decreased $23.9 compared to the same period in the prior year due primarily to an approximate 18% decrease in volumes and an approximate 6% decrease in average reimbursement per test. GeneSight revenues declined $10.8 compared to the same period in the prior year due primarily to an approximate 28% decrease in volumes and an approximate 27% decrease in average reimbursement per test. Prenatal revenues declined $7.0 compared to the same period in the prior year due primarily to a decrease in average reimbursement per test of approximately 34%. Pharmaceutical and clinical service revenue declined $4.8 compared to the same period in the prior year, primarily as a result of selling the Clinic in February 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents additional detail regarding the composition of our total revenue for the three months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$<br/>Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% of Total Revenue</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prenatal</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7.0)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeneSight</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vectra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">myChoice CDx</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prolaris</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoPredict</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total molecular diagnostic revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of molecular diagnostic testing as a % of revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of pharmaceutical and clinical services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of pharmaceutical and clinical services as a % of revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of molecular diagnostic testing as a percentage of revenue increased from 24.0% to 29.4% during the three months ended September&#160;30, 2020 compared to the same period in the prior year.&#160;&#160;The increase was primarily driven by the decline in revenue from lower test volumes during the period, attributable to the impact of COVID-19 as lower revenues were generated to cover fixed costs of performing the tests.  The cost of pharmaceutical and clinical services as a percentage of revenue decreased from 59.4% to 45.3% during the three months ended September 30, 2020 compared to the same period in the prior year due to the sale of the Clinic in February 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense as a % of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense for the three months ended September&#160;30, 2020 decreased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compared to the same period in the prior year primarily due to decreased personnel expenses from a decrease in headcount and decreased technology related expenses from synergies between our labs located in Salt Lake City and in San Francisco.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in the Fair Value of Contingent Consideration</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in the fair value of contingent consideration</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in the fair value of contingent consideration as a % of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration for the three months ended September&#160;30, 2020 decreased compared to the same period in the prior year due to changes in timing of expected cash payments associated with the contingent consideration related to the Sividon acquisition.&#160;&#160;</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11.4)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense as a % of sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense decreased for the three months ended September&#160;30, 2020 compared to the same period in the prior year primarily due to the Company implementing cost saving measures due to the decline in testing volumes as a result of the impacts of COVID-19 and due to a decline in expense from the sale of the Clinic in February 2020. The cost savings measures implemented by the Company have been partially offset by increased legal expenses and expenses related to our leadership transition in the current six-month transition period ending December 31, 2020.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense, net</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net increased for the three months ended September&#160;30, 2020 compared to the same period in the prior year, due to increased foreign exchange losses and to decreased interest income. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Benefit</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.5)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective tax rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax rate is the product of a blended U.S. federal effective rate of 21% and a blended state income tax rate of approximately 3%. Certain significant or unusual items are separately recognized during the period in which they occur and can be a source of variability in the effective tax rates from period to period.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income tax benefit for the three months ended September&#160;30, 2020 was $28.5, and our effective tax rate was 65.2%.&#160;&#160;The increase in the effective rate for the three months ended September&#160;30, 2020 as compared to the same period in the prior year is primarily due to carrying back net operating losses due to the CARES Act.  </span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_136"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing capital resources and the cash to be generated from future sales, taking into consideration the expected continuing impacts of COVID-19 on our operations, will be sufficient to meet our projected operating requirements and repay the outstanding Amended Facility, which matures on July 31, 2023 and which has no scheduled principal payments prior to that date. Our available capital resources, however, may be consumed more rapidly than currently expected, and we may need or want to raise additional financing. We may not be able to secure such financing in a timely manner or on favorable terms, if at all.&#160;We are subject to financial covenants as part of our outstanding Amended Facility. Based on the continued uncertainty regarding the impact of COVID-19 on our future operations, it is possible that we could be in violation of certain financial covenants contained in the Amended Facility within the Amendment Period, which runs through June 30, 2021. We may seek waivers or amendments from our lenders in order to avoid a future potential covenant violation, in addition to taking other potential actions. If we were unable to comply with the covenants in the future, that could result in an increase in the rate of interest and limits on our ability to incur certain additional indebtedness and could potentially cause the loan repayment to be accelerated. Without additional funds, we may be forced to delay, scale back or eliminate some of our sales and marketing efforts, research and development activities, or other operations and potentially delay development of our diagnostic tests in an effort to provide sufficient funds to continue our operations. If any of these events occurs, our ability to achieve our development and commercialization goals could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the COVID-19 pandemic and resulting global disruptions have caused significant volatility in financial markets. This disruption can contribute to potential defaults in our accounts receivable, affect asset valuations resulting in impairment charges, and affect the availability of lease and financing credit as well as other segments of the credit markets. We utilize a range of financing methods to fund our operations and capital expenditures and expect to continue to maintain financing flexibility in the current market conditions. However, due to the continuing rapidly evolving global situation, it is not possible to predict whether unanticipated consequences of the pandemic are reasonably likely to materially affect our liquidity and capital resources in the future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital deployment strategy focuses on use of resources in the key areas of research and development, acquisitions, debt repayment, and the repurchase of our common stock.&#160;&#160;We believe that investing organically through research and development or acquisitively to support business strategy provides the best return on invested capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the balances of cash, cash equivalents and marketable investment securities:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45.4)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable investment securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term marketable investment securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable investment securities</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254.8&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(64.2)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in cash, cash equivalents, and marketable investment securities was primarily driven by $59.3 in cash used by operations and the use of $3.8 for the proceeds from the issuance of common stock, net of shares exchanged for withholding tax, offset by $18.6 in proceeds from maturities of marketable investments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the condensed consolidated cash flow statement:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.4)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at the end of the period</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Operating Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in cash flows from operating activities for the three months ended September 30, 2020, compared to the same period in the prior year, was primarily due to the $107.9 change in the balance of prepaid taxes and the $17.0 change in the balance of trade accounts receivable, offset by an increase in the unrecognized tax benefit adjustment of $13.2 and an increase in the deferred income tax adjustment of $48.4.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Investing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2020, compared to the same period in the prior year, the change in cash flows from investing activities was driven primarily by the purchase of approximately $23.1 of marketable securities during the same period in the prior year that did not occur during the three months ended September 30, 2020. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2020, compared to the same period in the prior year, the decrease in cash flows from financing activities was driven primarily by the use of $8.6 in cash for repayment of the credit facility during the same period in the prior year that did not occur during the three months ended September 30, 2020. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of Inflation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that inflation has had a material impact on our business, sales, or operating results during the periods presented.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has previously authorized us to repurchase up to $200.0 of our outstanding common stock. We may repurchase our common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by our management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of September&#160;30, 2020, we are authorized to repurchase up to $110.7 under our current share repurchase authorization.&#160;&#160;See also &#8220;Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds &#8211; Issuer Purchases of Equity Securities&#8221;.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_139"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies are those policies which are both important to the presentation of a company&#8217;s financial condition and results and require management&#8217;s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.&#160;&#160;No significant changes to our accounting policies took place during the period.  For a further discussion of our critical accounting policies, see our Annual Report on Form&#160;10-K for the fiscal year ended June&#160;30, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our market risk during the three months ended September 30, 2020 compared to the disclosures in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/899923/000156459020040011/mygn-10k_20200630.htm#ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS">Part II, Item&#160;7A of our Annual Report on Form 10-K</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the fiscal year ended June&#160;30, 2020, which is incorporated by reference herein.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_148"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q, have concluded that, based on such evaluation, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Controls&#160;&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is in the midst of a multi-year transformation project to achieve better analytics and process efficiencies through the use of Oracle Fusion Cloud Services System. During the quarter ended September 30, 2020, the Company completed the implementation of certain modules used in the financial statement close process and management reporting. Additional phases will continue to be implemented over the coming year. Emphasis has been on the maintenance of effective internal controls and assessment of the design and operating effectiveness of key control activities throughout development and deployment of each phase.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as described above, there were no changes in our internal control over financial reporting that occurred during the three months ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - Other Information</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_154"></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purported Securities Class Action Claims</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2019, a purported class action complaint was filed in the United States District Court for the District of Utah, against the Company, its former President and Chief Executive Officer, Mark C. Capone, and its Executive Vice President and Chief Financial Officer, R. Bryan Riggsbee (&#8220;Defendants&#8221;). On February 21, 2020, the plaintiff filed an amended class action complaint, which added the Company&#8217;s Executive Vice President of Clinical Development, Bryan M. Dechairo, as an additional Defendant. This action, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re Myriad Genetics, Inc. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (No. 2:19-cv-00707-DBB), is premised upon allegations that the Defendants made false and misleading statements regarding our business, operations, and acquisitions.&#160;The lead plaintiff seeks the payment of damages allegedly sustained by it and the purported class by reason of the allegations set forth in the amended complaint, plus interest, and legal and other costs and fees.&#160;The Company intends to vigorously defend against this action.&#160;Due to the nature of this matter and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On August 24, 2018, our wholly-owned subsidiary, Assurex Health, Inc. ("Assurex") was served with an Amended Complaint which had been filed in the Circuit Court of Cook County, Illinois, County Department, Law Division, Civil Action No. 2018 L 004972, by Pipe Trades Services MN Welfare Plan ("Pipe Trades"), as a qui tam relator, on behalf of the State of Illinois, Pipe Trades, and all others similarly situated, purportedly arising from Assurex's alleged violations of the Illinois Insurance Claims Fraud Prevention Act and other causes of action. Pipe Trades seeks certification of a putative class, certification as the purported class representative, and the payment of treble damages allegedly sustained by Pipe Trades and the purported class by reason of the allegations set forth in the amended complaint, plus statutory damages and penalties, plus interest, and legal and other costs and fees. The State of Illinois and Cook County, Illinois, have declined to intervene in the matter. On September 11, 2019, plaintiffs filed a second amended complaint, and on October 10, 2019, Assurex filed a Motion to Dismiss Plaintiff&#8217;s Second Amended Complaint for Lack of Personal Jurisdiction and Standing, requesting that the second amended complaint be dismissed in its entirety, with prejudice, for lack of personal jurisdiction and standing. On July 20, 2020, this motion was denied. The Company&#8217;s motion filed on August 12, 2020, for interlocutory appeal of the denial of the motion to dismiss, was denied in a hearing on October 30, 2020. The Company intends to continue to vigorously defend against this action. Due to the nature of this matter and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Qui Tam Lawsuit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, our wholly-owned subsidiary, Crescendo Bioscience, Inc. (&#8220;CBI&#8221;), received a subpoena from the Office of Inspector General of the Department of Health and Human Services requesting that CBI produce documents relating to entities that received payment from CBI for the collection and processing of blood specimens for testing, including a named unrelated company, healthcare providers and other third party entities. The Office of Inspector General subsequently requested additional documentation in December 2017. CBI provided to the Office of Inspector General the documents requested. On January 30, 2020, the United States District Court for the Northern District of California unsealed a qui tam complaint, filed on April 16, 2016 against CBI and the Company, alleging violations of the Federal and California False Claims Acts and the California Insurance Fraud Prevention Act. On January 22, 2020, after a multi-year investigation into CBI&#8217;s and the Company&#8217;s alleged conduct, the United States declined to intervene. On January 27, 2020, the State of California likewise filed its notice of declination. The Company was not aware of the complaint until after it was unsealed. On May 23, 2020, the court denied CBI and the Company&#8217;s motion to dismiss. The Company intends to continue to vigorously defend against this action. Due to the nature of this matter and inherent uncertainties, it is not possible to provide an evaluation of the likelihood of an unfavorable outcome or an estimate of the amount or range of potential loss, if any.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as set forth above, we are not a party to any legal proceedings that we believe will have a material impact on our business, financial position or results of operations.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_157"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following risk factor disclosure should be read in conjunction with the risk factors described in the Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely impacted if we are unable to successfully implement new systems or unable to adapt systems to our change in fiscal year-end. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information technology systems are an important part of our business operations. We are in the midst of a multi-year transformation project to achieve better analytics and process efficiencies through the use of Oracle Fusion Cloud Services System ("Oracle Fusion"). This project is expected to improve the efficiency and effectiveness of certain financial and business transaction processes and the underlying systems environment. During the quarter ended September 30, 2020, we completed the implementation of certain modules used in the financial statement close process and management reporting. Additional integrations are expected to take place over the next year. An implementation of this nature is a major undertaking from a financial, management and personnel perspective. The implementation of Oracle Fusion may prove to be more difficult, costly, or time consuming than expected, and there can be no assurance that this system will be beneficial to the extent anticipated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have announced a change in our fiscal year end from a fiscal year ending on the last day of June of each year to a calendar fiscal year ending on the last day of December each year, effective January 1, 2021, which will require certain modifications to our systems used for accounting and management reporting. If the systems are not appropriately configured for the change in fiscal year-end it could have a material adverse effect on our results of operations and financial condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to debt covenants that impose operating and financial restrictions on us and if we are not able to comply with them, it could have a material adverse impact on our operations and liquidity.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Covenants in the Amended Facility impose operating and financial restrictions on us. These restrictions may prohibit or place limitations on, among other things, our ability to incur additional indebtedness, create certain types of liens, and complete mergers, consolidations, or change in control transactions. Under the Amended Facility, a change in control of the Company, which means that a shareholder or a group of shareholders is or becomes the beneficial owner, directly or indirectly, of more than 35% of the total voting power of the voting stock of the Company, would require mandatory prepayment of the outstanding debt. The Amended Facility may also prohibit or place limitations on our ability to sell assets, pay dividends or provide other distributions to shareholders. These restrictions could also limit our ability to take advantage of business opportunities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We must maintain specified leverage and interest ratios measured as of the end of each applicable quarter as financial covenants in the Amended Facility. The Amended Facility, through Amendment No. 2 entered into on May 1, 2020, modified compliance with the leverage covenant and the interest coverage ratio covenant, which were waived through March 31, 2021, and added a minimum EBITDA covenant for the quarters ending December 31, 2020 and March 31, 2021. Based on the continued uncertainty regarding the impact of COVID-19 on our future operations, it is possible that we could be in violation of certain financial covenants contained in the Amended Facility within the modification period, which runs through June 30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are unable to comply with the covenants and ratio in the Amended Facility, we may be in default under the agreement. A default would result in an increase in the rate of interest and limits on our ability to incur certain additional indebtedness and it could potentially cause the loan repayment to be accelerated, any of which could have a material adverse impact on our operations and liquidity. </span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_160"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has previously authorized us to repurchase up to $200.0 million of our outstanding common stock, of which $110.7 million is still available to repurchase as of September&#160;30, 2020. We are authorized to complete the repurchase through open market transactions or through an accelerated share repurchase program, in each case to be executed at management&#8217;s discretion based on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;The repurchase program may be suspended or discontinued at any time without prior notice. The transactions occurred in open market purchases and pursuant to a trading plan under Rule 10b5-1.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No stock repurchases were made under our stock repurchase program during the three months ended September 30, 2020.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_163"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_166"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_169"></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i35df2622b3a0423e9f409ac2173a31c8_172"></div><div style="-sec-extract:summary;margin-top:18pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-diazemploym.htm">Executive Employment Agreement between the Registrant and Paul J. Diaz dated July 24, 2020.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm">Performance</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm">-Based Restricted Stock Unit Agreement between the Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm"> and Paul J. Dia</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm">z dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm">O</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm">c</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-diazpsuagre.htm">tober 8, 2020.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103-diazrsuagre.htm">Restricted Stock Unit Agreement between the</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103-diazrsuagre.htm"> Registrant and Paul J. Dia</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103-diazrsuagre.htm">z dated August 13, 2020.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit104-diazperform.htm">Performance-Based Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit105-diaztimexba.htm">Non-Qualified Stock Option Agreement between the Registrant and Paul J. Diaz dated August 13, 2020.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-diazformofs.htm">Form of Separation and Release </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-diazformofs.htm">Agreement between the Registrant and Paul J. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit106-diazformofs.htm">Diaz.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-certificati.htm">Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-certificati.htm">Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-certificati.htm">Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Furnished).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, has been formatted in Inline XBRL.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* The appendix to this exhibit has been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of the     omitted appendix will be furnished to the SEC upon request. </span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i35df2622b3a0423e9f409ac2173a31c8_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.750%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MYRIAD GENETICS, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November 9, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Paul J. Diaz</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paul J. Diaz</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal executive officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November 9, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ R. Bryan Riggsbee</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R. Bryan Riggsbee</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal financial and accounting officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-diazemploym.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i340811bed2de431bbf894fbc1dabcda9_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Executive Employment Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), made and entered into this 24 day of July, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by and between Myriad Genetics, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and Paul J. Diaz (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Company wishes to employ Executive as its President and Chief Executive Officer&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Executive represents that Executive has no obligation to any other person or entity which would prevent, limit or interfere with Executive&#8217;s ability to do so&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Executive and the Company desire to enter into a formal employment agreement on the terms and conditions set forth below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual promises, terms, provisions, and conditions contained herein, the parties agree as follows&#58;  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Title&#59; Role&#59; Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Company shall employ Executive as its President and Chief Executive Officer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) beginning on the Commencement Date described in Section 2 and continuing for the Term (as defined in Section 2). Executive accepts such employment upon the terms and conditions set forth herein. During the Term, Executive shall report solely to the Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Executive shall have the duties, responsibilities and authorities normally associated with the position of chief executive officer of a company of a similar size and similar nature of the Company.  Executive agrees to faithfully and diligently perform to the best of Executive&#8217;s ability the duties and responsibilities of his position as CEO, as well as any such other duties and responsibilities (which are consistent with such position) as determined by the Board from time to time. Executive&#8217;s principal place of work for the Company shall be in the Company&#8217;s office locations in the Salt Lake City, Utah vicinity&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, however, that Executive shall not be required to relocate to the Salt Lake City vicinity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">During the Term and except as provided below, Executive shall devote all of Executive&#8217;s business time, energies and efforts to the business and affairs of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company shall appoint Executive as a member of the Board effective as of the Commencement Date.  Should any term of Executive as a member of the Board end or be scheduled to end during the Term, the Company shall nominate Executive for re-election to the Board for any succeeding term(s) as a Board member that commence during the Term.  Executive&#8217;s service as a Board member shall be without further compensation.  Should Executive&#8217;s employment with the Company cease for any reason, whether voluntary or involuntary, Executive shall promptly resign any and all positions held by Executive with the Company and its subsidiaries, whether as an officer of the Company or member of the Board, or on the board of directors or managers of any subsidiary of the Company, or as a member of any committees thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, nothing contained in this Section 1 shall prevent or limit Executive&#8217;s right to manage Executive&#8217;s personal investments, including the right to make passive investments in the securities of&#58; (i) any entity which Executive does not control, directly or indirectly, and which does not compete with the Company&#59; or (ii) any publicly held entity so long as Executive&#8217;s aggregate direct and indirect interest does not exceed five percent (5%) of the issued and outstanding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">securities of any class of securities of such publicly held entity.  Subject to the Board&#8217;s prior consent and the procedures associated with obtaining same, Executive shall be permitted to sit on boards of directors or similar governing bodies of other businesses&#59; provided that the Company acknowledges and agrees that Executive may continue to serve on the boards on which he currently serves and that he has disclosed to the Company (and applicable committees thereof).  In addition, nothing in this Section 1 shall prevent or limit Executive&#8217;s involvement in civic and charitable activities so long as such activities do not interfere with Executive&#8217;s duties for the Company.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Term of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive&#8217;s employment hereunder shall commence on August 13, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and shall continue until terminated hereunder by either party.  Such term of employment shall be referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#8221;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything else contained in this Agreement, Executive&#8217;s employment hereunder shall terminate upon the earliest to occur of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Immediately upon Executive&#8217;s death.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;If because of Executive&#8217;s Disability (as defined in Section 2(c)), upon written notice by the Company to Executive that Executive&#8217;s employment is being terminated as a result of Executive&#8217;s Disability, which termination shall be effective thirty (30) days after the date of such notice&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;If for Cause (as defined in Section 2(d)), upon written notice by the Company to Executive (following any cure period, if applicable) that Executive&#8217;s employment is being terminated for Cause, which termination shall be effective on the date of such notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;If by the Company for reasons other than Disability or Cause, upon written notice by the Company to Executive that Executive&#8217;s employment is being terminated, which termination shall be effective on the date of such notice. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;If for Good Reason (as defined in Section 2(e)), upon written notice by Executive to the Company (following any cure period, if applicable) that Executive is terminating Executive&#8217;s employment for Good Reason, which termination shall be effective on the date of such notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;If without Good Reason, upon written notice by Executive to the Company that Executive is terminating Executive&#8217;s employment, which termination shall be effective at least thirty (30) days after the date of such notice, unless the Company elects an earlier effective date, which the Company may so elect in its sole discretion without such election modifying the nature of such termination. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything in this Section 2(b), the Company may at any point terminate Executive&#8217;s employment for Cause pursuant to Section 2(b)(ii)(B) (to the extent Cause exists and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">applicable notice and cure periods have been satisfied) prior to the effective date of any other termination contemplated hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any notice of termination of Executive&#8217;s employment under this Agreement shall indicate the specific provision(s) of this Agreement relied upon in effecting the termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In no event shall Executive be obliged to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement, nor shall the amount of any payment or benefit hereunder be reduced by any compensation earned by the Executive as a result of employment by another employer, other than as described in Section 4(c)(iv) and 4(e)(iv).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Definition of &#8220;Disability&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean Executive&#8217;s inability to perform Executive&#8217;s duties with the Company for one hundred twenty (120) days or more (cumulative or consecutive) within any consecutive twelve (12) month period as a result of Executive&#8217;s physical or mental condition, subject to documentation by a medical expert appointed by mutual agreement between the Company and Executive who has examined Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Definition of &#8220;Cause&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean&#58; (i) Executive&#8217;s gross negligence in the performance of Executive&#8217;s duties to the Company&#59; (ii) Executive&#8217;s willful misconduct, embezzlement, misappropriation, fraud, or professional dishonesty&#59; (iii) Executive&#8217;s material breach of any non-disclosure, invention assignment, non-competition, or similar agreement between Executive and the Company&#59; (iv) Executive&#8217;s commission of a felony or of a crime involving moral turpitude&#59; (v) Executive&#8217;s willful and material failure to comply with lawful directives of the Board&#59; or (vi) Executive&#8217;s willful and material breach of a material provision of any employment agreement between Executive and the Company or willful and material violation of a material provision of any written Company employment policy applicable to its senior executive officers&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (A) the Company provides Executive with written notice that the Company intends to terminate Executive&#8217;s employment hereunder for one of the circumstances set forth in this Section 2(d) within sixty (60) days of the Board&#8217;s knowledge of such circumstance(s) occurring (which notice shall set forth in reasonable detail the circumstance(s) that the Company alleges constitute(s) Cause), (B) in the event that a circumstance described in (iii), (v) or (vi) is capable of being cured, Executive has failed to cure such circumstance within a period of thirty (30) days after the date of receipt of such written notice, and (C) the Company terminates Executive&#8217;s employment within sixty five (65) days from the date of the notice referred to in clause (A).  Conduct shall not be considered &#8220;willful&#8221; unless done (or omitted to be done) not in good faith and without a reasonable belief that such conduct (or lack thereof) was in the best interest of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Definition of &#8220;Good Reason&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean&#58; (i) a material diminution in Executive&#8217;s duties, authority or responsibilities&#59; (ii) a material diminution in Executive&#8217;s Base Salary (other than a reduction of similar magnitude to the base salaries of other Company senior executives if there is a reduction of Company senior executive base salaries generally), or a failure by the Company to provide the compensation and benefits provided for in this Agreement&#59; (iii) any change in Executive&#8217;s position such that he is no longer the Company&#8217;s CEO reporting solely to the Board&#59; or (iv) a material breach by the Company of this Agreement or any other agreement between the Company and Executive&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (A) Executive provides the Company with written notice that Executive intends to terminate Executive&#8217;s employment hereunder for one of the circumstances set forth in this Section 2(e) within sixty (60) days of such circumstance occurring (which notice shall set forth in reasonable detail the circumstance(s) that Executive alleges constitute(s) Good Reason), (B) if such circumstance is capable of being cured, the Company has failed to cure such circumstance within a period of thirty (30) days after </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the date of receipt of such written notice, and (C) Executive terminates Executive&#8217;s employment within sixty five (65) days from the date of the notice referred to in clause (A).  For purposes of clarification, the above-listed conditions shall apply separately to each occurrence of Good Reason, and failure to adhere to such conditions in the event of a specific occurrence of Good Reason shall not disqualify Executive from asserting Good Reason for any subsequent occurrence of Good Reason.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company shall pay Executive a base salary (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) at the annual rate of one million dollars ($1,000,000.00).  Executive&#8217;s Base Salary shall be reviewed annually and may be increased, but not decreased (other than a reduction of similar magnitude to the base salaries of other Company senior executives if there is a reduction of Company senior executive base salaries generally), from time to time from the level then in effect.  The Base Salary shall be payable in substantially equal periodic installments in accordance with the Company&#8217;s payroll practices as in effect from time to time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Cash Incentive Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive shall be eligible to receive an annual cash incentive bonus (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in a target amount equal to one hundred percent (100%) of Executive&#8217;s Base Salary. The Annual Bonus amount shall be determined as part of the Company&#8217;s Management Business Objectives (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">MBO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) program, which includes the assessment of Executive&#8217;s performance in established areas, the Company&#8217;s financial performance, and other factors. The Compensation Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), after  consultation with Executive, shall in its sole discretion approve MBOs for Executive for each fiscal year of the Company during the Term, which MBOs may consist of individual objectives, pre-established financial performance targets for the Company such as revenue and adjusted operating income, and other objectives. The Annual Bonus shall be paid to Executive no later than March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the calendar year immediately following the calendar year in which it was earned.   Except as provided in Section 4, Executive must be employed by the Company on the date that the Annual Bonus is payable in order to be eligible for such Annual Bonus.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Cash Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive shall be eligible to participate in the Company&#8217;s annual long-term incentive bonus program, subject to the terms and conditions of the program. Bonus performance metrics shall be determined by the Compensation Committee annually for the ensuing three-year period, and any bonus under the program shall be based on the achievement against such performance metrics measured at end of the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) fiscal year. For each annual long-term incentive bonus to be paid, the minimum pre-established financial metrics must be exceeded. The long-term incentive cash bonus percentage and amount is capped at one hundred fifty percent (150%) of the target annual long-term incentive bonus.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Signing Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company shall pay Executive a signing bonus (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Signing Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in the amount of one million dollars ($1,000,000.00), pursuant to the following schedule&#58; (i) the Company shall pay Executive one-half of such Signing Bonus ($500,000.00) on the Company&#8217;s first regularly scheduled payroll date following the Commencement Date&#59; and (ii) the Company shall pay Executive one-half of such Signing Bonus ($500,000.00) on the Company&#8217;s first regularly scheduled payroll date following the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the Commencement Date, with both Signing Bonus payments described herein subject (except as provided in Section 4) to Executive&#8217;s continuous employment with the Company through the date of payment. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Stock Unit Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Company shall grant Executive an initial annual grant of stock units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Stock Unit Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with respect to the Company&#8217;s common stock, $0.01 par value per share (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Initial Stock Unit Award is intended as an inducement grant under Nasdaq Rule 5635(c)(4) and will consist of both restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and performance stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  The RSU portion of the Initial Stock Unit Award shall be granted on the Commencement Date, as to a number of RSUs equal to four million dollars ($4,000,000) divided by the closing price of the Common Stock on the Nasdaq Stock Market on the Commencement Date.  The PSU portion of the Initial Stock Unit Award shall be granted within a reasonable period of time following the Commencement Date, as to a number of PSUs equal to four million dollars ($4,000,000.00) divided by the closing price of the Common Stock on the  Nasdaq Stock Market on the Commencement Date. Of the RSUs, one half (50%) shall vest on the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the Commencement Date, and the remaining one half (50%) shall vest in three (3) equal tranches on each of the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and fourth (4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversaries of the Commencement Date. The PSUs shall be subject to being earned based on achievement of pre-established milestones for the fiscal year ending June 30, 2021, set by the Compensation Committee after consultation with Executive and promptly communicated to Executive after being set.  Achievement of such milestones shall be evaluated by the Compensation Committee at a meeting of the Compensation Committee within a reasonable period of time following publication of the Company&#8217;s audited financial statements for such fiscal year (the date of such meeting, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Milestone Achievement Evaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). To the extent such PSUs are determined to have been earned based on milestone achievement, twenty-five percent (25%) of the earned PSUs shall vest on the Milestone Achievement Evaluation Date, and the remaining seventy-five percent (75%) of the earned PSUs shall vest in three (3) installments of twenty-five percent (25%) each on the following three anniversaries of the Commencement Date. Eligibility for, and the amount and terms of, future annual grants shall be determined by the Compensation Committee, with the expectation that there shall be annual grants (beginning in 2021 for the Company&#8217;s fiscal year ending June 30, 2022) with target grant sizes between the 50th and 75th percentiles for comparable chief executive officer positions at the Company&#8217;s peer group companies and on terms consistent with the market for those positions. The PSUs and RSUs shall be subject to the terms of the PSU and RSU award agreements attached as Exhibits A and B hereto, respectively.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Inducement Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. On the Commencement Date, the Company shall grant Executive stock options with an aggregate grant date value equal to five million five hundred thousand dollars ($5,500,000.00) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Inducement Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Inducement Equity Grant is intended as an inducement grant under Nasdaq Rule 5635(c)(4), and the exercise price of the stock options subject to the Inducement Equity Grant shall be the closing price of the Common Stock on the Nasdaq Stock Market on the Commencement Date.  Two million seven hundred fifty thousand dollars ($2,750,000.00) of the grant date value of the options covered by the Inducement Equity Grant shall be valued based on a Black Scholes valuation method using the fair market value of the Common Stock on the Nasdaq Stock Market on the Commencement Date and shall be time-based (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Time-Based Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and two million seven hundred fifty thousand dollars ($2,750,000.00) of the grant date value of the options covered by the Inducement Equity Grant shall be valued based on a Monte Carlo simulated valuation method using the fair market value of the Common Stock on the Nasdaq Stock Market on the Commencement Date and shall be performance-based (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Performance-Based Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Time-Based Options shall be subject to a four (4) year, time-based vesting schedule, with twenty-five percent (25%) of the Time-Based Options vesting on each of the first four (4) anniversaries of the Commencement Date. The Performance-Based Options shall vest as follows&#58; (i) one-fifth (1&#47;5) of the Performance-Based Options shall vest upon Achievement (as defined below) of a stock price that exceeds 1.5x the exercise price of the option&#59; (ii) one-fifth (1&#47;5) of the Performance-Based Options shall vest upon Achievement of a stock price that exceeds 2.0x the exercise price of the option&#59; (iii) one-fifth (1&#47;5) of the Performance-Based Option shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">vest upon Achievement of a stock price that exceeds 2.5x the exercise price of the option&#59; (iv) one-fifth (1&#47;5) of the Performance-Based Options shall vest upon Achievement of a stock price that exceeds 3.0x the exercise price of the option&#59; and (v) one-fifth (1&#47;5) of the Performance-Based Options shall vest upon Achievement of a stock price that exceeds 3.5x the exercise price of the option&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no portion of the Performance-Based Options may vest earlier than the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the Commencement Date. &#8220;Achievement&#8221; of each applicable stock price milestone shall be based on the average of the closing stock prices of the Common Stock on the Nasdaq Stock Market for a period of twenty (20) consecutive trading days exceeding such milestone. The Time-Based Options and Performance-Based Options shall be subject to the terms of the option agreements attached as Exhibits C and D hereto, respectively. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Paid Time Off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive may take paid time off each year, to be scheduled to minimize (to the extent reasonably possible) disruption to the Company&#8217;s operations, pursuant to the terms and conditions of Company policies and practices as applied to Company senior executives.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Fringe Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive shall be entitled to participate in all benefit, retirement, and welfare plans and fringe benefits provided to Company senior executives, if and when the Company offers such plans and benefits, subject to the terms of each applicable plan.  Executive understands that, except when prohibited by applicable law or the terms of the applicable plan, the Company&#8217;s benefit and retirement plans and fringe benefits may be amended or terminated by the Company from time to time in its sole discretion. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Housing and Travel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For a period of thirty six (36) months following the Commencement Date, the Company shall provide Executive with $2,800.00 per month for lodging expenses. During Executive&#8217;s employment hereunder, the Company also shall pay or reimburse Executive for the cost of first class airfare for Executive&#8217;s travel between Executive&#8217;s primary residence and the Company&#8217;s office in Salt Lake City, Utah.  Executive shall be responsible for any personal tax liability that may result from the housing and travel benefit described in this paragraph. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall reimburse Executive for attorneys&#8217; fees incurred in the negotiation, review and preparation of this Agreement, subject to a maximum amount of $15,000.00 for such attorneys&#8217; fees. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reimbursement of Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall reimburse Executive for all ordinary and reasonable out-of-pocket business expenses incurred by Executive in furtherance of the Company&#8217;s business in accordance with the Company&#8217;s policies and procedures with respect thereto as in effect from time to time.  All reimbursements provided under this Agreement shall be made or provided in accordance with the requirements of   Section 409A (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during Executive&#8217;s lifetime (or during a shorter period of time specified in this Agreement)&#59; (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year&#59; (iii) the reimbursement of an eligible expense shall be made no later than the last day of the calendar year following the year in which the expense is incurred&#59; and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payments upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Definition of Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means&#58; (i) the portion of Executive&#8217;s Base Salary that has accrued prior to any termination </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Executive&#8217;s employment with the Company and has not yet been paid (to be paid on or promptly after the date of termination of employment)&#59; (ii) any Annual Bonus with respect to the fiscal year prior to the year in which separation occurs and not yet paid (to the extent such Annual Bonus is determined to have been earned by the Compensation Committee based upon achievement of the applicable performance criteria and would have been payable had Executive&#8217;s employment with the Company continued, and to be paid when such Annual Bonus would have otherwise been paid had Executive&#8217;s employment with the Company continued) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that this clause (ii) shall not apply, and shall not be included as a component of the Accrued Obligations, in the event of a termination by the Company for Cause or by Executive without Good Reason)&#59; (iii) the entire Signing Bonus to the extent not previously paid (to be paid when such Signing Bonus or applicable portion thereof would have otherwise been paid had Executive&#8217;s employment with the Company continued) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that this clause (iii) shall not apply, and shall not be included as a component of the Accrued Obligations, in the event of a termination by the Company for Cause or by Executive without Good Reason)&#59; (iv) the amount of any expenses properly incurred by Executive on behalf of the Company prior to any such termination and not yet reimbursed (to be paid in the normal course)&#59; and (v) Executive&#8217;s entitlement to any other compensation or benefit under any retirement, health, welfare or other plan of the Company (which shall be governed by, and determined and paid in accordance with, the terms of the applicable plan, except as otherwise specified in this Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company for Cause or by Executive without Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If Executive&#8217;s employment hereunder is terminated by the Company for Cause or by Executive without Good Reason, then the Company shall pay the Accrued Obligations to Executive, and shall have no further payment or benefit obligation to Executive. Without limiting the foregoing&#58; (i) in the event of a termination by the Company for Cause, all vested and unvested options and all unvested RSUs and PSUs (even if the applicable performance goal(s) had been attained but the award had not vested in accordance with its terms) automatically shall terminate and be forfeited&#59; and (ii) in the event of a termination by Executive without Good Reason, any unvested portion of  options, RSUs and PSUs (even if the applicable performance goal(s) had been attained but the award had not vested in accordance with its terms) automatically shall terminate and be forfeited, and Executive shall have no right to vest in or further acquire any portion of such unvested equity grant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company other than for Cause, Disability or Death, or by Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that&#58; (i) Executive&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) Executive terminates Executive&#8217;s employment for Good Reason, then, in addition to the Accrued Obligations, Executive shall receive the following, subject to the terms and conditions of Section 4(f)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Payment in an amount equal to two (2) times Executive&#8217;s then-current Base Salary plus two (2) times Executive&#8217;s target amount of Annual Bonus, paid in one lump sum amount within sixty (60) days following Executive&#8217;s last day of employment with the Company (Executive&#8217;s last day of employment with the Company, the &#8220;Separation Date&#8221;), less customary and required taxes and employment-related deductions.  For purposes of this Section 4(c) and for purposes of Section 4(d), Executive&#8217;s Base Salary shall be taken into account at the highest annual Base Salary rate in effect at any time in the one year period preceding the Separation Date (i.e., without giving effect to any reduction thereof), and Executive&#8217;s target amount of Annual Bonus shall be based on such highest annual Base Salary rate in effect for Executive at any time in such one year period and the target Annual Bonus percentage set forth in Section 3(b).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pro-Rata Severance Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Payment in an amount equal to a pro-rata portion of Executive&#8217;s target amount of Annual Bonus for the year in which the Separation Date occurs (such pro-ration based on the portion of the year worked prior to Separation Date), paid in one lump sum amount within sixty (60) days following the Separation Date, less customary and required taxes and employment-related deductions.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Equity awards granted to Executive and outstanding immediately prior to the Separation Date shall vest on the Separation Date to the extent scheduled to vest on or before the date two (2) years following the Separation Date. For purpose of determining the portion of equity awards that vest under this Section 4(c)(iii)&#58; (A) any annual vesting installments shall be deemed to vest in monthly installments over the applicable vesting period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, an equity award initially scheduled to vest in annual installments over a four year period that was granted thirteen (13) months before the Separation Date shall, for purposes of determining such acceleration, be considered to vest in forty eight (48) monthly installments over that same four-year period, and the portion of the award that vests pursuant to this clause will be the portion of the forty-eight (48) monthly vesting installments that would be scheduled to vest on or before the date two (2) years following the Separation Date less the portion of the award that had already vested pursuant to its terms before the Separation Date, with no additional pro-rata vesting for a portion of a month if the end of such two-year period falls between the deemed monthly vesting dates), and (B) any outstanding equity award with an unsatisfied performance-based condition shall remain outstanding and, if the applicable performance condition is satisfied during such two (2) year period, shall, to the extent so earned based on performance, vest (to the extent the award would have vested had Executive&#8217;s employment with the Company continued during such two-year period) upon satisfaction of such performance-based condition. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefits Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon completion of appropriate forms and subject to applicable terms and conditions under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company shall pay or reimburse Executive for the premiums charged to continue Executive&#8217;s medical coverage pursuant to COBRA, at the same or reasonably equivalent medical coverage for Executive (and, if applicable, Executive&#8217;s eligible dependents) as in effect immediately prior to the Separation Date, until the earlier to occur of  eighteen (18) months following the Separation Date or the date Executive begins employment with another employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company as a Result of Executive&#8217;s Disability or Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that Executive&#8217;s employment hereunder is terminated by the Company as a result of Executive&#8217;s Disability or death, then, in addition to the Accrued Obligations, Executive (or Executive&#8217;s estate as applicable) shall receive the following, subject (other than in the case of death) to the terms and conditions of Section 4(f)&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pro-Rata Severance Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Payment in an amount equal to a pro-rata portion of Executive&#8217;s then-current target amount of Annual Bonus for the year in which the Separation Date occurs (such pro-ration based on the portion of the year worked prior to Separation Date), paid in one lump sum amount within sixty (60) days following the Separation Date, less customary and required taxes and employment-related deductions. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Pro-rata vesting of Executive&#8217;s time-based equity awards based on the period of employment between the most recent vesting date prior to the Separation Date and the Separation Date, and including any time-based vesting of performance-based awards that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Compensation Committee determines to have been earned based on achievement of applicable milestones prior to the Separation Date. For purpose of determining the portion of equity awards that vest under this Section 4(d)(ii), any annual vesting installments shall be deemed to vest in monthly installments over the applicable vesting period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, an equity award initially scheduled to vest in annual installments over a four year period that was granted thirteen (13) months before the Separation Date shall, for purposes of determining such acceleration, be considered to vest in forty eight (48) monthly installments over that same four-year period, and the portion of the award that vests pursuant to this clause will be the portion of the forty-eight (48) monthly vesting installments that would be scheduled to vest on or before the Separation Date less the portion of the award that had already vested pursuant to its terms before the Separation Date, with no additional pro-rata vesting for a portion of a month if the Separation Date falls between the deemed monthly vesting dates). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The severance payments and benefits described in Section 4(d) shall not be in addition to the severance payments and benefits described in Section 4(c). In the event that Executive is eligible for the severance payments and benefits under Section 4(d), Executive shall not be eligible for the severance payments and benefits under Section 4(c), unless Executive had become entitled to the severance payments and benefits under Section 4(c) before becoming entitled to the severance payments and benefits under Section 4(d) (in which case Executive would remain entitled to the severance payments and benefits under Section 4(c) but would not be entitled to the severance payments and benefits under Section 4(d)).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company other than for Cause, Disability or Death, or by Executive for Good Reason, Following a Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event that a Change of Control (as defined below) occurs, and within a period of three (3) months prior to, upon, or within twenty four (24) months following a Change of Control, either&#58; (i) Executive&#8217;s employment is terminated by the Company other than for Cause, Disability or death&#59; or (ii) Executive terminates Executive&#8217;s employment for Good Reason, then, in addition to the Accrued Obligations, Executive shall receive the following, subject to the terms and conditions of Section 4(f)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive shall receive the severance payment described in and on the terms set forth in Section 4(c)(i).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Pro-Rata Severance Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive shall receive the severance bonus described in and on the terms set forth in Section 4(c)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Equity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  All equity awards granted to Executive and outstanding on the date of termination shall be subject to the terms of any applicable equity plan and equity agreements, except that they shall fully vest as of the date described in Section 4(f)(iii). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefits Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive shall receive the benefits payments described in and on the terms set forth in Section 4(c)(iv).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For purposes of this section, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the occurrence of any of the following events&#58; (A)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  any &#8220;Person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#8220;Beneficial Owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%)  or more of the total voting power represented by the Company&#8217;s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company, any subsidiary of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Company, or any employee benefit plan of the Company)&#59; or (B)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Merger&#47;Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (1) a merger or consolidation of the Company whether or not approved by the Board, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such entity, as the case may be, outstanding immediately after such merger or consolidation&#59; or (2) the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or (C) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Board Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a change in the Board or its members such that individuals who, as of the Commencement Date (including Executive) or, if later, the date that is one year prior to such change (the later of such two dates referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Measurement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), constitute the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Incumbent Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) cease to constitute at least a majority of the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, however, that any individual becoming a director subsequent to the Measurement Date whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (including for these purposes, any new members whose election or nomination was so approved, without counting the member and his or her predecessor twice) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The severance payments and benefits described in Section 4(e) shall not be in addition to the severance payments and benefits described in Section 4(c) or 4(d). In the event that Executive is eligible for the severance payments and benefits under Section 4(e), Executive shall not be eligible for the severance payments and benefits under Section 4(c) or 4(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Separation Agreement&#59; Timing of Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Provision of any severance payments, benefits and equity described in Sections 4(c), 4(d) and 4(e) (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is expressly conditioned on Executive&#8217;s execution without revocation of a separation agreement and release substantially in the form attached hereto as Exhibit E, which document may be modified as necessary (and consistent with the intent of such document) to reflect changes in applicable federal, state and&#47;or local laws (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Separation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Separation Agreement shall be signed no later than sixty (60) days following the Separation Date. The Company shall commence payment of Severance Benefits on the next regular payroll date following the date on which the Separation Agreement becomes signed and irrevocable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58; (i) if the 60-day period during which the Separation Agreement is required to become signed and irrevocable crosses a tax year, then provision of the Severance Benefits shall be delayed until the second tax year&#59; (ii) if applicable, the first payment of the Severance Benefit shall include all amounts that the Company would otherwise have paid to Executive between the date on which the termination of Executive&#8217;s employment became effective and the date of the first payment&#59; and (iii) equity awards included in the Severance Benefits shall vest on the date in such 60-day period that the Separation Agreement becomes signed and irrevocable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if the 60-day period during which the Separation Agreement is required to become signed and irrevocable crosses a tax year, then such equity awards shall vest on the later of the date the Separation Agreement becomes signed and irrevocable and January 1 of the second tax year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If the payment of any COBRA or health insurance premiums by the Company on behalf of Executive as described herein would otherwise violate any applicable nondiscrimination rules or cause the reimbursement of claims to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the Health Care and Education Reconciliation Act of 2010 (collectively, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or Section 105(h) of the Code, the COBRA premiums paid by the Company shall be treated as taxable payments (subject to customary and required taxes and employment-related deductions) and be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.  If the Company determines in its reasonable discretion that it cannot provide the COBRA benefits described herein under the Company&#8217;s health insurance plan without violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a taxable lump sum payment in an amount equal to the sum of the monthly (or then remaining) COBRA premiums that Executive would be required to pay to maintain Executive&#8217;s group health insurance coverage in effect on Separation Date for the remaining portion of the period for which Executive shall receive the payments described in Sections 4(c) or 4(e) above, and subject to Section 4(f) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Forfeiture&#47;Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The compensation described in this Agreement shall be subject to any forfeiture or clawback policy established by the Company generally for executives from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive shall be entitled to indemnification with respect to Executive&#8217;s services provided hereunder pursuant to Utah law, and the Company&#8217;s Certificate of Incorporation, By-Laws and standard Director and Executive Officer Indemnification Agreement, attached as Exhibit F hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Confidentiality&#59; Prohibited Competition and Solicitation&#59; Inventions Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In light of the competitive and proprietary aspects of the business of the Company, and as a condition of Executive&#8217;s employment hereunder, Executive agrees to execute and abide by the Company&#8217;s Confidentiality, Non-Competition, Non-Solicitation and Inventions Assignment Agreement, attached as Exhibit G hereto. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Return of Property and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the termination of Executive&#8217;s employment hereunder for any reason, Executive shall&#58; (a) return to the Company all Company confidential information and copies thereof (regardless of how such confidential information or copies are maintained) then in Executive&#8217;s possession&#59; and (b) deliver to the Company any property of the Company which may be in Executive&#8217;s possession, including, but not limited to, cell phones, smart phones, laptops, products, materials, memoranda, notes, records, reports or other documents or photocopies of the same&#59; provided that Executive may retain copies of applicable benefit plans, contracts to which he personally (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, not in his capacity as a Company employee) is a party, and his personal contacts, calendars, and correspondence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Certification Regarding Conflicting Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive hereby represents and warrants that&#58; (a) the execution of this Agreement and the performance of Executive&#8217;s obligations hereunder shall not breach or be in conflict with any other agreement to which Executive is a party or is bound, or any other obligation or undertaking of Executive&#59; (b) Executive is not subject to any covenant against competition or similar covenant, or any court order, or any other legal obligation that would restrict, limit or affect the performance of Executive&#8217;s obligations hereunder&#59; (c) Executive shall not disclose to or use on behalf of the Company any proprietary information of a third party without such party&#8217;s consent&#59; and (d) all facts Executive has presented to the Company are accurate and true in all material respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Taxation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  All compensation, payments and benefits provided to Executive hereunder shall be subject to applicable and customary withholdings and deductions as required under law, statute, regulation, rule or term of any employee benefit plan in which Executive participates.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Executive acknowledges and agrees that the Company does not guarantee the tax treatment or tax consequences associated with any payment or benefit arising under this Agreement, including but not limited to consequences related to Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event that any payments or benefits set forth in this Agreement constitute &#8220;non-qualified deferred compensation&#8221; subject to Code Section 409A, then the following conditions apply to such payments or benefits&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Any termination of Executive&#8217;s employment triggering payments or benefits under Section 4 must constitute a &#8220;separation from service&#8221; under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. &#167;1.409A-1(h) before distribution of such benefits can commence.  To the extent that the termination of Executive&#8217;s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. &#167;1.409A-1(h) (as the result of further services that are reasonably anticipated to be provided by Executive to the Company at the time Executive&#8217;s employment terminates), any such payments under Section 4 that constitute deferred compensation under Code Section 409A shall be delayed until after the date of a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. &#167;1.409A-1(h).  For purposes of clarification, this Section 11(b) shall not cause any forfeiture of benefits on Executive&#8217;s part, but shall only act as a delay until such time as a &#8220;separation from service&#8221; occurs.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Notwithstanding any other provision with respect to the timing of payments  or benefits under Section 4 if, on the date of termination of Executive&#8217;s employment, Executive is deemed to be a &#8220;specified employee&#8221; of the Company (within the meaning of Section 409A(a)(2)(B)(i) of the Code), then limited only to the extent necessary to comply with the requirements of Code Section 409A, any payments or benefits to which Executive may become entitled under Section 4 which are subject to Code Section 409A (and not otherwise exempt from its application) shall be withheld until the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) business day of the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) month following the termination of Executive&#8217;s employment, at which time Executive shall be paid an aggregate amount equal to the accumulated, but unpaid, payments or benefits otherwise due to Executive under the terms of Section 4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;It is intended that each installment of the payments and benefits provided under Section 4 of this Agreement shall be treated as a separate &#8220;payment&#8221; for purposes of Code Section 409A.  Neither the Company nor Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Code Section 409A. Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall be interpreted and at all times administered in a manner that avoids the inclusion of compensation in income under Code Section 409A, or liability for increased taxes, excise taxes or other penalties under Code Section 409A.  The parties intend this Agreement to be in compliance with Code Section 409A. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 280G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If any payment or benefit Executive would receive under this Agreement, when combined with any other payment or benefit Executive receives pursuant to a Change of Control (for purposes of this section, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) would constitute a &#8220;parachute payment&#8221; within the meaning of Code Section 280G and, but for this sentence, be subject to the excise tax imposed by Code Section 4999 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), then such Payment shall be either&#58; (i) the full amount of such Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax&#59; or (ii) such lesser amount (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reduced Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) as would result in no portion of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employments taxes, income taxes and the Excise Tax, results in Executive&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;With respect to Section 12(a), if a Reduced Payment is required and there is more than one method of reducing the Reduced Payment amount that would result in no portion of the Payment being subject to the Excise Tax, then the Payment shall be reduced or eliminated in the following order (to the extent such reduction is required pursuant to Section 12(a))&#58; (i) cash severance, (ii) any payment or benefit in respect of any equity award that is treated as contingent on the change in ownership or control but is not covered by Treas. Reg. Section 1.280G-1 Q&#47;A 24(b) or (c), and (iii) any payment or benefit in respect of an equity award that is covered by Treas. Reg. Section 1.280G-1 Q&#47;A 24(c), in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the determination (as hereinafter defined).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The determination of whether Section 12(a)(i) or (ii) applies, and the calculation of the amount of the Reduced Payment if applicable, shall be performed by a nationally recognized certified public accounting firm as may be designated by the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Accounting Firm shall provide detailed supporting calculations to both the Company and Executive within fifteen (15) business days of the receipt of notice from Executive that there has been a Payment, or such earlier time as is requested by the Company, in a form that can be relied upon for tax filing purposes. All fees and expenses of the Accounting Firm shall be borne solely by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Executive may receive a Payment that is, in the aggregate, either more or less than the amount described in Section 12(a)(i) or (ii) (as applicable, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Overpayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Underpayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). If it is finally determined by a court of competent jurisdiction pursuant to a final non-appealable judgment, or the Internal Revenue Service, or by the Accounting Firm upon request by either the Company or Executive, that an Overpayment or Underpayment has been made, then&#58; (i) in the event of an Overpayment, Executive shall promptly repay the Overpayment to the Company, together with interest on the Overpayment at the applicable federal rate from the date of Executive&#8217;s receipt of such Overpayment until the date of such repayment&#59; and (ii) in the event of an Underpayment, the Company shall promptly pay an amount equal to the Underpayment to Executive, together with interest on such amount at the applicable federal rate from the date such amount would have been paid to Executive had the provisions of Section 12(a)(ii) not been applied until the date of payment.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party&#8217;s address set forth below or to such other address as a party may designate by notice hereunder, and shall be either (i)&#160;delivered by hand, (ii)&#160;sent by overnight courier, (iii)&#160;sent by registered mail, return receipt requested, postage prepaid&#59; or (iv) by electronic mail.&#160; All notices, requests, consents and other communications hereunder shall be deemed to have been given either (A)&#160;if by hand, at the time of the delivery thereof to the receiving party at the address of such party set forth in Executive&#8217;s Employment Agreement, (B)&#160;if sent by overnight courier, on the next business day following the day such notice is delivered to the courier service, (C) if sent by registered mail, on the fifth business day following the day such mailing is made or (D) if by electronic mail, then immediately upon delivery thereof to the receiving party&#8217;s email address.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Notices to Executive shall be sent to&#58;</font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The last known address in the Company&#8217;s records or such other address as Executive may specify in writing, with a copy to&#58;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">O&#8217;Melveny &#38; Myers LLP</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">610 Newport Center Drive</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17th Floor</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Newport Beach, CA 92660</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Jeffrey Walbridge, Esq.</font></div><div style="padding-left:0.36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Notices to the Company shall be sent to&#58;  </font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Myriad Genetics, Inc.</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">320 Wakara Way</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salt Lake City, Utah 84108</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Board Chair</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; General Counsel</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">or to such other the Company representative as the Company may specify in writing, with a copy to&#58;</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One Financial Center</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, MA  02111</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58;  Jonathan L. Kravetz, Esq.</font></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58;  H. Andrew Matzkin, Esq.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Modifications&#59; Amendments&#59; Waivers&#59; Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The terms of this Agreement may be modified or amended only by written agreement executed by the parties hereto. The terms of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms of this Agreement, whether or not similar.  Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall require any successor to all or substantially all of the Company&#8217;s business and&#47;or assets to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.  Executive may not assign Executive&#8217;s rights and obligations under this Agreement without the prior written consent of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by and construed in accordance with the substantive laws of the State of Utah, without giving effect to any choice or conflict of law provision or rule.  Any legal action permitted by this Agreement to enforce an award or for a claimed breach shall be governed by the laws of the State of Utah, and shall be commenced and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">maintained solely in any state or federal court located in the State of Utah, and both parties hereby submit to the jurisdiction and venue of any such court.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Headings and Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement, together with the other agreements specifically referenced herein, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.  No statement, representation, warranty, covenant or agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  For all purposes an electronic signature shall be treated as an original. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Signature Page to Follow&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PAUL J. DIAZ&#160;&#160;&#160;&#160;MYRIAD GENETICS, INC.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Paul J. Diaz                                   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;By&#58;    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; S. Louise Phanstiel                    </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Signature&#160;&#160;&#160;&#160;  S. Louise Phanstiel</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  Board Chair</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-diazpsuagre.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="id4b23c03bb524ef4811879f780f16444_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.2</font></div></div><div style="margin-top:0.12pt;padding-left:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center;text-indent:21.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">RESTRICTED STOCK UNIT AWARD NOTICE</font></div><div style="text-align:center;text-indent:21.75pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(Performance-Based) </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:51.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Name of Participant&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Paul J. Diaz<br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Grant Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">October 8, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Vesting Start Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">October 8, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Number of Restricted Stock Units (&#8220;RSUs&#8221;) Awarded&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">298,954</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.5pt">Vesting Schedule&#58; This Award shall be earned and vest as follows provided (except as otherwise set forth below) the Participant is an Employee of the Company or of an Affiliate on the applicable vesting date&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Award shall be earned based on achievement of the milestones for the fiscal year ending June 30, 2021 set forth on Appendix A hereto (the &#8220;Milestones&#8221;), with achievement of the Milestones to be evaluated by the Administrator at a meeting of the Administrator following publication of the Company&#8217;s audited financial statements for the fiscal year ending June 30, 2021 (the &#8220;Milestone Achievement Evaluation Date&#8221;).   To the extent the Award is determined to have been earned, the Award will vest as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.346%"><tr><td style="width:1.0%"></td><td style="width:27.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the Milestone Achievement Evaluation Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">25% of the Award</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the second anniversary of the Vesting Start Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">25% of the Award</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the third anniversary of the Vesting Start Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">25% of the Award</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the fourth anniversary of the Vesting Start Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">25% of the Award</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Notwithstanding the foregoing&#58;</font></div><div style="padding-left:40.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.7pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  In the event that (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(c)(iii) and 4(f) of the Employment Agreement, this Award shall vest to the extent scheduled to vest on or before the date two (2) years following the Termination Date&#59; provided that for purpose of determining the portion of this Award that will vest under this Section 5(a), (i) in the event the Termination Date is prior to the Milestone Achievement Evaluation Date, the Award shall remain outstanding and eligible to be earned on the Milestone Achievement Evaluation Date, and (ii) to the extent earned, each annual vesting installment (other than the first vesting installment) set forth above in this Section 5 shall be deemed to vest in monthly installments over the one-year period preceding the applicable scheduled annual vesting date (i.e., if an acceleration pursuant to this Section 5(a) occurred, for purposes of determining such acceleration, the 25% of the Award scheduled to vest on the Milestone Achievement Evaluation Date shall still be considered to vest on the Milestone Achievement Evaluation Date, the 25% of the Award scheduled to vest on the second anniversary of the Vesting Start Date shall be considered to vest in twelve (12) monthly installments following the first anniversary of the Vesting Start Date, and so on, and the portion of the Award that vests pursuant to this clause will be the portion of such monthly vesting installments (together with the 25% of the Award scheduled to vest on the Milestone Achievement Evaluation Date) that would be scheduled to vest on or before the date two (2) years following the Termination Date less the portion of the Award that had already vested pursuant to its terms before the Termination Date), with no additional pro-rata vesting for a portion of a month if the end of such two (2)-year period falls between the deemed monthly vesting dates&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.02pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason Following a Change of Control.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  In the event that a Change of Control occurs, and within a period of three (3) months prior to, upon, or twenty four (24) months following a Change of Control, either (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(e)(iii) and 4(f) of the Employment Agreement, this Award shall fully vest&#59; and </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.7pt;text-decoration:underline">Termination by the Company as a Result of the Participant&#8217;s Disability or Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that the Participant&#8217;s employment is terminated by the Company as a result of the Participant&#8217;s Disability or death, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(d)(ii) and 4(f) of the Employment Agreement, this Award shall vest (i) to the extent of certification by the Administrator that Achievement of any Milestone occurred prior to the Termination Date, and (ii) with respect to any earned portion of this Award, in a pro rata amount based on the period of employment between the most recent vesting date prior to the Termination Date and the Termination Date, provided that for purpose of determining the portion of the Award that vests under this Section 5(c)(ii), the annual vesting installments shall be deemed to vest in monthly installments over the applicable year of service, with no additional pro-rata vesting for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">portion of a month if the Termination Date falls between the deemed monthly vesting dates.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Award is granted to the Participant pursuant to the Participant&#8217;s Executive Employment Agreement with the Company dated August 13, 2020 (the &#8220;Employment Agreement&#8221;), and any capitalized terms not defined herein are defined in the Employment Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Company and the Participant acknowledge receipt of this Restricted Stock Unit Award notice and agree to the terms of the Restricted Stock Unit Agreement attached hereto, and the terms of this Award as set forth above (collectively, this &#8220;Agreement&#8221;).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  For all purposes an electronic signature shall be treated as an original.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:21.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">                                                                             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MYRIAD GENETICS, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">                                                                                    By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">     &#47;s&#47; S. Louise Phanstiel                        </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">                                                                                                S. Louise Phanstiel</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">                                                                                                Board Chair</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">                                                                                            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">     &#47;s&#47; Paul J. Diaz                                   </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">                                                                                                Paul J. Diaz</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AGREEMENT -</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INCORPORATED TERMS AND CONDITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AGREEMENT made as of the date of grant set forth in the Restricted Stock Unit Award Grant Notice by and between Myriad Genetics, Inc. (the &#8220;Company&#8221;), a Delaware corporation, and Paul J. Diaz (the &#8220;Participant&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to grant to the Participant RSUs related to the Company&#8217;s common stock, $0.01 par value per share (&#8220;Common Stock&#8221;), as an inducement material to the Participant&#8217;s entering into employment as President and Chief Executive Officer of the Company, effective August 13, 2020, in accordance with the terms of the Employment Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Agreement, have the following meanings&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the term Administrator means the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a corporation which, for purposes of Section 424 of the Code, is a parent or subsidiary of the Company, direct or indirect.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the United States Internal Revenue Code of 1986, as amended,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">including any successor statute, regulation and guidance thereto.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the committee of the Board of Directors to which the Board of Directors has delegated power to act.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any member of the Board of Directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disabled</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Restricted Stock Units granted as an inducement award under Nasdaq Listing Rule 5635(c)(4).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Survivor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the deceased Participant&#8217;s legal representatives and&#47;or any person or persons who acquire the Option by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grant of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company hereby grants to the Participant an award for the number of RSUs set forth in the Restricted Stock Unit Award Grant Notice (the &#8220;Award&#8221;).  Each RSU represents a contingent entitlement of the Participant to receive one share of Common Stock, on the terms and conditions and subject to all the limitations set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Vesting of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Subject to the terms and conditions set forth in this Agreement, the Award granted hereby shall vest as set forth in the Restricted Stock Unit Award Grant Notice and is subject to the other terms and conditions of this Agreement. On each vesting date set forth in the Restricted Stock Unit Award Grant Notice, the Participant shall be entitled to receive such number of shares of Common Stock equivalent to the amount of RSUs set forth opposite such vesting date provided that the Participant is employed by the Company or an Affiliate on such vesting date (except as otherwise set forth herein).  Such shares of Common Stock shall thereafter be promptly delivered (and in all events within thirty (30) days) by the Company to the Participant following the applicable vesting date and in accordance with this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Except as otherwise set forth in the Restricted Stock Unit Award Notice and this Agreement, if the Participant ceases to be employed for any reason by the Company or by an Affiliate (the &#8220;Termination Date&#8221;) prior to a vesting date set forth in the Restricted Stock Unit Award Grant Notice, then as of the Termination Date, all unvested RSUs shall immediately be forfeited to the Company and this Agreement shall terminate and be of no further force or effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Prohibitions on Transfer and Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Award (including any additional RSUs received by the Participant as a result of stock dividends, stock splits or any other similar transaction affecting the Company's securities without receipt of consideration) shall not be transferable by the Participant otherwise than (i) by will or by the laws of descent and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">distribution, (ii) pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder, or (iii) to a &#8220;family member&#8221; as such term is defined in the SEC&#8217;s General Instructions to a Registration Statement on Form S-8, pursuant to a transfer agreement approved by the Administrator (which approval shall not unreasonably be withheld) in which the family member acknowledges and agrees to the terms of this Agreement.  Except as provided in the previous sentence, the shares of Common Stock to be issued pursuant to this Agreement shall be issued, during the Participant&#8217;s lifetime, only to the Participant (or, in the event of legal incapacity or incompetency, to the Participant&#8217;s guardian or representative).  This Award shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer, assignment, pledge, hypothecation or other disposition of this Award or of any rights granted hereunder contrary to the provisions of this Section 3, or the levy of any attachment or similar process upon this Award shall be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the occurrence of any of the following events, the Participant&#8217;s rights with respect to the award shall be adjusted as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Stock Dividends and Stock Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i) the shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii) additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Common Stock, the Award and the number of shares of Common Stock deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made to reflect such events.  No fractional shares shall be issued under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Company is to be consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets other than a transaction to merely change the state of incorporation (a &#8220;Corporate Transaction&#8221;), either (a) the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder, shall make appropriate provision for the continuation of the Award by substituting on an equitable basis for the Common Stock then subject to the Award either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity, or (b) the Board of Directors may, in its discretion, provide that immediately prior to consummation of the Corporate Transaction, the Award shall be fully vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c)&#160;&#160;&#160;&#160;Recapitalization or Reorganization.  In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, the Participant shall be entitled to receive after the recapitalization or reorganization for the price paid, if any, the number of replacement securities which would have been received if such shares had been issued prior to such recapitalization or reorganization.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dissolution or Liquidation of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the dissolution or liquidation of the Company other than in connection with a transaction, recapitalization or reorganization referenced in Section 4(b) or 4(c), the RSUs will terminate and become null and void.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Securities Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant specifically acknowledges and agrees that any sales of shares of Common Stock shall be made in accordance with the requirements of the Securities Act.  If the Company does not have an effective registration statement on file with the Securities and Exchange Commission with respect to the Common Stock to be issued hereunder for any reason, the Participant will not be able to transfer or sell any of the shares of Common Stock issued to the Participant pursuant to this Agreement unless exemptions from registration or filings under applicable securities laws are available.  Furthermore, despite registration, applicable securities laws may restrict the ability of the Participant to sell his or her Common Stock, including due to the Participant&#8217;s affiliation with the Company.  The Company shall not be obligated to either issue the Common Stock or permit the resale of any shares of Common Stock if such issuance or resale would violate any applicable securities law, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the offering and sale of the shares to be issued upon the particular vesting of the Award shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue the Common Stock covered by such vesting unless and until the following conditions have been fulfilled&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Participant shall warrant to the Company, at the time of such vesting, that the Participant is acquiring the Common Stock for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such shares, in which event the Participant shall be bound by the provisions of the following legend (or a legend in substantially similar form) which shall be endorsed upon the certificate evidencing the shares issued pursuant to the Award&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1) either (a) a registration statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If the Company reasonably and in good faith determines that such an opinion is necessary, the Company shall have received an opinion of its counsel that the shares may be issued in compliance with the Securities Act without registration thereunder.  Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company reasonably and in good faith deems necessary under any applicable law (including without limitation state securities or &#8220;blue sky&#8221; laws), which the Company shall use commercially reasonable efforts to promptly obtain, provided, however, that any such delay shall not result in any liability to the Participant for any tax, penalty or interest under Section 409A of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant shall have no right as a stockholder, including voting and dividend rights, with respect to the RSUs subject to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Tax Liability of the Participant and Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant acknowledges and agrees that any income or other taxes due from the Participant with respect to this Award or the shares of Common Stock to be issued pursuant to this Agreement or otherwise sold shall be the Participant&#8217;s responsibility.  Without limiting the foregoing, the Participant agrees that if under applicable law the Participant will owe taxes at each vesting date on the portion of the Award then vested, the Company shall be entitled to immediate payment from the Participant of the amount of any tax or other amounts required to be withheld by the Company by applicable law or regulation.  Any taxes or other amounts due shall be paid, at the option of the Company as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">through reducing the number of shares of Common Stock entitled to be issued to the Participant on the applicable vesting date in an amount equal to the statutory minimum of the Participant&#8217;s total tax and other withholding obligations due and payable by the Company.  Fractional shares will not be retained to satisfy any portion of the Company&#8217;s withholding obligation.  Accordingly, the Participant agrees that in the event that the amount of withholding required would result in a fraction of a share being owed, that amount will be satisfied by withholding the fractional amount from the Participant&#8217;s paycheck&#59; or in the alternative, at the election of the Company, the Company may additionally reduce the number of shares of Common Stock entitled to be issued to the Participant on the applicable vesting date in an amount equal to those additional whole shares necessary to cover the minimum of the Participant&#8217;s total tax and other withholding obligations due and payable by the Company, and to the extent the proceeds of such sale exceed the Company&#8217;s withholding obligation, the Company agrees to pay such excess cash to the Participant as soon as practicable or to apply such excess as a payment of the Participant&#8217;s federal income tax withholding amount&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">requiring the Participant to deposit with the Company an amount of cash equal to the amount determined by the Company to be required to be withheld with respect to the statutory minimum amount of the Participant&#8217;s total tax and other withholding obligations due and payable by the Company or otherwise withholding from the Participant&#8217;s paycheck an amount equal to such amounts due and payable by the Company&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">if the Company believes that the sale of shares can be made in compliance with applicable securities laws, authorizing, at a time when the Participant is not in possession of material nonpublic information, the sale by the Participant on the applicable vesting date of such number of shares of Common Stock as the Company instructs a registered broker to sell to satisfy the Company&#8217;s withholding obligation, after deduction of the broker&#8217;s commission, and the broker shall be required to remit to the Company the cash necessary in order for the Company to satisfy its withholding obligation.  To the extent the proceeds of such sale exceed the Company&#8217;s withholding obligation the Company agrees to pay such excess cash to the Participant as soon as practicable, or to apply such excess as a payment of the Participant&#8217;s federal income tax withholding amount. In addition, if such sale is not sufficient to pay the Company&#8217;s withholding obligation the Participant agrees to pay to the Company as soon as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">practicable, including through additional payroll withholding, the amount of any withholding obligation that is not satisfied by the sale of shares of Common Stock.  The Participant agrees to hold the Company and the broker harmless from all costs, damages or expenses relating to any such sale.  The Participant acknowledges that the Company and the broker are under no obligation to arrange for such sale at any particular price.  In connection with such sale of shares of Common Stock, the Participant shall execute any such documents requested by the broker in order to effectuate the sale of shares of Common Stock and payment of the withholding obligation to the Company.  The Participant acknowledges that this paragraph is intended to comply with Section 10b5-1(c)(1(i)(B) under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">It is the Company&#8217;s intention that the Participant&#8217;s tax obligations under this Section 7 shall be satisfied through the procedure of Subsection (c) above, unless the Company provides notice of an alternate procedure under this Section, in its discretion. The Company shall not deliver any shares of Common Stock to the Participant until it is satisfied that all required withholdings have been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Participant Acknowledgements and Authorizations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Participant acknowledges the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The Company is not by this Award obligated to continue the Participant as an employee of the Company or an Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The grant of this Award is considered a one-time benefit and does not create a contractual or other right to receive any other award, benefits in lieu of awards or any other benefits in the future.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The value of this Award is an extraordinary item of compensation outside of the scope of the Participant&#8217;s employment or consulting contract, if any.  As such the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.  The future value of the shares of Common Stock is unknown and cannot be predicted with certainty.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The Participant (i) authorizes the Company and each Affiliate and any agent of the Company or any Affiliate facilitating the grant or administration of the Award, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant or administration of the Award&#59; and (ii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth in this Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;padding-left:27pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  Any notices required or permitted by the terms of this Agreement shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Company&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Myriad Genetics, Inc.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; General Counsel </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">320 Wakara Way</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Salt Lake City, UT 84108</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Participant, to the last known address provided to the Human Resources department by the Participant or to such other address or addresses of which notice in the same manner has previously been given.  Any such notice shall be deemed to have been given on the earliest of receipt, one business day following delivery by the sender to a recognized courier service, or three business days following mailing by registered or certified mail.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Assignment and Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant&#8217;s legal representatives.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns&#59; provided that the Company shall not assign this Agreement except to a parent entity, or a successor to all or substantially all of the business or assets of the Company (or a parent thereof), in a transaction or event to which Section 10 applies.  To the extent the Award continues after such event or there remains any unsatisfied obligation of the Company pursuant to Section 4, the Company shall require any successor to all or substantially all of the Company&#8217;s business and&#47;or assets to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without giving effect to the conflict of law principles thereof.  For the purpose of litigating any dispute that arises under this Agreement, whether at law or in equity, the parties hereby consent to exclusive jurisdiction in the state of Utah and agree that such litigation shall be conducted in the state courts of the state of Utah or the federal courts of the United States for the District of Utah.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, then such provision or provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible, then such provision shall be deemed to be excised from this Agreement, and the validity, legality and enforceability of the rest of this Agreement shall not be affected thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement and the relevant provisions of the Employment Agreement, constitute the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Modifications and Amendments&#59; Waivers and Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement may be modified or amended by the Administrator&#59; provided, however, any modification or amendment of this Agreement shall not, without the consent of the Participant, adversely affect the Participant&#8217;s rights under this Agreement, unless such amendment is required by applicable law.  The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar.  Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award of RSUs evidenced by this Agreement is intended to be exempt from the nonqualified deferred compensation rules of Section 409A of the Code as a &#8220;short term deferral&#8221; (as that term is used in the final regulations and other guidance issued under Section 409A of the Code, including Treasury Regulation Section 1.409A-1(b)(4)(i)), and shall be construed accordingly.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained in this Agreement, the Company may recover from the Participant any compensation received from the Award (whether or not settled) or cause the Participant to forfeit the Award (whether or not vested) in accordance with any forfeiture or clawback policy established by the Company generally for executives from time to time.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>exhibit103-diazrsuagre.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i6758dad2edd746628b502849ce905d37_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.3</font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MYRIAD GENETICS, INC.</font></div><div style="margin-top:0.12pt;padding-left:0.36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD NOTICE </font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Time-Based)</font></div><div style="padding-right:36pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;padding-right:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:51.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Name of Participant&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Paul J. Diaz<br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Grant Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">August 13, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Vesting Start Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">August 13, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt">Number of Restricted Stock Units (&#8220;RSUs&#8221;) Awarded&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">298,954</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.5pt">Vesting Schedule&#58; This Award shall vest as follows provided (except as otherwise set forth below) the Participant is an Employee of the Company or of an Affiliate on the applicable vesting date&#58;</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.346%"><tr><td style="width:1.0%"></td><td style="width:27.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the first anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">50% of the Award</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the second anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">16.66% of the Award</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the third anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">16.66% of the Award</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the fourth anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">16.68% of the Award</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Notwithstanding the foregoing&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.7pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In the event that (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(c)(iii) and 4(f) of the Employment Agreement, this Award shall vest to the extent scheduled to vest on or before the date two (2) years following the Termination Date&#59; provided that for purpose of determining the portion of this Award that will vest under this Section 5(a), each annual vesting installment set forth above in this Section 5 shall be deemed to vest in monthly installments over the one-year period preceding the applicable scheduled annual vesting date (i.e., if an acceleration pursuant to this Section 5(a) occurred, for purposes of determining such </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">acceleration, the 50% of the Award scheduled to vest on the first anniversary of the Vesting Start Date shall be deemed to vest in twelve (12) monthly installments following the Vesting Start Date, the 16.66% of the Award scheduled to vest on the second anniversary of the Vesting Start Date shall be deemed to vest in twelve (12) monthly installments following the first anniversary of the Vesting Start Date, and so on, and the portion of the Award that vests pursuant to this clause will be the portion of such monthly vesting installments that would be scheduled to vest on or before the date two (2) years following the Termination Date less the portion of the Award that had already vested pursuant to its terms before the Termination Date), with no additional pro-rata vesting for a portion of a month if the end of such two (2)-year period falls between the deemed monthly vesting dates&#59; and </font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.02pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason Following a Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that a Change of Control occurs, and within a period of three (3) months prior to, upon, or twenty four (24) months following a Change of Control, either (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(e)(iii) and 4(f) of the Employment Agreement, this Award shall fully vest&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:4.7pt;text-decoration:underline">Termination by the Company as a Result of the Participant&#8217;s Disability or Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that the Participant&#8217;s employment is terminated by the Company as a result of the Participant&#8217;s Disability or death, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(d)(ii) and 4(f) of the Employment Agreement, this Award shall vest in a pro rata amount based on the period of employment between the most recent vesting date prior to the Termination Date and the Termination Date, provided that for purpose of determining the portion of the Award that vests under this Section 5(c), the annual vesting installments shall be deemed to vest in monthly installments over the applicable year of service, with no additional pro-rata vesting for a portion of a month if the Termination Date falls between the deemed monthly vesting dates.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Award is granted to the Participant pursuant to the Participant&#8217;s Executive Employment Agreement with the Company dated August 13, 2020 (the &#8220;Employment Agreement&#8221;), and any capitalized terms not defined herein are defined in the Employment Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Company and the Participant acknowledge receipt of this Restricted Stock Unit Award notice and agree to the terms of the Restricted Stock Unit Agreement attached hereto, and the terms of this Award as set forth above (collectively, this &#8220;Agreement&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  For all purposes an electronic signature shall be treated as an original.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:27pt;text-align:justify"><font><br></font></div><div style="padding-left:21.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; S. Louise Phanstiel                        </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            S. Louise Phanstiel</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            Board Chair</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Paul J. Diaz             &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            Paul J. Diaz</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            </font></div><div><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AGREEMENT -</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INCORPORATED TERMS AND CONDITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AGREEMENT made as of the date of grant set forth in the Restricted Stock Unit Award Grant Notice by and between Myriad Genetics, Inc. (the &#8220;Company&#8221;), a Delaware corporation, and Paul J. Diaz (the &#8220;Participant&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to grant to the Participant RSUs related to the Company&#8217;s common stock, $0.01 par value per share (&#8220;Common Stock&#8221;), as an inducement material to the Participant&#8217;s entering into employment as President and Chief Executive Officer of the Company, effective August 13, 2020, in accordance with the terms of the Employment Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Agreement, have the following meanings&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the term Administrator means the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a corporation which, for purposes of Section 424 of the Code, is a parent or subsidiary of the Company, direct or indirect.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the United States Internal Revenue Code of 1986, as amended,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">including any successor statute, regulation and guidance thereto.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the committee of the Board of Directors to which the Board of Directors has delegated power to act.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any member of the Board of Directors.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disabled</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement. </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Restricted Stock Units granted as an inducement award under Nasdaq Listing Rule 5635(c)(4).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Survivor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the deceased Participant&#8217;s legal representatives and&#47;or any person or persons who acquire the Option by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Grant of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company hereby grants to the Participant an award for the number of RSUs set forth in the Restricted Stock Unit Award Grant Notice (the &#8220;Award&#8221;).  Each RSU represents a contingent entitlement of the Participant to receive one share of Common Stock, on the terms and conditions and subject to all the limitations set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Vesting of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Subject to the terms and conditions set forth in this Agreement, the Award granted hereby shall vest as set forth in the Restricted Stock Unit Award Grant Notice and is subject to the other terms and conditions of this Agreement. On each vesting date set forth in the Restricted Stock Unit Award Grant Notice, the Participant shall be entitled to receive such number of shares of Common Stock equivalent to the amount of RSUs set forth opposite such vesting date provided that the Participant is employed by the Company or an Affiliate on such vesting date (except as otherwise set forth herein).  Such shares of Common Stock shall thereafter be promptly delivered (and in all events within thirty (30) days) by the Company to the Participant following the applicable vesting date and in accordance with this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Except as otherwise set forth in the Restricted Stock Unit Award Notice and this Agreement, if the Participant ceases to be employed for any reason by the Company or by an Affiliate (the &#8220;Termination Date&#8221;) prior to a vesting date set forth in the Restricted Stock Unit Award Grant Notice, then as of the Termination Date, all unvested RSUs shall immediately be forfeited to the Company and this Agreement shall terminate and be of no further force or effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Prohibitions on Transfer and Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Award (including any additional RSUs received by the Participant as a result of stock dividends, stock splits or any other similar transaction affecting the Company's securities without receipt of consideration) shall not be transferable by the Participant otherwise than (i) by will or by the laws of descent and distribution, (ii) pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder, or (iii) to a &#8220;family member&#8221; as such term is defined in the SEC&#8217;s General Instructions to a Registration Statement </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">on Form S-8, pursuant to a transfer agreement approved by the Administrator (which approval shall not unreasonably be withheld) in which the family member acknowledges and agrees to the terms of this Agreement. Except as provided in the previous sentence, the shares of Common Stock to be issued pursuant to this Agreement shall be issued, during the Participant&#8217;s lifetime, only to the Participant (or, in the event of legal incapacity or incompetency, to the Participant&#8217;s guardian or representative).  This Award shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer, assignment, pledge, hypothecation or other disposition of this Award or of any rights granted hereunder contrary to the provisions of this Section 3, or the levy of any attachment or similar process upon this Award shall be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the occurrence of any of the following events, the Participant&#8217;s rights with respect to the award shall be adjusted as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Stock Dividends and Stock Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i) the shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii) additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Common Stock, the Award and the number of shares of Common Stock deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made to reflect such events.  No fractional shares shall be issued under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Company is to be consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets other than a transaction to merely change the state of incorporation (a &#8220;Corporate Transaction&#8221;), either (a) the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder, shall make appropriate provision for the continuation of the Award by substituting on an equitable basis for the Common Stock then subject to the Award either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity, or (b) the Board of Directors may, in its discretion, provide that immediately prior to consummation of the Corporate Transaction, the Award shall be fully vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recapitalization or Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, the Participant shall be entitled to receive after the recapitalization or reorganization for the price paid, if any, the number of replacement securities which would have been received if such shares had been issued prior to such recapitalization or reorganization.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dissolution or Liquidation of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the dissolution or liquidation of the Company other than in connection with a transaction, recapitalization or reorganization referenced in Section 4(b) or 4(c), the RSUs will terminate and become null and void.</font></div><div><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Securities Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant specifically acknowledges and agrees that any sales of shares of Common Stock shall be made in accordance with the requirements of the Securities Act.  If the Company does not have an effective registration statement on file with the Securities and Exchange Commission with respect to the Common Stock to be issued hereunder for any reason, the Participant will not be able to transfer or sell any of the shares of Common Stock issued to the Participant pursuant to this Agreement unless exemptions from registration or filings under applicable securities laws are available.  Furthermore, despite registration, applicable securities laws may restrict the ability of the Participant to sell his or her Common Stock, including due to the Participant&#8217;s affiliation with the Company.  The Company shall not be obligated to either issue the Common Stock or permit the resale of any shares of Common Stock if such issuance or resale would violate any applicable securities law, rule or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the offering and sale of the shares to be issued upon the particular vesting of the Award shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue the Common Stock covered by such vesting unless and until the following conditions have been fulfilled&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Participant shall warrant to the Company, at the time of such vesting, that the Participant is acquiring the Common Stock for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such shares, in which event the Participant shall be bound by the provisions of the following legend (or a legend in substantially similar form) which shall be endorsed upon the certificate evidencing the shares issued pursuant to the Award&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1) either (a) a registration statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If the Company reasonably and in good faith determines that such an opinion is necessary, the Company shall have received an opinion of its counsel that the shares may be issued in compliance with the Securities Act without registration thereunder.  Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company reasonably and in good faith deems necessary under any applicable law (including without limitation state securities or &#8220;blue sky&#8221; laws), which the Company shall use commercially reasonable efforts to promptly obtain, provided, however, that any such delay shall not result in any liability to the Participant for any tax, penalty or interest under Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant shall have no right as a stockholder, including voting and dividend rights, with respect to the RSUs subject to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Tax Liability of the Participant and Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant acknowledges and agrees that any income or other taxes due from the Participant with respect to </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">this Award or the shares of Common Stock to be issued pursuant to this Agreement or otherwise sold shall be the Participant&#8217;s responsibility.  Without limiting the foregoing, the Participant agrees that if under applicable law the Participant will owe taxes at each vesting date on the portion of the Award then vested, the Company shall be entitled to immediate payment from the Participant of the amount of any tax or other amounts required to be withheld by the Company by applicable law or regulation.  Any taxes or other amounts due shall be paid, at the option of the Company as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">through reducing the number of shares of Common Stock entitled to be issued to the Participant on the applicable vesting date in an amount equal to the statutory minimum of the Participant&#8217;s total tax and other withholding obligations due and payable by the Company.  Fractional shares will not be retained to satisfy any portion of the Company&#8217;s withholding obligation.  Accordingly, the Participant agrees that in the event that the amount of withholding required would result in a fraction of a share being owed, that amount will be satisfied by withholding the fractional amount from the Participant&#8217;s paycheck&#59; or in the alternative, at the election of the Company, the Company may additionally reduce the number of shares of Common Stock entitled to be issued to the Participant on the applicable vesting date in an amount equal to those additional whole shares necessary to cover the minimum of the Participant&#8217;s total tax and other withholding obligations due and payable by the Company, and to the extent the proceeds of such sale exceed the Company&#8217;s withholding obligation, the Company agrees to pay such excess cash to the Participant as soon as practicable or to apply such excess as a payment of the Participant&#8217;s federal income tax withholding amount&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">requiring the Participant to deposit with the Company an amount of cash equal to the amount determined by the Company to be required to be withheld with respect to the statutory minimum amount of the Participant&#8217;s total tax and other withholding obligations due and payable by the Company or otherwise withholding from the Participant&#8217;s paycheck an amount equal to such amounts due and payable by the Company&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">if the Company believes that the sale of shares can be made in compliance with applicable securities laws, authorizing, at a time when the Participant is not in possession of material nonpublic information, the sale by the Participant on the applicable vesting date of such number of shares of Common Stock as the Company instructs a registered broker to sell to satisfy the Company&#8217;s withholding obligation, after deduction of the broker&#8217;s commission, and the broker shall be required to remit to the Company the cash necessary in order for the Company to satisfy its withholding obligation.  To the extent the proceeds of such sale exceed the Company&#8217;s withholding obligation the Company agrees to pay such excess cash to the Participant as soon as practicable, or to apply such excess as a payment of the Participant&#8217;s federal income tax withholding amount. In addition, if such sale is not sufficient to pay the Company&#8217;s withholding obligation the Participant agrees to pay to the Company as soon as practicable, including through additional payroll withholding, the amount of any withholding obligation that is not satisfied by the sale of shares of Common Stock.  The Participant agrees to hold the Company and the broker harmless from all costs, damages or expenses relating to any such sale.  The Participant acknowledges that the Company and the broker are under no obligation to arrange for such sale at any particular price.  In connection with such sale of shares of Common Stock, the Participant shall execute any such documents requested by the broker in </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">order to effectuate the sale of shares of Common Stock and payment of the withholding obligation to the Company.  The Participant acknowledges that this paragraph is intended to comply with Section 10b5-1(c)(1(i)(B) under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">It is the Company&#8217;s intention that the Participant&#8217;s tax obligations under this Section 7 shall be satisfied through the procedure of Subsection (c) above, unless the Company provides notice of an alternate procedure under this Section, in its discretion. The Company shall not deliver any shares of Common Stock to the Participant until it is satisfied that all required withholdings have been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Participant Acknowledgements and Authorizations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Participant acknowledges the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The Company is not by this Award obligated to continue the Participant as an employee of the Company or an Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The grant of this Award is considered a one-time benefit and does not create a contractual or other right to receive any other award, benefits in lieu of awards or any other benefits in the future.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The value of this Award is an extraordinary item of compensation outside of the scope of the Participant&#8217;s employment or consulting contract, if any.  As such the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.  The future value of the shares of Common Stock is unknown and cannot be predicted with certainty.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The Participant (i) authorizes the Company and each Affiliate and any agent of the Company or any Affiliate facilitating the grant or administration of the Award, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant or administration of the Award&#59; and (ii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth in this Agreement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;padding-left:27pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">.  Any notices required or permitted by the terms of this Agreement shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Company&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Myriad Genetics, Inc.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; General Counsel </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">320 Wakara Way</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Salt Lake City, UT 84108</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Participant, to the last known address provided to the Human Resources department by the Participant or to such other address or addresses of which notice in the same manner has previously been given.  Any such notice shall be deemed to have been given on the earliest of receipt, one business day following delivery by the sender to a recognized courier service, or three business days following mailing by registered or certified mail.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Assignment and Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant&#8217;s legal representatives.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns&#59; provided that the Company shall not assign this Agreement except to a parent entity, or a successor to all or substantially all of the business or assets of the Company (or a parent thereof), in a transaction or event to which Section 10 applies.  To the extent the Award continues after such event or there remains any unsatisfied obligation of the Company pursuant to Section 4, the Company shall require any successor to all or substantially all of the Company&#8217;s business and&#47;or assets to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without giving effect to the conflict of law principles thereof.  For the purpose of litigating any dispute that arises under this Agreement, whether at law or in equity, the parties hereby consent to exclusive jurisdiction in the state of Utah and agree that such litigation shall be conducted in the state courts of the state of Utah or the federal courts of the United States for the District of Utah.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, then such provision or provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible, then such provision shall be deemed to be excised from this Agreement, and the validity, legality and enforceability of the rest of this Agreement shall not be affected thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement and the relevant provisions of the Employment Agreement, constitute the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Modifications and Amendments&#59; Waivers and Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement may be modified or amended by the Administrator&#59; provided, however, any modification or amendment of this Agreement shall not, without the consent of the Participant, adversely affect the Participant&#8217;s rights under this Agreement, unless such amendment is required by applicable law.  The terms and provisions of this Agreement may be waived, or </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar.  Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award of RSUs evidenced by this Agreement is intended to be exempt from the nonqualified deferred compensation rules of Section 409A of the Code as a &#8220;short term deferral&#8221; (as that term is used in the final regulations and other guidance issued under Section 409A of the Code, including Treasury Regulation Section 1.409A-1(b)(4)(i)), and shall be construed accordingly.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained in this Agreement, the Company may recover from the Participant any compensation received from the Award (whether or not settled) or cause the Participant to forfeit the Award (whether or not vested) in accordance with any forfeiture or clawback policy established by the Company generally for executives from time to time.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>exhibit104-diazperform.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i60db4ac21d024543ba683dd4864f0a06_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.4</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NON-QUALIFIED STOCK OPTION GRANT NOTICE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Performance-Based) </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.         Name of Participant&#58;                                      Paul J. Diaz</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.         Date of Option Grant&#58;                                    August 13, 2020</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.         Maximum Number of Shares for</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">            which this Option is exercisable&#58;                   339,088</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.         Exercise (purchase) price per share&#58;              $13.38</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.         Option Expiration Date&#58;                                 August 13, 2027</font></div><div><font><br></font></div><div style="padding-left:247.5pt;text-indent:-247.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6.         Vesting Start Date&#58;                                        This option shall vest and become                                                                                                exercisable as provided below, but in no                                                                               event earlier than August 13, 2021  </font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Vesting Schedule&#58;  This Option shall become vested and exercisable (and the Shares issued upon exercise shall be vested) on the date of certification by the Administrator of the achievement of the following milestone stock prices (each, a &#8220;Milestone Stock Price&#8221;), provided (except as otherwise set forth below) the Participant is an Employee of the Company or of an Affiliate on the applicable vesting date&#59; and provided further that no portion of the Option may vest (except as otherwise set forth below) earlier than August 13, 2021&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">20% of the Option shall vest upon Achievement (as defined below) of a stock price that exceeds 1.5x the exercise price per share of the Option&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">20% of the Option shall vest upon Achievement of a stock price that exceeds 2.0x the exercise price per share of the Option&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt"> 20% of the Option shall vest upon Achievement of a stock price that exceeds 2.5x the exercise price per share of the Option&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">20% of the Option shall vest upon Achievement of a stock price that exceeds 3.0x the exercise price per share of the Option&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">20% of the Option shall vest upon Achievement of a stock price that exceeds 3.5x the exercise price per share of the Option.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;Achievement&#8221; of each applicable Milestone Stock Price shall be based on the average of the closing prices of the Common Stock on the Nasdaq Stock Market for a period of twenty (20) consecutive trading days exceeding the applicable Milestone Stock Price.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the avoidance of doubt, upon the achievement of any of the Milestone Stock Prices described in clauses (b) through (e), above, the Milestone Stock Prices in the preceding clauses shall also be deemed achieved.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">n the event that (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(c)(iii) and 4(f) of the Employment Agreement, to the extent this Option is not fully vested as of the Termination Date, this Option shall remain outstanding and eligible for additional Milestone Stock Price vesting for two (2) years following the Termination Date, but in no event later than the Option Expiration Date&#59; and </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason Following a Change of Control.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  In the event that a Change of Control occurs, and within a period of three (3) months prior to, upon, or twenty four (24) months following a Change of Control, either (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(e)(iii) and 4(f) of the Employment Agreement, this Option shall become fully vested and exercisable&#59; and </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt;text-decoration:underline">Termination by the Company as a Result of the Participant&#8217;s Disability or Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that the Participant&#8217;s employment is terminated by the Company as a result of the Participant&#8217;s Disability or death, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(d)(ii) and 4(f) of the Employment Agreement, this Option shall become vested and exercisable to the extent of certification by the Administrator that Achievement of any Milestone occurred prior to the Termination Date. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing rights are cumulative and are subject to the other terms and conditions of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Option is granted to the Participant pursuant to the Participant&#8217;s Executive Employment Agreement with the Company dated August 13, 2020 (the &#8220;Employment Agreement&#8221;), and any capitalized terms not defined herein are defined in the Employment Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company and the Participant acknowledge receipt of this Stock Option Grant Notice and agree to the terms of the Stock Option Agreement attached hereto, and the terms of this Option Grant as set forth above (collectively, this &#8220;Agreement&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  For all purposes an electronic signature shall be treated as an original.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; S. Louise Phanstiel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            S. Louise Phanstiel</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            Board Chair</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Paul J. Diaz&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            Paul J. Diaz</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i60db4ac21d024543ba683dd4864f0a06_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">NON-QUALIFIED STOCK OPTION AGREEMENT </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AGREEMENT made as of the date of grant set forth in the Stock Option Grant Notice by and between Myriad Genetics, Inc. (the &#8220;Company&#8221;), a Delaware</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">corporation, and Paul J. Diaz (the &#8220;Participant&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to grant to the Participant an Option to purchase shares of its common stock, $.01 par value per share (&#8220;Common Stock&#8221; or the &#8220;Shares&#8221;) as an inducement material to the Participant&#8217;s entering into employment as President and Chief Executive Officer of the Company, effective August 13, 2020, in accordance with the terms of the Employment Agreement&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and the Participant each intend that the Option granted herein shall be a non-qualified stock option.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">DEFINITIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Agreement, have the following meanings&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the term Administrator means the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a corporation which, for purposes of Section 424 of the Code, is a parent or subsidiary of the Company, direct or indirect.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the United States Internal Revenue Code of 1986, as amended,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">including any successor statute, regulation and guidance thereto.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the committee of the Board of Directors to which the Board of Directors has delegated power to act.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any member of the Board of Directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disabled</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of a Share of Common Stock means&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting system for the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Common Stock is not traded on a national securities exchange but is traded on the over-the-counter market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in the preceding paragraph, and if bid and asked prices for the Common Stock are regularly reported, the mean between the bid and the asked price for the Common Stock at the close of trading in the over-the-counter market for the trading day on which Common Stock was traded on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Common Stock is neither listed on a national securities exchange nor traded in the over-the-counter market, such value as the Administrator, in good faith, shall determine in compliance with applicable laws.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Qualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an option which is not intended to qualify as an incentive stock option under Section&#160;422 of the Code.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a Non-Qualified Option granted as an inducement award under Nasdaq Listing Rule 5635(c)(4).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Participant is an Employee of the Company or an Affiliate, a consultant to the Company or an Affiliate, or a member of the board of directors of the Company or an Affiliate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Survivor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the deceased Participant&#8217;s legal representatives and&#47;or any person or persons who acquire the Option by will or by the laws of descent and distribution.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GRANT OF OPTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of the number of Shares set forth in the Stock Option Grant Notice, on the terms and conditions and subject to all the limitations set forth herein and under United States securities and tax laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EXERCISE PRICE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The exercise price of the Shares covered by the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to adjustment, as provided in Section 10, in the event of a stock split, reverse stock split or other events affecting the holders of Shares after the date hereof (the &#8220;Exercise Price&#8221;).  Payment shall be made in accordance with Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of this Agreement.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EXERCISABILITY OF OPTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to the terms and conditions set forth in this Agreement, the Option granted hereby shall become vested and exercisable as set forth in the Stock Option Grant Notice and is subject to the other terms and conditions of this Agreement.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">TERM OF OPTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Option shall terminate on the Option Expiration Date as specified in the Stock Option Grant Notice, but shall be subject to earlier termination as provided herein. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If the Participant&#8217;s Service ceases (the date the Participant&#8217;s Service ceases is referred to as the &#8220;Termination Date&#8221;) for any reason other than (i) termination of the Participant by the Company without Cause or by the Participant for Good Reason, (ii) the death or Disability of the Participant, or (iii) termination of the Participant for Cause (including any related resignation or removal from the Board of Directors related thereto), the Option to the extent then vested and exercisable pursuant to Section 4 hereof as of the Termination Date, and not previously terminated in accordance with this Agreement, may be exercised within three months after the Termination Date, or on or prior to the Option Expiration Date as specified in the Stock Option Grant Notice, whichever is earlier, but may not be exercised thereafter except as set forth below in the last paragraph of this Section 5.  In such event, the unvested portion of the Option shall not be exercisable and shall expire and be cancelled as of the Termination Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Participant&#8217;s Service ceases as a result of (i) termination by the Company without Cause (excluding termination as a result of Disability or death), or (ii) termination by the Participant for Good Reason, the Option to the extent vested and exercisable pursuant to Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4 hereof (including the acceleration provisions of Section 7(b) of the Grant Notice) as of the Termination Date, and not previously terminated in accordance with this Agreement, may be exercised within three months after the Termination Date, or on or prior to the Option Expiration Date as specified in the Stock Option Grant Notice, whichever is earlier, but may not be exercised thereafter&#59; provided, however, that, subject to and in accordance with the provisions of this Agreement and Sections 4(c)(iii) and 4(f) of the Employment Agreement, to the extent the Option is not vested, the Option shall remain outstanding and eligible for vesting for two (2) years following the Termination Date, but in no event later than the Option Expiration Date, and upon any such vesting, the Option may be exercised within three months after the vesting date. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event the Participant&#8217;s Service is terminated by the Company or an Affiliate for Cause (including any related resignation or removal from the Board of Directors related thereto), the Participant&#8217;s right to exercise any unexercised portion of this Option even if vested shall cease immediately as of the time the Participant is notified pursuant to the Employment Agreement that his Service is terminated for Cause, and this Option shall thereupon terminate. Notwithstanding anything herein to the contrary, if subsequent to the Participant&#8217;s termination, but prior to the exercise of the Option, the Administrator determines that, prior to the Participant&#8217;s termination, the Participant engaged in conduct which would constitute Cause, then the Participant shall immediately cease to have any right to exercise the Option and this Option shall thereupon terminate.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event of the death or Disability of the Participant, the Option shall be exercisable, to the extent that the Option has become exercisable but has not been exercised as of the date of death or Disability, within one year after the Participant&#8217;s termination due to death or Disability or, if earlier, on or prior to the Option Expiration Date as specified in the Stock Option Grant Notice.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, other than in the event of termination by the Company for Cause, in the event of the Participant&#8217;s Disability or death within three months after the Termination Date, the Participant or the Participant&#8217;s Survivors may exercise the Option, to the extent vested as of the Termination Date, within one year after the Termination Date, but in no event after the Option Expiration Date as specified in the Stock Option Grant Notice.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">METHOD OF EXERCISING OPTION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to the terms and conditions of this Agreement, the Option may be exercised by written notice to the Company or its designee, in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> attached hereto (or in such other form acceptable to the Company, which may include electronic notice).  Such notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Company).  Payment of the Exercise Price for such Shares and any tax withholding obligations arising in connection with an exercise of the Option shall be made (a) in United States dollars in cash or by check&#59; or (b) at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six months (if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">required to avoid negative accounting treatment) having a Fair Market Value (as defined below) equal as of the date of the exercise to the aggregate cash exercise price (and related withholding obligations) for the number of Shares as to which the Option is being exercised&#59; (c) at the discretion of the Administrator, by having the Company retain from the Shares otherwise issuable upon exercise of the Option, a number of Shares having a Fair Market Value equal as of the date of exercise to the aggregate exercise price for the number of Shares as to which the Option is being exercised (and related withholding obligations)&#59; or (d) in accordance with a cashless exercise program established at the discretion of the Company with a securities brokerage firm&#59; or (e) at the discretion of the Administrator, by any combination of (a), (b), (c) and (d) above&#59; or (f) at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine.  The Company shall deliver such Shares as soon as practicable after the notice shall be received, provided, however, that the Company may delay issuance of such Shares until completion of any action or obtaining of any consent (which the Company will use commercially reasonable efforts to promptly obtain), which the Company reasonably deems necessary under any applicable law (including, without limitation, state securities or &#8220;blue sky&#8221; laws).  The Shares as to which the Option shall have been so exercised shall be registered in the Company&#8217;s share register in the name of the person so exercising the Option (or, if the Option shall be exercised by the Participant and if the Participant shall so request in the notice exercising the Option, shall be registered in the Company&#8217;s share register in the name of the Participant and another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the person exercising the Option.  In the event the Option shall be exercised, pursuant to Section 5 hereof, by any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option.  All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable. The Company will use commercially reasonable efforts to register, under the Securities Act of 1933, as amended, the offer and sale to the Participant of the Shares subject to the Option.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PARTIAL EXERCISE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Exercise of this Option to the extent above stated may be made in part at any time and from time to time within the above limits, except that no fractional share shall be issued pursuant to this Option.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-ASSIGNABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Option shall not be transferable by the Participant otherwise than (a) by will or by the laws of descent and distribution, (b) pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder, or (c) to a &#8220;family member&#8221; as such term is defined in the SEC&#8217;s General Instructions to a Registration Statement on Form S-8, pursuant to a transfer agreement approved by the Administrator (which approval shall not unreasonably be withheld) in which the family member acknowledges and agrees to the terms of this Agreement.  Except as provided above in this paragraph, the Option shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant (or, in the event of legal incapacity or incompetency, by the Participant&#8217;s guardian or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer, assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 8, or the levy of any attachment or similar process upon the Option shall be null and void.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until registration of the Shares in the Company&#8217;s share register in the name of the Participant.  Except as is expressly provided in Section 10 of this Agreement with respect to certain changes in the capitalization of the Company, no adjustment shall be made for dividends or similar rights for which the record date is prior to the date of such registration.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ADJUSTMENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon the occurrence of any of the following events, the Participant&#8217;s rights with respect to the Option shall be adjusted as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Dividends and Stock Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i)&#160;the Shares shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any Shares as a stock dividend on its outstanding Shares, or (ii)&#160;additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares, the Option and the number of Shares deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made including, in the exercise price per share, to reflect such events.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Company is to be consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets, or the acquisition of all of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a single entity other than a transaction to merely change the state of incorporation (a &#8220;Corporate Transaction&#8221;), the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the &#8220;Successor Board&#8221;), shall, as to the unexercised portion of the Option, either (i) make appropriate provision for the continuation of the Option by substituting on an equitable basis for the Shares then subject to the Option either the consideration payable with respect to the outstanding Shares in connection with the Corporate Transaction or securities of any successor or acquiring entity&#59; or (ii) upon written notice to the Participant, provide that the Option is fully vested and exercisable and must be exercised within a specified number of days of the date of such notice (such specified number of days to give the Participant reasonable notice of the impending termination and a reasonable opportunity to exercise the Option during such notice period), at the end of which period the Option shall terminate&#59; or (iii) terminate the Option in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to the holder of the number of Shares into which the Option would have been exercisable (assuming the Option was fully vested and exercisable) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">less the aggregate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> exercise price thereof.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of determining the payments to be made pursuant to Subclause (iii) above, in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined reasonably and in good faith by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recapitalization or Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding Shares, the Participant upon exercising the Option after the recapitalization or reorganization shall be entitled to receive for the price paid upon such exercise or acceptance if any, the number of replacement securities which would have been received if the Option had been exercised prior to such recapitalization or reorganization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Modification of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, any adjustments made pursuant to Subsection (a), (b) or (c) above shall be made only after the Administrator determines whether such adjustments would cause any adverse tax consequences, including, but not limited to, pursuant to Section 409A of the Code.  If the Administrator determines that such adjustments would constitute a modification of the Option or other adverse tax consequence to the Participant, it may refrain from making such adjustments, unless the Participant specifically agrees in writing that such adjustment be made and agrees to accept full responsibility for any tax liability resulting therefrom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dissolution or Liquidation of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the dissolution or liquidation of the Company other than in connection with a transaction, recapitalization or reorganization referenced in Section 10(b) or 10(c), the Option will terminate and become null and void&#59; provided, however, that if the rights of the Participant or the Participant&#8217;s Survivors have not otherwise terminated and expired, the Participant or the Participant&#8217;s Survivors will have the right immediately prior to such dissolution or liquidation to exercise the Option to the extent that the Option is exercisable as of the date immediately prior to such dissolution or liquidation.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">TAXES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant acknowledges and agrees that (i) any income or other taxes due from the Participant with respect to this Option or the Shares issuable pursuant to this Option shall be the Participant&#8217;s responsibility&#59; (ii) the Participant was free to use professional advisors of his or her choice in connection with this Agreement, has received advice from his or her professional advisors in connection with this Agreement, understands its meaning and import, and is entering into this Agreement freely and without coercion or duress&#59; (iii) the Participant has not received and is not relying upon any advice, representations or assurances made by or on behalf of the Company or any Affiliate or any employee of or counsel to the Company or any Affiliate regarding any tax or other effects or implications of the Option, the Shares or other matters contemplated by this Agreement&#59; and (iv) neither the Administrator, the Company, its Affiliates, nor any of its officers or directors, shall be held liable for any applicable costs, taxes, or penalties associated with the Option if, in fact, the Internal Revenue Service were to determine that the Option constitutes deferred compensation under Section 409A of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant agrees that the Company may withhold from the Participant&#8217;s remuneration, if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered compensation includable in such person&#8217;s gross income (to the extent such withholding obligations are not satisfied as provided in Section 6).  At the Company&#8217;s discretion, the amount required to be withheld  (to the extent such withholding obligations are not satisfied as provided in Section 6) may be withheld in cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant on exercise of the Option.  The Participant further agrees that, if the Company does not withhold an amount from the Participant&#8217;s remuneration sufficient to satisfy the Company&#8217;s income tax withholding obligation and such withholding obligations are not satisfied as provided in Section 6, the Participant will reimburse the Company on demand, in cash, for the amount under-withheld.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PURCHASE FOR INVESTMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unless the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue the Shares covered by such exercise unless the Company has determined (which determination shall be made promptly, reasonably and in good faith) that such exercise and issuance would be exempt from the registration requirements of the Securities Act and until the following conditions have been fulfilled&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The person(s) who exercise the Option shall warrant to the Company, at the time of such exercise, that such person(s) are acquiring such Shares for their own respective accounts, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person(s) acquiring such Shares shall be bound by the provisions of the following legend which shall be endorsed upon any certificate(s) evidencing the Shares issued pursuant to such exercise&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:40.5pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws&#59;&#8221; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If the Company reasonably and in good faith determines that such an opinion is necessary, the Company shall have received an opinion of its counsel that the Shares may be issued upon such particular exercise in compliance with the Securities Act without registration thereunder.  Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company reasonably and in good faith deems necessary under any applicable law (including without limitation state securities or &#8220;blue sky&#8221; laws), which the Company shall use commercially reasonable efforts to promptly obtain.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OBLIGATION TO MAINTAIN RELATIONSHIP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant acknowledges that&#58; (i) the Company is not by this Agreement obligated to continue the Participant as an employee of the Company or an Affiliate&#59; (ii) the grant of the Option is a one-time benefit which does not create any contractual or other right to receive future grants of options, or benefits in lieu of options&#59; (iii) all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the number of shares subject to each option, the option price, and the time or times when each option shall be exercisable, will be at the sole discretion of the Company&#59; (iv) the value of the Option is an extraordinary item of compensation which is outside the scope of the Participant&#8217;s employment or consulting contract, if any&#59; and (v) the Option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.  Nothing in the preceding sentence, however, limits any right or remedy of the Participant, or obligation of the Company, under the Employment Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NOTICES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any notices required or permitted by the terms of this Agreement shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to the Company&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Myriad Genetics, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attention&#58; General Counsel </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;320 Wakara Way</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Salt Lake City, UT 84108</font></div><div style="padding-left:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to the Participant to the last known address provided to the Human Resources department by the Participant or to such other address or addresses of which notice in the same manner has previously been given.  Any such notice shall be deemed to have been given upon the earlier of receipt, one business day following delivery to a recognized courier service or three business days following mailing by registered or certified mail.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of law principles thereof.  For the purpose of litigating any dispute that arises under this Agreement, the parties hereby consent to exclusive jurisdiction in the state of Utah and agree that such litigation shall be conducted in the state courts of the state of Utah or the federal courts of the United States for the District of Utah</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">BENEFIT OF AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant&#8217;s legal representatives.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns&#59; provided that the Company shall not assign this Agreement except to a parent entity, or a successor to all or substantially all of the business or assets of the Company (or a parent thereof), in a transaction or event to which Section 10 applies. To the extent the Option continues after such event or there remains any unsatisfied obligation of the Company pursuant to Section 10, the Company shall require any successor to all or substantially all of the Company&#8217;s business and&#47;or assets to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, then such provision or provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible, then such provision shall be deemed to be excised from this Agreement, and the validity, legality and enforceability of the rest of this Agreement shall not be affected thereby.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ENTIRE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Agreement and the relevant provisions of the Employment Agreement embody the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">MODIFICATIONS AND AMENDMENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; The terms of this Agreement may be modified or amended by the Administrator&#59; provided that any modification or amendment of this Agreement shall not, without the consent of the Participant, adversely affect the Participant&#8217;s rights under this Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">WAIVERS AND CONSENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DATA PRIVACY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;By entering into this Agreement, the Participant&#58;  (i) authorizes the Company and each Affiliate, and any agent of the Company or any Affiliate facilitating the grant or administration of the Option, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant or administration of the Option&#59; and (ii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth in this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CLAWBACK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Agreement, the Company may recover from the Participant any compensation received from the Option or cause the Participant to forfeit the Option (whether or not vested) in accordance with any forfeiture or clawback policy established by the Company generally for executives from time to time.  </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i60db4ac21d024543ba683dd4864f0a06_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NOTICE OF EXERCISE OF STOCK OPTION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Form for Shares registered in the United States&#93;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;MYRIAD GENETICS, INC.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IMPORTANT NOTICE&#58;  This form of Notice of Exercise may only be used at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance of the Shares for which this exercise is being made is registered and such Registration Statement remains effective.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I hereby exercise my Stock Option to purchase _________ shares (the &#8220;Shares&#8221;) of the common stock, $0.01 par value, of MYRIAD GENETICS, INC. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(the &#8220;Company&#8221;), at the exercise price of $________ per share, pursuant to and subject to the terms of that Stock Option Grant Notice dated August 13, 2020.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I understand the nature of the investment I am making and the financial risks thereof.  I am aware that it is my responsibility to have consulted with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option and the purchase and subsequent sale of the Shares.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I am paying the option exercise price for the Shares as follows&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please issue the Shares (check one)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#9744; to me&#59; or </font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#9744; to me and ____________________________, as joint tenants with right of survivorship,</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">at the following address&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:54.807%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit A-1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My mailing address for stockholder communications, if different from the address listed above, is&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:54.807%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Very truly yours,</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Participant (signature)</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Print Name</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Date</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A-2</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>exhibit105-diaztimexba.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i678e876559f348deab974b891ed80e63_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.5</font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NON-QUALIFIED STOCK OPTION GRANT NOTICE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Time-Based)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Name of Participant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Paul J. Diaz</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Date of Option Grant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;August 13, 2020</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Maximum Number of Shares for</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;which this Option is exercisable&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;342,040</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Exercise (purchase) price per share&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$13.38</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Option Expiration Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;August 13, 2027</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Vesting Start Date&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            This option shall vest and become exercisable as provided below, but in no event earlier than August 13, 2021.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Vesting Schedule&#58;  This Option shall become vested and exercisable (and the Shares issued upon exercise shall be vested) as follows, provided (except as otherwise set forth below) the Participant is an Employee of the Company or of an Affiliate on the applicable vesting date&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.346%"><tr><td style="width:1.0%"></td><td style="width:27.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the first anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">25% of the Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the second anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">an additional 25% of the Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the third anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">an additional 25% of the Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On the fourth anniversary of the Vesting Start Date</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">an additional 25% of the Shares</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">n the event that (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(c)(iii) and 4(f) of the Employment Agreement, this Option shall become vested and exercisable to the extent scheduled to vest on or before the date two (2) years following the Termination Date, provided that for purpose of determining the portion of this Option that will vest under this Section 7(a), each annual vesting installment set forth above in this Section 7 shall be deemed to vest in monthly installments over the one-year period preceding the applicable scheduled annual vesting date (i.e., if an acceleration pursuant to this Section 7(a) occurred, for purposes of determining such acceleration the Option shall be considered to vest in forty eight (48) monthly installments following the Vesting Start Date, and the portion of the award that vests pursuant to this clause will be the portion of the forty-eight (48) monthly vesting installments that would be scheduled to vest on or before the date two (2) years following the Termination Date less the portion of the Option that had already vested pursuant to its terms before the Termination Date), with no additional pro-rata vesting for a portion of a month if the end of such two (2)-year period falls between the deemed monthly vesting dates&#59; and </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt;text-decoration:underline">Termination by the Company without Cause or by the Participant for Good Reason Following a Change of Control.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  In the event that a Change of Control occurs, and within a period of three (3) months prior to, upon, or twenty four (24) months following a Change of Control, either (i) the Participant&#8217;s employment is terminated by the Company other than for Cause, Disability or death, or (ii) the Participant terminates his employment for Good Reason, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(e)(iii) and 4(f) of the Employment Agreement, this Option shall become fully vested and exercisable&#59; and </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt;text-decoration:underline">Termination by the Company as a Result of the Participant&#8217;s Disability or Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that the Participant&#8217;s employment is terminated by the Company as a result of the Participant&#8217;s Disability or death, subject to and in accordance with the conditions set forth in this Agreement and Sections 4(d)(ii) and 4(f) of the Employment Agreement, this Option shall become vested and exercisable in a pro rata amount based on the period of employment between the most recent vesting date prior to the Termination Date and the Termination Date, provided that for purpose of determining the portion of the Option that vests under this Section 7(c), the annual vesting installments shall be deemed to vest in monthly installments over the applicable year of service, with no additional pro-rata vesting for a portion of a month if the Termination Date falls between the deemed monthly vesting dates.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing rights are cumulative and are subject to the other terms and conditions of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Option is granted to the Participant pursuant to the Participant&#8217;s Executive Employment Agreement with the Company dated August 13, 2020 (the &#8220;Employment Agreement&#8221;), and any capitalized terms not defined herein are defined in the Employment Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company and the Participant acknowledge receipt of this Stock Option Grant Notice and agree to the terms of the Stock Option Agreement attached hereto, and the terms of this Option Grant as set forth above (collectively, this &#8220;Agreement&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  For all purposes an electronic signature shall be treated as an original.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; S. Louise Phanstiel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            S. Louise Phanstiel</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            Board Chair</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Paul J. Diaz&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            Paul J. Diaz</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;           </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i678e876559f348deab974b891ed80e63_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MYRIAD GENETICS, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">NON-QUALIFIED STOCK OPTION AGREEMENT </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AGREEMENT made as of the date of grant set forth in the Stock Option Grant Notice by and between Myriad Genetics, Inc. (the &#8220;Company&#8221;), a Delaware</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">corporation, and Paul J. Diaz (the &#8220;Participant&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company desires to grant to the Participant an Option to purchase shares of its common stock, $.01 par value per share (&#8220;Common Stock&#8221; or the &#8220;Shares&#8221;) as an inducement material to the Participant&#8217;s entering into employment as President and Chief Executive Officer of the Company, effective August 13, 2020, in accordance with the terms of the Employment Agreement&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and the Participant each intend that the Option granted herein shall be a non-qualified stock option.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">DEFINITIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Agreement, have the following meanings&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the term Administrator means the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a corporation which, for purposes of Section 424 of the Code, is a parent or subsidiary of the Company, direct or indirect.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the United States Internal Revenue Code of 1986, as amended,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">including any successor statute, regulation and guidance thereto.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the committee of the Board of Directors to which the Board of Directors has delegated power to act.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any member of the Board of Directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disabled</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of a Share of Common Stock means&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting system for the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Common Stock is not traded on a national securities exchange but is traded on the over-the-counter market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in the preceding paragraph, and if bid and asked prices for the Common Stock are regularly reported, the mean between the bid and the asked price for the Common Stock at the close of trading in the over-the-counter market for the trading day on which Common Stock was traded on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Common Stock is neither listed on a national securities exchange nor traded in the over-the-counter market, such value as the Administrator, in good faith, shall determine in compliance with applicable laws.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> has the meaning given to such term in the Employment Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Qualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an option which is not intended to qualify as an incentive stock option under Section&#160;422 of the Code.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a Non-Qualified Option granted as an inducement award under Nasdaq Listing Rule 5635(c)(4).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Participant is an Employee of the Company or an Affiliate, a consultant to the Company or an Affiliate, or a member of the board of directors of the Company or an Affiliate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Survivor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the deceased Participant&#8217;s legal representatives and&#47;or any person or persons who acquire the Option by will or by the laws of descent and distribution.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GRANT OF OPTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of the number of Shares set forth in the Stock Option Grant Notice, on the terms and conditions and subject to all the limitations set forth herein and under United States securities and tax laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EXERCISE PRICE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The exercise price of the Shares covered by the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to adjustment, as provided in Section 10, in the event of a stock split, reverse stock split or other events affecting the holders of Shares after the date hereof (the &#8220;Exercise Price&#8221;).  Payment shall be made in accordance with Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of this Agreement.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">EXERCISABILITY OF OPTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to the terms and conditions set forth in this Agreement, the Option granted hereby shall become vested and exercisable as set forth in the Stock Option Grant Notice and is subject to the other terms and conditions of this Agreement.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">TERM OF OPTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Option shall terminate on the Option Expiration Date as specified in the Stock Option Grant Notice, but shall be subject to earlier termination as provided herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If the Participant&#8217;s Service ceases (the date the Participant&#8217;s Service ceases is referred to as the &#8220;Termination Date&#8221;) for any reason other than (i) the death or Disability of the Participant, or (ii) termination of the Participant for Cause (including any related resignation or removal from the Board of Directors related thereto), the Option to the extent vested and exercisable pursuant to Section 4 hereof (including the acceleration provisions of Section 7(b) of the Grant Notice) as of the Termination Date, and not previously terminated in accordance with this Agreement, may be exercised within three months after the Termination Date, or on or prior to the Option Expiration Date as specified in the Stock Option Grant Notice, whichever is earlier, but may not be exercised thereafter except as set forth below in the last paragraph of this Section 5.  In such event, subject to Section 4 hereof, the unvested portion of the Option shall not be exercisable and shall expire and be cancelled as of the Termination Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event the Participant&#8217;s Service is terminated by the Company or an Affiliate for Cause (including any related resignation or removal from the Board of Directors related thereto), the Participant&#8217;s right to exercise any unexercised portion of this Option even if vested </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall cease immediately as of the time the Participant is notified pursuant to the Employment Agreement that his Service is terminated for Cause, and this Option shall thereupon terminate.  Notwithstanding anything herein to the contrary, if subsequent to the Participant&#8217;s termination, but prior to the exercise of the Option, the Administrator determines that, prior to the Participant&#8217;s termination, the Participant engaged in conduct which would constitute Cause, then the Participant shall immediately cease to have any right to exercise the Option and this Option shall thereupon terminate.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event of the death or Disability of the Participant, the Option shall be exercisable, to the extent that the Option has become exercisable but has not been exercised as of the date of death or Disability, within one year after the Participant&#8217;s termination due to death or Disability or, if earlier, on or prior to the Option Expiration Date as specified in the Stock Option Grant Notice.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, other than in the event of termination by the Company for Cause, in the event of the Participant&#8217;s Disability or death within three months after the Termination Date, the Participant or the Participant&#8217;s Survivors may exercise the Option, to the extent vested as of the Termination Date, within one year after the Termination Date, but in no event after the Option Expiration Date as specified in the Stock Option Grant Notice.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">METHOD OF EXERCISING OPTION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to the terms and conditions of this Agreement, the Option may be exercised by written notice to the Company or its designee, in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> attached hereto (or in such other form acceptable to the Company, which may include electronic notice).  Such notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Company).  Payment of the Exercise Price for such Shares and any tax withholding obligations arising in connection with an exercise of the Option shall be made (a) in United States dollars in cash or by check&#59; or (b) at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six months (if required to avoid negative accounting treatment) having a Fair Market Value (as defined below) equal as of the date of the exercise to the aggregate cash exercise price (and related withholding obligations) for the number of Shares as to which the Option is being exercised&#59; (c) at the discretion of the Administrator, by having the Company retain from the Shares otherwise issuable upon exercise of the Option, a number of Shares having a Fair Market Value equal as of the date of exercise to the aggregate exercise price for the number of Shares as to which the Option is being exercised (and related withholding obligations)&#59; or (d) in accordance with a cashless exercise program established at the discretion of the Company with a securities brokerage firm&#59; or (e) at the discretion of the Administrator, by any combination of (a), (b), (c) and (d) above&#59; or (f) at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine.  The Company shall deliver such Shares as soon as practicable after the notice shall be received, provided, however, that the Company may delay issuance of such Shares until completion of any action or obtaining of any consent (which the Company will use commercially reasonable efforts to promptly obtain), which the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">reasonably deems necessary under any applicable law (including, without limitation, state securities or &#8220;blue sky&#8221; laws).  The Shares as to which the Option shall have been so exercised shall be registered in the Company&#8217;s share register in the name of the person so exercising the Option (or, if the Option shall be exercised by the Participant and if the Participant shall so request in the notice exercising the Option, shall be registered in the Company&#8217;s share register in the name of the Participant and another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the person exercising the Option.  In the event the Option shall be exercised, pursuant to Section 5 hereof, by any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option.  All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable.  The Company will use commercially reasonable efforts to register, under the Securities Act of 1933, as amended, the offer and sale to the Participant of the Shares subject to the Option.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PARTIAL EXERCISE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Exercise of this Option to the extent above stated may be made in part at any time and from time to time within the above limits, except that no fractional share shall be issued pursuant to this Option.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-ASSIGNABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Option shall not be transferable by the Participant otherwise than (a) by will or by the laws of descent and distribution, (b) pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder, or (c) to a &#8220;family member&#8221; as such term is defined in the SEC&#8217;s General Instructions to a Registration Statement on Form S-8, pursuant to a transfer agreement approved by the Administrator (which approval shall not unreasonably be withheld) in which the family member acknowledges and agrees to the terms of this Agreement.  Except as provided above in this paragraph, the Option shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant (or, in the event of legal incapacity or incompetency, by the Participant&#8217;s guardian or representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer, assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 8, or the levy of any attachment or similar process upon the Option shall be null and void.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until registration of the Shares in the Company&#8217;s share register in the name of the Participant.  Except as is expressly provided in Section 10 of this Agreement with respect to certain changes in the capitalization of the Company, no adjustment shall be made for dividends or similar rights for which the record date is prior to the date of such registration.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ADJUSTMENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon the occurrence of any of the following events, the Participant&#8217;s rights with respect to the Option shall be adjusted as hereinafter provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Dividends and Stock Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i)&#160;the Shares shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any Shares as a stock dividend on its outstanding Shares, or (ii)&#160;additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares, the Option and the number of Shares deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made including, in the exercise price per share, to reflect such events.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Company is to be consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets, or the acquisition of all of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a single entity other than a transaction to merely change the state of incorporation (a &#8220;Corporate Transaction&#8221;), the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the &#8220;Successor Board&#8221;), shall, as to the unexercised portion of the Option, either (i) make appropriate provision for the continuation of the Option by substituting on an equitable basis for the Shares then subject to the Option either the consideration payable with respect to the outstanding Shares in connection with the Corporate Transaction or securities of any successor or acquiring entity&#59; or (ii) upon written notice to the Participant, provide that the Option is fully vested and exercisable and must be exercised within a specified number of days of the date of such notice (such specified number of days to give the Participant reasonable notice of the impending termination and a reasonable opportunity to exercise the Option during such notice period), at the end of which period the Option shall terminate&#59; or (iii) terminate the Option in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to the holder of the number of Shares into which the Option would have been exercisable (assuming the Option was fully vested and exercisable) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">less the aggregate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> exercise price thereof.  For purposes of determining the payments to be made pursuant to Subclause (iii) above, in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined reasonably and in good faith by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recapitalization or Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding Shares, the Participant upon exercising the Option after the recapitalization or reorganization shall be entitled to receive for the price paid upon such exercise or acceptance if any, the number of replacement securities which would have been received if the Option had been exercised prior to such recapitalization or reorganization.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Modification of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, any adjustments made pursuant to Subsection (a), (b) or (c) above shall be made only after the Administrator determines whether such adjustments would cause any adverse tax consequences, including, but not limited to, pursuant to Section 409A of the Code.  If the Administrator determines that such adjustments would constitute a modification of the Option or other adverse tax consequence to the Participant, it may refrain from making such adjustments, unless the Participant specifically agrees in writing that such adjustment be made and agrees to accept full responsibility for any tax liability resulting therefrom.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dissolution or Liquidation of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon the dissolution or liquidation of the Company other than in connection with a transaction, recapitalization or reorganization referenced in Section 10(b) or 10(c), the Option will terminate and become null and void&#59; provided, however, that if the rights of the Participant or the Participant&#8217;s Survivors have not otherwise terminated and expired, the Participant or the Participant&#8217;s Survivors will have the right immediately prior to such dissolution or liquidation to exercise the Option to the extent that the Option is exercisable as of the date immediately prior to such dissolution or liquidation.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">TAXES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant acknowledges and agrees that (i) any income or other taxes due from the Participant with respect to this Option or the Shares issuable pursuant to this Option shall be the Participant&#8217;s responsibility&#59; (ii) the Participant was free to use professional advisors of his or her choice in connection with this Agreement, has received advice from his or her professional advisors in connection with this Agreement, understands its meaning and import, and is entering into this Agreement freely and without coercion or duress&#59; (iii) the Participant has not received and is not relying upon any advice, representations or assurances made by or on behalf of the Company or any Affiliate or any employee of or counsel to the Company or any Affiliate regarding any tax or other effects or implications of the Option, the Shares or other matters contemplated by this Agreement&#59; and (iv) neither the Administrator, the Company, its Affiliates, nor any of its officers or directors, shall be held liable for any applicable costs, taxes, or penalties associated with the Option if, in fact, the Internal Revenue Service were to determine that the Option constitutes deferred compensation under Section 409A of the Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant agrees that the Company may withhold from the Participant&#8217;s remuneration, if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered compensation includable in such person&#8217;s gross income (to the extent such withholding obligations are not satisfied as provided in Section 6).  At the Company&#8217;s discretion, the amount required to be withheld (to the extent such withholding obligations are not satisfied as provided in Section 6) may be withheld in cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant on exercise of the Option.  The Participant further agrees that, if the Company does not withhold an amount from the Participant&#8217;s remuneration sufficient to satisfy the Company&#8217;s income tax withholding obligation and such withholding obligations are not satisfied as provided in Section 6, the Participant will reimburse the Company on demand, in cash, for the amount under-withheld.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PURCHASE FOR INVESTMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unless the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue the Shares covered by such exercise unless the Company has determined (which determination shall be made promptly, reasonably and in good faith) that such exercise and issuance would be exempt from the registration requirements of the Securities Act and until the following conditions have been fulfilled&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The person(s) who exercise the Option shall warrant to the Company, at the time of such exercise, that such person(s) are acquiring such Shares for their own respective accounts, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person(s) acquiring such Shares shall be bound by the provisions of the following legend which shall be endorsed upon any certificate(s) evidencing the Shares issued pursuant to such exercise&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:40.5pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws&#59;&#8221; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If the Company reasonably and in good faith determines that such an opinion is necessary, the Company shall have received an opinion of its counsel that the Shares may be issued upon such particular exercise in compliance with the Securities Act without registration thereunder.  Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company reasonably and in good faith deems necessary under any applicable law (including without limitation state securities or &#8220;blue sky&#8221; laws), which the Company shall use commercially reasonable efforts to promptly obtain.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OBLIGATION TO MAINTAIN RELATIONSHIP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Participant acknowledges that&#58; (i) the Company is not by this Agreement obligated to continue the Participant as an employee of the Company or an Affiliate&#59; (ii) the grant of the Option is a one-time benefit which does not create any contractual or other right to receive future grants of options, or benefits in lieu of options&#59; (iii) all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the number of shares subject to each option, the option price, and the time or times when each option shall be exercisable, will be at the sole discretion of the Company&#59; (iv) the value of the Option is an extraordinary item of compensation which is outside the scope of the Participant&#8217;s employment or consulting contract, if any&#59; and (v) the Option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">payments, bonuses, long-service awards, pension or retirement benefits or similar payments.  Nothing in the preceding sentence, however, limits any right or remedy of the Participant, or obligation of the Company, under the Employment Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NOTICES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any notices required or permitted by the terms of this Agreement shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Company&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Myriad Genetics, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; General Counsel </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">320 Wakara Way</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Salt Lake City, UT 84108</font></div><div style="padding-left:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Participant to the last known address provided to the Human Resources department by the Participant or to such other address or addresses of which notice in the same manner has previously been given.  Any such notice shall be deemed to have been given upon the earlier of receipt, one business day following delivery to a recognized courier service or three business days following mailing by registered or certified mail.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of law principles thereof.  For the purpose of litigating any dispute that arises under this Agreement, the parties hereby consent to exclusive jurisdiction in the state of Utah and agree that such litigation shall be conducted in the state courts of the state of Utah or the federal courts of the United States for the District of Utah</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">BENEFIT OF AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant&#8217;s legal representatives.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns&#59; provided that the Company shall not assign this Agreement except to a parent entity, or a successor to all or substantially all of the business or assets of the Company (or a parent thereof), in a transaction or event to which Section 10 applies.  To the extent the Option continues after such event or there remains any unsatisfied obligation of the Company pursuant to Section 10, the Company shall require any successor to all or substantially all of the Company&#8217;s business and&#47;or assets to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, then such provision or provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible, then such provision shall be deemed to be excised from this Agreement, and the validity, legality and enforceability of the rest of this Agreement shall not be affected thereby.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ENTIRE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Agreement and the relevant provisions of the Employment Agreement embody the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">MODIFICATIONS AND AMENDMENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The terms of this Agreement may be modified or amended by the Administrator&#59; provided that any modification or amendment of this Agreement shall not, without the consent of the Participant, adversely affect the Participant&#8217;s rights under this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">WAIVERS AND CONSENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DATA PRIVACY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;By entering into this Agreement, the Participant&#58;  (i) authorizes the Company and each Affiliate, and any agent of the Company or any Affiliate facilitating the grant or administration of the Option, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant or administration of the Option&#59; and (ii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth in this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CLAWBACK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary contained in this Agreement, the Company may recover from the Participant any compensation received from the Option or cause the Participant to forfeit the Option (whether or not vested) in accordance with any forfeiture or clawback policy established by the Company generally for executives from time to time.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i678e876559f348deab974b891ed80e63_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NOTICE OF EXERCISE OF STOCK OPTION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Form for Shares registered in the United States&#93;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To&#58;&#160;&#160;&#160;&#160;MYRIAD GENETICS, INC.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IMPORTANT NOTICE&#58;  This form of Notice of Exercise may only be used at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance of the Shares for which this exercise is being made is registered and such Registration Statement remains effective.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I hereby exercise my Stock Option to purchase _________ shares (the &#8220;Shares&#8221;) of the common stock, $0.01 par value, of MYRIAD GENETICS, INC. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(the &#8220;Company&#8221;), at the exercise price of $________ per share, pursuant to and subject to the terms of that Stock Option Grant Notice dated August 13, 2020.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I understand the nature of the investment I am making and the financial risks thereof.  I am aware that it is my responsibility to have consulted with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option and the purchase and subsequent sale of the Shares.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I am paying the option exercise price for the Shares as follows&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.352%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please issue the Shares (check one)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#9744; to me&#59; or </font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#9744; to me and ____________________________, as joint tenants with right of survivorship,</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">at the following address&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:40.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:54.807%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit A-1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My mailing address for stockholder communications, if different from the address listed above, is&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:40.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:54.807%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Very truly yours,</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Participant (signature)</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Print Name</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Date</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A-2</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>exhibit106-diazformofs.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i9f070c2594d0425aa9bb51af2eddb6b7_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.6</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">FORM OF SEPARATION AND RELEASE AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Separation and Release Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), dated as of &#91;&#9679;&#93;, is entered into between Myriad Genetics, Inc. (together with its subsidiaries, affiliates, successors and assigns, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and &#91;&#9679;&#93; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (Executive, together with the Company, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Executive served as the &#91;&#9679;&#93; of the Company and as a member of the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) pursuant to that certain Executive Employment Agreement dated &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Executive&#8217;s employment with the Company and engagement as a member of the Board and any committees thereof ended effective as of &#91;&#9679;&#93;&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and undertakings set out below, the Parties herby agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Employment Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">Effective as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Executive&#8217;s employment with the Company and engagement in any role pursuant thereto, including but not limited to serving on the Board and any committees thereof, shall end on the Separation Date.  From and after the Separation Date, Executive shall have no authority and shall not represent himself as an employee or agent of the Company.  This Agreement constitutes the &#8220;Separation Agreement&#8221; contemplated by Section 4(f) of the Employment Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Payments and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">The Company shall provide Executive with the Accrued Obligations (as such term is defined in the Employment Agreement).  </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">Provided that this Agreement is signed by Executive in the period of time set forth in Section 4(f) of the Employment Agreement and not revoked by Executive, the Company shall provide Executive with the Severance Benefits (as such term is defined in the Employment Agreement) set forth in Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;4(c) &#47; 4(d) &#47; 4(e)&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Employment Agreement. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">The payments referenced in Sections 2(a) and 2(b) shall be made at the applicable time(s) provided for in the Employment Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">Executive agrees and acknowledges that the payments and benefits referred to in this Section 2 are in lieu of and in full satisfaction of any amounts that might otherwise be payable under any contract, plan, policy or practice, past or present, of the Company.  Executive acknowledges that, other than any payment described in this Section 2 or otherwise in this Agreement, all outstanding payments or benefits for all outstanding employment periods shall be forfeited in accordance with their terms.  All outstanding equity awards held by Executive shall be treated in accordance with their terms and the provisions of Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;4(c) &#47; 4(d) &#47; 4(e)&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Employment Agreement, including with respect to any post-termination exercise periods for vested stock options.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">General Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In consideration of the payments and benefits to be made pursuant to Section 2(b), Executive, with the intention of binding Executive and Executive&#8217;s heirs, executors, administrators and assigns, does hereby release, remise, acquit and forever discharge the Company and each of its subsidiaries and affiliates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company Affiliated Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), their present and former officers, directors, executives, agents, attorneys, employees and employee benefits plans (and the fiduciaries thereof), and the successors, predecessors and assigns of each of the foregoing (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company Released Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), of and from any and all claims, actions, causes of action, complaints, charges, demands, rights, damages, debts, sums of money, accounts, financial obligations, suits, expenses, attorneys&#8217; fees and liabilities of whatever kind or nature in law, equity or otherwise, whether accrued, absolute, contingent, unliquidated or otherwise and whether now known or unknown, suspected or unsuspected which Executive, individually or as a member of a class, now has, owns or holds, or has at any time heretofore had, owned or held, against any Company Released Party in any capacity (as they may have been amended through the Effective Date), including, without limitation, any and all claims&#58; (a)&#160;arising out of or in any way connected with Executive&#8217;s service to any member of the Company Affiliated Group (or the predecessors thereof) in any capacity, or the termination of such service in any such capacity&#59; (b)&#160;for severance or vacation benefits, unpaid wages, salary or incentive payments&#59; (c)&#160;for breach of contract, breach of covenant of good faith and fair dealing, wrongful discharge, impairment of economic opportunity, defamation, promissory estoppel, fraud, negligent or intentional infliction of emotional harm, or other tort&#59; (d) for any violation of applicable state and local labor and employment laws, including, without limitation, all laws concerning unlawful and unfair labor and employment practices, and further including, without limitation, any and all claims based on the Executive Retirement Income Security Act of 1974 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Title VII of the Civil Rights Act of 1964 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Title VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Civil Rights Act of 1991, the Americans with Disabilities Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Sections 503 and 504 of the Rehabilitation Act, the Family and Medical Leave Act, the Age Discrimination in Employment Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Older Workers Benefit Protection Act, the Equal Pay Act, the Worker Adjustment and Retraining Notification Act, the Uniformed Services Employment and Re-Employment Act, the Rehabilitation Act of 1973, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief and Economic Security Act, the Employment Relations and Collective Bargaining Act, the Utah Right to Work Act, the Utah Drug and Alcohol Testing Act, the Utah Minimum Wage Act, the Utah Protection of Activities in Private Vehicles Act, the Utah Employment Selection Procedures Act, and the Utah Occupational Safety and Health Act, and any and all claims arising under the civil rights laws of any federal, state or local jurisdiction, each as amended and including each of their respective implementing regulations&#59; and (e) under any whistleblower laws or whistleblower provisions of other laws&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">excepting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> only&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">rights of Executive under this Agreement&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">rights of Executive relating to equity awards held by Executive as of his or her Separation Date (as defined in the Employment Agreement)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">the right of Executive to receive COBRA continuation coverage in accordance with applicable law&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">rights to indemnification Executive may have (i)&#160;under applicable corporate law, (ii)&#160;under the by-laws, certificate of incorporation or similar governing documents of any Company Released Party, (iii) under a written indemnification agreement with any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Company Released Party, or (iv)&#160;as an insured under any director&#8217;s and officer&#8217;s liability insurance policy now or previously in force&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">claims (i)&#160;for benefits under any health, disability, retirement, deferred compensation, life insurance or other, similar Executive benefit plan or arrangement of the Company Affiliated Group and (ii)&#160;for earned but unused vacation pay through the Separation Date in accordance with applicable Company policy&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">claims for the reimbursement of unreimbursed business expenses incurred prior to the Separation Date pursuant to applicable Company policy&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.08pt">any rights that Executive may have as a stockholder (or former stockholder) of Company with respect to dividend payment rights or payments in respect of shares of Company common stock sold in a merger or other transaction in accordance with the applicable merger or transaction agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section does not&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;release the Company from any obligation expressly set forth in this Agreement or from any obligation, including, without limitation, obligations under the Workers Compensation Act, which as a matter of law cannot be released&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;prohibit Executive from filing a charge with the Equal Employment Opportunity Commission (&#8220;EEOC&#8221;)&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;prohibit Executive from participating in an investigation or proceeding by the EEOC or any comparable state or local agency, or providing information or documents to the EEOC or any comparable state or local agency.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive acknowledges and agrees, however, that Executive&#8217;s waiver and release of claims are intended to be a complete bar to any recovery or personal benefit by or to Executive with respect to any Claim whatsoever arising out of Executive&#8217;s employment with the Company, including those raised through a charge with the EEOC, except those which, as a matter of law, cannot be released.  In the event that Executive successfully challenges the validity of this release of claims, the Company and any Company Released Party sought to be released hereunder shall be entitled to recover from the Executive the full amount of the payments and benefits described in Section 2(b) of this Agreement.  Nothing in the Agreement, however, shall limit the right of the Company or any Company Released Party sought to be released hereunder to seek immediate dismissal of a charge on the basis that Executive signing of this Agreement constitutes a full release of any rights Executive might otherwise have to pursue the charge.  Executive further acknowledges and agrees that, but for providing this waiver and release, Executive would not be receiving the payments and benefits being provided to Executive as set forth above in Section 2(b) of this Agreement.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">No Admissions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive acknowledges and agrees that this Agreement is not to be construed in any way as an admission of any liability whatsoever by any Company Released Party, any such liability being expressly denied.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Application to all Forms of Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> This Agreement applies to any relief no matter how called, including, without limitation, wages, back pay, front pay, compensatory damages, liquidated damages, emotional distress damages, punitive damages for pain or suffering, costs and attorney&#8217;s fees and expenses.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Specific Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive specifically acknowledges that his or her acceptance of the terms of this Agreement is, among other things, a specific waiver of his or her rights, claims and causes of action under Title VII, ADEA, ADA and any state or local law or regulation in respect of discrimination of any kind&#59; provided, however, that nothing herein shall be deemed, nor does anything herein purport, to be a waiver of any right or claim or cause of action which by law Executive is not permitted to waive or as to those matters that are expressly outside of the scope of the release pursuant to Section 3.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">No Complaints or Other Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Executive acknowledges and agrees that he or she has not, with respect to any transaction or state of facts existing prior to the date hereof, filed any complaints, charges or lawsuits against any Company Released Party with any governmental agency, court or tribunal. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Ongoing Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Terms and Conditions. Executive acknowledges Executive remains bound by the terms of his Confidentiality, Non-Competition, Non-Solicitation and Inventions Assignment Agreement with the Company dated &#91;&#9679;&#93; (the &#8220;Confidentiality Agreement&#8221;), which is incorporated herein by reference, and the terms of which remain in full force and effect following the termination of Executive&#8217;s employment with the Company as set forth in such agreement.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Return of Company Material. Executive represents that he has satisfied his obligations pursuant to Section 8 of the Employment Agreement and Section 1(d) of the Confidentiality Agreement.  Should Executive later discover any materials that Executive is obligated pursuant to such provisions to return to Company, he will promptly do so.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;Cooperation. Following the Separation Date, Executive shall reasonably cooperate with the Company upon reasonable request of the Board and be reasonably available to the Company with respect to matters arising out of Executive&#8217;s services to the Company Affiliated Group.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;Non-Disparagement. Executive agrees not to disparage the Company or the products or businesses of the Company, and the Company agrees that the Board shall not disparage Executive, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that  nothing in this Section shall restrict Executive, the Company or any Board member from making any disclosures mandated by state or federal law, from participating in an investigation with a state or federal agency if requested by the agency to do so, or from providing information or documents to a state or federal agency if requested by the agency to do so.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;No Representation. Executive acknowledges that, other than as set forth in this Agreement and the Employment Agreement (and the other plans, agreements and documents referenced herein or therein), (i)&#160;no promises have been made to him or her and (ii)&#160;in signing this Agreement Executive is not relying upon any statement or representation made by or on behalf of any Company Released Party and each or any of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">them concerning the merits of any claims or the nature, amount, extent or duration of any damages relating to any claims or the amount of any money, benefits, or compensation due to Executive or claimed by Executive, or concerning the Agreement or concerning any other thing or matter.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f) &#160;&#160;&#160;&#160;Injunctive Relief. In the event of a breach or threatened breach by Executive of this Section, Executive agrees that the Company shall be entitled to injunctive relief in a court of appropriate jurisdiction to remedy any such breach or threatened breach, Executive acknowledging that damages would be inadequate or insufficient.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Pursuant to 18 U.S.C. &#167; 1833(b), Executive understands that Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret of the Company that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to Executive&#8217;s attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding.  Executive understands that if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive&#8217;s attorney and use the trade secret information in the court proceeding if Executive (x) files any document containing the trade secret under seal, and (y) does not disclose the trade secret, except pursuant to court order.  Nothing in this Agreement, or any other agreement that Executive has with the Company, is intended to conflict with 18 U.S.C. &#167; 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section.  Further, nothing in this Agreement or any other agreement that Executive has with the Company shall prohibit or restrict Executive from (A) making any voluntary disclosure of information or documents concerning possible violations of law to any governmental agency or legislative body, or any self-regulatory organization, in each case, without advance notice to the Company&#59; or (B) responding to a valid subpoena, court order or similar legal process&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that prior to making any such disclosure pursuant to this Section, Executive shall provide the Company with written notice of the subpoena, court order or similar legal process sufficiently in advance of such disclosure to afford the Company a reasonable opportunity to challenge the subpoena, court order or similar legal process.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Voluntariness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive agrees that he or she is relying solely upon his or her own judgment&#59; that Executive is over eighteen years of age and is legally competent to sign this Agreement&#59; that Executive is signing this Agreement of his or her own free will&#59; that the Executive has read and understood the Agreement before signing it&#59; and that Executive is signing this Agreement in exchange for consideration that he or she believes is satisfactory and adequate.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Legal Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive acknowledges that he or she has been informed of the right to consult with legal counsel and has been encouraged to do so.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Complete Agreement&#47;Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement constitutes the complete and final agreement between the parties and supersedes and replaces all prior or contemporaneous agreements, negotiations, or discussions relating to the subject matter of this Agreement. All provisions and portions of this Agreement are severable. If any provision or portion of this Agreement or the application of any provision or portion of the Agreement shall be determined to be invalid or unenforceable to any extent or for any reason, all other provisions and portions of this Agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall remain in full force and shall continue to be enforceable to the fullest and greatest extent permitted by law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive acknowledges that he or she has been given a period of twenty-one (21)&#160;days within which to consider this Agreement, unless applicable law requires a longer period, in which case Executive shall be advised of such longer period and such longer period shall apply. Executive may accept this Agreement at any time within this period of time by signing the Agreement and returning it to the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Revocability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement shall not become effective or enforceable until seven (7)&#160;calendar days after Executive signs it. Executive may revoke his or her acceptance of this Agreement at any time within that seven (7)&#160;calendar day period by sending written notice to the Company. Such notice must be received by the Company within the seven (7)&#160;calendar day period in order to be effective and, if so received, would void this Agreement for all purposes.  This Agreement shall become effective (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on the day following the conclusion of the seven (7) calendar day period.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except for issues or matters as to which federal law is applicable, this Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Utah without giving effect to the conflicts of law principles thereof.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Executive has executed this Agreement as of the date last set forth below.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.565%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">EXECUTIVE</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:7pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Date&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>exhibit311-certificati.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4785a55ce54d4649bb98596b160b913e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Paul J. Diaz, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">I have reviewed this quarterly report on Form 10-Q of Myriad Genetics, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:61.695%"><tr><td style="width:1.0%"></td><td style="width:5.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 9, 2020</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>exhibit312-certificati.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i1381d3053324497bb18790e080122b00_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, R. Bryan Riggsbee, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">I have reviewed this quarterly report on Form 10-Q of Myriad Genetics, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:37.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.421%"><tr><td style="width:1.0%"></td><td style="width:5.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 9, 2020</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; R. Bryan Riggsbee</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bryan Riggsbee</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>exhibit321-certificati.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i71d1edd87d794139b6985de5a87761d3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2020 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:43.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 9, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 9, 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; R. Bryan Riggsbee</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul J. Diaz</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bryan Riggsbee</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Financial and Accounting Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>mygn-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e951f29c-a210-45d5-8fef-ac7c87c1a1f9,g:048ed3a0-61ad-4824-a735-4ab2d7ea0155-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mygn="http://www.myriad.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.myriad.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.myriad.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.myriad.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.myriad.com/role/BasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.myriad.com/role/Revenue">
        <link:definition>2103102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.myriad.com/role/RevenueTables">
        <link:definition>2304301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" roleURI="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails">
        <link:definition>2405401 - Disclosure - Revenue - Total Revenue by Product and by US versus Rest of World (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueReconciliationofDeferredRevenueBalancesDetails" roleURI="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails">
        <link:definition>2406402 - Disclosure - Revenue - Reconciliation of Deferred Revenue Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.myriad.com/role/RevenueNarrativeDetails">
        <link:definition>2407403 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecurities" roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities">
        <link:definition>2108103 - Disclosure - Marketable Investment Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesTables" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables">
        <link:definition>2309302 - Disclosure - Marketable Investment Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails">
        <link:definition>2410404 - Disclosure - Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails">
        <link:definition>2411405 - Disclosure - Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.myriad.com/role/FairValueMeasurements">
        <link:definition>2112104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.myriad.com/role/FairValueMeasurementsTables">
        <link:definition>2313303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2414406 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails">
        <link:definition>2415407 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails">
        <link:definition>2416408 - Disclosure - Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNet" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet">
        <link:definition>2117105 - Disclosure - Property, Plant and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetTables" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables">
        <link:definition>2318304 - Disclosure - Property, Plant and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetBalancesDetails" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails">
        <link:definition>2419409 - Disclosure - Property, Plant and Equipment, Net - Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetDepreciationExpenseDetails" roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails">
        <link:definition>2420410 - Disclosure - Property, Plant and Equipment, Net - Depreciation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets">
        <link:definition>2121106 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2322305 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsSummaryofGoodwillDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails">
        <link:definition>2423411 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails">
        <link:definition>2424412 - Disclosure - Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1">
        <link:definition>2424412 - Disclosure - Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails">
        <link:definition>2425413 - Disclosure - Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://www.myriad.com/role/AccruedLiabilities">
        <link:definition>2126107 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables">
        <link:definition>2327306 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails">
        <link:definition>2428414 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.myriad.com/role/LongTermDebt">
        <link:definition>2129108 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.myriad.com/role/LongTermDebtTables">
        <link:definition>2330307 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2431415 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtDetails" roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails">
        <link:definition>2432416 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilities" roleURI="http://www.myriad.com/role/OtherLongTermLiabilities">
        <link:definition>2133109 - Disclosure - Other Long-Term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilitiesTables" roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables">
        <link:definition>2334308 - Disclosure - Other Long-Term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLongTermLiabilitiesDetails" roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails">
        <link:definition>2435417 - Disclosure - Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquity" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity">
        <link:definition>2136110 - Disclosure - Preferred and Common Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityTables" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables">
        <link:definition>2337309 - Disclosure - Preferred and Common Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityNarrativeDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails">
        <link:definition>2438418 - Disclosure - Preferred and Common Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails">
        <link:definition>2439419 - Disclosure - Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails">
        <link:definition>2440420 - Disclosure - Preferred and Common Stockholders' Equity - Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails">
        <link:definition>2441421 - Disclosure - Preferred and Common Stockholders' Equity - Potentially Dilutive Common Shares Excluded from EPS Computation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.myriad.com/role/ShareBasedCompensation">
        <link:definition>2142111 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.myriad.com/role/ShareBasedCompensationTables">
        <link:definition>2343310 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2444422 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>2445423 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRSUActivityDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails">
        <link:definition>2446424 - Disclosure - Share-Based Compensation - RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationShareBasedCompensationExpenseDetails" roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails">
        <link:definition>2447425 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.myriad.com/role/IncomeTaxes">
        <link:definition>2148112 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.myriad.com/role/IncomeTaxesDetails">
        <link:definition>2449426 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.myriad.com/role/CommitmentsandContingencies">
        <link:definition>2150113 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformation" roleURI="http://www.myriad.com/role/SegmentandRelatedInformation">
        <link:definition>2151114 - Disclosure - Segment and Related Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationTables" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables">
        <link:definition>2352311 - Disclosure - Segment and Related Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationNarrativeDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails">
        <link:definition>2453427 - Disclosure - Segment and Related Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails">
        <link:definition>2454428 - Disclosure - Segment and Related Information - Segment Revenue and Operating Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails">
        <link:definition>2455429 - Disclosure - Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformation" roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation">
        <link:definition>2156115 - Disclosure - Supplemental Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationTables" roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables">
        <link:definition>2357312 - Disclosure - Supplemental Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationDetails" roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails">
        <link:definition>2458430 - Disclosure - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.myriad.com/role/SubsequentEvents">
        <link:definition>2159116 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mygn_OperatingLeaseLiabilityEstablished" abstract="false" name="OperatingLeaseLiabilityEstablished" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" abstract="false" name="UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_PharmaceuticalAndClinicalServicesMember" abstract="true" name="PharmaceuticalAndClinicalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" abstract="true" name="OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_MolecularDiagnosticOtherTestingMember" abstract="true" name="MolecularDiagnosticOtherTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticEndoPredictTestingMember" abstract="true" name="MolecularDiagnosticEndoPredictTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_NonEmployeeDirectorMember" abstract="true" name="NonEmployeeDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" abstract="false" name="PrepaidExpenseExcludingPrepaidTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncomeTaxExpenseBenefitCARESAct" abstract="false" name="IncomeTaxExpenseBenefitCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" abstract="false" name="IncreaseDecreaseInUnrecognizedTaxBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_CostOfPharmaceuticalAndClinicalServicesMember" abstract="true" name="CostOfPharmaceuticalAndClinicalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_OptionsAndRestrictedStockUnitsMember" abstract="true" name="OptionsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EighthShareRepurchaseProgramMember" abstract="true" name="EighthShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_NonCashInterestExpense" abstract="false" name="NonCashInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_MolecularDiagnosticGenesightTestingMember" abstract="true" name="MolecularDiagnosticGenesightTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_DebtInstrumentLIBORFloorPercentage" abstract="false" name="DebtInstrumentLIBORFloorPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mygn_MolecularDiagnosticHereditaryCancerTestingMember" abstract="true" name="MolecularDiagnosticHereditaryCancerTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_InvestmentsAndCashAmortizedCost" abstract="false" name="InvestmentsAndCashAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" abstract="false" name="StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mygn_CARESActOf2020MedicarePaymentAmount" abstract="false" name="CARESActOf2020MedicarePaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_MolecularDiagnosticMyChoiceCDxMember" abstract="true" name="MolecularDiagnosticMyChoiceCDxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MassachusettsDepartmentOfRevenueMember" abstract="true" name="MassachusettsDepartmentOfRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" abstract="true" name="TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_IntangibleAssetsLineItems" abstract="true" name="IntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mygn_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_EmployeeStockPurchasePlanTwentyTwelveMember" abstract="true" name="EmployeeStockPurchasePlanTwentyTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ChangeInFairValueOfContingentConsideration" abstract="false" name="ChangeInFairValueOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_PurchasedLicensesAndTechnologiesMember" abstract="true" name="PurchasedLicensesAndTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" abstract="true" name="OptionsGrantedAfterDecemberFiveTwentyTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticProlarisTestingMember" abstract="true" name="MolecularDiagnosticProlarisTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" abstract="true" name="TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticTestingMember" abstract="true" name="MolecularDiagnosticTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticVectraTestingMember" abstract="true" name="MolecularDiagnosticVectraTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ScheduleOfIntangibleAssetsTable" abstract="true" name="ScheduleOfIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" abstract="true" name="InProcessResearchAndDevelopmentWithIndefiniteLivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_MolecularDiagnosticPrenatalTestingMember" abstract="true" name="MolecularDiagnosticPrenatalTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_AmendmentToCreditAgreementMember" abstract="true" name="AmendmentToCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_CostOfMolecularDiagnosticTestingMember" abstract="true" name="CostOfMolecularDiagnosticTestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mygn_ContractWithCustomerLiabilityPrepayments" abstract="false" name="ContractWithCustomerLiabilityPrepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" abstract="false" name="IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>mygn-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e951f29c-a210-45d5-8fef-ac7c87c1a1f9,g:048ed3a0-61ad-4824-a735-4ab2d7ea0155-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20200930.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3ad286f0-d7e1-40e5-a97e-e861ef8a9c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02f704f3-6303-493a-b79c-36b492ea7877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3ad286f0-d7e1-40e5-a97e-e861ef8a9c23" xlink:to="loc_us-gaap_Liabilities_02f704f3-6303-493a-b79c-36b492ea7877" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2e3ca352-b8ae-48a0-ba6b-ec024fcf740c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3ad286f0-d7e1-40e5-a97e-e861ef8a9c23" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2e3ca352-b8ae-48a0-ba6b-ec024fcf740c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ee05b8a2-0a5c-4c2f-82b1-be33bd1a50c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3ad286f0-d7e1-40e5-a97e-e861ef8a9c23" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ee05b8a2-0a5c-4c2f-82b1-be33bd1a50c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fa5254de-98e3-4ab9-9fa6-0b71def29d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f177b62-c38f-4e72-b60d-519b579543a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fa5254de-98e3-4ab9-9fa6-0b71def29d47" xlink:to="loc_us-gaap_StockholdersEquity_1f177b62-c38f-4e72-b60d-519b579543a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e92f69b7-27b3-4ef1-ac01-3648456c2a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fa5254de-98e3-4ab9-9fa6-0b71def29d47" xlink:to="loc_us-gaap_MinorityInterest_e92f69b7-27b3-4ef1-ac01-3648456c2a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_77f9481a-4b56-429e-8248-abb8a19c0ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0ae7fe42-8273-41db-95f5-8b2e3b1b7746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77f9481a-4b56-429e-8248-abb8a19c0ec8" xlink:to="loc_us-gaap_CommonStockValue_0ae7fe42-8273-41db-95f5-8b2e3b1b7746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_73dede23-2fcb-4d76-8ca2-c40230d02c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77f9481a-4b56-429e-8248-abb8a19c0ec8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_73dede23-2fcb-4d76-8ca2-c40230d02c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0bbc5737-898c-4cb8-bf27-b841a236fda2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77f9481a-4b56-429e-8248-abb8a19c0ec8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0bbc5737-898c-4cb8-bf27-b841a236fda2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_570ec3ab-b33f-4bc5-994e-1cc39d6f7852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77f9481a-4b56-429e-8248-abb8a19c0ec8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_570ec3ab-b33f-4bc5-994e-1cc39d6f7852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_209d228a-a177-43d1-8d73-f5c7d10ac49d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e128edfa-9795-43f2-ab35-e028bb27a3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_209d228a-a177-43d1-8d73-f5c7d10ac49d" xlink:to="loc_us-gaap_AccountsPayableCurrent_e128edfa-9795-43f2-ab35-e028bb27a3de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_fc7fa81b-268b-4d13-b5b8-62b0c3723ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_209d228a-a177-43d1-8d73-f5c7d10ac49d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_fc7fa81b-268b-4d13-b5b8-62b0c3723ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_173503eb-681c-400b-92f6-b8d4b1b7ce8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_209d228a-a177-43d1-8d73-f5c7d10ac49d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_173503eb-681c-400b-92f6-b8d4b1b7ce8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_78a7caf1-121c-48eb-9853-5c1e4eda3342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_209d228a-a177-43d1-8d73-f5c7d10ac49d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_78a7caf1-121c-48eb-9853-5c1e4eda3342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d95e7e2f-ecce-4c06-ad1d-5550bc99616d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_209d228a-a177-43d1-8d73-f5c7d10ac49d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d95e7e2f-ecce-4c06-ad1d-5550bc99616d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32e5a82b-8c61-40db-a2db-dd94652742bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32e5a82b-8c61-40db-a2db-dd94652742bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_ca16cf0e-4567-4506-8ef4-f56ca17a265f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_ca16cf0e-4567-4506-8ef4-f56ca17a265f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_5066e374-f586-48e3-a23c-1593665de910" xlink:href="mygn-20200930.xsd#mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_5066e374-f586-48e3-a23c-1593665de910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ce58ce0a-c0c4-4b35-adf7-3837659ee019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_us-gaap_InventoryNet_ce58ce0a-c0c4-4b35-adf7-3837659ee019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3b59fdd8-b3c4-4b8d-9888-85fa9c7c773f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3b59fdd8-b3c4-4b8d-9888-85fa9c7c773f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_6d283915-1825-4f92-afb2-e03579f4cd4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_us-gaap_PrepaidTaxes_6d283915-1825-4f92-afb2-e03579f4cd4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_6b434ed4-1b5d-4f88-ade7-4b43bf2b779c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6dbe2e01-2c4c-4660-801e-f840e09e911c" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_6b434ed4-1b5d-4f88-ade7-4b43bf2b779c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_13307a32-6c7a-479d-926e-e5832e67262b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_AssetsCurrent_13307a32-6c7a-479d-926e-e5832e67262b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_04f068c8-74b8-4b95-9807-955ac590107d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_04f068c8-74b8-4b95-9807-955ac590107d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_16893511-473b-4fe2-840d-2b9a79f1906e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_16893511-473b-4fe2-840d-2b9a79f1906e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_58de9695-71ec-4387-a818-6c1dccf9cfb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_58de9695-71ec-4387-a818-6c1dccf9cfb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3262056b-7f26-493c-9664-ea1751d62a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3262056b-7f26-493c-9664-ea1751d62a99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_626a0ce8-1164-4306-b6c2-ae54c96f3f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_Goodwill_626a0ce8-1164-4306-b6c2-ae54c96f3f4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_610f00bf-4e7e-47df-9b93-12637adc5a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d5ef08d-6911-4222-bc01-d83a48f74772" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_610f00bf-4e7e-47df-9b93-12637adc5a24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2ac7d7dd-8656-468b-b4bc-cd7839f0f071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:to="loc_us-gaap_LiabilitiesCurrent_2ac7d7dd-8656-468b-b4bc-cd7839f0f071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3275c855-62db-4449-ba88-22c643e6ed1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3275c855-62db-4449-ba88-22c643e6ed1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2bb8819f-6c04-4e43-bb49-bb8bbb36dc89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2bb8819f-6c04-4e43-bb49-bb8bbb36dc89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_31d4b618-f5bf-490f-a91c-70a58b0dd493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:to="loc_us-gaap_LongTermDebt_31d4b618-f5bf-490f-a91c-70a58b0dd493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4cf539d9-843d-4bb3-b4d7-aca08a84d7a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4cf539d9-843d-4bb3-b4d7-aca08a84d7a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d13e9941-56f6-425e-8d27-d9352072e7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_961879ca-ed4d-40df-a614-1821374867bb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d13e9941-56f6-425e-8d27-d9352072e7ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a59de040-a47a-46ec-9dc4-130ca75ca40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8880b721-f13f-4ff0-9cda-9349ba78bece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a59de040-a47a-46ec-9dc4-130ca75ca40d" xlink:to="loc_us-gaap_ProfitLoss_8880b721-f13f-4ff0-9cda-9349ba78bece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_92ea6feb-9481-49d3-b5fb-5406f9e5d517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a59de040-a47a-46ec-9dc4-130ca75ca40d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_92ea6feb-9481-49d3-b5fb-5406f9e5d517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_429b2516-89dc-421e-9564-50b09e00d100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5ee3d0dc-241b-494e-ba40-396e0f6645de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_429b2516-89dc-421e-9564-50b09e00d100" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5ee3d0dc-241b-494e-ba40-396e0f6645de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8f7cb562-cb31-4bb4-a34a-56c9c4266e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_429b2516-89dc-421e-9564-50b09e00d100" xlink:to="loc_us-gaap_InterestExpense_8f7cb562-cb31-4bb4-a34a-56c9c4266e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_48d85c7a-74fd-4536-b4cb-52cda005e193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_429b2516-89dc-421e-9564-50b09e00d100" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_48d85c7a-74fd-4536-b4cb-52cda005e193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a4c8a867-df70-4af4-9c25-515bb3903aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b964167b-5670-4106-9fa5-81ea809a9c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a4c8a867-df70-4af4-9c25-515bb3903aa3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b964167b-5670-4106-9fa5-81ea809a9c4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_60c6b181-8dd1-469e-9839-ca77d7eb8f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a4c8a867-df70-4af4-9c25-515bb3903aa3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_60c6b181-8dd1-469e-9839-ca77d7eb8f53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a24dc23a-c8a1-4e2e-ae94-12ebfee48667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0a7cb84f-6ef8-4dc4-93ec-5b80a0d19361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a24dc23a-c8a1-4e2e-ae94-12ebfee48667" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0a7cb84f-6ef8-4dc4-93ec-5b80a0d19361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_66afbe3d-79e5-494e-9b01-4e6d0b62061f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a24dc23a-c8a1-4e2e-ae94-12ebfee48667" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_66afbe3d-79e5-494e-9b01-4e6d0b62061f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_285ddaed-48ce-4fda-8d0d-a3c46225830a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a24dc23a-c8a1-4e2e-ae94-12ebfee48667" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_285ddaed-48ce-4fda-8d0d-a3c46225830a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9c31e8db-4b56-41db-b188-aeb1ddf5282c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a24dc23a-c8a1-4e2e-ae94-12ebfee48667" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9c31e8db-4b56-41db-b188-aeb1ddf5282c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b98df296-c398-4685-aea6-77fd08491195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_278a4ae4-b59a-4155-b4c6-f607ea84901e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b98df296-c398-4685-aea6-77fd08491195" xlink:to="loc_us-gaap_OperatingIncomeLoss_278a4ae4-b59a-4155-b4c6-f607ea84901e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cc4f0dee-1c19-4e86-ae8b-cfeba0fde33c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b98df296-c398-4685-aea6-77fd08491195" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cc4f0dee-1c19-4e86-ae8b-cfeba0fde33c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_599865ab-7863-40bf-a95d-dc48f696e472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39dfea8a-7955-4d0e-9e12-4bdadb17c87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_599865ab-7863-40bf-a95d-dc48f696e472" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39dfea8a-7955-4d0e-9e12-4bdadb17c87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_83a3a842-4917-4029-89e0-29bbe1afb4fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_599865ab-7863-40bf-a95d-dc48f696e472" xlink:to="loc_us-gaap_CostsAndExpenses_83a3a842-4917-4029-89e0-29bbe1afb4fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e13c03c9-3f63-42dd-baef-758fc9fa3b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5ded5b64-02f3-4aab-a551-764671c86c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e13c03c9-3f63-42dd-baef-758fc9fa3b13" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5ded5b64-02f3-4aab-a551-764671c86c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_df5ff6de-accd-476c-a151-f1c9beafe40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e13c03c9-3f63-42dd-baef-758fc9fa3b13" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_df5ff6de-accd-476c-a151-f1c9beafe40c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_19fce358-54fc-4c51-ace4-63f11db24392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a53d9a2a-1cbf-4f84-828e-62fae28f15cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_19fce358-54fc-4c51-ace4-63f11db24392" xlink:to="loc_us-gaap_NetIncomeLoss_a53d9a2a-1cbf-4f84-828e-62fae28f15cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8ac7386e-f165-42da-9822-1b7b6d8d640c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_19fce358-54fc-4c51-ace4-63f11db24392" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8ac7386e-f165-42da-9822-1b7b6d8d640c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47220b37-f525-4ba0-9d36-b198d8fc5732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_19fce358-54fc-4c51-ace4-63f11db24392" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47220b37-f525-4ba0-9d36-b198d8fc5732" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_df2d2d9a-2ab3-410c-93d4-9cf0cb3206de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_NetIncomeLoss_df2d2d9a-2ab3-410c-93d4-9cf0cb3206de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_8e95b17e-0025-4f6f-8e90-78b7b724efbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_DepreciationAndAmortization_8e95b17e-0025-4f6f-8e90-78b7b724efbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonCashInterestExpense_b0c14231-c216-486e-8f88-eb478a071b3c" xlink:href="mygn-20200930.xsd#mygn_NonCashInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_mygn_NonCashInterestExpense_b0c14231-c216-486e-8f88-eb478a071b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ef788f69-e24d-4d4b-80a8-652d038f84b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ef788f69-e24d-4d4b-80a8-652d038f84b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_54bbe133-a3b8-4249-b76f-983f4a8ade52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_54bbe133-a3b8-4249-b76f-983f4a8ade52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9640828a-2c98-49cd-a0aa-320d8a770c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_ShareBasedCompensation_9640828a-2c98-49cd-a0aa-320d8a770c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5272de37-36a1-442b-a78f-b239480c1f17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5272de37-36a1-442b-a78f-b239480c1f17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_630a9c6f-b588-4042-8c42-6e9304a44c04" xlink:href="mygn-20200930.xsd#mygn_IncreaseDecreaseInUnrecognizedTaxBenefits"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_630a9c6f-b588-4042-8c42-6e9304a44c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ChangeInFairValueOfContingentConsideration_65a89a75-493e-45a0-818c-db0143b7bbba" xlink:href="mygn-20200930.xsd#mygn_ChangeInFairValueOfContingentConsideration"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_mygn_ChangeInFairValueOfContingentConsideration_65a89a75-493e-45a0-818c-db0143b7bbba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_5c58f7f2-ea57-4f78-9c2c-61a61771306f" xlink:href="mygn-20200930.xsd#mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_5c58f7f2-ea57-4f78-9c2c-61a61771306f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c6a9b5ad-9711-480c-9291-91b4182d3804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c6a9b5ad-9711-480c-9291-91b4182d3804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_899670b9-8d4a-418d-936d-bbfc1c6ff11f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_899670b9-8d4a-418d-936d-bbfc1c6ff11f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0a071471-a08c-4a08-afb8-2839ac5a0956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0a071471-a08c-4a08-afb8-2839ac5a0956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_f74a75d2-7720-4f16-8349-4c881e8a16c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_f74a75d2-7720-4f16-8349-4c881e8a16c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_3daf5b15-4ff0-42f4-a170-1ace09f8ceed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_3daf5b15-4ff0-42f4-a170-1ace09f8ceed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3ac81d1-5d08-4326-81e7-12bbd7a18d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c3ac81d1-5d08-4326-81e7-12bbd7a18d88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_162550ca-ed59-4685-a5f9-0195a20657ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_162550ca-ed59-4685-a5f9-0195a20657ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e3e4cfdd-0c40-486e-a301-01228d2deb43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc718e80-9c5b-4ac1-b21c-caa2349fc073" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e3e4cfdd-0c40-486e-a301-01228d2deb43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f5fdd26b-1992-4255-9d00-96691f282ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e424fd01-e4c5-4ddc-887a-b8b3f8cafbc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f5fdd26b-1992-4255-9d00-96691f282ef0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e424fd01-e4c5-4ddc-887a-b8b3f8cafbc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c945612a-45e2-4203-842c-4fe556b99981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f5fdd26b-1992-4255-9d00-96691f282ef0" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c945612a-45e2-4203-842c-4fe556b99981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_ffd84db1-3ba9-4e41-a4e5-a7dd9e24c1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f5fdd26b-1992-4255-9d00-96691f282ef0" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_ffd84db1-3ba9-4e41-a4e5-a7dd9e24c1ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_25504cf1-c19d-41b8-972a-a8325248f149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_cfe9ae60-db60-40fe-96b3-eb56606302e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_25504cf1-c19d-41b8-972a-a8325248f149" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_cfe9ae60-db60-40fe-96b3-eb56606302e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_11bc8398-1349-4b7d-b474-25581f384d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_25504cf1-c19d-41b8-972a-a8325248f149" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_11bc8398-1349-4b7d-b474-25581f384d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_94d779f6-50d4-4ead-bb89-5275dfb53862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_25504cf1-c19d-41b8-972a-a8325248f149" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_94d779f6-50d4-4ead-bb89-5275dfb53862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_035bbd9f-ad86-40f3-bc8f-a97aeb25a30c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd9e9a34-49a0-4a48-b018-db67a5341432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_035bbd9f-ad86-40f3-bc8f-a97aeb25a30c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd9e9a34-49a0-4a48-b018-db67a5341432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e18362c-e69c-4227-9a4f-80819edb0a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_035bbd9f-ad86-40f3-bc8f-a97aeb25a30c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e18362c-e69c-4227-9a4f-80819edb0a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7deb88d-3c42-4270-a3ab-66d252cac042" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_035bbd9f-ad86-40f3-bc8f-a97aeb25a30c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7deb88d-3c42-4270-a3ab-66d252cac042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25d6b97b-fadb-49af-a8c3-186c956fd8af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_035bbd9f-ad86-40f3-bc8f-a97aeb25a30c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25d6b97b-fadb-49af-a8c3-186c956fd8af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mygn-20200930.xsd#BasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mygn-20200930.xsd#BasisofPresentationPolicies"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/BasisofPresentationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/Revenue" xlink:type="simple" xlink:href="mygn-20200930.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueReconciliationofDeferredRevenueBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/RevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecurities"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_ead182e7-14b2-471b-8498-56fccba651b5" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_1694a9dc-08b4-4187-9396-695afef826bc" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_ead182e7-14b2-471b-8498-56fccba651b5" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_1694a9dc-08b4-4187-9396-695afef826bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_c98512c4-d621-4ade-80ca-f16ab980516a" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_ead182e7-14b2-471b-8498-56fccba651b5" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_c98512c4-d621-4ade-80ca-f16ab980516a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_405c533a-44cf-45c6-ac51-df9d21dbc772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_ead182e7-14b2-471b-8498-56fccba651b5" xlink:to="loc_us-gaap_InvestmentsAndCash_405c533a-44cf-45c6-ac51-df9d21dbc772" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8267fc41-2e95-4348-8dc2-4c3f61e307b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_36b0581f-0a1c-456d-97b4-b8c7b7ef7ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8267fc41-2e95-4348-8dc2-4c3f61e307b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_36b0581f-0a1c-456d-97b4-b8c7b7ef7ea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_584e1ec2-2cd2-4e06-963f-c2c690b07dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8267fc41-2e95-4348-8dc2-4c3f61e307b0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_584e1ec2-2cd2-4e06-963f-c2c690b07dfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b0e1dab9-1db2-410f-8250-8e60ff9e7b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8267fc41-2e95-4348-8dc2-4c3f61e307b0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b0e1dab9-1db2-410f-8250-8e60ff9e7b7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_77fd3766-8c0c-46d5-b467-e25b97e46b28" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e13fc00a-68b9-4baa-a67a-7bb8c4f17b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_77fd3766-8c0c-46d5-b467-e25b97e46b28" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e13fc00a-68b9-4baa-a67a-7bb8c4f17b70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_20134bb6-2a62-4ddc-90c5-b89f435e58b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_77fd3766-8c0c-46d5-b467-e25b97e46b28" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_20134bb6-2a62-4ddc-90c5-b89f435e58b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_2e01a42e-7130-4a7f-b3f3-8025653ee0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_77fd3766-8c0c-46d5-b467-e25b97e46b28" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_2e01a42e-7130-4a7f-b3f3-8025653ee0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_6f4d425e-e2e5-4f50-9a0d-9cc360365235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost_77fd3766-8c0c-46d5-b467-e25b97e46b28" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_6f4d425e-e2e5-4f50-9a0d-9cc360365235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_e1a5f195-bf3a-4e33-bbf3-492b15d1fb4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_1ffe75c2-1b5a-41d4-a738-10b3816c3b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_e1a5f195-bf3a-4e33-bbf3-492b15d1fb4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_1ffe75c2-1b5a-41d4-a738-10b3816c3b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7e21f165-6308-4674-b488-cc1245e48751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_e1a5f195-bf3a-4e33-bbf3-492b15d1fb4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7e21f165-6308-4674-b488-cc1245e48751" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_29662db5-301d-4ac4-98d7-9fb19022029b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_e1a5f195-bf3a-4e33-bbf3-492b15d1fb4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_29662db5-301d-4ac4-98d7-9fb19022029b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_27ef5bc4-4bfe-4a12-ac27-942858ba6947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsAndCash_e1a5f195-bf3a-4e33-bbf3-492b15d1fb4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_27ef5bc4-4bfe-4a12-ac27-942858ba6947" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_a55c8d77-3245-4c0d-bafc-ab09b70a2e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2108269d-77c3-4b50-aab0-a07f3a64d972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_a55c8d77-3245-4c0d-bafc-ab09b70a2e65" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2108269d-77c3-4b50-aab0-a07f3a64d972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6f8394de-c52a-4948-a62f-775838e6847a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_a55c8d77-3245-4c0d-bafc-ab09b70a2e65" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6f8394de-c52a-4948-a62f-775838e6847a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNet"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b3a071fa-5306-42b7-984c-a5a385fca8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_6378664a-198c-401d-94d7-2e68907409c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_b3a071fa-5306-42b7-984c-a5a385fca8d7" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_6378664a-198c-401d-94d7-2e68907409c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_a081a964-1418-43c5-a1cd-9a95f7791b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_b3a071fa-5306-42b7-984c-a5a385fca8d7" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_a081a964-1418-43c5-a1cd-9a95f7791b7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aa6248d5-bf8d-4730-a431-729d2581aabb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_47dd77fe-19c7-4ea1-b700-755e8c3b62c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_aa6248d5-bf8d-4730-a431-729d2581aabb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_47dd77fe-19c7-4ea1-b700-755e8c3b62c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7a9a5a15-c175-4093-aaef-fb7aaef21984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_aa6248d5-bf8d-4730-a431-729d2581aabb" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7a9a5a15-c175-4093-aaef-fb7aaef21984" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummaryofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_21a3ea57-ef62-405a-80b9-0c78f7e23709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_aca64b37-90f6-4f2d-937f-2d54d80e9143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_21a3ea57-ef62-405a-80b9-0c78f7e23709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_aca64b37-90f6-4f2d-937f-2d54d80e9143" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4f6dc34e-f50d-4dc7-87fa-91fac66f20ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_21a3ea57-ef62-405a-80b9-0c78f7e23709" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4f6dc34e-f50d-4dc7-87fa-91fac66f20ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c0d9881f-9651-4240-8d28-ca3b5476a7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e30f72a6-5b01-4baa-8b9b-7f5710d12ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c0d9881f-9651-4240-8d28-ca3b5476a7dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e30f72a6-5b01-4baa-8b9b-7f5710d12ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_58343350-4f69-4d4f-bf13-07f9f446e683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c0d9881f-9651-4240-8d28-ca3b5476a7dc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_58343350-4f69-4d4f-bf13-07f9f446e683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb50ce8e-6ec3-4591-83db-fbec7f2f3df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_48dfa902-25bf-438d-8c3d-bf7aed2a4109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb50ce8e-6ec3-4591-83db-fbec7f2f3df5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_48dfa902-25bf-438d-8c3d-bf7aed2a4109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_47395218-5b4f-4f5d-a8fc-f491a5c02695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eb50ce8e-6ec3-4591-83db-fbec7f2f3df5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_47395218-5b4f-4f5d-a8fc-f491a5c02695" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbd604d8-5f3e-4c2e-8796-403e0b49d83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6f31c277-29fe-4051-98cf-bcffa6acd9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbd604d8-5f3e-4c2e-8796-403e0b49d83c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6f31c277-29fe-4051-98cf-bcffa6acd9ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9f6cbf42-33a6-4515-a115-0beedb8bbeaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bbd604d8-5f3e-4c2e-8796-403e0b49d83c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9f6cbf42-33a6-4515-a115-0beedb8bbeaa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilities"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/AccruedLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f034c11b-0b5a-4746-b175-099ae42b3a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_de2b0032-3e90-452e-a484-6c90813ee6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f034c11b-0b5a-4746-b175-099ae42b3a0d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_de2b0032-3e90-452e-a484-6c90813ee6a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_b562c95e-4288-4305-ab3b-c8a61ff16b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f034c11b-0b5a-4746-b175-099ae42b3a0d" xlink:to="loc_us-gaap_TaxesPayableCurrent_b562c95e-4288-4305-ab3b-c8a61ff16b3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_18832387-71b2-478e-9283-0fb55db628be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f034c11b-0b5a-4746-b175-099ae42b3a0d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_18832387-71b2-478e-9283-0fb55db628be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebt" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebt"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_19a9f08d-82a3-45b5-a526-bdd7e5c51f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_90250eee-4c4a-4642-8156-ccdf873dfdc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_19a9f08d-82a3-45b5-a526-bdd7e5c51f82" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_90250eee-4c4a-4642-8156-ccdf873dfdc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_bc72cd0d-dd60-4806-8cef-ef3a0817a5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_19a9f08d-82a3-45b5-a526-bdd7e5c51f82" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_bc72cd0d-dd60-4806-8cef-ef3a0817a5fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilities"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_37b5c35b-7ce9-4176-80d3-8e13d50d5cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_cd6559f7-b3fd-4e03-8afb-b0ff8c175252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_37b5c35b-7ce9-4176-80d3-8e13d50d5cd4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_cd6559f7-b3fd-4e03-8afb-b0ff8c175252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_161a144f-7f76-4c93-9665-82e2cc031e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_37b5c35b-7ce9-4176-80d3-8e13d50d5cd4" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_161a144f-7f76-4c93-9665-82e2cc031e87" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e413ae9a-746b-4fa0-b536-784495dc2b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ae37f71-d1d6-4b9f-b3a6-20189886d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e413ae9a-746b-4fa0-b536-784495dc2b1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ae37f71-d1d6-4b9f-b3a6-20189886d0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3675cf20-8333-40e0-9b2f-89d86aeecd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e413ae9a-746b-4fa0-b536-784495dc2b1e" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3675cf20-8333-40e0-9b2f-89d86aeecd1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationRSUActivityDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mygn-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mygn-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6eec8e3a-e824-421c-94db-268597e6ccb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2002eaa6-1c6a-483b-a68c-e31a463e5cd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6eec8e3a-e824-421c-94db-268597e6ccb6" xlink:to="loc_us-gaap_OperatingIncomeLoss_2002eaa6-1c6a-483b-a68c-e31a463e5cd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c876984b-eb13-4a8a-8481-bb1df250dcb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6eec8e3a-e824-421c-94db-268597e6ccb6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c876984b-eb13-4a8a-8481-bb1df250dcb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_96e79fcb-213a-42a3-ab28-849bb3ffb703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6eec8e3a-e824-421c-94db-268597e6ccb6" xlink:to="loc_us-gaap_InterestExpense_96e79fcb-213a-42a3-ab28-849bb3ffb703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ad668fc0-d0af-4cd6-b662-9c14a18404c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6eec8e3a-e824-421c-94db-268597e6ccb6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ad668fc0-d0af-4cd6-b662-9c14a18404c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformation"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformationTables"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEvents" xlink:type="simple" xlink:href="mygn-20200930.xsd#SubsequentEvents"/>
  <link:calculationLink xlink:role="http://www.myriad.com/role/SubsequentEvents" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>mygn-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e951f29c-a210-45d5-8fef-ac7c87c1a1f9,g:048ed3a0-61ad-4824-a735-4ab2d7ea0155-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20200930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/Cover" xlink:type="extended" id="ic958e929ef924cfda83e7991ed8639fb_Cover"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="iba60ce8d0fc54c4381aa4f6297f95e85_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i39391ee8864e42bc89d3f37756199e58_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="iec5d4cb602ca42b5ac772e60fbdcef85_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_112ab2f3-b615-492e-ac0b-eab5fce26194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_112ab2f3-b615-492e-ac0b-eab5fce26194" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_350cd21a-1bdd-42e2-95f0-5bc51a90f259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_350cd21a-1bdd-42e2-95f0-5bc51a90f259" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fd7aaedc-2587-4b99-8abc-d535ade2a0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fd7aaedc-2587-4b99-8abc-d535ade2a0f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e0a654e6-cea0-4f93-97ab-254a02324e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e0a654e6-cea0-4f93-97ab-254a02324e44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd944fe1-5d15-46ec-8c31-b60e8bb3dfcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd944fe1-5d15-46ec-8c31-b60e8bb3dfcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_67613797-6e7e-4039-9b03-c487c82fc996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_CostsAndExpenses_67613797-6e7e-4039-9b03-c487c82fc996" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee92b715-41e2-4cb4-9c72-f6b811a12085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_OperatingIncomeLoss_ee92b715-41e2-4cb4-9c72-f6b811a12085" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7cfc443b-ae71-40d5-a21a-b91395c18352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7cfc443b-ae71-40d5-a21a-b91395c18352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dc8ca43a-5267-4fee-8fe3-9be051e99f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_InterestExpense_dc8ca43a-5267-4fee-8fe3-9be051e99f31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e2f8d876-b61a-4603-8c58-06e7b7e24a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e2f8d876-b61a-4603-8c58-06e7b7e24a5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_16c5eebd-a69d-4d1f-831e-6e07dff0df0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_16c5eebd-a69d-4d1f-831e-6e07dff0df0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_014bd8c7-4d93-4db2-81e3-b84c100a1f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_014bd8c7-4d93-4db2-81e3-b84c100a1f75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e0aba52e-a22f-47a3-acf0-a30004cd3b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e0aba52e-a22f-47a3-acf0-a30004cd3b19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8a447515-edaa-44cc-b3e5-7076bc167ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_ProfitLoss_8a447515-edaa-44cc-b3e5-7076bc167ea0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3163fa8e-b483-4365-b9b8-1ecb892fa3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3163fa8e-b483-4365-b9b8-1ecb892fa3c0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_008aeae0-ba6b-41d4-990e-b9007b3a8a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_NetIncomeLoss_008aeae0-ba6b-41d4-990e-b9007b3a8a9e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_abc8d26f-efd5-4226-b2b1-c9dd47cb3974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_abc8d26f-efd5-4226-b2b1-c9dd47cb3974" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_60f5cdf1-f050-485a-9fc8-f4920c325706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_abc8d26f-efd5-4226-b2b1-c9dd47cb3974" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_60f5cdf1-f050-485a-9fc8-f4920c325706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c9b68a32-3dfc-474b-b596-7feec8415b95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c9b68a32-3dfc-474b-b596-7feec8415b95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_7a4d751b-aff4-4314-930a-866f944a7492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c9b68a32-3dfc-474b-b596-7feec8415b95" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_7a4d751b-aff4-4314-930a-866f944a7492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:to="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_de3d5095-6801-49c7-a88f-64fbbcbeea8e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:to="loc_srt_ProductsAndServicesDomain_de3d5095-6801-49c7-a88f-64fbbcbeea8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:to="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_ac290fc8-4a2a-490c-9544-99f50743d50d" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_ac290fc8-4a2a-490c-9544-99f50743d50d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_4165825a-ba2b-4f8b-8e04-22c6f6b9d7b2" xlink:href="mygn-20200930.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_4165825a-ba2b-4f8b-8e04-22c6f6b9d7b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended" id="i18d94b3058b14fa5b6f82b4ffba4274f_CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="if116e446db4e471f996cff9b78a31300_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf01aeb-0425-4aab-af51-bcf3ecbd4814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf01aeb-0425-4aab-af51-bcf3ecbd4814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ee1237b-2a2e-458f-9952-884a6908fa8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ee1237b-2a2e-458f-9952-884a6908fa8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e2d9b0-4f3a-466c-b456-f42772484a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e2d9b0-4f3a-466c-b456-f42772484a44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_493dabc9-7073-4410-a4dc-5f3413a1944a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_NetIncomeLoss_493dabc9-7073-4410-a4dc-5f3413a1944a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8beaa2c2-80a3-47bd-aa90-454b09cd0a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8beaa2c2-80a3-47bd-aa90-454b09cd0a09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab28774d-3176-4d24-b811-2b7943cd0a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b87bfaba-94ea-4829-b883-2355e46f7b88_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:to="loc_us-gaap_EquityComponentDomain_b87bfaba-94ea-4829-b883-2355e46f7b88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:to="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b1fb74e1-732c-4f73-99c0-24e2d4356962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_CommonStockMember_b1fb74e1-732c-4f73-99c0-24e2d4356962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bcef059e-c119-42bb-914d-16c34fa1e74e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bcef059e-c119-42bb-914d-16c34fa1e74e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_59ac4e5c-641f-454f-a073-30e55d6438ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_59ac4e5c-641f-454f-a073-30e55d6438ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_262cdedc-0f3c-40ef-9c1e-66704aae5e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_RetainedEarningsMember_262cdedc-0f3c-40ef-9c1e-66704aae5e9c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i7e2850b92afb4765bea393a64c3f27e6_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mygn-20200930.xsd#BasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BasisofPresentation" xlink:type="extended" id="ic5ae5d548d02446cb0a9dfd0aa17ef0e_BasisofPresentation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mygn-20200930.xsd#BasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/BasisofPresentationPolicies" xlink:type="extended" id="i407de15c6eea4ab9a027afec7731881c_BasisofPresentationPolicies"/>
  <link:roleRef roleURI="http://www.myriad.com/role/Revenue" xlink:type="simple" xlink:href="mygn-20200930.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/Revenue" xlink:type="extended" id="i6cf6bcb0f6e8437b9761672dd8c1dd09_Revenue"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/RevenueTables" xlink:type="extended" id="i291d7f9505c54e5d9e263d5ec774be50_RevenueTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" xlink:type="extended" id="i5297c09399a24dbfa3910c3efc326d11_RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c1654973-616b-44be-89c7-861cd85f86ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4a347af4-219e-481a-8868-c35622ec610a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c1654973-616b-44be-89c7-861cd85f86ce" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4a347af4-219e-481a-8868-c35622ec610a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c1654973-616b-44be-89c7-861cd85f86ce" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:to="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:to="loc_srt_ProductsAndServicesDomain_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:to="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_d0d4307a-a913-4f49-8ab9-6921d102c441" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticHereditaryCancerTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_d0d4307a-a913-4f49-8ab9-6921d102c441" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticPrenatalTestingMember_8fb653c9-42cf-4b33-b218-a71d87a1eaf6" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticPrenatalTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticPrenatalTestingMember_8fb653c9-42cf-4b33-b218-a71d87a1eaf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticGenesightTestingMember_c6e27bb3-02c6-4783-be06-3aede58bfcc7" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticGenesightTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticGenesightTestingMember_c6e27bb3-02c6-4783-be06-3aede58bfcc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticVectraTestingMember_073140b7-1fec-40dd-93f2-9809a88a35b9" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticVectraTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticVectraTestingMember_073140b7-1fec-40dd-93f2-9809a88a35b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_e53860dd-1d1b-4eb2-b115-8180e310f467" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticMyChoiceCDxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_e53860dd-1d1b-4eb2-b115-8180e310f467" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticProlarisTestingMember_ead6c357-e9f7-421b-be06-e398cf541c08" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticProlarisTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticProlarisTestingMember_ead6c357-e9f7-421b-be06-e398cf541c08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_bd8a6058-2eae-40a8-bf7a-d84339c238b9" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticEndoPredictTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_bd8a6058-2eae-40a8-bf7a-d84339c238b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticOtherTestingMember_5a24eafe-b4d7-4327-a5d8-5bf9fe1a03ae" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticOtherTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticOtherTestingMember_5a24eafe-b4d7-4327-a5d8-5bf9fe1a03ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_324442e4-ac09-454e-9341-7891b1f0e3bf" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_324442e4-ac09-454e-9341-7891b1f0e3bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_798e0d1a-9a2e-4d2c-849b-bed8f526bec1" xlink:href="mygn-20200930.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_798e0d1a-9a2e-4d2c-849b-bed8f526bec1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:to="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dfddc2d3-b336-4c5c-88f8-1536cb257118_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:to="loc_srt_SegmentGeographicalDomain_dfddc2d3-b336-4c5c-88f8-1536cb257118_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:to="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fab5b00e-e157-4a38-9558-3d3e4c7ad105" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:to="loc_country_US_fab5b00e-e157-4a38-9558-3d3e4c7ad105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ac4076fc-3549-439b-94df-c3f904d8acce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:to="loc_us-gaap_NonUsMember_ac4076fc-3549-439b-94df-c3f904d8acce" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueReconciliationofDeferredRevenueBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails" xlink:type="extended" id="i15927b341f6d4724879e7af4290bf896_RevenueReconciliationofDeferredRevenueBalancesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/RevenueNarrativeDetails" xlink:type="extended" id="i3700c909ee8b4e56b0e13178b8b98562_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d04ecbd0-1bef-4f23-9289-96f5f146f578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_05fbc7ba-26df-4bad-90cd-17b4cb1dc86e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d04ecbd0-1bef-4f23-9289-96f5f146f578" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_05fbc7ba-26df-4bad-90cd-17b4cb1dc86e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d04ecbd0-1bef-4f23-9289-96f5f146f578" xlink:to="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_36571281-aa3f-457a-b4ef-35e2c1d993f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_36571281-aa3f-457a-b4ef-35e2c1d993f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790e451d-201b-4a51-89f9-db45c2e83ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790e451d-201b-4a51-89f9-db45c2e83ec5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_b87cbbe0-6c9b-44fa-96f0-765060d2f764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790e451d-201b-4a51-89f9-db45c2e83ec5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_b87cbbe0-6c9b-44fa-96f0-765060d2f764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_358bb5c1-1f62-4e4b-ad16-da037e833f70_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_358bb5c1-1f62-4e4b-ad16-da037e833f70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f267e081-03e2-407e-b414-17330aa0cfe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f267e081-03e2-407e-b414-17330aa0cfe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_486607dc-86aa-4b79-a91e-e5c6bc34eee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f267e081-03e2-407e-b414-17330aa0cfe6" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_486607dc-86aa-4b79-a91e-e5c6bc34eee5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecurities"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="extended" id="i33e8569eb3a7456c9c4eadf2285f5dbf_MarketableInvestmentSecurities"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="extended" id="i5024e309258342f7808b2453aaba475f_MarketableInvestmentSecuritiesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="extended" id="i36e5d0857ba140f795f079ede7b54f2b_MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5493b8c5-b901-40c8-b34f-f5fa8ef0bef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5493b8c5-b901-40c8-b34f-f5fa8ef0bef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6dbb7ac6-d19e-4574-9565-718f6ac42dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6dbb7ac6-d19e-4574-9565-718f6ac42dfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07eb5c43-a3b8-401a-9681-b3ee9a905c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07eb5c43-a3b8-401a-9681-b3ee9a905c94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_40ea7fa5-a259-4226-b5ab-34332681e504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_40ea7fa5-a259-4226-b5ab-34332681e504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7dab26bf-f1c9-450b-afc2-12db60929cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7dab26bf-f1c9-450b-afc2-12db60929cb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f588ebd1-dd83-41f0-81a2-e87873f34550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f588ebd1-dd83-41f0-81a2-e87873f34550" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCashAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_eef43514-4864-4942-b732-0219b1112428" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_eef43514-4864-4942-b732-0219b1112428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_bb25787c-802f-41a5-99d9-26c8f7c1262e" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_bb25787c-802f-41a5-99d9-26c8f7c1262e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_170f951a-8252-4a1f-bbb1-ffdc9be697df" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_170f951a-8252-4a1f-bbb1-ffdc9be697df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_44599898-0ba3-4adf-84e9-7694f4e4635f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_us-gaap_InvestmentsAndCash_44599898-0ba3-4adf-84e9-7694f4e4635f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:to="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_13b81157-0b23-410f-9e6d-22d239c11ccf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_13b81157-0b23-410f-9e6d-22d239c11ccf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5d6caa36-7efe-426e-8a09-380d2c398b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5d6caa36-7efe-426e-8a09-380d2c398b04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_836459cb-929a-4088-8437-11b2b7031403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_MunicipalBondsMember_836459cb-929a-4088-8437-11b2b7031403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_370777dc-583e-41c5-aa4e-363a95c8dcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_370777dc-583e-41c5-aa4e-363a95c8dcfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_eb797fe1-3b35-4876-bf3a-ace0369d6a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_eb797fe1-3b35-4876-bf3a-ace0369d6a63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_275d34a5-ab9f-4a03-9f2b-8ab776ec3306_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_275d34a5-ab9f-4a03-9f2b-8ab776ec3306_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_b892640f-6471-4b8c-b65b-086ead920831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:to="loc_us-gaap_CashMember_b892640f-6471-4b8c-b65b-086ead920831" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_07568333-fae5-478e-afda-691bdc6d2135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:to="loc_us-gaap_CashEquivalentsMember_07568333-fae5-478e-afda-691bdc6d2135" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="extended" id="ifa635951627d4df39fcd086312bc65ce_MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81bdc676-8bb5-44d8-a954-cff2b13bf530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81bdc676-8bb5-44d8-a954-cff2b13bf530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_2a4b63e4-2948-4e06-9126-ca83b922c71c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_2a4b63e4-2948-4e06-9126-ca83b922c71c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_283c49a7-bc30-4383-8e75-5b698322d904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_283c49a7-bc30-4383-8e75-5b698322d904" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_5a5e02d3-107b-47b6-87c0-19ed209833f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_5a5e02d3-107b-47b6-87c0-19ed209833f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_1533415d-8c3e-4c20-8994-6ae77ad152c0" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_1533415d-8c3e-4c20-8994-6ae77ad152c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eb0e80b6-ee26-4009-8f1c-e539224801e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eb0e80b6-ee26-4009-8f1c-e539224801e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_1c12c914-df82-4b1e-b355-c967a5d33f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_1c12c914-df82-4b1e-b355-c967a5d33f68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_8a50228f-ecef-4792-8d28-1a605dc6a7b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_8a50228f-ecef-4792-8d28-1a605dc6a7b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_ef868e89-b052-4093-b6d1-1b3a41b77414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_ef868e89-b052-4093-b6d1-1b3a41b77414" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_2c3ccb85-d185-4065-b729-20e139be346b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_InvestmentsAndCash_2c3ccb85-d185-4065-b729-20e139be346b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9e4f3a62-5512-405a-b887-c54340b37f03_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9e4f3a62-5512-405a-b887-c54340b37f03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_05d5be89-1d7f-4caa-bd4e-c0051a5ed273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:to="loc_us-gaap_CashMember_05d5be89-1d7f-4caa-bd4e-c0051a5ed273" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_2196ff2b-8b43-4664-b750-9abf87d9083d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:to="loc_us-gaap_CashEquivalentsMember_2196ff2b-8b43-4664-b750-9abf87d9083d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurements" xlink:type="extended" id="i2919b5198f6748fe9b8c2706f9e3bb4b_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i6c5f2dda6b164f72840278eeadebb4ef_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i8dd4ed4e6f18461e898a679d374855de_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_905f05bb-ad75-420d-a488-4b796b9fdab9" xlink:href="mygn-20200930.xsd#mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:to="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_905f05bb-ad75-420d-a488-4b796b9fdab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_422b2d93-530c-4c8f-b324-73131c14d205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:to="loc_us-gaap_LongTermDebtFairValue_422b2d93-530c-4c8f-b324-73131c14d205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_03672f9d-d877-40d4-9f03-76db8fb6892d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_03672f9d-d877-40d4-9f03-76db8fb6892d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3cdee320-8b3d-4b45-97c2-8775d376bae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_03672f9d-d877-40d4-9f03-76db8fb6892d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3cdee320-8b3d-4b45-97c2-8775d376bae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1177e37e-a512-4925-88f6-15aae4fafbcf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1177e37e-a512-4925-88f6-15aae4fafbcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_07286706-1ceb-43e5-8952-116934b26f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_07286706-1ceb-43e5-8952-116934b26f6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_742f4014-086a-414e-938f-b342e656772a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_07286706-1ceb-43e5-8952-116934b26f6a" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_742f4014-086a-414e-938f-b342e656772a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="extended" id="ic884ba9dfc79434cb1865ee6dc51d5a8_FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3921c358-0147-4a71-95b4-3a86e32570d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3921c358-0147-4a71-95b4-3a86e32570d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6625708d-04e6-4c5d-8b84-fcbd9da39430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6625708d-04e6-4c5d-8b84-fcbd9da39430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_cbec064e-f6a8-47ad-b474-bcd5da8e183d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_FairValueNetAssetLiability_cbec064e-f6a8-47ad-b474-bcd5da8e183d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_47d281c2-ffc2-4c58-b3da-3fa08f685816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_47d281c2-ffc2-4c58-b3da-3fa08f685816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5ff448aa-577c-4626-8f71-88de57f33881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5ff448aa-577c-4626-8f71-88de57f33881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_29c29305-a57b-406e-8a12-4026128e7d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_29c29305-a57b-406e-8a12-4026128e7d4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_573b47fd-ac86-4048-9066-03383e681239_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_573b47fd-ac86-4048-9066-03383e681239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_cba19fab-d76d-4139-9be2-a90bda15aba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_cba19fab-d76d-4139-9be2-a90bda15aba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContingentConsiderationMember_ab02a1e1-9716-4826-aa32-e99c5f2af7ea" xlink:href="mygn-20200930.xsd#mygn_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_cba19fab-d76d-4139-9be2-a90bda15aba9" xlink:to="loc_mygn_ContingentConsiderationMember_ab02a1e1-9716-4826-aa32-e99c5f2af7ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_42066729-6257-4349-bfb6-bd8c7e5a7958_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_42066729-6257-4349-bfb6-bd8c7e5a7958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_338ae8ea-7471-4875-8ef8-b271e958fa0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_MoneyMarketFundsMember_338ae8ea-7471-4875-8ef8-b271e958fa0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d9d3757f-ab7c-48c9-84a0-4cc9ffc343de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d9d3757f-ab7c-48c9-84a0-4cc9ffc343de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_a5fc4a7f-628e-4361-86f0-9bfefe8d86cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_MunicipalBondsMember_a5fc4a7f-628e-4361-86f0-9bfefe8d86cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_0d8cb35a-da2f-4f3f-bfa6-f15b12d97372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_0d8cb35a-da2f-4f3f-bfa6-f15b12d97372" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_010981c7-d82c-4bce-bfa9-058abd8cd3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_010981c7-d82c-4bce-bfa9-058abd8cd3d5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="extended" id="i1be89cfd4b72454f857d29201acbd2be_FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNet"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="extended" id="i3cc8a87896ae4ff5887c199799c6a0f5_PropertyPlantandEquipmentNet"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended" id="ia5888f8583064aa49d1372612cdaafcb_PropertyPlantandEquipmentNetTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="extended" id="i4c6aed9cec234ba09d505e821059a319_PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="extended" id="ibba878b17cb54c5db12fd7a3b9a42b25_PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="extended" id="id8efd4c7f22b4de3bf1d0bfdc03862ab_GoodwillandIntangibleAssets"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended" id="iba63199b0934425db332fe6ad59377f1_GoodwillandIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummaryofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" xlink:type="extended" id="i91f9ae06a9ac4036899ab354f7a679c1_GoodwillandIntangibleAssetsSummaryofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9d16fe1f-434a-4244-bda1-d38bbbb5e218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9d16fe1f-434a-4244-bda1-d38bbbb5e218" xlink:to="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e6731d87-ccb5-4825-b956-839d13624e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:to="loc_us-gaap_Goodwill_e6731d87-ccb5-4825-b956-839d13624e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c7ef681f-2ad6-4b85-be4d-df38477d4f8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c7ef681f-2ad6-4b85-be4d-df38477d4f8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ade0b8e8-c887-418d-80e0-b3156def65c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9d16fe1f-434a-4244-bda1-d38bbbb5e218" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:to="loc_us-gaap_SegmentDomain_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:to="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticsMember_cde58cdf-5af1-4e06-b276-8ccc928dbf53" xlink:href="mygn-20200930.xsd#mygn_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:to="loc_mygn_DiagnosticsMember_cde58cdf-5af1-4e06-b276-8ccc928dbf53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_9fe749ed-5e30-4c5c-93bf-37a1b41bb2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:to="loc_us-gaap_AllOtherSegmentsMember_9fe749ed-5e30-4c5c-93bf-37a1b41bb2d9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" xlink:type="extended" id="i940f3d86f44b4d0dae6166610e190d32_GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:href="mygn-20200930.xsd#mygn_IntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9445a801-0e66-4876-96bf-9c7b921a7857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9445a801-0e66-4876-96bf-9c7b921a7857" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e113c4e6-e4f2-4310-80cf-07ca6c4f0a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e113c4e6-e4f2-4310-80cf-07ca6c4f0a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_42113a99-3e12-490d-98d6-aaffe9e9c76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_42113a99-3e12-490d-98d6-aaffe9e9c76b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_65a4658e-aa38-488c-981b-36b6883144c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_65a4658e-aa38-488c-981b-36b6883144c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b4db5506-2963-4820-b5b8-a4c5a2b0e0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b4db5506-2963-4820-b5b8-a4c5a2b0e0b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e6efa840-c01e-4e79-bcfe-3b9d633ec4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e6efa840-c01e-4e79-bcfe-3b9d633ec4e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:href="mygn-20200930.xsd#mygn_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_feff2875-80f8-46bb-a64e-815b6fab037f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_feff2875-80f8-46bb-a64e-815b6fab037f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_976902fd-ec0b-4631-b19f-c15f919aaead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_976902fd-ec0b-4631-b19f-c15f919aaead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_3561c97b-06d9-4813-a6eb-4378c5136730" xlink:href="mygn-20200930.xsd#mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_976902fd-ec0b-4631-b19f-c15f919aaead" xlink:to="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_3561c97b-06d9-4813-a6eb-4378c5136730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e06c9a4-281e-4bc1-97ed-feb753c4ad78_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e06c9a4-281e-4bc1-97ed-feb753c4ad78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember_703d8ce7-3cd1-4be1-8b65-b0bc572f8457" xlink:href="mygn-20200930.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:to="loc_mygn_PurchasedLicensesAndTechnologiesMember_703d8ce7-3cd1-4be1-8b65-b0bc572f8457" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e78bb5b5-36c9-44d9-ba03-389e8f4e8bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e78bb5b5-36c9-44d9-ba03-389e8f4e8bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_1663e837-4daf-484d-b90b-b3cb3f48d2f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:to="loc_us-gaap_TrademarksMember_1663e837-4daf-484d-b90b-b3cb3f48d2f9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="extended" id="i015d25bc0b8b409483340b0b4a428855_GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilities"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/AccruedLiabilities" xlink:type="extended" id="i2da6979dc910462ba58bcf81a4162894_AccruedLiabilities"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="extended" id="i05d3de1ef5f2474d8b9b5eaacec3288a_AccruedLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="icfff472c23924a23b28de0ad3f248674_AccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebt" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebt"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebt" xlink:type="extended" id="iacec41beb70d476191c977c8d9b76ed7_LongTermDebt"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebtTables" xlink:type="extended" id="i0c1df0185d0c4b4d9f20725aa093fa06_LongTermDebtTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="idf01fb70f05a4ceda8738dd8affc4b9f_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_4a3c24e5-b343-44aa-8957-48203d067879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_4a3c24e5-b343-44aa-8957-48203d067879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9bdb7954-0469-4d4c-a718-55f5efdf5fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9bdb7954-0469-4d4c-a718-55f5efdf5fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_545f7189-5981-4735-bc7d-f560f63869eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_545f7189-5981-4735-bc7d-f560f63869eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_5adb8622-18a6-487e-bdef-ff218b451b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_5adb8622-18a6-487e-bdef-ff218b451b56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_48fe3dc1-0f48-4eb8-aaf5-667a9e354fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_48fe3dc1-0f48-4eb8-aaf5-667a9e354fd1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7cc6591e-72df-4375-9ff5-b0f30c42618a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LongTermDebt_7cc6591e-72df-4375-9ff5-b0f30c42618a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_fd002df8-932b-4122-babc-bc3a0e225861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_fd002df8-932b-4122-babc-bc3a0e225861" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5d0ed0ac-5e5a-4c86-ad57-850483fa6912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5d0ed0ac-5e5a-4c86-ad57-850483fa6912" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b472078f-0b50-4b79-b59c-fc915fdbbcbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b472078f-0b50-4b79-b59c-fc915fdbbcbc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtInstrumentLIBORFloorPercentage_a14e5e27-31b0-4d00-9fbe-758a5978b7f8" xlink:href="mygn-20200930.xsd#mygn_DebtInstrumentLIBORFloorPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_mygn_DebtInstrumentLIBORFloorPercentage_a14e5e27-31b0-4d00-9fbe-758a5978b7f8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_307f640e-4fbd-48e9-bb09-cb6301f89a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_307f640e-4fbd-48e9-bb09-cb6301f89a3f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7588cff4-cc8b-4a31-bd7d-55df68deaccb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:to="loc_us-gaap_CreditFacilityDomain_7588cff4-cc8b-4a31-bd7d-55df68deaccb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c504c8a7-ae26-4226-9942-41ed5908d5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:to="loc_us-gaap_CreditFacilityDomain_c504c8a7-ae26-4226-9942-41ed5908d5bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_519ff859-3e92-4727-bab0-314d9a893d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c504c8a7-ae26-4226-9942-41ed5908d5bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_519ff859-3e92-4727-bab0-314d9a893d99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_51e07433-e71d-422d-adba-4a844b98c4c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_51e07433-e71d-422d-adba-4a844b98c4c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_643fb40f-c3e2-4317-a553-6129a8da954e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_643fb40f-c3e2-4317-a553-6129a8da954e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember_cd9f714d-cbf2-4c1d-b3d3-43e9390a6939" xlink:href="mygn-20200930.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_643fb40f-c3e2-4317-a553-6129a8da954e" xlink:to="loc_mygn_AmendmentToCreditAgreementMember_cd9f714d-cbf2-4c1d-b3d3-43e9390a6939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a690b69c-37ef-48e6-924e-82d770903ce6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:to="loc_us-gaap_VariableRateDomain_a690b69c-37ef-48e6-924e-82d770903ce6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_932cb430-a952-4a73-b3ac-a4c1ce630d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:to="loc_us-gaap_VariableRateDomain_932cb430-a952-4a73-b3ac-a4c1ce630d06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d29af574-f25b-4800-abc6-40d9851829b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_932cb430-a952-4a73-b3ac-a4c1ce630d06" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d29af574-f25b-4800-abc6-40d9851829b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a0eb0805-67ec-4411-a445-c404cda4dd13_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a0eb0805-67ec-4411-a445-c404cda4dd13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c47b35f3-2cf2-4216-80da-23b62873c350" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c47b35f3-2cf2-4216-80da-23b62873c350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2b293bd6-3e83-4c9b-8c7d-8f47e42f8539" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_c47b35f3-2cf2-4216-80da-23b62873c350" xlink:to="loc_srt_ScenarioForecastMember_2b293bd6-3e83-4c9b-8c7d-8f47e42f8539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3e7ea109-9969-447d-a3ec-930058d1381a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:to="loc_srt_RangeMember_3e7ea109-9969-447d-a3ec-930058d1381a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:to="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2617788e-3e67-4ac2-8ebe-d4c7928d86f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:to="loc_srt_MinimumMember_2617788e-3e67-4ac2-8ebe-d4c7928d86f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d5919ac-f437-4fc5-8f03-655ba8fc5156" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:to="loc_srt_MaximumMember_2d5919ac-f437-4fc5-8f03-655ba8fc5156" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended" id="ie0fc41b71e624d40842533d2c11d7bbd_LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilities"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="extended" id="i67b8b63ab16540a6a85af28b86010234_OtherLongTermLiabilities"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="extended" id="ic7282deb3db949f0853b08a8993fbef7_OtherLongTermLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails" xlink:type="extended" id="i9464dbb662cf4e798a51fe6d5e4c0108_OtherLongTermLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="extended" id="i3837d372fbff449dabc287e165fb9e74_PreferredandCommonStockholdersEquity"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="extended" id="i0996dc5e12e9403f89260e7d0148c5dd_PreferredandCommonStockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="extended" id="i4c5d91f2ab97430a98034608e5b577ec_PreferredandCommonStockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_da319fac-5673-4f81-a4b6-2019789b5230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_da319fac-5673-4f81-a4b6-2019789b5230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6fc4ba5c-09a9-4999-9efc-d065855063cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6fc4ba5c-09a9-4999-9efc-d065855063cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_2b7df0dc-e41d-4416-99e5-60526c2cfdb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_2b7df0dc-e41d-4416-99e5-60526c2cfdb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b6e5d3d8-8803-432a-903c-51464c951ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b6e5d3d8-8803-432a-903c-51464c951ec8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a473d60c-36c3-4355-a1eb-5f4f23d112da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a473d60c-36c3-4355-a1eb-5f4f23d112da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_75f51520-aed4-4d4f-b01f-683e609a580d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockSharesIssued_75f51520-aed4-4d4f-b01f-683e609a580d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc59025a-43cd-4867-9914-976e9ee568e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc59025a-43cd-4867-9914-976e9ee568e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_33a0bc6a-c546-4ab2-ada6-ce825c72e6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_33a0bc6a-c546-4ab2-ada6-ce825c72e6fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_55066432-19f9-4f1c-8169-923023f635a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_55066432-19f9-4f1c-8169-923023f635a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_83b1aed0-1284-4e37-8cef-fc34fb6a8871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_83b1aed0-1284-4e37-8cef-fc34fb6a8871" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_877a581a-fe0f-4c25-a7db-466ff3d27d19_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_877a581a-fe0f-4c25-a7db-466ff3d27d19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f0a63708-9488-4214-bbf6-bc576eac865f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f0a63708-9488-4214-bbf6-bc576eac865f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EighthShareRepurchaseProgramMember_b663c01d-9a07-449a-a6c5-24a08d2e25dc" xlink:href="mygn-20200930.xsd#mygn_EighthShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f0a63708-9488-4214-bbf6-bc576eac865f" xlink:to="loc_mygn_EighthShareRepurchaseProgramMember_b663c01d-9a07-449a-a6c5-24a08d2e25dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="extended" id="i6532c7b5c8714b59895b88ca086a97cf_PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" xlink:type="extended" id="ifbdb6a1e109f45149ad94d3258542f7a_PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" xlink:type="extended" id="i1b35a2e117b14058936dc127d107bbe0_PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="extended" id="i0d3844fa861c4197ad601ea5ab65441d_ShareBasedCompensation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="extended" id="id30f9453ee2648839a95b128b6ddf641_ShareBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="ibd3c5f64e2354fc59adfc8e762e7fb0c_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_eff584af-5e6a-472d-83ee-840ba235af41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_eff584af-5e6a-472d-83ee-840ba235af41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75c48422-8c55-4fed-9208-6e81274e625a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75c48422-8c55-4fed-9208-6e81274e625a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_afbaec68-4981-4116-8913-2e36e3190ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_afbaec68-4981-4116-8913-2e36e3190ad6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_60fd687a-ceb6-4c90-bb1a-0f8b5fbd0766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_60fd687a-ceb6-4c90-bb1a-0f8b5fbd0766" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e579974a-e59e-452a-8626-4e708be985b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e579974a-e59e-452a-8626-4e708be985b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c285acb-882c-4554-bdea-13a3e3f369ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c285acb-882c-4554-bdea-13a3e3f369ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a507a414-eeac-43fd-a394-c8d9ef134670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a507a414-eeac-43fd-a394-c8d9ef134670" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_43d87044-2b51-4aae-8de4-f71f9e7d3d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_43d87044-2b51-4aae-8de4-f71f9e7d3d52" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ad53cb7e-1d41-4b11-8363-8d58632d917a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:to="loc_us-gaap_PlanNameDomain_ad53cb7e-1d41-4b11-8363-8d58632d917a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:to="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_4c601e6b-be97-4a65-825d-92748372ff38" xlink:href="mygn-20200930.xsd#mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:to="loc_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_4c601e6b-be97-4a65-825d-92748372ff38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_d4bb7b80-c09a-473e-b01c-597fcf62cb49" xlink:href="mygn-20200930.xsd#mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:to="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_d4bb7b80-c09a-473e-b01c-597fcf62cb49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f4f4b69b-020a-472b-ad8b-95e9b147080c" xlink:href="mygn-20200930.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f4f4b69b-020a-472b-ad8b-95e9b147080c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_86040494-9bde-4d5c-9a71-212dad81577a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_86040494-9bde-4d5c-9a71-212dad81577a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_eda1fa96-3bee-4a58-a3a0-6d2132664c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:to="loc_us-gaap_EmployeeStockOptionMember_eda1fa96-3bee-4a58-a3a0-6d2132664c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4572a805-13df-4dc2-8421-f30093ddaeed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4572a805-13df-4dc2-8421-f30093ddaeed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsAndRestrictedStockUnitsMember_c4cf31d1-a6a0-442c-ab4d-3f8f8b1c4032" xlink:href="mygn-20200930.xsd#mygn_OptionsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:to="loc_mygn_OptionsAndRestrictedStockUnitsMember_c4cf31d1-a6a0-442c-ab4d-3f8f8b1c4032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:to="loc_us-gaap_AwardDateDomain_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:to="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_31ac00a1-6f9d-426b-8204-8e5aa1f18edc" xlink:href="mygn-20200930.xsd#mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:to="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_31ac00a1-6f9d-426b-8204-8e5aa1f18edc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_72015f31-3c7a-4c78-847c-9edc43665235" xlink:href="mygn-20200930.xsd#mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:to="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_72015f31-3c7a-4c78-847c-9edc43665235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfa3f221-9712-41a1-90f3-e27212a01503_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfa3f221-9712-41a1-90f3-e27212a01503_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7683ebff-abd5-460d-8539-f093ede7dcae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7683ebff-abd5-460d-8539-f093ede7dcae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonEmployeeDirectorMember_6de6af73-f424-4f16-9df2-2e3d4c8e3b26" xlink:href="mygn-20200930.xsd#mygn_NonEmployeeDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7683ebff-abd5-460d-8539-f093ede7dcae" xlink:to="loc_mygn_NonEmployeeDirectorMember_6de6af73-f424-4f16-9df2-2e3d4c8e3b26" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended" id="i6aaa9559231a4d3a9b9822dc92a3db37_ShareBasedCompensationStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails" xlink:type="extended" id="i68b28da1f8514cd5bfa6a94e97a6646a_ShareBasedCompensationRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddfac1c5-1f74-4646-9afc-143263578d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddfac1c5-1f74-4646-9afc-143263578d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb1af532-d5a9-4e5e-880a-0c528053201b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb1af532-d5a9-4e5e-880a-0c528053201b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2f495240-6e9d-4b4b-a56a-638d7a860ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2f495240-6e9d-4b4b-a56a-638d7a860ec8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_03de6d15-96ae-4a07-b163-fe2ce982fdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_03de6d15-96ae-4a07-b163-fe2ce982fdf3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c868e29c-5e6e-4866-a943-1f863e655c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfc6c07e-ce99-4c15-837c-13e7d14e589d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfc6c07e-ce99-4c15-837c-13e7d14e589d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84d12d01-c4c2-49e3-95fd-e25eec61f98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84d12d01-c4c2-49e3-95fd-e25eec61f98d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_208c7bb7-d8ef-46bb-934c-69625ed87208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_208c7bb7-d8ef-46bb-934c-69625ed87208" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6fab7486-48af-4669-8cd0-2b813b47b34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6fab7486-48af-4669-8cd0-2b813b47b34f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dd65be62-7e3d-4345-8bf3-2a1fc155da71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:to="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9322723a-d02b-42c7-83e0-b5738699746f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9322723a-d02b-42c7-83e0-b5738699746f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_204d2ad3-fa51-4559-b8fb-ef8418d5382f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_204d2ad3-fa51-4559-b8fb-ef8418d5382f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_53c14510-70f3-4163-abff-989950c90160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_204d2ad3-fa51-4559-b8fb-ef8418d5382f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_53c14510-70f3-4163-abff-989950c90160" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended" id="i48a90421067848a9aa7548f31963e2d2_ShareBasedCompensationShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b17b2d81-1649-403c-89c6-f131d958ae24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ed4fcf3b-43c2-4c9e-a231-0dfc85f38135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b17b2d81-1649-403c-89c6-f131d958ae24" xlink:to="loc_us-gaap_ShareBasedCompensation_ed4fcf3b-43c2-4c9e-a231-0dfc85f38135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b17b2d81-1649-403c-89c6-f131d958ae24" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfMolecularDiagnosticTestingMember_f12ca616-1852-4cf1-ac9a-6d60736bb295" xlink:href="mygn-20200930.xsd#mygn_CostOfMolecularDiagnosticTestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_mygn_CostOfMolecularDiagnosticTestingMember_f12ca616-1852-4cf1-ac9a-6d60736bb295" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_5ca4a03c-2731-43bf-ba0b-bbd45fa04c2c" xlink:href="mygn-20200930.xsd#mygn_CostOfPharmaceuticalAndClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_5ca4a03c-2731-43bf-ba0b-bbd45fa04c2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b6069438-062c-4bf7-bf85-dbe1a88fd528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b6069438-062c-4bf7-bf85-dbe1a88fd528" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b8f0b184-0274-49a5-a2d3-774de6ba2ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b8f0b184-0274-49a5-a2d3-774de6ba2ff0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mygn-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxes" xlink:type="extended" id="ib32d513fe5c9416ab8612129e3a942d8_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/IncomeTaxesDetails" xlink:type="extended" id="i525eff315db047f2b9b5b891ee001c6c_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8908804e-78b1-4521-9cf5-c59e5d4b12df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8908804e-78b1-4521-9cf5-c59e5d4b12df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_38ddd6b2-f58a-4710-83cc-f655772b9f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_38ddd6b2-f58a-4710-83cc-f655772b9f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxExpenseBenefitCARESAct_4f505aa1-b60a-400c-8892-65ec203c51e3" xlink:href="mygn-20200930.xsd#mygn_IncomeTaxExpenseBenefitCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_mygn_IncomeTaxExpenseBenefitCARESAct_4f505aa1-b60a-400c-8892-65ec203c51e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_1a2f7b2f-c02b-41c5-9f70-f0c1e4fad373" xlink:href="mygn-20200930.xsd#mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_1a2f7b2f-c02b-41c5-9f70-f0c1e4fad373" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_99102280-f765-4044-b641-d1fab27210c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_99102280-f765-4044-b641-d1fab27210c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_45e9b987-d076-432c-b7cc-2c207fbd1922_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_45e9b987-d076-432c-b7cc-2c207fbd1922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_b2655cf8-e95b-425a-88c2-1605db8e664a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_b2655cf8-e95b-425a-88c2-1605db8e664a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_8506e01f-346d-4321-be4d-7418df9cd08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:to="loc_us-gaap_ForeignCountryMember_8506e01f-346d-4321-be4d-7418df9cd08b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5349baf8-b8b6-4edb-9758-8c566c45bfe5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5349baf8-b8b6-4edb-9758-8c566c45bfe5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember_e080cadc-322a-4ff5-a8c7-11dd924382d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_NewJerseyDivisionOfTaxationMember_e080cadc-322a-4ff5-a8c7-11dd924382d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_3cef50c2-591d-4c2a-abda-2decda7c93cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_3cef50c2-591d-4c2a-abda-2decda7c93cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MassachusettsDepartmentOfRevenueMember_aa144804-88b9-4065-a467-266400b998a6" xlink:href="mygn-20200930.xsd#mygn_MassachusettsDepartmentOfRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_mygn_MassachusettsDepartmentOfRevenueMember_aa144804-88b9-4065-a467-266400b998a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_ba4a273b-136b-4004-8e83-1e07a2e776b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalMinistryOfFinanceGermanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_ba4a273b-136b-4004-8e83-1e07a2e776b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_863d2e11-1fd8-4ce3-a3fb-622354c0ef14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_863d2e11-1fd8-4ce3-a3fb-622354c0ef14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_54d00172-1cd8-4f96-b97e-792facabef5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:to="loc_us-gaap_TaxPeriodDomain_54d00172-1cd8-4f96-b97e-792facabef5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:to="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_e391e0d1-54c5-4a48-853b-da1ccd076837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:to="loc_us-gaap_EarliestTaxYearMember_e391e0d1-54c5-4a48-853b-da1ccd076837" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_1a5bd371-1ade-493d-827b-875c14d39197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:to="loc_us-gaap_LatestTaxYearMember_1a5bd371-1ade-493d-827b-875c14d39197" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mygn-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="extended" id="i72d1af8183f94268a63f57392f9f8a3c_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="extended" id="i47607b1fa6a346de81addca8662d0d3c_SegmentandRelatedInformation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="extended" id="icbfdb29934164130a518fc1e1c1950e9_SegmentandRelatedInformationTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="extended" id="i77c6aaa42db041a2a5577fed1647136a_SegmentandRelatedInformationNarrativeDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" xlink:type="extended" id="i0f7b42971cfd42c09646a9c846545fcc_SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fef6ac31-823c-452b-b518-3cb4772feeee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fef6ac31-823c-452b-b518-3cb4772feeee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_77bd42d1-6b42-4613-be89-2a2139e8bdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_DepreciationAndAmortization_77bd42d1-6b42-4613-be89-2a2139e8bdeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0d271f3-6986-4f95-9ce0-20a80fa01af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0d271f3-6986-4f95-9ce0-20a80fa01af8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6a5a8716-0a77-493c-991c-759f3d02dcb1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:to="loc_us-gaap_SegmentDomain_6a5a8716-0a77-493c-991c-759f3d02dcb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:to="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticsMember_afedfca8-0b45-4354-8697-90adb4d2f8fc" xlink:href="mygn-20200930.xsd#mygn_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:to="loc_mygn_DiagnosticsMember_afedfca8-0b45-4354-8697-90adb4d2f8fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b1a80d45-c519-48e5-bc4b-af8ea279a7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b1a80d45-c519-48e5-bc4b-af8ea279a7dd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="extended" id="i8396ffa58c4143898053eee4b6d1c61d_SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformation"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="extended" id="ifa81ca1f78df4f73a0a1d837ed0b3f2c_SupplementalCashFlowInformation"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformationTables"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="extended" id="icfcb3e6f5e3348d6b53c8f732aa09678_SupplementalCashFlowInformationTables"/>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended" id="i2127000552e34331ae90dd3662806dfe_SupplementalCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_f5e3bc4d-0c8f-468f-8234-1b6e7e8671d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_IncomeTaxesPaid_f5e3bc4d-0c8f-468f-8234-1b6e7e8671d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_faec32db-6cd1-4afb-9e48-3bdc1120315d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_InterestPaidNet_faec32db-6cd1-4afb-9e48-3bdc1120315d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ef1f9162-8c1e-467b-9d02-aa4432453445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ef1f9162-8c1e-467b-9d02-aa4432453445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLeaseLiabilityEstablished_e5dfc63e-c871-44d8-af3c-3fba0e6400b9" xlink:href="mygn-20200930.xsd#mygn_OperatingLeaseLiabilityEstablished"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:to="loc_mygn_OperatingLeaseLiabilityEstablished_e5dfc63e-c871-44d8-af3c-3fba0e6400b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_10758c23-1b88-4c09-804a-a582a98ce855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_10758c23-1b88-4c09-804a-a582a98ce855" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_bea7fca0-65dd-417d-a3a0-45ac37ee8452_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:to="loc_us-gaap_TypeOfAdoptionMember_bea7fca0-65dd-417d-a3a0-45ac37ee8452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_853a5222-b098-483c-b9b1-e2412f640cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:to="loc_us-gaap_TypeOfAdoptionMember_853a5222-b098-483c-b9b1-e2412f640cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_ba108952-e089-47b3-bea5-0b35ee2e5b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_853a5222-b098-483c-b9b1-e2412f640cec" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_ba108952-e089-47b3-bea5-0b35ee2e5b41" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEvents" xlink:type="simple" xlink:href="mygn-20200930.xsd#SubsequentEvents"/>
  <link:definitionLink xlink:role="http://www.myriad.com/role/SubsequentEvents" xlink:type="extended" id="i26e41d17be554563a51478fc5329d853_SubsequentEvents"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>mygn-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e951f29c-a210-45d5-8fef-ac7c87c1a1f9,g:048ed3a0-61ad-4824-a735-4ab2d7ea0155-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ac2677b1-a5d3-49f9-9388-41df18ccbc9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f20fff1a-0739-43b2-a9af-4ee584fbf7bf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9e1f589a-1cfa-4801-b349-49e797a0c84e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_60debb29-a5dc-4dc6-a539-f16923fa48a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_68a18598-de77-4706-9f64-47e92e730187_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_12dd3916-2151-4d57-be14-fb5ec7dae628_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_08e6dbf2-76d3-4b46-98b6-91294bca208b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Investment Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LatestTaxYearMember_9ea703e0-8d09-45f6-b942-ec31d005be82_terseLabel_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest tax year</link:label>
    <link:label id="lab_us-gaap_LatestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LatestTaxYearMember" xlink:to="lab_us-gaap_LatestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_514fc736-16dc-4fe2-ba6e-b3d3c6a80abd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f1608c42-9638-4756-931a-7ab2c06457bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_bea184a4-9490-4e93-9a5d-75e9cbb1454e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_26e1d815-62d5-4ff5-a705-5034b775b1af_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d9b790af-fc6e-47ca-a03c-ba76d885a14b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities and sales of marketable investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_dcf94656-7c3a-469e-8b5b-5a583c2aadee_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b9ef081-3b86-475a-a5e0-72830ac03a09_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d30cd425-db1d-4870-aaa0-a069e17e88a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_447c48c7-eda8-48b9-9af0-fcc568e34cdb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_295d0f58-b347-4c28-9341-ac4e4a17efaf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9e4484f4-c6d1-4b17-9e55-0784c09fbe7f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2130e8cc-8ebc-448c-a5b9-3c5c1ba2829c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_31e1c1f4-5edb-4bed-97a2-f1d4f43667d3_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net, total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalMinistryOfFinanceGermanyMember_feac9040-4a28-446d-92ef-5a9d09535632_terseLabel_en-US" xlink:label="lab_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany</link:label>
    <link:label id="lab_us-gaap_FederalMinistryOfFinanceGermanyMember_label_en-US" xlink:label="lab_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Ministry of Finance, Germany [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalMinistryOfFinanceGermanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:to="lab_us-gaap_FederalMinistryOfFinanceGermanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6f9e122d-501d-4a22-9d34-3bba15b95c4f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e418ea3f-a5a4-4c18-b53b-18a268c5d954_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f591344a-7d0d-490d-9b7d-b8060397bcfb_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating loss for reportable segments</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_94b3bd16-0ff6-4b0e-aac8-fb1ef0a08ea7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_668f31a0-a8b2-4518-b854-8f17d3cddaff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Deferred Revenue Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8886d327-1757-40e9-bd43-f6d1a9973b7e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, beginning (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_30815757-4b12-41a8-abc2-071110811740_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, ending (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_a32f5b1c-6123-4a7e-b3d6-809cce84903b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_5598a6fc-0eed-4950-b4f1-33ffc4205652_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember_33d86971-f89d-4528-b609-d960e0d53b33_terseLabel_en-US" xlink:label="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of pharmaceutical and clinical services</link:label>
    <link:label id="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember_label_en-US" xlink:label="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Pharmaceutical And Clinical Services [Member]</link:label>
    <link:label id="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember_documentation_en-US" xlink:label="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primary financial statement caption in which the reported facts about the cost of pharmaceutical and clinical services expense have been included.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:href="mygn-20200930.xsd#mygn_CostOfPharmaceuticalAndClinicalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:to="lab_mygn_CostOfPharmaceuticalAndClinicalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ec32148b-10ce-4aa7-944e-4668454fddad_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8dd8b07d-6ef0-453f-946f-88a33548a643_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_ecca7248-8aa2-4d79-95a3-ace0ebe1e25b_terseLabel_en-US" xlink:label="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York</link:label>
    <link:label id="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_label_en-US" xlink:label="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York State Division of Taxation and Finance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:to="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_58d2c32e-693b-4fdf-ba37-1dc24983f54f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service period for award vesting (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_cf9b0fc2-b3d6-4ac1-892e-43a6463599f2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_26bc9d89-d7ad-44df-94d7-4a0ab33201ec_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0b22a4d0-8a3d-4edb-8977-4603aad4d703_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_122a57a2-9d82-4a2c-9711-256430623683_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments prior to maturity date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Annual Principal Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_66292c0d-b3cb-4c06-99e2-f17bf8988118_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fc73facd-e3a5-4218-a851-e98602090b59_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_f10cca86-d29a-4242-83d5-23cf00480636_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b37f4275-4dad-472c-89b4-605b1d9cac0e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_e0556796-cbb5-43c5-97ff-d70d910e3d71_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12f08f7c-5eaf-4c6c-9d8b-7af1d3c73f16_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_9dc6d11e-6900-4bee-b06a-8af1f9c7e471_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_d6fb0c42-512e-4c14-a69c-0a3f3207babf_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_af678e51-a07e-4bae-9ca7-f97dce6f1c97_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncomeTaxExpenseBenefitCARESAct_84b7ceda-3d81-485e-9019-411aaa77d184_negatedTerseLabel_en-US" xlink:label="lab_mygn_IncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax net benefit related to CARES Act</link:label>
    <link:label id="lab_mygn_IncomeTaxExpenseBenefitCARESAct_label_en-US" xlink:label="lab_mygn_IncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), CARES Act</link:label>
    <link:label id="lab_mygn_IncomeTaxExpenseBenefitCARESAct_documentation_en-US" xlink:label="lab_mygn_IncomeTaxExpenseBenefitCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxExpenseBenefitCARESAct" xlink:href="mygn-20200930.xsd#mygn_IncomeTaxExpenseBenefitCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncomeTaxExpenseBenefitCARESAct" xlink:to="lab_mygn_IncomeTaxExpenseBenefitCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_265fc653-74b0-4efb-9250-39ac5d079869_terseLabel_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest tax year</link:label>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarliestTaxYearMember" xlink:to="lab_us-gaap_EarliestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_f303d0ee-eeeb-457e-b6dc-c3d31357bde3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_98e81498-61e0-4857-bfc9-3f56fca0fe7b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a5877e72-bf11-4690-bf1c-5a1e91a064d2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OperatingLeaseLiabilityEstablished_c7d14642-a726-4b8d-a7f4-0c947d5b54ff_negatedTerseLabel_en-US" xlink:label="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mygn_OperatingLeaseLiabilityEstablished_label_en-US" xlink:label="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Established</link:label>
    <link:label id="lab_mygn_OperatingLeaseLiabilityEstablished_documentation_en-US" xlink:label="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Established</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLeaseLiabilityEstablished" xlink:href="mygn-20200930.xsd#mygn_OperatingLeaseLiabilityEstablished"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OperatingLeaseLiabilityEstablished" xlink:to="lab_mygn_OperatingLeaseLiabilityEstablished" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_3bdbf471-e6d4-4fbe-8814-e27976e73b16_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal agency issues</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fd3fb121-be6b-4051-a060-ba924665eb6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_4cdeb237-17b7-413a-ad55-cf6415339c69_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_0ae1b63b-219e-4a0e-8379-e81c5429dd58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticGenesightTestingMember_160c0f99-fa09-4265-b6a2-ae6622c40423_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - GeneSight</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticGenesightTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Genesight Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticGenesightTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic GeneSight testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticGenesightTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticGenesightTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticGenesightTestingMember" xlink:to="lab_mygn_MolecularDiagnosticGenesightTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b4747a86-ec3e-4e70-84f5-87cb09d6ed89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_76facdda-bca2-43d2-9eba-4ea587d4ff58_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8495dc23-5035-4f15-acb8-d55eb4c03d91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled or expired (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_282a33af-dc70-402a-a26e-80e6400c4e62_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_4ecd4dd0-97ef-4972-87be-faa548ce57c9_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable investment securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_fd2fecd8-ef76-432f-a506-3399cfc75030_terseLabel_en-US" xlink:label="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted after December 5, 2012</link:label>
    <link:label id="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_label_en-US" xlink:label="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted After December Five Twenty Twelve [Member]</link:label>
    <link:label id="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_documentation_en-US" xlink:label="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted after December 5, 2012.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:href="mygn-20200930.xsd#mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:to="lab_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f7532033-91c5-4af0-90ae-44a3e151dddf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b71735f8-cc8f-4393-8063-8656446049e7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d95ff3f3-de34-46a3-90ee-9edec5556f70_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled or expired (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a6e78089-082f-4d88-87e1-3823b6dc3e21_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be63f992-4656-459f-a45d-1722309d1b9f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b039c356-4c24-4ce0-a4bb-ee02c2fb6611_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_2e929881-9349-45a9-9eac-0cfc84acb2de_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_6668cdc5-f5b0-4c12-9710-e8431251843d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4f37d712-86b8-4ccf-8a3a-8100403887c0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_3856f2fd-8ae5-4081-9fa9-35987f9fdbdd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3df2763d-856e-4523-a795-bf1fb319caf1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Anti-Dilutive Options and Restricted Stock Units Excluded from EPS Computation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_036f70c1-c79f-44ff-8a61-690c9d6ac1c7_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3cac81e2-bba8-4e69-aceb-5bcd48a1eb12_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_3ffc0a5b-5bad-4add-af97-1fbecf319c10_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9b197b8f-20d1-427d-b616-70b371ac04cd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_e2fcb6ee-244a-4871-8d62-02003c866dad_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3b243f19-bbaf-4925-b3d1-cabe38f32c70_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_d2db32d4-772f-4709-bedd-2c2b909d87e0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1be53968-cb20-491e-9e3c-34b533f75576_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_19ab85c1-a230-406f-9274-488e558a9387_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_dda6d768-854d-49f4-b35d-231852024ed5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_31b1bd26-544f-4db6-a0e9-a14447d91433_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_21c5ca93-65ad-4fda-996c-6a630b741b6a_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_0c981517-1fa3-4942-898e-83bc989224f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_773b4360-0f93-4030-891d-07b8fe374e77_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_ac60389d-7fd4-4b21-97fb-e8025f7eabb9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_faf1d0a6-072a-4253-a1c0-118fbf6f7cce_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9604314d-c717-44c7-a517-b4e4080ce7ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_AmendmentToCreditAgreementMember_87de1c96-e253-47b0-93a3-a1dea7af9290_terseLabel_en-US" xlink:label="lab_mygn_AmendmentToCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Facility</link:label>
    <link:label id="lab_mygn_AmendmentToCreditAgreementMember_label_en-US" xlink:label="lab_mygn_AmendmentToCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment To Credit Agreement [Member]</link:label>
    <link:label id="lab_mygn_AmendmentToCreditAgreementMember_documentation_en-US" xlink:label="lab_mygn_AmendmentToCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment to Credit Agreement [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember" xlink:href="mygn-20200930.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_AmendmentToCreditAgreementMember" xlink:to="lab_mygn_AmendmentToCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9a2e851f-b354-4f24-98f8-eb59c808530c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e0d6a20b-3358-4d71-8f0a-ea68e8950d84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fa9d8a80-ba3a-4b72-9f39-af8e5945a96a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_fb8a5074-5f7d-4795-90a6-eed7617d4712_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_457e085a-82fa-4959-8c48-90f51f7c19a4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_acda70e1-b9e1-4493-909e-35ad4f152138_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c82c18b-6731-43d0-b294-da31ac115319_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_71c8ba92-5508-4868-b867-2711d800d360_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7ca3e87f-ccf9-4506-ab85-17bb342e0632_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_ed528af3-5fa2-4345-80a4-938be31892ea_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_6264d473-7f9d-41ac-b384-87ba4695ad98_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_d3e6d0ff-54fe-4592-a251-8696ee1725f8_terseLabel_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Gross unrealized holding losses</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c8411ecf-f0a0-4f3b-b0cc-fcd25294e9cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_50570dad-0362-43d8-be16-e9cf459dd734_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_83c47df3-3602-4318-a5bc-eb136c97d9bd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_bd422af2-49de-4438-be32-a524afcb88f1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_66b5b756-fb57-41db-821a-b3ea28c1fb33_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7e89aab9-f381-4528-939a-0b3384757782_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amortizable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CostOfMolecularDiagnosticTestingMember_5cefceee-3c16-42cc-ad72-e7e34627e222_terseLabel_en-US" xlink:label="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of molecular diagnostic testing</link:label>
    <link:label id="lab_mygn_CostOfMolecularDiagnosticTestingMember_label_en-US" xlink:label="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Molecular Diagnostic Testing [Member]</link:label>
    <link:label id="lab_mygn_CostOfMolecularDiagnosticTestingMember_documentation_en-US" xlink:label="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primary financial statement caption in which the reported facts about the cost of molecular diagnostic testing expense have been included.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfMolecularDiagnosticTestingMember" xlink:href="mygn-20200930.xsd#mygn_CostOfMolecularDiagnosticTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CostOfMolecularDiagnosticTestingMember" xlink:to="lab_mygn_CostOfMolecularDiagnosticTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_68df5bfe-8c43-439d-9b83-d8f9cc8ff370_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3b0388d2-c536-4988-97a5-c518277302f6_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. [Member]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_c9d022ea-7795-40a5-85c5-c3a55bafac96_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_14e122db-7328-4c94-9c66-5764a0ae53a2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_aecb07b3-d9de-4c53-9730-8ae304029d6d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_2b6daee8-1760-4199-ae46-0d1c5cb2392d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense related to stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_62ea47db-e8b8-448d-bd88-f43e0aa195d6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Gross unrealized holding gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3d94466a-e4c7-4e38-a864-0476c2955f29_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticProlarisTestingMember_cfccacc4-b821-4221-b160-da78688cd2be_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Prolaris</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticProlarisTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Prolaris Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticProlarisTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic Prolaris testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticProlarisTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticProlarisTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticProlarisTestingMember" xlink:to="lab_mygn_MolecularDiagnosticProlarisTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_76452715-e7b8-47ea-90ce-252381d1bf06_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a009086d-a287-4b11-80dc-299e6435198c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_72f1ed05-a0c9-4b65-ae7e-d8d959dac37a_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f7b9a25e-ab18-44e4-b4af-1bd7a4b06a52_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_20cc33fc-1e99-4c79-a9d6-fe92d2c88714_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_a6dd22a4-f02d-4e04-90b2-d166494f816e_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_653f08d7-26fd-40f9-a0f1-231f966041ea_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_d87c1bf2-7f03-4aec-81ff-a98db1cb9892_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_76cfb694-ad73-42f1-8fdd-0d873a1a26f6_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9e2cd6e4-6ea6-466c-88bc-901a50ad6cea_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_82a99d31-b0bf-47eb-bf8c-03a6b7d313f0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_09c49751-071d-4d55-a831-56308036afe1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_58f819a4-07ad-4933-af68-f3335e723fd0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_c5eb22a9-a95a-4d93-a949-6c50f6344063_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Related Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1cd9652e-6875-4197-bf49-0ab0d1036075_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_83cedec7-ae6f-4678-b4dd-89cb904f05b0_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_53e8339c-f498-46c0-aaa6-12ad495759e2_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable investment securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_55946306-aed1-44e7-8e05-64614bbfd9f7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_45fbc006-a731-4933-978c-de9523d67459_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_1a0a1745-7927-48d3-a982-8df8c14a815a_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_95e099cf-3256-47df-9c3d-dadae081d128_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c5faba6c-3ce7-4ed7-9461-9d660dd67bdc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, beginning (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8678f7d3-084a-4484-82ab-d4a6bef133a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding, ending (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b485a87c-02bf-422c-b7b2-90e4197eaf96_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c44c8134-b4ec-4937-a46c-6235a3698642_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f8f2d7e3-991c-47a9-858e-0aeb7d07450d_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net, amortizable</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_01bb0feb-9d86-41db-b1ec-b7b614772c00_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on available-for-sale debt securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1153d64a-2444-4ba9-a2a7-4a97ec62dd0c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_58b8b999-6848-4b2d-be58-9189066bed3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Common Shares Issued and Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_20ed6bd5-ce8e-4e56-88aa-8eb7f1462b86_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_835426dc-0234-4713-8079-5c8d0dd24543_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_63cccc02-6692-42c2-98ed-a0a7ce7cc5c7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0787055a-1c82-4fac-8695-bf74d8c18553_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_fef9d40f-87ed-4120-ac3f-57e0c04c49ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_2afb394d-4044-4082-b2d7-8707652ebac0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_11f68535-3d31-4cac-ad0f-b1e415055fb6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for recognition of share-based compensation expense (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_f38b5768-f802-4dc2-845c-a055c1497724_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_0e443ac7-b486-474f-859f-9852388cb0e7_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_5ecd99c6-2064-429a-bf99-8ce11a5f773d_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RoW</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ceb5b80c-ec1e-4333-8d1e-5ef044bb301a_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2243bcb0-f054-40b3-a721-e19639944c30_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_77803696-b21a-4c38-a80b-87545be398fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b5537a63-6264-4e15-bd6f-1357efbc6bb1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_5752d6b2-73fe-40bd-b758-0ebc28992220_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fb793263-f34f-42a7-9685-3534a4539f04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_c107fb92-9e70-4404-a73d-551828b0afdb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_53ed51ea-5e4b-41b0-892c-6e0ea9d4404b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs, Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_57f02d8e-19e1-428b-aec9-b83e946645a7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_d06f94ae-7b2d-4051-a6eb-1fb9e153db80_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input, expected term</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_f5425411-0422-4a87-9f79-a88132820de3_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_b381ca5d-6b6b-4795-bb14-4f39071c7242_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_9aa87c46-2d79-4837-803e-58077375406a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_1b445513-7e77-4f15-b6a7-c63b5c8fd279_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e90fa326-b356-4f08-80de-aac35076d5a8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_ad5b961e-1c57-44b7-bca5-5ec28667ca37_terseLabel_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in uncertain tax benefit accrual, CARES Act</link:label>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_label_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting From CARES Act</link:label>
    <link:label id="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_documentation_en-US" xlink:label="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting From CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" xlink:href="mygn-20200930.xsd#mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" xlink:to="lab_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0cb0e900-f035-4a5d-bfb2-338ccb425d96_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e6b1d260-449d-4a9d-b4a6-191187835b29_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0f2ca395-98cf-449e-9a7c-9896bea0331e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_efa15f2b-7d57-4c80-aff0-e4e9eb4f9669_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning common stock outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_783cf42e-28cf-42b0-90a0-4aadb3cf7cd9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_9e7982c0-5329-461f-add0-8b94e7d701aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_d247dd69-3dbc-4700-a7a1-010681585403_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_49af29f4-774e-4444-b8ab-be009139563b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_697aacf6-0b34-4c14-af81-f57228dba981_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_077c668d-a149-4047-83a6-9df8e1902a9a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_f3b8e34c-9435-4236-99a0-96a9b2f944d0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsMember_60462b77-ad56-4daf-bbe4-f2ede3e05675_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsMember" xlink:to="lab_us-gaap_CashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationYearUnderExamination_e9fdd2b2-edec-44fb-ab78-15a9413104a5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax year being audited in income tax examination</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationYearUnderExamination_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Year under Examination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:to="lab_us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fc8ed282-5087-4281-ae02-4d28cc28fc6b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_58a8323a-a981-49b5-b962-5e5d32d128ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4d90d12f-84e1-4a08-ba0b-b54659db679b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_a47aeaa6-19b0-4530-b4f6-d1c3eaf98f17_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d36db64c-d326-4a44-820a-da2eb1aed30d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_6f406f9a-18c8-4e0a-80b6-c17b24e9c04c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9638915b-3f06-43c4-8e6c-61d185c432d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Revenue and Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_9803bbd0-6fab-49a6-a2e4-cc2cc8a159ea_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticEndoPredictTestingMember_af8d7900-4a9a-4e16-9707-493dea1c140b_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - EndoPredict</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticEndoPredictTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Endo Predict Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticEndoPredictTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic EndoPredict testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticEndoPredictTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:to="lab_mygn_MolecularDiagnosticEndoPredictTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f695bae9-373c-4817-924d-6cec7616fbe6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d94b62ed-b3c0-4515-847e-0307855d94f7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_d552a01f-1920-444d-a0b5-d2d56084c002_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_CARESActOf2020MedicarePaymentAmount_ac0a8291-5f06-423e-8f45-5a756a76cd30_terseLabel_en-US" xlink:label="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare payments to provide relief from economic impacts of COVID-19</link:label>
    <link:label id="lab_mygn_CARESActOf2020MedicarePaymentAmount_label_en-US" xlink:label="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Of 2020 Medicare Payment Amount</link:label>
    <link:label id="lab_mygn_CARESActOf2020MedicarePaymentAmount_documentation_en-US" xlink:label="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act of 2020 Medicare payment amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020MedicarePaymentAmount" xlink:href="mygn-20200930.xsd#mygn_CARESActOf2020MedicarePaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_CARESActOf2020MedicarePaymentAmount" xlink:to="lab_mygn_CARESActOf2020MedicarePaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a2fa86f7-d829-4383-9833-f5d22254f07c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_71e8d234-ffec-4447-898e-0158bc645c46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_47f4d9e9-7a3a-468e-b14f-3321f0f15f6b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_83b10c5c-b16f-4cf3-b929-aa0b0625f7f7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_05b915d0-2af4-4aa0-bdd1-02f688367893_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8b14f795-3d2b-4fb4-8f0e-f8a4a1e3503f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_da63fa4b-bb02-49d9-bb7c-e3322598116a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Myriad Genetics, Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_da4eeb83-ff39-4e21-be31-b7f149956e3a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription_9c29f7b0-6da3-4f0f-bef6-ea2687074a38_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, practical expedient, remaining performance obligation, description</link:label>
    <link:label id="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription_label_en-US" xlink:label="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Practical Expedient, Remaining Performance Obligation, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription" xlink:to="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_8a975b1b-d12b-4d43-aa25-5a1ce52ba43e_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticPrenatalTestingMember_9ed7677f-6e6e-43da-b745-2c38cb5723c9_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Prenatal</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticPrenatalTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Prenatal Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticPrenatalTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic Prenatal testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticPrenatalTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:to="lab_mygn_MolecularDiagnosticPrenatalTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9f2e951c-fd2b-411b-acf2-2546ac6f3bb6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_3d4c1e13-6971-4ea5-9265-bfc0aa1326a2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Establishment of operating lease right-of-use assets and lease liabilities</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e5281d46-7af8-4deb-9546-48240bb4bbac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_98ee8420-078b-402a-bd8f-25282c304d83_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e6822768-f820-40ad-891f-6a0cf89927ae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_a8c3986c-cb26-439a-a944-587c824ae4c0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8051bb16-7a08-4530-a438-f9aa43f0a71a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the Plan</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5f8503ae-d524-438e-a012-8c9c694e34f3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_9b00ca84-b1d5-48bc-ae27-bd7340d6671c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_53bdcc42-3b5b-4ef2-93a9-4236fe8ce9cd_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_29ff3b21-4ccf-4d23-a951-224e197f51eb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Revenue by Product and by U.S versus Rest of World</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_add6eaa6-4431-44f7-9475-8b75dd15e1b4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_8801b014-23cc-43f6-8789-b51a330071e8_negatedLabel_en-US" xlink:label="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_documentation_en-US" xlink:label="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in prepaid expense excluding increase decrease in prepaid taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:href="mygn-20200930.xsd#mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:to="lab_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d6215060-cc84-4412-be9c-a7fc11efee00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_449178d8-8884-4d08-ab9c-1c75781010db_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_4ce9b1db-1975-4d0d-a7eb-6434d91c4567_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_1ad26a56-d2c5-48e7-a9a1-3cbc41623761_terseLabel_en-US" xlink:label="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_label_en-US" xlink:label="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Unrecognized Tax Benefits</link:label>
    <link:label id="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_documentation_en-US" xlink:label="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in unrecognized tax benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:href="mygn-20200930.xsd#mygn_IncreaseDecreaseInUnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:to="lab_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bc4a6767-ac4c-49e5-bf7b-7c12ca7d1499_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for tax withholding for common stock issued under share-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_bc19c705-d10f-45f4-bfb2-34ad7b8aea2c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_e22ef7c6-ecd7-44a5-84a9-05873eefc86c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_NonEmployeeDirectorMember_ba05f3be-7ca5-4d4f-b48c-067da4890c50_terseLabel_en-US" xlink:label="lab_mygn_NonEmployeeDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-employee director</link:label>
    <link:label id="lab_mygn_NonEmployeeDirectorMember_label_en-US" xlink:label="lab_mygn_NonEmployeeDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Employee Director [Member]</link:label>
    <link:label id="lab_mygn_NonEmployeeDirectorMember_documentation_en-US" xlink:label="lab_mygn_NonEmployeeDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non employee director.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonEmployeeDirectorMember" xlink:href="mygn-20200930.xsd#mygn_NonEmployeeDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_NonEmployeeDirectorMember" xlink:to="lab_mygn_NonEmployeeDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_b01470be-d40b-478f-9dcd-1969b9536dae_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_6952f67f-b842-43c9-b85d-d96d02c3c7d9_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_616057a1-f41a-49b8-8f02-dee7aae26593_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_a530f85f-0e45-4069-a1f2-ba74d7001b47_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_dd0d71ea-552c-40b5-af52-112da189d227_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_1abe0ed3-6710-4a0e-85db-630f42ed156a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_4e2536fd-504b-45e8-b1c1-595ff3cef509_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3549ae65-da3c-451a-ad07-bd7dddbd4036_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_dcae4d44-b6bc-4712-b6dc-76ebf39a6cfb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a52616bf-0b1f-4b8f-8242-7f07b05542cb_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_615f3f2f-796c-4676-a385-23b23e949c29_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6ce3aab9-6d88-405d-8042-6e0ca7a49dc7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_914fea7e-d7c0-48b3-b50f-64b9185efefd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f9cdbeab-5b18-46e1-84e3-1626f3491ae6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PurchasedLicensesAndTechnologiesMember_118d4146-641e-42c9-ac26-b90eaabad05b_terseLabel_en-US" xlink:label="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased licenses and technologies</link:label>
    <link:label id="lab_mygn_PurchasedLicensesAndTechnologiesMember_label_en-US" xlink:label="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Licenses And Technologies [Member]</link:label>
    <link:label id="lab_mygn_PurchasedLicensesAndTechnologiesMember_documentation_en-US" xlink:label="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased licenses and technologies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember" xlink:href="mygn-20200930.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PurchasedLicensesAndTechnologiesMember" xlink:to="lab_mygn_PurchasedLicensesAndTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_58ab56fe-7d7d-4d03-a720-47e5f640efd0_terseLabel_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Gross unrealized holding gains</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_03e8d004-0147-4f09-b5c6-1616147fa8e2_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_f29f2a67-3847-4a08-aaab-b51a5331fd33_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_062a9a35-8e24-4794-9baa-80ac4f11d0f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a713a941-2c65-4f74-9498-e84f0b046c56_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_91cfeaa9-bfd3-4476-8a51-64f09a1ac52b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e849c47b-823d-405b-9cb0-427cfde1fbd9_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_a4154b61-c2d4-419f-ae52-d76b4f942b9c_terseLabel_en-US" xlink:label="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan</link:label>
    <link:label id="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_label_en-US" xlink:label="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Ten Employee Director And Consultant Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand ten employee director and consultant equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:href="mygn-20200930.xsd#mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:to="lab_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fc583d09-acba-40d8-888a-40c92cf5138e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_246fde27-95ed-428d-99f5-add9b7719bbc_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a5d64368-f8fc-4d93-9a78-8ddccd387556_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense related to RSUs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_9ec14539-56a2-4d91-b36b-783237a56709_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_c763cc9f-a8a6-4b16-999c-7db9ec8b7bdb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dce902cb-df66-4fdf-ad02-7584a95d1b07_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f4c35076-6832-4719-a1ea-19445bf83bf2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs canceled (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_59939838-3c2c-46e6-a5a6-1845bcae6379_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndCash_0199e2f6-6bb1-40a7-83f5-68d5b2788d79_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCash_250c15df-1065-4288-8b48-099084b63d6f_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Estimated fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCash_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndCash" xlink:to="lab_us-gaap_InvestmentsAndCash" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_3c4d2157-51d7-423f-b3b9-bee3fd322902_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9ba6f5ae-8fe6-4704-a509-7f03ed3c011c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DiagnosticsMember_e1571c3e-e280-4fe4-856c-2a73b01505bf_terseLabel_en-US" xlink:label="lab_mygn_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_mygn_DiagnosticsMember_label_en-US" xlink:label="lab_mygn_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_mygn_DiagnosticsMember_documentation_en-US" xlink:label="lab_mygn_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticsMember" xlink:href="mygn-20200930.xsd#mygn_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DiagnosticsMember" xlink:to="lab_mygn_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_7abe847b-896b-4cf5-a0ec-395849ee6bed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_166eefe8-2a48-4bd3-b07f-d03f0c671e49_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ee47fc52-3d78-408f-af9a-d4cba5fdd416_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred and Common Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_32ac3d6c-7444-400e-9ec3-8bc899e730df_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_dacbad05-93ab-41d1-9fa1-4ded5ee5d4d1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued refund liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_519431a9-041d-4fd6-a5fc-43bdf282a393_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_000d900e-2d36-4ac3-91b3-c82427a7a7cd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b5ee868a-1452-4189-993a-2987eea97451_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_931eacca-88d4-4ff3-b885-e05886669f6d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_e62bc135-4f3f-45c0-b9ae-c35ca68f2638_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EighthShareRepurchaseProgramMember_c38850ee-65d2-4011-bb88-13160c826d58_terseLabel_en-US" xlink:label="lab_mygn_EighthShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eighth Share Repurchase Program</link:label>
    <link:label id="lab_mygn_EighthShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mygn_EighthShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eighth Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mygn_EighthShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mygn_EighthShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eighth share repurchase program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EighthShareRepurchaseProgramMember" xlink:href="mygn-20200930.xsd#mygn_EighthShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EighthShareRepurchaseProgramMember" xlink:to="lab_mygn_EighthShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0615a927-c9d1-44d0-a8bc-fb7d263103a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3db02f91-64c6-4a30-9240-2e5b637d8e58_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_a9002e8f-18c9-4f6a-ae1d-b95200ac9866_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segment</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a45a0eca-625f-4a6c-b5fe-f7f8b67cb43a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in the fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_6c5fb5fd-5653-4b4a-ad7e-9187925dc2a8_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ChangeInFairValueOfContingentConsideration_27af2027-75b2-4548-b7bf-e76ad149e058_terseLabel_en-US" xlink:label="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_mygn_ChangeInFairValueOfContingentConsideration_label_en-US" xlink:label="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Fair Value Of Contingent Consideration</link:label>
    <link:label id="lab_mygn_ChangeInFairValueOfContingentConsideration_documentation_en-US" xlink:label="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ChangeInFairValueOfContingentConsideration" xlink:href="mygn-20200930.xsd#mygn_ChangeInFairValueOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ChangeInFairValueOfContingentConsideration" xlink:to="lab_mygn_ChangeInFairValueOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ba67d287-4e05-49c3-a083-c2ec64a05efe_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MassachusettsDepartmentOfRevenueMember_d388cc4d-9d60-466b-9453-2a4603e01bda_terseLabel_en-US" xlink:label="lab_mygn_MassachusettsDepartmentOfRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts</link:label>
    <link:label id="lab_mygn_MassachusettsDepartmentOfRevenueMember_label_en-US" xlink:label="lab_mygn_MassachusettsDepartmentOfRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts Department Of Revenue [Member]</link:label>
    <link:label id="lab_mygn_MassachusettsDepartmentOfRevenueMember_documentation_en-US" xlink:label="lab_mygn_MassachusettsDepartmentOfRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts department of revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MassachusettsDepartmentOfRevenueMember" xlink:href="mygn-20200930.xsd#mygn_MassachusettsDepartmentOfRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MassachusettsDepartmentOfRevenueMember" xlink:to="lab_mygn_MassachusettsDepartmentOfRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_83570015-c1ac-45be-ae60-b823f0b5da08_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityPrepayments_32136a4a-0534-4902-a0ed-230e8ae01406_terseLabel_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments</link:label>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityPrepayments_label_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Prepayments</link:label>
    <link:label id="lab_mygn_ContractWithCustomerLiabilityPrepayments_documentation_en-US" xlink:label="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability, prepayments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContractWithCustomerLiabilityPrepayments" xlink:href="mygn-20200930.xsd#mygn_ContractWithCustomerLiabilityPrepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ContractWithCustomerLiabilityPrepayments" xlink:to="lab_mygn_ContractWithCustomerLiabilityPrepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_cd8caa50-7c13-4a0f-9d1b-ef978cd89da1_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_af994a0a-a164-449e-b774-bc176ecf0fc3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_74884569-6f09-449c-9c6d-5867138278f2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_c479fcb9-b08f-4639-a77e-f3d2bde790fa_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on disposition of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9602b6e3-9d31-4e7f-9b31-a2d993f16703_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Gross unrealized holding losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_60d1a79e-5f9c-49a7-bfb5-540fbd8005cb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fc56381b-9a7f-4da9-b850-afbfbc7170e4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_9c8d5dbf-d6ee-4d31-8dfa-aa5daca533d0_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticVectraTestingMember_6fdf0ca5-3523-42d5-95d6-f6678f85b155_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Vectra</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticVectraTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Vectra Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticVectraTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic Vectra testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticVectraTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticVectraTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticVectraTestingMember" xlink:to="lab_mygn_MolecularDiagnosticVectraTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_873980c7-6802-4096-8eaf-d260cb2cdc85_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_a64339df-0bf9-45ed-a478-29693332b680_terseLabel_en-US" xlink:label="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_label_en-US" xlink:label="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense Excluding Prepaid Taxes Current</link:label>
    <link:label id="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_documentation_en-US" xlink:label="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense excluding prepaid taxes current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:href="mygn-20200930.xsd#mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:to="lab_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6099aa48-61fb-4e57-8691-07377a076d87_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_29a51ca9-afa5-44a2-9aa9-58b70d8144a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_972d0a33-2581-4080-a785-2eface2cf641_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_701aae30-60af-4837-bcee-ca8944b2c7d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ef2c69ba-fdcb-4bea-9fd5-1bb2ae67d14f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3bf1094d-9d26-418f-8c38-381f534c5394_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_b883ecad-35d0-4e40-9f1e-c90db2d99138_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_82b7a25a-c396-42f6-bace-abd7adb132cd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0cf14df2-286f-4755-a139-197fec518a43_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863b2c86-dffc-472f-a309-37c98847185a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_523a6dc3-9bed-4b0e-b383-3861b23a9104_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized costs incurred to obtain or fulfill contract</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostGross" xlink:to="lab_us-gaap_CapitalizedContractCostGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_ad92066f-b392-48d5-851e-47ae4edf47e3_terseLabel_en-US" xlink:label="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_label_en-US" xlink:label="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development With Indefinite Lives [Member]</link:label>
    <link:label id="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_documentation_en-US" xlink:label="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development with indefinite lives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:href="mygn-20200930.xsd#mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:to="lab_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_f6a67121-ac8c-43db-9461-eb83864a66df_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b8abb70a-7ae9-4416-9828-4ad6dea749f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_3a81111c-4624-4e45-beba-564e6a3e4b54_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticOtherTestingMember_08609bda-de82-4d85-b8f0-b92b10195ab3_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Other</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticOtherTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Other Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticOtherTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic other testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticOtherTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticOtherTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticOtherTestingMember" xlink:to="lab_mygn_MolecularDiagnosticOtherTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_5c5a54fd-250f-4011-b175-0de74d29d9bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_7084fecf-5ba3-4a8c-a548-05fb4443b871_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_19353acd-9c90-4654-8d86-fbf9f9a11585_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_df7af33e-7bee-4f65-8101-929e6e69b018_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_3ba3624c-c636-4707-82bc-c34b270ac522_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue - beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f4408798-d0ab-468e-aeb4-af35b2de7a01_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue - ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dfccd41f-c465-4e9c-814b-8daeb4f0b2c4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_IntangibleAssetsLineItems_6ffdc9b6-d190-4106-bec7-e07dc40eb180_terseLabel_en-US" xlink:label="lab_mygn_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_mygn_IntangibleAssetsLineItems_label_en-US" xlink:label="lab_mygn_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_mygn_IntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_mygn_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IntangibleAssetsLineItems" xlink:href="mygn-20200930.xsd#mygn_IntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_IntangibleAssetsLineItems" xlink:to="lab_mygn_IntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_72b2cdef-f7d9-42a0-9181-5fe3edf95091_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_b61a6b3c-66fb-4eda-ab67-dbc2c2e98350_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_45bf4f5c-1758-41fa-a9de-361eb679c2d5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_933afd05-6642-4a74-8e54-2cddbdbc62d2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_b92ae90d-aafc-44fa-aa71-7cb53aee591e_terseLabel_en-US" xlink:label="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_label_en-US" xlink:label="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Twenty Twelve [Member]</link:label>
    <link:label id="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_documentation_en-US" xlink:label="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Twenty Twelve [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:href="mygn-20200930.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:to="lab_mygn_EmployeeStockPurchasePlanTwentyTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_d49bb6e5-d08f-4682-9ba2-e4a5dd285711_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Financial Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e864e1a6-45bb-4528-94b7-9874b9cd2377_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9f0557f5-02ad-4567-81e4-8bb24da033f6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs canceled (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_aabaf24c-6a46-4949-b223-5f7e1387b35c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_05d58b60-51a5-41a7-afdf-22378f1b6c5f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ContingentConsiderationMember_e0417e4b-e911-46c5-be84-9900337ada21_terseLabel_en-US" xlink:label="lab_mygn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_mygn_ContingentConsiderationMember_label_en-US" xlink:label="lab_mygn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_mygn_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_mygn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContingentConsiderationMember" xlink:href="mygn-20200930.xsd#mygn_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ContingentConsiderationMember" xlink:to="lab_mygn_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_2187d82a-dba8-41af-be29-3b07a9229bcf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_InvestmentsAndCashAmortizedCost_4c402bd1-43f7-4596-91ef-df621711ec80_totalLabel_en-US" xlink:label="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Amortized cost</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAmortizedCost_label_en-US" xlink:label="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Amortized Cost</link:label>
    <link:label id="lab_mygn_InvestmentsAndCashAmortizedCost_documentation_en-US" xlink:label="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments And Cash, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_InvestmentsAndCashAmortizedCost" xlink:to="lab_mygn_InvestmentsAndCashAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b8c52727-fe4c-4fbf-83d4-c2a4a3953f27_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_ca13e056-05d0-44a7-944a-d4c8344390ac_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_eb7b6ace-7328-4eec-bc1c-f990dd8d586e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 75.2 and 74.7 shares outstanding at September 30, 2020 and June 30, 2020 respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b1779c60-9329-4dce-933e-483db7b1471c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_765ef32a-dc5b-4e17-88fa-f3ab71c71323_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_b2c5dd75-a1af-45b7-aff2-b2e533054016_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f2f02e81-34ff-4cab-b175-8abe42e5790b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ad963f58-129e-4df8-a59a-1a9b38a56875_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in the income statement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_4c8b8d91-e239-4b93-8152-50b24b913771_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_b15ce891-e60a-4824-9f96-998e877578d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4b4de6ec-6905-48bd-8c83-8a6e68b05079_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a38bc197-47b7-4a7e-8b0b-01a52a27768c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a472a25f-2083-46d4-a29b-989677400e56_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_73609127-c1ab-4adf-811e-968bb1309121_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_422b1854-90d0-4e30-866a-fbd8b75b6eb8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs granted (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3c8433fb-31b9-4f4d-beb8-58de5a95863a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_95d56918-38a6-421e-b7e5-05f4fb1f2d1a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning common stock issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c874e5f1-0252-455a-9280-92fd7c2bb082_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued at end of period</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_195e1c10-bd4a-4a5a-ab99-b97bca733ed9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a516e2bd-8e79-443d-8975-4c0c51c1e70f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4898838e-ca8e-44fd-b101-b456496d3c0f_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, Amortized cost</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_88fa26c1-3767-45b0-862f-f943992a039f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_7c0e9915-7988-4024-b489-016ade88a6b7_terseLabel_en-US" xlink:label="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period for earn out liability</link:label>
    <link:label id="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_label_en-US" xlink:label="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input, Term</link:label>
    <link:label id="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_documentation_en-US" xlink:label="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:href="mygn-20200930.xsd#mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:to="lab_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewJerseyDivisionOfTaxationMember_3b2976d0-f198-48e0-b0e0-03e0685950df_terseLabel_en-US" xlink:label="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey</link:label>
    <link:label id="lab_us-gaap_NewJerseyDivisionOfTaxationMember_label_en-US" xlink:label="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey Division of Taxation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:to="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_f473cf2d-daea-44d5-80da-fc3a7b2072c7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_c5302b2f-367b-49d4-a1d2-7a6c0c1210b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5b14a624-5521-4830-bca3-fb14d30288f5_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_83b00919-4945-4ecb-83c9-aea795f0d7ca_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_762c57c2-d237-4da7-a7a3-8c673e59adb1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0b95fbe8-bfa3-4734-9945-e041572546a9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_af0ffe22-0f85-4dce-960b-0cb24fff39eb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Myriad Genetics, Inc. stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_50177a0f-fffc-484f-8beb-c899956b8802_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e280abd3-e630-4748-9741-41da5ab73b33_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9aaefd1-e628-4cdd-8bcb-e572ba76a5e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8e1d8ae8-7b6f-4ea8-9114-0433d4ade511_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4d64ab79-a72c-4b49-9aee-df67c8e6a036_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_75e421d3-a329-4b4e-b187-f5a63df48ff1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c86d83c4-b60b-42da-8065-f7600d1062c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_024bd8cb-6890-4759-b6be-b10df2abd6cf_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_PharmaceuticalAndClinicalServicesMember_218df339-f07c-4cc5-bbc3-8eda957fbd3f_terseLabel_en-US" xlink:label="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and clinical services</link:label>
    <link:label id="lab_mygn_PharmaceuticalAndClinicalServicesMember_label_en-US" xlink:label="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical And Clinical Services [Member]</link:label>
    <link:label id="lab_mygn_PharmaceuticalAndClinicalServicesMember_documentation_en-US" xlink:label="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and clinical services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember" xlink:href="mygn-20200930.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_PharmaceuticalAndClinicalServicesMember" xlink:to="lab_mygn_PharmaceuticalAndClinicalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_d66f0ede-5f11-4d1c-99b6-c47e58fc736f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_NonCashInterestExpense_b2825f2a-222b-439a-9fec-97b2bdab85f8_terseLabel_en-US" xlink:label="lab_mygn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_mygn_NonCashInterestExpense_label_en-US" xlink:label="lab_mygn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Interest Expense</link:label>
    <link:label id="lab_mygn_NonCashInterestExpense_documentation_en-US" xlink:label="lab_mygn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonCashInterestExpense" xlink:href="mygn-20200930.xsd#mygn_NonCashInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_NonCashInterestExpense" xlink:to="lab_mygn_NonCashInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_10aaa6fc-06f7-4b8e-b849-bc2c0f4b33b0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive options and RSUs excluded from EPS computation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_375906fe-4e82-4829-a98c-4288f5ffc9e3_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9d03bfaf-5584-4418-ac7d-e6f7d36eabf8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ef1545ed-9afe-4b0f-a4f3-6abbdb2a1eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9c4b2653-763e-4a86-98f3-a58caa17cde1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_96cdba10-be19-42e2-8152-055fcc7c557a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c73e5149-c5da-4e6d-921b-5682a0a3a1ff_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticMyChoiceCDxMember_514487ab-f007-42b3-abf1-ec8071c545d6_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - myChoice CDx</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticMyChoiceCDxMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic myChoice CDx [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticMyChoiceCDxMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic myChoice CDx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticMyChoiceCDxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:to="lab_mygn_MolecularDiagnosticMyChoiceCDxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0971839b-1766-48af-a43f-75f205ad5e1f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_82d33684-450f-4cf4-a847-78c160f255b0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_9b654146-7b5d-4ed2-b5ef-68dfa1277f2a_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Myriad Genetics, Inc. stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e7964efb-e676-417a-a35b-0166826e0b66_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Myriad Genetics, Inc. stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_aa79abdb-807d-4214-801e-1fbc5a65c837_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_c35b72cb-62f1-4f33-b98c-895537e665a7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4fbc529b-f887-44c4-ad5d-78200e7e5684_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_8df754d0-1858-4e59-a22d-df30bfcc1c23_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_18faf5f8-ba2a-42e8-a55f-a71deac699ee_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OptionsAndRestrictedStockUnitsMember_40296cb4-e2c5-4772-8b58-383f7755c263_terseLabel_en-US" xlink:label="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options and RSUs</link:label>
    <link:label id="lab_mygn_OptionsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_mygn_OptionsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options and Restricted Stock Units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsAndRestrictedStockUnitsMember" xlink:href="mygn-20200930.xsd#mygn_OptionsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OptionsAndRestrictedStockUnitsMember" xlink:to="lab_mygn_OptionsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_98bee4d4-b4b5-4794-a330-7aa2d60b596c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_00866deb-ba26-4619-b640-016bf07e769e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8c519806-3e77-45bc-a7ab-f94b8cd66a26_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_654429ba-27dc-4697-906b-574c62c4b664_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_dd14c34e-cd29-4e0f-8b7f-260fc60cc6e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62f9bc6-86cd-4703-ae9c-987ba572e53d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ac1715f6-19aa-4db1-9287-01f06febcb76_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndCashAbstract_9e4e2966-a9f1-4248-82c5-01c5a35372e1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total:</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCashAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCashAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract" xlink:to="lab_us-gaap_InvestmentsAndCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2eda46b8-91ef-4f67-bed3-29a31edf18e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_d78b1ad5-eff0-41d8-ae1d-60e235be5269_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_1a30d5d4-bafa-4699-98a8-3e294fa6f752_terseLabel_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_us-gaap_SwissFederalTaxAdministrationFTAMember_label_en-US" xlink:label="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Federal Tax Administration (FTA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:to="lab_us-gaap_SwissFederalTaxAdministrationFTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_DebtInstrumentLIBORFloorPercentage_fd62ef4e-7fa0-49a4-98e9-9b424690e617_terseLabel_en-US" xlink:label="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR floor (percent)</link:label>
    <link:label id="lab_mygn_DebtInstrumentLIBORFloorPercentage_label_en-US" xlink:label="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, LIBOR Floor, Percentage</link:label>
    <link:label id="lab_mygn_DebtInstrumentLIBORFloorPercentage_documentation_en-US" xlink:label="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, LIBOR Floor, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtInstrumentLIBORFloorPercentage" xlink:href="mygn-20200930.xsd#mygn_DebtInstrumentLIBORFloorPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_DebtInstrumentLIBORFloorPercentage" xlink:to="lab_mygn_DebtInstrumentLIBORFloorPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_aaf62e88-722d-4394-aae6-7afd614de403_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c65f6d66-194b-4a8b-b966-7f0a99fbad05_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b18568f5-eaab-48e0-ad2b-117045ccdb6f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a023a51f-31e9-4472-a9bd-9dbeb3669b34_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_3a88403f-7ebd-41c7-87a9-2243d1849ccc_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_0dc5cae5-6cf1-4794-b223-5726f378478c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_f41e4e22-c4cd-43f4-937d-4b294205a9de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember_e633cdda-82d8-4caa-858b-66e1696cbfc2_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic - Hereditary Cancer Testing</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Hereditary Cancer Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic hereditary cancer testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticHereditaryCancerTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:to="lab_mygn_MolecularDiagnosticHereditaryCancerTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9f811d8c-067d-49f7-9d32-e93f94d0b414_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_cf476980-990f-4c26-a9b2-00f1042e76ff_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, amortizable</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_dd448792-1db2-4bc7-bd83-9913ec36e732_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, Due after five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_1b82c79b-fe31-4195-8f0b-4898081ec6b2_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_5931e145-2c11-4309-85bc-c75a581b6bf3_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4a93dfe4-7e89-4d27-afe3-608e8802356d_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_880fa9e1-20bd-41e6-8faf-0eb11d2f9f60_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_be65cf7b-5a63-4892-afe6-40b76387874c_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_074736d1-000e-4400-8698-80dd514a2cd5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_16c9638f-0060-4e9d-9961-3e1a878df271_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_aa01bf25-2e69-44ad-abc6-8d8263404bec_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3767fd60-68a2-4c90-992d-1349da79f485_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding used to compute basic EPS</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7dcf2a1d-81bb-4c98-a356-ffddd844dfc3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_608352de-af34-4651-acdb-ea70207ea6b7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_95ebc6d1-8721-49d9-b095-f3be96a77426_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2ad8695b-81c7-40ee-850d-893f2ae7b8e7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in foreign currency translation adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_015c39ff-4b61-4f55-886e-7bae7db01a39_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_a21b198e-56af-4783-ab6a-b67af00564e5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_1cd962da-c0ed-4940-ac80-dfeb0c7ccbfe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_6b5af63c-3ad5-4494-baf0-ffe587a8136f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_87572bc0-195f-461e-8831-ae0328f69a1b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fe46dd5-ae19-4d96-822b-e42e4a31a583_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99427542-ec47-42e0-8862-0a9bd0fe5e6e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1c88aaf8-2a5b-4215-a8c9-c8c5057e8300_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a4ef5f3b-2cf2-49a4-a0eb-6df215e6a046_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_e307b014-4db3-4396-9118-1e2a5492eb20_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5d936591-7541-47cc-9e5d-5baa6d88d32f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c44c19e0-85a9-4a61-a123-ffaea1fcfd74_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_564c3d99-5582-41de-9e00-bf85a4ce1e0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_0e08a80d-8c2e-47a1-a85e-f86699a6952d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_389762ae-ee25-4264-bf42-fb71cbfc78c3_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_736672e8-d159-4368-a3e5-9b832352a490_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_fcb5982f-0bdf-4fb9-b629-c2401b3215d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5dc7e3b3-2ba5-4e56-9244-93d289950fa7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_850e5ede-7cee-4e6a-b15a-054d0fb92780_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7eb45e2b-f68b-4714-913a-454523773b84_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_fe0b508d-087b-480c-a75d-c02015251341_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_640da5c5-1f04-4d3e-bdf0-ce197e81a0ce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recorded Amortization Expense for Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_cbb4bc09-55f2-4f3b-b398-b1bb60e01f78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_d9f52c21-df3f-4565-909f-0608e43d0b91_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6225f458-41e0-460d-9c6c-b7ac7feb8725_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Fair Value of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_5922ae53-1bca-453e-8f5a-a20eb81ddceb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-amortizable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d7c7e27-0fe4-42e8-bfc0-67fe7b5945eb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_cb9c4201-e8ba-4c19-8fa9-08bd001cfe83_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount of loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_2e56493d-a6e2-49e0-9452-62fe518808fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_89b22a8e-2fad-4373-b451-0d3e09945eeb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_e84c945d-44cb-4e1f-993a-2afdc5013a98_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3ce12f38-1ed4-4475-baf1-cd2cca3ef8cb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_162026f2-5323-4997-932d-87206aab98db_terseLabel_en-US" xlink:label="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted prior to December 5, 2012</link:label>
    <link:label id="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_label_en-US" xlink:label="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted Prior To December Five Twenty Twelve [Member]</link:label>
    <link:label id="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_documentation_en-US" xlink:label="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted prior to December 5, 2012.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:href="mygn-20200930.xsd#mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:to="lab_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_88408069-0f7d-4d83-959a-2b0d7c662461_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4794a8e4-0fe9-47b4-b86b-4f83d993a5b6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-amortizable</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_ScheduleOfIntangibleAssetsTable_1d4d2e29-906a-4ae2-ad75-57609f3b60c1_terseLabel_en-US" xlink:label="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets [Table]</link:label>
    <link:label id="lab_mygn_ScheduleOfIntangibleAssetsTable_label_en-US" xlink:label="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets [Table]</link:label>
    <link:label id="lab_mygn_ScheduleOfIntangibleAssetsTable_documentation_en-US" xlink:label="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfIntangibleAssetsTable" xlink:href="mygn-20200930.xsd#mygn_ScheduleOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable" xlink:to="lab_mygn_ScheduleOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_064a32eb-2276-4d77-84e4-6068a901733b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate principal commitment</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_b58110e1-13c8-4bf8-8825-810e2bcd65cc_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_970e528e-a0a4-44b3-976a-1f8c4e23e60f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs, Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract_ddef3ef5-6ff9-459e-abc1-0e5e029851d2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue practical expedient, incremental cost of obtaining contract</link:label>
    <link:label id="lab_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract_label_en-US" xlink:label="lab_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true false]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract" xlink:to="lab_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_528a70c2-aea0-4f51-849c-aff95e564a06_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_99f12f4c-1aed-4bd3-99ad-7eec434eeffd_terseLabel_en-US" xlink:label="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Plan</link:label>
    <link:label id="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_label_en-US" xlink:label="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Three Employee Director And Consultant Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2003 Employee Director And Consultant Equity Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:href="mygn-20200930.xsd#mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:to="lab_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e909c6fd-0ce5-46f5-8f59-6c9b1566887d_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_476e8bd8-356a-49ac-ac3e-bb67c0afcc7d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3e05bdcd-8fd4-4403-b0cd-7ae5849df0b5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_163a1874-81b1-44cf-86c9-45afbf10be5b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2fe9f110-3a89-4879-92ac-bb3337bfc8dc_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration recognized at acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_77f62dab-0045-4580-9b47-da8ad3ae8bda_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate rate on pre-tax income</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8015a8ca-a0ba-4098-b65e-c3b3da0be055_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_8799767a-cedf-4376-b600-cac4e0755172_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89adc57f-f869-49e6-b194-dceac63b5be1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56a60bb2-7a03-4cb6-81e7-6ece5022b49e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_45d7ada7-c647-4e9a-8e19-2dfdcc5aeb86_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_7e4fe77e-38a3-4d82-bae8-6fbe600bb7b2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_eda898c2-82a4-4342-8045-b7812b0e6878_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds and notes</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9e61d624-fcbb-4a00-b4b0-115ba69c6d2a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation_b4b536e7-89d7-445c-ac04-80a8e204a6bb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, practical expedient, remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Optional Exemption, Performance Obligation [true false]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b9770842-17a0-4db4-ab90-f595fb4d44df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at end of period (dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_e2fe8e3c-0c5a-47b1-8cac-d6f9d97bea59_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_65331edd-57fc-46de-a649-5c222951d167_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undrawn fee (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_ab8a5a9d-02e1-4507-bccd-5157b6bd2acf_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_label_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability" xlink:to="lab_us-gaap_FairValueNetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_26692cb1-117e-43ba-a5cb-503ef715a73f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_15d55b33-b5a9-4ad9-987c-62e0a7a3d339_terseLabel_en-US" xlink:label="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans</link:label>
    <link:label id="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans</link:label>
    <link:label id="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_documentation_en-US" xlink:label="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:href="mygn-20200930.xsd#mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:to="lab_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_57a8f964-c3d8-427b-907f-5f24fd0dcfaa_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7d06ee36-fd55-46a5-8b19-4ecbabf652fb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b44642be-346e-4369-938a-88c6c7d1ecb4_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_2686cbf2-ee3f-4874-ac14-d0205e1b1a63_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_779890d6-d7e3-4cce-a271-d753c4ca17a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3f516a7e-4c59-435b-af05-8ad0434474c4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mygn_MolecularDiagnosticTestingMember_3e6c694e-0c9c-48dd-ab4f-d52987a15b33_terseLabel_en-US" xlink:label="lab_mygn_MolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic testing</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticTestingMember_label_en-US" xlink:label="lab_mygn_MolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostic Testing [Member]</link:label>
    <link:label id="lab_mygn_MolecularDiagnosticTestingMember_documentation_en-US" xlink:label="lab_mygn_MolecularDiagnosticTestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular diagnostic testing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mygn_MolecularDiagnosticTestingMember" xlink:to="lab_mygn_MolecularDiagnosticTestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_98d5bce3-6cd3-4d2a-847c-c3f1592c5a84_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>mygn-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e951f29c-a210-45d5-8fef-ac7c87c1a1f9,g:048ed3a0-61ad-4824-a735-4ab2d7ea0155-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.myriad.com/role/Cover" xlink:type="simple" xlink:href="mygn-20200930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7cabd84d-8f7a-4c66-846f-f910f2b0614c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_DocumentType_7cabd84d-8f7a-4c66-846f-f910f2b0614c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4ee1ef6d-9c4b-4c81-ae0f-c76814e458df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_AmendmentFlag_4ee1ef6d-9c4b-4c81-ae0f-c76814e458df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3ffee071-c299-43d2-bbbc-d245819cec1f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_DocumentQuarterlyReport_3ffee071-c299-43d2-bbbc-d245819cec1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_91aa270c-34d6-4daf-ab42-9427e779e1ac" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_DocumentPeriodEndDate_91aa270c-34d6-4daf-ab42-9427e779e1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_63dff3c4-f35d-4b56-878f-f1c23c783fa7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_DocumentTransitionReport_63dff3c4-f35d-4b56-878f-f1c23c783fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8b928cfe-e3e6-411d-bdfe-28430d3545e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityFileNumber_8b928cfe-e3e6-411d-bdfe-28430d3545e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a6c28c66-63c0-48d5-8282-cc1264297ce6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityRegistrantName_a6c28c66-63c0-48d5-8282-cc1264297ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_05454d7f-3e23-424b-b152-3acacd3a7cd0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityCentralIndexKey_05454d7f-3e23-424b-b152-3acacd3a7cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_84c3fc14-e8bc-4b5d-a95b-d5098c1b22c8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_CurrentFiscalYearEndDate_84c3fc14-e8bc-4b5d-a95b-d5098c1b22c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4039c703-9477-471e-aff5-401f928ab902" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_DocumentFiscalYearFocus_4039c703-9477-471e-aff5-401f928ab902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3e47a696-448e-4d43-8948-db06b3c3e223" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3e47a696-448e-4d43-8948-db06b3c3e223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7957459e-25e9-4ad5-b5bb-b577495ad3b2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7957459e-25e9-4ad5-b5bb-b577495ad3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_38363168-47c3-4bc6-86fc-df155b697992" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityTaxIdentificationNumber_38363168-47c3-4bc6-86fc-df155b697992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7cf82709-382d-4dc7-98fa-7bf385fb8d8d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityAddressAddressLine1_7cf82709-382d-4dc7-98fa-7bf385fb8d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_417ed361-896c-490e-bc95-8d5fcec6be7a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityAddressCityOrTown_417ed361-896c-490e-bc95-8d5fcec6be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_220a8c76-9412-4d80-a643-f766abfadb0e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityAddressStateOrProvince_220a8c76-9412-4d80-a643-f766abfadb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_53e6ba16-291f-4797-bc98-f70c021872c3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityAddressPostalZipCode_53e6ba16-291f-4797-bc98-f70c021872c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_929f9e87-e461-494d-af8f-c7d81c3052f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_CityAreaCode_929f9e87-e461-494d-af8f-c7d81c3052f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_97484478-2d67-40c9-af04-0dd0e4d25acc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_LocalPhoneNumber_97484478-2d67-40c9-af04-0dd0e4d25acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_14aaf776-1a64-4349-b881-ffb4a7ff1561" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_Security12bTitle_14aaf776-1a64-4349-b881-ffb4a7ff1561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fbe185fc-749e-4291-a27a-6189f3a1adbf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_TradingSymbol_fbe185fc-749e-4291-a27a-6189f3a1adbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c21d5845-ac54-46ae-88ae-6a4332c61427" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_SecurityExchangeName_c21d5845-ac54-46ae-88ae-6a4332c61427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_71e7d0d8-96da-412c-b83c-1293f25db6da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityCurrentReportingStatus_71e7d0d8-96da-412c-b83c-1293f25db6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_8eebb38c-d1b5-4ca1-b0b9-ba6d76f96cbe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityInteractiveDataCurrent_8eebb38c-d1b5-4ca1-b0b9-ba6d76f96cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_76be1b83-a91e-42fc-a6f8-916b7c28e495" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityFilerCategory_76be1b83-a91e-42fc-a6f8-916b7c28e495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_bb9ae30d-063a-4941-979d-a4ecf2c2f184" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntitySmallBusiness_bb9ae30d-063a-4941-979d-a4ecf2c2f184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3549c2ec-6067-4d29-aabb-55c0cbee3029" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityEmergingGrowthCompany_3549c2ec-6067-4d29-aabb-55c0cbee3029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_be55ae92-b404-44df-9c6b-31ceb9ddf2c8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityShellCompany_be55ae92-b404-44df-9c6b-31ceb9ddf2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_527154a8-39d1-4b99-9474-45e1f7af89ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_93275a76-3eeb-4492-92ab-c4c6a3ce2f58" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_527154a8-39d1-4b99-9474-45e1f7af89ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1fa6432b-a855-4180-bb4d-a589f05cafba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1fa6432b-a855-4180-bb4d-a589f05cafba" xlink:to="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_573c8071-eba5-42c8-b138-d4988c73684e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_573c8071-eba5-42c8-b138-d4988c73684e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_62c47234-f4cf-4208-932a-52209727c9eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_62c47234-f4cf-4208-932a-52209727c9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_8bcd7c84-31aa-4485-aaeb-9b4453dd5a27" xlink:href="mygn-20200930.xsd#mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent_8bcd7c84-31aa-4485-aaeb-9b4453dd5a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_878b58ea-b4b6-4a07-888c-a395c6de9e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_InventoryNet_878b58ea-b4b6-4a07-888c-a395c6de9e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a5d38988-3b8c-441a-b828-9d6626351a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a5d38988-3b8c-441a-b828-9d6626351a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_69905fd6-437e-4163-893e-9d12fcd829c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_PrepaidTaxes_69905fd6-437e-4163-893e-9d12fcd829c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e53d937a-7e08-4b7c-8fbe-c0a02cf9ac1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e53d937a-7e08-4b7c-8fbe-c0a02cf9ac1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bc6b4235-6091-4024-a29a-b8c453778826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0d859d0a-b051-4139-8d6b-d30b2b575344" xlink:to="loc_us-gaap_AssetsCurrent_bc6b4235-6091-4024-a29a-b8c453778826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c857f1e5-d55a-47bd-b71b-4d90d7da58eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c857f1e5-d55a-47bd-b71b-4d90d7da58eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7a39d21-2f79-4b7e-868b-0c8ae9ac70b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e7a39d21-2f79-4b7e-868b-0c8ae9ac70b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_c5866712-a1ef-4cb6-8552-fcc3558153ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_c5866712-a1ef-4cb6-8552-fcc3558153ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_63c3b9ce-23d0-4c40-a460-3a31db8d40d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_63c3b9ce-23d0-4c40-a460-3a31db8d40d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_072d8405-74c0-4118-9ddb-f7ac42855226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_Goodwill_072d8405-74c0-4118-9ddb-f7ac42855226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9b47e9ed-9d15-45e1-ac1c-d8c33edc1b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9b47e9ed-9d15-45e1-ac1c-d8c33edc1b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e40e0bb8-5e44-45a1-a6a1-c4e2d402889f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8a2d8114-3106-4e31-8683-1e535ae8a94c" xlink:to="loc_us-gaap_Assets_e40e0bb8-5e44-45a1-a6a1-c4e2d402889f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1fa6432b-a855-4180-bb4d-a589f05cafba" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f1ef3aab-68e8-4452-9b18-c650785eed9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:to="loc_us-gaap_AccountsPayableCurrent_f1ef3aab-68e8-4452-9b18-c650785eed9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8a17fd43-16dc-40d5-bc6c-6324cf687967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8a17fd43-16dc-40d5-bc6c-6324cf687967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0c180008-cde0-460e-99d5-4da7db4dfb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0c180008-cde0-460e-99d5-4da7db4dfb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5d9d89b1-33f3-4f33-881e-a84d5992e80a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_5d9d89b1-33f3-4f33-881e-a84d5992e80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9f9d1d88-f2e7-4b4a-a354-f340f3e28b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9f9d1d88-f2e7-4b4a-a354-f340f3e28b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a4ddf11b-3194-4cf1-99ab-45c2e8b48922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0edd98f7-f850-4323-b683-70a6d6cfef45" xlink:to="loc_us-gaap_LiabilitiesCurrent_a4ddf11b-3194-4cf1-99ab-45c2e8b48922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b357d4d2-092f-452e-976f-c6ece0642946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b357d4d2-092f-452e-976f-c6ece0642946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3880c039-5fd7-4365-a6e8-a481407b6875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3880c039-5fd7-4365-a6e8-a481407b6875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_505b69da-5883-4dfd-8255-f89e362b2be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_LongTermDebt_505b69da-5883-4dfd-8255-f89e362b2be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_64c964c7-ef18-4a84-8dd5-5c49f25792a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_64c964c7-ef18-4a84-8dd5-5c49f25792a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2d0f53e3-80a7-41af-a951-64f722864b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2d0f53e3-80a7-41af-a951-64f722864b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_29e92bf5-7016-494c-9081-8a729789c7d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_Liabilities_29e92bf5-7016-494c-9081-8a729789c7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fafc32f8-8ccb-4592-a514-24395101d262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fafc32f8-8ccb-4592-a514-24395101d262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d0690322-ddc4-40a8-8d38-8121e2d9226a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_CommonStockValue_d0690322-ddc4-40a8-8d38-8121e2d9226a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0fe6764f-ffc0-4420-9d3b-ef7cf9317425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0fe6764f-ffc0-4420-9d3b-ef7cf9317425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5788a7da-42d3-4908-bb39-8bc05b80ec14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5788a7da-42d3-4908-bb39-8bc05b80ec14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cfb75b16-e65d-4546-b766-3986ba45368e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cfb75b16-e65d-4546-b766-3986ba45368e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3560c3a2-cb12-493b-b397-cefe8f16a0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_StockholdersEquity_3560c3a2-cb12-493b-b397-cefe8f16a0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5d1e5f05-e9dd-4d41-8c5b-874febc0af83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_MinorityInterest_5d1e5f05-e9dd-4d41-8c5b-874febc0af83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f02dd18b-d459-4e15-a81c-3f0c47d21821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ce1a46fa-5f65-4763-8e4b-3cf649050f3f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f02dd18b-d459-4e15-a81c-3f0c47d21821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6c8a1eb8-e80f-416c-a5ff-0b2d907c4d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dac96ab1-6c21-43c1-ae3c-ec9313bc3260" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_6c8a1eb8-e80f-416c-a5ff-0b2d907c4d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dc5766f1-e83e-40c9-84f9-a87a3bfcfb08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_43c0e1aa-43c4-4a0f-9335-0c04cf7a843a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc5766f1-e83e-40c9-84f9-a87a3bfcfb08" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_43c0e1aa-43c4-4a0f-9335-0c04cf7a843a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_288998e3-72c9-41a0-95b1-996f55f1989f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_288998e3-72c9-41a0-95b1-996f55f1989f" xlink:to="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:to="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_de3d5095-6801-49c7-a88f-64fbbcbeea8e" xlink:to="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_ac290fc8-4a2a-490c-9544-99f50743d50d" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_ac290fc8-4a2a-490c-9544-99f50743d50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_4165825a-ba2b-4f8b-8e04-22c6f6b9d7b2" xlink:href="mygn-20200930.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee48f56f-b4dc-45b6-9d18-2250419d75f8" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_4165825a-ba2b-4f8b-8e04-22c6f6b9d7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12403923-76e0-417a-af86-3e8da3404689" xlink:to="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_112ab2f3-b615-492e-ac0b-eab5fce26194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_112ab2f3-b615-492e-ac0b-eab5fce26194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_350cd21a-1bdd-42e2-95f0-5bc51a90f259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_350cd21a-1bdd-42e2-95f0-5bc51a90f259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fd7aaedc-2587-4b99-8abc-d535ade2a0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fd7aaedc-2587-4b99-8abc-d535ade2a0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e0a654e6-cea0-4f93-97ab-254a02324e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e0a654e6-cea0-4f93-97ab-254a02324e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd944fe1-5d15-46ec-8c31-b60e8bb3dfcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cd944fe1-5d15-46ec-8c31-b60e8bb3dfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_67613797-6e7e-4039-9b03-c487c82fc996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_4d7836d1-f00c-4f8d-ab93-e89922911f1d" xlink:to="loc_us-gaap_CostsAndExpenses_67613797-6e7e-4039-9b03-c487c82fc996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee92b715-41e2-4cb4-9c72-f6b811a12085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_OperatingIncomeLoss_ee92b715-41e2-4cb4-9c72-f6b811a12085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7cfc443b-ae71-40d5-a21a-b91395c18352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7cfc443b-ae71-40d5-a21a-b91395c18352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dc8ca43a-5267-4fee-8fe3-9be051e99f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_InterestExpense_dc8ca43a-5267-4fee-8fe3-9be051e99f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e2f8d876-b61a-4603-8c58-06e7b7e24a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e2f8d876-b61a-4603-8c58-06e7b7e24a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_16c5eebd-a69d-4d1f-831e-6e07dff0df0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_2e009171-f0bc-48c6-8d27-1b228f9ca36d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_16c5eebd-a69d-4d1f-831e-6e07dff0df0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_014bd8c7-4d93-4db2-81e3-b84c100a1f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_014bd8c7-4d93-4db2-81e3-b84c100a1f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e0aba52e-a22f-47a3-acf0-a30004cd3b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e0aba52e-a22f-47a3-acf0-a30004cd3b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8a447515-edaa-44cc-b3e5-7076bc167ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_ProfitLoss_8a447515-edaa-44cc-b3e5-7076bc167ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3163fa8e-b483-4365-b9b8-1ecb892fa3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3163fa8e-b483-4365-b9b8-1ecb892fa3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_008aeae0-ba6b-41d4-990e-b9007b3a8a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_NetIncomeLoss_008aeae0-ba6b-41d4-990e-b9007b3a8a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_abc8d26f-efd5-4226-b2b1-c9dd47cb3974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_abc8d26f-efd5-4226-b2b1-c9dd47cb3974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_60f5cdf1-f050-485a-9fc8-f4920c325706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_abc8d26f-efd5-4226-b2b1-c9dd47cb3974" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_60f5cdf1-f050-485a-9fc8-f4920c325706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c9b68a32-3dfc-474b-b596-7feec8415b95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03444e4a-4ade-4349-88c9-5a8fe841829f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c9b68a32-3dfc-474b-b596-7feec8415b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_7a4d751b-aff4-4314-930a-866f944a7492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c9b68a32-3dfc-474b-b596-7feec8415b95" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_7a4d751b-aff4-4314-930a-866f944a7492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_284f06bb-b3b1-4baa-981d-1aa1e336cad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:to="loc_us-gaap_NetIncomeLoss_284f06bb-b3b1-4baa-981d-1aa1e336cad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_598bb15f-bf86-4649-a7fc-50d8790f10fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_598bb15f-bf86-4649-a7fc-50d8790f10fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_00ff03de-6929-4737-a6da-ac99c142bf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_00ff03de-6929-4737-a6da-ac99c142bf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9d9acec3-0806-48a9-8e5a-a5462b6ba500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9d9acec3-0806-48a9-8e5a-a5462b6ba500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5d1db37e-fbb7-4b8f-8be3-21d4b48bbcdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5d1db37e-fbb7-4b8f-8be3-21d4b48bbcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c5a8f235-2e81-4545-b1e7-27ec0789e1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9fd08dbb-4988-4a86-b44c-0f2ed0739428" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c5a8f235-2e81-4545-b1e7-27ec0789e1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1b803d4e-249a-43f8-b099-81c158d11304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1b803d4e-249a-43f8-b099-81c158d11304" xlink:to="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b87bfaba-94ea-4829-b883-2355e46f7b88" xlink:to="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b1fb74e1-732c-4f73-99c0-24e2d4356962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_CommonStockMember_b1fb74e1-732c-4f73-99c0-24e2d4356962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bcef059e-c119-42bb-914d-16c34fa1e74e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bcef059e-c119-42bb-914d-16c34fa1e74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_59ac4e5c-641f-454f-a073-30e55d6438ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_59ac4e5c-641f-454f-a073-30e55d6438ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_262cdedc-0f3c-40ef-9c1e-66704aae5e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41ae738b-7b1c-4e5d-8115-555dfe4e67a4" xlink:to="loc_us-gaap_RetainedEarningsMember_262cdedc-0f3c-40ef-9c1e-66704aae5e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d4212c4f-a2c2-4a69-9d7d-8cedaaffca62" xlink:to="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf01aeb-0425-4aab-af51-bcf3ecbd4814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf01aeb-0425-4aab-af51-bcf3ecbd4814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ee1237b-2a2e-458f-9952-884a6908fa8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ee1237b-2a2e-458f-9952-884a6908fa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e2d9b0-4f3a-466c-b456-f42772484a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e2d9b0-4f3a-466c-b456-f42772484a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_493dabc9-7073-4410-a4dc-5f3413a1944a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_NetIncomeLoss_493dabc9-7073-4410-a4dc-5f3413a1944a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8beaa2c2-80a3-47bd-aa90-454b09cd0a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8beaa2c2-80a3-47bd-aa90-454b09cd0a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab28774d-3176-4d24-b811-2b7943cd0a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8ea5f6a-a2ab-442f-bd77-99ec24009558" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab28774d-3176-4d24-b811-2b7943cd0a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mygn-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad4dfb35-62e0-495d-a0bc-0bf3582fe07b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad4dfb35-62e0-495d-a0bc-0bf3582fe07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b6d31716-8e79-4a0d-abfb-8eb6f417cbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad4dfb35-62e0-495d-a0bc-0bf3582fe07b" xlink:to="loc_us-gaap_NetIncomeLoss_b6d31716-8e79-4a0d-abfb-8eb6f417cbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad4dfb35-62e0-495d-a0bc-0bf3582fe07b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_138ca971-a6b8-474f-b5e1-ce5810752910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_us-gaap_DepreciationAndAmortization_138ca971-a6b8-474f-b5e1-ce5810752910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonCashInterestExpense_2f67d38e-e076-4d55-a5bb-c6800a2af320" xlink:href="mygn-20200930.xsd#mygn_NonCashInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_mygn_NonCashInterestExpense_2f67d38e-e076-4d55-a5bb-c6800a2af320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_64ec0eac-5c8d-43a9-801f-f12bc2664559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_64ec0eac-5c8d-43a9-801f-f12bc2664559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_24dd32cd-0463-43ae-8f27-5493f793f09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_24dd32cd-0463-43ae-8f27-5493f793f09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4fea070e-1793-4509-96ae-8a922168b18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_us-gaap_ShareBasedCompensation_4fea070e-1793-4509-96ae-8a922168b18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_22dfa2ce-4060-43f8-a7e1-4e4b3e661e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_22dfa2ce-4060-43f8-a7e1-4e4b3e661e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_ff4d2ba5-bcbf-41d3-9d12-14b9077a662f" xlink:href="mygn-20200930.xsd#mygn_IncreaseDecreaseInUnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits_ff4d2ba5-bcbf-41d3-9d12-14b9077a662f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ChangeInFairValueOfContingentConsideration_9cad249f-86de-4368-94f4-03faeef16ad6" xlink:href="mygn-20200930.xsd#mygn_ChangeInFairValueOfContingentConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_mygn_ChangeInFairValueOfContingentConsideration_9cad249f-86de-4368-94f4-03faeef16ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3b7e9a2-1aa4-4be6-a275-5d0e92e442aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_0dfd0f06-b656-4196-b599-b0f466db0295" xlink:href="mygn-20200930.xsd#mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes_0dfd0f06-b656-4196-b599-b0f466db0295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_efa2735b-b710-4a69-aa7a-c157b4592b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_efa2735b-b710-4a69-aa7a-c157b4592b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_392aba01-7b31-45b3-a77b-ba2071d6c3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_392aba01-7b31-45b3-a77b-ba2071d6c3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_46123b95-131e-4375-bdd3-1cd99a9eae6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_46123b95-131e-4375-bdd3-1cd99a9eae6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_725d04c4-f113-439f-86ff-a687f60cf226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_725d04c4-f113-439f-86ff-a687f60cf226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0337f05a-90db-4220-983c-479a7b5625d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0337f05a-90db-4220-983c-479a7b5625d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d925dbf9-2100-43d9-9b7f-16d899a0e485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d925dbf9-2100-43d9-9b7f-16d899a0e485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_51ce8eb6-2618-4f91-bf42-66f06fa03f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_51ce8eb6-2618-4f91-bf42-66f06fa03f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4ebb7ba4-7356-442b-ad50-81e86bbb18d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9661e3a-d5c5-4485-8bd5-540abde98cc2" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4ebb7ba4-7356-442b-ad50-81e86bbb18d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_982a32d5-dcbf-4b68-b572-2965b5c890fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad4dfb35-62e0-495d-a0bc-0bf3582fe07b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_982a32d5-dcbf-4b68-b572-2965b5c890fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a2320ea4-2e8b-4027-9633-4d2e57488f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a2320ea4-2e8b-4027-9633-4d2e57488f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_8bcb706f-e458-466b-85b7-44cf45c6a9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a2320ea4-2e8b-4027-9633-4d2e57488f86" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_8bcb706f-e458-466b-85b7-44cf45c6a9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_39e0c134-c141-4314-8dc6-a933deb2d532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a2320ea4-2e8b-4027-9633-4d2e57488f86" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_39e0c134-c141-4314-8dc6-a933deb2d532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_19a4a506-54f6-4b3b-ad17-8f3ad5c4cc6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a2320ea4-2e8b-4027-9633-4d2e57488f86" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_19a4a506-54f6-4b3b-ad17-8f3ad5c4cc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7b171eaf-ec82-4ebb-a403-0b6585f8745b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a2320ea4-2e8b-4027-9633-4d2e57488f86" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7b171eaf-ec82-4ebb-a403-0b6585f8745b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_87a95402-c3c1-45e2-b9f3-0a72f4bf60e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_87a95402-c3c1-45e2-b9f3-0a72f4bf60e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3dd9bc01-e1ed-4dc3-930d-2e27afe9c282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_87a95402-c3c1-45e2-b9f3-0a72f4bf60e2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3dd9bc01-e1ed-4dc3-930d-2e27afe9c282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_7f245882-4483-4c7c-877d-d3140f34942c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_87a95402-c3c1-45e2-b9f3-0a72f4bf60e2" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_7f245882-4483-4c7c-877d-d3140f34942c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d9a73f1f-65a5-4fc6-ac73-afa22e4a9cd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_87a95402-c3c1-45e2-b9f3-0a72f4bf60e2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d9a73f1f-65a5-4fc6-ac73-afa22e4a9cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25a55ee4-6a83-460d-a118-b3da7d49c09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_87a95402-c3c1-45e2-b9f3-0a72f4bf60e2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25a55ee4-6a83-460d-a118-b3da7d49c09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_412f3df5-c170-4e2c-ac68-d8db39ca4336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_412f3df5-c170-4e2c-ac68-d8db39ca4336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_95fef54d-89e2-4863-ad96-a9f53b107ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_95fef54d-89e2-4863-ad96-a9f53b107ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f28817ba-dcee-4814-b97e-e134c6e6b2b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f28817ba-dcee-4814-b97e-e134c6e6b2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe9c2955-01d0-4765-8ce8-cf557649a214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_762f0834-94de-4ec6-a7fe-40c63788b464" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe9c2955-01d0-4765-8ce8-cf557649a214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mygn-20200930.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bab1c4cb-26e1-4bb3-98f2-978bfdd1a507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_342af78e-80c6-42f0-a844-e956a629e009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bab1c4cb-26e1-4bb3-98f2-978bfdd1a507" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_342af78e-80c6-42f0-a844-e956a629e009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mygn-20200930.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90f610e3-bf85-4f64-92bc-ca465df1b91d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_df4e9998-ade5-4bd1-a4ec-a494c91c9532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90f610e3-bf85-4f64-92bc-ca465df1b91d" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_df4e9998-ade5-4bd1-a4ec-a494c91c9532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d17e822a-399a-473c-8c5a-5d89d4cef1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90f610e3-bf85-4f64-92bc-ca465df1b91d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d17e822a-399a-473c-8c5a-5d89d4cef1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/Revenue" xlink:type="simple" xlink:href="mygn-20200930.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b95bd7f1-faac-458f-aac3-19f03e3f19a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_93a6bb66-d983-46c4-b8b3-d81a9f6b4514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b95bd7f1-faac-458f-aac3-19f03e3f19a8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_93a6bb66-d983-46c4-b8b3-d81a9f6b4514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f3a257ab-2058-43d4-aef5-38a92890d999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_35ad17cd-03b1-4523-af5c-c8c0ed2159fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f3a257ab-2058-43d4-aef5-38a92890d999" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_35ad17cd-03b1-4523-af5c-c8c0ed2159fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ee89a455-7a8b-449d-a7d5-3fb707291987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f3a257ab-2058-43d4-aef5-38a92890d999" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ee89a455-7a8b-449d-a7d5-3fb707291987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_41acbe93-fc49-4863-a7ec-3e3fa4e439f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_41acbe93-fc49-4863-a7ec-3e3fa4e439f2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:to="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_fa2cb6cc-2ef1-411b-af3c-b259cb4c73af" xlink:to="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_d0d4307a-a913-4f49-8ab9-6921d102c441" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticHereditaryCancerTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticHereditaryCancerTestingMember_d0d4307a-a913-4f49-8ab9-6921d102c441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticPrenatalTestingMember_8fb653c9-42cf-4b33-b218-a71d87a1eaf6" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticPrenatalTestingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticPrenatalTestingMember_8fb653c9-42cf-4b33-b218-a71d87a1eaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticGenesightTestingMember_c6e27bb3-02c6-4783-be06-3aede58bfcc7" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticGenesightTestingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticGenesightTestingMember_c6e27bb3-02c6-4783-be06-3aede58bfcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticVectraTestingMember_073140b7-1fec-40dd-93f2-9809a88a35b9" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticVectraTestingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticVectraTestingMember_073140b7-1fec-40dd-93f2-9809a88a35b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_e53860dd-1d1b-4eb2-b115-8180e310f467" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticMyChoiceCDxMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticMyChoiceCDxMember_e53860dd-1d1b-4eb2-b115-8180e310f467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticProlarisTestingMember_ead6c357-e9f7-421b-be06-e398cf541c08" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticProlarisTestingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticProlarisTestingMember_ead6c357-e9f7-421b-be06-e398cf541c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_bd8a6058-2eae-40a8-bf7a-d84339c238b9" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticEndoPredictTestingMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticEndoPredictTestingMember_bd8a6058-2eae-40a8-bf7a-d84339c238b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticOtherTestingMember_5a24eafe-b4d7-4327-a5d8-5bf9fe1a03ae" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticOtherTestingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticOtherTestingMember_5a24eafe-b4d7-4327-a5d8-5bf9fe1a03ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MolecularDiagnosticTestingMember_324442e4-ac09-454e-9341-7891b1f0e3bf" xlink:href="mygn-20200930.xsd#mygn_MolecularDiagnosticTestingMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_MolecularDiagnosticTestingMember_324442e4-ac09-454e-9341-7891b1f0e3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PharmaceuticalAndClinicalServicesMember_798e0d1a-9a2e-4d2c-849b-bed8f526bec1" xlink:href="mygn-20200930.xsd#mygn_PharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8f0bc0cb-3dc6-4769-a33e-81714ddd3f87" xlink:to="loc_mygn_PharmaceuticalAndClinicalServicesMember_798e0d1a-9a2e-4d2c-849b-bed8f526bec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:to="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_dfddc2d3-b336-4c5c-88f8-1536cb257118" xlink:to="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fab5b00e-e157-4a38-9558-3d3e4c7ad105" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:to="loc_country_US_fab5b00e-e157-4a38-9558-3d3e4c7ad105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ac4076fc-3549-439b-94df-c3f904d8acce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f016adbe-6e43-4739-9f1e-a4d623fd6794" xlink:to="loc_us-gaap_NonUsMember_ac4076fc-3549-439b-94df-c3f904d8acce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c1654973-616b-44be-89c7-861cd85f86ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_326b532c-8b17-4636-b4a6-5514700f59e7" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c1654973-616b-44be-89c7-861cd85f86ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4a347af4-219e-481a-8868-c35622ec610a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c1654973-616b-44be-89c7-861cd85f86ce" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4a347af4-219e-481a-8868-c35622ec610a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueReconciliationofDeferredRevenueBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f550cd18-00dd-4c32-a7f7-9b0f5b4563af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_6937d397-c4d4-44c2-a65b-fe490f84d515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f550cd18-00dd-4c32-a7f7-9b0f5b4563af" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_6937d397-c4d4-44c2-a65b-fe490f84d515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2a8dafb7-3457-44de-89e9-4c1eade22f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_6937d397-c4d4-44c2-a65b-fe490f84d515" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2a8dafb7-3457-44de-89e9-4c1eade22f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7b8eb7d9-88b4-42fc-93e6-cfcc119ce3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_6937d397-c4d4-44c2-a65b-fe490f84d515" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7b8eb7d9-88b4-42fc-93e6-cfcc119ce3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContractWithCustomerLiabilityPrepayments_69e89e98-3de3-482f-be91-42d103e9d507" xlink:href="mygn-20200930.xsd#mygn_ContractWithCustomerLiabilityPrepayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_6937d397-c4d4-44c2-a65b-fe490f84d515" xlink:to="loc_mygn_ContractWithCustomerLiabilityPrepayments_69e89e98-3de3-482f-be91-42d103e9d507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_90347450-83c9-4cb2-a822-071cd494739e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_6937d397-c4d4-44c2-a65b-fe490f84d515" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_90347450-83c9-4cb2-a822-071cd494739e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CARESActOf2020MedicarePaymentAmount_dd7e34cd-e1e7-4a0c-b302-44ecb1b647b1" xlink:href="mygn-20200930.xsd#mygn_CARESActOf2020MedicarePaymentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_mygn_CARESActOf2020MedicarePaymentAmount_dd7e34cd-e1e7-4a0c-b302-44ecb1b647b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription_af1fccd6-c788-4045-9fd8-e8d9df5e9566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription_af1fccd6-c788-4045-9fd8-e8d9df5e9566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation_4f015a8b-9e1e-40b5-a76e-a888a9fce0ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation_4f015a8b-9e1e-40b5-a76e-a888a9fce0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a79f4885-7a78-4151-a6b1-2d7c19677996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a79f4885-7a78-4151-a6b1-2d7c19677996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability_4f10ba61-04c4-4909-a184-7cb3393b96f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiability_4f10ba61-04c4-4909-a184-7cb3393b96f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract_5030271f-2da5-4991-a8ce-6e066ea02548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract_5030271f-2da5-4991-a8ce-6e066ea02548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_6e180430-d28f-47b7-83ed-fae13220d327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_CapitalizedContractCostGross_6e180430-d28f-47b7-83ed-fae13220d327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db607934-61a9-4ee9-9cec-d0ad28e5171a" xlink:to="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790e451d-201b-4a51-89f9-db45c2e83ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36571281-aa3f-457a-b4ef-35e2c1d993f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790e451d-201b-4a51-89f9-db45c2e83ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_b87cbbe0-6c9b-44fa-96f0-765060d2f764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790e451d-201b-4a51-89f9-db45c2e83ec5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_b87cbbe0-6c9b-44fa-96f0-765060d2f764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f267e081-03e2-407e-b414-17330aa0cfe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_358bb5c1-1f62-4e4b-ad16-da037e833f70" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f267e081-03e2-407e-b414-17330aa0cfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_486607dc-86aa-4b79-a91e-e5c6bc34eee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f267e081-03e2-407e-b414-17330aa0cfe6" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_486607dc-86aa-4b79-a91e-e5c6bc34eee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d04ecbd0-1bef-4f23-9289-96f5f146f578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a398f19c-e90c-48a5-99b3-415d9faf7571" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_d04ecbd0-1bef-4f23-9289-96f5f146f578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_05fbc7ba-26df-4bad-90cd-17b4cb1dc86e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d04ecbd0-1bef-4f23-9289-96f5f146f578" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_05fbc7ba-26df-4bad-90cd-17b4cb1dc86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecurities"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5e60760e-3e1f-4485-9980-645a938c9cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_e9f420cc-dbb6-4e0a-b371-10dd0d4200de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5e60760e-3e1f-4485-9980-645a938c9cd4" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_e9f420cc-dbb6-4e0a-b371-10dd0d4200de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c797ccb1-6ae5-40e9-866d-bacc30ad8935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_85b9db70-ec3b-4d46-aef5-6e19588ce751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c797ccb1-6ae5-40e9-866d-bacc30ad8935" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_85b9db70-ec3b-4d46-aef5-6e19588ce751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_cb53a35f-5533-48a9-b922-a9b3b67c4732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c797ccb1-6ae5-40e9-866d-bacc30ad8935" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_cb53a35f-5533-48a9-b922-a9b3b67c4732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_aa381794-8fc9-42ca-96db-e49bc486e13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_aa381794-8fc9-42ca-96db-e49bc486e13e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:to="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_13b81157-0b23-410f-9e6d-22d239c11ccf" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5d6caa36-7efe-426e-8a09-380d2c398b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5d6caa36-7efe-426e-8a09-380d2c398b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_836459cb-929a-4088-8437-11b2b7031403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_MunicipalBondsMember_836459cb-929a-4088-8437-11b2b7031403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_370777dc-583e-41c5-aa4e-363a95c8dcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_370777dc-583e-41c5-aa4e-363a95c8dcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_eb797fe1-3b35-4876-bf3a-ace0369d6a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3f14824d-e4b5-48bc-a0d7-8d1ab6886e09" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_eb797fe1-3b35-4876-bf3a-ace0369d6a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_275d34a5-ab9f-4a03-9f2b-8ab776ec3306" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_b892640f-6471-4b8c-b65b-086ead920831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:to="loc_us-gaap_CashMember_b892640f-6471-4b8c-b65b-086ead920831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_07568333-fae5-478e-afda-691bdc6d2135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6cf333aa-0acc-44e0-9d19-2421b8187b83" xlink:to="loc_us-gaap_CashEquivalentsMember_07568333-fae5-478e-afda-691bdc6d2135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b1cdc97b-8472-42c3-b541-b3e93c51fd7e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5493b8c5-b901-40c8-b34f-f5fa8ef0bef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5493b8c5-b901-40c8-b34f-f5fa8ef0bef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6dbb7ac6-d19e-4574-9565-718f6ac42dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_cc517df9-dee3-47d4-9f9f-9b691537f310" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6dbb7ac6-d19e-4574-9565-718f6ac42dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07eb5c43-a3b8-401a-9681-b3ee9a905c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_07eb5c43-a3b8-401a-9681-b3ee9a905c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_40ea7fa5-a259-4226-b5ab-34332681e504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_40ea7fa5-a259-4226-b5ab-34332681e504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7dab26bf-f1c9-450b-afc2-12db60929cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7dab26bf-f1c9-450b-afc2-12db60929cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f588ebd1-dd83-41f0-81a2-e87873f34550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_33b980b2-b63f-4dc5-8459-c85ee63f4dae" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f588ebd1-dd83-41f0-81a2-e87873f34550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCashAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_90c976da-26f2-4751-a5c0-3a407cfe60cd" xlink:to="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_eef43514-4864-4942-b732-0219b1112428" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_eef43514-4864-4942-b732-0219b1112428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_bb25787c-802f-41a5-99d9-26c8f7c1262e" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax_bb25787c-802f-41a5-99d9-26c8f7c1262e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_170f951a-8252-4a1f-bbb1-ffdc9be697df" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax_170f951a-8252-4a1f-bbb1-ffdc9be697df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_44599898-0ba3-4adf-84e9-7694f4e4635f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAndCashAbstract_c62ddc58-2fb7-413d-a87b-c3632b9897ac" xlink:to="loc_us-gaap_InvestmentsAndCash_44599898-0ba3-4adf-84e9-7694f4e4635f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_236e9d86-84e3-4856-bf1e-9a179d7ce239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_236e9d86-84e3-4856-bf1e-9a179d7ce239" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_9e4f3a62-5512-405a-b887-c54340b37f03" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_05d5be89-1d7f-4caa-bd4e-c0051a5ed273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:to="loc_us-gaap_CashMember_05d5be89-1d7f-4caa-bd4e-c0051a5ed273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_2196ff2b-8b43-4664-b750-9abf87d9083d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_60da06c0-31c0-4c67-9a1d-cf32e993d532" xlink:to="loc_us-gaap_CashEquivalentsMember_2196ff2b-8b43-4664-b750-9abf87d9083d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_61ff16ff-7d30-484d-8ccd-3b5fd69234d6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81bdc676-8bb5-44d8-a954-cff2b13bf530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81bdc676-8bb5-44d8-a954-cff2b13bf530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_2a4b63e4-2948-4e06-9126-ca83b922c71c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_2a4b63e4-2948-4e06-9126-ca83b922c71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_283c49a7-bc30-4383-8e75-5b698322d904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_283c49a7-bc30-4383-8e75-5b698322d904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_5a5e02d3-107b-47b6-87c0-19ed209833f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_5a5e02d3-107b-47b6-87c0-19ed209833f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InvestmentsAndCashAmortizedCost_1533415d-8c3e-4c20-8994-6ae77ad152c0" xlink:href="mygn-20200930.xsd#mygn_InvestmentsAndCashAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_d0e44129-f1e4-4354-ac98-a71157a8c564" xlink:to="loc_mygn_InvestmentsAndCashAmortizedCost_1533415d-8c3e-4c20-8994-6ae77ad152c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8a8e655d-3f18-4b72-b7c4-b5ab5c8fe586" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eb0e80b6-ee26-4009-8f1c-e539224801e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eb0e80b6-ee26-4009-8f1c-e539224801e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_1c12c914-df82-4b1e-b355-c967a5d33f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_1c12c914-df82-4b1e-b355-c967a5d33f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_8a50228f-ecef-4792-8d28-1a605dc6a7b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_8a50228f-ecef-4792-8d28-1a605dc6a7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_ef868e89-b052-4093-b6d1-1b3a41b77414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_ef868e89-b052-4093-b6d1-1b3a41b77414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_2c3ccb85-d185-4065-b729-20e139be346b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_2c0afabc-3869-4ec7-bb66-98610ad7dca2" xlink:to="loc_us-gaap_InvestmentsAndCash_2c3ccb85-d185-4065-b729-20e139be346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ed896dd9-202f-43ed-9fe4-c2d968f6b52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_121b45a2-5d02-423e-913f-fa325dc805df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed896dd9-202f-43ed-9fe4-c2d968f6b52d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_121b45a2-5d02-423e-913f-fa325dc805df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4a713c28-3354-4765-a8e8-546aac25e418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_0f9c57b3-3716-4a53-aa64-0818c2237bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4a713c28-3354-4765-a8e8-546aac25e418" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_0f9c57b3-3716-4a53-aa64-0818c2237bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1715227a-5c41-4b23-8268-6524e1b33c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4a713c28-3354-4765-a8e8-546aac25e418" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1715227a-5c41-4b23-8268-6524e1b33c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e5228b46-008b-4de1-8d78-23dcb46fc6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e5228b46-008b-4de1-8d78-23dcb46fc6dd" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_03672f9d-d877-40d4-9f03-76db8fb6892d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f40f2ec2-99aa-4672-b57b-eeb8fb78b77e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_03672f9d-d877-40d4-9f03-76db8fb6892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3cdee320-8b3d-4b45-97c2-8775d376bae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_03672f9d-d877-40d4-9f03-76db8fb6892d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3cdee320-8b3d-4b45-97c2-8775d376bae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_07286706-1ceb-43e5-8952-116934b26f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1177e37e-a512-4925-88f6-15aae4fafbcf" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_07286706-1ceb-43e5-8952-116934b26f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_742f4014-086a-414e-938f-b342e656772a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_07286706-1ceb-43e5-8952-116934b26f6a" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_742f4014-086a-414e-938f-b342e656772a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0792cf76-54a7-42a3-95c6-6d881ab2c50a" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_905f05bb-ad75-420d-a488-4b796b9fdab9" xlink:href="mygn-20200930.xsd#mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:to="loc_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm_905f05bb-ad75-420d-a488-4b796b9fdab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_422b2d93-530c-4c8f-b324-73131c14d205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67983411-0993-4b9a-aed7-7e83de75cccb" xlink:to="loc_us-gaap_LongTermDebtFairValue_422b2d93-530c-4c8f-b324-73131c14d205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c86c5556-aeb0-45af-8351-7ae48f6cc9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c86c5556-aeb0-45af-8351-7ae48f6cc9ef" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6a6085e8-b5de-4d1e-b1cb-5aabfa82fa24" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_47d281c2-ffc2-4c58-b3da-3fa08f685816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_47d281c2-ffc2-4c58-b3da-3fa08f685816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5ff448aa-577c-4626-8f71-88de57f33881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5ff448aa-577c-4626-8f71-88de57f33881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_29c29305-a57b-406e-8a12-4026128e7d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b43e4b76-4e24-40c9-a276-66d5f64e2273" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_29c29305-a57b-406e-8a12-4026128e7d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_cba19fab-d76d-4139-9be2-a90bda15aba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_573b47fd-ac86-4048-9066-03383e681239" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_cba19fab-d76d-4139-9be2-a90bda15aba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ContingentConsiderationMember_ab02a1e1-9716-4826-aa32-e99c5f2af7ea" xlink:href="mygn-20200930.xsd#mygn_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_cba19fab-d76d-4139-9be2-a90bda15aba9" xlink:to="loc_mygn_ContingentConsiderationMember_ab02a1e1-9716-4826-aa32-e99c5f2af7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_42066729-6257-4349-bfb6-bd8c7e5a7958" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_338ae8ea-7471-4875-8ef8-b271e958fa0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_MoneyMarketFundsMember_338ae8ea-7471-4875-8ef8-b271e958fa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d9d3757f-ab7c-48c9-84a0-4cc9ffc343de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d9d3757f-ab7c-48c9-84a0-4cc9ffc343de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_a5fc4a7f-628e-4361-86f0-9bfefe8d86cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_MunicipalBondsMember_a5fc4a7f-628e-4361-86f0-9bfefe8d86cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_0d8cb35a-da2f-4f3f-bfa6-f15b12d97372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_0d8cb35a-da2f-4f3f-bfa6-f15b12d97372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_010981c7-d82c-4bce-bfa9-058abd8cd3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c7eeda87-a7c3-4154-8d45-225db5cc9851" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_010981c7-d82c-4bce-bfa9-058abd8cd3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_34fff07e-afa0-4c65-8446-bcd4a89f3d7d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3921c358-0147-4a71-95b4-3a86e32570d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3921c358-0147-4a71-95b4-3a86e32570d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6625708d-04e6-4c5d-8b84-fcbd9da39430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6625708d-04e6-4c5d-8b84-fcbd9da39430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_cbec064e-f6a8-47ad-b474-bcd5da8e183d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_300de249-dede-430e-94bb-b9e8ff9d53e9" xlink:to="loc_us-gaap_FairValueNetAssetLiability_cbec064e-f6a8-47ad-b474-bcd5da8e183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_215f66be-4584-4895-a892-f581e0560f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8ddce0d1-e0c3-4edb-b8a0-f1e0d192e93a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_215f66be-4584-4895-a892-f581e0560f0d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8ddce0d1-e0c3-4edb-b8a0-f1e0d192e93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8ddce0d1-e0c3-4edb-b8a0-f1e0d192e93a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6b0a6942-f368-4aed-bc91-1f93ab169315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6b0a6942-f368-4aed-bc91-1f93ab169315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_fcde7f02-0169-4132-a16c-d5a612c7ce2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_fcde7f02-0169-4132-a16c-d5a612c7ce2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a1a44ab2-e903-46a2-87e0-689ef9619981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a1a44ab2-e903-46a2-87e0-689ef9619981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_1eec40c1-d921-4248-a7b5-ff4668953f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_1eec40c1-d921-4248-a7b5-ff4668953f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_68d74529-4489-4c7b-bbcb-0e41826bbd16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_86d56594-6643-4ebe-a690-a05ef326712b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_68d74529-4489-4c7b-bbcb-0e41826bbd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b3a666f8-50c8-46c0-afb1-8987bb67551b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c52e4da4-040b-47f4-9bac-c0654831fed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b3a666f8-50c8-46c0-afb1-8987bb67551b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c52e4da4-040b-47f4-9bac-c0654831fed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_504ff890-cdf2-47f4-b6c2-8c115eb72f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fdc90d99-0e3e-4ddf-a114-a4f0cb8825c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_504ff890-cdf2-47f4-b6c2-8c115eb72f15" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fdc90d99-0e3e-4ddf-a114-a4f0cb8825c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6a20b10-6336-4c4f-8e0e-9b21e9fceddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_17ce6fb3-a09d-42a6-b49c-6b84b7b8dae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6a20b10-6336-4c4f-8e0e-9b21e9fceddc" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_17ce6fb3-a09d-42a6-b49c-6b84b7b8dae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_8ed40238-cdf0-4819-afe1-312fe2850181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6a20b10-6336-4c4f-8e0e-9b21e9fceddc" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_8ed40238-cdf0-4819-afe1-312fe2850181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_37e7ebf1-a1fe-439b-a54b-6a6a0dd5385d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6a20b10-6336-4c4f-8e0e-9b21e9fceddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_37e7ebf1-a1fe-439b-a54b-6a6a0dd5385d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_18e85aca-9eaf-4992-aef0-d1bc1a814d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6a20b10-6336-4c4f-8e0e-9b21e9fceddc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_18e85aca-9eaf-4992-aef0-d1bc1a814d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_090154c5-5eca-4b07-b517-7c943cdcd89c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6a20b10-6336-4c4f-8e0e-9b21e9fceddc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_090154c5-5eca-4b07-b517-7c943cdcd89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PropertyPlantandEquipmentNetDepreciationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a02e67eb-470a-49a0-b15d-ea15c4671241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e25d36ca-6582-4751-a0ce-157f44523a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a02e67eb-470a-49a0-b15d-ea15c4671241" xlink:to="loc_us-gaap_Depreciation_e25d36ca-6582-4751-a0ce-157f44523a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb9e8dcd-55dd-4672-a65d-49c42a38d2b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7c519bf7-8b48-4b60-9994-02f952a830bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb9e8dcd-55dd-4672-a65d-49c42a38d2b3" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7c519bf7-8b48-4b60-9994-02f952a830bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_523e99fd-8cc7-47fe-854e-2a0e96ec9d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_ed4d1fe7-44a5-4f85-95ca-eda8838f7b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_523e99fd-8cc7-47fe-854e-2a0e96ec9d74" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_ed4d1fe7-44a5-4f85-95ca-eda8838f7b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6391b7d0-14da-4b9f-a76c-21a6880065e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_523e99fd-8cc7-47fe-854e-2a0e96ec9d74" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6391b7d0-14da-4b9f-a76c-21a6880065e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_a6aac328-ee3d-4f4d-9ee0-efabdd67a17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_523e99fd-8cc7-47fe-854e-2a0e96ec9d74" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_a6aac328-ee3d-4f4d-9ee0-efabdd67a17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_c5a8f408-9476-439f-8c44-eb3f614c11dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_523e99fd-8cc7-47fe-854e-2a0e96ec9d74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_c5a8f408-9476-439f-8c44-eb3f614c11dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummaryofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e2ed214-cc1b-44ea-8358-991b7630fdb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e2ed214-cc1b-44ea-8358-991b7630fdb5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_46b5905c-b5cf-4b11-8a6a-667dbc2ec23a" xlink:to="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticsMember_cde58cdf-5af1-4e06-b276-8ccc928dbf53" xlink:href="mygn-20200930.xsd#mygn_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:to="loc_mygn_DiagnosticsMember_cde58cdf-5af1-4e06-b276-8ccc928dbf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_9fe749ed-5e30-4c5c-93bf-37a1b41bb2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d92b450b-2ccc-4fb9-bb8a-baf723a56d55" xlink:to="loc_us-gaap_AllOtherSegmentsMember_9fe749ed-5e30-4c5c-93bf-37a1b41bb2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9d16fe1f-434a-4244-bda1-d38bbbb5e218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_3bd6669e-8721-4167-b403-d7a754a01c23" xlink:to="loc_us-gaap_GoodwillLineItems_9d16fe1f-434a-4244-bda1-d38bbbb5e218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9d16fe1f-434a-4244-bda1-d38bbbb5e218" xlink:to="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e6731d87-ccb5-4825-b956-839d13624e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:to="loc_us-gaap_Goodwill_e6731d87-ccb5-4825-b956-839d13624e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c7ef681f-2ad6-4b85-be4d-df38477d4f8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c7ef681f-2ad6-4b85-be4d-df38477d4f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ade0b8e8-c887-418d-80e0-b3156def65c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b3016ca9-0f36-4af4-930b-1973189b65d5" xlink:to="loc_us-gaap_Goodwill_ade0b8e8-c887-418d-80e0-b3156def65c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43122675-ec15-49f4-b2f8-57116a786104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:href="mygn-20200930.xsd#mygn_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_43122675-ec15-49f4-b2f8-57116a786104" xlink:to="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_976902fd-ec0b-4631-b19f-c15f919aaead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_feff2875-80f8-46bb-a64e-815b6fab037f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_976902fd-ec0b-4631-b19f-c15f919aaead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_3561c97b-06d9-4813-a6eb-4378c5136730" xlink:href="mygn-20200930.xsd#mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_976902fd-ec0b-4631-b19f-c15f919aaead" xlink:to="loc_mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember_3561c97b-06d9-4813-a6eb-4378c5136730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3e06c9a4-281e-4bc1-97ed-feb753c4ad78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_PurchasedLicensesAndTechnologiesMember_703d8ce7-3cd1-4be1-8b65-b0bc572f8457" xlink:href="mygn-20200930.xsd#mygn_PurchasedLicensesAndTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:to="loc_mygn_PurchasedLicensesAndTechnologiesMember_703d8ce7-3cd1-4be1-8b65-b0bc572f8457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e78bb5b5-36c9-44d9-ba03-389e8f4e8bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e78bb5b5-36c9-44d9-ba03-389e8f4e8bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_1663e837-4daf-484d-b90b-b3cb3f48d2f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4ef1d62-a290-4c3f-8e2f-cfc03e2d1af2" xlink:to="loc_us-gaap_TrademarksMember_1663e837-4daf-484d-b90b-b3cb3f48d2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:href="mygn-20200930.xsd#mygn_IntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_ScheduleOfIntangibleAssetsTable_139a4e47-1fb0-475e-b64a-fc18619c5a51" xlink:to="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9445a801-0e66-4876-96bf-9c7b921a7857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9445a801-0e66-4876-96bf-9c7b921a7857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e113c4e6-e4f2-4310-80cf-07ca6c4f0a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e113c4e6-e4f2-4310-80cf-07ca6c4f0a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_42113a99-3e12-490d-98d6-aaffe9e9c76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_42113a99-3e12-490d-98d6-aaffe9e9c76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_65a4658e-aa38-488c-981b-36b6883144c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_65a4658e-aa38-488c-981b-36b6883144c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b4db5506-2963-4820-b5b8-a4c5a2b0e0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b4db5506-2963-4820-b5b8-a4c5a2b0e0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e6efa840-c01e-4e79-bcfe-3b9d633ec4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mygn_IntangibleAssetsLineItems_e0748453-2407-4f79-842c-46832c7198e5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e6efa840-c01e-4e79-bcfe-3b9d633ec4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_072dcaf4-63ba-4934-bf35-64478072ea91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_86aa30e3-c22f-4c10-869a-13e6d1881063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_072dcaf4-63ba-4934-bf35-64478072ea91" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_86aa30e3-c22f-4c10-869a-13e6d1881063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_f438a9ab-074a-420d-b362-ab9f416c0c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_366f829d-4cb1-49dc-b645-cf856b3ba8e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f438a9ab-074a-420d-b362-ab9f416c0c65" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_366f829d-4cb1-49dc-b645-cf856b3ba8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_2e084429-2838-41c3-bc38-538727322976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_881598df-057d-4687-bbdf-f815c80aa2e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_2e084429-2838-41c3-bc38-538727322976" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_881598df-057d-4687-bbdf-f815c80aa2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_1e4d95f8-095b-4130-9b8b-4633ea28fb51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_533cd1ed-7a20-42a7-a203-c1fac8f25bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1e4d95f8-095b-4130-9b8b-4633ea28fb51" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_533cd1ed-7a20-42a7-a203-c1fac8f25bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_1c7e3fd9-3a40-464e-be9d-d84c3d262642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1e4d95f8-095b-4130-9b8b-4633ea28fb51" xlink:to="loc_us-gaap_TaxesPayableCurrent_1c7e3fd9-3a40-464e-be9d-d84c3d262642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2b372257-e4e0-46a2-92fe-c33730292231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1e4d95f8-095b-4130-9b8b-4633ea28fb51" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2b372257-e4e0-46a2-92fe-c33730292231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7a2a7e96-8a48-463c-8725-7d8e3a3557a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1e4d95f8-095b-4130-9b8b-4633ea28fb51" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7a2a7e96-8a48-463c-8725-7d8e3a3557a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebt" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_84fc25ba-efbb-499a-8978-766bfffddcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_0fe3d079-1517-42af-951c-4d854f4ac50d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_84fc25ba-efbb-499a-8978-766bfffddcd4" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_0fe3d079-1517-42af-951c-4d854f4ac50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f6b70f23-fb24-4d80-bfb8-a8eee99e8e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3b609cf1-477d-4dbc-a35a-289627b3b1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f6b70f23-fb24-4d80-bfb8-a8eee99e8e4a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3b609cf1-477d-4dbc-a35a-289627b3b1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a314d0df-bd05-4240-9461-b29452a9644a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a314d0df-bd05-4240-9461-b29452a9644a" xlink:to="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c504c8a7-ae26-4226-9942-41ed5908d5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7588cff4-cc8b-4a31-bd7d-55df68deaccb" xlink:to="loc_us-gaap_CreditFacilityDomain_c504c8a7-ae26-4226-9942-41ed5908d5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_519ff859-3e92-4727-bab0-314d9a893d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c504c8a7-ae26-4226-9942-41ed5908d5bf" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_519ff859-3e92-4727-bab0-314d9a893d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_643fb40f-c3e2-4317-a553-6129a8da954e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_51e07433-e71d-422d-adba-4a844b98c4c3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_643fb40f-c3e2-4317-a553-6129a8da954e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_AmendmentToCreditAgreementMember_cd9f714d-cbf2-4c1d-b3d3-43e9390a6939" xlink:href="mygn-20200930.xsd#mygn_AmendmentToCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_643fb40f-c3e2-4317-a553-6129a8da954e" xlink:to="loc_mygn_AmendmentToCreditAgreementMember_cd9f714d-cbf2-4c1d-b3d3-43e9390a6939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_932cb430-a952-4a73-b3ac-a4c1ce630d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_a690b69c-37ef-48e6-924e-82d770903ce6" xlink:to="loc_us-gaap_VariableRateDomain_932cb430-a952-4a73-b3ac-a4c1ce630d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d29af574-f25b-4800-abc6-40d9851829b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_932cb430-a952-4a73-b3ac-a4c1ce630d06" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d29af574-f25b-4800-abc6-40d9851829b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c47b35f3-2cf2-4216-80da-23b62873c350" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a0eb0805-67ec-4411-a445-c404cda4dd13" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c47b35f3-2cf2-4216-80da-23b62873c350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2b293bd6-3e83-4c9b-8c7d-8f47e42f8539" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_c47b35f3-2cf2-4216-80da-23b62873c350" xlink:to="loc_srt_ScenarioForecastMember_2b293bd6-3e83-4c9b-8c7d-8f47e42f8539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3e7ea109-9969-447d-a3ec-930058d1381a" xlink:to="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2617788e-3e67-4ac2-8ebe-d4c7928d86f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:to="loc_srt_MinimumMember_2617788e-3e67-4ac2-8ebe-d4c7928d86f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d5919ac-f437-4fc5-8f03-655ba8fc5156" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4429f7e4-e8df-4710-8fe0-ddebb2ba5a7f" xlink:to="loc_srt_MaximumMember_2d5919ac-f437-4fc5-8f03-655ba8fc5156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfc0e660-b2fe-4e22-85e0-30679c87755f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_4a3c24e5-b343-44aa-8957-48203d067879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_4a3c24e5-b343-44aa-8957-48203d067879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9bdb7954-0469-4d4c-a718-55f5efdf5fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9bdb7954-0469-4d4c-a718-55f5efdf5fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_545f7189-5981-4735-bc7d-f560f63869eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_545f7189-5981-4735-bc7d-f560f63869eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_5adb8622-18a6-487e-bdef-ff218b451b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_5adb8622-18a6-487e-bdef-ff218b451b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_48fe3dc1-0f48-4eb8-aaf5-667a9e354fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross_48fe3dc1-0f48-4eb8-aaf5-667a9e354fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7cc6591e-72df-4375-9ff5-b0f30c42618a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LongTermDebt_7cc6591e-72df-4375-9ff5-b0f30c42618a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_fd002df8-932b-4122-babc-bc3a0e225861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_fd002df8-932b-4122-babc-bc3a0e225861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5d0ed0ac-5e5a-4c86-ad57-850483fa6912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5d0ed0ac-5e5a-4c86-ad57-850483fa6912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b472078f-0b50-4b79-b59c-fc915fdbbcbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b472078f-0b50-4b79-b59c-fc915fdbbcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DebtInstrumentLIBORFloorPercentage_a14e5e27-31b0-4d00-9fbe-758a5978b7f8" xlink:href="mygn-20200930.xsd#mygn_DebtInstrumentLIBORFloorPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_mygn_DebtInstrumentLIBORFloorPercentage_a14e5e27-31b0-4d00-9fbe-758a5978b7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_307f640e-4fbd-48e9-bb09-cb6301f89a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e5d214a-5b3b-4e4c-ba2e-210350a242ef" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_307f640e-4fbd-48e9-bb09-cb6301f89a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b6bb35e3-1521-4e18-84f5-6891d8db7d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_4cf3d9f8-367f-4e26-adbd-da420d455ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b6bb35e3-1521-4e18-84f5-6891d8db7d49" xlink:to="loc_us-gaap_LongTermDebtAbstract_4cf3d9f8-367f-4e26-adbd-da420d455ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8c123207-1d55-48b1-b7f5-acf573409918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_4cf3d9f8-367f-4e26-adbd-da420d455ec6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8c123207-1d55-48b1-b7f5-acf573409918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_ad091c4e-e423-4719-bf79-919dc92e5476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_4cf3d9f8-367f-4e26-adbd-da420d455ec6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_ad091c4e-e423-4719-bf79-919dc92e5476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1b2bb6a7-6ff0-4282-93b8-048663f1c606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_4cf3d9f8-367f-4e26-adbd-da420d455ec6" xlink:to="loc_us-gaap_LongTermDebt_1b2bb6a7-6ff0-4282-93b8-048663f1c606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilities"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239a159d-41fe-4391-9a4c-4ecad4a4fc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_632b971d-1293-465d-833e-cdd187983e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_239a159d-41fe-4391-9a4c-4ecad4a4fc91" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_632b971d-1293-465d-833e-cdd187983e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5efbca74-7666-4222-a08f-825cd03ac3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_42682dd3-202e-40f4-a2bf-ecccd91af16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5efbca74-7666-4222-a08f-825cd03ac3d9" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_42682dd3-202e-40f4-a2bf-ecccd91af16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#OtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/OtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_125c348f-acfa-4e3a-ad13-5da417dc53f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_100f5c6b-7028-41db-bcce-a664408faee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_125c348f-acfa-4e3a-ad13-5da417dc53f0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_100f5c6b-7028-41db-bcce-a664408faee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_93c4c772-e4b0-4770-9f37-dc01716c1eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_125c348f-acfa-4e3a-ad13-5da417dc53f0" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_93c4c772-e4b0-4770-9f37-dc01716c1eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_40752f1f-8e5d-48e8-b325-7d96a30a2df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_125c348f-acfa-4e3a-ad13-5da417dc53f0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_40752f1f-8e5d-48e8-b325-7d96a30a2df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4375ffe7-c1eb-457a-b65a-b761b0c31061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8a06f359-be53-48f5-a19d-e3bc1ddd6696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4375ffe7-c1eb-457a-b65a-b761b0c31061" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8a06f359-be53-48f5-a19d-e3bc1ddd6696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1021d721-1f15-4cc3-9e30-4fb3dec5b673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_19b63adc-7391-4312-8851-2c3db231fd79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1021d721-1f15-4cc3-9e30-4fb3dec5b673" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_19b63adc-7391-4312-8851-2c3db231fd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_00e92655-c136-425e-a444-f3d84809203a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1021d721-1f15-4cc3-9e30-4fb3dec5b673" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_00e92655-c136-425e-a444-f3d84809203a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0244d412-b4a2-43f2-a053-bc0b09d89fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1021d721-1f15-4cc3-9e30-4fb3dec5b673" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0244d412-b4a2-43f2-a053-bc0b09d89fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8d1bc7e0-3e41-4156-89f2-50c20a204a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d1bc7e0-3e41-4156-89f2-50c20a204a73" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f0a63708-9488-4214-bbf6-bc576eac865f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_877a581a-fe0f-4c25-a7db-466ff3d27d19" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f0a63708-9488-4214-bbf6-bc576eac865f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EighthShareRepurchaseProgramMember_b663c01d-9a07-449a-a6c5-24a08d2e25dc" xlink:href="mygn-20200930.xsd#mygn_EighthShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f0a63708-9488-4214-bbf6-bc576eac865f" xlink:to="loc_mygn_EighthShareRepurchaseProgramMember_b663c01d-9a07-449a-a6c5-24a08d2e25dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d4ab7b47-9b93-421e-87bc-f60843c038d7" xlink:to="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_da319fac-5673-4f81-a4b6-2019789b5230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_da319fac-5673-4f81-a4b6-2019789b5230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6fc4ba5c-09a9-4999-9efc-d065855063cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6fc4ba5c-09a9-4999-9efc-d065855063cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_2b7df0dc-e41d-4416-99e5-60526c2cfdb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_2b7df0dc-e41d-4416-99e5-60526c2cfdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b6e5d3d8-8803-432a-903c-51464c951ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b6e5d3d8-8803-432a-903c-51464c951ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a473d60c-36c3-4355-a1eb-5f4f23d112da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a473d60c-36c3-4355-a1eb-5f4f23d112da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_75f51520-aed4-4d4f-b01f-683e609a580d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockSharesIssued_75f51520-aed4-4d4f-b01f-683e609a580d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc59025a-43cd-4867-9914-976e9ee568e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc59025a-43cd-4867-9914-976e9ee568e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_33a0bc6a-c546-4ab2-ada6-ce825c72e6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_33a0bc6a-c546-4ab2-ada6-ce825c72e6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_55066432-19f9-4f1c-8169-923023f635a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_55066432-19f9-4f1c-8169-923023f635a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_83b1aed0-1284-4e37-8cef-fc34fb6a8871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_30fe48d0-f988-4191-9de2-e015ca2f6fab" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_83b1aed0-1284-4e37-8cef-fc34fb6a8871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e6a5b59f-db7c-439a-82db-7a397783ef4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e6a5b59f-db7c-439a-82db-7a397783ef4e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_170ac9fc-e1cc-4e9c-b369-11795c521fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:to="loc_us-gaap_CommonStockSharesIssued_170ac9fc-e1cc-4e9c-b369-11795c521fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc3dc202-72ce-4db2-afd9-bb0a361b21e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc3dc202-72ce-4db2-afd9-bb0a361b21e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_bc610eed-e2bb-4189-ac40-9bec00d70c55" xlink:href="mygn-20200930.xsd#mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:to="loc_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans_bc610eed-e2bb-4189-ac40-9bec00d70c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3addc18c-91d4-450d-ad5c-4e9b09e0ea54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:to="loc_us-gaap_CommonStockSharesIssued_3addc18c-91d4-450d-ad5c-4e9b09e0ea54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_27fb0082-515b-4b65-bd3e-0dc7d1f8ec2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be45d404-f338-4c37-ab60-9a470d15b058" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_27fb0082-515b-4b65-bd3e-0dc7d1f8ec2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dded945f-ca3c-4810-80ca-a8a37ef258a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f3a30001-777e-4f40-9cf3-edd6adf46aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dded945f-ca3c-4810-80ca-a8a37ef258a9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f3a30001-777e-4f40-9cf3-edd6adf46aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_335e2eb2-e33b-4627-90f9-33d1af06d007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dded945f-ca3c-4810-80ca-a8a37ef258a9" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_335e2eb2-e33b-4627-90f9-33d1af06d007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_50d9b479-fc9a-4f01-b30d-885cdceb597f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dded945f-ca3c-4810-80ca-a8a37ef258a9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_50d9b479-fc9a-4f01-b30d-885cdceb597f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_473cac02-1aef-448f-90c0-116fe093b96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0d99319-2ecd-4cfe-ab0d-8bc415360422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_473cac02-1aef-448f-90c0-116fe093b96b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0d99319-2ecd-4cfe-ab0d-8bc415360422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6396e245-f700-4475-b545-a3b74fb141da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5ad87ef1-4463-4cc4-8e43-17b418b7f852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6396e245-f700-4475-b545-a3b74fb141da" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5ad87ef1-4463-4cc4-8e43-17b418b7f852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98af48b4-732d-4956-9874-2c93cac782db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5fa54b60-0136-431a-b748-1920fff914a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98af48b4-732d-4956-9874-2c93cac782db" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5fa54b60-0136-431a-b748-1920fff914a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_24381c4e-3c2d-402a-aa36-e233b9ac81b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98af48b4-732d-4956-9874-2c93cac782db" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_24381c4e-3c2d-402a-aa36-e233b9ac81b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a3d5db64-7305-43e2-a33c-b90b89a076f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98af48b4-732d-4956-9874-2c93cac782db" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a3d5db64-7305-43e2-a33c-b90b89a076f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fbf6b68c-78f9-4b04-bb00-7075d4ebbc5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fbf6b68c-78f9-4b04-bb00-7075d4ebbc5a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ad53cb7e-1d41-4b11-8363-8d58632d917a" xlink:to="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_4c601e6b-be97-4a65-825d-92748372ff38" xlink:href="mygn-20200930.xsd#mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:to="loc_mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember_4c601e6b-be97-4a65-825d-92748372ff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_d4bb7b80-c09a-473e-b01c-597fcf62cb49" xlink:href="mygn-20200930.xsd#mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:to="loc_mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember_d4bb7b80-c09a-473e-b01c-597fcf62cb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f4f4b69b-020a-472b-ad8b-95e9b147080c" xlink:href="mygn-20200930.xsd#mygn_EmployeeStockPurchasePlanTwentyTwelveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6ea8c109-4b8e-46bb-9e2d-03e819e7d980" xlink:to="loc_mygn_EmployeeStockPurchasePlanTwentyTwelveMember_f4f4b69b-020a-472b-ad8b-95e9b147080c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_86040494-9bde-4d5c-9a71-212dad81577a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_eda1fa96-3bee-4a58-a3a0-6d2132664c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:to="loc_us-gaap_EmployeeStockOptionMember_eda1fa96-3bee-4a58-a3a0-6d2132664c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4572a805-13df-4dc2-8421-f30093ddaeed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4572a805-13df-4dc2-8421-f30093ddaeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsAndRestrictedStockUnitsMember_c4cf31d1-a6a0-442c-ab4d-3f8f8b1c4032" xlink:href="mygn-20200930.xsd#mygn_OptionsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_47590d3a-29d3-4b11-841e-a1b4f15ce039" xlink:to="loc_mygn_OptionsAndRestrictedStockUnitsMember_c4cf31d1-a6a0-442c-ab4d-3f8f8b1c4032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_ac28a8e4-8ee8-46b7-bdcf-235f93a737d6" xlink:to="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_31ac00a1-6f9d-426b-8204-8e5aa1f18edc" xlink:href="mygn-20200930.xsd#mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:to="loc_mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember_31ac00a1-6f9d-426b-8204-8e5aa1f18edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_72015f31-3c7a-4c78-847c-9edc43665235" xlink:href="mygn-20200930.xsd#mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_8aeb4205-062a-43f2-8547-de522f6f4ea0" xlink:to="loc_mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember_72015f31-3c7a-4c78-847c-9edc43665235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7683ebff-abd5-460d-8539-f093ede7dcae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_cfa3f221-9712-41a1-90f3-e27212a01503" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7683ebff-abd5-460d-8539-f093ede7dcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_NonEmployeeDirectorMember_6de6af73-f424-4f16-9df2-2e3d4c8e3b26" xlink:href="mygn-20200930.xsd#mygn_NonEmployeeDirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7683ebff-abd5-460d-8539-f093ede7dcae" xlink:to="loc_mygn_NonEmployeeDirectorMember_6de6af73-f424-4f16-9df2-2e3d4c8e3b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9279f685-82ec-4d37-8fc0-fd2e6fadb227" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_eff584af-5e6a-472d-83ee-840ba235af41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_eff584af-5e6a-472d-83ee-840ba235af41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75c48422-8c55-4fed-9208-6e81274e625a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75c48422-8c55-4fed-9208-6e81274e625a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_afbaec68-4981-4116-8913-2e36e3190ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_afbaec68-4981-4116-8913-2e36e3190ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_60fd687a-ceb6-4c90-bb1a-0f8b5fbd0766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_60fd687a-ceb6-4c90-bb1a-0f8b5fbd0766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e579974a-e59e-452a-8626-4e708be985b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e579974a-e59e-452a-8626-4e708be985b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c285acb-882c-4554-bdea-13a3e3f369ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0c285acb-882c-4554-bdea-13a3e3f369ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a507a414-eeac-43fd-a394-c8d9ef134670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a507a414-eeac-43fd-a394-c8d9ef134670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_43d87044-2b51-4aae-8de4-f71f9e7d3d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48c34058-d3f8-4aa9-866e-ad2547c61b2e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_43d87044-2b51-4aae-8de4-f71f9e7d3d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aec9f76e-94c2-4967-b735-8e8752e7362a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aec9f76e-94c2-4967-b735-8e8752e7362a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1253560-dce8-49e2-a591-f1d86ce50e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d1253560-dce8-49e2-a591-f1d86ce50e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8ad4efd6-2a99-4152-85bd-15e2dffb6fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8ad4efd6-2a99-4152-85bd-15e2dffb6fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2842a2c1-6ceb-49dd-8c59-15f6f6178729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2842a2c1-6ceb-49dd-8c59-15f6f6178729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_a7cbbdb3-ba8d-4aed-ab8c-f8f78e37639e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_a7cbbdb3-ba8d-4aed-ab8c-f8f78e37639e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60a0b5e9-e52d-4465-811e-0dc06a4a8e90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60a0b5e9-e52d-4465-811e-0dc06a4a8e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d2ec1453-9a53-4b8b-ab30-1af3aca7c9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd7fcc32-22e3-4560-b1c3-77fce886eddb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d2ec1453-9a53-4b8b-ab30-1af3aca7c9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aec9f76e-94c2-4967-b735-8e8752e7362a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_895101a4-870f-4f15-aabe-658f3a1b85fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_895101a4-870f-4f15-aabe-658f3a1b85fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3187e1c7-f5b1-451e-bed7-6a1f10ab3660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3187e1c7-f5b1-451e-bed7-6a1f10ab3660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_16bad4f6-5e3e-444c-b7a8-b8d0d01393e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_16bad4f6-5e3e-444c-b7a8-b8d0d01393e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8887f892-d934-4c7b-af26-13f406a55a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8887f892-d934-4c7b-af26-13f406a55a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f8776d63-6ba8-41f1-aad5-e2106e1069c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f8776d63-6ba8-41f1-aad5-e2106e1069c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_837b4fc1-5f77-4655-8154-bb69ac47f4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e1ac8279-b2f1-42f4-9f7e-52b6ed520f75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_837b4fc1-5f77-4655-8154-bb69ac47f4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_590d8e4c-9ad5-4795-9863-05a0093c5c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_590d8e4c-9ad5-4795-9863-05a0093c5c58" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:to="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_204d2ad3-fa51-4559-b8fb-ef8418d5382f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9322723a-d02b-42c7-83e0-b5738699746f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_204d2ad3-fa51-4559-b8fb-ef8418d5382f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_53c14510-70f3-4163-abff-989950c90160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_204d2ad3-fa51-4559-b8fb-ef8418d5382f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_53c14510-70f3-4163-abff-989950c90160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15f9066c-cf1c-4105-b9bf-66ed989c3426" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddfac1c5-1f74-4646-9afc-143263578d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ddfac1c5-1f74-4646-9afc-143263578d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb1af532-d5a9-4e5e-880a-0c528053201b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb1af532-d5a9-4e5e-880a-0c528053201b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2f495240-6e9d-4b4b-a56a-638d7a860ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2f495240-6e9d-4b4b-a56a-638d7a860ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_03de6d15-96ae-4a07-b163-fe2ce982fdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_03de6d15-96ae-4a07-b163-fe2ce982fdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c868e29c-5e6e-4866-a943-1f863e655c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_278e5607-c913-4ace-80e6-7482b97696b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c868e29c-5e6e-4866-a943-1f863e655c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_502ef058-c0e0-4a65-893c-c37478aabe41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfc6c07e-ce99-4c15-837c-13e7d14e589d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dfc6c07e-ce99-4c15-837c-13e7d14e589d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84d12d01-c4c2-49e3-95fd-e25eec61f98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84d12d01-c4c2-49e3-95fd-e25eec61f98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_208c7bb7-d8ef-46bb-934c-69625ed87208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_208c7bb7-d8ef-46bb-934c-69625ed87208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6fab7486-48af-4669-8cd0-2b813b47b34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6fab7486-48af-4669-8cd0-2b813b47b34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dd65be62-7e3d-4345-8bf3-2a1fc155da71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a878edb9-6aa4-4aff-adba-40a2c5d98491" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dd65be62-7e3d-4345-8bf3-2a1fc155da71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b72782-cb92-4484-b7ed-8f1d9e70b5a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7b72782-cb92-4484-b7ed-8f1d9e70b5a7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28be2b5b-4c4a-4166-9a17-c08b2b72e8c8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfMolecularDiagnosticTestingMember_f12ca616-1852-4cf1-ac9a-6d60736bb295" xlink:href="mygn-20200930.xsd#mygn_CostOfMolecularDiagnosticTestingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_mygn_CostOfMolecularDiagnosticTestingMember_f12ca616-1852-4cf1-ac9a-6d60736bb295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_5ca4a03c-2731-43bf-ba0b-bbd45fa04c2c" xlink:href="mygn-20200930.xsd#mygn_CostOfPharmaceuticalAndClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_mygn_CostOfPharmaceuticalAndClinicalServicesMember_5ca4a03c-2731-43bf-ba0b-bbd45fa04c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b6069438-062c-4bf7-bf85-dbe1a88fd528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b6069438-062c-4bf7-bf85-dbe1a88fd528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b8f0b184-0274-49a5-a2d3-774de6ba2ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7089c462-cbb6-4bd6-8b94-fb002a3993bd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b8f0b184-0274-49a5-a2d3-774de6ba2ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b17b2d81-1649-403c-89c6-f131d958ae24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1664f09a-2a22-4566-851a-e57ab0ca4d53" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b17b2d81-1649-403c-89c6-f131d958ae24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ed4fcf3b-43c2-4c9e-a231-0dfc85f38135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b17b2d81-1649-403c-89c6-f131d958ae24" xlink:to="loc_us-gaap_ShareBasedCompensation_ed4fcf3b-43c2-4c9e-a231-0dfc85f38135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mygn-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7905fc39-56af-46f8-9742-7e3bc0cd27b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_223033c0-0765-4bfa-85e2-d77fbe9aaed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7905fc39-56af-46f8-9742-7e3bc0cd27b0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_223033c0-0765-4bfa-85e2-d77fbe9aaed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_aa04babd-533f-4159-a3b7-085183a70c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aa04babd-533f-4159-a3b7-085183a70c5a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_45e9b987-d076-432c-b7cc-2c207fbd1922" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_b2655cf8-e95b-425a-88c2-1605db8e664a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_b2655cf8-e95b-425a-88c2-1605db8e664a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_8506e01f-346d-4321-be4d-7418df9cd08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1b1386e1-a988-445f-8ffd-3e7f5012031f" xlink:to="loc_us-gaap_ForeignCountryMember_8506e01f-346d-4321-be4d-7418df9cd08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5349baf8-b8b6-4edb-9758-8c566c45bfe5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember_e080cadc-322a-4ff5-a8c7-11dd924382d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_NewJerseyDivisionOfTaxationMember_e080cadc-322a-4ff5-a8c7-11dd924382d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_3cef50c2-591d-4c2a-abda-2decda7c93cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_3cef50c2-591d-4c2a-abda-2decda7c93cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_MassachusettsDepartmentOfRevenueMember_aa144804-88b9-4065-a467-266400b998a6" xlink:href="mygn-20200930.xsd#mygn_MassachusettsDepartmentOfRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_mygn_MassachusettsDepartmentOfRevenueMember_aa144804-88b9-4065-a467-266400b998a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_ba4a273b-136b-4004-8e83-1e07a2e776b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalMinistryOfFinanceGermanyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_FederalMinistryOfFinanceGermanyMember_ba4a273b-136b-4004-8e83-1e07a2e776b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_863d2e11-1fd8-4ce3-a3fb-622354c0ef14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SwissFederalTaxAdministrationFTAMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d68c9013-1a0d-48ca-aa4b-1dce176055e7" xlink:to="loc_us-gaap_SwissFederalTaxAdministrationFTAMember_863d2e11-1fd8-4ce3-a3fb-622354c0ef14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_54d00172-1cd8-4f96-b97e-792facabef5c" xlink:to="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_e391e0d1-54c5-4a48-853b-da1ccd076837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:to="loc_us-gaap_EarliestTaxYearMember_e391e0d1-54c5-4a48-853b-da1ccd076837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_1a5bd371-1ade-493d-827b-875c14d39197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_80f34731-df90-498e-bdf9-96cd58b8d6b9" xlink:to="loc_us-gaap_LatestTaxYearMember_1a5bd371-1ade-493d-827b-875c14d39197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_14bdb244-40ff-46c8-bd36-5f06bd32e85a" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8908804e-78b1-4521-9cf5-c59e5d4b12df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8908804e-78b1-4521-9cf5-c59e5d4b12df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_38ddd6b2-f58a-4710-83cc-f655772b9f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_38ddd6b2-f58a-4710-83cc-f655772b9f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_IncomeTaxExpenseBenefitCARESAct_4f505aa1-b60a-400c-8892-65ec203c51e3" xlink:href="mygn-20200930.xsd#mygn_IncomeTaxExpenseBenefitCARESAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_mygn_IncomeTaxExpenseBenefitCARESAct_4f505aa1-b60a-400c-8892-65ec203c51e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_1a2f7b2f-c02b-41c5-9f70-f0c1e4fad373" xlink:href="mygn-20200930.xsd#mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct_1a2f7b2f-c02b-41c5-9f70-f0c1e4fad373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_99102280-f765-4044-b641-d1fab27210c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_be90d64d-6931-44d9-8fdc-a24509f0bb75" xlink:to="loc_us-gaap_IncomeTaxExaminationYearUnderExamination_99102280-f765-4044-b641-d1fab27210c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mygn-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cfc1d0d9-9039-4e8e-a374-fc45dcaf7312" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3e236293-a15a-4a9b-a495-2e38794ff4d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cfc1d0d9-9039-4e8e-a374-fc45dcaf7312" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3e236293-a15a-4a9b-a495-2e38794ff4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_325db061-afdd-41ff-a03d-2c6f75e6611f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_245db67c-9464-4755-8239-9b4ed0080308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_325db061-afdd-41ff-a03d-2c6f75e6611f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_245db67c-9464-4755-8239-9b4ed0080308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5919de8c-6c80-4cb5-a6b9-50b45b678dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_079539c5-abfc-487e-a41a-a73c94002b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5919de8c-6c80-4cb5-a6b9-50b45b678dd6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_079539c5-abfc-487e-a41a-a73c94002b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b8a5e3d2-e354-4a61-98cc-aa99e6299794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a70cd497-a026-49ac-8309-0c3e58184901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8a5e3d2-e354-4a61-98cc-aa99e6299794" xlink:to="loc_us-gaap_NumberOfReportableSegments_a70cd497-a026-49ac-8309-0c3e58184901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ef69a0e3-d88b-495c-a2cc-bec8dbbab2ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ef69a0e3-d88b-495c-a2cc-bec8dbbab2ce" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6a5a8716-0a77-493c-991c-759f3d02dcb1" xlink:to="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_DiagnosticsMember_afedfca8-0b45-4354-8697-90adb4d2f8fc" xlink:href="mygn-20200930.xsd#mygn_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:to="loc_mygn_DiagnosticsMember_afedfca8-0b45-4354-8697-90adb4d2f8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b1a80d45-c519-48e5-bc4b-af8ea279a7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4f1f717b-c499-4eda-b813-45ac8bd1d100" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b1a80d45-c519-48e5-bc4b-af8ea279a7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cf3a5257-3310-47c8-869c-03bc394edc31" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fef6ac31-823c-452b-b518-3cb4772feeee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fef6ac31-823c-452b-b518-3cb4772feeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_77bd42d1-6b42-4613-be89-2a2139e8bdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_DepreciationAndAmortization_77bd42d1-6b42-4613-be89-2a2139e8bdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0d271f3-6986-4f95-9ce0-20a80fa01af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_93fc42a4-f57b-4e03-af55-7ffa40e588f1" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0d271f3-6986-4f95-9ce0-20a80fa01af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_06c1dee3-3c5f-4905-b27a-bd39f0a2428c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_OperatingIncomeLoss_06c1dee3-3c5f-4905-b27a-bd39f0a2428c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0f58fdfe-761a-431d-9e41-fe1b6f982e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0f58fdfe-761a-431d-9e41-fe1b6f982e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bad1ecbc-759a-4f77-88b0-7aacd4bc9152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_InterestExpense_bad1ecbc-759a-4f77-88b0-7aacd4bc9152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6cbc1d8d-1eae-45a2-ad33-c26787ec30e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6cbc1d8d-1eae-45a2-ad33-c26787ec30e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c169ba4a-e92b-407e-b15b-2cd4aaa07bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c169ba4a-e92b-407e-b15b-2cd4aaa07bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f5117250-dd01-4ce1-901e-26e522334c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f5117250-dd01-4ce1-901e-26e522334c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c4d60a44-5dea-4569-b09c-abbc10c6b2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_ProfitLoss_c4d60a44-5dea-4569-b09c-abbc10c6b2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f3db420b-455c-461b-932f-762b13782860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f3db420b-455c-461b-932f-762b13782860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18888eac-1748-4800-bb6c-150224ca37b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31d6ea65-36a5-4b92-8b06-163103027355" xlink:to="loc_us-gaap_NetIncomeLoss_18888eac-1748-4800-bb6c-150224ca37b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_38dde1a6-8922-47fc-b6a1-92732d5079f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_5542af81-3f15-4d6a-9097-49a3dc17c883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_38dde1a6-8922-47fc-b6a1-92732d5079f9" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_5542af81-3f15-4d6a-9097-49a3dc17c883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_72f26123-e529-474f-8a64-38bb8499d15b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c00e1583-bf72-4296-8cc6-fafcafe54a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_72f26123-e529-474f-8a64-38bb8499d15b" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c00e1583-bf72-4296-8cc6-fafcafe54a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mygn-20200930.xsd#SupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_ee860389-dcd6-48e3-ba4c-43e3e8209d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_ee860389-dcd6-48e3-ba4c-43e3e8209d16" xlink:to="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_853a5222-b098-483c-b9b1-e2412f640cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bea7fca0-65dd-417d-a3a0-45ac37ee8452" xlink:to="loc_us-gaap_TypeOfAdoptionMember_853a5222-b098-483c-b9b1-e2412f640cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_ba108952-e089-47b3-bea5-0b35ee2e5b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_853a5222-b098-483c-b9b1-e2412f640cec" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_ba108952-e089-47b3-bea5-0b35ee2e5b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_76918102-e155-4fcf-a14e-e11db4329d2f" xlink:to="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_f5e3bc4d-0c8f-468f-8234-1b6e7e8671d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_IncomeTaxesPaid_f5e3bc4d-0c8f-468f-8234-1b6e7e8671d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_faec32db-6cd1-4afb-9e48-3bdc1120315d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_InterestPaidNet_faec32db-6cd1-4afb-9e48-3bdc1120315d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_519a5b7f-12ef-4dbe-a161-5519b332033e" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ef1f9162-8c1e-467b-9d02-aa4432453445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ef1f9162-8c1e-467b-9d02-aa4432453445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mygn_OperatingLeaseLiabilityEstablished_e5dfc63e-c871-44d8-af3c-3fba0e6400b9" xlink:href="mygn-20200930.xsd#mygn_OperatingLeaseLiabilityEstablished"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:to="loc_mygn_OperatingLeaseLiabilityEstablished_e5dfc63e-c871-44d8-af3c-3fba0e6400b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_10758c23-1b88-4c09-804a-a582a98ce855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c24bd9b4-6288-4aba-891e-168cbf7bf01f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_10758c23-1b88-4c09-804a-a582a98ce855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.myriad.com/role/SubsequentEvents" xlink:type="simple" xlink:href="mygn-20200930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.myriad.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_74d04090-d580-43ce-b42f-272aa4364a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_9e8e5b7f-9959-4329-8ad6-ae977303722c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_74d04090-d580-43ce-b42f-272aa4364a22" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_9e8e5b7f-9959-4329-8ad6-ae977303722c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>mygn-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mygn="http://www.myriad.com/20200930"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mygn-20200930.xsd" xlink:type="simple"/>
    <context id="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i912f7c983e734c25aaf08678ad9b5ec8_I20201102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2020-11-02</instant>
        </period>
    </context>
    <context id="i5fe991d524ac4629ab0f930806f7c992_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iff8a54753cc14cc7995dfd3ffab42f61_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6234236191e840b3ba0820dd275841bf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0afd5266f1674cd890c5e822e8608051_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i60c68c3b6a064506b03ca32fad5428a0_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6b5f2e721cba4626be7e73ae2f98f5be_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i645c55a2b3c240cc83b60c6876b52044_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i139906c1954e43c39560efe073ca515b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0e44f0801a764c629e60704da55af897_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i74aa2b09d6d7450b992f13f174e86815_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5c0dc32b94684fb9a72074a4467ddbb3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iac1b61b427d34cd1aee1ba7384109a9d_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i091efe167f3c4e1da67fb808d46a17cf_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iacae5069b54f4a67b0357cd8ef5efb1a_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i25198efed29e4e92b99f0262f821c2d3_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i61a8af6463ab4c92ba4435534752e1a2_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7ccc458b8fab4e1aaf73e23ed8876645_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib1b31638ad944d72af7bea5c92686dee_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i005afd72b0d346de9ebc794edf8af44d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if3201828072042f8be79031422bab5b1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie8725d74790d48458cfdfa6233888a31_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i82a7856a26e14144a676ceba1c64446a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaedb6702dab54acfb883a731f04b482f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2efecfeca2f34c238cfefcdb778c6425_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i160b5ebaf0a348a6bf32eaa61276f655_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i877b14486ab2428ba1f01ad23fccb179_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i64095d8f93a94fbeb281e9c293c679a9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i055da3a2d6c44d7597f0360c7843f5ff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie1795c5c48c34f16b22b8ae598cdd22a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id178ba580c6f4185bc51f217377478d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifcedbfd8cc754e8492395b6e8c733e64_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9bfb911643b349c899f841b445e06512_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i422deb02b92f488ca820658db810b31a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i401a6d1f82534405a2c00ba1f907da60_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticHereditaryCancerTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieb347fa85ae744768f8361fb2ca325eb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i200b85a83c6a46bbabdea8dcc39d8562_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic51c9413854143499e5aaf57989d7eb7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3348c1dccc754570a3090cd6065878a9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7687ee73ec6a4a2fb7d9c3c95f5ed679_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i08483a8a185e4dfb9ae69070970276d7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticPrenatalTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i951685b4432940a2b6070e5ae3bd49a5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6744579210784fdeb06463912c24a193_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7fd0de429b834c25b696cffe376cd572_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8769527161654967b1c9d612b500e5bf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7a7219c652fa40129553545f083b6ffd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i45fc867c897b4386aeaf67795c276626_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticGenesightTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9fad8fd2ba87493e8cae157d3442bae9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0bfa2d578a84425184f03060039d64fd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic2742d972b9a4d7fbbde1e0bbed5c74e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i74596ec49a7a4ebe83e5358874b6f8b1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic3644e7dfea0400597ac774c4595f9c1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia3668121649b4395acd610e7f38044b8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticVectraTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id62e373c9cfa4d13b74004a4f087e81d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3af57be3ac8745b59d1c5c8f835c759c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibca7cd2a9ed64068a730c3d0940649c7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2228b67d6e046568399abed69752b24_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad0b089eccab490aa3d7e32307f073dc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7cc249590a16407aa43f1bcdf46a5e5c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticMyChoiceCDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5dad84e61a5648f68b1f50c0b983bede_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7033a2b43a11471a8ee110193d73fa2b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22d3d58394a04580baac5d76d025fa35_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2bf5e0d1693441a18f30a9d95fe4163b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i67246cad5fa34d69b25bfc809dd1c777_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i567a2a9416d34f3c92557d9422f0348b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticProlarisTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8ebbd429b95f49139bb9281a342136de_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i484f743506ee4902aef30c20d43aa898_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i280ce449a5d6421ca8511c92eeddca0a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i605a9571af9c4c29b51405c5fa8a5180_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie8720515f7754cf1bb2ae4218d464c2a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i59e287da7a7c4198b40966eba2b62146_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticEndoPredictTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i285edd982b994ad2b3b7a0af7f283e6b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i51fd75ee62c145e2952ac446346d9b7c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia4121b8b21d442e292a4ed42bdb30d70_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i29558741c2674b39926f43730a6b171b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id1bb8d1c57184d4f94dc2c42b00f8a29_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3ef0215658fa4d7c85eef815a3644861_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticOtherTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icd11d9c02bce445fa4341df9cbdb8482_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i378ad67948644fae91e1885f07d8b2c2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6600cdbac0c2465bb71dca2e44416ef6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9ede0c04f58f4611b03fdd8721157941_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:MolecularDiagnosticTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia52c822bff2e4272a00b3a632878266f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba547eb3ac564cf5bc3176aceeb2d680_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if78ac333a8f347ea8edf5c2f08bf8df0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie8835dd209114523bb9e8a64833ef8ff_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mygn:PharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i47d31e10974947898926c5dcd4c0a95a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iec7def734f4846fea024f404d1b6f52f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a8093dea57344778918ad7b5f751bce_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if2a611ec025e4fe6ac0191daf64556af_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4464ac83ed924822929712315bbc20be_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9a31395d02b44be398a13e91e3f5d44b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0632e32f05f944ccbf27e6259c5b238b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic645e61b77c341fab940f4bbab5081e8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6fb745cf587b4aee882556505e97108b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i363e9516fa95448388f9372a48406019_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6c6e2f5995484ce7b6fa8a39920efa01_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i283089fe02a54c5b92e07efd341a571b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i044fc58634da4848b1552fffbacd4a03_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic47a7731c378469ba7051e67d843a0e0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6b0749afe2864e698e44179a9a3109aa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia50d0d8131d5462795581f189d2f1d14_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i03b12526fbc2445095fb01cac8a0200e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib9ca61745af34a4892fb24f02df51ce3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id4cd1faa18234928a9a39c3bbf242061_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icbd1f3cce2e5428eb21ef3b840688e1a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i54e3cdbd09e6474bad78d5f7ae7c8d95_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if4fbe575c144479f93f88f70cd2f64f0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idbadb5bbe9c24d9aacd4015398fe5cb0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i72a3a4c04f3d40f5a2832e1afe743ff6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf4e8d24654e407fa0d279355277f975_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2b08211082a3454893716f0969068c16_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib95e73f78d584d03824f89f24d888618_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic3996efae676460a9efe08f0472b97ac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iefcec8bb3032434d9fab30ffede5b08b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id08f528c9e5845f9a07f73e22be9e0d6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i18fd7203ded848c0a6062cace377683e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if5db99cba11444b8bdf61c2da7e49565_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6b57287f98834cbca2dae9554a148b7c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5d6b05ed9dff446597fbac8b9a5c2d2d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iadafeb4cc83d4d8f830a67adc9b80fc3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i02975ce7a7184746bad04769367d2d8a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i89284fd7a0a14425a733d40a934ae931_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iab197615130e49f98518a5172359cd51_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e11187b43e04a0093140e12fee973c1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idd13afd135f940fbbf70581c789f8cf3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i56c502380d0d43a88063a06a16530a3e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie0daf004372944a1bac9f844e1eef37d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib60c105243a44ff2b52cb830ca3f0612_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9169f553a75d40ea8601058742b6ce6b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia17529a19c854ba3a5b3782a119a6641_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i51e7fa915fa440fba6edada1d950d356_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idc6cbaca5036438d8e4b5fc144239335_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i469e373b8c0c43c2a5d70d03cf8bbd0f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia7ffbeab905e44cf92eeca09b81182f1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i97e8d8a8b99d42c2827899164b67f836_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i57248bec235b477e86c27bec023182d8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifc90dd9b027a488592fd2345f76e07b8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i06989fe731e041ec9c47378d113e9ba4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia3c91e9de9334c18b4886936541914c8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8924bcae1bc14f7ea6e74dd68cf95dbc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if285d2c4c39b48fea6ad28b9de16c7ef_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3f53f70b2fc74581bf96fa47b43ca738_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7e0b0e9caa9844859a83f02b58ec38d1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mygn:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifa131e48ae9f404b915d24c15ada4467_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2cd593b0b41a4e759514f092f1f9e3ec_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if6e717c6e6cf4c1cacf0ce093a7d1b51_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6a3c6b6633454ca5abeba426ba6e1898_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i116991c09d6949c597cc44e8be8f1a92_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i977c59e776264b9e898cb3877c491df2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i44895c20478e407d8960b3da61962bfd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3f595a1c9de24b2d8b457b7d67db72dc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iedc11b500619497e955129438d050806_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie3b56267b5884c6b82c4eba0a047ea30_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibd37b997bb634ad6af913ee6c81e67d4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id401e6b7bcfc481bb6f8a4e878338fe9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mygn:PurchasedLicensesAndTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibd87820edea446099b7bfa0e8c2239a6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id69e12ae53554f31b7c4a41249056530_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i605e7ce6614b44f98a3ad36551642783_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mygn:InProcessResearchAndDevelopmentWithIndefiniteLivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i131e53046dba42e784ea6b9c4a34ebb0_D20180731-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-31</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i3e77d4115af8402f8e7c73bf41aa6d84_I20161223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-23</instant>
        </period>
    </context>
    <context id="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i799a546ec5224cf79c846d48840419b5_I20200501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-01</instant>
        </period>
    </context>
    <context id="i39160baa532a49a3a841ba3506e61d34_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib9f213a904c342bc9d88379906d18608_D20200331-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i817593bab77d4c76bee489fbd71601e8_D20200331-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f336dee21354bffb60cdbdea5421626_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i7dd85ff567e346758c47e5bf8e86f56e_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i9a3c8e67aaa446f9b27da019f00dc7c7_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mygn:AmendmentToCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="iac78c7144eeb42a297b36f757e868180_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mygn:EighthShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="i0f9212ac2aa140f8a16748ce2ea8a434_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icfa07cb7aed64763a7a9f6f9ebf99038_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8531ebcd74e04283a1b94b983fa04b07_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mygn:NonEmployeeDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mygn:OptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6e56313342974e7382a91c90b4089dd6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibe25ff804ef6473c900712207237104f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedAfterDecemberFiveTwentyTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8426764c4bf94a13a8f122cbaf9d20f2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">mygn:OptionsGrantedPriorToDecemberFiveTwentyTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4d168ccbb6474a0bbbe80bbe0520d013_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id7b2b333937b4d8ab126f4324d951eb8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibbc4477be5174638b6d2d9c390dc35df_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mygn:EmployeeStockPurchasePlanTwentyTwelveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i03913453337a4247aeed7aa0ba49835a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia9ebc3017dbc42c68c8b36d9f7808984_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfMolecularDiagnosticTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i935d96454093413f9b4072fbc7472673_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a60af6e087f4872829727b5a4666fd3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mygn:CostOfPharmaceuticalAndClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i692152fef23148a68888c9f3d749a1ac_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i713e3bcca2f747c69452acd15600fa56_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ica96d2399231445fa8ea26045d7379d9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic7029214bab44cbb90983534da0be3e1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i89373e9be2a0449893aabbe615c8f4d4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie481d4259b1e43cb9c6b7ea0cea96d16_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5e1f249221245de8a6c79eb95cdc6de_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3457c831a65d4dc386d66b85605c73bf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:MassachusettsDepartmentOfRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i590b46ab6f6241c0854149f1703f3040_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic9b0b4b7980a4b0bae0e190d4c2adc80_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">mygn:MassachusettsDepartmentOfRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic84b54586f924efeb788832bba77a03a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c12ff8b2c1b4feca4bfe7d6b0767522_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:FederalMinistryOfFinanceGermanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia11bd3e88b394e2aaacc3f17950ab8a0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9a4299d589f945d99e682d367f4fde51_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:SwissFederalTaxAdministrationFTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mygn:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifd70072490624e738ef4b03b84386198_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>mygn:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl80LTEtMS0xLTA_27ba3252-2eed-4d4b-855c-c470f2786d8b">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl8yLTEtMS0xLTE4OTQ_704f36f7-ce2b-4eef-86a0-eebe2d76b1e1">0000899923</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl8zLTEtMS0xLTE4OTQ_aa287260-4a8a-41e9-a565-6348d760de34">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl82LTEtMS0xLTA_52a3bffe-c351-497b-b8dc-f05ca92c386e">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80L2ZyYWc6YWU1ODc3MDg5YjczNDkwZjlkNTdmYTQ0NWRiMzBjYWEvdGFibGU6ZTQwNTZkODgzY2JlNGVjMmEwN2EyZDRmZDljMTdkZTYvdGFibGVyYW5nZTplNDA1NmQ4ODNjYmU0ZWMyYTA3YTJkNGZkOWMxN2RlNl83LTEtMS0xLTA_170ab23a-d57b-45a6-bb6c-1e3832a8ac02">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:RevenuePracticalExpedientRemainingPerformanceObligation
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80My9mcmFnOjE2NTYyOGI1Y2FlYTRjZTRiMzk4MTIzYWU2OTliNTI3L3RhYmxlOjcxODc0M2NiYmJjYjRlYTg5NjZjZGE4Njg2ZTRiYThmL3RhYmxlcmFuZ2U6NzE4NzQzY2JiYmNiNGVhODk2NmNkYTg2ODZlNGJhOGZfNC0xLTEtMS0w_6c879270-2c34-41b1-a8b1-fbea23bd7625">true</us-gaap:RevenuePracticalExpedientRemainingPerformanceObligation>
    <dei:DocumentType
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk1_fc8ba804-65d1-495d-abf8-08f4320c5c8a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6YzA5NzA3NTA4Y2NhNDQxNzhiYTM1ZWVkNmIzOGEzOTQvdGFibGVyYW5nZTpjMDk3MDc1MDhjY2E0NDE3OGJhMzVlZWQ2YjM4YTM5NF8wLTAtMS0xLTA_919fe7c0-7b16-4527-b1e5-3f20262453a6">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl84MjQ2MzM3MjEwODkw_d166c704-1d40-4255-a426-a5c9bbed1180">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6NGRkMWM5NzU5MzcwNDI5ODg4Y2NkNDMxYTU1OWY4NDEvdGFibGVyYW5nZTo0ZGQxYzk3NTkzNzA0Mjk4ODhjY2Q0MzFhNTU5Zjg0MV8wLTAtMS0xLTA_cb4dbfb0-ab2b-442a-83bd-26a88f640854">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAx_179d10ec-e7ad-4939-b9d4-21c1e2fb25af">0-26642</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk2_537d3f85-4a66-4a72-8e9c-cad1f92f9ab1">MYRIAD GENETICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk3_bfcd3ec7-dc7a-4fff-a2b2-0eed75cc12a4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAy_37ebfafa-3d44-423c-a4e1-a8166f517169">320 Wakara Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA2_bfe7b8e8-0488-47a9-93e0-0ccdbbecf668">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk4_2a62cb12-9dc6-4cf6-88db-9719b0bd2aa9">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityTaxIdentificationNumber
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAz_98e0092c-cc1e-4e30-999e-9e33c174e54a">87-0494517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressPostalZipCode
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA0_e8dd6945-28ad-4a41-89cf-10da2b30be81">84108</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA3_5ffffa17-fd7c-4e6d-ae03-f57ab68a770e">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDAw_16545646-c257-422b-bcf3-0f092cb63400">584-3600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6M2FmN2U3NDI0YzI5NGI3NmIxYWE3ODYzYjhhMDRmZTQvdGFibGVyYW5nZTozYWY3ZTc0MjRjMjk0Yjc2YjFhYTc4NjNiOGEwNGZlNF8xLTAtMS0xLTA_3ea1c8bd-d972-46f6-9f55-44f80ca56605">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6M2FmN2U3NDI0YzI5NGI3NmIxYWE3ODYzYjhhMDRmZTQvdGFibGVyYW5nZTozYWY3ZTc0MjRjMjk0Yjc2YjFhYTc4NjNiOGEwNGZlNF8xLTItMS0xLTA_ccaa2b88-6023-46d8-bb92-f4adefb9001b">MYGN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6M2FmN2U3NDI0YzI5NGI3NmIxYWE3ODYzYjhhMDRmZTQvdGFibGVyYW5nZTozYWY3ZTc0MjRjMjk0Yjc2YjFhYTc4NjNiOGEwNGZlNF8xLTQtMS0xLTA_03b2d4a2-10c5-4d0d-a031-5ef79da63dd5">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yNDA4_f12edfc7-8b88-4720-aa8f-8f45a4e1ef02">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl8yMzk5_fd7599ad-5aad-44c8-822f-a47ad807a0cd">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6Y2I1NGE1Yzk3YzAyNGExNmE4ZGMyYzA3NWVkZDgyOTYvdGFibGVyYW5nZTpjYjU0YTVjOTdjMDI0YTE2YThkYzJjMDc1ZWRkODI5Nl8wLTAtMS0xLTE4MzQ_45720c77-45c3-460a-8d73-2210acc9eea0">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6Y2I1NGE1Yzk3YzAyNGExNmE4ZGMyYzA3NWVkZDgyOTYvdGFibGVyYW5nZTpjYjU0YTVjOTdjMDI0YTE2YThkYzJjMDc1ZWRkODI5Nl8xLTMtMS0xLTA_4b495518-dcf8-4ff6-abc8-1389dd633cd7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGFibGU6Y2I1NGE1Yzk3YzAyNGExNmE4ZGMyYzA3NWVkZDgyOTYvdGFibGVyYW5nZTpjYjU0YTVjOTdjMDI0YTE2YThkYzJjMDc1ZWRkODI5Nl8yLTQtMS0xLTc2NjM_448b4b50-de63-408b-b436-aff0d4123b3f">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl84MjQ2MzM3MjEwOTE1_b4eb4cb5-d767-41f5-beb9-ea39549ce306">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i912f7c983e734c25aaf08678ad9b5ec8_I20201102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xL2ZyYWc6NGVjMzJmY2ExNzA2NDA5MWE3ODE0NzkzYjE2M2U5YTYvdGV4dHJlZ2lvbjo0ZWMzMmZjYTE3MDY0MDkxYTc4MTQ3OTNiMTYzZTlhNl82MDQ3MzEzOTU1Mjkx_9451f239-fb1f-4bea-8d86-b274dab82944"
      unitRef="shares">75210480</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMi0xLTEtMS0w_ebea7f58-7fe8-44b9-80af-c52e654d629f"
      unitRef="usd">118300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMi0zLTEtMS0w_eb4352d6-7f13-4e44-897e-1e1e85ded5d5"
      unitRef="usd">163700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMy0xLTEtMS0w_1bb2ad43-0a5a-4e21-9de7-13f53855e13a"
      unitRef="usd">42100000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMy0zLTEtMS0w_1753ae01-1669-4e3d-b74f-5beffc798dca"
      unitRef="usd">54100000</us-gaap:MarketableSecuritiesCurrent>
    <mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNC0xLTEtMS0w_9985f199-cc8b-4b5e-bc0f-6492d11d3378"
      unitRef="usd">12500000</mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent>
    <mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNC0zLTEtMS0w_5c342c66-2d45-4f4a-a065-8e21106ebc65"
      unitRef="usd">13800000</mygn:PrepaidExpenseExcludingPrepaidTaxesCurrent>
    <us-gaap:InventoryNet
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNS0xLTEtMS0w_48e88af2-0592-4bbb-9e09-dff3138ca5ee"
      unitRef="usd">26600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNS0zLTEtMS0w_474ef2f1-7f0c-4f78-a9a4-904b7200fbbc"
      unitRef="usd">29100000</us-gaap:InventoryNet>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNi0xLTEtMS0w_a8cd2459-3eff-4c10-ab61-9b60fd878060"
      unitRef="usd">85100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNi0zLTEtMS0w_155158d9-3df6-4131-88ea-1067d117c088"
      unitRef="usd">68100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0xLTEtMS01Njky_a9dd5bed-43f4-41a5-acd4-f8e17e33c20f"
      unitRef="usd">107900000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0zLTEtMS01Njk1_96eeca0a-7f98-4e53-b114-1cf14b8d33b6"
      unitRef="usd">0</us-gaap:PrepaidTaxes>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0xLTEtMS0w_d5c4b1e6-7c31-4dbb-a4b3-293b06dab62f"
      unitRef="usd">2000000.0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOC0zLTEtMS0w_08e807b9-9c9a-4a29-b1ae-5e13ca8038af"
      unitRef="usd">2900000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOS0xLTEtMS0w_bf00166c-fe27-4841-93fe-0676cdc5eeb2"
      unitRef="usd">394500000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfOS0zLTEtMS0w_0ed34614-207e-4fd5-8bf5-a6eaaa54934f"
      unitRef="usd">331700000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTAtMS0xLTEtMA_aec3f1c9-03c6-430f-b9d9-ad62e655f529"
      unitRef="usd">36700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTAtMy0xLTEtMA_4f1541d4-dbf8-4aac-9118-2d52b66b46ea"
      unitRef="usd">37000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTEtMS0xLTEtMA_b850a53a-80b9-4611-b21b-36c710c40319"
      unitRef="usd">62700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTEtMy0xLTEtMA_ec1fda17-7ed9-412b-9f90-f1c72a971b69"
      unitRef="usd">66000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTItMS0xLTEtMA_b6b320b9-4a43-4cbd-bfe2-280a6a74c2e6"
      unitRef="usd">30200000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTItMy0xLTEtMA_020a7e2d-a940-497b-ab75-9093c56b2f00"
      unitRef="usd">37000000.0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTMtMS0xLTEtMA_ed7e10c0-bd9e-4404-ad01-75147c78de1b"
      unitRef="usd">590900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTMtMy0xLTEtMA_a5390655-44e7-45cd-ad8c-fddd6d31ce0a"
      unitRef="usd">605300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTQtMS0xLTEtMA_b2681238-5a28-4381-9e3b-3f21ff47e988"
      unitRef="usd">328300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTQtMy0xLTEtMA_fd81f306-f800-41e0-aa75-1a1d42f1eb65"
      unitRef="usd">327600000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTUtMS0xLTEtMjY5MQ_da02a5af-9e1d-4348-a93f-6a520e7bd866"
      unitRef="usd">1200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTQtMy0xLTEtMjg0NQ_fcd37adb-25e6-4403-9e31-deabf89c8b89"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTUtMS0xLTEtMA_7927ce78-19a3-4a99-9d2e-1a488f498ed3"
      unitRef="usd">1444500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTUtMy0xLTEtMA_9080f26e-02cb-4fda-b50b-01e1853d68be"
      unitRef="usd">1404600000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTgtMS0xLTEtMA_076a38a9-83eb-46b9-81b3-cc4bd4a650e7"
      unitRef="usd">19100000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTgtMy0xLTEtMA_e75846bd-666d-4dd7-b5ba-7bbbf4f3d58a"
      unitRef="usd">21700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTktMS0xLTEtMA_098f9ed8-8fca-4b68-a55e-27ea23df8dea"
      unitRef="usd">65400000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMTktMy0xLTEtMA_aa8a34db-2ea2-4112-bee3-24209c7dffc4"
      unitRef="usd">75900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjAtMS0xLTEtMA_807bb62d-dbb8-42e5-a76a-a33142fcd94d"
      unitRef="usd">13600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjAtMy0xLTEtMA_b68c80b2-d438-4fa5-ac01-fb468f285c59"
      unitRef="usd">13500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjEtMS0xLTEtMA_a5f7e12d-7f9d-4fab-b8bf-b3805a97c6c5"
      unitRef="usd">3300000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjEtMy0xLTEtMA_2ba6642d-c960-42ee-b118-911ed45cbedb"
      unitRef="usd">3100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjItMS0xLTEtMA_026e9220-2d0c-4966-bbf9-e2b29cf559a1"
      unitRef="usd">32300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjItMy0xLTEtMA_d23cbda7-4883-405f-b59f-d521d11a4604"
      unitRef="usd">32800000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjMtMS0xLTEtMA_d28b9019-9343-434e-a404-488e76dc48d3"
      unitRef="usd">133700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjMtMy0xLTEtMA_2c39ef2a-2bb5-46c3-8b7d-d7c26439836f"
      unitRef="usd">147000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjQtMS0xLTEtMA_80eaaa75-c860-42d5-89db-746ed64c1a83"
      unitRef="usd">37400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjQtMy0xLTEtMA_dcb31311-7fcd-48a5-9156-bc12929cedc4"
      unitRef="usd">23500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjUtMS0xLTEtNDk1Mw_4cb14504-5cd9-4425-b08e-81a8fa33719e"
      unitRef="usd">75300000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjUtMy0xLTEtNDk1Mw_ee69b618-83b6-4aba-93d8-cf8b6fd0e8ce"
      unitRef="usd">26600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebt
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjgtMS0xLTEtMA_f003ce32-bb93-4d87-b6bb-ab2429a3a232"
      unitRef="usd">224600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjgtMy0xLTEtMA_512a8573-a5f8-4bde-a127-77b0e30a66e9"
      unitRef="usd">224400000</us-gaap:LongTermDebt>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjktMS0xLTEtMA_fea75a61-cecd-42f8-a87c-a6b0ea1fce10"
      unitRef="usd">53500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMjktMy0xLTEtMA_d5a9f356-1361-47e3-ad25-6384132555ae"
      unitRef="usd">56900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMS0xLTEtNDk3Mg_2b6a1ed3-2d08-4f38-855a-cbe2f385846b"
      unitRef="usd">10700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMy0xLTEtNDk3Mg_1783f457-a5df-408c-9168-e60ffcdce1e6"
      unitRef="usd">8000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMS0xLTEtMA_7b5dc410-78ef-43e4-b44a-d40ce91a81cb"
      unitRef="usd">535200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzAtMy0xLTEtMA_8178ea18-2401-4567-8f72-e2339d83db72"
      unitRef="usd">486400000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzEtMS0xLTEtMA_0c9619df-3f18-4878-8406-80b10275a52e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzEtMy0xLTEtMA_0edb2cc3-be0b-4c8b-98eb-a8f18a2d9f82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMC0xLTEtMjkyMy90ZXh0cmVnaW9uOmM3NzcwOGIxZTQ1YjQzMWM4YTk3ZTIxOWUyZmRiY2Y5XzgyNDYzMzcyMDg0Mjc_3a27fb3b-ba99-4827-9496-aa0608d3188e"
      unitRef="shares">75200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMC0xLTEtMjkyMy90ZXh0cmVnaW9uOmM3NzcwOGIxZTQ1YjQzMWM4YTk3ZTIxOWUyZmRiY2Y5XzgyNDYzMzcyMDg0MzQ_e97c5a82-896f-480f-99a4-bcc6c689d98c"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMS0xLTEtMA_dc07247b-cfbf-4efb-8528-62d737ec5c87"
      unitRef="usd">800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzMtMy0xLTEtMA_7f3983c7-20ba-4f4d-8f95-827f1b41a7b7"
      unitRef="usd">700000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzQtMS0xLTEtMA_b7812de2-0333-47cc-b49b-c463286fedf3"
      unitRef="usd">1101200000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzQtMy0xLTEtMA_c68d4f5b-75c5-4376-abf4-753321ef03ce"
      unitRef="usd">1096600000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzUtMS0xLTEtMA_785b2f39-ce65-4538-825d-066f6caff453"
      unitRef="usd">-3600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzUtMy0xLTEtMA_b30f6e7f-1394-4879-bd02-94410cb10185"
      unitRef="usd">-5200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzYtMS0xLTEtMA_f7c81c37-637f-4611-a176-67a8c2067143"
      unitRef="usd">-189100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzYtMy0xLTEtMA_2a19c152-6062-43e3-8432-27dd02c02e4f"
      unitRef="usd">-173900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzctMS0xLTEtMA_1f06f8b7-43c2-47eb-8b1c-9343dbf83aaa"
      unitRef="usd">909300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzctMy0xLTEtMA_5e783edd-5ab4-496b-99de-a17094b9382f"
      unitRef="usd">918200000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzgtMS0xLTEtMA_e841b8b8-6e0a-4ac0-88cf-0daf3998e09f"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzgtMy0xLTEtMA_70f55906-fbca-4e50-b59e-76a722b00808"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzktMS0xLTEtMA_c9432184-0846-49db-a997-a5f58c083535"
      unitRef="usd">909300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfMzktMy0xLTEtMA_cef37cc4-051b-4265-8ca5-4124a7e50f1f"
      unitRef="usd">918200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNDAtMS0xLTEtMA_a2fdbb48-975d-4877-8c6d-fbc06c360319"
      unitRef="usd">1444500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xNi9mcmFnOmMxYzEzNDljNjQ5NjQ1MjhhZTgwMGY3YjMxNDk5NWY2L3RhYmxlOjUzZjk0NjZjNjdiZTQxZTk5Nzg1NWU2MzRkZTUzNDNhL3RhYmxlcmFuZ2U6NTNmOTQ2NmM2N2JlNDFlOTk3ODU1ZTYzNGRlNTM0M2FfNDAtMy0xLTEtMA_05d109df-1ddb-48c5-a4c2-8429af4f6fc7"
      unitRef="usd">1404600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMi0xLTEtMS0w_43f9dab0-3eb7-4123-9316-1b9be521a754"
      unitRef="usd">135700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMi0zLTEtMS0w_37fdb709-5013-436d-a3fb-b3e8bcfad59e"
      unitRef="usd">172000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMy0xLTEtMS0w_3e3213f0-a21b-4d75-8ac9-aa79cccf48a4"
      unitRef="usd">9500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMy0zLTEtMS0w_f23baebc-8aba-4dc7-9a3e-3eff4b5bc9b4"
      unitRef="usd">14300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNC0xLTEtMS0w_4ab76a58-a3ae-4e58-adb9-67ee12276af3"
      unitRef="usd">145200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNC0zLTEtMS0w_a32e1f7b-f6af-4e2c-ab8a-04ef149a6c95"
      unitRef="usd">186300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNi0xLTEtMS0w_d2fb2c6e-c5cf-4d57-b534-14bc54fb17fe"
      unitRef="usd">39900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNi0zLTEtMS0w_75b2ca28-a604-4152-b220-ce061c38a257"
      unitRef="usd">41200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNy0xLTEtMS0w_14a0ce61-fb9f-437b-a670-bef637afabeb"
      unitRef="usd">4300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfNy0zLTEtMS0w_e4f0f4da-6a9c-42b7-8d7b-dc4df694904b"
      unitRef="usd">8500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOC0xLTEtMS0w_d65087f9-71d4-4645-98e9-5b7016dd471a"
      unitRef="usd">17600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOC0zLTEtMS0w_3f4b179f-bb1d-4b87-a58e-11f2b420ba42"
      unitRef="usd">21300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOS0xLTEtMS0w_1b9fda2a-c0fb-4270-90fb-fa0f750c7bd6"
      unitRef="usd">-1100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfOS0zLTEtMS0w_747fe2ce-d110-4d20-bfdd-18cdbf88a2ce"
      unitRef="usd">700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTAtMS0xLTEtMA_4e7fbb3e-833d-4626-b2cf-6c9f93372b5e"
      unitRef="usd">124100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTAtMy0xLTEtMA_c080f326-3d0e-42c2-b4f7-f64ecb3b42d2"
      unitRef="usd">135500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTItMS0xLTEtMA_c23e392a-3c12-4385-9ef5-19a698268f28"
      unitRef="usd">184800000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTItMy0xLTEtMA_b90fd22d-2b0a-41ac-b042-0a3c1d3ace2a"
      unitRef="usd">207200000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTMtMS0xLTEtMA_0ece6648-794c-40ff-9146-6e132ce8f3bf"
      unitRef="usd">-39600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTMtMy0xLTEtMA_13aab9dc-a359-4831-a2b9-e916e89136be"
      unitRef="usd">-20900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTUtMS0xLTEtMA_520ef652-189b-4d3a-8a6f-8810e9b8ea7e"
      unitRef="usd">400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTUtMy0xLTEtMA_f81c4fd1-d2f9-41ba-b27d-3cfbe0c83e3e"
      unitRef="usd">900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTYtMS0xLTEtMA_350e288f-a2b1-4273-89ee-f8d4e4b201e2"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTYtMy0xLTEtMA_555d3df2-204b-4916-9e02-e7e974735b98"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTctMS0xLTEtMA_5d09fa39-292f-493f-b37f-d3bd5d92054a"
      unitRef="usd">-1600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTctMy0xLTEtMA_3fe3c814-d537-4782-a3f3-beb8f2f3be91"
      unitRef="usd">600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTgtMS0xLTEtMA_ac8d926a-b37c-4760-85eb-c56f623dd851"
      unitRef="usd">-4100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTgtMy0xLTEtMA_946f4325-a50d-44e1-bc50-0e764f9d71a7"
      unitRef="usd">-1400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTktMS0xLTEtMA_85ffb759-c275-4f6a-a2d0-02aa7bc1d226"
      unitRef="usd">-43700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMTktMy0xLTEtMA_6150a651-3ed4-4502-b515-4224105f8831"
      unitRef="usd">-22300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjAtMS0xLTEtMA_71316029-bf41-4b46-99b9-f2a96e620026"
      unitRef="usd">-28500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjAtMy0xLTEtMA_cf2c0810-eb38-405f-a85d-6dbc115cc1c7"
      unitRef="usd">-1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjEtMS0xLTEtMA_5d096ba7-06b1-4d79-b573-68d26a52f794"
      unitRef="usd">-15200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjEtMy0xLTEtMA_881e54a1-d2d0-410c-9089-7e3eeec78779"
      unitRef="usd">-20600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjItMS0xLTEtMA_ce8395dd-ea92-4dd8-9a71-cc950e43813d"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjItMy0xLTEtMA_d0c2de83-ffdc-4148-98d3-5ede0cacbe06"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjMtMS0xLTEtMA_38623ca0-f9c4-4bcf-aa3f-e1a091ff26ef"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjMtMy0xLTEtMA_02c6d265-9b68-4ae1-a8e4-11ab5a371a0d"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjUtMS0xLTEtMA_b50845bd-f9dc-4e9e-b799-493d9c970226"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjUtMy0xLTEtMA_43ac0a91-c804-4ec0-ab6c-ca1ad278f5eb"
      unitRef="usdPerShare">-0.28</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjgtMS0xLTEtMA_de120159-b4b1-4546-af80-e89a75c3b1b4"
      unitRef="shares">74700000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yMi9mcmFnOjQ1NzZlOGNhMDJlZjRmNWE4MGI2NDgwYWE4MjIwOGRmL3RhYmxlOjMyOTNkY2ZkNjYwYzRhZWQ4OGNhYWQxODJlM2UyNWUwL3RhYmxlcmFuZ2U6MzI5M2RjZmQ2NjBjNGFlZDg4Y2FhZDE4MmUzZTI1ZTBfMjgtMy0xLTEtMA_d9cee638-351e-49ce-8cb4-230c4d054df7"
      unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMi0xLTEtMS0w_3e0b0bd6-7ce9-4c4e-849d-7d9fa2acaa12"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMi0zLTEtMS0w_b0422e9d-166b-45ac-a044-5311f68827a3"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMy0xLTEtMS0w_d838ef3a-d9da-4c1c-a753-7a09383c9a24"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfMy0zLTEtMS0w_193e097f-ee1b-476b-a496-dd0fe6990924"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNC0xLTEtMS0w_2c904c32-58d2-4a41-a0fb-34965d2002d0"
      unitRef="usd">1800000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNC0zLTEtMS0w_7a22d8d4-ee58-4313-8f76-c4d75b1074eb"
      unitRef="usd">-2200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNS0xLTEtMS0w_19b49658-c611-4cd1-8ad1-60a3a069e07e"
      unitRef="usd">-13600000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNS0zLTEtMS0w_cd0ce758-7020-4e88-a2e5-34ae9e34688d"
      unitRef="usd">-22800000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNi0xLTEtMS0w_1cde374c-fcad-4988-8612-f1b3b197bd41"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNi0zLTEtMS0w_deffc74e-7de0-4c25-9e1d-a6f2657a6b13"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNy0xLTEtMS0w_19d47660-86bf-499b-a7ac-b8a513796d2d"
      unitRef="usd">-13600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yNS9mcmFnOmRhNjE3NzJkMjAzODRiNDY4YjJiMDgzNjVjYTkxMDAzL3RhYmxlOjUwZmE4NWFmZTI0MzRmMThiMjE1N2NkMDRiY2RmZWIyL3RhYmxlcmFuZ2U6NTBmYTg1YWZlMjQzNGYxOGIyMTU3Y2QwNGJjZGZlYjJfNy0zLTEtMS0w_ffa3323f-b2d4-4088-89a4-661086d17663"
      unitRef="usd">-22800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0afd5266f1674cd890c5e822e8608051_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS0xLTEtMS0w_06c4d5df-d788-42eb-ad3d-9cf12b45a61a"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60c68c3b6a064506b03ca32fad5428a0_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS0zLTEtMS0w_7969d6d7-b6b2-4aa0-bac2-cf504205fae1"
      unitRef="usd">1068000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b5f2e721cba4626be7e73ae2f98f5be_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS01LTEtMS0w_afffb658-d670-4d7c-a642-6ef483ee19e2"
      unitRef="usd">-5400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i645c55a2b3c240cc83b60c6876b52044_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS03LTEtMS0w_b001151e-45ac-46f6-b714-7c5b95cc9be4"
      unitRef="usd">25600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i139906c1954e43c39560efe073ca515b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMS0xMS0xLTEtMA_46dc51f2-343d-4e51-b692-3f50c21ffb78"
      unitRef="usd">1088900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0e44f0801a764c629e60704da55af897_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMi0zLTEtMS0w_16ef7d04-5e4f-4422-bdaf-cf57fb9462d4"
      unitRef="usd">-500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMi0xMS0xLTEtMA_8755ec5b-9277-41c9-8394-e87738ea8148"
      unitRef="usd">-500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0e44f0801a764c629e60704da55af897_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMy0zLTEtMS05MQ_8948ba4f-e697-444e-ae38-60c4dceed572"
      unitRef="usd">8800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMy0xMS0xLTEtOTE_e217d5ae-e3fb-48e2-9749-f081e38742a6"
      unitRef="usd">8800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i74aa2b09d6d7450b992f13f174e86815_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNS03LTEtMS0w_0570061d-07e4-4fe6-b86e-b0d5edac43ac"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNS0xMS0xLTEtMA_35a4771a-ec1a-4c73-8817-fffcb2d800e0"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5c0dc32b94684fb9a72074a4467ddbb3_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNi01LTEtMS0w_331cf889-6340-471c-b912-0925cb32ac73"
      unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNi0xMS0xLTEtMA_433bf0ad-3df6-4bce-b866-884aee0023a6"
      unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac1b61b427d34cd1aee1ba7384109a9d_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy0xLTEtMS0w_a9cd8610-4e7a-451c-b674-f0203b4fd344"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i091efe167f3c4e1da67fb808d46a17cf_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy0zLTEtMS0w_86e6890e-f880-49dc-8ce3-8dc496f2a268"
      unitRef="usd">1076300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacae5069b54f4a67b0357cd8ef5efb1a_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy01LTEtMS0w_f987a6e3-d480-46e2-a0cc-ad5fb7dc47ff"
      unitRef="usd">-7500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25198efed29e4e92b99f0262f821c2d3_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy03LTEtMS0w_8031fcae-9d02-4fb3-85e2-b0e68278efa5"
      unitRef="usd">5000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61a8af6463ab4c92ba4435534752e1a2_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfNy0xMS0xLTEtMA_5fbac2ae-0106-4a28-9f3e-f841b957b1d5"
      unitRef="usd">1074500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ccc458b8fab4e1aaf73e23ed8876645_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtMS0xLTEtMA_c646620a-370d-4ca3-9863-a977573dd123"
      unitRef="usd">700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1b31638ad944d72af7bea5c92686dee_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtMy0xLTEtMA_2e48c2d3-10c4-49e5-9657-ce9755842c23"
      unitRef="usd">1096600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i005afd72b0d346de9ebc794edf8af44d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtNS0xLTEtMA_e13fd696-debb-491f-8d81-7090cf8eeaf6"
      unitRef="usd">-5200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3201828072042f8be79031422bab5b1_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtNy0xLTEtMA_5fe86b3d-f4d0-4ca1-9bae-342af6fa5373"
      unitRef="usd">-173900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjAtMTEtMS0xLTA_dc7b3844-9ec0-47ba-9c3e-9595858ce17a"
      unitRef="usd">918200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie8725d74790d48458cfdfa6233888a31_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjEtMS0xLTEtMA_1b295d6d-309b-43c4-9434-3fe9e0b3ebf2"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i82a7856a26e14144a676ceba1c64446a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjEtMy0xLTEtMA_232e6c5f-ae63-4f78-bf79-c6408a9856aa"
      unitRef="usd">-3800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjEtMTEtMS0xLTA_4a55ea71-ddab-488d-b751-efc02b9d394f"
      unitRef="usd">-3700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i82a7856a26e14144a676ceba1c64446a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjItMy0xLTEtMA_1c476a60-e0e4-4166-96f2-93e33138993c"
      unitRef="usd">8400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjItMTEtMS0xLTA_07d07afb-ca38-4007-9b23-71092f1b43a8"
      unitRef="usd">8400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="iaedb6702dab54acfb883a731f04b482f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjMtNy0xLTEtMA_5790a06d-bdf9-4110-8e98-976736729c0b"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjMtMTEtMS0xLTA_c49d69d8-75fd-4199-a448-e3c98cf1dfc5"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2efecfeca2f34c238cfefcdb778c6425_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjQtNS0xLTEtMA_f3f44ec3-3449-4159-8e3c-524ee7528d06"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjQtMTEtMS0xLTA_20c1d2e9-29b6-499f-8a73-681b2108fd41"
      unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i160b5ebaf0a348a6bf32eaa61276f655_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtMS0xLTEtMA_9f51c9c0-96a7-402e-9f4c-a6c9ecb71639"
      unitRef="usd">800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i877b14486ab2428ba1f01ad23fccb179_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtMy0xLTEtMA_6eae638d-b0cd-4813-843d-10bfb2be3399"
      unitRef="usd">1101200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64095d8f93a94fbeb281e9c293c679a9_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtNS0xLTEtMA_c55de458-e2fb-4fc2-94b1-4cc09cef291b"
      unitRef="usd">-3600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i055da3a2d6c44d7597f0360c7843f5ff_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtNy0xLTEtMA_23bc42a2-baff-477a-bb3f-9992cf3819ef"
      unitRef="usd">-189100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8yOC9mcmFnOjExYjQ4YzgzN2RjZTRlYWViNTU2ZTljZTg5YjI0MmFlL3RhYmxlOjYwM2JmMGQxMDI3MTQ1MmVhZWU1NGYwNjkyNjc5MTE3L3RhYmxlcmFuZ2U6NjAzYmYwZDEwMjcxNDUyZWFlZTU0ZjA2OTI2NzkxMTdfMjUtMTEtMS0xLTA_8ee7c9a1-3b19-4491-b91b-f3b466d4a2cc"
      unitRef="usd">909300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMy0xLTEtMS0w_45f693fc-c05a-4346-9efe-e3556ae8cdba"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMy0zLTEtMS0w_f9a19f35-5e08-4d9b-bbbf-c766f56f8795"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNS0xLTEtMS0w_a366ccf3-fab0-4fe5-be1f-9f30ce44a67b"
      unitRef="usd">17700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNS0zLTEtMS0w_25a71d41-3bd1-4310-b2dc-289cf5912e7f"
      unitRef="usd">18200000</us-gaap:DepreciationAndAmortization>
    <mygn:NonCashInterestExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNi0xLTEtMS0w_04826be0-4a26-4172-9ad8-29e10d44adc4"
      unitRef="usd">200000</mygn:NonCashInterestExpense>
    <mygn:NonCashInterestExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNi0zLTEtMS0w_d0e1b5b5-1acf-45cc-8f86-77c5d38cb7ad"
      unitRef="usd">100000</mygn:NonCashInterestExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNy0xLTEtMS03MzE4_00ffe859-2a57-479f-8924-2d91d385b934"
      unitRef="usd">3300000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNy0zLTEtMS03MzE4_55ab2992-d696-48c5-9bfc-e3a57ef374ff"
      unitRef="usd">3200000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOC0xLTEtMS0w_e89dcf40-8fff-4c9d-a3d4-9ecbbb6e614d"
      unitRef="usd">-100000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOC0zLTEtMS0w_1fc7a18c-d745-4525-97c4-e7d452833307"
      unitRef="usd">100000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:ShareBasedCompensation
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOS0xLTEtMS0w_46d1a360-70fb-416d-9a4c-2f760293b3d8"
      unitRef="usd">8400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfOS0zLTEtMS0w_57823db0-93a5-4ada-900c-22e7af8d86f7"
      unitRef="usd">8800000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTAtMS0xLTEtMA_da29d64d-35bc-440b-837c-72fb80595c8e"
      unitRef="usd">-48400000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTAtMy0xLTEtMA_8dbc841e-3cda-449c-bd5a-6dc224d0ec24"
      unitRef="usd">5100000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <mygn:IncreaseDecreaseInUnrecognizedTaxBenefits
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTEtMS0xLTEtMA_d366cb51-a4b8-468b-b9f1-258836619377"
      unitRef="usd">13900000</mygn:IncreaseDecreaseInUnrecognizedTaxBenefits>
    <mygn:IncreaseDecreaseInUnrecognizedTaxBenefits
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTEtMy0xLTEtMA_3d6a04f0-6ec2-49de-8e84-76584648e41b"
      unitRef="usd">400000</mygn:IncreaseDecreaseInUnrecognizedTaxBenefits>
    <mygn:ChangeInFairValueOfContingentConsideration
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTMtMS0xLTEtMA_f43b0864-18c5-40ef-abe2-9c7ce0b26255"
      unitRef="usd">-1100000</mygn:ChangeInFairValueOfContingentConsideration>
    <mygn:ChangeInFairValueOfContingentConsideration
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTMtMy0xLTEtMA_40f6a15f-6570-4c63-be1b-38bf7396655f"
      unitRef="usd">700000</mygn:ChangeInFairValueOfContingentConsideration>
    <mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTYtMS0xLTEtMA_e37965db-2436-4915-b266-74db76aed60c"
      unitRef="usd">-1200000</mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes>
    <mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTYtMy0xLTEtMA_73a2e2bc-a7dc-4d42-905a-51d01530e57c"
      unitRef="usd">-2600000</mygn:IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTctMS0xLTEtMA_2701956f-a351-4c35-a381-072bc9cbba92"
      unitRef="usd">17000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTctMy0xLTEtMA_fea84b84-1935-4d62-9c0f-5fbbfa890a84"
      unitRef="usd">-16700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMS0xLTEtMA_71a04dc4-e40e-40eb-b77a-07d5c204233f"
      unitRef="usd">-900000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMy0xLTEtMA_67238a9b-c844-43d4-a170-64a6c19e8269"
      unitRef="usd">100000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTktMS0xLTEtMA_e528259f-ac66-46c3-921d-2ff035aaec44"
      unitRef="usd">-2600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTktMy0xLTEtMA_2ab04ffd-f7e0-4289-a490-b0cbe2b54f4e"
      unitRef="usd">-3100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjAtMS0xLTEtMA_c8a6a200-1d90-4006-8967-09233564e74d"
      unitRef="usd">107900000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjAtMy0xLTEtMA_ec873007-0cbd-429c-a15b-953f5a44bf2e"
      unitRef="usd">-2100000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMS0xLTEtMzgzOA_0c2584b4-c6e4-4777-9029-cab85875085a"
      unitRef="usd">1200000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMTgtMy0xLTEtMzkwNg_50c59fc4-18cd-45d2-a198-d249ab52c1b1"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjEtMS0xLTEtMA_df689fcf-395c-4a62-85d9-cc62bbcd4d01"
      unitRef="usd">-3200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjEtMy0xLTEtMA_862479a7-ae4d-48e9-8697-eea36ac47de2"
      unitRef="usd">-9300000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjItMS0xLTEtMA_1b99930f-e6ef-4022-b4a2-ff773e72edb5"
      unitRef="usd">-9800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjItMy0xLTEtMA_caee9b80-6a78-490c-9ad1-8fe9ede03966"
      unitRef="usd">-4900000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjMtMS0xLTEtMA_09d145dd-982e-435c-8552-a27083f99a38"
      unitRef="usd">-600000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjMtMy0xLTEtMA_cedf02bb-636f-4286-b310-26e5ed4e85fd"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjQtMS0xLTEtMA_4714a8d0-0599-4aad-bebf-968f4a37cc25"
      unitRef="usd">-59300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjQtMy0xLTEtMA_7304f4f4-ae84-43d2-941d-bcc41339a166"
      unitRef="usd">15800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjYtMS0xLTEtMA_1cc42304-0bd5-4cb3-a2e9-16453e1f9ffc"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjYtMy0xLTEtMA_79b5a4bf-a48b-4265-abe6-85650a0313ed"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjktMS0xLTEtMA_578fca73-883b-4eda-ba99-6ef9a418a31e"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMjktMy0xLTEtMA_6f37040e-a931-4f2b-8b6b-38933c62cb4d"
      unitRef="usd">23100000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzAtMS0xLTEtMA_a7a051b5-1b19-4620-994f-49c6d0ac4eb6"
      unitRef="usd">18600000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzAtMy0xLTEtMA_356cd64f-b697-448f-8fc3-3307f16a3f3a"
      unitRef="usd">17400000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzEtMS0xLTEtMA_cb39a64d-925d-401d-8289-a1635b2bad79"
      unitRef="usd">17100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzEtMy0xLTEtMA_016e6c7c-a4c8-4304-8f7d-565c08a924a6"
      unitRef="usd">-7100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzMtMS0xLTEtMA_a5c8da4a-662f-41cd-8a8f-70293c17e98f"
      unitRef="usd">3800000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzMtMy0xLTEtMA_08b2f09c-9f6d-4609-a0b0-49f1068e3d93"
      unitRef="usd">400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzQtMS0xLTEtMA_e187c4fe-0ed2-465d-a9eb-f55ffd45da4c"
      unitRef="usd">100000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzQtMy0xLTEtMA_890383c9-70c9-4ff2-9377-4ebcd1226647"
      unitRef="usd">3300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzYtMS0xLTEtMA_28baf386-8661-496a-80da-9f6c29690c88"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzYtMy0xLTEtMA_131fa92a-d418-4018-9473-3fd9f735a499"
      unitRef="usd">8600000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzktMS0xLTEtMA_051771e6-fc86-4a42-a5b5-2ac476d434ed"
      unitRef="usd">-3900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfMzktMy0xLTEtMA_d7d0752d-7e29-4771-bd1d-35dddd04bf98"
      unitRef="usd">-12300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDAtMS0xLTEtMA_111fdaf6-e2aa-4fe2-bc8c-0e58b1fd39ad"
      unitRef="usd">700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDAtMy0xLTEtMA_66c488b8-eb76-498b-b564-1ba60ac8f0aa"
      unitRef="usd">300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDEtMS0xLTEtMA_88a9a847-1063-4407-a60a-7e75acd0d0f8"
      unitRef="usd">-45400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDEtMy0xLTEtMA_cff7a99a-ce8b-4221-82e2-3f91d1c07fc4"
      unitRef="usd">-3300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDItMS0xLTEtMA_ddc2bd66-2450-4f9a-9d56-9778556a2963"
      unitRef="usd">163700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i139906c1954e43c39560efe073ca515b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDItMy0xLTEtMA_d518b4e3-25c8-4192-bb8f-a56aee4b8ecd"
      unitRef="usd">93200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDMtMS0xLTEtMA_c76feb09-a267-4842-b724-e0c91f3d8aa2"
      unitRef="usd">118300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61a8af6463ab4c92ba4435534752e1a2_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zMS9mcmFnOjMwMWU1ZThlMGU4NjRlNDI5ODJiZTJlYTRkMmExZjNlL3RhYmxlOmE1NzIzYmRkZTFhYTRjNTc5MGQxNTA4ZGI3NzM1MGY4L3RhYmxlcmFuZ2U6YTU3MjNiZGRlMWFhNGM1NzkwZDE1MDhkYjc3MzUwZjhfNDMtMy0xLTEtMA_dbdb9f36-dc86-44fb-a983-848848f35142"
      unitRef="usd">89900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zNy9mcmFnOjZlZDE3NWI4Yzc0MTQ2NDZhOTJkN2Y3ZmJkZTY2ZGIxL3RleHRyZWdpb246NmVkMTc1YjhjNzQxNDY0NmE5MmQ3ZjdmYmRlNjZkYjFfOTk3Ng_c0d04fa1-fa8c-437d-9119-9a0a4addee15">BASIS OF PRESENTATION&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements for Myriad Genetics, Inc. and subsidiaries (the &#x201c;Company&#x201d; or &#x201c;Myriad&#x201d;) have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). &#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Operating results for the three months ended September&#160;30, 2020 may not necessarily be indicative of results to be expected for any other interim period or for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full impact of the COVID-19 outbreak continues to evolve and its future impact remains highly uncertain and unpredictable. As such, it is uncertain as to the full magnitude of the effect that the pandemic will have on the Company's financial condition, liquidity, and future results of operations. Management is actively monitoring the impact of the global situation on the Company's financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evaluation of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have historically experienced seasonality in our testing business. The volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, the quarter ending March 31 is typically negatively impacted by the annual reset of patient deductibles. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders&#x2019; equity, cash flows from operations, or net loss for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (the "FASB") issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326) (&#x201c;ASU 2016-13&#x201d;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company is required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are also recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, Intangibles &#x2013; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#x201c;ASU 2018-15&#x201d;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements as of September 30, 2020. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of the other assets financial statement line item in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standards Effective in Future Years and Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact this new standard will have on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zNy9mcmFnOjZlZDE3NWI4Yzc0MTQ2NDZhOTJkN2Y3ZmJkZTY2ZGIxL3RleHRyZWdpb246NmVkMTc1YjhjNzQxNDY0NmE5MmQ3ZjdmYmRlNjZkYjFfOTk3Nw_a50e16cb-a3a6-4abe-acdc-b54e52ebdf77">BASIS OF PRESENTATION&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements for Myriad Genetics, Inc. and subsidiaries (the &#x201c;Company&#x201d; or &#x201c;Myriad&#x201d;) have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). &#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Operating results for the three months ended September&#160;30, 2020 may not necessarily be indicative of results to be expected for any other interim period or for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full impact of the COVID-19 outbreak continues to evolve and its future impact remains highly uncertain and unpredictable. As such, it is uncertain as to the full magnitude of the effect that the pandemic will have on the Company's financial condition, liquidity, and future results of operations. Management is actively monitoring the impact of the global situation on the Company's financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evaluation of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have historically experienced seasonality in our testing business. The volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, the quarter ending March 31 is typically negatively impacted by the annual reset of patient deductibles. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders&#x2019; equity, cash flows from operations, or net loss for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8zNy9mcmFnOjZlZDE3NWI4Yzc0MTQ2NDZhOTJkN2Y3ZmJkZTY2ZGIxL3RleHRyZWdpb246NmVkMTc1YjhjNzQxNDY0NmE5MmQ3ZjdmYmRlNjZkYjFfODI0NjMzNzIzODgxMg_9dd6f685-4193-433e-a9f9-e922937a0273">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (the "FASB") issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326) (&#x201c;ASU 2016-13&#x201d;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company is required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are also recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, Intangibles &#x2013; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#x201c;ASU 2018-15&#x201d;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements as of September 30, 2020. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of the other assets financial statement line item in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standards Effective in Future Years and Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact this new standard will have on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIxMTg1Nw_e92e3f5d-91df-40d4-b13c-6432ae080b66">REVENUE&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp;amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated amount of consideration to be received. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents detail regarding the composition of our total revenue by product and by U.S. versus rest of world, &#x201c;RoW&#x201d;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;RoW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;RoW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Molecular diagnostic revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hereditary Cancer Testing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prenatal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GeneSight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vectra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;myChoice CDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prolaris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EndoPredict&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total molecular diagnostic revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;135.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;166.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceutical and clinical service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;174.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets. Occasionally, customers make payments prior to the Company's performance of its contractual obligations. When this occurs, the Company records a contract liability as deferred revenue. During fiscal year 2020, the Company received approximately $29.7 in advance Medicare payments to provide relief from the economic impacts of COVID-19 on the Company. The advance Medicare payments are included in the beginning and ending balance of deferred revenue. A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue - beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue - ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#x2019;s right to payment is in an amount that directly corresponds with the value of Company&#x2019;s performance to date. However, the Company periodically enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of September&#160;30, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $2.8.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may provide discounts to its customers. In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. The Company applies the expected value method for sales where the Company has a large number of contracts with similar characteristics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. The Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. The Company excludes from the measurement of transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer. for example, sales tax, value added tax, etc. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in accrued liabilities on the balance sheet in anticipation of requests for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the consolidated statements of operations and comprehensive loss. As of September 30, 2020, the Company recorded a $2.2 accrued liability and corresponding reduction in revenues for future refund of payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates our estimate of the amounts to be recognized for previously delivered tests, the impact of which was not material to our consolidated statements of operations for the three months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, no costs incurred to obtain or fulfill a contract have been capitalized. The Company also applies the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and the vast majority of payment terms have a payback period of less than one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#x2019;s accounts receivable are with companies in the healthcare industry, U.S. and state governmental agencies that make payments on the customer's behalf, and with individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare represented approximately 16% and 14% of total revenue for the three months ended September 30, 2020 and 2019, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#x2019;s customers as well as their dispersion across many geographic regions. No payor accounted for more than 10% of accounts receivable at September&#160;30, 2020 or 2019. The Company does not require collateral from its customers.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMzUwNA_c79ee56d-6d2b-4703-b903-16db87c85688">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents detail regarding the composition of our total revenue by product and by U.S. versus rest of world, &#x201c;RoW&#x201d;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;RoW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;RoW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Molecular diagnostic revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hereditary Cancer Testing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;104.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prenatal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GeneSight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vectra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;myChoice CDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prolaris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EndoPredict&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total molecular diagnostic revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;135.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;166.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceutical and clinical service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;174.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1795c5c48c34f16b22b8ae598cdd22a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC0xLTEtMS0w_c217d711-1f54-442e-981b-6e2dae32405b"
      unitRef="usd">72100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id178ba580c6f4185bc51f217377478d5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC0zLTEtMS0w_c74e9516-2679-4862-ba11-ea4f8bcad575"
      unitRef="usd">8500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcedbfd8cc754e8492395b6e8c733e64_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC01LTEtMS0w_2efdc777-bf6d-470a-adc1-c75cb94cea5c"
      unitRef="usd">80600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bfb911643b349c899f841b445e06512_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC03LTEtMS0w_273286c1-c7fb-4153-af41-224c86d6c2c0"
      unitRef="usd">100600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i422deb02b92f488ca820658db810b31a_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC05LTEtMS0w_4a46845e-e412-444a-b58f-295191f0c105"
      unitRef="usd">3900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i401a6d1f82534405a2c00ba1f907da60_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNC0xMS0xLTEtMA_9ec210f3-dbe8-4ddc-a73c-1aa58d278c78"
      unitRef="usd">104500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb347fa85ae744768f8361fb2ca325eb_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xLTEtMS01OTMy_885921f5-0d37-404d-9a8b-d3e38c6fa962"
      unitRef="usd">16400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i200b85a83c6a46bbabdea8dcc39d8562_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0zLTEtMS01OTMy_94426a0e-bbff-4304-9a9d-278c26d59db8"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic51c9413854143499e5aaf57989d7eb7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS01LTEtMS01OTMy_ac60ee18-6d7f-4b07-a663-3eeb666bee0f"
      unitRef="usd">16500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3348c1dccc754570a3090cd6065878a9_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS03LTEtMS01OTMy_fa435c10-ec37-4203-a968-c1f9f3e46c53"
      unitRef="usd">23500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7687ee73ec6a4a2fb7d9c3c95f5ed679_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS05LTEtMS01OTMy_d37c40b9-2793-4140-b32f-129653507f64"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08483a8a185e4dfb9ae69070970276d7_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xMS0xLTEtNTkzMg_2c469acb-737e-4156-9e89-b271e338b18a"
      unitRef="usd">23500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i951685b4432940a2b6070e5ae3bd49a5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xLTEtMS0w_1ee750ec-8f51-46c9-b051-72031c467905"
      unitRef="usd">11900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6744579210784fdeb06463912c24a193_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0zLTEtMS0w_0ed729f9-77c0-4c7e-9c00-ff448fcfb3b7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fd0de429b834c25b696cffe376cd572_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS01LTEtMS0w_0cada45a-8e82-4e13-8be6-23072a0d901c"
      unitRef="usd">11900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8769527161654967b1c9d612b500e5bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS03LTEtMS0w_0e97af6b-e5a4-42ff-ba24-91065c09cc8c"
      unitRef="usd">22700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a7219c652fa40129553545f083b6ffd_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS05LTEtMS0w_dbeea1fd-a210-4281-afb7-b8ccbf5eaf6c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45fc867c897b4386aeaf67795c276626_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNS0xMS0xLTEtMA_5aa08e81-e405-45ae-a022-da0dd5ad0576"
      unitRef="usd">22700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fad8fd2ba87493e8cae157d3442bae9_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy0xLTEtMS0w_1594ad78-3466-4a80-a39d-a357c81990c7"
      unitRef="usd">9100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bfa2d578a84425184f03060039d64fd_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy0zLTEtMS0w_99d80845-1d23-4414-aadf-aa4faf97e5ab"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2742d972b9a4d7fbbde1e0bbed5c74e_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy01LTEtMS0w_46edc309-107f-4ce7-93ed-4edfc0b66f6d"
      unitRef="usd">9100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74596ec49a7a4ebe83e5358874b6f8b1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy03LTEtMS0w_27932156-c7f3-4f04-97db-e5d327b53667"
      unitRef="usd">11000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3644e7dfea0400597ac774c4595f9c1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy05LTEtMS0w_7e55b564-2519-4b62-835b-6ea70a11bd4f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3668121649b4395acd610e7f38044b8_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfNy0xMS0xLTEtMA_2ff13c18-bed4-49ea-85f0-78b44efddbde"
      unitRef="usd">11000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id62e373c9cfa4d13b74004a4f087e81d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xLTEtMS02OTM3_b4099d60-e04d-4075-a150-c51889b16ca0"
      unitRef="usd">7600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3af57be3ac8745b59d1c5c8f835c759c_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0zLTEtMS02OTM3_46ee6a1d-40fd-4b82-b7c2-efc7604a68a5"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibca7cd2a9ed64068a730c3d0940649c7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC01LTEtMS02OTM3_d843d940-fec6-4b1e-9f7e-d72e65989dc5"
      unitRef="usd">7800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2228b67d6e046568399abed69752b24_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC03LTEtMS02OTM3_0f12cce3-1c16-4876-ae93-432dfb08d33c"
      unitRef="usd">1300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad0b089eccab490aa3d7e32307f073dc_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC05LTEtMS02OTM3_3a9b09a4-cd60-453d-9292-c294e1b07e6c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cc249590a16407aa43f1bcdf46a5e5c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xMS0xLTEtNjkzNw_0261e9b0-f196-4a86-81ec-a49b4d2e4f7d"
      unitRef="usd">1300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5dad84e61a5648f68b1f50c0b983bede_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xLTEtMS0w_8d2a1f6f-baa1-46bd-a9da-5e9105501178"
      unitRef="usd">6400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7033a2b43a11471a8ee110193d73fa2b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0zLTEtMS0w_7c35304e-964f-4011-a0a9-31a3c7c16f67"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22d3d58394a04580baac5d76d025fa35_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC01LTEtMS0w_a9ff9555-d44b-48f1-9137-2b0e6addc71b"
      unitRef="usd">6400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bf5e0d1693441a18f30a9d95fe4163b_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC03LTEtMS0w_831b4407-dce0-4bc3-9e79-4afe1b0b854e"
      unitRef="usd">6500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67246cad5fa34d69b25bfc809dd1c777_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC05LTEtMS0w_c040bb99-fcd9-4b67-942a-011f2772eeff"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i567a2a9416d34f3c92557d9422f0348b_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOC0xMS0xLTEtMA_0593ec18-8790-4bc8-9403-e4437b4ddf59"
      unitRef="usd">6500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ebbd429b95f49139bb9281a342136de_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS0xLTEtMS0w_85abee2e-8a0f-4cb7-a28b-e03216981c54"
      unitRef="usd">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i484f743506ee4902aef30c20d43aa898_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS0zLTEtMS0w_34479753-4231-4c4f-b47a-0105dc153ceb"
      unitRef="usd">2400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i280ce449a5d6421ca8511c92eeddca0a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS01LTEtMS0w_ecfd8ee5-423a-47c0-abd0-615f05075278"
      unitRef="usd">2800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i605a9571af9c4c29b51405c5fa8a5180_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS03LTEtMS0w_83982864-5e85-4d2d-ae54-d4d96792fc9c"
      unitRef="usd">500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8720515f7754cf1bb2ae4218d464c2a_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS05LTEtMS0w_6c22d4ce-3982-4783-a4b2-a0e26209162a"
      unitRef="usd">1800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59e287da7a7c4198b40966eba2b62146_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfOS0xMS0xLTEtMA_ee97d30c-8a62-4157-bba2-54cc708a9841"
      unitRef="usd">2300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i285edd982b994ad2b3b7a0af7f283e6b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtMS0xLTEtMA_a22751b3-710d-4a58-af53-5651d4b41609"
      unitRef="usd">600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51fd75ee62c145e2952ac446346d9b7c_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtMy0xLTEtMA_3e3067d1-f3d5-4a89-81ac-4c47dbabe4e5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4121b8b21d442e292a4ed42bdb30d70_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtNS0xLTEtMA_0a6ef48f-6021-434e-880e-d04bda9f750e"
      unitRef="usd">600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29558741c2674b39926f43730a6b171b_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtNy0xLTEtMA_2ee52ab7-10c0-4e57-9160-b78f84d63bf9"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1bb8d1c57184d4f94dc2c42b00f8a29_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtOS0xLTEtMA_59a18b3e-5032-49a2-a52d-3baa2deeb873"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ef0215658fa4d7c85eef815a3644861_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTAtMTEtMS0xLTA_6ff186ee-fa1a-4f49-a311-28c02537948d"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd11d9c02bce445fa4341df9cbdb8482_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtMS0xLTEtMA_34993b3a-c35f-4aff-b356-4e3407c89990"
      unitRef="usd">124500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i378ad67948644fae91e1885f07d8b2c2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtMy0xLTEtMA_dff981c9-9149-4af9-bff2-38a7257831be"
      unitRef="usd">11200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied7456a090b14cd58d14abdc5f499f08_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtNS0xLTEtMA_28d1c80b-4897-4538-aa08-f0c1484eeb1c"
      unitRef="usd">135700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6600cdbac0c2465bb71dca2e44416ef6_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtNy0xLTEtMA_5594203a-0ce9-4fbe-98b6-8d3fccc958b3"
      unitRef="usd">166200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ede0c04f58f4611b03fdd8721157941_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtOS0xLTEtMA_c4455b95-6c7c-47b1-8435-3c4dfc989148"
      unitRef="usd">5800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8bd4ec412b9c43818064a286671312e6_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTEtMTEtMS0xLTA_4b5366be-caae-4bc9-aa64-a15477c9bdc7"
      unitRef="usd">172000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia52c822bff2e4272a00b3a632878266f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItMS0xLTEtMA_6a9edc95-6dc8-49cb-9c0b-ad7651059467"
      unitRef="usd">9500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba547eb3ac564cf5bc3176aceeb2d680_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItMy0xLTEtMA_1264e765-0310-443b-984d-c5f0efaa5730"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27ad9b68cdc249fbbbece8f4b7df8c72_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItNS0xLTEtMA_66524662-6144-4c6c-9a5f-7cfd66f6a011"
      unitRef="usd">9500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if78ac333a8f347ea8edf5c2f08bf8df0_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItNy0xLTEtMA_3d8a9ed4-0a4b-4e0f-a210-d485d28f9383"
      unitRef="usd">8500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8835dd209114523bb9e8a64833ef8ff_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItOS0xLTEtMA_3c178b8f-29d6-47f5-a71a-6447a9f37336"
      unitRef="usd">5900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib925b27f5c5943efb3fd81934d95893d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTItMTEtMS0xLTA_94c54db3-9377-4222-a2fb-698701f47e07"
      unitRef="usd">14300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47d31e10974947898926c5dcd4c0a95a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtMS0xLTEtMA_fb749246-1cf6-47a7-b3fe-e68b82d7bb4f"
      unitRef="usd">134000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec7def734f4846fea024f404d1b6f52f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtMy0xLTEtMA_f0886364-819c-4f51-922e-9c4745d56499"
      unitRef="usd">11200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtNS0xLTEtMA_1f4e3c7b-890f-4c0c-b3bd-0f86a1c591bf"
      unitRef="usd">145200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a8093dea57344778918ad7b5f751bce_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtNy0xLTEtMA_5af4c4a7-0824-47b0-bf3f-e5405909420f"
      unitRef="usd">174700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2a611ec025e4fe6ac0191daf64556af_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtOS0xLTEtMA_a64673b5-8f8e-4ac0-825f-2c4319aa0c99"
      unitRef="usd">11700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOjliY2UwMzY1YTMxNjQ4ZDJhZGY0NmIxYWMxZDE4NjdmL3RhYmxlcmFuZ2U6OWJjZTAzNjVhMzE2NDhkMmFkZjQ2YjFhYzFkMTg2N2ZfMTMtMTEtMS0xLTA_b39ff4b6-05c1-44b6-99d9-a990206f341e"
      unitRef="usd">186300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mygn:CARESActOf2020MedicarePaymentAmount
      contextRef="i4464ac83ed924822929712315bbc20be_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMjc0ODc3OTA3MzAzOQ_3b9246a4-2283-4da0-ab72-e6ed6f74dba1"
      unitRef="usd">29700000</mygn:CARESActOf2020MedicarePaymentAmount>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMzUwNQ_c89d686c-0d12-4ed8-bdb1-4d6b9ae64df2">A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.010%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue - beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue - ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMi0xLTEtMS0w_af807977-a281-4087-8f74-97b654f6d5ec"
      unitRef="usd">32800000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i139906c1954e43c39560efe073ca515b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMi0zLTEtMS0w_6a08d997-4cf0-4dfb-bf09-3232f25030f8"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMy0xLTEtMS0w_91263365-0446-4eab-aeab-1b4e56899299"
      unitRef="usd">2300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfMy0zLTEtMS0w_57a35f30-15b4-45dd-b8b4-1c448a349551"
      unitRef="usd">400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <mygn:ContractWithCustomerLiabilityPrepayments
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNC0xLTEtMS0w_53c1d5b1-dad3-45df-8ac0-5f27ed7cbe09"
      unitRef="usd">1800000</mygn:ContractWithCustomerLiabilityPrepayments>
    <mygn:ContractWithCustomerLiabilityPrepayments
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNC0zLTEtMS0w_7de3f257-86a6-4aa9-b365-53dde9aee0d7"
      unitRef="usd">300000</mygn:ContractWithCustomerLiabilityPrepayments>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNS0xLTEtMS0w_790ed98e-b056-4d96-b63d-efce4e1abb5c"
      unitRef="usd">32300000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i61a8af6463ab4c92ba4435534752e1a2_I20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RhYmxlOmIwZDYzY2RhYzMwZDQzMDBhODk0OGE4ZmQyMjdkNzRhL3RhYmxlcmFuZ2U6YjBkNjNjZGFjMzBkNDMwMGE4OTQ4YThmZDIyN2Q3NGFfNS0zLTEtMS0w_6e420c2d-42a9-4ceb-88c4-0cce13fc24ce"
      unitRef="usd">2100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:RevenuePracticalExpedientRemainingPerformanceObligationDescription
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMTI1Nw_9624b43f-8b87-4b1a-8846-ba82bdb43550">In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#x2019;s right to payment is in an amount that directly corresponds with the value of Company&#x2019;s performance to date. However, the Company periodically enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations.</us-gaap:RevenuePracticalExpedientRemainingPerformanceObligationDescription>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfNjA0NzMxMzk2MTkwNQ_9e1c72b3-e78c-4c87-a404-ec6e81425a6e"
      unitRef="usd">2800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerRefundLiability
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIyNTczMw_1ae2c5d7-c155-468d-86ce-a5adbb5ae579"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:RevenuePracticalExpedientIncrementalCostOfObtainingContract
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIxMTg1NQ_ed09cbc0-c6fa-42ac-b558-fe45f14a2e47">true</us-gaap:RevenuePracticalExpedientIncrementalCostOfObtainingContract>
    <us-gaap:CapitalizedContractCostGross
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfMjc3OA_ad1311a2-e410-43d8-bb6b-e85b81dc0cba"
      unitRef="usd">0</us-gaap:CapitalizedContractCostGross>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9a31395d02b44be398a13e91e3f5d44b_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIyNTc0Mw_676bc2ce-7a12-4324-af33-24f37f7797a0"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0632e32f05f944ccbf27e6259c5b238b_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF80MC9mcmFnOjAwOGRmMDI4ZDVlNTQ0Y2JiYjliNDgyZDA5M2E4YzJhL3RleHRyZWdpb246MDA4ZGYwMjhkNWU1NDRjYmJiOWI0ODJkMDkzYThjMmFfODI0NjMzNzIyNTc0OA_9049cc77-ae8d-4130-bb55-2d4a682ff129"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RleHRyZWdpb246Y2EzMGY4OTFlYzZlNDMwMTkxMmI3NTU0OTk1MGRkNDRfOTgx_97bbd86d-fe27-48ec-b5d9-6d4fcf393246">MARKETABLE INVESTMENT SECURITIES&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its debt investment securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#x2019; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#x2019;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.&#160;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at September&#160;30, 2020 and June&#160;30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;253.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;254.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the adoption of ASC 2016-13, the Company assesses any unrealized loss positions for available-for-sale debt securities for which an allowance for credit losses has not been recorded. The aggregate amount of unrealized losses of these securities was not significant, and the impact of the securities in a continuous loss position to the condensed consolidated statements of operations and comprehensive loss were not material as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due after five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RleHRyZWdpb246Y2EzMGY4OTFlYzZlNDMwMTkxMmI3NTU0OTk1MGRkNDRfOTgy_34ea6c23-7860-4a3f-9e2b-27a04d44f451">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at September&#160;30, 2020 and June&#160;30, 2020 were as follows:&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;unrealized&lt;br/&gt;holding&lt;br/&gt;losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;253.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;254.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMy0xLTEtMS0w_93a688c4-e0de-4302-9a5c-b8f9d35cdfc6"
      unitRef="usd">68300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMy03LTEtMS0w_fe1802ff-4a44-47a2-9baf-13a8f61310f1"
      unitRef="usd">68300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNC0xLTEtMS0w_9e28ee66-b1d8-4669-9188-97c31189c705"
      unitRef="usd">50000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNC03LTEtMS0w_e338ab33-ec66-46f5-893b-894c3a9b7ae1"
      unitRef="usd">50000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNS0xLTEtMS0w_62515226-cdbd-49dd-b507-4502ffa99914"
      unitRef="usd">118300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNS03LTEtMS0w_e6478b40-f39e-4f06-aba6-a896829e899a"
      unitRef="usd">118300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy0xLTEtMS0w_35e996be-5e14-4e74-acb1-1559ef148642"
      unitRef="usd">40500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy0zLTEtMS0w_6ed08b01-1aac-4f34-97a0-bf0d8622fa5a"
      unitRef="usd">600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy01LTEtMS0w_47d7bf1c-005f-4e65-beec-bda6ebec7dae"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfNy03LTEtMS0w_b77c3cd7-1d18-49c3-a102-46007c04ac2d"
      unitRef="usd">41100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC0xLTEtMS0w_bbd43bb4-6a39-490f-8b0b-f95264ad7bdd"
      unitRef="usd">12600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC0zLTEtMS0w_a806b9ae-3cd3-44e3-a4bf-f696bd8f3a00"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC01LTEtMS0w_4b965ef1-4705-48fa-8884-1977f5d886f5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOC03LTEtMS0w_f5712bca-bdc0-45e2-84b1-1858c135d680"
      unitRef="usd">12800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS0xLTEtMS0w_e461e56d-2987-41e6-8f91-3ddd42ce4f84"
      unitRef="usd">4000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS0zLTEtMS0w_acbd976f-d851-4d53-9679-7f3e15ecb009"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS01LTEtMS0w_17111fc7-2862-4d96-87c9-7736deb94abc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfOS03LTEtMS0w_cf951eed-4b06-4865-91d1-a9ef687d84e3"
      unitRef="usd">4100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6fb745cf587b4aee882556505e97108b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtMS0xLTEtMA_24323b6a-1e82-4ae5-8e8f-856c50ecd9f2"
      unitRef="usd">14200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6fb745cf587b4aee882556505e97108b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtMy0xLTEtMA_d112fe01-73fb-433c-8c82-a809fdded3e4"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6fb745cf587b4aee882556505e97108b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtNS0xLTEtMA_1a4fc41b-c098-432e-a4b2-dd3b83072fb2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6fb745cf587b4aee882556505e97108b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTAtNy0xLTEtMA_0f45022d-e6f7-4d6b-9969-746d6a5e03c9"
      unitRef="usd">14300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <mygn:InvestmentsAndCashAmortizedCost
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtMS0xLTEtMA_1a8787f0-e496-450d-b390-444ce6d50756"
      unitRef="usd">189600000</mygn:InvestmentsAndCashAmortizedCost>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtMy0xLTEtMA_d088563c-fe9a-4180-9a5d-30438d33760f"
      unitRef="usd">1000000.0</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtNS0xLTEtMA_da4fb94a-e09e-4999-a52e-f08a6887573a"
      unitRef="usd">0</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsAndCash
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjEyYWE5N2MzMTc1ODQ1ZjU5M2VmNGM0N2I2YmI3N2Q5L3RhYmxlcmFuZ2U6MTJhYTk3YzMxNzU4NDVmNTkzZWY0YzQ3YjZiYjc3ZDlfMTEtNy0xLTEtMA_26b17904-f98b-459b-a409-dcc52adaa1be"
      unitRef="usd">190600000</us-gaap:InvestmentsAndCash>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i363e9516fa95448388f9372a48406019_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMy0xLTEtMS0w_277686e7-157b-4750-b808-500292c93773"
      unitRef="usd">132800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i363e9516fa95448388f9372a48406019_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMy03LTEtMS0w_f54d7348-c1fb-4bea-ae4f-185f3b1e40a0"
      unitRef="usd">132800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6c6e2f5995484ce7b6fa8a39920efa01_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNC0xLTEtMS0w_08c5e4eb-37b9-4dbf-b7bf-0b701698c66b"
      unitRef="usd">30900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6c6e2f5995484ce7b6fa8a39920efa01_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNC03LTEtMS0w_43c8638b-1a06-4075-8c73-71c49dfce243"
      unitRef="usd">30900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNS0xLTEtMS0w_57025004-f566-444e-b54d-9ef0df9c77ba"
      unitRef="usd">163700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNS03LTEtMS0w_a82dac2e-abd6-487f-9942-712d329a743d"
      unitRef="usd">163700000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy0xLTEtMS0w_68a86af1-255b-481f-abd7-d511ed92b3cf"
      unitRef="usd">50100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy0zLTEtMS0w_56f44aba-79c0-4769-9190-c028098edd89"
      unitRef="usd">800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy01LTEtMS0w_a743f76a-9f4b-4e9d-9ae3-9851e35861ae"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfNy03LTEtMS0w_d6ec8d41-d215-45b2-bd8d-9b0e1d6d0da6"
      unitRef="usd">50900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC0xLTEtMS0w_60f7b4fe-c1f0-4d5e-abfa-3763aa20287d"
      unitRef="usd">17800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC0zLTEtMS0w_f0b87e5e-bea2-4326-be5b-b14ae289e5e1"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC01LTEtMS0w_e2d159e6-4b40-46ab-a3a7-fc2f2344d310"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOC03LTEtMS0w_9624b335-f006-4459-a841-2b0db2e9ad3a"
      unitRef="usd">18000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS0xLTEtMS0w_a4a76fa3-2aed-4978-846d-b2804cc7551f"
      unitRef="usd">5500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS0zLTEtMS0w_9fea4c94-caef-4a58-a489-4e8fefd1d530"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS01LTEtMS0w_422c6593-3848-46ec-a515-ee87ba6d7dad"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfOS03LTEtMS0w_b4ea4632-a8e4-4c7f-a087-3a243bf5390d"
      unitRef="usd">5600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtMS0xLTEtMA_c007a34d-f295-4e19-a0a3-fece7744c55e"
      unitRef="usd">16400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtMy0xLTEtMA_7884eae6-5e59-4bfc-a3dd-31a60bbf5004"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtNS0xLTEtMA_51417622-70c9-4ef7-9307-e33f475dc5e0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTAtNy0xLTEtMA_c3102dda-1a10-4743-8146-f772f9ea9e19"
      unitRef="usd">16600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <mygn:InvestmentsAndCashAmortizedCost
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtMS0xLTEtMA_8f4f4f39-8e48-4216-a5e0-8c0b671bd8c7"
      unitRef="usd">253500000</mygn:InvestmentsAndCashAmortizedCost>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtMy0xLTEtMA_37580ba9-92df-425d-8483-c19203f310d8"
      unitRef="usd">1300000</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax>
    <mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtNS0xLTEtMA_23d3dea2-02c5-4384-834d-23b2cec360de"
      unitRef="usd">0</mygn:InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsAndCash
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjYwMzQ1YmQxMjFkZTQzNmRiN2E4NjkzZGIzNDkwODMwL3RhYmxlcmFuZ2U6NjAzNDViZDEyMWRlNDM2ZGI3YTg2OTNkYjM0OTA4MzBfMTEtNy0xLTEtMA_6c8ba303-9eef-44cb-8895-7cc74858f773"
      unitRef="usd">254800000</us-gaap:InvestmentsAndCash>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RleHRyZWdpb246Y2EzMGY4OTFlYzZlNDMwMTkxMmI3NTU0OTk1MGRkNDRfOTgz_dc863b18-ad7a-4066-991e-8717201547fe">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due after five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;189.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMS0xLTEtMS0w_485ca50f-464e-411e-bac8-b32eec622f92"
      unitRef="usd">68300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2f57621ff8594336baf9a6ecc3bb8fec_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMS0zLTEtMS0w_f855555a-05ee-4ffe-aed8-e906a88d0c4a"
      unitRef="usd">68300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMi0xLTEtMS0w_6d1e40d3-9645-4232-95de-fb2035407d7a"
      unitRef="usd">50000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie70baa6f3a9b44e2a70b362e5ba27abe_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfMi0zLTEtMS0w_b17acbdd-8fe9-4931-b9ce-55d852ee9359"
      unitRef="usd">50000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNC0xLTEtMS0w_e38ba9cb-ac7e-4781-b5aa-009078eb3e46"
      unitRef="usd">41800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNC0zLTEtMS0w_92d35407-9d62-4521-ba81-fc6ffadd35f1"
      unitRef="usd">42100000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNS0xLTEtMS0w_4ade2128-ffee-4a48-a9be-00ae48af2a7c"
      unitRef="usd">29500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNS0zLTEtMS0w_863a740c-2c89-454f-a23b-b0e9a2cc7b94"
      unitRef="usd">30200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNi0xLTEtMS0w_823c5ab7-45a5-4a1a-8378-b3af2d034cd8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81Mi9mcmFnOmNhMzBmODkxZWM2ZTQzMDE5MTJiNzU1NDk5NTBkZDQ0L3RhYmxlOjZiMTE2ODAzMTFhNTRlYTY5N2FjODUxNjBjNjE4ZDZiL3RhYmxlcmFuZ2U6NmIxMTY4MDMxMWE1NGVhNjk3YWM4NTE2MGM2MThkNmJfNi0zLTEtMS0w_42841f56-10ea-4758-9b01-430225b00de7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNDM1MQ_9117339c-57c1-4933-b788-dc29b1f8d0fe">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1&#x2014;quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2&#x2014;observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;&#160;Some of the Company&#x2019;s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&#x2014;unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s financial instruments are valued using quoted prices in active markets or based on other observable inputs.&#160;&#160;For Level 2 securities, the Company uses a third party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information. The fair value of contingent consideration related to the Sividon Diagnostics GmbH ("Sividon") acquisition in fiscal year 2016 as well as long-term debt are categorized as Level 3 liabilities, as the measurement amount is based primarily on significant inputs not observable in the market. &#160;For Level 3 contingent consideration, the Company reassesses the fair value of expected contingent consideration and the corresponding liability each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected earn out liability.&#160;This fair value measurement is considered a Level 3 measurement because the Company estimates projections during the expected measurement period of approximately 9.25 years, utilizing various potential pay-out scenarios.&#160;&#160;Probabilities were applied to each potential scenario and the resulting values were discounted using a rate that considers weighted average cost of capital as well as a specific risk premium associated with the riskiness of the earn-out itself, the related projections, and the overall business.&#160;The contingent earn-out liabilities are classified as a component of long-term and short-term contingent consideration in the Company&#x2019;s consolidated balance sheets.&#160;&#160;Changes to the earn-out liabilities are reflected in change in the fair value of contingent consideration in our consolidated statements of operations. Changes to the unobservable inputs could have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our long-term debt, which we consider a Level 3 measurement, is estimated using discounted cash flow analyses, based on the Company&#x2019;s current estimated incremental borrowing rates for similar borrowing arrangements.&#160;&#160;The fair value of long-term debt is estimated to be $226.5 at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the fair value of the financial assets and liabilities that the Company re-measures on a regular basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the change in the fair value of the contingent consideration during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in fair value recognized in the income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Translation adjustments recognized in other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The fair value of contingent consideration for the three months ended September&#160;30, 2020 decreased compared to the same period in the prior year due to changes in timing of expected cash payments associated with the contingent consideration related to the Sividon acquisition.</us-gaap:FairValueDisclosuresTextBlock>
    <mygn:BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm
      contextRef="i6b0749afe2864e698e44179a9a3109aa_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfODI0NjMzNzIxNDMyMA_8a98adf4-618b-4baa-aee9-464bfcacf20d">P9Y3M</mygn:BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia50d0d8131d5462795581f189d2f1d14_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNzE0NjgyNTU4NTkwNg_bc083e1d-70b5-4ddd-9ecf-9771e81868e2"
      unitRef="usd">226500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNDM0OQ_42936dae-5e8f-4ad4-8dd6-9aebb1cca4d0">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the fair value of the financial assets and liabilities that the Company re-measures on a regular basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds and notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal agency issues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt"&gt;Money market funds are primarily comprised of exchange traded funds and accrued interest.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i03b12526fbc2445095fb01cac8a0200e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi0xLTEtMS0w_371a6c94-391b-4c77-9d09-0d17e835dcab"
      unitRef="usd">50000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib9ca61745af34a4892fb24f02df51ce3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi0zLTEtMS0w_452cdc52-3909-4f4a-8e98-680a3222c088"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id4cd1faa18234928a9a39c3bbf242061_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi01LTEtMS0w_56f1af5f-2a04-4bfc-9c27-309fd28ba8d8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icbd1f3cce2e5428eb21ef3b840688e1a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMi03LTEtMS0w_a27220d7-95a6-4b08-b64e-636307bbfa24"
      unitRef="usd">50000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i54e3cdbd09e6474bad78d5f7ae7c8d95_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy0xLTEtMS0w_51aabf0b-5f81-439a-b355-8d9369aa3466"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if4fbe575c144479f93f88f70cd2f64f0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy0zLTEtMS0w_54175dd3-00fe-48eb-9028-5ed70468a661"
      unitRef="usd">41100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idbadb5bbe9c24d9aacd4015398fe5cb0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy01LTEtMS0w_9be7b8b0-61db-4874-9de2-4d356eee07fb"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic645e61b77c341fab940f4bbab5081e8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfMy03LTEtMS0w_5e2e0d6a-93f1-466c-b3e2-1f597b2ac68b"
      unitRef="usd">41100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i72a3a4c04f3d40f5a2832e1afe743ff6_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC0xLTEtMS0w_60a2737c-848f-4d7c-b6db-e6320902f37d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icf4e8d24654e407fa0d279355277f975_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC0zLTEtMS0w_c2c0389b-65da-42b5-96f5-eeaddef3eb2e"
      unitRef="usd">12800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2b08211082a3454893716f0969068c16_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC01LTEtMS0w_b8c30287-6de2-45dd-a1ce-b524072aa28b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibe227e1bc62d4bdcadee113ac8f6a370_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNC03LTEtMS0w_41ee3364-e963-4509-bbdc-c1e7393e96dd"
      unitRef="usd">12800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib95e73f78d584d03824f89f24d888618_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS0xLTEtMS0w_485cf3ae-2976-45b8-a320-921577d4dea3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic3996efae676460a9efe08f0472b97ac_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS0zLTEtMS0w_63d689c4-d759-4ef1-90b7-dfbad5ab37d7"
      unitRef="usd">4100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iefcec8bb3032434d9fab30ffede5b08b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS01LTEtMS0w_d5089823-188d-4c59-830d-566ebc5a1984"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5e0d79816a8044b28e2ee03f44ee78e0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNS03LTEtMS0w_bcf696ea-746c-4a19-95e5-490ab2ec4607"
      unitRef="usd">4100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id08f528c9e5845f9a07f73e22be9e0d6_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi0xLTEtMS0w_9dd6bb03-34ee-4e61-bf65-3a1a31b9353a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i18fd7203ded848c0a6062cace377683e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi0zLTEtMS0w_c92d02ea-8057-4065-8be1-3a4577f9a85e"
      unitRef="usd">14300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if5db99cba11444b8bdf61c2da7e49565_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi01LTEtMS0w_839d1224-ace0-4aa1-99a9-866c0a763a19"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6fb745cf587b4aee882556505e97108b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNi03LTEtMS0w_9ab49877-78fa-43d7-9641-1264040d670d"
      unitRef="usd">14300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6b57287f98834cbca2dae9554a148b7c_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy0xLTEtMS0w_4fea1136-60b1-4430-a040-cf8f87a6412e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5d6b05ed9dff446597fbac8b9a5c2d2d_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy0zLTEtMS0w_c29b2da9-8487-414a-8be1-47f2f2f4ce5c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iadafeb4cc83d4d8f830a67adc9b80fc3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy01LTEtMS0w_60fd87d3-c515-45f2-a805-80ebebb695e4"
      unitRef="usd">5900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i02975ce7a7184746bad04769367d2d8a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfNy03LTEtMS0w_fbb57bab-4a15-4054-9e71-a3f6323b2d0f"
      unitRef="usd">5900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i89284fd7a0a14425a733d40a934ae931_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC0xLTEtMS0w_c3443c75-5944-4150-aec9-fc351452bdc8"
      unitRef="usd">50000000.0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="iab197615130e49f98518a5172359cd51_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC0zLTEtMS0w_29806da2-5d4d-4e7f-a443-09927c61c5ab"
      unitRef="usd">72300000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ia50d0d8131d5462795581f189d2f1d14_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC01LTEtMS0w_0542d926-955a-4cac-b40e-b709e762c27b"
      unitRef="usd">-5900000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmI5MGMzMmZkNWY1MDRjZGViNDlhMGNiOThlYzBlYmM5L3RhYmxlcmFuZ2U6YjkwYzMyZmQ1ZjUwNGNkZWI0OWEwY2I5OGVjMGViYzlfOC03LTEtMS0w_f2f811b1-92b8-491c-8fd7-459995e581c2"
      unitRef="usd">116400000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9e11187b43e04a0093140e12fee973c1_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi0xLTEtMS0w_1987fa30-98a1-452c-bb48-ea6918f19519"
      unitRef="usd">30900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idd13afd135f940fbbf70581c789f8cf3_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi0zLTEtMS0w_a318845d-7780-44b8-b104-71b5b6858f1f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i56c502380d0d43a88063a06a16530a3e_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi01LTEtMS0w_609b0b7b-553d-4d1b-9c61-462b74ee2bb5"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie0daf004372944a1bac9f844e1eef37d_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMi03LTEtMS0w_b2e4cd20-02d4-4d98-9835-acf2816e9345"
      unitRef="usd">30900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib60c105243a44ff2b52cb830ca3f0612_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy0xLTEtMS0w_15423b3b-d11e-4c0e-a6b8-a948a3c18e70"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9169f553a75d40ea8601058742b6ce6b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy0zLTEtMS0w_f8a60df4-eceb-4545-b583-413a197c7801"
      unitRef="usd">50900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia17529a19c854ba3a5b3782a119a6641_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy01LTEtMS0w_dad2fc6f-5bc1-449c-a838-27ca08463fd7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i283089fe02a54c5b92e07efd341a571b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfMy03LTEtMS0w_da2c198f-2156-47e9-9dd1-e66ad6e6b4d8"
      unitRef="usd">50900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i51e7fa915fa440fba6edada1d950d356_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC0xLTEtMS0w_4ccee3ff-12cd-40dc-be7f-f478bc8997e6"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idc6cbaca5036438d8e4b5fc144239335_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC0zLTEtMS0w_b29d8487-88df-4709-842f-58a7d2c0e393"
      unitRef="usd">18000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i469e373b8c0c43c2a5d70d03cf8bbd0f_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC01LTEtMS0w_dea267f5-7fde-48ab-8ba8-eecd447d9b37"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib15cb0b0dad342d5b599e3ea14c7e579_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNC03LTEtMS0w_b91815ad-5f35-4a76-842d-25b88c4a1f49"
      unitRef="usd">18000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia7ffbeab905e44cf92eeca09b81182f1_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS0xLTEtMS0w_81d5443e-d007-432b-872e-ce8169b9b174"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i97e8d8a8b99d42c2827899164b67f836_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS0zLTEtMS0w_bf4bb817-d385-4f77-9731-35f539fde197"
      unitRef="usd">5600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i57248bec235b477e86c27bec023182d8_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS01LTEtMS0w_cf97d5f9-be92-4393-a7cd-8b1ea0e7bc15"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i044fc58634da4848b1552fffbacd4a03_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNS03LTEtMS0w_38271925-64fa-46a7-bbee-e22e7a617e09"
      unitRef="usd">5600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc90dd9b027a488592fd2345f76e07b8_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi0xLTEtMS0w_6407f1f1-07a0-48f3-bd39-528214772eb3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i06989fe731e041ec9c47378d113e9ba4_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi0zLTEtMS0w_08424bde-6c94-4047-b217-825106bc8234"
      unitRef="usd">16600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia3c91e9de9334c18b4886936541914c8_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi01LTEtMS0w_ee6c93b7-5bba-42bf-bc7f-cce4afb8c428"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic47a7731c378469ba7051e67d843a0e0_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNi03LTEtMS0w_12773bc4-900b-4b16-8c20-383ca000a984"
      unitRef="usd">16600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8924bcae1bc14f7ea6e74dd68cf95dbc_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy0xLTEtMS0w_f64123ac-e29d-4d84-a51c-399683ff9b44"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if285d2c4c39b48fea6ad28b9de16c7ef_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy0zLTEtMS0w_81fc7585-7c10-44bc-b64c-e18c9de4210d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3f53f70b2fc74581bf96fa47b43ca738_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy01LTEtMS0w_2556d7a6-ca79-4e77-9364-8a7a0fd9c4c6"
      unitRef="usd">6800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7e0b0e9caa9844859a83f02b58ec38d1_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfNy03LTEtMS0w_cb2ebf89-2302-4a36-888e-382cedb00fed"
      unitRef="usd">6800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ifa131e48ae9f404b915d24c15ada4467_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC0xLTEtMS0w_619f4c68-e7b6-4830-888c-e2d68ac145ee"
      unitRef="usd">30900000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i2cd593b0b41a4e759514f092f1f9e3ec_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC0zLTEtMS0w_0c247f39-49ca-4324-b2c9-669ffe8f2759"
      unitRef="usd">91100000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="if6e717c6e6cf4c1cacf0ce093a7d1b51_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC01LTEtMS0w_f98300af-b4d7-4fe9-97cd-55bca0bf566c"
      unitRef="usd">-6800000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOjc1OGE4YTVjMzJkNDQ0YjNhNWU0YzgwZTA1MDA4NDdjL3RhYmxlcmFuZ2U6NzU4YThhNWMzMmQ0NDRiM2E1ZTRjODBlMDUwMDg0N2NfOC03LTEtMS0w_a8da6b08-eb5a-43a1-ae12-7c7373382149"
      unitRef="usd">115200000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RleHRyZWdpb246MTMwZGQ2MTc5NTdkNDFmMmI1NTRiODMzNzAyMzU0MGFfNDM1MA_78156d8d-ccfe-4160-9b3d-56a4b8a9adc2">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the change in the fair value of the contingent consideration during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in fair value recognized in the income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Translation adjustments recognized in other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfMS0xLTEtMS0w_ea234309-7b0b-4424-8379-68f8c2e03d7e"
      unitRef="usd">6800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfMi0xLTEtMS0w_22eeabfb-41c0-4908-bcd7-e95c9eda70e1"
      unitRef="usd">100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfMy0xLTEtMS0w_d9ab9c8d-eaf0-47f3-93b2-084c2a8cb2a9"
      unitRef="usd">1100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfNC0xLTEtMS0w_da0c604c-ac39-4d68-9901-8e3feb519327"
      unitRef="usd">-300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF85NC9mcmFnOjEzMGRkNjE3OTU3ZDQxZjJiNTU0YjgzMzcwMjM1NDBhL3RhYmxlOmYyMGI3YzIwNzc2YjQwMWZhOWEyM2EzM2E4N2M5MDg0L3RhYmxlcmFuZ2U6ZjIwYjdjMjA3NzZiNDAxZmE5YTIzYTMzYTg3YzkwODRfNS0xLTEtMS0w_85f4863b-7ca1-4929-910e-c8a8ac85e7f4"
      unitRef="usd">5900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RleHRyZWdpb246NTE0MWQwNTU1Yzc4NDcwYjllNDg2Y2MzNjAwYWY0ZjhfMjg1_d87ac4cf-9851-437e-aaf0-2ec5837f6940">PROPERTY, PLANT AND EQUIPMENT, NET&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;114.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;146.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(110.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(106.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RleHRyZWdpb246NTE0MWQwNTU1Yzc4NDcwYjllNDg2Y2MzNjAwYWY0ZjhfMjg2_38c9c257-f693-4dbd-9d53-5e0e829ea5b2">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;114.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;146.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;143.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(110.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(106.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfMy0xLTEtMS0w_6d06834f-2d82-4996-b527-084398fc60dc"
      unitRef="usd">32600000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfMy0zLTEtMS0w_25777c05-f841-4fab-b488-2c89a21c9719"
      unitRef="usd">31800000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNC0xLTEtMS0w_96fc37e6-06e5-4a2f-93c0-b437254d4014"
      unitRef="usd">114100000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNC0zLTEtMS0w_367b7bf7-7722-434d-9a19-6dde9eb339fa"
      unitRef="usd">112100000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNS0xLTEtMS0w_bf17d030-b25e-4ee5-982f-8675a175b460"
      unitRef="usd">146700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNS0zLTEtMS0w_66aad824-a262-42fd-bb17-d0fb5a96568d"
      unitRef="usd">143900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNi0xLTEtMS0w_be190e6d-83ca-425f-8c35-f9e40381c7e7"
      unitRef="usd">110000000.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNi0zLTEtMS0w_d23eb5f6-60f7-43c4-b0a9-17ddff37da60"
      unitRef="usd">106900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNy0xLTEtMS0w_22add731-81da-4c71-aa0e-59e66faf6eac"
      unitRef="usd">36700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmIzMjZiNzk0MmRkZTQ1YWRiOWI1YjBlZWFlM2I3MzBhL3RhYmxlcmFuZ2U6YjMyNmI3OTQyZGRlNDVhZGI5YjViMGVlYWUzYjczMGFfNy0zLTEtMS0w_6c4618e1-77f9-410d-997b-826f02b27800"
      unitRef="usd">37000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmZjY2IxM2JkNjExYTQwMTFiNmUxNzQxYmNmN2Y2Njg4L3RhYmxlcmFuZ2U6ZmNjYjEzYmQ2MTFhNDAxMWI2ZTE3NDFiY2Y3ZjY2ODhfMi0xLTEtMS0w_55037c02-8a2b-42b2-86c6-8ed27ee6381a"
      unitRef="usd">2400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF81OC9mcmFnOjUxNDFkMDU1NWM3ODQ3MGI5ZTQ4NmNjMzYwMGFmNGY4L3RhYmxlOmZjY2IxM2JkNjExYTQwMTFiNmUxNzQxYmNmN2Y2Njg4L3RhYmxlcmFuZ2U6ZmNjYjEzYmQ2MTFhNDAxMWI2ZTE3NDFiY2Y3ZjY2ODhfMi0zLTEtMS0w_0b9a892a-82f0-4608-99aa-26a0ad2dd4b3"
      unitRef="usd">2900000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMg_7f60be4c-8af2-4162-bb95-173a226b5b68">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended September&#160;30, 2020, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:93.421%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company will perform its annual goodwill impairment testing during the quarter ended December 31, 2020 as a result of its change in fiscal year end (see Note 16). The upcoming annual assessment may result in impairment charges if there is deterioration in business conditions, negative changes in market factors, or changes in the strategic priorities of the Company and its reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and trade names as well as non-amortizable intangible assets of in-process technologies and research and development.&#160;The following summarizes the amounts reported as intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;816.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(232.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;584.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;824.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;586.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;829.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;590.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;815.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(217.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;823.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;600.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;828.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;605.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded amortization expense during the respective periods for these intangible assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzQ5OQ_a9a18da8-8655-412d-98fd-3ebbbb7e71b8">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended September&#160;30, 2020, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:93.421%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i6a3c6b6633454ca5abeba426ba6e1898_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMS0xLTEtMS0zMTg2_30fde889-73e6-45ac-90c9-fe9270ead817"
      unitRef="usd">270700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i116991c09d6949c597cc44e8be8f1a92_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMS0zLTEtMS0zMjM0_e484675f-955b-4113-a7c8-cd4a7eefdf16"
      unitRef="usd">56900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMS01LTEtMS0zMjM2_8b6bc619-2fe6-4a4a-baa5-5c6b4a3b1061"
      unitRef="usd">327600000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMi0xLTEtMS0zMTg4_82abc67f-68cf-42ed-b3a4-45d68ff81f9b"
      unitRef="usd">700000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMi0zLTEtMS0zMjM0_82cfe3b9-3783-401e-804d-5afd0fd54200"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMi01LTEtMS0zMjM2_79e57c3a-315e-4be8-8c67-eac58a8d7af7"
      unitRef="usd">700000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i44895c20478e407d8960b3da61962bfd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMy0xLTEtMS0zMjMy_9ed83e68-15d3-4f0a-9dd5-f4a62f97307b"
      unitRef="usd">271400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3f595a1c9de24b2d8b457b7d67db72dc_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMy0zLTEtMS0zMjM0_d8766b6f-282e-4beb-960e-51ed40659502"
      unitRef="usd">56900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjk2MDQ3YTE3YTY1MjQ4Y2Q5ZTU5NGE4NTg4ZTFlNDc0L3RhYmxlcmFuZ2U6OTYwNDdhMTdhNjUyNDhjZDllNTk0YTg1ODhlMWU0NzRfMy01LTEtMS0zMjM2_2daccf4e-3487-46e6-a3ca-5d9c07ba907f"
      unitRef="usd">328300000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMA_ce8f7b5a-3a5d-4633-9ee5-f5d160945b70">The following summarizes the amounts reported as intangible assets:&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;816.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(232.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;584.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;824.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;586.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;829.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;590.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;815.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(217.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;823.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;600.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;828.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;605.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMA_f23e1d5e-1f11-4f41-9bb5-7ea21c04fd09">The following summarizes the amounts reported as intangible assets:&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;816.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(232.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;584.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;824.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;586.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;829.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;590.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased licenses and technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;815.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(217.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;823.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;600.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;828.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(222.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;605.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iedc11b500619497e955129438d050806_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMi0xLTEtMS0w_0f8ba39e-f59f-4590-b3e7-97e82778a72e"
      unitRef="usd">816600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iedc11b500619497e955129438d050806_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMi0zLTEtMS0w_165e68bc-059d-4771-bfdc-d97679fe162d"
      unitRef="usd">232400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iedc11b500619497e955129438d050806_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMi01LTEtMS0w_e61c2204-4b33-4eae-a01c-14beff19076f"
      unitRef="usd">584200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie3b56267b5884c6b82c4eba0a047ea30_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMy0xLTEtMS0w_630fc415-264f-4fdf-9af9-f01bc2f3df9a"
      unitRef="usd">4700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3b56267b5884c6b82c4eba0a047ea30_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMy0zLTEtMS0w_6dfa2b0c-b182-4ac8-9caf-b0cc98485bb9"
      unitRef="usd">4400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie3b56267b5884c6b82c4eba0a047ea30_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfMy01LTEtMS0w_63554ab4-06df-4c34-acdc-309355fa17d5"
      unitRef="usd">300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibd37b997bb634ad6af913ee6c81e67d4_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNC0xLTEtMS0w_1f342004-d66c-497c-8249-aefa5a2e6fe0"
      unitRef="usd">3000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibd37b997bb634ad6af913ee6c81e67d4_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNC0zLTEtMS0w_cd8cb5d4-030c-4f3b-9008-cd5aab8f913c"
      unitRef="usd">1400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibd37b997bb634ad6af913ee6c81e67d4_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNC01LTEtMS0w_224f4cad-095f-411e-9619-8efc2b31f926"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNS0xLTEtMS0w_650547f6-182f-4de0-bff8-807ff21531ff"
      unitRef="usd">824300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNS0zLTEtMS0w_92df2b8e-75f5-4627-9fc0-3bc7c304712c"
      unitRef="usd">238200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNS01LTEtMS0w_1f3dce96-21e2-4f82-ac64-c42ab968bde3"
      unitRef="usd">586100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id401e6b7bcfc481bb6f8a4e878338fe9_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNi0xLTEtMS0w_6260650c-9fae-414e-babb-2b04601812f1"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id401e6b7bcfc481bb6f8a4e878338fe9_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNi01LTEtMS0w_1ad645b1-6ada-41d3-a3ed-b257fb365c66"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNy0xLTEtMS0w_6b02c681-a00f-46f2-ae50-6215e4e0f0c0"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfNy01LTEtMS0w_233e9cdf-a6de-49a5-9b77-2a3656d6c71d"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfOC0xLTEtMS0w_97b8457b-4598-40a0-aa36-0406e965438a"
      unitRef="usd">829100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfOC0zLTEtMS0w_4b211b0c-c78d-40c9-8f92-efd2c3f5987c"
      unitRef="usd">238200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjJjZWQ1NzI2MDczMTQxODU5N2NlMjAzODZkYmFiYWFlL3RhYmxlcmFuZ2U6MmNlZDU3MjYwNzMxNDE4NTk3Y2UyMDM4NmRiYWJhYWVfOC01LTEtMS0w_142d4f87-b312-476f-9a84-3b8a23fe4ee3"
      unitRef="usd">590900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMi0xLTEtMS0w_439d52c9-575f-4428-8dc6-083736771b33"
      unitRef="usd">815600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMi0zLTEtMS0w_4c51ec64-c7b3-49b2-8d51-60b520e02ffd"
      unitRef="usd">217100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ied17f6ffd15e47e2807a94fc3b5e5a5b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMi01LTEtMS0w_18560861-c1bd-4f3f-a9f7-4e68b82f44a9"
      unitRef="usd">598500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibd87820edea446099b7bfa0e8c2239a6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMy0xLTEtMS0w_c95d4fa2-836d-411a-8521-fe47311d3ee0"
      unitRef="usd">4600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibd87820edea446099b7bfa0e8c2239a6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMy0zLTEtMS0w_3cdf2e53-6504-4fa7-bbc8-66b08835d030"
      unitRef="usd">4200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibd87820edea446099b7bfa0e8c2239a6_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfMy01LTEtMS0w_5a50cbd3-f9cf-427d-8d84-f28f4244287c"
      unitRef="usd">400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id69e12ae53554f31b7c4a41249056530_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNC0xLTEtMS0w_bf4b115c-7209-40f9-82ed-2a1b81ae5c53"
      unitRef="usd">3000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id69e12ae53554f31b7c4a41249056530_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNC0zLTEtMS0w_e554d434-a070-4e5c-a4fb-83957d35e0ec"
      unitRef="usd">1400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id69e12ae53554f31b7c4a41249056530_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNC01LTEtMS0w_a7e5c35e-e2a4-4bf6-aed5-fd102dce7f62"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNS0xLTEtMS0w_4358aec3-feef-458e-bf4e-ffc41360adb6"
      unitRef="usd">823200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNS0zLTEtMS0w_ad506f99-4959-4936-b659-3f6737489cff"
      unitRef="usd">222700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNS01LTEtMS0w_5704dabf-aece-4626-a971-878084b2d7a4"
      unitRef="usd">600500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i605e7ce6614b44f98a3ad36551642783_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNi0xLTEtMS0w_f118a791-7b68-40a7-ac5a-2525d5812ff0"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i605e7ce6614b44f98a3ad36551642783_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNi01LTEtMS0w_ad4ad003-def2-4d71-82f7-bef3a7f06e98"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNy0xLTEtMS0w_74c160d9-5db2-41f6-8a10-636d6395fccb"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfNy01LTEtMS0w_a0423fb1-cd6d-4596-a5f9-de6af493e619"
      unitRef="usd">4800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfOC0xLTEtMS0w_6abec92f-5355-4e71-b281-073617fdb525"
      unitRef="usd">828000000.0</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfOC0zLTEtMS0w_c85a0d3f-6b06-46ba-8812-b9e6b1aa7562"
      unitRef="usd">222700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOmMwYzllYWU3YmJkMTRiYTZiOWMxMDkyNTRlMTk3ZmU5L3RhYmxlcmFuZ2U6YzBjOWVhZTdiYmQxNGJhNmI5YzEwOTI1NGUxOTdmZTlfOC01LTEtMS0w_853a5a56-8c8d-4950-9c62-ad8d3f0f118e"
      unitRef="usd">605300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RleHRyZWdpb246OTIyM2NmYzRjMDg2NDM4OTkyMzQ5Y2FlMzhlMGUzODlfMzUwMQ_ea9dd61d-abe3-40fb-8e92-d6c7a8373938">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded amortization expense during the respective periods for these intangible assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjgzMWMzYjAxOTQ3MTQwNmM5NTA5OWE1YWU3MWQ1ZTAyL3RhYmxlcmFuZ2U6ODMxYzNiMDE5NDcxNDA2Yzk1MDk5YTVhZTcxZDVlMDJfMi0xLTEtMS0w_a6cd529a-f12d-45f3-87c2-b450285a7e01"
      unitRef="usd">15300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82MS9mcmFnOjkyMjNjZmM0YzA4NjQzODk5MjM0OWNhZTM4ZTBlMzg5L3RhYmxlOjgzMWMzYjAxOTQ3MTQwNmM5NTA5OWE1YWU3MWQ1ZTAyL3RhYmxlcmFuZ2U6ODMxYzNiMDE5NDcxNDA2Yzk1MDk5YTVhZTcxZDVlMDJfMi0zLTEtMS0w_454aa34b-9956-420a-86eb-9ccd8f485357"
      unitRef="usd">15300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RleHRyZWdpb246MWRiYmEyNjhjNzE1NGFiOGIxZGExYTJiY2FlOTZhZmVfMjc_4f694915-7e37-48a0-b0c9-fae64cd15cd5">ACCRUED LIABILITIES&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RleHRyZWdpb246MWRiYmEyNjhjNzE1NGFiOGIxZGExYTJiY2FlOTZhZmVfMjg_034b91f8-616d-436e-9a58-ca000d4ba0f1">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMS0xLTEtMS0w_88d238d8-bdb7-46b5-86d5-5d3307265c00"
      unitRef="usd">47200000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMS0zLTEtMS0w_7c9f9d1c-4be1-4a6f-b33d-0a2510e7461f"
      unitRef="usd">47400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMi0xLTEtMS0w_9c4bc3e9-19fe-4dd0-9bdb-730ffd919652"
      unitRef="usd">3500000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfMi0zLTEtMS0w_ce1338d0-0ca4-4b58-adcc-4dcbb5797ce1"
      unitRef="usd">6100000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNC0xLTEtMS0w_41538b66-76bb-4fb5-a3e3-e48a78be2577"
      unitRef="usd">14700000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNC0zLTEtMS0w_ef0f4716-a14c-4f9f-a925-bed26c465253"
      unitRef="usd">22400000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNS0xLTEtMS0w_b052fa7d-b4f6-47f7-8d3a-90faf8468152"
      unitRef="usd">65400000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82NC9mcmFnOjFkYmJhMjY4YzcxNTRhYjhiMWRhMWEyYmNhZTk2YWZlL3RhYmxlOmIyNDBiY2FlZDkxODQ0ODNiNjM2YTAwMjY5OTUyZjJhL3RhYmxlcmFuZ2U6YjI0MGJjYWVkOTE4NDQ4M2I2MzZhMDAyNjk5NTJmMmFfNS0zLTEtMS0w_0a70e09c-1944-434f-96af-1f58e91ae0c8"
      unitRef="usd">75900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMjk0OA_52e4c096-72f6-46c2-a9c0-a7b1a8632b65">LONG-TERM DEBT&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 23, 2016, the Company entered into a senior secured revolving credit facility (the &#x201c;Facility&#x201d;) by and among Myriad, as borrower, and the lenders from time to time party thereto. On July 31, 2018, the Company entered into Amendment No. 1 which effected an &#x201c;amend and extend&#x201d; transaction with respect to the Facility by which the maturity date thereof was extended to July 31, 2023 and the maximum aggregate principal commitment was increased from $300.0 to $350.0.&#160;On May 1, 2020, the Company entered into Amendment No. 2 (the &#x201c;Amended Facility&#x201d;), which waived the Company's compliance with certain covenants and modified the interest rate and other terms during the Amendment Period from March 31, 2020 through June 30, 2021 (the "Amendment Period"). Both amendments were accounted for as modifications pursuant to guidance in ASC 470-50.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Amended Facility, the Company borrowed revolving loans in an aggregate principal amount of $300.0 with $1.8 in upfront fees and $0.3 debt issuance costs recorded as a debt discount to be amortized over the term of the Amended Facility. The Company incurred an additional $1.0 in upfront fees as a result of Amendment No. 2, which was also recorded as a debt discount that will be amortized over the term of the Amended Facility. The current balance of the net long-term debt is $224.6. There are no scheduled principal payments of the Amended Facility prior to its maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Facility contains customary loan terms, interest rates, representations and warranties, affirmative and negative covenants, in each case, subject to customary limitations, exceptions and exclusions. The Amended Facility also contains certain customary events of default. Amendment No. 2 modified the Facility to increase the interest rate to be fixed at a spread of LIBOR plus 350 basis points on drawn balance and the undrawn fee was increased to 50 basis points during the Amendment Period. At the end of the Amendment Period, interest rates return to the previous pricing of 200 basis points on drawn balances and an undrawn fee ranging from 25 to 45 basis points based on the Company's leverage ratio. The LIBOR floor was also increased to 1.0% during the Amendment Period. The interest rate as of September&#160;30, 2020 was 4.5%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Covenants in the Amended Facility impose operating and financial restrictions on the Company. These restrictions may prohibit or place limitations on, among other things, the Company&#x2019;s ability to incur additional indebtedness, create certain types of liens, and complete mergers, consolidations, or complete change in control transactions. The Amended Facility may also prohibit or place limitations on the Company&#x2019;s ability to sell assets, pay dividends or provide other distributions to shareholders. The Company must maintain specified leverage and interest ratios measured as of the end of each quarter as a financial covenant in the Amended Facility. Amendment No. 2 modified the Amended Facility's compliance with the leverage covenant and the interest coverage ratio covenant, which were waived through March 31, 2021. A minimum liquidity covenant was added for the period beginning May 2020 until March 2021, and a minimum EBITDA covenant was added for the quarters ending December 31, 2020 and March 31, 2021. Amendment No. 2 also revised certain negative covenants of the Amended Facility during the Amendment Period. The Company was in compliance with all financial covenants at September&#160;30, 2020. Based on the continued uncertainty regarding the impact of COVID-19 on the Company&#x2019;s future operations, it is possible that the Company could be in violation of certain financial covenants contained in the Amended Facility within the Amendment Period, which runs through June 30, 2021. The Company may seek waivers or amendments from the lenders in order to avoid a future potential covenant violation, in addition to taking other potential actions. If the Company were unable to comply with the covenants in the future, it could result in an increase in the rate of interest and limits on the Company's ability to incur certain additional indebtedness and it could potentially cause the loan repayment to be &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accelerated, any of which could have a material adverse impact on the Company&#x2019;s operations and liquidity. The Company has and continues to take actions to mitigate the risk of an event of default under the Amended Facility, however there is no assurance it will be successful in doing so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Facility is secured by a first-lien security interest in substantially all of the assets of Myriad and certain of its domestic subsidiaries and each such domestic subsidiary of Myriad has guaranteed the repayment of the Amended Facility. Amounts outstanding under the Amended Facility and Facility were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i131e53046dba42e784ea6b9c4a34ebb0_D20180731-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxMzA3Nw_f8edcd15-01b5-40f5-abc7-2f965318bd1f">2023-07-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3e77d4115af8402f8e7c73bf41aa6d84_I20161223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNTA0_59fb2bf9-d6a0-4de8-b868-3c2aec326791"
      unitRef="usd">300000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNTEw_ea6c7e22-2a1d-4982-91b9-b1786278f382"
      unitRef="usd">350000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNjkz_415637ed-e50a-43f1-83ef-1000edfef75c"
      unitRef="usd">300000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNzAx_81041247-a563-485a-84cb-86e45ffabcde"
      unitRef="usd">1800000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross
      contextRef="i85e2446e00f14a6a95b101f9ffe32a7d_I20180731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfNzI0_43ef6334-9ca4-4703-b6f9-34d768eb75c3"
      unitRef="usd">300000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsGross>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i799a546ec5224cf79c846d48840419b5_I20200501"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMTY0OTI2NzQ0NTI0MQ_8123d196-3345-4bb0-9e50-18347791a061"
      unitRef="usd">1000000.0</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LongTermDebt
      contextRef="i39160baa532a49a3a841ba3506e61d34_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODc5_6ea4cf70-dbba-4e85-9677-7307e6102a2e"
      unitRef="usd">224600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="i39160baa532a49a3a841ba3506e61d34_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODkz_20420f07-4c5b-40fd-b250-77b139391aa2"
      unitRef="usd">0</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib9f213a904c342bc9d88379906d18608_D20200331-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc2OQ_68d394a4-6a16-41ad-b459-18ee37e36195"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i817593bab77d4c76bee489fbd71601e8_D20200331-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc3NA_7bfdc2ed-46a4-4c6d-b4ab-abdc788fa0dd"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0f336dee21354bffb60cdbdea5421626_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc3OA_aa72235f-b000-417f-88cb-089a29a2c73e"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i7dd85ff567e346758c47e5bf8e86f56e_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc4Mw_586ec45b-4920-4f61-a089-2c4b59acb3ec"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i9a3c8e67aaa446f9b27da019f00dc7c7_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc4Nw_eb66cfb4-d912-433e-9844-376be7d686ec"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <mygn:DebtInstrumentLIBORFloorPercentage
      contextRef="i817593bab77d4c76bee489fbd71601e8_D20200331-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfODI0NjMzNzIxNjc5MQ_a88195c6-ddd5-4d9c-8b85-f7c99d52b1ba"
      unitRef="number">0.010</mygn:DebtInstrumentLIBORFloorPercentage>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i39160baa532a49a3a841ba3506e61d34_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMTY0OTI2NzQ0NTQ3OQ_8e964603-b00d-4890-8114-a5103f56c7f1"
      unitRef="number">0.045</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RleHRyZWdpb246NGM2NjIwMmVkYTNkNDlhN2I1YWVlZmUzNzU1YTBjZGNfMjk0OQ_5e1855db-79a9-435c-8928-92044f15cb41">Amounts outstanding under the Amended Facility and Facility were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMS0xLTEtMS0w_1c221326-1e78-4937-967f-0cdf1c10d12b"
      unitRef="usd">226700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMS0zLTEtMS0w_188fbd3b-be1a-4ccc-9fe3-1690bdf9dafd"
      unitRef="usd">226700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMi0xLTEtMS0w_022b09b6-dc31-4808-a04a-ae1f09b0b6ca"
      unitRef="usd">2100000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMi0zLTEtMS0w_20dab4f0-8ef8-47f3-8f86-cb8b75a873ee"
      unitRef="usd">2300000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMy0xLTEtMS0w_a64f35c6-b12a-44d2-b635-ecb025f7a4b2"
      unitRef="usd">224600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF82Ny9mcmFnOjRjNjYyMDJlZGEzZDQ5YTdiNWFlZWZlMzc1NWEwY2RjL3RhYmxlOmYyZWI3MzVmYjA0OTRmMTFhMmE2NmRhZWU2ZTM0NDg3L3RhYmxlcmFuZ2U6ZjJlYjczNWZiMDQ5NGYxMWEyYTY2ZGFlZTZlMzQ0ODdfMy0zLTEtMS0w_b2b6c77b-a620-4793-aca2-232e2e284d00"
      unitRef="usd">224400000</us-gaap:LongTermDebt>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RleHRyZWdpb246Y2EwNWM3MDk2MzljNDExN2FhMmQ2OGVkOWZkYzQ5Y2VfMzM0_207105cc-81d9-473b-9e2d-236170befba4">OTHER LONG-TERM LIABILITIES&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The Company's balance of other long-term liabilities as of September&#160;30, 2020 and June&#160;30, 2020 consists of the Company's portion of social security taxes that have been deferred under the CARES Act that do not have to be deposited until December 2021 and December 2022.</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RleHRyZWdpb246Y2EwNWM3MDk2MzljNDExN2FhMmQ2OGVkOWZkYzQ5Y2VfODI0NjMzNzIwOTI3OA_d0691cca-d29b-4c1c-baec-58a8cb50bc64">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMS0xLTEtMS03ODE2_d0477c02-6ee3-4de5-98df-05ae58e4245c"
      unitRef="usd">2600000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMS0zLTEtMS03ODE2_6a538f46-8770-4bc9-aac4-45f80dbf1071"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMi0xLTEtMS03ODE2_b04508c0-5d03-4a5a-a1d9-295e78881908"
      unitRef="usd">8100000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMi0zLTEtMS03ODE2_45809435-4a27-43ad-b265-3e45af6a5ab7"
      unitRef="usd">4300000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMy0xLTEtMS03ODE2_ec1efadc-f04d-42d6-9601-b48a0737408e"
      unitRef="usd">10700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83My9mcmFnOmNhMDVjNzA5NjM5YzQxMTdhYTJkNjhlZDlmZGM0OWNlL3RhYmxlOmY0Y2M1YTZlOTU3YjQ3OGZiZDVjNmQ0NGVkMWMzZmE1L3RhYmxlcmFuZ2U6ZjRjYzVhNmU5NTdiNDc4ZmJkNWM2ZDQ0ZWQxYzNmYTVfMy0zLTEtMS03ODE2_f0eacd87-c609-4738-8bbe-e6cf5d9a4c29"
      unitRef="usd">8000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMA_6cf9d3f0-135c-49fa-99f6-00fcbfcf639e">PREFERRED AND COMMON STOCKHOLDERS' EQUITY&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 5.0 shares of preferred stock, par value $0.01 per share.&#160;&#160;There were no preferred shares outstanding at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 150.0 shares of common stock, par value $0.01 per share. There were 75.2 shares issued and outstanding at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning common stock issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock issued and outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.&#160;&#160;In periods when the Company has a net loss, stock awards are excluded from the calculation of diluted net loss per share as their inclusion would have an antidilutive effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the denominators of the basic and diluted earnings per share (&#x201c;EPS&#x201d;) computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:80.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding used to compute basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of dilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding and dilutive securities used to compute diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain outstanding options and restricted stock units (&#x201c;RSUs&#x201d;) were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Anti-dilutive options and RSUs excluded from EPS computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Company&#x2019;s Board of Directors authorized a share repurchase program of $200.0 of the Company&#x2019;s outstanding common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company's management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of September&#160;30, 2020, the Company is authorized to repurchase up to $110.7 of shares under this authorization. No shares were repurchased during the three months ended September 30, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfODk_451adb13-433c-475f-ba47-3ab1718077a2"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTI5_b5f1d999-e71a-45f1-8ef0-4a2315941035"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTU1_a867c78a-47e5-4f85-a999-c53772bd68fc"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjM1_74875659-4356-44c5-ae45-a5c421020733"
      unitRef="shares">150000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjcy_4ba458be-adf7-406b-8988-88ef5df60753"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjk3_0b8cd940-e2f2-46bd-b4c1-94774b9090d8"
      unitRef="shares">75200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjk3_7536603f-9408-4d53-be7e-c2e63cc11b06"
      unitRef="shares">75200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMQ_815624d3-05fe-44d8-800c-7de0c559e56e">&lt;div style="margin-top:18pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Common shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning common stock issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock issued and outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0xLTEtMS0w_c3591340-6e36-46da-bffe-edda042e1e85"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0xLTEtMS0w_e01acc2a-7852-4d76-9c2c-87ccfceee9af"
      unitRef="shares">74700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i139906c1954e43c39560efe073ca515b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0zLTEtMS0w_17907dad-4629-45dc-9d50-5d647fe5d0a3"
      unitRef="shares">73500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i139906c1954e43c39560efe073ca515b_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMi0zLTEtMS0w_2eea4978-72c9-4e0e-9a76-ac3f15ba41fc"
      unitRef="shares">73500000</us-gaap:CommonStockSharesOutstanding>
    <mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMy0xLTEtMS0w_ad97ff8b-316c-4af3-b009-274ff00328ca"
      unitRef="shares">500000</mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans>
    <mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
      contextRef="i4464ac83ed924822929712315bbc20be_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfMy0zLTEtMS0w_81e4e9c7-7de2-45c8-9670-b43a210442f3"
      unitRef="shares">1200000</mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0xLTEtMS0w_3ad5291c-23b3-47a3-bb71-28fddc87520a"
      unitRef="shares">75200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0xLTEtMS0w_bdb2ab0a-181d-4014-9ca8-050cab3f7217"
      unitRef="shares">75200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0zLTEtMS0w_304de0d2-4945-4f36-b6e2-79bc7233b0bd"
      unitRef="shares">74700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjA1OTkxODIyYWQyNTRmNjE5YjVmMzg1Yjg4NmQyMjRmL3RhYmxlcmFuZ2U6MDU5OTE4MjJhZDI1NGY2MTliNWYzODViODg2ZDIyNGZfNS0zLTEtMS0w_7dc50812-8833-48b3-a313-a9197a2a074c"
      unitRef="shares">74700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMg_8e3566db-dd3b-448f-8b2d-567df45c4ecb">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the denominators of the basic and diluted earnings per share (&#x201c;EPS&#x201d;) computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:80.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding used to compute basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of dilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average shares outstanding and dilutive securities used to compute diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfMy0xLTEtMS0w_a15dc247-7ac1-412a-8aea-cc73066c07fb"
      unitRef="shares">74700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfMy0zLTEtMS0w_d18301a1-2549-4240-936d-f094e9724d1a"
      unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNC0xLTEtMS0w_0d71f9dd-bbb0-4320-a4cc-68332aa37ed1"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNC0zLTEtMS0w_b0aceec3-b1ed-4b4f-ab5d-71ab5b405f62"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNS0xLTEtMS0w_d08ddf75-b377-4526-b394-a74b06673648"
      unitRef="shares">74700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjI1YWZhYjBhNzZiYjQ4OWY5NmViOTk0ZTFlZGQ1ZTI4L3RhYmxlcmFuZ2U6MjVhZmFiMGE3NmJiNDg5Zjk2ZWI5OTRlMWVkZDVlMjhfNS0zLTEtMS0w_b6d4ef68-e971-434c-b427-3e478ed70e4c"
      unitRef="shares">73700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMjMzMw_79f1fdc0-d0ce-4350-85b3-c37be6b70d14">These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Anti-dilutive options and RSUs excluded from EPS computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjhhOWE1MTIyZmI0OTRmYmU5NzEyMzdmYzUxNjViMTUxL3RhYmxlcmFuZ2U6OGE5YTUxMjJmYjQ5NGZiZTk3MTIzN2ZjNTE2NWIxNTFfMi0xLTEtMS0w_1e88fdd9-fe29-4771-8df3-3e6065372a7a"
      unitRef="shares">7300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RhYmxlOjhhOWE1MTIyZmI0OTRmYmU5NzEyMzdmYzUxNjViMTUxL3RhYmxlcmFuZ2U6OGE5YTUxMjJmYjQ5NGZiZTk3MTIzN2ZjNTE2NWIxNTFfMi0zLTEtMS0w_8fa2e5f1-34fc-4d43-9aa6-c19133108634"
      unitRef="shares">1700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iac78c7144eeb42a297b36f757e868180_I20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTM4MQ_4b816d2c-6963-4be3-a337-279103352e85"
      unitRef="usd">200000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfMTg0NA_b57cda13-1a44-4eff-990c-8b821701e3aa"
      unitRef="usd">110700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfOTM0NTg0ODgzOTMzNw_745abdd2-8c8a-4e2c-93e8-9506915a1008"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF83Ni9mcmFnOjE1ZjAyZWY3YTgwNjRjMmU4ZDQ1NjM3NWJkYWIzOWQ2L3RleHRyZWdpb246MTVmMDJlZjdhODA2NGMyZThkNDU2Mzc1YmRhYjM5ZDZfOTM0NTg0ODgzOTMzNw_e977a306-247f-417d-8952-3e43ef1c6276"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAyOQ_20a61b7e-f9a3-4027-b2f8-77958e1f8880">SHARE-BASED COMPENSATION&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 30, 2017, the Company&#x2019;s shareholders approved the adoption of the 2017 Employee, Director and Consultant Equity Incentive Plan (as amended, the &#x201c;2017 Plan&#x201d;).&#160;On November 29, 2018 and December 5, 2019, the shareholders approved amendments to the 2017 Plan increasing the shares available to grant. The 2017 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of restricted and unrestricted stock awards to employees, consultants and directors. As of September&#160;30, 2020, the Company may grant additional shares of common stock under the 2017 Plan with respect to the 0.1 options outstanding under our 2003 Plan and 4.8 options and restricted stock units outstanding under our 2010 Plan, to the extent that those options and restricted stock units expire or are cancelled without delivery of shares of common stock. If an RSU awarded under the 2017 Plan is cancelled or forfeited without the issuance of shares of common stock, the unissued or reacquired shares, which were subject to the RSU, shall again be available for issuance pursuant to the 2017 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares, terms, and vesting periods are determined by the Company&#x2019;s Board of Directors or a committee thereof on an award-by-award basis. RSUs granted to employees generally vest ratably over four years on the anniversary date of the designated day of the last week of the month in which the RSUs are granted. The number of RSUs awarded to certain executive officers may be increased or reduced based on certain additional performance metrics. Options and RSUs granted to our non-employee directors vest in full upon completion of one year of service on the anniversary following the date of the grant. Options generally vest ratably over service periods of four years.&#160;&#160;Options granted after December 5, 2012 expire eight years from the date of grant, and options granted prior to that date generally expire ten years from the date of grant. In September 2014, the Company began generally issuing RSUs in lieu of stock options.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2020, the Company granted stock-based awards to the Company's new President and Chief Executive Officer as an inducement material to his commencement of employment and entry into an employment agreement with the Company. The inducement awards were made in accordance with Nasdaq Stock Market rules and were not made under the Company's existing equity plans; the inducement awards are included in the tables below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the stock option activity under the Company&#x2019;s equity plans, including the Company's inducement awards, for the three months ended September&#160;30, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercisable at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, there was $5.2 of unrecognized share-based compensation expense related to the inducement stock options that will be recognized over a weighted-average period of 2.8 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the RSU activity under the Company&#x2019;s plans, including the Company's inducement awards and RSU awards with performance metrics, for the three months ended September&#160;30, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant date&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs outstanding at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, there was $44.1 of total unrecognized share-based compensation expense related to RSUs that will be recognized over a &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;weighted-average period of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 2.5 years.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has an Employee Stock Purchase Plan that was approved by shareholders in 2012 (the &#x201c;2012 Purchase Plan&#x201d;), under which 2.0 shares of common stock have been authorized.&#160;&#160;Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period.&#160;&#160;As of September&#160;30, 2020, approximately 0.3 shares of common stock are available for issuance under the 2012 Purchase Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense recognized and included in the condensed consolidated statements of operations and comprehensive loss was allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i0f9212ac2aa140f8a16748ce2ea8a434_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfNjI2_43bf4114-9958-4620-8e1a-3c9a50f52bd1"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="icfa07cb7aed64763a7a9f6f9ebf99038_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfNjcz_d5bbc467-d85f-4548-bd3d-d62ee8169401"
      unitRef="shares">4800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTg2OTE2OTc2ODQyNTc_c426ea6f-c420-48ef-b61b-937603aaf569">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8531ebcd74e04283a1b94b983fa04b07_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfODI0NjMzNzIyMjA0NA_9b407daa-6ea5-4955-b40c-c0d199cf410a">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6e56313342974e7382a91c90b4089dd6_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTI2OA_c25632ef-a1ab-40c5-9ff7-4f8f7dd28766">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ibe25ff804ef6473c900712207237104f_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTMxOQ_7f6b0976-e904-4b97-ae43-f3233af70300">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8426764c4bf94a13a8f122cbaf9d20f2_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTQwMg_42aaf289-8c95-48d6-87de-f3913fa7f97a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAzMA_77ca416d-f72b-4995-aa43-77b075189bc6">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the stock option activity under the Company&#x2019;s equity plans, including the Company's inducement awards, for the three months ended September&#160;30, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options exercisable at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMS0xLTEtMS0w_4a8f3b0f-ca9c-4451-8c8e-60b8cb679285"
      unitRef="shares">4800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iff8a54753cc14cc7995dfd3ffab42f61_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMS0zLTEtMS0w_857b4fdc-84da-425f-a6ff-6b5ede5038ec"
      unitRef="usdPerShare">24.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMi0xLTEtMS0w_b61b11b7-1a12-4958-9bfc-bca3c5f60498"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfMi0zLTEtMS0w_c1d2733d-869c-45d0-9cf4-010eaf2d0f36"
      unitRef="usdPerShare">13.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNC0xLTEtMS0w_7d8f2d1c-ca92-4338-b0d0-09e7fcb1143e"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNC0zLTEtMS0w_d186889b-27c5-4f38-aeeb-c113ccd7b954"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNS0xLTEtMS0w_090c066a-17f2-4280-aaeb-1a3ab8b4dcf7"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNS0zLTEtMS0w_e8450a15-0f11-44d6-97bc-241bbc3e3c00"
      unitRef="usdPerShare">16.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNi0xLTEtMS0w_ccb37482-4342-4a6b-9493-42b75d68dd4a"
      unitRef="shares">5400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNi0zLTEtMS0w_54611494-f3ec-4585-93c3-44b81a15c4a5"
      unitRef="usdPerShare">23.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNy0xLTEtMS0w_7babca29-1a07-4975-a75b-2dee4242953f"
      unitRef="shares">4700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmUwNjI4ZmYzYmUwMTQxZjk4MjU1YTdmM2UxNjNlNGU2L3RhYmxlcmFuZ2U6ZTA2MjhmZjNiZTAxNDFmOTgyNTVhN2YzZTE2M2U0ZTZfNy0zLTEtMS0w_680d77c7-5f08-4e66-8592-2ddc29fc1ef1"
      unitRef="usdPerShare">24.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i5fe991d524ac4629ab0f930806f7c992_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTY0OTI2NzQ1MTA5NQ_d7c368c9-f2de-4ebc-9164-037f4ef82227"
      unitRef="usd">5200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i6e56313342974e7382a91c90b4089dd6_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMTY0OTI2NzQ1MzUxNQ_fc07a7de-b24d-4380-a033-8b1d6a64ef3d">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAzMQ_6ca96d5b-2ab8-47b3-a983-f04d6ba67721">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the RSU activity under the Company&#x2019;s plans, including the Company's inducement awards and RSU awards with performance metrics, for the three months ended September&#160;30, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number&lt;br/&gt;of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant date&lt;br/&gt;fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs outstanding at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4d168ccbb6474a0bbbe80bbe0520d013_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMS0xLTEtMS0w_444ca0d8-184b-4ba8-8156-f885290f6467"
      unitRef="shares">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4d168ccbb6474a0bbbe80bbe0520d013_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMS0zLTEtMS0w_94c0642d-d9fe-4018-85c8-85a831dcae66"
      unitRef="usdPerShare">32.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMi0xLTEtMS0w_c009e68e-a520-4cbd-aad1-0d9e631e3bb1"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfMi0zLTEtMS0w_079d3c6e-701b-4bbb-8a8c-cd2dc6babf66"
      unitRef="usdPerShare">13.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNC0xLTEtMS0w_d91012eb-4ee5-437a-a999-1abb1774cf80"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNC0zLTEtMS0w_42334a15-5e43-447f-97f9-89ab5054bb4a"
      unitRef="usdPerShare">33.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNS0xLTEtMS0w_c305ef7f-5d5c-4282-8756-e97d8c89a108"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNS0zLTEtMS0w_06142471-390d-4f6b-8f79-0446f6a7224b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id7b2b333937b4d8ab126f4324d951eb8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNi0xLTEtMS0w_5f12c8f7-9b47-4df6-9345-bc4b86f0ab8e"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id7b2b333937b4d8ab126f4324d951eb8_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmFlZTQwODc0YTRhMjRhZmM4YmUxMDMzYzEyZWYwZTRjL3RhYmxlcmFuZ2U6YWVlNDA4NzRhNGEyNGFmYzhiZTEwMzNjMTJlZjBlNGNfNi0zLTEtMS0w_9167597c-d669-4f5a-9b8c-76abe851c63b"
      unitRef="usdPerShare">27.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="id7b2b333937b4d8ab126f4324d951eb8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjE4OQ_398a7824-3fa4-4e74-99d6-9c2166f2ef72"
      unitRef="usd">44100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5fda694944da482cb46d4d3288bf1099_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjMyMQ_60cd228f-5aac-471b-95d5-659646fb42f6">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ibbc4477be5174638b6d2d9c390dc35df_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjU4Mg_02b89827-474a-4f30-8b30-3293abd12682"
      unitRef="shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ibbc4477be5174638b6d2d9c390dc35df_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMjc1Mg_821ca18c-bf14-4186-88f5-e8d433569721"
      unitRef="shares">300000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RleHRyZWdpb246ZjNiZjlmZGQzZmQxNDY1MWI4YmY4ZmQxNDgxNThiYTdfMzAyOA_da35329a-b396-4d0b-8969-094a989bd022">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense recognized and included in the condensed consolidated statements of operations and comprehensive loss was allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of molecular diagnostic testing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of pharmaceutical and clinical services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i03913453337a4247aeed7aa0ba49835a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMi0xLTEtMS0w_c98db239-7699-42a8-9eb0-c4f1b3777fec"
      unitRef="usd">300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia9ebc3017dbc42c68c8b36d9f7808984_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMi0zLTEtMS0w_7e00dfc0-645c-4e9c-98ce-b29886ed45f4"
      unitRef="usd">200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i935d96454093413f9b4072fbc7472673_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMy0xLTEtMS0w_e512e823-a379-4e16-95d8-b9fefa53dfca"
      unitRef="usd">100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2a60af6e087f4872829727b5a4666fd3_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfMy0zLTEtMS0w_436adf1e-8302-4f4b-8cf3-f9a8d0884009"
      unitRef="usd">100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i692152fef23148a68888c9f3d749a1ac_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNC0xLTEtMS0w_736a6e3d-21a0-477b-ab32-09a797e6ccea"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i713e3bcca2f747c69452acd15600fa56_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNC0zLTEtMS0w_82598f44-1cf5-4a84-9243-4598ab758337"
      unitRef="usd">1500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ica96d2399231445fa8ea26045d7379d9_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNS0xLTEtMS0w_72b1bca4-7467-47e0-aef7-dd6b615bd250"
      unitRef="usd">6700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic7029214bab44cbb90983534da0be3e1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNS0zLTEtMS0w_5bd280ce-08f7-4be0-b20d-b3e61de9c6e9"
      unitRef="usd">7000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNi0xLTEtMS0w_ff454610-5f90-4115-9c73-668d66c9b3d6"
      unitRef="usd">8400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84OC9mcmFnOmYzYmY5ZmRkM2ZkMTQ2NTFiOGJmOGZkMTQ4MTU4YmE3L3RhYmxlOmE5ZTNlZmM2YzRlNzQxNjdiOWFlYWRlNzlhNDljNjNkL3RhYmxlcmFuZ2U6YTllM2VmYzZjNGU3NDE2N2I5YWVhZGU3OWE0OWM2M2RfNi0zLTEtMS0w_e4eaf33f-06d3-462e-947f-de52ab198430"
      unitRef="usd">8800000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAzNQ_44f840d6-400f-4f07-8c0a-f91211d63c72">INCOME TAXES&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to determine the Company&#x2019;s quarterly provision for income taxes, the Company used an estimated annual effective tax rate that is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates.&#160;Under the Tax Cuts and Jobs Act, the federal corporate tax rate is 21% for calendar year 2020.&#160;Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rate from quarter to quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit for the three months ended September&#160;30, 2020 was $28.5, or approximately 65.2% of pre-tax loss compared to an income tax benefit of $1.7, or approximately 7.6% of pre-tax loss, for the three months ended September&#160;30, 2019.&#160;&#160;Income tax benefit for the three months ended September&#160;30, 2020 is based on the Company&#x2019;s estimated annualized effective tax rate for the six-month transition period ending December 31, 2020, adjusted by discrete items recognized during the period.&#160;&#160;For the three months ended September&#160;30, 2020, the Company&#x2019;s recognized effective tax rate differs from the U.S. federal statutory rate primarily due to carrying back net operating losses due to the CARES Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES&#x201d;) was enacted.&#160;&#160;CARES impacted several provisions to the U.S. tax code that have affected our six-month transition period ending December 31, 2020, including, but not limited to, (1) NOL carry-back and carry-forward provisions, (2) deductibility of interest, (3) acceleration of corporate AMT credits, and (4) classification of qualified improvement property.&#160;&#160;As of the quarter ended September&#160;30, 2020, the Company recognized an income tax net benefit of $20.0 related to the CARES Act, which included an increase in the uncertain tax benefit accrual of $14.3, related to carrying back net operating losses to tax years with higher corporate tax rates than the year the net operating loss originated. The Company will continue to evaluate the application of any and all provisions through the remainder of the six-month transition period ending December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files U.S., foreign and state income tax returns in jurisdictions with various statutes of limitations.&#160;&#160;The Company is currently under audit by the state of New Jersey for the fiscal years June 30, 2013 through 2017; the state of New York and Massachusetts for the fiscal years June 30, 2014 through 2016; Germany for the fiscal years June 30, 2013 through 2015; and Switzerland for the fiscal years June 30, 2015 through 2016. Annual and interim tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNjIy_21eb1d33-1b0a-4f21-97c6-7082f8401eec"
      unitRef="usd">-28500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNjQz_775970c8-1225-4a35-901e-c98526b32081"
      unitRef="number">0.652</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNjk4_889c5502-554e-458e-a0e3-124b05313722"
      unitRef="usd">-1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfNzE5_627ae494-fbb1-4cce-bbb4-a481ec317445"
      unitRef="number">0.076</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <mygn:IncomeTaxExpenseBenefitCARESAct
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMzM5OQ_15f08f15-9d2b-4f6e-8dbb-d26e8a4359ca"
      unitRef="usd">-20000000.0</mygn:IncomeTaxExpenseBenefitCARESAct>
    <mygn:UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMzQwOQ_604aa783-8574-453a-9828-40b040f00fc9"
      unitRef="usd">14300000</mygn:UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i89373e9be2a0449893aabbe615c8f4d4_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjE3NQ_171a958f-f64b-4edd-beb1-1d0898d3e609">2013</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="ie481d4259b1e43cb9c6b7ea0cea96d16_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjE4Ng_7a185bf1-adb7-4acd-9c8d-9fd146f16e33">2017</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="ia5e1f249221245de8a6c79eb95cdc6de_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjI2MA_3bdd2771-27bc-4300-9fe8-a98da7fdca52">2014</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i3457c831a65d4dc386d66b85605c73bf_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjI2MA_ef426461-9748-4254-9a85-2a8fc1bc72b5">2014</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i590b46ab6f6241c0854149f1703f3040_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAyNA_2b074be8-6451-49f6-a516-4d0685f5ec19">2016</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="ic9b0b4b7980a4b0bae0e190d4c2adc80_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAyNA_a7111a80-da90-435a-b1eb-1d5f663b97ef">2016</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="ic84b54586f924efeb788832bba77a03a_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMDk4MQ_96827056-dea6-409c-849e-78c169572a82">2013</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i6c12ff8b2c1b4feca4bfe7d6b0767522_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfODI0NjMzNzIxMTAwNw_2859cc0a-89ce-4a17-9c7a-65cdf0156f62">2015</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="ia11bd3e88b394e2aaacc3f17950ab8a0_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjM3NA_b012e5b2-239f-4097-8805-4e083c4d133e">2015</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="i9a4299d589f945d99e682d367f4fde51_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF84Mi9mcmFnOmZlODE1YzkyZGUzYzRlZWVhZjJjNmMxYmY5M2Q2NWE2L3RleHRyZWdpb246ZmU4MTVjOTJkZTNjNGVlZWFmMmM2YzFiZjkzZDY1YTZfMjM4NQ_6a99e886-6315-402f-87ba-58431c95321a">2016</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDAvZnJhZzowYWYzYWVmN2Y0MGE0OTIwYWE1Y2Q3NDYyZmYzYWVkYS90ZXh0cmVnaW9uOjBhZjNhZWY3ZjQwYTQ5MjBhYTVjZDc0NjJmZjNhZWRhXzIyNzA_2da330f2-fbed-41e2-9121-ce2550ea990d">COMMITMENTS AND CONTINGENCIESThe Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of September&#160;30, 2020, the management of the Company believes any reasonably possible liability that may result from the resolution of these matters will not have a material adverse effect on the Company&#x2019;s consolidated financial position, operating results, or cash flows.From time to time, the Company receives recoupment requests from third-party payors for alleged overpayments. The Company disagrees with the contentions of the pending requests or has recorded an estimated reserve for the alleged overpayments.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90ZXh0cmVnaW9uOmJhMTI2MGY4YzAwNDQ4MzZhZmU1ZjJlMTRjYWMwYzdmXzEwMjY_c8b6ae58-9851-4eff-8fc7-e90b8850338a">SEGMENT AND RELATED INFORMATIONThe Company&#x2019;s business is aligned with how the chief operating decision maker reviews performance and makes decisions in managing the Company.&#160;&#160;The business units have been aggregated into two reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual&#x2019;s risk for developing disease later in life, identify a patient&#x2019;s likelihood of responding to drug therapy and guide a patient&#x2019;s dosing to ensure optimal treatment, or assess a patient&#x2019;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology.&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment revenue and operating income (loss) were as follows during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(39.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three months ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:81.140%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.314%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.314%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating loss for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss from operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to Myriad Genetics, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90ZXh0cmVnaW9uOmJhMTI2MGY4YzAwNDQ4MzZhZmU1ZjJlMTRjYWMwYzdmXzIyNw_fc041cd7-f0db-4cda-abf7-20a2d63742f5"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90ZXh0cmVnaW9uOmJhMTI2MGY4YzAwNDQ4MzZhZmU1ZjJlMTRjYWMwYzdmXzEwMjc_843fc99b-c231-4cfb-9927-ee1a47f0c603">&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment revenue and operating income (loss) were as follows during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(39.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three months ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:81.140%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.314%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.314%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating loss for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss from operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss attributable to Myriad Genetics, Inc. stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzItMS0xLTEtMA_637de77c-b5cc-465e-9edf-12a5df4850a7"
      unitRef="usd">130500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzItMy0xLTEtMA_cb1e7afb-4614-4ad3-b5e3-00b945c3ddff"
      unitRef="usd">14700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzItNS0xLTEtMA_35266f98-c0c1-489a-89da-8134defbee4a"
      unitRef="usd">145200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationAndAmortization
      contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzMtMS0xLTEtMA_13dac44c-9a85-483f-9e80-98e42b8747d5"
      unitRef="usd">16700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzMtMy0xLTEtMA_a2d430db-1bfa-4b1b-b41c-ea054b0c0308"
      unitRef="usd">1000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzMtNS0xLTEtMA_c9e6b3c7-4c75-4e20-a431-b527c54303a0"
      unitRef="usd">17700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="i977c59e776264b9e898cb3877c491df2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzQtMS0xLTEtMA_392489ad-538b-450a-a1a6-dbb95a760d85"
      unitRef="usd">-300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie5bdf91f4b6d42daa720a6dfb657a0ad_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzQtMy0xLTEtMA_f3994d1f-32a6-4c59-ba53-e047fc02b568"
      unitRef="usd">-39300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzQtNS0xLTEtMA_40b35972-4651-4ef2-9bf1-fce31d7b707f"
      unitRef="usd">-39600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzYtMS0xLTEtMA_edc1a573-24fd-4c45-8deb-c2e323e5c6e3"
      unitRef="usd">170400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd70072490624e738ef4b03b84386198_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzYtMy0xLTEtMA_4ace4837-7b5f-4f6f-8b0b-9facbd9b4281"
      unitRef="usd">15900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzYtNS0xLTEtMA_bd2bf7b0-7b65-40f3-a783-262061c21c1c"
      unitRef="usd">186300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationAndAmortization
      contextRef="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzctMS0xLTEtMA_ca4c73bc-f08f-4535-afe0-71f1df2740cc"
      unitRef="usd">16900000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifd70072490624e738ef4b03b84386198_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzctMy0xLTEtMA_ef2f4fce-d2e0-4c97-a1db-2ba9b3b283f0"
      unitRef="usd">1300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzctNS0xLTEtMA_d09be67c-49c8-4357-a165-27065373dee6"
      unitRef="usd">18200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="id46c7fd18baa4a1794d9c6b189a25edd_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzgtMS0xLTEtMA_26a1082b-6d00-420f-9ac5-dbf9d8297a06"
      unitRef="usd">17300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifd70072490624e738ef4b03b84386198_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzgtMy0xLTEtMA_8f31830d-e424-49d8-9abc-421c78a24a80"
      unitRef="usd">-38200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTo4ZWM4MzA0MjY0NzI0NWQ3YjBjN2JhZWRhYjZkZDRjOS90YWJsZXJhbmdlOjhlYzgzMDQyNjQ3MjQ1ZDdiMGM3YmFlZGFiNmRkNGM5XzgtNS0xLTEtMA_f5cccec1-57bf-471c-90b6-e1955916a0fc"
      unitRef="usd">-20900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzItMS0xLTEtMA_efc7563d-6a47-465e-b023-c858c8c171fc"
      unitRef="usd">-39600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzItMy0xLTEtMA_8bf36d73-a4d6-47f9-ac1e-b64055ac0a51"
      unitRef="usd">-20900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzQtMS0xLTEtMA_ef963e0f-b90c-48c4-94a1-77a247ed9e6d"
      unitRef="usd">400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzQtMy0xLTEtMA_590c765e-81b4-4b4a-85d5-85bc9fd0a927"
      unitRef="usd">900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzUtMS0xLTEtMA_adbd1130-27a1-439b-ad98-e666bdbbccaa"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzUtMy0xLTEtMA_00868869-4fd8-4625-bf16-63dad9c9e05c"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzYtMS0xLTEtMA_56977aec-4c96-404f-b4b0-c9e2fbfe218a"
      unitRef="usd">-1600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzYtMy0xLTEtMA_af6a6828-90dd-4652-a0cf-c596cfd44620"
      unitRef="usd">600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzctMS0xLTEtMA_e679e00f-4d24-4c71-a44f-ca255b0f2bad"
      unitRef="usd">-43700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzctMy0xLTEtMA_31013ce6-eac9-4f8c-99fa-73f320ea2c46"
      unitRef="usd">-22300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzgtMS0xLTEtMA_9100b7c2-0558-426d-97fc-7cef485990c8"
      unitRef="usd">-28500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzgtMy0xLTEtMA_a35d3114-f537-47f2-a251-4801807d4110"
      unitRef="usd">-1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzktMS0xLTEtMA_863666aa-d712-4550-b3e8-8f7733dbe762"
      unitRef="usd">-15200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzktMy0xLTEtMA_fd47f1c9-6e0c-477f-89b0-c5085febd076"
      unitRef="usd">-20600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzEwLTEtMS0xLTA_f7b1dc9c-806a-4081-bf64-2d5b104cfe06"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzEwLTMtMS0xLTA_eda8dc85-80f3-4f71-ab68-005ff9daabb4"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzExLTEtMS0xLTA_565799ef-c77b-4828-8a3d-e0a272938c2a"
      unitRef="usd">-15200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDYvZnJhZzpiYTEyNjBmOGMwMDQ0ODM2YWZlNWYyZTE0Y2FjMGM3Zi90YWJsZTpjYzhjNzUyNmFmYTA0ZGNiYTc1NGM2NWFkZmM5MjI3Ni90YWJsZXJhbmdlOmNjOGM3NTI2YWZhMDRkY2JhNzU0YzY1YWRmYzkyMjc2XzExLTMtMS0xLTA_a1ffbaa7-38b6-4d58-98a3-f232cd8d9a9f"
      unitRef="usd">-20600000</us-gaap:NetIncomeLoss>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90ZXh0cmVnaW9uOjYwNWFmNTQ2NzA2ZDQ5ODRiODQ0ODBjYjlkZmQ1NDQ2XzQy_4c9339e8-ebc6-4af2-b354-8797e4c1766c">SUPPLEMENTAL CASH FLOW INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid during the period for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Establishment of operating lease right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(78.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities and other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90ZXh0cmVnaW9uOjYwNWFmNTQ2NzA2ZDQ5ODRiODQ0ODBjYjlkZmQ1NDQ2XzQz_9ff1957b-c0eb-4dd7-b074-79269e1865c4">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid during the period for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Establishment of operating lease right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(78.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities and other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzItMS0xLTEtMA_d63d810a-4b39-4b97-b6bd-2888104af3a0"
      unitRef="usd">1300000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzItMy0xLTEtMA_0aeaea6b-53a7-40f5-a69a-1914f4221a85"
      unitRef="usd">200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzMtMS0xLTEtMA_5d4838b8-e286-4676-a8a7-1951f6551ad0"
      unitRef="usd">2600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6234236191e840b3ba0820dd275841bf_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzMtMy0xLTEtMA_bcca9a22-d7f3-495a-984a-40fe28e5756b"
      unitRef="usd">2800000</us-gaap:InterestPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzUtMy0xLTEtMA_872e8c6a-f498-4177-9b85-3fd8a64eabde"
      unitRef="usd">74500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <mygn:OperatingLeaseLiabilityEstablished
      contextRef="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzYtMy0xLTEtMA_beb2ae74-3290-4831-bd8c-803153312906"
      unitRef="usd">78800000</mygn:OperatingLeaseLiabilityEstablished>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i19d6444d32d4425ebcfef5e017e25abe_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMDkvZnJhZzo2MDVhZjU0NjcwNmQ0OTg0Yjg0NDgwY2I5ZGZkNTQ0Ni90YWJsZTplMTEwMzMxODA3Nzg0OGYyOTZkZWNiZGZjMDEzYzc5Mi90YWJsZXJhbmdlOmUxMTAzMzE4MDc3ODQ4ZjI5NmRlY2JkZmMwMTNjNzkyXzctMy0xLTEtMA_3b8b3985-afe1-44bf-9f48-ef916d40e263"
      unitRef="usd">4300000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1ZGYyNjIyYjNhMDQyM2U5ZjQwOWFjMjE3M2EzMWM4L3NlYzozNWRmMjYyMmIzYTA0MjNlOWY0MDlhYzIxNzNhMzFjOF8xMTUvZnJhZzplYTMyNzcyNmM5NWU0MzhjYTU2ZWU2NTg1NGZhNzg2MS90ZXh0cmVnaW9uOmVhMzI3NzI2Yzk1ZTQzOGNhNTZlZTY1ODU0ZmE3ODYxXzI5MjA_fddae262-32f6-44aa-a749-bc45fc17f768">SUBSEQUENT EVENTS&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Change in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 9, 2020, the Company&#x2019;s Board of Directors approved a change in the Company&#x2019;s fiscal year from a fiscal year ending on the last day of June of each year to a calendar fiscal year ending on the last day of December of each year, effective January 1, 2021. Accordingly, the Company will be issuing financial statements for a six-month transition period ending December 31, 2020 and calendar year financial statements thereafter.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694447095672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 02, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MYRIAD GENETICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0494517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">320 Wakara Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-3600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MYGN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,210,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694448120856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 118.3<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable investment securities</a></td>
<td class="nump">42.1<span></span>
</td>
<td class="nump">54.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent', window );">Prepaid expenses</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable</a></td>
<td class="nump">85.1<span></span>
</td>
<td class="nump">68.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">107.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">394.5<span></span>
</td>
<td class="nump">331.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">36.7<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">62.7<span></span>
</td>
<td class="nump">66.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable investment securities</a></td>
<td class="nump">30.2<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net</a></td>
<td class="nump">590.9<span></span>
</td>
<td class="nump">605.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">328.3<span></span>
</td>
<td class="nump">327.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,444.5<span></span>
</td>
<td class="nump">1,404.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">65.4<span></span>
</td>
<td class="nump">75.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating lease liabilities</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Short-term contingent consideration</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">32.3<span></span>
</td>
<td class="nump">32.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">133.7<span></span>
</td>
<td class="nump">147.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">37.4<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred taxes</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">224.6<span></span>
</td>
<td class="nump">224.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">53.5<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">535.2<span></span>
</td>
<td class="nump">486.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, 75.2 and 74.7 shares outstanding at September 30, 2020 and June 30, 2020 respectively</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,101.2<span></span>
</td>
<td class="nump">1,096.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(189.1)<span></span>
</td>
<td class="num">(173.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Myriad Genetics, Inc. stockholders&#8217; equity</a></td>
<td class="nump">909.3<span></span>
</td>
<td class="nump">918.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">909.3<span></span>
</td>
<td class="nump">918.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,444.5<span></span>
</td>
<td class="nump">$ 1,404.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expense excluding prepaid taxes current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694439443880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">75.2<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694447502472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in the fair value of contingent consideration</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expense</a></td>
<td class="nump">124.1<span></span>
</td>
<td class="nump">135.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">207.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax</a></td>
<td class="num">(43.7)<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(28.5)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(15.2)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted (shares)</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 135.7<span></span>
</td>
<td class="nump">$ 172.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">41.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Costs and expenses</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694526192504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized loss on available-for-sale debt securities, net of tax</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in foreign currency translation adjustment, net of tax</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(13.6)<span></span>
</td>
<td class="num">(22.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Myriad Genetics, Inc. shareholders</a></td>
<td class="num">$ (13.6)<span></span>
</td>
<td class="num">$ (22.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694448580168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings (accumulated deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2019</a></td>
<td class="nump">$ 1,088.9<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 1,068.0<span></span>
</td>
<td class="num">$ (5.4)<span></span>
</td>
<td class="nump">$ 25.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based payment expense</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(20.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">1,074.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1,076.3<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="nump">918.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1,096.6<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(173.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based payment expense</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 909.3<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1,101.2<span></span>
</td>
<td class="num">$ (3.6)<span></span>
</td>
<td class="num">$ (189.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694448796488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">18.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_NonCashInterestExpense', window );">Non-cash interest expense</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on disposition of assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes', window );">Prepaid expenses</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(17.0)<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="num">(107.9)<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(9.8)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(59.3)<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable investment securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(23.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities and sales of marketable investment securities</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">17.1<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment for tax withholding for common stock issued under share-based compensation plans</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration recognized at acquisition</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of revolving credit facility</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="num">(12.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash and cash equivalents</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(45.4)<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of the period</a></td>
<td class="nump">163.7<span></span>
</td>
<td class="nump">93.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of the period</a></td>
<td class="nump">$ 118.3<span></span>
</td>
<td class="nump">$ 89.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in prepaid expense excluding increase decrease in prepaid taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncreaseDecreaseInUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncreaseDecreaseInUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_NonCashInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_NonCashInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443611576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements for Myriad Genetics, Inc. and subsidiaries (the &#8220;Company&#8221; or &#8220;Myriad&#8221;) have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). &#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Operating results for the three months ended September&#160;30, 2020 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full impact of the COVID-19 outbreak continues to evolve and its future impact remains highly uncertain and unpredictable. As such, it is uncertain as to the full magnitude of the effect that the pandemic will have on the Company's financial condition, liquidity, and future results of operations. Management is actively monitoring the impact of the global situation on the Company's financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evaluation of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced seasonality in our testing business. The volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, the quarter ending March 31 is typically negatively impacted by the annual reset of patient deductibles. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders&#8217; equity, cash flows from operations, or net loss for the period.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Standards</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (the "FASB") issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326) (&#8220;ASU 2016-13&#8221;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company is required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are also recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, Intangibles &#8211; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU 2018-15&#8221;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements as of September 30, 2020. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of the other assets financial statement line item in the consolidated balance sheets.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards Effective in Future Years and Not Yet Adopted</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact this new standard will have on the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443543928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">REVENUE<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Myriad generates revenue by performing molecular diagnostic testing and pharmaceutical services. The Company previously provided clinical services until selling Privatklinik Dr. Robert Schindlbeck GmbH &amp; Co. KG (the "Clinic") in February 2020. Revenue from the sale of molecular diagnostic tests and pharmaceutical and clinical services is recorded at the estimated amount of consideration to be received. The Company has determined that the communication of test results or the completion of clinical and pharmaceutical services indicates transfer of control for revenue recognition purposes.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents detail regarding the composition of our total revenue by product and by U.S. versus rest of world, &#8220;RoW&#8221;:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:31.655%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RoW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RoW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeneSight</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vectra</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">myChoice CDx</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prolaris</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoPredict</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total molecular diagnostic revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs its obligation under a contract with a customer by processing diagnostic tests and communicating the test results to customers, in exchange for consideration from the customer. The Company has the right to bill its customers upon the completion of performance obligations and thus does not record contract assets. Occasionally, customers make payments prior to the Company's performance of its contractual obligations. When this occurs, the Company records a contract liability as deferred revenue. During fiscal year 2020, the Company received approximately $29.7 in advance Medicare payments to provide relief from the economic impacts of COVID-19 on the Company. The advance Medicare payments are included in the beginning and ending balance of deferred revenue. A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:77.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - beginning balance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#8217;s right to payment is in an amount that directly corresponds with the value of Company&#8217;s performance to date. However, the Company periodically enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. As of September&#160;30, 2020, the aggregate amount of the transaction price of such contracts that is allocated to the remaining performance obligations is $2.8.&#160;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may provide discounts to its customers. In determining the transaction price, Myriad includes an estimate of the expected amount of consideration as revenue. The Company applies this method consistently for similar contracts when estimating the effect of any uncertainty on an amount of variable consideration to which it will be entitled. The Company applies the expected value method for sales where the Company has a large number of contracts with similar characteristics.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the Company considers all the information (historical, current, and forecast) that is reasonably available to identify possible consideration amounts. The Company considers the probability of the variable consideration for each possible scenario. The Company also has significant experience with historical discount patterns and uses this experience to estimate transaction prices. The Company excludes from the measurement of transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer. for example, sales tax, value added tax, etc. When assessing the total consideration for insurance carriers and patients, revenues are further constrained for estimated refunds. The Company reserves certain amounts in accrued liabilities on the balance sheet in anticipation of requests for refunds of payments made previously by insurance carriers, which are accounted for as reductions in revenues in the consolidated statements of operations and comprehensive loss. As of September 30, 2020, the Company recorded a $2.2 accrued liability and corresponding reduction in revenues for future refund of payments. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash collections for certain diagnostic tests delivered may differ from rates originally estimated, primarily driven by changes in the estimated transaction price due to contractual adjustments, obtaining updated information from payors and patients that was unknown at the time the performance obligation was met and settlements with third party payors. As a result of this new information, the Company updates our estimate of the amounts to be recognized for previously delivered tests, the impact of which was not material to our consolidated statements of operations for the three months ended September 30, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the practical expedient related to costs to obtain or fulfill a contract since the amortization period for such costs will be one year or less. Accordingly, no costs incurred to obtain or fulfill a contract have been capitalized. The Company also applies the practical expedient for not adjusting revenue recognized for the effects of the time value of money. This practical expedient has been elected because the Company collects very little cash from customers under payment terms and the vast majority of payment terms have a payback period of less than one year. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Substantially all of the Company&#8217;s accounts receivable are with companies in the healthcare industry, U.S. and state governmental agencies that make payments on the customer's behalf, and with individuals. The Company does not believe that receivables due from U.S. and state governmental agencies, such as Medicare, represent a credit risk since the related healthcare programs are funded by the U.S. and state governments. The Company only has one payor, Medicare, that represents greater than 10% of its revenues. Revenues received from Medicare represented approximately 16% and 14% of total revenue for the three months ended September 30, 2020 and 2019, respectively. Concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many geographic regions. No payor accounted for more than 10% of accounts receivable at September&#160;30, 2020 or 2019. The Company does not require collateral from its customers.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694441936776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Investment Securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Investment Securities</a></td>
<td class="text">MARKETABLE INVESTMENT SECURITIES<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its debt investment securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The Company&#8217;s cash equivalents consist of short-term, highly liquid investments that are readily convertible to known amounts of cash.&#160;The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at September&#160;30, 2020 and June&#160;30, 2020 were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253.5&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the adoption of ASC 2016-13, the Company assesses any unrealized loss positions for available-for-sale debt securities for which an allowance for credit losses has not been recorded. The aggregate amount of unrealized losses of these securities was not significant, and the impact of the securities in a continuous loss position to the condensed consolidated statements of operations and comprehensive loss were not material as of September&#160;30, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at September&#160;30, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due within one year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due after five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443775272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:</span></div><div style="margin-top:6pt;padding-left:76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1&#8212;quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2&#8212;observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&#160;&#160;Some of the Company&#8217;s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.</span></div><div style="margin-top:6pt;padding-left:76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#8212;unobservable inputs.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s financial instruments are valued using quoted prices in active markets or based on other observable inputs.&#160;&#160;For Level 2 securities, the Company uses a third party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information. The fair value of contingent consideration related to the Sividon Diagnostics GmbH ("Sividon") acquisition in fiscal year 2016 as well as long-term debt are categorized as Level 3 liabilities, as the measurement amount is based primarily on significant inputs not observable in the market. &#160;For Level 3 contingent consideration, the Company reassesses the fair value of expected contingent consideration and the corresponding liability each reporting period using the Monte Carlo Method, which is consistent with the initial measurement of the expected earn out liability.&#160;This fair value measurement is considered a Level 3 measurement because the Company estimates projections during the expected measurement period of approximately 9.25 years, utilizing various potential pay-out scenarios.&#160;&#160;Probabilities were applied to each potential scenario and the resulting values were discounted using a rate that considers weighted average cost of capital as well as a specific risk premium associated with the riskiness of the earn-out itself, the related projections, and the overall business.&#160;The contingent earn-out liabilities are classified as a component of long-term and short-term contingent consideration in the Company&#8217;s consolidated balance sheets.&#160;&#160;Changes to the earn-out liabilities are reflected in change in the fair value of contingent consideration in our consolidated statements of operations. Changes to the unobservable inputs could have a material impact on the Company&#8217;s financial statements.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term debt, which we consider a Level 3 measurement, is estimated using discounted cash flow analyses, based on the Company&#8217;s current estimated incremental borrowing rates for similar borrowing arrangements.&#160;&#160;The fair value of long-term debt is estimated to be $226.5 at September&#160;30, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the fair value of the financial assets and liabilities that the Company re-measures on a regular basis:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.9)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.9)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:6pt;padding-left:36pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the change in the fair value of the contingent consideration during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:86.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance June 30, 2020</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value recognized in the income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Translation adjustments recognized in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of contingent consideration for the three months ended September&#160;30, 2020 decreased compared to the same period in the prior year due to changes in timing of expected cash payments associated with the contingent consideration related to the Sividon acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694441904200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT, NET<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(110.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(106.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:72.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443464264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended September&#160;30, 2020, are as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"/><td style="width:38.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company will perform its annual goodwill impairment testing during the quarter ended December 31, 2020 as a result of its change in fiscal year end (see Note 16). The upcoming annual assessment may result in impairment charges if there is deterioration in business conditions, negative changes in market factors, or changes in the strategic priorities of the Company and its reporting units.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and trade names as well as non-amortizable intangible assets of in-process technologies and research and development.&#160;The following summarizes the amounts reported as intangible assets:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">816.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(232.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">584.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">824.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(238.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">586.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">829.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(238.2)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">590.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.2)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">823.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(222.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">828.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(222.7)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">605.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense during the respective periods for these intangible assets as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"/><td style="width:62.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443802120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">ACCRUED LIABILITIES<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee compensation and benefits</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694530744120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">LONG-TERM DEBT<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2016, the Company entered into a senior secured revolving credit facility (the &#8220;Facility&#8221;) by and among Myriad, as borrower, and the lenders from time to time party thereto. On July 31, 2018, the Company entered into Amendment No. 1 which effected an &#8220;amend and extend&#8221; transaction with respect to the Facility by which the maturity date thereof was extended to July 31, 2023 and the maximum aggregate principal commitment was increased from $300.0 to $350.0.&#160;On May 1, 2020, the Company entered into Amendment No. 2 (the &#8220;Amended Facility&#8221;), which waived the Company's compliance with certain covenants and modified the interest rate and other terms during the Amendment Period from March 31, 2020 through June 30, 2021 (the "Amendment Period"). Both amendments were accounted for as modifications pursuant to guidance in ASC 470-50.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended Facility, the Company borrowed revolving loans in an aggregate principal amount of $300.0 with $1.8 in upfront fees and $0.3 debt issuance costs recorded as a debt discount to be amortized over the term of the Amended Facility. The Company incurred an additional $1.0 in upfront fees as a result of Amendment No. 2, which was also recorded as a debt discount that will be amortized over the term of the Amended Facility. The current balance of the net long-term debt is $224.6. There are no scheduled principal payments of the Amended Facility prior to its maturity date.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility contains customary loan terms, interest rates, representations and warranties, affirmative and negative covenants, in each case, subject to customary limitations, exceptions and exclusions. The Amended Facility also contains certain customary events of default. Amendment No. 2 modified the Facility to increase the interest rate to be fixed at a spread of LIBOR plus 350 basis points on drawn balance and the undrawn fee was increased to 50 basis points during the Amendment Period. At the end of the Amendment Period, interest rates return to the previous pricing of 200 basis points on drawn balances and an undrawn fee ranging from 25 to 45 basis points based on the Company's leverage ratio. The LIBOR floor was also increased to 1.0% during the Amendment Period. The interest rate as of September&#160;30, 2020 was 4.5%.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covenants in the Amended Facility impose operating and financial restrictions on the Company. These restrictions may prohibit or place limitations on, among other things, the Company&#8217;s ability to incur additional indebtedness, create certain types of liens, and complete mergers, consolidations, or complete change in control transactions. The Amended Facility may also prohibit or place limitations on the Company&#8217;s ability to sell assets, pay dividends or provide other distributions to shareholders. The Company must maintain specified leverage and interest ratios measured as of the end of each quarter as a financial covenant in the Amended Facility. Amendment No. 2 modified the Amended Facility's compliance with the leverage covenant and the interest coverage ratio covenant, which were waived through March 31, 2021. A minimum liquidity covenant was added for the period beginning May 2020 until March 2021, and a minimum EBITDA covenant was added for the quarters ending December 31, 2020 and March 31, 2021. Amendment No. 2 also revised certain negative covenants of the Amended Facility during the Amendment Period. The Company was in compliance with all financial covenants at September&#160;30, 2020. Based on the continued uncertainty regarding the impact of COVID-19 on the Company&#8217;s future operations, it is possible that the Company could be in violation of certain financial covenants contained in the Amended Facility within the Amendment Period, which runs through June 30, 2021. The Company may seek waivers or amendments from the lenders in order to avoid a future potential covenant violation, in addition to taking other potential actions. If the Company were unable to comply with the covenants in the future, it could result in an increase in the rate of interest and limits on the Company's ability to incur certain additional indebtedness and it could potentially cause the loan repayment to be </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated, any of which could have a material adverse impact on the Company&#8217;s operations and liquidity. The Company has and continues to take actions to mitigate the risk of an event of default under the Amended Facility, however there is no assurance it will be successful in doing so.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Facility is secured by a first-lien security interest in substantially all of the assets of Myriad and certain of its domestic subsidiaries and each such domestic subsidiary of Myriad has guaranteed the repayment of the Amended Facility. Amounts outstanding under the Amended Facility and Facility were as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net long-term debt</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224.4&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694441928328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Long-Term Liabilities</a></td>
<td class="text">OTHER LONG-TERM LIABILITIES<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The Company's balance of other long-term liabilities as of September&#160;30, 2020 and June&#160;30, 2020 consists of the Company's portion of social security taxes that have been deferred under the CARES Act that do not have to be deposited until December 2021 and December 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694531675880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Preferred and Common Stockholders' Equity</a></td>
<td class="text">PREFERRED AND COMMON STOCKHOLDERS' EQUITY<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 5.0 shares of preferred stock, par value $0.01 per share.&#160;&#160;There were no preferred shares outstanding at September&#160;30, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 150.0 shares of common stock, par value $0.01 per share. There were 75.2 shares issued and outstanding at September&#160;30, 2020.</span></div><div style="margin-top:18pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common shares issued and outstanding</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning common stock issued and outstanding</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued and outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding.&#160;&#160;Diluted earnings per share is computed based on the weighted-average number of shares of common stock, including the dilutive effect of common stock equivalents, outstanding.&#160;&#160;In periods when the Company has a net loss, stock awards are excluded from the calculation of diluted net loss per share as their inclusion would have an antidilutive effect.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share (&#8220;EPS&#8221;) computations:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:80.994%"><tr><td style="width:1.0%"/><td style="width:68.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive shares</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain outstanding options and restricted stock units (&#8220;RSUs&#8221;) were excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"/><td style="width:62.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><div style="margin-top:18pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Company&#8217;s Board of Directors authorized a share repurchase program of $200.0 of the Company&#8217;s outstanding common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company's management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.&#160;&#160;As of September&#160;30, 2020, the Company is authorized to repurchase up to $110.7 of shares under this authorization. No shares were repurchased during the three months ended September 30, 2020 or 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694441900408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2017, the Company&#8217;s shareholders approved the adoption of the 2017 Employee, Director and Consultant Equity Incentive Plan (as amended, the &#8220;2017 Plan&#8221;).&#160;On November 29, 2018 and December 5, 2019, the shareholders approved amendments to the 2017 Plan increasing the shares available to grant. The 2017 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of restricted and unrestricted stock awards to employees, consultants and directors. As of September&#160;30, 2020, the Company may grant additional shares of common stock under the 2017 Plan with respect to the 0.1 options outstanding under our 2003 Plan and 4.8 options and restricted stock units outstanding under our 2010 Plan, to the extent that those options and restricted stock units expire or are cancelled without delivery of shares of common stock. If an RSU awarded under the 2017 Plan is cancelled or forfeited without the issuance of shares of common stock, the unissued or reacquired shares, which were subject to the RSU, shall again be available for issuance pursuant to the 2017 Plan.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares, terms, and vesting periods are determined by the Company&#8217;s Board of Directors or a committee thereof on an award-by-award basis. RSUs granted to employees generally vest ratably over four years on the anniversary date of the designated day of the last week of the month in which the RSUs are granted. The number of RSUs awarded to certain executive officers may be increased or reduced based on certain additional performance metrics. Options and RSUs granted to our non-employee directors vest in full upon completion of one year of service on the anniversary following the date of the grant. Options generally vest ratably over service periods of four years.&#160;&#160;Options granted after December 5, 2012 expire eight years from the date of grant, and options granted prior to that date generally expire ten years from the date of grant. In September 2014, the Company began generally issuing RSUs in lieu of stock options.&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, the Company granted stock-based awards to the Company's new President and Chief Executive Officer as an inducement material to his commencement of employment and entry into an employment agreement with the Company. The inducement awards were made in accordance with Nasdaq Stock Market rules and were not made under the Company's existing equity plans; the inducement awards are included in the tables below.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the stock option activity under the Company&#8217;s equity plans, including the Company's inducement awards, for the three months ended September&#160;30, 2020 is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.47&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options canceled or expired</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.40&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding at September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercisable at September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.62&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there was $5.2 of unrecognized share-based compensation expense related to the inducement stock options that will be recognized over a weighted-average period of 2.8 years. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the RSU activity under the Company&#8217;s plans, including the Company's inducement awards and RSU awards with performance metrics, for the three months ended September&#160;30, 2020 is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.50&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs canceled</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs outstanding at September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there was $44.1 of total unrecognized share-based compensation expense related to RSUs that will be recognized over a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted-average period of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2.5 years.&#160;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has an Employee Stock Purchase Plan that was approved by shareholders in 2012 (the &#8220;2012 Purchase Plan&#8221;), under which 2.0 shares of common stock have been authorized.&#160;&#160;Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period.&#160;&#160;As of September&#160;30, 2020, approximately 0.3 shares of common stock are available for issuance under the 2012 Purchase Plan.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation Expense</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense recognized and included in the condensed consolidated statements of operations and comprehensive loss was allocated as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"/><td style="width:62.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total share-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443813720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine the Company&#8217;s quarterly provision for income taxes, the Company used an estimated annual effective tax rate that is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates.&#160;Under the Tax Cuts and Jobs Act, the federal corporate tax rate is 21% for calendar year 2020.&#160;Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rate from quarter to quarter.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the three months ended September&#160;30, 2020 was $28.5, or approximately 65.2% of pre-tax loss compared to an income tax benefit of $1.7, or approximately 7.6% of pre-tax loss, for the three months ended September&#160;30, 2019.&#160;&#160;Income tax benefit for the three months ended September&#160;30, 2020 is based on the Company&#8217;s estimated annualized effective tax rate for the six-month transition period ending December 31, 2020, adjusted by discrete items recognized during the period.&#160;&#160;For the three months ended September&#160;30, 2020, the Company&#8217;s recognized effective tax rate differs from the U.S. federal statutory rate primarily due to carrying back net operating losses due to the CARES Act.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES&#8221;) was enacted.&#160;&#160;CARES impacted several provisions to the U.S. tax code that have affected our six-month transition period ending December 31, 2020, including, but not limited to, (1) NOL carry-back and carry-forward provisions, (2) deductibility of interest, (3) acceleration of corporate AMT credits, and (4) classification of qualified improvement property.&#160;&#160;As of the quarter ended September&#160;30, 2020, the Company recognized an income tax net benefit of $20.0 related to the CARES Act, which included an increase in the uncertain tax benefit accrual of $14.3, related to carrying back net operating losses to tax years with higher corporate tax rates than the year the net operating loss originated. The Company will continue to evaluate the application of any and all provisions through the remainder of the six-month transition period ending December 31, 2020.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S., foreign and state income tax returns in jurisdictions with various statutes of limitations.&#160;&#160;The Company is currently under audit by the state of New Jersey for the fiscal years June 30, 2013 through 2017; the state of New York and Massachusetts for the fiscal years June 30, 2014 through 2016; Germany for the fiscal years June 30, 2013 through 2015; and Switzerland for the fiscal years June 30, 2015 through 2016. Annual and interim tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443515848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIESThe Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of September&#160;30, 2020, the management of the Company believes any reasonably possible liability that may result from the resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated financial position, operating results, or cash flows.From time to time, the Company receives recoupment requests from third-party payors for alleged overpayments. The Company disagrees with the contentions of the pending requests or has recorded an estimated reserve for the alleged overpayments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443813720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Related Information</a></td>
<td class="text">SEGMENT AND RELATED INFORMATIONThe Company&#8217;s business is aligned with how the chief operating decision maker reviews performance and makes decisions in managing the Company.&#160;&#160;The business units have been aggregated into two reportable segments: (i)&#160;diagnostics and (ii) other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual&#8217;s risk for developing disease later in life, identify a patient&#8217;s likelihood of responding to drug therapy and guide a patient&#8217;s dosing to ensure optimal treatment, or assess a patient&#8217;s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology.<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment revenue and operating income (loss) were as follows during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(39.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(39.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended September 30, 2019</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"/><td style="width:68.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating loss for reportable segments</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(39.6)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.9)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated amounts:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations before income taxes</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.5)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15.2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics, Inc. stockholders</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15.2)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.6)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443515848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid during the period for income taxes</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishment of operating lease right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(78.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities and other long-term liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443813720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Fiscal Year</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 9, 2020, the Company&#8217;s Board of Directors approved a change in the Company&#8217;s fiscal year from a fiscal year ending on the last day of June of each year to a calendar fiscal year ending on the last day of December of each year, effective January 1, 2021. Accordingly, the Company will be issuing financial statements for a six-month transition period ending December 31, 2020 and calendar year financial statements thereafter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694543646824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements for Myriad Genetics, Inc. and subsidiaries (the &#8220;Company&#8221; or &#8220;Myriad&#8221;) have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). &#160;All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2020. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Operating results for the three months ended September&#160;30, 2020 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full impact of the COVID-19 outbreak continues to evolve and its future impact remains highly uncertain and unpredictable. As such, it is uncertain as to the full magnitude of the effect that the pandemic will have on the Company's financial condition, liquidity, and future results of operations. Management is actively monitoring the impact of the global situation on the Company's financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evaluation of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for future periods. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically experienced seasonality in our testing business. The volume of testing is negatively impacted by the summer season, which is generally reflected in the quarter ended June 30. The quarter ending December 31 is generally strong as we see an increase in volumes from patients who have met their annual insurance deductible. Conversely, the quarter ending March 31 is typically negatively impacted by the annual reset of patient deductibles. Due to the global pandemic, we cannot predict if seasonality will follow the same pattern as in prior years. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation. The reclassifications have no impact on the total assets, total liabilities, stockholders&#8217; equity, cash flows from operations, or net loss for the period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Standards</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (the "FASB") issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326) (&#8220;ASU 2016-13&#8221;) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company is required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are also recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. On July 1, 2020, the Company adopted ASU 2016-13 under the modified retrospective approach by initially applying ASU 2016-13 at the adoption date, rather than at the beginning of the earliest comparative period presented. This guidance was adopted with no material impact to the Company's consolidated financial statements.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, Intangibles &#8211; Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU 2018-15&#8221;). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software, including hosting arrangements that include an internal-use </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">software license. On July 1, 2020, the Company adopted ASU 2018-15 on a prospective basis with no material impact to the Company's consolidated financial statements as of September 30, 2020. The amounts capitalized may be material in future periods; implementation costs incurred in cloud computing arrangements are capitalized as part of the other assets financial statement line item in the consolidated balance sheets.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards Effective in Future Years and Not Yet Adopted</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"). ASC 2019-12 is a new accounting standard to simplify accounting for income taxes and remove, modify, and add to the disclosure requirements of income taxes. The standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact this new standard will have on the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443710760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Total Revenue by Product and by U.S versus Rest of World</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents detail regarding the composition of our total revenue by product and by U.S. versus rest of world, &#8220;RoW&#8221;:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:31.655%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RoW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RoW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Molecular diagnostic revenues:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hereditary Cancer Testing</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prenatal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GeneSight</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vectra</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">myChoice CDx</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prolaris</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoPredict</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total molecular diagnostic revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical and clinical service revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Reconciliation of Deferred Revenue Balances</a></td>
<td class="text">A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:77.010%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - beginning balance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepayments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue - ending balance</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694531675880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Investment Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security</a></td>
<td class="text">The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at September&#160;30, 2020 and June&#160;30, 2020 were as follows:<div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>unrealized<br/>holding<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253.5&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at September&#160;30, 2020:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due within one year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due after one year through five years</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due after five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443501032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Fair Value of Financial Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the fair value of the financial assets and liabilities that the Company re-measures on a regular basis:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.9)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.9)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:46.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds (a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds and notes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Municipal bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal agency issues</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">US government securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:27.13pt">Money market funds are primarily comprised of exchange traded funds and accrued interest.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Change in Fair Value of Contingent Consideration</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the change in the fair value of the contingent consideration during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:86.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance June 30, 2020</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value recognized in the income statement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Translation adjustments recognized in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443729304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment, Net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(110.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(106.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:72.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694439407176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended September&#160;30, 2020, are as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:93.421%"><tr><td style="width:1.0%"/><td style="width:38.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Amortizable Intangible Assets</a></td>
<td class="text">The following summarizes the amounts reported as intangible assets:<div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">816.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(232.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">584.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">824.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(238.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">586.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">829.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(238.2)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">590.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.2)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">823.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(222.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">828.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(222.7)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">605.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Non-amortizable Intangible Assets</a></td>
<td class="text">The following summarizes the amounts reported as intangible assets:<div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">816.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(232.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">584.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.4)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">824.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(238.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">586.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">829.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(238.2)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">590.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2020:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased licenses and technologies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">598.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.2)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">823.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(222.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unamortized intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">828.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(222.7)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">605.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Schedule of Recorded Amortization Expense for Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense during the respective periods for these intangible assets as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"/><td style="width:62.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694442131912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee compensation and benefits</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443501032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text">Amounts outstanding under the Amended Facility and Facility were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net long-term debt</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224.6&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224.4&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694525771800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443593992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Summary of Common Shares Issued and Outstanding</a></td>
<td class="text"><div style="margin-top:18pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common shares issued and outstanding</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning common stock issued and outstanding</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock issued and outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the denominators of the basic and diluted earnings per share (&#8220;EPS&#8221;) computations:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:80.994%"><tr><td style="width:1.0%"/><td style="width:68.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.340%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding used to compute basic EPS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive shares</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-Dilutive Options and Restricted Stock Units Excluded from EPS Computation</a></td>
<td class="text">These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"/><td style="width:62.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-dilutive options and RSUs excluded from EPS computation</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694531652168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the stock option activity under the Company&#8217;s equity plans, including the Company's inducement awards, for the three months ended September&#160;30, 2020 is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>exercise<br/>price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.47&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options canceled or expired</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.40&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding at September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options exercisable at September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.62&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the RSU activity under the Company&#8217;s plans, including the Company's inducement awards and RSU awards with performance metrics, for the three months ended September&#160;30, 2020 is as follows:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number<br/>of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs outstanding at June 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.50&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs canceled</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs outstanding at September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense recognized and included in the condensed consolidated statements of operations and comprehensive loss was allocated as follows:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:68.567%"><tr><td style="width:1.0%"/><td style="width:62.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.866%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of molecular diagnostic testing</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of pharmaceutical and clinical services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total share-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443501032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Revenue and Operating Income (Loss)</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment revenue and operating income (loss) were as follows during the periods presented:</span></div><div style="margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:59.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(39.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(39.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three months ended September 30, 2019</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"/><td style="width:68.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating loss for reportable segments</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(39.6)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.9)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated amounts:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations before income taxes</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.5)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15.2)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.6)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to Myriad Genetics, Inc. stockholders</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15.2)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.6)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694525771800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:72.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid during the period for income taxes</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishment of operating lease right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(78.8)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities and other long-term liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694542416664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Total Revenue by Product and by US versus Rest of World (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">134.0<span></span>
</td>
<td class="nump">174.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember', window );">Molecular diagnostic - Hereditary Cancer Testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">80.6<span></span>
</td>
<td class="nump">104.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember', window );">Molecular diagnostic - Hereditary Cancer Testing | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">72.1<span></span>
</td>
<td class="nump">100.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember', window );">Molecular diagnostic - Hereditary Cancer Testing | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember', window );">Molecular diagnostic - Prenatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember', window );">Molecular diagnostic - Prenatal | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember', window );">Molecular diagnostic - Prenatal | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember', window );">Molecular diagnostic - GeneSight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember', window );">Molecular diagnostic - GeneSight | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember', window );">Molecular diagnostic - GeneSight | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember', window );">Molecular diagnostic - Vectra</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember', window );">Molecular diagnostic - Vectra | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember', window );">Molecular diagnostic - Vectra | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember', window );">Molecular diagnostic - myChoice CDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember', window );">Molecular diagnostic - myChoice CDx | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember', window );">Molecular diagnostic - myChoice CDx | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember', window );">Molecular diagnostic - Prolaris</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember', window );">Molecular diagnostic - Prolaris | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember', window );">Molecular diagnostic - Prolaris | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember', window );">Molecular diagnostic - EndoPredict</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember', window );">Molecular diagnostic - EndoPredict | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember', window );">Molecular diagnostic - EndoPredict | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember', window );">Molecular diagnostic - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember', window );">Molecular diagnostic - Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember', window );">Molecular diagnostic - Other | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">135.7<span></span>
</td>
<td class="nump">172.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">124.5<span></span>
</td>
<td class="nump">166.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember', window );">Molecular diagnostic testing | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember', window );">Pharmaceutical and clinical services | RoW</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticHereditaryCancerTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticPrenatalTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticGenesightTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticVectraTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticMyChoiceCDxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticProlarisTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticEndoPredictTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticOtherTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_MolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mygn_PharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694441907288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Reconciliation of Deferred Revenue Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Reconciliation of Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue - beginning balance</a></td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_ContractWithCustomerLiabilityPrepayments', window );">Prepayments</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue - ending balance</a></td>
<td class="nump">$ 32.3<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_ContractWithCustomerLiabilityPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer, liability, prepayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_ContractWithCustomerLiabilityPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694447793736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_CARESActOf2020MedicarePaymentAmount', window );">Advance Medicare payments to provide relief from economic impacts of COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription', window );">Revenue, practical expedient, remaining performance obligation, description</a></td>
<td class="text">In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company&#8217;s right to payment is in an amount that directly corresponds with the value of Company&#8217;s performance to date. However, the Company periodically enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation', window );">Revenue, practical expedient, remaining performance obligation</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Accrued refund liability</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract', window );">Revenue practical expedient, incremental cost of obtaining contract</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Capitalized costs incurred to obtain or fulfill contract</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenues | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_CARESActOf2020MedicarePaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act of 2020 Medicare payment amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_CARESActOf2020MedicarePaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121551570&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether practical expedient was elected to recognize incremental cost of obtaining contract as expense when incurred if amortization period would have been one year or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL51790836-203054<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130569-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether optional exemption was applied not to disclose amount of transaction price allocated to and explanation of expected timing of revenue recognition for remaining performance obligation, when contract has expected duration of one year or less or right to consideration corresponds directly to performance completed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of consideration that is not included in transaction price and not allocated to remaining performance obligation. Includes, but is not limited to, variable consideration that is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694448926616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, Amortized cost</a></td>
<td class="nump">$ 118.3<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Estimated fair value</a></td>
<td class="nump">118.3<span></span>
</td>
<td class="nump">163.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCashAbstract', window );"><strong>Total:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAmortizedCost', window );">Total, Amortized cost</a></td>
<td class="nump">189.6<span></span>
</td>
<td class="nump">253.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax', window );">Total, Gross unrealized holding gains</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax', window );">Total, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Total, Estimated fair value</a></td>
<td class="nump">190.6<span></span>
</td>
<td class="nump">254.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, Amortized cost</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Estimated fair value</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, Amortized cost</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Estimated fair value</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">40.5<span></span>
</td>
<td class="nump">50.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, Amortized cost</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale, Gross unrealized holding gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale, Gross unrealized holding losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, Estimated fair value</a></td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 16.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Accumulated Gross Unrealized Gain, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Accumulated Gross Unrealized Loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694448575560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 118.3<span></span>
</td>
<td class="nump">$ 163.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Available-for-sale, Due within one year</a></td>
<td class="nump">41.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Available-for-sale, Due after one year through five years</a></td>
<td class="nump">29.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis', window );">Available-for-sale, Due after five years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_InvestmentsAndCashAmortizedCost', window );">Total, Amortized cost</a></td>
<td class="nump">189.6<span></span>
</td>
<td class="nump">253.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Estimated fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">118.3<span></span>
</td>
<td class="nump">163.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Available-for-sale, Due within one year</a></td>
<td class="nump">42.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Available-for-sale, Due after one year through five years</a></td>
<td class="nump">30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue', window );">Available-for-sale, Due after five years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Total, Estimated fair value</a></td>
<td class="nump">190.6<span></span>
</td>
<td class="nump">254.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Estimated fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">132.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Estimated fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="nump">$ 30.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_InvestmentsAndCashAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments And Cash, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_InvestmentsAndCashAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694441884168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - Level 3<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 226.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Measurement input, expected term</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm', window );">Measurement period for earn out liability</a></td>
<td class="text">9 years 3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Measurement Input, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694526228008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">$ 116.4<span></span>
</td>
<td class="nump">$ 115.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mygn_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">72.3<span></span>
</td>
<td class="nump">91.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Corporate bonds and notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Federal agency issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="num">$ (5.9)<span></span>
</td>
<td class="num">$ (6.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mygn_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mygn_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694439391272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Reconciliation of change in fair value of contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payment of contingent consideration</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in the income statement</a></td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Translation adjustments recognized in other comprehensive income</a></td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 5.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694442116712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">$ 32.6<span></span>
</td>
<td class="nump">$ 31.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Equipment</a></td>
<td class="nump">114.1<span></span>
</td>
<td class="nump">112.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">146.7<span></span>
</td>
<td class="nump">143.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(110.0)<span></span>
</td>
<td class="num">(106.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 36.7<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443672936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Depreciation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694527711480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Summary of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 327.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">328.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">270.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">271.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">56.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Translation adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 56.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694449085816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">$ 824.3<span></span>
</td>
<td class="nump">$ 823.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(238.2)<span></span>
</td>
<td class="num">(222.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, amortizable</a></td>
<td class="nump">586.1<span></span>
</td>
<td class="nump">600.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount, total</a></td>
<td class="nump">829.1<span></span>
</td>
<td class="nump">828.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net, total</a></td>
<td class="nump">590.9<span></span>
</td>
<td class="nump">605.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_PurchasedLicensesAndTechnologiesMember', window );">Purchased licenses and technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">816.6<span></span>
</td>
<td class="nump">815.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(232.4)<span></span>
</td>
<td class="num">(217.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, amortizable</a></td>
<td class="nump">584.2<span></span>
</td>
<td class="nump">598.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, amortizable</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, amortizable</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net, amortizable</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_PurchasedLicensesAndTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mygn_PurchasedLicensesAndTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443694984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Amortization on Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694440316664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">$ 47.2<span></span>
</td>
<td class="nump">$ 47.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes payable</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 65.4<span></span>
</td>
<td class="nump">$ 75.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694525468888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Dec. 23, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Aggregate principal amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,700,000<span></span>
</td>
<td class="nump">$ 226,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,600,000<span></span>
</td>
<td class="nump">$ 224,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum aggregate principal commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Aggregate principal amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Upfront fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Scheduled principal payments prior to maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended Facility | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Undrawn fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_DebtInstrumentLIBORFloorPercentage', window );">LIBOR floor (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended Facility | Forecast | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Undrawn fee (percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended Facility | Forecast | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Undrawn fee (percent)</a></td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Amended Facility | LIBOR | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on rate (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_DebtInstrumentLIBORFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, LIBOR Floor, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_DebtInstrumentLIBORFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section S45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68176171&amp;loc=SL68176184-208336<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mygn_AmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mygn_AmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694439278328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 226.7<span></span>
</td>
<td class="nump">$ 226.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Long-term debt discount</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net long-term debt</a></td>
<td class="nump">$ 224.6<span></span>
</td>
<td class="nump">$ 224.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694439334792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Long-Term Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 10.7<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694447952456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (shares)</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (shares)</a></td>
<td class="nump">150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (shares)</a></td>
<td class="nump">75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,700,000<span></span>
</td>
<td class="nump">73,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (shares)</a></td>
<td class="nump">75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,700,000<span></span>
</td>
<td class="nump">73,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 110,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mygn_EighthShareRepurchaseProgramMember', window );">Eighth Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mygn_EighthShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mygn_EighthShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694442201496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Common shares issued and outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning common stock issued</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning common stock outstanding</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans', window );">Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued at end of period</a></td>
<td class="nump">75.2<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding at end of period</a></td>
<td class="nump">75.2<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694439462792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding used to compute basic EPS</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive shares</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares outstanding and dilutive securities used to compute diluted EPS</a></td>
<td class="nump">74.7<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694444169144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stockholders' Equity - Potentially Dilutive Common Shares Excluded from EPS Computation (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive options and RSUs excluded from EPS computation</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694449033720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense related to stock options | $</a></td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Service period for award vesting (in years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of share-based compensation expense (in years)</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Awards granted after December 5, 2012</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Awards granted prior to December 5, 2012</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Service period for award vesting (in years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation expense related to RSUs | $</a></td>
<td class="nump">$ 44.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of share-based compensation expense (in years)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mygn_OptionsAndRestrictedStockUnitsMember', window );">Options and RSUs | Non-employee director</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Service period for award vesting (in years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember', window );">2003 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Shares available for future grant</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember', window );">2010 Plan | Options and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Shares available for future grant</a></td>
<td class="nump">4,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember', window );">2012 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">2,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for issuance under the Plan</a></td>
<td class="nump">300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mygn_OptionsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mygn_OptionsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=mygn_NonEmployeeDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=mygn_NonEmployeeDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mygn_EmployeeStockPurchasePlanTwentyTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694526292120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Option Activity (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning (shares) | shares</a></td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (shares) | shares</a></td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options canceled or expired (shares) | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending (shares) | shares</a></td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at end of period (shares) | shares</a></td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Options, Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning (dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (dollars per share) | $ / shares</a></td>
<td class="nump">13.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options canceled or expired (dollars per share) | $ / shares</a></td>
<td class="nump">16.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending (dollars per share) | $ / shares</a></td>
<td class="nump">24.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at end of period (dollars per share) | $ / shares</a></td>
<td class="nump">$ 24.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694526217768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - RSU Activity (Details) - RSUs<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>RSUs, Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding, beginning (shares) | shares</a></td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (shares) | shares</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">RSUs canceled (shares) | shares</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding, ending (shares) | shares</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>RSUs, Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">RSUs outstanding, beginning (dollars per share) | $ / shares</a></td>
<td class="nump">$ 32.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">RSUs granted (dollars per share) | $ / shares</a></td>
<td class="nump">13.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (dollars per share) | $ / shares</a></td>
<td class="nump">33.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">RSUs canceled (dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">RSUs outstanding, ending (dollars per share) | $ / shares</a></td>
<td class="nump">$ 27.70<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694526199464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfMolecularDiagnosticTestingMember', window );">Cost of molecular diagnostic testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfPharmaceuticalAndClinicalServicesMember', window );">Cost of pharmaceutical and clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfMolecularDiagnosticTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mygn_CostOfMolecularDiagnosticTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mygn_CostOfPharmaceuticalAndClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mygn_CostOfPharmaceuticalAndClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694449260920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (28.5)<span></span>
</td>
<td class="num">$ (1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Approximate rate on pre-tax income</a></td>
<td class="nump">65.20%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_IncomeTaxExpenseBenefitCARESAct', window );">Income tax net benefit related to CARES Act</a></td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct', window );">Increase in uncertain tax benefit accrual, CARES Act</a></td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New Jersey | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New Jersey | Latest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New York | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New York | Latest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Massachusetts | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Massachusetts | Latest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Germany | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Germany | Latest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Switzerland | Earliest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Switzerland | Latest tax year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Tax year being audited in income tax examination</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_IncomeTaxExpenseBenefitCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_IncomeTaxExpenseBenefitCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase Resulting From CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationYearUnderExamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year being audited in the income tax examination, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationYearUnderExamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=mygn_MassachusettsDepartmentOfRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=mygn_MassachusettsDepartmentOfRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_FederalMinistryOfFinanceGermanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_FederalMinistryOfFinanceGermanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_SwissFederalTaxAdministrationFTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443744104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694448099832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Segment Revenue and Operating Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 145.2<span></span>
</td>
<td class="nump">$ 186.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">18.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">130.5<span></span>
</td>
<td class="nump">170.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">17.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income (loss)</a></td>
<td class="num">$ (39.3)<span></span>
</td>
<td class="num">$ (38.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mygn_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694447119928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating loss for reportable segments</a></td>
<td class="num">$ (39.6)<span></span>
</td>
<td class="num">$ (20.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax</a></td>
<td class="num">(43.7)<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(28.5)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(15.2)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Myriad Genetics, Inc. stockholders</a></td>
<td class="num">$ (15.2)<span></span>
</td>
<td class="num">$ (20.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140694443566264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Establishment of operating lease right-of-use assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mygn_OperatingLeaseLiabilityEstablished', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Accrued liabilities and other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mygn_OperatingLeaseLiabilityEstablished">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability Established</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mygn_OperatingLeaseLiabilityEstablished</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mygn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>83
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MH92(S.&:,Y]+_0#<7PJACB?Z!?E&ZO _4$L#!!0    ( 'U :5&103')OP8
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MT6@V#9CI+F?GH&[\N&XUTO![LZ+W#(P+H/^EUGATW T87LCL#5!+ P04
M" !]0&E1<,E7#6 %  #U%   &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;*U8;6_C*!#^*RC:#ZW4Q@8[;U4::9N]ETK7VZJYO?U,;9*@M4T.2-+]]S?8
MCNT$3'O2?4F,/3,\,PSS#,R/0OY06\8T>LNS0MT/MEKO[H) )5N64S44.U;
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M$XK="BFI*G88(HERH<-D*^"J$! ?$=!FMUIA9ME;$I+N^X<$4Q+%.Z*K^&3
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MR5.6$ 4O,P5_P%M*(KY 8R)7Z X\+M$9^C[[@CY^^(0^():C>Y:FX UYV5$
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M&A\$]6QBD4SZ0FP0C02%8:7!/4SJ FVV;U=M0T-<R/A%/SE? '"6J#J.#/$
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MA< '2J;NVF!O :9%*A"4SBQ.?_L9D*F>AFAIP'\1B0ADI!SL$,YZR@--ASV
MJ+M!35R ,37P^C:4E48G5D.VT\0\WG<NGEBKK38F+7'<V*7#$ +'>#%T<2[=
MIS>5$[=1IVI+:$>A2BXQ-QI:'6A&E=WXF=B^GXU^N$_Q KMHMAB%R+%GB6;
M';>8X]G![#&]B #7;+F_='SQSMJ<NP4-0>?L_0$=1*.0Y<$G ']E-V%'<'FP
M:M8A\LGCZ<&CZ<,78LFOV93KU[5]BCBKZI)-C1/8$G@@8DPU0:.N6):VR=GI
MAA];.$<O WC.O"30GQ'(5LI=ZXR"8_@UTFTV(P<'+PKZF\"RWIIVR>&2[E_5
M9++6Z".Q#/6^K1G;JO=L+6P<A>3 1BY,&HB![6ACUMK8-<&_HABHR+&(E;:F
M3F77B6%3@HB9?$K0."W3)/,.2Q.'I(4[3DIW2$%3S6C5^[GZY%#3:R'BIZX>
M8^G___!.A(,J_'9SC*-$.YYTT8486BFQ)O:ZS:VA^>6/$Y\Q1+,.HGM!I9 -
M%<)$L$*W <5U-&WK=_@DZ*TDVJ.J6OK<BP+F/N8/?DV->N^GA3>\7U"4\=S;
MZ-+O-,UQ)7_ ;/@[IIIV+ %/=$,TTO7\7J9X?C";\RM+E+6XE%_Z(>(I5_R*
MHJ4W-^V^=[O@]QX<#82.N"Z7[64L&1HS!E.%3]X1-'Q2='OJT%%#8 WQ;5IE
MKP%^[@EI(91YWL*K?X6R7X;(SU!41%!G *Q378!YT^I?,OE!3Y ;6@2ZT!++
MQEIAT%.KN.E[#!!7Z9"ZP]ZPD:;DP;ZZOTZ'0L>9K#/PFU7_Q\WBKC?OAX/?
M/\#C6_Z5ARH1$8\_A71WNQ^2%O'WD_YX_!4*:]"67GV4:H-'IY.GCT?"Q5]V
MX@5Z!_^:LK8!38,_%EBIE:,#^'YC;6@O2$'W\]K)_P!02P,$%     @ ?4!I
M4;%5<_J]#   TR$  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6S-6EES
MW#82_BNH62>QJ\:CN73XK+)E.W9M.5%9/AZV]@%#8H:(2((!0(V47[]?-P .
MYY!EOVU5XN$!-/K\^J">KXV]<H527MQ49>U># KOFZ='1RXK5"7=R#2JQINE
ML97TN+6K(]=8)7/>5)5'T_'XY*B2NAZ\?,[/+NS+YZ;UI:[5A16NK2II;U^K
MTJQ?#":#]."37A6>'AR]?-[(E;I4_DMS87%WU%')=:5JITTMK%J^&+R:/'T]
MI_6\X*M6:]>[%B3)PI@KNOF0OQB,B2%5JLP3!8F?:W6NRI((@8V_(\U!=R1M
M[%\GZN]8=LBRD$Z=F_*;SGWQ8G V$+E:RK;TG\SZO8KR'!.]S)2._Q7KL'9^
M.A!9Z[RIXF9P4.DZ_,J;J(?>AK/Q'1NF<<.4^0X',9=OI)<OGUNS%I96@QI=
ML*B\&\SIFHQRZ2W>:NSS+S^I:U6WZOF1!S%Z=)3%C:_#QND=&V?BHZE]X<3;
M.E?Y]OXC,-%Q,DV<O)Y^E^"E:D9B-AZ*Z7@Z_@Z]62?9C.G-OB^96%I3B7/P
M:N$!T*XOQ#GK55GQGU<+Q\__^YT#Y]V!<SYP_O.JO&?CVZ]O__CR5GR\M5KF
M8J5J9:57#DX?1%C<BD99BD!=KT1EX-)M*:W(M5S5QGF="2SW]%+6N6@*"7_-
M5(L7LA1.V6N=*3<2GPL%352-K$$0Q+5I74F7YEK#B"(#9UM;1%M[3;=E2<0O
MK+Z6_HI678DW=B0^F86R7EQFA:[S<J&R*_%[M7@O?I55\PQ'C<2_?Q<//8X=
MG#/MP2.A:_%.+6P+"&!3@TK?4K38R5()L[Q;4G=(3GJT+X$F-6;&DGS2,WE2
M%>*9'E0&$M)1F0'.Y*1WP@IOQ$+1/@7(R+<55TB'L/>*C $2OHA4,U-5+1W.
M%$"2& 4-!WQPPMBTJ"E56M%Q^QVK05\Y$<45/+5V2[AMX-=;H 6<HG,3DG-5
M:Z;>M+8Q+AE]:4J@+YG0RP5T"^,[57L61,+ 5JVDS?E]9-(XG;@T+7@W7I9;
M_FA-WB*>B'/<?AE=CL2ULJXE=3M6*>"XS(?BUW^=3:?C9Y_,-[Z:/'L*EJQ2
ML"[CAR+\$(A^KRIX4P<!^&?R1#S\4 /VX'ZPSZ-P#"B)S\S/SNW'0^X2>79/
MQ7ME5:X]^=VYK#,<]3D&S0-Q.AU-\',V.J9_QZ,3_$S&X7<V>L)W<[R\L*J6
M=-;D9#078VS"Q;&8SO /B3>9/@LWOR.(+RDCB,D$^],[OIE.1Z>;U73S%3G*
M2O$$]-)SNL;J<7_K6%2WYX6!6XCS-S?B%.R-1U/\GHG):+99B>L+.(>T<'[B
M,[V@ZY,>IW0-^#87I!@8<XSW4_[_#-?'('2&ZYGX$UYA!6DC[1SST9/X_S0:
MX&"\)J>93$F!D&(J)K-C"#TY.<'U,3$/]8_%Q?WAW!%[TI."KLEPQU#M9 YV
M/V\Y*TPWFX/\@W V?N;'X?=T#B[X,?^<G=#>/D0&S$4(4@ O2KT*L=W"8ZV0
M(0:[I")CNL:K$!\(7D?>=1"[>F@1HVX++@! B9H;$F2JFZR0]4IQP&^#50>;
M:<<^7M%;R]Y(R(9P8I&Z$T3;$.CMX5-4  5+3_X@@"\0ZKD!+-7&1XC=:$0Z
MIU LBC^S3%+])LOR=M@[L))70"%Y6S$*-583/AIF(?+]F]L^?AE8C@>T,'"/
MHY'X5BB2  YOLJPEI?5H1?9<WV:EEE"$]K>"\1RPBB!(3C,2;UI+AEEJ1^YW
MJ^#3!$I[9#E!"-G WC><5)!/'TR?P*-@-)E?,_,?*;RD[4D,66/6!9%2J^7&
MBF"U-A6<1>.0C#QO*<[__/KAS6/ 83139" 8^NY3Z$;76=D2PNJP=:%6NJY3
MJ0#PI<N%+).6]U7QBM579]#6)K?=0\D=(D6YV!5F72=>0C):4&=P,"ELTL";
M75*/>\<G[@'5A%P/@%G3KJB(2?$?['T(+'LD'@+E'A&0=VJ:,-S-#AVRHQ\^
M8<8G3,0'ZBG(K_@58\"KRR_$[_SQ^,FVIU 0<B<"ZA0OL'\.URJ1HGF=7*TH
M!WO5*TE80Y3R96A@$"4X!Y%D,BY>0,,JZKN(P[M"E>"B'S@N%"SD&:96P;&Q
MI 16#45"BHVYU$T3F.XJHJ1,DC>:L58WGBF-Q+O64JZHC%7_9PJ0H*^"O=?@
M4.FM2.)<<OK,;5 R>@<I@2*Y3GRQ^G(-37B$.LP/R 9Z ES8 XCFM2Q;CJ5=
MXGT>20&08B3>FS7T;;?5A97:4#@#-^&$GC!3U]@CK:4T$ 6A$S>@V@.5PYW!
M$73Q0T4S"UE),MLU929*@J7!N53%0A>=Z]#VB#"B0N;2#567ATT!)&%8V"_U
MAC_I GCAVJS8=6J8:LLY@B_?YR#8]0"PL9TT2?:-+EU&_+""M_+FB# @]0)=
M'M]E=Y@:NZ@HRI]=#Y*$[ +MKI9$N@TB]SE%ZD'^<"'W5<H7)@\[G8>/P'LH
M )Q&#2UM3V%KRI>1B<2Y6B[! QU-A%LJD=$=U$B1IA\!>'^-TI*Q>Z]M6A<:
MAM%4$Z'* &2 ">W+W29JPW5/]! W409F&WU@#-<],)$" J$>JEMVI=02!>$H
M+CJ9X?!XBH"B< @VDWG.[<UVT"5AV(WXC:[#V(N$>P@%>V,I4*B20=S7?L@!
M@#4*98Y_U+FA5=*AZ%E _?(:#1;KBKPG)W4LX5L&M>&^ H.&=SKU#5O$$KQR
MD2J7Z#MW6(,TJ"2LT1WF,G0O )8=6Y3.L$J=!K8O(2",3$:Q6G69;2-\%P^
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MYDQV^VO+3V$RDZ&1&:F5*ECZZ%W>[L377C00>Q5JMA6K.69GGNUT[=4AG][
M!+2X5H2<C(":O@#@=.O"EW>+,@D^"9VO%)FM*;BL7H6QP!\F:'^G:*,ATI:V
M#T:0/Z0$8UD'=W@R59O:*L9 ,BETS8;:[NT/?1$^ZGUHQZ(5_SD!#=? 5OCF
MWCWM_F+A5?A0OUD>_MSA([I7@!FP<(FMX]'I\2 ,G]*--PU_MD>S H[X$NX/
M,*8%>+\T0+YX0P=T?\?Q\G]02P,$%     @ ?4!I41D:6VCB!0  SPX  !D
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MO5%T6Y*?&:>*WE>9EU-(*R8,,)'#[%=3UE1X<PIS-,/ $(^U#K(=YK3%C-_
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MJ.P&^G\IJ76$#ZN@N;R>_0=02P,$%     @ ?4!I4?6.?H:A"   *!<  !D
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MD+8CB7N<ZNN^2W@2Y*CNNO>;H2MP]AL/73N,Y=GIQT3];QG:[&=MC5,M[]D
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M %JG:GEQ3*LVDG61*E.;*+TUID>S WK]YI>4T,>2S40B_ KL;90O!@Y#8'Z
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M>^@R7;_NMJ=++,XT]'&@2J\A.LV.CT;DT\4PO437R&5LY2*N=O)8XBZM/6_
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MGK:7JHUY>S6]4@[_<9C3O(#K)-G;&6!<QNM>^Q%L':]8<QMP88NO!6[([,0
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M-IU-'Y!WU+E\Q/*.[I%WX=;2Z&_LZ5B<6>/A;!X=ER;?C@0B\TX;:3(M2['
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M%:E^ SZ(3'&X+1,0L-1&B<R@FZJ2.@KBZXDVDA= F;/@ MC./+\I; Q3I;B
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M*OCIV1RJGR<#3>;,I4'<0-_4T,$;T"$\BD*G"NZ+!)/^_0'1;+D&>ZXWP5G
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MIP'H;@)T!ZL:WW4K9:F'_;:BH8G:*=#[6BF[/S@#_1B>_P%02P,$%     @
M?4!I477?#&9*!   \0X  !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL
M[5==;]LV%/TK%YHQ)$"K+\NVXMD&'+?K.J!MD&3;P[ '6KJVN$JD1E)QTE_?
M2\I6W<4VL@X#]I 7293NQ[GG\%+D9"/51UT@&KBO2J&G7F%,/0X"G158,>W+
M&@5]64E5,4-#M0YTK9#ESJDJ@S@,AT'%N/!F$_?N2LTFLC$E%WBE0#=5Q=3#
M)99R,_4B;_?BFJ\+8U\$LTG-UGB#YI?Z2M$HZ*+DO$*AN12@<#7UYM'X<F3M
MG<&O'#=Z[QEL)4LI/]K!VWSJA180EI@9&X'1[0X76)8V$,'X:QO3ZU):Q_WG
M7?0?7>U4RY)I7,CR-YZ;8NJE'N2X8DUIKN7F)]S6,[#Q,EEJ=X5-:SM,/,@:
M;62U=28$%1?MG=UO>=AS2,,C#O'6(7:XVT0.Y2MFV&RBY :4M:9H]L&5ZKP)
M'!=6E!NCZ"LG/S-[(V6^X64)3.3P5A@FUGQ9(LRU1J/A[);12)]/ D/)K$N0
M;0-?MH'C(X'[\$X*4VAX+7+,O_8/"&2'--XAO8Q/!KS!VH=^^ +B, Y/Q.MW
ME?==O/ZW5?Z*ZZR4NE$(O\^7VBB:/W^<2)MT:1.7-CE6!K55WE >N8)%04E1
M Q>P8$H]<+&&>24;8>S7'<!#W)_,81MYK&N6X=2C3M6H[M";W18(V9>$Q@YW
M25F7=+UCA?K=V9A"(4+5:HE62R E#%9+5)T<+X 13TR35TEMKL=$'UL+J0W/
MX .%47 K#2OA$M=<")MRR4HF,H0>Q*/0']%],/0OZ-:/1_X0;A43NF1MY^9_
M4B/02D"R6-/OOTOC*/[!/=/L^GNTR$_VHZ5^'T[H-NAT&SQ9-])(&?[)ML;C
MF7-(KI.AC\O5LFGK:]=,_HFTLZ*T>FE:%6M"0I(PJVD'A#D@8WBCI-8PS[*F
M:HA+LGM/R_S<'%!P#%>-HNFAR:CD&:VZE,IVAL&L$+*4:TXO>I!&0U*G!V=Q
M/_:3<TMTFO@Q+-Q210$5MJKI@M<:$I+H++&&(<E HN;T3Z'_#?3]$,XB^R&R
M:KO)P5I:"<&C6B"-$PI 65,_/J><0S\BZE_62F:H+1$:&>%WD'.\HY]-;2<,
M 4B[^6*?VTR-.)7KL,]C.V(COB <O0X7L7$1TKP[2OS/C<!OX'RPY3P:^5&;
M)?4'QSD?6LYCRWGR[SCOD[)G<1S[HW,8AB'E_#]PGE(=O0Y7CY -3O?XL.OQ
MX9-[_+T4+]D_[?.3X9_[_+G/G_O\O^SS4=?GHR?W^35F4ME=S>ZG[K8<K^]K
M*Y/;!3VI\T\F/-[Y"UG53#P0QUL4;!\%;E'DC;*+@UT1R+M&=Y*!&A67N=[M
MU,CN,8W[6[+;QSLY.SOI$EU\73W1<DB1R-*_O1U2(=@[AM!T7;O#EH;,KF'M
MB:1[VYWGYNTQYHMY>QA\QQ1M%#64N")7VNC1#DJU!ZQV8&3M#C5+::@WW&-!
M9U)4UH"^KZ0TNX%-T)UR9Y\!4$L#!!0    ( 'U :5%D%7]G8 (   \%   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;'U436_;, S]*X31PP8,MF,G
M35<D 9*NPS:L6-!VVV'80;;I6*@^/$ENTG\_2DZ\#&ARL42)[_&1)C7;:O-D
M&T0'.RF4G4>-<^UUDMBR0<ELK%M4=%-K(YDCTVP2VQID50!)D61I>IE(QE6T
MF(6SM5G,=.<$5[@V8#LIF7E9H=#;>32*#@?W?-,X?Y L9BW;X .Z[^W:D)4,
M+!67J"S7"@S6\V@YNEZ-O7]P^,%Q:X_VX#,IM'[RQN=J'J5>$ HLG6=@M#SC
M#0KAB4C&GSUG-(3TP./]@?UCR)UR*9C%&RU^\LHU\^@J@@IKU@EWK[>?<)_/
MQ/.56MCPA6WOF^<1E)UU6N[!I$!RU:]LMZ_#$> J/0'(]H LZ.X#!94?F&.+
MF=%;,-Z;V/PFI!K0)(XK_U,>G*%;3CBW6):EZ;""KYP57'#'T<*;1U8(M&]G
MB:,(WB\I]VRKGBT[P9;#G5:NL7"K*JS^QR>D;)"7'>2MLK.$#]C&D*?O($NS
M] Q?/J2;![[\!-^:O83<@*D*0NY,6/BU+*PSU""_SX08#R'&(<3XE&2:FZH3
M"+J&5ZK[6E'/$OJQO+8M*W$>T=Q9-,\8^<(XE 6:4)TOG<*PN96MT"^(4&I)
M<VM9W_J4;($*:^XL7,!X&F?],AX4.K:CJK1]>2"/)W 9C^";:RC":!Q/(<O(
M^U$[)FB2>HPXZID+N)R0PP5,)_%[>*V,R5&32C2;,(J6A';*]?TZG [3ONR;
M_)][_U3<,;/ARH+ FJ!I/)U$8/KQZPVGV]#RA78T0&';T(N%QCO0?:VU.Q@^
MP/ &+OX"4$L#!!0    ( 'U :5&:R%%Y9 (  "L%   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,Q+GAM;'U444_;,!#^*Z=H#R!M34A+054;J86A;1H3 K8]
M3'MPDDMBX=B9[1#X]SL[:2@;[4OLL^_[_-W%GY>=T@^F0K3P5 MI5D%E;;,(
M0Y-56#,S40U*VBF4KIFE4)>A:32RW(-J$<91- ]KQF60+/W:C4Z6JK6"2[S1
M8-JZ9OIY@T)UJ^ DV"[<\K*R;B%,E@TK\0[M]^9&4Q2.+#FO41JN)&@L5L'Z
M9+&9N7R?\(-C9W;FX"I)E7IPP>=\%41.$ K,K&-@-#SB!0KAB$C&GX$S&(]T
MP-WYEOW*UTZUI,S@A1(_>6ZK57 >0(X%:X6]5=TG'.HY=7R9$L9_H>MSX[,
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M*RZ,/.5'GITT<(#*AS&<<9FR ? \DM(\7MA35'5J7OT$4$L#!!0    ( 'U
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MM:V76"V0*</BF!GB-12.2][[:+T!W\^-H:W@ S3_).D[4$L#!!0    ( 'U
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MJ[%U:9$4%K3D^D%L/D&3S]#X2P17U2_9-+:N19)2:9$U8B3(6%Y_Z4M3AX[
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MVB)$(="_[SE7SS?%@;O^@V7S'U!+ P04    " !]0&E1*:]1 $8"  !:!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6R=5-MNVS ,_17!Z$,+;+%C
MI]U6. 9RV:4/ 8H&W1Z&/2@V$PN5)4^BZVY?/TIVO+1+NV& 88L2S^$A93)M
MM;FS)0"RATHJ.PU*Q/HR#&U>0L7M2->@Z&2K3<613+,+;6V %QY4R3".HHNP
MXD(%6>KWKDV6Z@:E4'!MF&VJBIL?<Y"ZG0;C8+]Q(W8ENHTP2VN^@S7@;7UM
MR H'ED)4H*S0BAG83H/9^'(Q<?[>X;. UAZLF<MDH_6=,ZZ*:1 Y02 A1\?
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M.]55$&U7:R>*-[8QY%SI-F.'E?X0@# !>G_#N3I,3*_I/RW9'U!+ P04
M" !]0&E10;DUB'0$  "C%   &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6RU6-%NXC@4?9[]"@OM2AUIAL1."'0$2 7:*:MVMBK;W8?5/KB) 6N2.&,[
MT$K[\6,G(8$E.%%5>(#$\3GW^/KZ.'BX9?R[6!,BP4L4QF+464N9?+$LX:])
MA$67)2163Y:,1UBJ6[ZR1,()#C)0%%K(MCTKPC3NC(=9VP,?#UDJ0QJ3!PY$
M&D68OTY(R+:C#NSL&A[I:BUU@S4>)GA%%D0^)0]<W5DE2T C$@O*8L#)<M2Y
M@E]N'5L#LAY_4;(5>]= #^69L>_Z9AZ,.K961$+B2TV!U<^&3$D8:B:EXT=!
MVBEC:N#^]8[])AN\&LPS%F3*PK]I(->CSJ # K+$:2@?V?:6% /J:3Z?A2+[
M!MN\K^=U@)\*R:("K!1$-,Y_\4N1B#T =$\ 4 % _P><BN 4 *=M!+< N&T!
MO0+0:POP"H#7%M O /VV@QX4@$$VN_ET9',YPQ*/AYQM =>]%9N^R HB0ZLI
MI+&NW87DZBE5.#F^8_'J\Y^$1V!&GB7X#+YASK&N)W Q(Q+34'Q4K4^+&;CX
M]>/0DBJF1EI^P3_)^=$)_M_3L ML^ D@&\$:^+0%W,G@<% #GS7!8P6W3T:_
M-L,7)"GA=@W\IGWT.OA7,_P>O^XR5X>^-:-GQ.\"Y&29\P[AEJJ1LE!062@H
MXW-.\JGRF,="\E19EP3_W*D.8"Y))/XUT#LEO9/1NR?HKU8K3E98$I!P&OLT
MP2' $4M5)+8$(<-QW?3EG)<9IW;IS1@AKV_KS]#:[,]4FYX'PMU2N&L4_DWM
M+Z%>1%(OHD!EJ4YHSM$[".]Z=4+=&J&N:Q#:*X7VC$(?R8:%&QJO@,])0"58
M8I^&5+X:9L\KN;US%$>_I.\;I=_C%QJE$< U1>*S**)21ZU;(_VC;#IV\:G/
MYJ"4-'A;-L%_X$JI"4@ ;IH3?%F&NSQ'@J%=;0-V0XIERK7\0*6WUJ?-^)U1
M__+A@_(KQZ1I;VN"YYGV:4%\,.\]X[S#R@<A>G^GFA:DO?:5""OKA&;O?$J6
MG*GP2T)$;6SG*#8<U'C/5WCLDM HL3)):';)K'ZI$"F.?:(F3\AZI<?NYYCB
M5]X'S>;7SJ4+$K--'RJH'!)Z1@4+]:\C2$-E"U79)/A55[#038P#R=2;G7D9
M7A=1]C-T2EKEKM!LK_-8984(";BNZHN$<%^IJGO9NVY@<KL]^S?3VJ_L%;Z?
MOZHF]3^&^%A(4^S*:^%9S!959HO,9OD4!QQO8[U@C>F>-?#8#>E&E=4BL]7>
MS2=_/()ER%09FA69>6#7-BO:>]TTV^P;"T!=WM-8;QLF%96U(N<LI5 9(S(;
M8]M2F#3PV%W4,R:^LDKTQO?$YL3G^[5)1667Z"QOE*@R/62VJO:)-_/87=><
M^,KRT+M:7KYD6UD?JJP/G<7ZG,KZ'+-E3;"@ N3G;$ ??S5M.9,&0G3L.+E3
M->"<4]YI[1VFZ..[>\Q7-!8@)$M%9'?[:OGP_$0LOY$LR<Y7GIF4+,HNUVIT
MA.L.ZOF2,;F[T4<VY;GD^"=02P,$%     @ ?4!I45\,D9\^ @  Q@4  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULE51=CYLP$/PK%KJ'.^D2".2C
M.A&DNT156_6JZ-*T#U4?'%@2ZXQ-;9-<_WW7AJ T(DG[ EY[9F=VP1OOI7K5
M6P!#W@HN]-3;&E,^^+Y.MU!0W9<E"#S)I2JHP5!M?%TJH)DC%=P/@V#L%Y0)
M+XG=WD(EL:P,9P(6BNBJ**CZ_01<[J?>P#MLO+#-UM@-/XE+NH$EF%6Y4!CY
M;9:,%2 TDX(HR*?>X^!A-K)X!_C&8*^/UL16LI;RU08?LZD76$/ (34V \77
M#F; N4V$-GXU.;U6TA*/UX?L[UWM6,N::IA)_IUE9COUWGDD@YQ6W+S(_0=H
MZG$&4\FU>Y)]C9T@.*VTD45#1@<%$_6;OC5]."(,AF<(84,(_Y40-83(%5H[
M<V7-J:%)K.2>*(O&;';A>N/86 T3]BLNC<)3ACR3?)9BT_L*JB!S6!O2(TO\
M3[** Y$Y.3F\G8.AC.L[A*V6<W)[<T=N"!/DF7&.WT3'OD%+-K&?-O)/M7QX
M1GX)99]$P3T)@S#HH,\NTS]5XAS=QT:TW0C;;H0N7W2I&^90\#U9B913K5G.
M(",_'M?:*/SO?EY0BEJER"D-KRIEJ-35N)H_=GQ[%W=)&([[D]C?'??G&NHO
M<\/6W/ _S)&,Z516HM-EG6ARI-\+^X,3DYV@J-OCJ/4XNNCQ"TXX?K6)HX[V
M#/OC$W_=J.&)0?_HEMD)]TS5A@E-..3("_H33*/JJ5$'1I;NXJVEP6OLEEL<
MM* L ,]S*<TAL'>Y'=W)'U!+ P04    " !]0&E1W?#>R5$"  "R!0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6R-5%UOFS 4_2L6ZD,KK8% DG85
M06H33=O4:E'3;@_3'ARX :O&9O8E:?_];$,8:SZT%_"U[SGWG.N/>"O5BRX
MD+R67.BI5R!6-[ZOTP)*J@>R F%6UE*5%$VH<E]7"FCF0"7WPR"8^"5EPDMB
M-[=022QKY$S 0A%=ER55;W? Y7;J#;W=Q"/+"[03?A)7-(<EX'.U4";R.Y:,
ME2 TDX(H6$^]V^'-;&SS7<)W!EO=&Q/K9"7EBPV^9%,OL(* 0XJ6@9K?!F;
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M<PQZIB?#W8$!/FN&?RNRQM7G)\.-JU^?#@\;8NE7>>$K/O\(WQ1#Q@!9ZUP
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M$A^[PYD=<37::?-H<P!DSX54=ASDB.5-&-HDAX+;CBY!T4ZF3<&1IF83VM(
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M-W4?KB>H2]_*UAJI,?IA3K\N,"Z ]C.M<3]Q![0_P\E?4$L#!!0    ( 'U
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MPZ7NL4&8!?K[G'.UG9@ 5=<^_@U02P,$%     @ ?4!I4?@#,=D, P  - H
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MV8JX=%W#\_ %[FS2J/Z BP?4A#)UZ1\H4-90 >7P2!DS%JH;:0-D9:/QROG
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M60-\/Y/2K#<V0#V0C_X"4$L#!!0    ( 'U :5'15]I\2P0  /45   9
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;+58VV[C-A#]%<+8 KO QI)(7Y+
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M.LLHW?B_J/S3-_PS<J.D71AR)3/(7MI'B+4&3)\!7]"@PRDLNX3%GPF-:=R
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M[B^L*Z^XK*X,\Q_;%V+RPN]?+SLISUS95W6I>;U[.77W8NWI+U!+ P04
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M;/PCVN(%4$L! A0#%     @ ?4!I40=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !]0&E1G_EUA.\
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ?4!I462?8-TS @
M+04  !@              ("!:10  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( 'U :5%PR5<-8 4  /44   8              " @=(6
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !]0&E1]U^.
MNCT#   D"0  &               @(%H'   >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ ?4!I4; 0)U F!   F@\  !@
M ("!VQ\  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( 'U
M:5&C3$A%" <  #@<   8              " @3<D  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " !]0&E1.'K5A<8*  !J&P  &
M        @(%U*P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    ( 'U :5'Y>3G_\ 0  "8,   9              "
M@1-5  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ ?4!I
M4:X)PRIA @  #@4  !D              ("!.EH  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " !]0&E1"'D/5"0)  #M%P  &0
M        @('27   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( 'U :5'V7$7B50(   @%   9              " @2UF  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ ?4!I45^7>&"R!0  R X
M !D              ("!N6@  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " !]0&E1]8Y^AJ$(   H%P  &0              @(&B;@
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( 'U :5&U)6]3
M9 8  *D/   9              " @7IW  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ ?4!I477IV"%C P  *@<  !D
M ("!%7X  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !]
M0&E1SO? \B<%  !_"P  &0              @(&O@0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( 'U :5&8;7:;NP(   <&   9
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M970R-BYX;6Q02P$"% ,4    " !]0&E1"F$:02H$  #I"@  &0
M    @($+H0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M 'U :5%31(/.C (  )(%   9              " @6RE  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ ?4!I477?#&9*!   \0X  !D
M             ("!+Z@  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " !]0&E19!5_9V "   /!0  &0              @(&PK   >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( 'U :5&:R%%Y9 (
M "L%   9              " @4>O  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ ?4!I409,%8M, @   04  !D              ("!
MXK$  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !]0&E1
M1SRWV=L#  #?"0  &0              @(%EM   >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( 'U :5'1W$.V3 0   X+   9
M      " @7>X  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ ?4!I4=RLY 1^ P  XP<  !D              ("!^KP  'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !]0&E14G8@V*L"  #Y!0
M&0              @(&OP   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( 'U :5'EV(D72 <  #XS   9              " @9'#  !X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ ?4!I4>3J@FZ6
M @  'P<  !D              ("!$,L  'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " !]0&E10I@TDM,$  !^#@  &0
M@('=S0  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( 'U
M:5%;ADT:*@4  $P;   9              " @>?2  !X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ ?4!I45)ST[BV P  00\  !D
M         ("!2-@  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
M    " !]0&E1<R#CJ)D"  !5!@  &0              @($UW   >&PO=V]R
M:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( 'U :5'Q2*D.5@8  &<P
M   9              " @07?  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
M4$L! A0#%     @ ?4!I480_OP&V @  ]08  !D              ("!DN4
M 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !]0&E1</;0
MN)P"   N!P  &0              @(%_Z   >&PO=V]R:W-H965T<R]S:&5E
M=#0U+GAM;%!+ 0(4 Q0    ( 'U :5$^KE/*00(  #8%   9
M  " @5+K  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
M?4!I488W.:O6 @  G0D  !D              ("!RNT  'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    " !]0&E1+;89J@\$  !L$0  &0
M            @('7\   >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    ( 'U :5$IKU$ 1@(  %H%   9              " @1WU  !X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ ?4!I40/$X19W @
M9@8  !D              ("!FO<  'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    " !]0&E10;DUB'0$  "C%   &0              @(%(
M^@  >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( 'U :5%?
M#)&?/@(  ,8%   9              " @?/^  !X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ ?4!I4=WPWLE1 @  L@4  !D
M     ("!: $! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'U :5%TJS3,6@0   ,3   9              "
M@6D0 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ ?4!I
M418/<V-" P  P0L  !D              ("!^A0! 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    " !]0&E1^ ,QV0P#   T"@  &0
M        @(%S& $ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   ( 'U :5&W7; F+P,  )P+   9              " @;8; 0!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ ?4!I4=%7VGQ+!   ]14
M !D              ("!'!\! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    " !]0&E1RTTVF! "  !E!   &0              @(&>(P$
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( 'U :5'EQ9L>
M2P,  /L+   9              " @>4E 0!X;"]W;W)K<VAE971S+W-H965T
M-C0N>&UL4$L! A0#%     @ ?4!I49A<HR)N P  EPH  !D
M ("!9RD! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " !]
M0&E1M*]X1N4"  #Q!P  &0              @($,+0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( 'U :5%B2#H,0@(  %H+   -
M          "  2@P 0!X;"]S='EL97,N>&UL4$L! A0#%     @ ?4!I49>*
MNQS     $P(   L              ( !E3(! %]R96QS+RYR96QS4$L! A0#
M%     @ ?4!I41,P-N8$!0  W"L   \              ( !?C,! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( 'U :5$>WYE>' (  #TG   :
M      "  :\X 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( 'U :5&E?PYQ[@$  ) F   3              "  0,[ 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@    !* $H /10  "(] 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>212</ContextCount>
  <ElementCount>339</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>66</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Marketable Investment Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecurities</Role>
      <ShortName>Marketable Investment Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Property, Plant and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNet</Role>
      <ShortName>Property, Plant and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2129108 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2133109 - Disclosure - Other Long-Term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilities</Role>
      <ShortName>Other Long-Term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2136110 - Disclosure - Preferred and Common Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquity</Role>
      <ShortName>Preferred and Common Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2142111 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150113 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2151114 - Disclosure - Segment and Related Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformation</Role>
      <ShortName>Segment and Related Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2156115 - Disclosure - Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2159116 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/Revenue</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Marketable Investment Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesTables</Role>
      <ShortName>Marketable Investment Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/MarketableInvestmentSecurities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/FairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - Property, Plant and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetTables</Role>
      <ShortName>Property, Plant and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/PropertyPlantandEquipmentNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2327306 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/AccruedLiabilities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/LongTermDebt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2334308 - Disclosure - Other Long-Term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilitiesTables</Role>
      <ShortName>Other Long-Term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/OtherLongTermLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2337309 - Disclosure - Preferred and Common Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables</Role>
      <ShortName>Preferred and Common Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/PreferredandCommonStockholdersEquity</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2343310 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/ShareBasedCompensation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2352311 - Disclosure - Segment and Related Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationTables</Role>
      <ShortName>Segment and Related Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SegmentandRelatedInformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2357312 - Disclosure - Supplemental Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementalCashFlowInformationTables</Role>
      <ShortName>Supplemental Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Revenue - Total Revenue by Product and by US versus Rest of World (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails</Role>
      <ShortName>Revenue - Total Revenue by Product and by US versus Rest of World (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenue - Reconciliation of Deferred Revenue Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails</Role>
      <ShortName>Revenue - Reconciliation of Deferred Revenue Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails</Role>
      <ShortName>Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails</Role>
      <ShortName>Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Property, Plant and Equipment, Net - Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Property, Plant and Equipment, Net - Depreciation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Depreciation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Summary of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2435417 - Disclosure - Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/OtherLongTermLiabilitiesDetails</Role>
      <ShortName>Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/OtherLongTermLiabilitiesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2438418 - Disclosure - Preferred and Common Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2439419 - Disclosure - Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2440420 - Disclosure - Preferred and Common Stockholders' Equity - Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2441421 - Disclosure - Preferred and Common Stockholders' Equity - Potentially Dilutive Common Shares Excluded from EPS Computation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails</Role>
      <ShortName>Preferred and Common Stockholders' Equity - Potentially Dilutive Common Shares Excluded from EPS Computation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2444422 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2445423 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2446424 - Disclosure - Share-Based Compensation - RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails</Role>
      <ShortName>Share-Based Compensation - RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2447425 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/IncomeTaxes</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2453427 - Disclosure - Segment and Related Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails</Role>
      <ShortName>Segment and Related Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2454428 - Disclosure - Segment and Related Information - Segment Revenue and Operating Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails</Role>
      <ShortName>Segment and Related Information - Segment Revenue and Operating Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2455429 - Disclosure - Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails</Role>
      <ShortName>Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mygn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2458430 - Disclosure - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.myriad.com/role/SupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.myriad.com/role/SupplementalCashFlowInformationTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mygn-20200930.htm">mygn-20200930.htm</File>
    <File>exhibit101-diazemploym.htm</File>
    <File>exhibit102-diazpsuagre.htm</File>
    <File>exhibit103-diazrsuagre.htm</File>
    <File>exhibit104-diazperform.htm</File>
    <File>exhibit105-diaztimexba.htm</File>
    <File>exhibit106-diazformofs.htm</File>
    <File>exhibit311-certificati.htm</File>
    <File>exhibit312-certificati.htm</File>
    <File>exhibit321-certificati.htm</File>
    <File>mygn-20200930.xsd</File>
    <File>mygn-20200930_cal.xml</File>
    <File>mygn-20200930_def.xml</File>
    <File>mygn-20200930_lab.xml</File>
    <File>mygn-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>89
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mygn-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "contextCount": 212,
   "dts": {
    "calculationLink": {
     "local": [
      "mygn-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mygn-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mygn-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mygn-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mygn-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mygn-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 475,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 6
   },
   "keyCustom": 16,
   "keyStandard": 323,
   "memberCustom": 26,
   "memberStandard": 40,
   "nsprefix": "mygn",
   "nsuri": "http://www.myriad.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.myriad.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Marketable Investment Securities",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecurities",
     "shortName": "Marketable Investment Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Fair Value Measurements",
     "role": "http://www.myriad.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Property, Plant and Equipment, Net",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNet",
     "shortName": "Property, Plant and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Accrued Liabilities",
     "role": "http://www.myriad.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129108 - Disclosure - Long-Term Debt",
     "role": "http://www.myriad.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - Other Long-Term Liabilities",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilities",
     "shortName": "Other Long-Term Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136110 - Disclosure - Preferred and Common Stockholders' Equity",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquity",
     "shortName": "Preferred and Common Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142111 - Disclosure - Share-Based Compensation",
     "role": "http://www.myriad.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - Income Taxes",
     "role": "http://www.myriad.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150113 - Disclosure - Commitments and Contingencies",
     "role": "http://www.myriad.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151114 - Disclosure - Segment and Related Information",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformation",
     "shortName": "Segment and Related Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156115 - Disclosure - Supplemental Cash Flow Information",
     "role": "http://www.myriad.com/role/SupplementalCashFlowInformation",
     "shortName": "Supplemental Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159116 - Disclosure - Subsequent Events",
     "role": "http://www.myriad.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://www.myriad.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Revenue (Tables)",
     "role": "http://www.myriad.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Marketable Investment Securities (Tables)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesTables",
     "shortName": "Marketable Investment Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - Property, Plant and Equipment, Net (Tables)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetTables",
     "shortName": "Property, Plant and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://www.myriad.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.myriad.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334308 - Disclosure - Other Long-Term Liabilities (Tables)",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilitiesTables",
     "shortName": "Other Long-Term Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337309 - Disclosure - Preferred and Common Stockholders' Equity (Tables)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables",
     "shortName": "Preferred and Common Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343310 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352311 - Disclosure - Segment and Related Information (Tables)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationTables",
     "shortName": "Segment and Related Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357312 - Disclosure - Supplemental Cash Flow Information (Tables)",
     "role": "http://www.myriad.com/role/SupplementalCashFlowInformationTables",
     "shortName": "Supplemental Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Revenue - Total Revenue by Product and by US versus Rest of World (Details)",
     "role": "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails",
     "shortName": "Revenue - Total Revenue by Product and by US versus Rest of World (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i47d31e10974947898926c5dcd4c0a95a_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue - Reconciliation of Deferred Revenue Balances (Details)",
     "role": "http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails",
     "shortName": "Revenue - Reconciliation of Deferred Revenue Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i139906c1954e43c39560efe073ca515b_I20190630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i4464ac83ed924822929712315bbc20be_D20190701-20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mygn:CARESActOf2020MedicarePaymentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.myriad.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i4464ac83ed924822929712315bbc20be_D20190701-20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mygn:CARESActOf2020MedicarePaymentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails",
     "shortName": "Marketable Investment Securities - Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)",
     "role": "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
     "shortName": "Marketable Investment Securities - Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ia50d0d8131d5462795581f189d2f1d14_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ia50d0d8131d5462795581f189d2f1d14_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)",
     "role": "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails",
     "shortName": "Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseholdImprovementsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Property, Plant and Equipment, Net - Balances (Details)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails",
     "shortName": "Property, Plant and Equipment, Net - Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseholdImprovementsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Property, Plant and Equipment, Net - Depreciation Expense (Details)",
     "role": "http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails",
     "shortName": "Property, Plant and Equipment, Net - Depreciation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Summary of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Summarized Amounts Reported as Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)",
     "role": "http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Amortization on Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://www.myriad.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i3e77d4115af8402f8e7c73bf41aa6d84_I20161223",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "role": "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435417 - Disclosure - Other Long-Term Liabilities (Details)",
     "role": "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails",
     "shortName": "Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438418 - Disclosure - Preferred and Common Stockholders' Equity - Narrative (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439419 - Disclosure - Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Common Shares Issued and Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440420 - Disclosure - Preferred and Common Stockholders' Equity - Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441421 - Disclosure - Preferred and Common Stockholders' Equity - Potentially Dilutive Common Shares Excluded from EPS Computation (Details)",
     "role": "http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails",
     "shortName": "Preferred and Common Stockholders' Equity - Potentially Dilutive Common Shares Excluded from EPS Computation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444422 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i5fe991d524ac4629ab0f930806f7c992_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "iff8a54753cc14cc7995dfd3ffab42f61_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i139906c1954e43c39560efe073ca515b_I20190630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i139906c1954e43c39560efe073ca515b_I20190630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i4d168ccbb6474a0bbbe80bbe0520d013_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Share-Based Compensation - RSU Activity (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails",
     "shortName": "Share-Based Compensation - RSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i4d168ccbb6474a0bbbe80bbe0520d013_I20200630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447425 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)",
     "role": "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i03913453337a4247aeed7aa0ba49835a_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Income Taxes (Details)",
     "role": "http://www.myriad.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453427 - Disclosure - Segment and Related Information - Narrative (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails",
     "shortName": "Segment and Related Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454428 - Disclosure - Segment and Related Information - Segment Revenue and Operating Income (Loss) (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails",
     "shortName": "Segment and Related Information - Segment Revenue and Operating Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "i977c59e776264b9e898cb3877c491df2_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455429 - Disclosure - Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)",
     "role": "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails",
     "shortName": "Segment and Related Information - Total Operating Income (Loss) for Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458430 - Disclosure - Supplemental Cash Flow Information (Details)",
     "role": "http://www.myriad.com/role/SupplementalCashFlowInformationDetails",
     "shortName": "Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mygn:NonCashInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.myriad.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Revenue",
     "role": "http://www.myriad.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mygn-20200930.htm",
      "contextRef": "ieb6f82d3fb384efe8b4fcf3aff07a969_D20200701-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 66,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mygn_AmendmentToCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to Credit Agreement [Member].",
        "label": "Amendment To Credit Agreement [Member]",
        "terseLabel": "Amended Facility"
       }
      }
     },
     "localname": "AmendmentToCreditAgreementMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Measurement Input, Term",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input, Term",
        "terseLabel": "Measurement period for earn out liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInputTerm",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mygn_CARESActOf2020MedicarePaymentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CARES Act of 2020 Medicare payment amount.",
        "label": "CARES Act Of 2020 Medicare Payment Amount",
        "terseLabel": "Advance Medicare payments to provide relief from economic impacts of COVID-19"
       }
      }
     },
     "localname": "CARESActOf2020MedicarePaymentAmount",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ChangeInFairValueOfContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in fair value of contingent consideration.",
        "label": "Change In Fair Value Of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "ChangeInFairValueOfContingentConsideration",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_ContractWithCustomerLiabilityPrepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer, liability, prepayments.",
        "label": "Contract With Customer, Liability, Prepayments",
        "terseLabel": "Prepayments"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityPrepayments",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_CostOfMolecularDiagnosticTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about the cost of molecular diagnostic testing expense have been included.",
        "label": "Cost Of Molecular Diagnostic Testing [Member]",
        "terseLabel": "Cost of molecular diagnostic testing"
       }
      }
     },
     "localname": "CostOfMolecularDiagnosticTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_CostOfPharmaceuticalAndClinicalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about the cost of pharmaceutical and clinical services expense have been included.",
        "label": "Cost Of Pharmaceutical And Clinical Services [Member]",
        "terseLabel": "Cost of pharmaceutical and clinical services"
       }
      }
     },
     "localname": "CostOfPharmaceuticalAndClinicalServicesMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_DebtInstrumentLIBORFloorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, LIBOR Floor, Percentage",
        "label": "Debt Instrument, LIBOR Floor, Percentage",
        "terseLabel": "LIBOR floor (percent)"
       }
      }
     },
     "localname": "DebtInstrumentLIBORFloorPercentage",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mygn_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_EighthShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Eighth share repurchase program.",
        "label": "Eighth Share Repurchase Program [Member]",
        "terseLabel": "Eighth Share Repurchase Program"
       }
      }
     },
     "localname": "EighthShareRepurchaseProgramMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_EmployeeStockPurchasePlanTwentyTwelveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan Twenty Twelve [Member]",
        "label": "Employee Stock Purchase Plan Twenty Twelve [Member]",
        "terseLabel": "2012 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanTwentyTwelveMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_InProcessResearchAndDevelopmentWithIndefiniteLivesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process research and development with indefinite lives.",
        "label": "In Process Research And Development With Indefinite Lives [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentWithIndefiniteLivesMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_IncomeTaxExpenseBenefitCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Expense (Benefit), CARES Act",
        "label": "Income Tax Expense (Benefit), CARES Act",
        "negatedTerseLabel": "Income tax net benefit related to CARES Act"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitCARESAct",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase decrease in prepaid expense excluding increase decrease in prepaid taxes.",
        "label": "Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IncreaseDecreaseInUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (decrease) in unrecognized tax benefits.",
        "label": "Increase (Decrease) In Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInUnrecognizedTaxBenefits",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_IntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets.",
        "label": "Intangible Assets [Line Items]",
        "terseLabel": "Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsLineItems",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 1.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments And Cash, Accumulated Gross Unrealized Gain, before Tax",
        "label": "Investments And Cash, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Total, Gross unrealized holding gains"
       }
      }
     },
     "localname": "InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 2.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments And Cash, Accumulated Gross Unrealized Loss, before Tax",
        "label": "Investments And Cash, Accumulated Gross Unrealized Loss, before Tax",
        "terseLabel": "Total, Gross unrealized holding losses"
       }
      }
     },
     "localname": "InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_InvestmentsAndCashAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments And Cash, Amortized Cost",
        "label": "Investments And Cash, Amortized Cost",
        "totalLabel": "Total, Amortized cost"
       }
      }
     },
     "localname": "InvestmentsAndCashAmortizedCost",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_MassachusettsDepartmentOfRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Massachusetts department of revenue.",
        "label": "Massachusetts Department Of Revenue [Member]",
        "terseLabel": "Massachusetts"
       }
      }
     },
     "localname": "MassachusettsDepartmentOfRevenueMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticEndoPredictTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic EndoPredict testing.",
        "label": "Molecular Diagnostic Endo Predict Testing [Member]",
        "terseLabel": "Molecular diagnostic - EndoPredict"
       }
      }
     },
     "localname": "MolecularDiagnosticEndoPredictTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticGenesightTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic GeneSight testing.",
        "label": "Molecular Diagnostic Genesight Testing [Member]",
        "terseLabel": "Molecular diagnostic - GeneSight"
       }
      }
     },
     "localname": "MolecularDiagnosticGenesightTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticHereditaryCancerTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic hereditary cancer testing.",
        "label": "Molecular Diagnostic Hereditary Cancer Testing [Member]",
        "terseLabel": "Molecular diagnostic - Hereditary Cancer Testing"
       }
      }
     },
     "localname": "MolecularDiagnosticHereditaryCancerTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticMyChoiceCDxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular Diagnostic myChoice CDx",
        "label": "Molecular Diagnostic myChoice CDx [Member]",
        "terseLabel": "Molecular diagnostic - myChoice CDx"
       }
      }
     },
     "localname": "MolecularDiagnosticMyChoiceCDxMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticOtherTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic other testing.",
        "label": "Molecular Diagnostic Other Testing [Member]",
        "terseLabel": "Molecular diagnostic - Other"
       }
      }
     },
     "localname": "MolecularDiagnosticOtherTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticPrenatalTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic Prenatal testing.",
        "label": "Molecular Diagnostic Prenatal Testing [Member]",
        "terseLabel": "Molecular diagnostic - Prenatal"
       }
      }
     },
     "localname": "MolecularDiagnosticPrenatalTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticProlarisTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic Prolaris testing.",
        "label": "Molecular Diagnostic Prolaris Testing [Member]",
        "terseLabel": "Molecular diagnostic - Prolaris"
       }
      }
     },
     "localname": "MolecularDiagnosticProlarisTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic testing.",
        "label": "Molecular Diagnostic Testing [Member]",
        "terseLabel": "Molecular diagnostic testing"
       }
      }
     },
     "localname": "MolecularDiagnosticTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_MolecularDiagnosticVectraTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Molecular diagnostic Vectra testing.",
        "label": "Molecular Diagnostic Vectra Testing [Member]",
        "terseLabel": "Molecular diagnostic - Vectra"
       }
      }
     },
     "localname": "MolecularDiagnosticVectraTestingMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_NonCashInterestExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non cash interest expense.",
        "label": "Non Cash Interest Expense",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "NonCashInterestExpense",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_NonEmployeeDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non employee director.",
        "label": "Non Employee Director [Member]",
        "terseLabel": "Non-employee director"
       }
      }
     },
     "localname": "NonEmployeeDirectorMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_OperatingLeaseLiabilityEstablished": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease Liability Established",
        "label": "Operating Lease Liability Established",
        "negatedTerseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityEstablished",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_OptionsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Options and Restricted Stock Units.",
        "label": "Options And Restricted Stock Units [Member]",
        "terseLabel": "Options and RSUs"
       }
      }
     },
     "localname": "OptionsAndRestrictedStockUnitsMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_OptionsGrantedAfterDecemberFiveTwentyTwelveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Options granted after December 5, 2012.",
        "label": "Options Granted After December Five Twenty Twelve [Member]",
        "terseLabel": "Awards granted after December 5, 2012"
       }
      }
     },
     "localname": "OptionsGrantedAfterDecemberFiveTwentyTwelveMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_OptionsGrantedPriorToDecemberFiveTwentyTwelveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Options granted prior to December 5, 2012.",
        "label": "Options Granted Prior To December Five Twenty Twelve [Member]",
        "terseLabel": "Awards granted prior to December 5, 2012"
       }
      }
     },
     "localname": "OptionsGrantedPriorToDecemberFiveTwentyTwelveMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_PharmaceuticalAndClinicalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical and clinical services.",
        "label": "Pharmaceutical And Clinical Services [Member]",
        "terseLabel": "Pharmaceutical and clinical services"
       }
      }
     },
     "localname": "PharmaceuticalAndClinicalServicesMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Prepaid expense excluding prepaid taxes current.",
        "label": "Prepaid Expense Excluding Prepaid Taxes Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseExcludingPrepaidTaxesCurrent",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mygn_PurchasedLicensesAndTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased licenses and technologies.",
        "label": "Purchased Licenses And Technologies [Member]",
        "terseLabel": "Purchased licenses and technologies"
       }
      }
     },
     "localname": "PurchasedLicensesAndTechnologiesMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_ScheduleOfIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Table]",
        "label": "Schedule Of Intangible Assets [Table]",
        "terseLabel": "Schedule Of Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTable",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mygn_StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans",
        "label": "Stock Issued During Period, Shares, Share-Based Payment Arrangement And Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued upon exercise of options, vesting of restricted stock units and employee stock plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mygn_TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two thousand ten employee director and consultant equity incentive plan.",
        "label": "Two Thousand Ten Employee Director And Consultant Equity Incentive Plan [Member]",
        "terseLabel": "2010 Plan"
       }
      }
     },
     "localname": "TwoThousandTenEmployeeDirectorAndConsultantEquityIncentivePlanMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2003 Employee Director And Consultant Equity Incentive Plan.",
        "label": "Two Thousand Three Employee Director And Consultant Equity Incentive Plan [Member]",
        "terseLabel": "2003 Plan"
       }
      }
     },
     "localname": "TwoThousandThreeEmployeeDirectorAndConsultantEquityIncentivePlanMember",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mygn_UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase Resulting From CARES Act",
        "label": "Unrecognized Tax Benefits, Increase Resulting From CARES Act",
        "terseLabel": "Increase in uncertain tax benefit accrual, CARES Act"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct",
     "nsuri": "http://www.myriad.com/20200930",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r285",
      "r287",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r474",
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r285",
      "r287",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r474",
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r165",
      "r263",
      "r268",
      "r428",
      "r473",
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r165",
      "r263",
      "r268",
      "r428",
      "r473",
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r276",
      "r285",
      "r287",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r474",
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r276",
      "r285",
      "r287",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r474",
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r166",
      "r167",
      "r263",
      "r269",
      "r476",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r166",
      "r167",
      "r263",
      "r269",
      "r476",
      "r508",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "U.S. [Member]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r233",
      "r286",
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r171",
      "r414"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "ASU 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r22",
      "r172",
      "r173"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails",
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r32",
      "r221"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r57",
      "r58",
      "r59",
      "r460",
      "r485",
      "r489"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r59",
      "r60",
      "r105",
      "r106",
      "r107",
      "r371",
      "r480",
      "r481"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r320",
      "r321",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r343",
      "r344",
      "r345",
      "r346",
      "r430",
      "r431",
      "r432",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r288",
      "r290",
      "r325",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based payment expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r134",
      "r152",
      "r153",
      "r154",
      "r155",
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r92",
      "r206",
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsAmortizationonIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive options and RSUs excluded from EPS computation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityPotentiallyDilutiveCommonSharesExcludedfromEPSComputationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r100",
      "r147",
      "r154",
      "r161",
      "r188",
      "r365",
      "r372",
      "r395",
      "r437",
      "r457"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r53",
      "r100",
      "r188",
      "r365",
      "r372",
      "r395"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r179"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale, Gross unrealized holding gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "terseLabel": "Available-for-sale, Gross unrealized holding losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r177",
      "r195"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Available-for-sale, Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Available-for-sale:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Available-for-sale, Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Available-for-sale, Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 4.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost",
        "terseLabel": "Available-for-sale, Due after five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value",
        "terseLabel": "Available-for-sale, Due after five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "Available-for-sale, Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "Available-for-sale, Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract]",
        "terseLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r175",
      "r178",
      "r195",
      "r442"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale, Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r292",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r292",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r91",
      "r358"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in the fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r356",
      "r357"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Short-term contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r356",
      "r357"
     ],
     "calculation": {
      "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostGross": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Gross",
        "terseLabel": "Capitalized costs incurred to obtain or fulfill contract"
       }
      }
     },
     "localname": "CapitalizedContractCostGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r29",
      "r94"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents, Amortized cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentsAndCash",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents, Estimated fair value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r87",
      "r94",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of the period",
        "periodStartLabel": "Cash and cash equivalents at beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r87",
      "r396"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Establishment of operating lease right-of-use assets and lease liabilities"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Reconciliation of Deferred Revenue"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r232",
      "r443",
      "r465"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares available for issuance under the Plan"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r105",
      "r106"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Common stock issued at end of period",
        "periodStartLabel": "Beginning common stock issued",
        "terseLabel": "Common stock, issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock outstanding at end of period",
        "periodStartLabel": "Beginning common stock outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "verboseLabel": "Common stock, outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails",
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, 75.2 and 74.7 shares outstanding at September 30, 2020 and June 30, 2020 respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r66",
      "r72",
      "r448",
      "r470"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Myriad Genetics, Inc. shareholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r65",
      "r71",
      "r363",
      "r364",
      "r376",
      "r447",
      "r469"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r65",
      "r70",
      "r362",
      "r376",
      "r446",
      "r468"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r131",
      "r132",
      "r169",
      "r392",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r131",
      "r132",
      "r169",
      "r392",
      "r393",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r131",
      "r132",
      "r169",
      "r392",
      "r393",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r131",
      "r132",
      "r169",
      "r392",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r129",
      "r131",
      "r132",
      "r133",
      "r392",
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r131",
      "r132",
      "r169",
      "r392",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Reconciliation of Deferred Revenue Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r250",
      "r251",
      "r264"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Deferred revenue - ending balance",
        "periodStartLabel": "Deferred revenue - beginning balance",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueReconciliationofDeferredRevenueBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiability": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.",
        "label": "Contract with Customer, Refund Liability",
        "terseLabel": "Accrued refund liability"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r277",
      "r284",
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds and notes"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r74",
      "r428"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Costs and expenses"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r130",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Debt Instrument, Annual Principal Payment",
        "terseLabel": "Scheduled principal payments prior to maturity date"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r18",
      "r235",
      "r439",
      "r456"
     ],
     "calculation": {
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Aggregate principal amount of loan"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Upfront fees"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r43",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r102",
      "r242",
      "r245",
      "r246",
      "r247",
      "r404",
      "r405",
      "r407",
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": {
     "auth_ref": [
      "r404",
      "r407"
     ],
     "calculation": {
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Noncurrent",
        "negatedLabel": "Long-term debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsGross": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r330",
      "r331"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r92",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetDepreciationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r92",
      "r219"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r263",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Total Revenue by Product and by U.S versus Rest of World"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarliestTaxYearMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Earliest identified tax year.",
        "label": "Earliest Tax Year [Member]",
        "terseLabel": "Earliest tax year"
       }
      }
     },
     "localname": "EarliestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Basic and diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Approximate rate on pre-tax income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-Based Compensation Expense [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of share-based compensation expense (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense related to RSUs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense related to stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r118",
      "r126",
      "r192",
      "r241",
      "r248",
      "r320",
      "r321",
      "r322",
      "r345",
      "r346",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r388",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Financial Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r378",
      "r390",
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r379",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r277",
      "r278",
      "r283",
      "r284",
      "r379",
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r277",
      "r278",
      "r283",
      "r284",
      "r379",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r379",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Reconciliation of change in fair value of contingent consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r383",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Change in Fair Value of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Change in fair value recognized in the income statement"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "negatedTerseLabel": "Translation adjustments recognized in other comprehensive income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsChangeinFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalMinistryOfFinanceGermanyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government of Germany.",
        "label": "Federal Ministry of Finance, Germany [Member]",
        "terseLabel": "Germany"
       }
      }
     },
     "localname": "FederalMinistryOfFinanceGermanyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Recorded Amortization Expense for Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r207",
      "r209",
      "r212",
      "r215",
      "r429",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r212",
      "r433"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount, amortizable"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r207",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r212",
      "r429"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net, amortizable"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r92",
      "r218",
      "r223"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss (gain) on disposition of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r200",
      "r201",
      "r436"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r147",
      "r153",
      "r157",
      "r160",
      "r163",
      "r434",
      "r444",
      "r450",
      "r471"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r336",
      "r338",
      "r340",
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r334",
      "r339",
      "r341",
      "r347",
      "r349",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationYearUnderExamination": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax year being audited in the income tax examination, in CCYY format.",
        "label": "Income Tax Examination, Year under Examination",
        "terseLabel": "Tax year being audited in income tax examination"
       }
      }
     },
     "localname": "IncomeTaxExaminationYearUnderExamination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r101",
      "r117",
      "r118",
      "r145",
      "r332",
      "r348",
      "r350",
      "r472"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/IncomeTaxesDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r89",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Accrued liabilities and other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Common shares issued and outstanding"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityCommonSharesIssuedandOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r208",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Non-amortizable"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r208",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross Carrying Amount, total"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r205",
      "r210"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangibles, net",
        "totalLabel": "Net, total"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r67",
      "r141",
      "r403",
      "r406",
      "r449"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r85",
      "r88",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r52"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r76",
      "r140"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAndCash": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails": {
       "order": 3.0,
       "parentTag": "mygn_InvestmentsAndCashAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of investments and unrestricted cash as of the balance sheet date.",
        "label": "Investments and Cash",
        "terseLabel": "Total, Estimated fair value",
        "totalLabel": "Total, Estimated fair value"
       }
      }
     },
     "localname": "InvestmentsAndCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAndCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments and Cash [Abstract]",
        "terseLabel": "Total:"
       }
      }
     },
     "localname": "InvestmentsAndCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents, and Maturities of Debt Securities Classified as Available-For-Sale Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r435",
      "r454",
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Marketable Investment Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LatestTaxYearMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Latest identified tax year.",
        "label": "Latest Tax Year [Member]",
        "terseLabel": "Latest tax year"
       }
      }
     },
     "localname": "LatestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r11",
      "r220"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r100",
      "r155",
      "r188",
      "r366",
      "r372",
      "r373",
      "r395"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r100",
      "r188",
      "r395",
      "r441",
      "r463"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r100",
      "r188",
      "r366",
      "r372",
      "r373",
      "r395"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "negatedTerseLabel": "Financial liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum aggregate principal commitment"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Undrawn fee (percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r18",
      "r236",
      "r439",
      "r459"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Net long-term debt",
        "verboseLabel": "Net long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails",
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term Debt, Unclassified [Abstract]",
        "terseLabel": "Long-term Debt, Unclassified [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Estimated fair value of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Interest rate (percent)"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r11",
      "r220"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r6",
      "r39"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable investment securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term marketable investment securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Measurement input, expected term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r100",
      "r188",
      "r395",
      "r440",
      "r462"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r87",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r61",
      "r64",
      "r69",
      "r93",
      "r100",
      "r108",
      "r112",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r121",
      "r147",
      "r153",
      "r157",
      "r160",
      "r163",
      "r188",
      "r395",
      "r445",
      "r467"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss attributable to Myriad Genetics, Inc. stockholders",
        "totalLabel": "Net loss attributable to Myriad Genetics, Inc. stockholders",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r64",
      "r117",
      "r118",
      "r368",
      "r375"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewJerseyDivisionOfTaxationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New Jersey.",
        "label": "New Jersey Division of Taxation [Member]",
        "terseLabel": "New Jersey"
       }
      }
     },
     "localname": "NewJerseyDivisionOfTaxationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New York.",
        "label": "New York State Division of Taxation and Finance [Member]",
        "terseLabel": "New York"
       }
      }
     },
     "localname": "NewYorkStateDivisionOfTaxationAndFinanceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "RoW"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segment"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r147",
      "r153",
      "r157",
      "r160",
      "r163"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Segment operating income (loss)",
        "totalLabel": "Operating loss",
        "verboseLabel": "Total operating loss for reportable segments"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current maturities of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r410"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r40"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Change in foreign currency translation adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r62",
      "r65",
      "r362",
      "r363",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r55",
      "r57"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized loss on available-for-sale debt securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19",
      "r438",
      "r458"
     ],
     "calculation": {
      "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/OtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Payment of contingent consideration recognized at acquisition"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payment for tax withholding for common stock issued under share-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r79",
      "r80",
      "r176"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchases of marketable investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r292",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r7",
      "r9",
      "r196",
      "r197"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities and sales of marketable investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r61",
      "r64",
      "r86",
      "r100",
      "r108",
      "r117",
      "r118",
      "r147",
      "r153",
      "r157",
      "r160",
      "r163",
      "r188",
      "r362",
      "r367",
      "r369",
      "r375",
      "r376",
      "r395",
      "r450"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/SegmentandRelatedInformationTotalOperatingIncomeLossforReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r226",
      "r509",
      "r510",
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r31",
      "r220"
     ],
     "calculation": {
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r222",
      "r464"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r16",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r83",
      "r103"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayment of revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r328",
      "r521"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r248",
      "r323",
      "r461",
      "r484",
      "r489"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r118",
      "r192",
      "r320",
      "r321",
      "r322",
      "r345",
      "r346",
      "r480",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r138",
      "r139",
      "r152",
      "r158",
      "r159",
      "r165",
      "r166",
      "r169",
      "r262",
      "r263",
      "r428"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/RevenueTotalRevenuebyProductandbyUSversusRestofWorldDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r131",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r266",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract": {
     "auth_ref": [
      "r199",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates (true false) whether practical expedient was elected to recognize incremental cost of obtaining contract as expense when incurred if amortization period would have been one year or less.",
        "label": "Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true false]",
        "terseLabel": "Revenue practical expedient, incremental cost of obtaining contract"
       }
      }
     },
     "localname": "RevenuePracticalExpedientIncrementalCostOfObtainingContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_RevenuePracticalExpedientRemainingPerformanceObligation": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates (true false) whether optional exemption was applied not to disclose amount of transaction price allocated to and explanation of expected timing of revenue recognition for remaining performance obligation, when contract has expected duration of one year or less or right to consideration corresponds directly to performance completed.",
        "label": "Revenue, Remaining Performance Obligation, Optional Exemption, Performance Obligation [true false]",
        "terseLabel": "Revenue, practical expedient, remaining performance obligation"
       }
      }
     },
     "localname": "RevenuePracticalExpedientRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_RevenuePracticalExpedientRemainingPerformanceObligationDescription": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of consideration that is not included in transaction price and not allocated to remaining performance obligation. Includes, but is not limited to, variable consideration that is constrained.",
        "label": "Revenue, Practical Expedient, Remaining Performance Obligation, Description",
        "terseLabel": "Revenue, practical expedient, remaining performance obligation, description"
       }
      }
     },
     "localname": "RevenuePracticalExpedientRemainingPerformanceObligationDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r412",
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Anti-Dilutive Options and Restricted Stock Units Excluded from EPS Computation"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Schedule of Available-for-sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r452",
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesCashCashEquivalentsandMaturitiesofDebtSecuritiesClassifiedasAvailableForSaleSecuritiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in common stock outstanding.",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "terseLabel": "Summary of Common Shares Issued and Outstanding"
       }
      }
     },
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r45",
      "r102",
      "r242",
      "r245",
      "r246",
      "r247",
      "r404",
      "r405",
      "r407",
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r290",
      "r313",
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r290",
      "r313",
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r207",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Amortizable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r203",
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r203",
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r214",
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Non-amortizable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r147",
      "r150",
      "r156",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r147",
      "r150",
      "r156",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Revenue and Operating Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r292",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r297",
      "r309",
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r48",
      "r98",
      "r127",
      "r128",
      "r238",
      "r239",
      "r240",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r134",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r163",
      "r169",
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r136",
      "r137",
      "r147",
      "r151",
      "r157",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r168",
      "r169",
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Related Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.myriad.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Service period for award vesting (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "RSUs canceled (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "RSUs canceled (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "RSUs granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "RSUs granted (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "RSUs outstanding, ending (shares)",
        "periodStartLabel": "RSUs outstanding, beginning (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "RSUs, Number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "RSUs outstanding, ending (dollars per share)",
        "periodStartLabel": "RSUs outstanding, beginning (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "RSUs, Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "RSUs vested (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Shares available for future grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable at end of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable at end of period (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Options canceled or expired (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options canceled or expired (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r299",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending (shares)",
        "periodStartLabel": "Options outstanding, beginning (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options, Number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, beginning (dollars per share)",
        "periodStartLabel": "Options outstanding, ending (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Options, Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r289",
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.myriad.com/role/ShareBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r134",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r154",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r163",
      "r169",
      "r203",
      "r225",
      "r227",
      "r228",
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails",
      "http://www.myriad.com/role/SegmentandRelatedInformationSegmentRevenueandOperatingIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r118",
      "r126",
      "r192",
      "r241",
      "r248",
      "r320",
      "r321",
      "r322",
      "r345",
      "r346",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r126",
      "r428"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r20",
      "r21",
      "r241",
      "r248",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r248",
      "r291",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under share-based compensation plans, net of shares exchanged for withholding tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r20",
      "r21",
      "r241",
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r26",
      "r27",
      "r100",
      "r174",
      "r188",
      "r395"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Myriad Genetics, Inc. stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r188",
      "r192",
      "r248",
      "r320",
      "r321",
      "r322",
      "r345",
      "r346",
      "r360",
      "r361",
      "r374",
      "r395",
      "r397",
      "r398",
      "r402",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r248",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Preferred and Common Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r415",
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SwissFederalTaxAdministrationFTAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government of Switzerland.",
        "label": "Swiss Federal Tax Administration (FTA) [Member]",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "SwissFederalTaxAdministrationFTAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.myriad.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Accrued taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/GoodwillandIntangibleAssetsSummarizedAmountsReportedasIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r343",
      "r344",
      "r345",
      "r346",
      "r430",
      "r431",
      "r432",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r277",
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "US government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r277",
      "r451",
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Federal agency issues"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetails",
      "http://www.myriad.com/role/MarketableInvestmentSecuritiesFairValueforAvailableforSaleSecuritiesbyMajorSecurityTypeandClassofSecurityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r329",
      "r337"
     ],
     "calculation": {
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive shares"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r120",
      "r123"
     ],
     "calculation": {
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-average shares outstanding and dilutive securities used to compute diluted EPS"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Basic and diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r119",
      "r123"
     ],
     "calculation": {
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted-average shares outstanding used to compute basic EPS"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.myriad.com/role/PreferredandCommonStockholdersEquityReconciliationofDenominatorsofBasicandDilutedEarningsPerShareComputationsDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL51790836-203054"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130569-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130611-203046-203046"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=68176171&loc=SL68176184-208336"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1,2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r522": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r523": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r524": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r525": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r526": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r527": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>90
<FILENAME>0001628280-20-016036-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-20-016036-xbrl.zip
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MVT*7"<Z=B.ALD>B9]Z4WLUD2Z>(??WOPY/L]VR:WR$*O8!-@7K!1"U5Y?UG
M)F5YD$]A)<R88"=Q7W/8Y")8Z:*$S_(")4E2P78ODF@17.9U&@<PY@5\' 9I
ML@0M#+Z4H+B9@<2!8ZD6[C5(B9-'WY>!FB8I#@,OB?.@S&G;\5SV=NN1YGQZ
M!7T_@?U!>L7-8LFL@EE>+%4J-$Q*C[+J#QX*C #?7I8T7I1G,5DE95#J"I^%
MS9[J-+\\W(]]?/WF]S#X@)OYTYMWYR%L$JX9;[%(3U!?<$N6=57#KJV*?)F4
M&D0N[5&('UPD)6Y0V-XP^+%2\,(X /K62<;<9*6**H'YTZ8CXYCE*6QG"?3Y
M^/O@5OQSI>(8++N#5,_$BKIFGP^VN-&3PRW*S\9.'3\Z?/3 ;%:_4/V !B]S
MC'>Y^>EYC0>W33%[>#OZ&.ZM&ZGQ8*CAY/ Q[L,'CW.6"Y6F7R;E!ZXUGIV_
M&8*^"*($B#9#]Y2('C@"D$01BR,TP%",144R)=,R>(^F&7SUV##;*LEJ?!PD
M$SW_ =AR,(*3BO6,>*__$.BGWFE&D5[!<98UJ!F>-*Q7-Y."S-3!1J@+G(!Y
MN2^1F8Y )8('0 5)=4KZB">DK;KR+%=%C,+F.<CLJ,J+<@?L-IKT$.@(&&-[
MUQ<*?L0=C(EMAW ,Y0HE.^F%)('A9%5=+?*"?\](,8(C4F691PFY3DFY)+&=
MLW<6CRBB*Z_M"W.Y\O G!;3"/(1^*4%=3541X)KH?>:#3%5UH8UR(<306 7I
M!V1MS!1,8E;3S&"(&.8_!T*%7T%G1FW.T-14EQ4.N4$9MOM!0W6V!!Y&SXU=
M+-PCX!0A_GNI85-521H[71E6VS>--F(5GOT1\(>RPOM%6THCF->, [JO>-_H
MRDYYHGPE9J!Q!140#:T2_CWL6=\*KF"4K%!!2U5$^WJ9%Q\M5V@R]JE&KM!W
M"_DD@S2/%%]W^=Y[E5;!2_41GH!M#(/?*K4(+I(HR>!7U@Z&>4-)/8WU5B]I
M&"SR2[#?BK!M$O)Q9'F%1U+H/^H$/8APSH6F(]"&LIO[;W=^3VR0T71(VM"$
MU*&65&,7[R>4F'A9#5FQ*=@5>;&^R.'T\,=>?C3%D)0N2[K0(=BG&HY+V(B>
MH7PM+5,S7R5V/0-F6)0=OKDG=!"-__&WR<.C[[O_[6JG:K7*P:)OJJ<J6.KE
ME$618Z':>K25OW5-/0N$S_L%.5OP'<B+&T>W870X%V"S<(/+:*'C.N4KC!_'
M;=6HRXLSL*<SO.GN3<BT"WV@4U';A!!$', ?101%6L<T/ P]*L<\0_Z6S)/8
M320K;<_&E[:6,.'D+E "=,>RH@/E5UZ#%E@7) %1X.NL)-;K-K$[M*=B6JW"
M[$6D5:GMV@KX+<_"X'*AZ0T7>5IGE2JNV/%E?^W>.W1/K% S0!-EGM%H=&_P
M;R)M2]!<4Q*R[NG.A/"AA)3C*=@ZB2I(A3(3(C7 5WO\1V&./602XN>B6$^-
MKAM;71<?4IF::[[<?,+RZJO6&VBH%CG2)L)!)U5%6A,JY_EL7^1#O)8OO,XK
M/+NR@@,SQ UDI.? &^8ABM8%?NQ<4:30@(IG;**)I1SRL.+6LH^U2\"<+0"W
MD4^J3PTC'RYH84"DH(LBK9?H4HO2VL[.&^4C>L/*$@G0>\#H7"6,7ABUE+UC
MHV1,)]WP$#LJCG/2XBM:;I&GH1!8*A?'_,:>.G[:>P:N<=6]"JS=P?.C1-Z^
MJJ=I$L&@=(]D+F4.6B,L495]ZO<<E/DY&;,T!;Y>,A]V9:/J;N>"@A;.:H:+
M@CV-*#+]X-_'YB(D95GKF$8!3F0/?RVU^XD6A@T\!1U+X2S7IE[(Y3ARCZ@I
M&+%UM?Z1820Z?/?CI+,5/(\??Y@6/_;E;_!_%X69Z H(_& *C/CC@9K!.IZJ
M]%)=E=_=*H?EFG?>EAUM:2\;]Y 9;0JW%G]I_HEMNI[+@5*QGOX3:=V7Y;[U
MEA=D(AJG&EG<11Z!.E&@6M@RR/,I<C,D^5*A_M@6@U.Z-B0,2!<I$PIMD-PI
M.X+'V.3S'&P4&G6:Q[(F-G*-#JI+Y@96_24%HR$WHX]9?@DJT-PX&,2,;QH^
M2W5EG%=DXZ#:H1OBL<3?F$7!1[#-!9O\],U2-@G&7'!@+4[**,U+7JX_H1%-
M8K6"0U'35/<(272>O !5(687EQ,:7R J2$FY8.42(RH)*%7L25N *E'13!2J
MI$P\'O,D(O+^%.?$$:\-]XD?HF7P?X[#?/OR_OAPG;@?II/A@S$6K(:[U2#)
MGBA]:JW2-UPJV')P;*/1A=R.IBMLS-J%P-I.ZSF<?C YV9DLM8[]/@0W/"O6
M9GM%O(&MFJ0!.W=)A+N# !M4)YS]H0K1$X#]&^>#=WA6KA<:I(!X"3D"@U)C
M\,>U]<LA1[0W >3I#G)'I'_X>+M,LNTQ "V)U3V=EKK'46#SC</;L5=[X5U
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MMLN<6K.XIO976D9)Z0'E8.2.N0*#).\PSIE#/V2/^;89_6VJ\6<8!)O"D]3
M</&ZJ95U<2$(*1CSN3()^RM52%H)\5W^XQCK&E*-&#=]HN)6$N+ZS9(.='TS
M[)T=R5B;R,SM7\.U>\[@ZMR.O?^DW1T]'DLU1TH%#7%2&I;?<;O/I(T9B1]X
MKZ1:T(?][<<4W2?WLK/Q0!4XNB02M=C^]5>!:%ER^7AVJ/I@[U^]G-K6Q^0]
M0(7H(HEKE99P@_/0<QQTVK)BX-6H(M8N!/(NJ!J'VAZ%7N4L#5]Z0#TFXXK>
M+K.D+F#<,<DK1^7<!;@>,UU(+@LR 30J&]KA, GB%7""NG#[-@#S"=1@O,/
M#NI*>W0Q_"9L+[*H!J)%=#2<\1#V,H@T<E(6269/K03 #J+_S OBR#.WU<S(
MAKG'0T!T#X,%B,0+9B$"^.68D\L?46+/B2C1?]0ZLR[5]LU#EE9BGHSQO)">
M8SVSU Q/_K;.0BNK//JXR%/L[!Y24I^O)"F4U^R"6'_^9L)B[F%!;9&4)I>T
M1> ^DY6TGE);7Q*;<!ELN6'ES16V%HC3+7,[8X?^1B!T9@8\%/=B2:CA <$T
M ^/5D2Y+G,1E$MD*JF::(3'DO)XOF'E[1W9)G0K-Z+8_9&.U(>786 LW[)BX
MH;-Q_:%IT9*QB9I"O5P9]58Z8)NV+,UR--1@HPJ'H/> H59I="'8_4,E$_WG
M?;UA_$T&(LLO%"DO[G@M0GWO.TKJCUI9/1S.Y!/I=ZQ?D0-U2FI< \]?22]N
M7PNW7&5/LHF^(+E/?\/D/CP+=&9]^R0__4V3_.PZ]H-: LIBV:6@CI?#:_M"
ML$( $Y#R&R_\+B>Y]9*G"Y!2DI.,3+A#=Z$C.B]0V7>=2DDVO6^<Q'1Q1[ :
MXJD7:'D.6@T=UNFXSL#4ZQOD%+8TLCE?7 ;3DY[&GZ!B('I H2_RR$HDY?<U
ML_%FJ:1,2>EMFN]B8V+9& 'V8R9^X#I\GW]:)-,$>&4HWJ$X!^E/$ _DA0B6
M><Q=4[ %'"D;Z)8>20);F915 P\GR2K?O6%&&[,_:(:D)'8E-RUW,?49Z#*%
M2L- *L.SF'QWP!?3'*$F4G59[H QU,='AD"'W,Z^;W9>]@-($AVW&B3?JL27
MW]*$,8G$2>&ZBO1Q4A.'SF!K@5+F=:JH#TD!KV-O1?/%G,:QIC+:K<W$JV1I
M5&A9\)4B4))A$M$0K+V@V9A 2ET>'AT@1KAD%@O6U35GD)1>E7=N"A?Z3R2(
MBKS$B+S"@G#R2DFGFY4O[/A='1KRBO)2=86M%RTJ3(EP1;$=U&LZV8*I(6Z9
M%&7ETVOO^^1UTJZ,'*5<'5_:M!_GQ2>GN^M&1:615&#?R%EJU QU*+S50W-C
M<C/L,I:(,8Z.28=JY#^UU]EH00/[TDRQLDW9DFSS[OM0G[% AI,L:)*.W:&[
M:_MUK^W6+RK'-1K$TZ4,ZT_VG-&?10OT^Z\JJU$MF=C84/.V[XE5-9KOF%&U
M=7@U;L[&44'+S)$?T\S8CX8M#+%XM1;+R4"JM>-COL?'RS+UG1,2 6DS^XLD
M3UFG;6219F@,X*.6J1=U*MXFJL;%UUOT-S/[*%7)LI3^O4#@-)2#['L+(^$W
MP3:LQ+^ -^1T-L,67/C=,^S4* D^QT>3(P33G'.,V:KQO_"NT%>INT1<BPW2
M#_N'XS1MQ? N;Z5!B9.CN\25KVO4#)7IP948@L&';,1X&"='#T:+L8L:QZ+G
M,A>T'(_TT1;;<QURR$O.T03A.M:Y.?+RYK\,WFEL>OYY(R;+5<WI(*2/H%"G
MR9CNM>3VE0[2UD,!G^LTL7T$KP*/U>;X=SL"^FQA0;11CH\28]NT@TZTF*WR
MP$] "*!&;,$S-;^>,5HY[%X!D\^XXS5IC=Z!]+B]1;+XT*S-(%A7CF'NEG$B
ML02BX)R3/ZFZ]$)9+O)$G3P%L,*L__C1Y*%9_=MZ"D,8&?%>%Q<8S>%,SB[I
MP*S31-><(\0Q%5YNHU;#TI0%&EMM;MI%"4!+,R4#K#!B!WSFTHS&;2)OA08L
M1H6O^5(/U3S (;#%98^E-2_R>M7==(N'ZB!,\ZR+#R%A I<+U0*Y,"C?6)5+
M*ONF'/_^U/Z&5Y>C"QHNUS2WG5_=!?.K3?@K>Z(P/SC<+7WY)VYT6A>:?)]G
M<$.G*OJX70T:/7J-MN -.FMVTNZMI)*&OK(R4F]E84#WP$FN" T4>$JYZ%:#
MSX$7%N3)IE0 <P_*8%;D2^XWANP _MT3FGVX8S3[ GY<9LDL80-A6+50+4"0
MI#G73@I!E\^7+-U*([9B#V37!QOZK5(+%*@.@JDMH,\TL'AZ,[G?7H R4ZQR
M PSU[.K@)08XB#-CTB?FF3PW:33-KL=O*'VB"%H[[VYAZ"(]7HCG)PG[[,D]
M>;1C]^0LSV8);EJB$,6"O:U@I=/AP$D1HEZ56(O]O9>+PE]^D6%N PGUTQ*]
M8=N.+5'214J(8**X1&81XG#F3@2Z(G. KIG-79W6):K*[>1IOD"4$^1:A%SG
M[+9WTD_1H.@H.4I8:O",U!25SS699*TS"H/7>7;@'0Q_X)\,C=E[,-==QY_-
M==P3]*_'.W8?WVG01HBTX!*"PEVQP8K^K2+>-K0"M?6X;<C'2::9%/04 FS3
M$HL2U5-C^ )M@AA4%B >)*?7V,9>"9"?!#]K"3_*5PD7 Y)I-RKT'.16*K=Z
MD5]*(OFZ,2BOCH9 1Z,QM[#.D(RX7LMK16&'TG)%"EA-QQCR2RYTT5E+=D5<
MB ZX4UJ#MI4D.ESSLC#P+&7,B$33G2QE4BW"(-+8LF.!R*5A4,+5K>QOJ5I5
M^0J[/1<Y.CK@IR7&/V [\$>]!/($B1_BF/C]@FD0?T##T,M:-/D4]!$,7^6R
M?R;NH9::M\7J*RU[%U<+IXY6K7O4<PKXI5\EI:17A4*V#?O*^\7V*?HU4"N_
M RUMY4@C7<#F$JBF6JF(PF HS@S5F2H[2@U26!!4B=2CI%K96MIY1;028<\5
M4 @%W@MH U76'#E^M"]6SY,=DQY.F^>@"/(]=.2@!@&42JXV#RUL,$@]R*FG
M7NTT6QR7JD $E=+/^5!C<:R:A#2#D7#:R#H3=Y7MZ]8KI'*W$YZ4\G)H05!A
MP_!"&'$DNVAZZQA0.)?P9KE1(\E7;A/54I7!-*^Q#9'(0A[!S00_IWE4ZF,7
M+IZR0Z;CYO XU99? QU^&=J :JX0 -=IP/R&$B0$9C*9[]GI1'E=H(>9E-;&
M%%,@IM2?J(>E"X=6%; Q(8L>>E#:PW_V.<ABHW%O>C/ZK=.<:VEPQTK=C(3V
MR5JC\3=$/>8N(LAR+&=DO,W<N (_LM.47'M/OF-**J+GD"3R<5#1,#?EF6W)
MC[%++#&PT/M%S<GGB%(A\M=8_[?KC3Q</CHYVC%&^D%"+P/ E/*=G.&:S'VG
M5N4MKNKSM);_TVE7)+]M@ RO -8M ?OAU[@X&*H,-B+!0Y-W"9-C:\2MYA1)
MGBJF#5 8"Y$_),&AOY;?PO*ZN>/5 W-VA>6<A\%=Q-Y=I<F>1.P'P)4F.\:5
M,,#KPF)'3[:=Q+0G/B)0*M?1@>>WBSYF^66JX[DD#!A'7CNG-LXUZV3S6A$
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M28PE4QC+*^L5L7],$G+TP7A<N80473Z\7[8MIB^V'T*(Q]'D03.T9(NX1$O
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MTFF1Q'/0Z,[+/]:K0(U%'1VN*1G\VGQD\T#7U37>Z0%?K =T?88M36!#V>F
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M>[(-RF*LJB=$( H^4%[#G*#V\/NM21EL^MXY737Z\."G#E9!8D<R3:]('1&
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MROH5;LISW%)DY6X>=_.XU3S^NDKJP\]34N]-\_@*_EE4R_3'_P]02P,$%
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MD(HB=JFER+<P9>_)5/VK0#W2-W57+D45Y2+)]2*SH2P?P>YSMX/JER9*8NK
M+6QW]WU<?!XMLO<N'+V4,UK$+Y7$E65R#)T?$PHC/""*3X X I@7T(*A(XUY
MR-CZ(E+79%A,DYFB3!094"(TIB$/U5A&(\_FF.@\5XIT#DOW0&;*:>!:\DXY
M#_?->YERCY,,;)^<%2 !Z=O=?&#-H@R;\7.P=U :8B&>,0X "IK2KE+,, /=
MK[U* F>OA41=^! P/_V\_N?<9*T5./!VGJ^=U_J?#:5"+_4X4+22R<VJ5%R#
M,Q.C'.5*"Y25#THK69L3JF?&/YW6*I\6Z(,5D6Z(5A%T144+9P@]8'+H!:9A
M%ZRYD*H&KUX^9S@#3B@$;_.>TS]"T.,;)[W,'=-Q$!6F,G:.9!R S8=*'/:M
MP/SA5%T7$=L%Z+E?%YH1E9P]\3\#31N3=$4(.[#SL=JZ18^#1#))/>V?=QOT
MZW^>=A=6X#B1Y2;*]IYM/ZNGS%&W:\\>6:1R?3C&UA$ME6= *RT1$KUM?R(5
M/F;3M+L\YC%1\5*-J44D8KLFKXC247=OXMQS%F+?U8!'&BP0%Z,M1YN-$P*#
MHBSA"BTT*SG)UP;P4H,!)?5@7LN[[Q?/75FB7$@77P-V<(^"? 5H \_C4@5%
MJBG8YL^.G:7] ]]96O_S\2K;'[-T7_MSPLR'%>"?CNLC; %<(VM"4C8-5]6>
MRRR4_Q+O-%<!7A21$L^>[U-][<&?0!1Z<F<EA6$I _?_7#+PL@!-?K,2#C-7
MS0:*2NK;4HP0TL"^;]-49<!@Y I37@OE16.E$E@:4Y5FW,")?\K(<)$!1<;I
M'1^FMM, =:DJN]U$<F8:E&6!358*,8ZIAP5^94TRT!Y/\@EG(L*)5#KK+F//
MMH7PBS=-AA*)_JPM60][Y9'XM[=:Q.4M1)C']_"$3#]+DC[V;K<XQ0I!&+_D
M$8[^QJATJ(-A3)?U^E>"5!H!)9S(=<-E@9PK2-&9,DVP;[M=<+(=\HC73X3S
MO\HF),!?Q%G.I_"7SNEF:\)52[LO\-Y<95O_K09?K<?I+Z]3<?/X][ /$VIV
MQX:=[+J@_8_?<-6:N$;L>1U]Y+>(,FI1E/GR K]N&IJU3=?5H)?(UH>8ZZ(K
M[70>/*5^0R26%SVQZ Q](4G^62G925YF=8$I,"GO1D:J3.LVS8.:RB"9$G!O
M1JZU"/);_=2GZ=JVM32(2QL7=S5'O^72,);4J&(N"ZX];ULH[Q7%#@F!QVW#
M].-I'F&*>X0]2/&",MN:"AZFOEF9[;Z'ET_D<]';W]V$:<VSS?I:6C1MM1%G
MQW5DW=VPJM2T)L)H:5TIVX31[AYNQ.E"^KH#FWHRHRZH=-.2(2_"77)F.6-D
M?(24.U@V&86J77Q\U#.VFMVUS561KGF7_)Y2*/:*>5KZF 'O%+%I&\M"A)A/
M3R8JQ*E'U)("7C]2NEDPTK*-EGMM7SI3]H-3B!,QPGM %%[WE@;4()2+,];$
M=EO:E;KWMMT^ILE8#ZTZC,45D$TV4BDWZP,ELW0GR;6(Z56S3[P>;J:2B71H
MV-9JMM8"D<J9P!-'_1>'6=_\0P:B'CO),4^SV9"!HQ%)X$;<%\DIK9+KB(R&
M,!SP%U2[#OZQL0^OZ4ZER&73< ?VB*(>)[SKI&=:YE^*..K+BFT/[X8V/*4#
M6%IZ_OC3 58$_=MXZV-8?6Y_Z;=FD^)?!4R3*DS"9((J+.!"0Y8R>)^DH)PB
M[H3FU&9(FN *S6)Q5BV[4ZCM<IVR:CF+ QC7XJUS1EL9%TF+2&5L,Y*8LUV*
MN5.HM,J7]\7DTQC-2\Y'&2')ZJW:+D^/'72(!:LIB)XS:FYD>IK2"R[4-9<J
M:+)CS76D@AI<P["76R_[M=W*G<PM>V=-T3SOND6U9TK@Z"&\]-3)DB)F4P0$
M">EKE$-C%86;96D%%>7XJ_?KY[*RYU?6TO2K:MR*T@9SSH39JFFJ;G12H$P$
MGH^M(]1AY[-5I;.LJ/6L;[4HW*-]$1:I%<.M^*X> <U,%$),4:NQWTO2?O6&
M$9@;P\*@;>14!J8?KD:*FRI<"_8BZRY;O2Y 5VGJ5%5#EC>KZJRB &2&G:]P
M25.N8\2OC^=3%/R!-#W J+&ZG./Q<^\M((YDZI5G@@80MLP2M04WUZV\R/.-
MN;T8A^6I5=O$EF08G0>'BOF=,.TCU+<Y4/*43#]#KWTS;3::>>)];]::87-6
MI'A;K%$:M=9O-I0/9C3*F*R"#G"T"Q''%$M$S,83N645%][6F^SWK22(U,W<
MCKQP@=1]730Z# \19(6_J50UT?>+W:RN;7KP:&S3HQ"WCMK[+MD*_30U&+5I
M"XW^OJ$LHZ5*U( 1B ;PXP2$(?)ZOV@"&ZK4)VG]' EFP(11$"MLUX0@5P[J
M7!C>)(5U8ET'=I/HWR[)>U@RH9Z-W!T0"S$UU@3L 9$$!NTV-+8.V237U'61
M4K"R"7P#?FSBDJE%2BP*8# #U,["_-XV!W+'JDZ8+0WU;]^J18G,91.>WU?.
M(U8SSA:S33#+CXP?5_IF+9ED]$B<Q%N!S,:HU10&NK!9K[5T5=C@V*P;N?2Q
M;MLFX598UP":Y .6]JLG#M#<FZ8&C &#).7(-G7KM[_@(]QEFAXS_8G+;QJA
M4NNQ3KU>"(<>82].7AH+,B"J\T2,4O9]RTVOV6)^L_>'91*ML( :;O[ZR^#Y
M[NOF_U<S?_38E.<JAG/XZ)8LFLZJ7*<MEHJP2!)I;L--+(;X"V=7A(R?,GM2
MO&3.MR9,5'J-]F?Y96WNS\EDQ*J9H1&L+@9QDFN)=[F8#K9MC6X,SWN7W\@*
MY@.3A9<BXYDD1Q*QN6F*A-Y!61'=DV7OHI:#*/OBV%M[Y&:+DV>LV*&M\0C]
MNEM*R^4-@9D7$^L%)4-@(.D%MZHI!L8C9MZ=R"\5H5):U2[)@"/]1:7_"TLU
MC-KAWF+/7XK]QI3;"\>6,X@E,YVY<:K>'F+1M1@=#VKVP[S9:STSE7,:M<UH
M\C5&AV3E5C:Q\1"\%O MIT-44U$6U5(W1YUDZ]$1L&X:;G;53TWDG)Q,U&^@
M4$!4,[D:.XX#<#[0[@( N O%9%+9_]99-V^S1+#>76"T-K:BZ 6=LOA"N1[\
MSO>\4$EZ+6/S+_7K=>@>AK3E:VGE:PV+P1<2[43D@QBFO?9" V3DQ)PO2- "
M,>KU891_S_ SNQ<YMU^Z;5,L;P.Q!MAQ28?F4L]YOV;OI&H:29/#ZF/DM"]\
M;2*UBQEB0S@'X^M1Q<+"VPWI 0L361ZAAVZ?[U-EG&.B%X\$"E_.[G2)EU[X
MR*S $^ 4)$C##N_TOPIC*=4DT*J *V%UPE'GA'T)W*+;*Y9;_RZR#/P>1:@.
MX:RN=0WJ='@8K^=FF4:!1@J[U</:%(^X!2Y\8-NJU=7&SQX-E.AEYK^3,Z*C
M2&/:SM+#VS7US*W9 G97NN(R=/\H6J4R8IU_&]9#_GU'CTO3X\W<HC9J*61@
M7,GGOS!1?+\1Z6TT_%UKS=0/?V5^^&ND(^^UWBMP::YXC!HH9)ECYIK-TQTW
M*A&3:E9.TP8B!K:!%W.SNXO!D?E/;.RPW2ZO@M][ZSU5E1"6:9.FOF(LA=RT
M49I,JKL&4\!\H?C:7J'GWZU>;AO%^]%$E#=21_@IWJ_">35X3TP?,P&FF/SG
MC]Y?-!I>/).:I")&I.V-D*VYW;11N#X,5L$\JZ9GF:X1%FI1R$R:]*B:<\9=
MI:IY\I58EG%V^0R,[\C88X-2N'ICHG-#\@XFZ 8IK?V)(Q+'D-J@+[+->J.3
MB!7 O'M/^Q20YN_:UBAKXHM]*CM')@B[<F).Z" 8CW4JC%I8?4]=6H,"(W$W
M90IYW9$M70,G9**Y(6E*_[3(8UUL53LB.UG(C\>)AY70]>CMA(-=;0T054ER
M-7R,ZRW DXIJ02 OQ[B</_CC0.@@SQ=WP'Q41-"3G59Q0[?1"<#)^@VI7;,_
MDX.,X7IW=;S9['YGBG*)Q#0.#I6 )YJ2&6N_ D/5(PKHX^@<NL931)EBK,<;
M#7N#%Y8EK$N(H)MV9M\:K2X7QD.+K-_J];2T5_IV..1#F)O+]Z@'N'W:BM0U
M!DQZ=$^I^47'-:C3AKAA_I/-^@U?\(TDS7Q6+._,16P$(S*!W57#PJW9&893
MUXB>;6YNN7"7Q&&S<8"H_.TJ^3N77U1<(RX;_IF3;K5)&$D45A(UG/GA,&];
M=^BK46ER+)3KMMH;;/H@LNRROA:%KDJJ<#9<ET1MJVBM@)]584L[X_ <3(F9
MZMBP"7(BF _ 6[G.1A*!4LKNT+DU;TL;J<5$,J$Q7 ;.2V<FP]E:0N9BYKU-
MCJ0U5$G@' ##]&CQ>3H\YWSKBG6T;8#[]2#T!4&MFK'O9929J@?JX#Z2N''V
M3FCKEM"1>$<-)P,R$VA5IO,VA;R(1C3UDF<Z<1K 4*VY(M%()=T\T1;J+9-R
M/4HJ(ZU@:G[V6Y98 7C-J7Z>&0PLKJX3HYG*%>&<0A7)N6<S&G^*)\V6 LU4
M^?JBC#PD0^R<;RPANE865 #IJ#)Y[X[GHB;>UEM'HFJJ8KZ8EU7=;-C29 28
MHQ&10[P!(OMB+^8@%MELFR<?=)%Q,SJ5!JRAW/1)\B0IU[VZ\A[>B?)&\KX8
M)S-0H6G?\W^1V'C'2\? I'F;?#D@">/"M);Z\);D\BN\2,4RLLE^:%EFN=DU
MAP?MOCKR>QD_0<I.FKQ\))#RHQ35SQ\-S';!N6V4WT-F^!@L';747A!M(%NI
M>< -I'P\+R6)I^S;73=);GU;EZ[$67S]5HR*RZ?\ /<:)L6\>#1$>26_BG=Z
M 9+%%T?-;1,#>%XM.X^O3K*W0L&:*R)<,EN.BR#@C8SG)@1:)UL_'?L[I.I7
MO!OR=\H+G;L28V$ZF/7!!]5EC=5LK\HF>7NB1TWL%,V=5BP8# NS8?#-9O6W
MA:LXKZZ*49';P2D6'7B3'VAW21Z8T4+[U'HZY@UE5;<Q4LKCY8\R"]Z'YEQL
MN4>]$G78,/NJ@"1G^/,6--Z!1.16PW%^8XLGT[;@W%TO6'I4XF[EDI0WWN;C
M-"FND8W#PJ$UMS</\,BQY.06X]A0?5<!/-G7ED05%GS90;@9./KSF,XV*28M
M,M<Q?9[D^$V@;91J3'A$Q2 RR WR$MK"@J.M-ANL2N08_&ADJ?JAGE296\D0
M "'8P0 M5;ZN9P:VSP99AH)I\,_1_!99Y.<<.4>VY&[_#8ZA.<;@.3,N!Y?3
MEKB7SE#1M&8L?5 7\*BT;D2::)V:427_/21*R^TR7VN31FXC8-N#L<)[_9Z]
M>LUN$B\DHF[YZ-HXR: B%;1L:M-?+K.YR27$7G>K0<=)IOQ4\QELG%.*I5M-
M.7HW!BS[J>3.")=9+\A(BRU339,*,P>B$WJ-W3A4> _ZKIY461 XE<;MQA&S
M3%#"?%N_*K" DR3FVD D,]YZT]< SJ(ZC.1+@>8=C:3<9$<JI+)+8^[@1OKS
MYV-<HTL95['S!HNHEKI+/-I0$7C1B.-Z3(;H+U)-16F8SQR<V#!AF,V[[)TV
M-ZRIA\H)_'C^K%K _AAW$K)M0HFQ5<\JZWZ[E=%KP@7!*G$!&5^UPJ>ABK2Z
ML0J?J,]$P8W*". \O42<1ORA,R<#Y'P!VBC5_R:?!U4\!TEGZ'FTQ$31VH$W
M !MFBO-H8!;NPMTXB:<%$'$ SV!LT!/V-..VYA.+%:C5,[=J;)E5MDR;ROG,
MA:TXT)XF7_A^$<HN\6RU^R@OSF0.T9[PS1 >O'*[,><:]5V9EGF_<WA\B9,J
MRB"I=KZA\"G*L](JT+%I<N#5/U@A9E>C\P6FY=6/4NL_1*OW?XY:W\;D?6N2
M]<O\<(K.,]V[FX)SNZI[;DV;"6\&JO4[*G?B*0I@Y?2K=8P"+&DO*_Q58M'6
MZ?=<$Z#.-,',FI*L^RWX42?52Z<V*MYBBQ*K2?0VG-+Q#+ZJ9@!6!"R,.*$<
M!C*'4-@&28:(>B@G\IIQ*/5UJN),F5OJ:?F)EV C*>-Q(53JU'''+-"'[D@(
MHSRE:\490$[0&+C52UVC^A>N+*HGHI=?Z]S#K@H=;LZAO#!G$A2<HXL:B?NT
MF5,R:W%:![,A*9>C0/U\^SE:.]*7TEW44I&"=]Q]C69M"J0AIYA.2>'5.&25
M2H80$Z>+LPYVA\^V!MC)?M#3F[W?-KV$%/^2B36)I)S9_)6&HJ*-*KFTTVE!
M9-AS3+Q2;+NE+[RZ?\?D5I8X^R(LN#WS93',S!?A%(0<)C=ESI'/328X3])#
MVYX8#A#R1VW.J:4D<KLCU]=4QB_*UFTQ5CC;0M/N^HM&%HXB#VDK2=W/UD13
M?4TH[.6CB=7YYW=4BA(6?"BFCHPS)%>@I/W!=SD@*:R.I7&+"/=23Y_B.3\2
M4O!EGS'(;+ZIB<SZ]0ZF-+\13C77QBRXL\MO2+LF FX585(\SNO4A7/=*6+Z
ML&EN@!F/>#'"%@$Z0Q6KD3:WA-@"JX#Z\)A+%] E0"S0A6@Y=\6OX';%D=1+
MJF\'15M"1%H5I*+QHUJ?4_\YXODB![6]+N2Q>O@A4L>-Q!3*!G50ZC.<-047
M"4[*U81SIB?H#YDBL2)'&G*%-D$R58L@%E7>]$7MGF(,+)I2%2(L6[V/D4W;
M!].E.1AYA&X/-W!.)TR'Z*)1 ^K*Y-!GFA;I-,G85 MD%!3&A2,C#A,Y);6%
M!&,.*$;:4MT0C %)/1:I*=2(;P8,7,($.(C#)"XRK*R($MA5^SD3-:5Q9J[(
MUS4,=>3M=_\S(QHOABG>/Y0%E7]@7**2Y%NN QF;$/,4%L#]N,FAP3(!"4;\
M?%WX*%PE/BK%;*6C)[8(,T:BRAJ^/V7WE/W8*96*H%#/]ZWHRKGW]$@&F)LD
MR]1PEN_P7-FZIYXB1-U"T<>),*1<@Q&M#.9D=_<FPW\>1,]:0>:R#J.;$;@4
MPLV4?2>#%%20 ;<&=><5<#")"BKTO787X>X\24V3?2QQ0?R\L328'N4+I$FL
M ZI8*IN+6"&RX&*1.S/7[JHRU_X^@J?+<M+@[?=STOA2@64Y7[19)F.-80<O
M#<[5^7KP6$?_XA(1X>LQAYA_$B37,4P#U5F1:NH;2.JECWQ#BH-4EHM6H2KE
M6C#X92)UA)^"'HE=YW>'UO41LP5MDG%#S_5+D<.RH8IT6[RV/UUT9+#[R,(C
M*XQ9O)^G6H;4A1TD )A]9W'0K0=6>"%'N8%XB5E<6_EC4_;V&)>TO[<K/LLO
M,I7PUWQ-0+)+&>7B'79,/*:.?Y^NQ,N#P6ZS[NF1BV[/E'9M[B,)-J1Q=UB%
M>9>'\2-_*V .>!\1J$U4R*%"5Y%=KY:,DK)QFP$KS+")^Y&]+BXF-,$%@TQD
M<H)Y-'%,0<3,735 %QZ 'B=M;NP#3DSAKSMUCZ61//,2[&<3P"0!* F&#MK-
MU+N.U'B?[J\<%AE6NF9XEYA7D&_"$W,7-56Q,;;E0I.";%RP1BKC9M[ :%#@
MW\/Y0IMC3;S+P>[JA"D&MW2F=_<>< -PVQWT$04D5I<.5A*:KW@.&-"F[@QE
M_FJ]GLS64G-L%5M5SE+T2F);T5T'&UJN [GC;5#>35 LK6^Y=%I<M?E!.D;T
MRZS&0M$4SPVYBHEN:NN8TN(;M==$/JUFD.'^1SG4W#+6-7_Q$1R$H5RS8U-J
M2,28,0K4O#6T2<#\A;J[;2X$):T(QH&[/9K;)TNOQ;*YYWE1^VZG,?&KIG5W
ME9^X/8YY$3*,2D:;?:ZDR:OMGDUACNW46Z:A<,ZKREHS,AD8MV&XS*2<EIWS
M#3^FF$(*6IKNLL8^#&4J@I=74YN\7UCIN@^TU1<:X*/6H_H.&UA/-7$;"B?^
MZR\'+UZ7&XNC88]Q7#WR=68:3E"N%Z5'JI1 N]J!M]AK7LD*_;/;SAHM<?%3
M+?O6OD;3!9*<6\5+QNW!_L#<@(>:#:^)S!D,'HU-] ?605'KDG=RMO3RZ7:D
M#W5OGA:*;^4P.JWC(M]2D^+/E[;5_XF*,-2D^D[%@^] O> IY<Z2-[QI%&EN
MF83UMF #Q* KW=UTR0CK%:LH-SVK<Y())E"&MV85N6D1+U.=J:SUI@WLN\)W
M@L%SIKY7FW[\INJ.4A959N_<MF8(70061,#^X O]$SR4#"-8!I:W930TM4^Y
M'/N,[]K]V#ECOQAOIS'WOKP1CH=!'ZB4U=6AS6;87/#JHWBS+5US2]$1&QXX
MT:97I1EC7;A^[]%P_25%<KED?_EW'[F<Q,PIU;KA3N5BIF8TOH'C)X>ZB&L&
MKF3Z<V%WTE,^>Y@[E8D!O%>F?NN^LO]N$K*[7JW7K-21TG4<M>%X?IZL*GN;
MU2L_;:8M_C?!XA]-C[9-L@4)&5(MB<;8A"E/JTH7FS9-$R*10I8^W3_BSZ[2
M8R,U&$IKW,5Z.B0UN88%Y=*Z</ *W0!]"P>?QI@E49[/:JEN2WBIBM0-]59N
M=,8\+3-;/(HE58^WTW"<6_$J965@V@5WA<90Y3.EXH:R1,>@K;S4-/B9X,68
MU&14&1\K*Q =4)@7C93.[G^2<L*,A0'<3++F5*H%#YTO>^H_YMG)CRRV]KBD
MV0K=&7J+-'M/FC8PE1"4,8Y]2HG1&,'X+!&LY\^.V0A>A6Y/75D*IM&ELR#0
M+^?.JZUW0U=1&J]I(C7<\#;'#516_;1KZ7X%RZRAEY5PD0QQ8[$[MS2^4 =*
M:*Y ;7=D3)F)*7:W$]1>DD>CFU%E"ZF8J7D_<&-'9T@'W+[6+LJZ%1R](A -
M)2U91.928G.5-&*N1I#;PBQ;LE7V<(8QYI4^)1X>5Q;RFH/W#4>^<Y$^I5FF
M_B3;K;?$EBQ[>D^V?+NNR;S;5)KS:&Y>Z6?BI9M8,LC)E'@9N S&M\ZY[#%,
MVVA]0W/K!=6$DP^.AUC+ :/?&:'#_A(RXZ!=OW;'=67]!IVCYJ;U2:V+I;E"
ME[#<ZBN6?5170.*:HHH1]VLT7<^])M\5M]&O621G"7M3EZT\XB3&+ATLHD-E
M.GE7<J+Q'@CBJ*YVLEPM;[KK9N,$O$_D23.<C&RCW9ZTE97X*>8B9R7,,M(Q
M!6!L:[?,:V1RC=<I(7=5KFSMFHY?=7R%S7H+\%,OW, E3+Z-W]P:](:;O8/-
MGM[<]%FR"KJ5';/6A?M6J#?K+=QW#(IR*(,O2^:\\R1''>2\+E! P&VEI\/E
M""D!E*9?6R/CM]E&#-,L4+RWME/D/MH^*]I^X^YQE@6]NG)3.:INN@0LD$76
M++;"A.HD'2F=+QB&VT-NML',.#4S -7>PGO,,8EI A8.V \97JBJLW&S)9)I
M3![1$,;\P'BK61;6%.&FPM\/Y;:E^G2__O)J\/KB]/W1V?G)Z87X\+OX>/3'
MJ3@[OSH]OSK[<'[T[MT_Q+O3WZ_$;^^.SO\''M^_[TU\1]@3YQMO)(4_3WYX
MB5P_S _?&2;A'/X:YY/H[?\#4$L#!!0    ( 'U :5'F1&/ZTB<  $T2 0 :
M    97AH:6)I=#$P,RUD:6%Z<G-U86=R92YH=&WM/6ESVSB6W_=7<-([/7*5
M?!^)DYY4N6UWCW?23LIV-C6?MB 2DC"A2#5!6M'\^GT' (*7?'0GDA5WS22.
M18' P[O/G_YR]O[TYE\?SH-Q/HF##Q]_?G=Q&KS8W-[^M'^ZO7UV<Q;\X^:W
M=\'!ULYN<).)1*M<I8F(M[?/+U\$+\9Y/GV]O3V;S;9F^UMI-MJ^N=K&I0ZV
MXS35<BO*HQ=O?\+?P)]21&__ZZ>_;&X&9VE83&22!V$F12ZCH- J&06?(JD_
M!YN;YJG3=#K/U&B<!WL[>SO!IS3[K&X%?YZK/)9O[3H_;?._?]JFE_PT2*/Y
MVY\B=1NHZ.\OU-'+PU>1B/9D%+T\.#K:>S4XW-E[=7 <RN.=PVC_Y?_MPB:W
MX7'^CL[GL?S[BXE*-L<2W__ZY=XT?S-343Y^O;NS\]<7U>=$-H)'\W3Z>A>?
MFXHH@M-LQG*8O]X_@M_D\DN^*6(U2E[3>>#[PQ1.;Q8(TSC-7O^P0_^]P4\V
MAV*BXOGKO]VHB=3!I9P%5^E$)'_K:[B#32TS->0'M?J/Y-?2/V=FO[!.K!)I
M][^[>PB;/O\R5@.5![L[6_L_;>/S]M3-LS_D3"'<@,R6=*C?_G5U<7(6_'I^
M>7YS<7K=#RXN3[>JIVL_U\Y6\V0 F!4Y&V'9U?GUS=7%Z<WY67!]\_[TG\''
MRXN;X.33R=59</D>CGL>W.>D'3=H?T,HN3*72@?OX6J;/PLMHXW.$SY@_\ 1
MLK=W@6J0YGDZ>?T T.1B$$N[RB#-(IEM HAB,=7RM?WA3:3T-!;SURJA@]*7
MWMS*+%>AB,V2<$V&OQP?;[W:/T86D\.6\\@N;[C/%G&?[3QJ?G8('QX==7X,
M^-[YV:)E#XZV7NX?W&O9;=HR;QN.KZ<B^?N+_1>U"WN]-_T2[%9!BEC9 I-6
M1FON"5[<S9A4$L$EO=[<?37]^MSVH)4Q[3HN].W?7@7+,<+@4DQDD Z##P*!
MK.!J\A]_.'SUIB8(S!7_6;>W#,!_$$4<_,]6<*;$?RIT_XRB-4CMK1:*_@H*
M9AZ<@4*XIIAY4HP*#?K7?I\TVF?$[ +4_FHAYO]*G:-]<IT#\WQ&T&<$?7NP
M6@AZ64P&,D/Q?@6HFJD0;>KK/ T_!Q\3E>N@]^,/K_;V=MY<77_4]./NFXW@
M9"9 98W6%)?WCE_UCP\/FCB\31JX9P?<QT:X"Q7WMPZ7AHR'*X.,!PP%QR_#
ML8R*F+EE<#-6FG$NT&,1Q\$M/!8('0S!4DIG.IAFZ:T"A QZ\DLHI_19FH]E
M-E,:S"R9PY-9/@X&$A[?". 37YL-8'61!.>3:9S.)>FZ^,1I.H%/YT%*Y $/
MG R'*E; PX,TH2?$=!H#QJ(I=VLV'K6S> \?_-L_\.[^L9:FPZNO95;N;NT?
M'#W&K-Q[N75P_#BS<M%G>UM'.R__=&/U"#=[OV6_DCQ;#@MXSZ@\5!F25)(H
MV)X6V=Q205.#>3##WT$PO%@/V7"X\U<+&6)(WT+162IB:!FF2?2,&7=[;8ZV
MCHZ^,^3(QRI[QHUGW&B5*&F!*M<S<MP'.5[=A1P-T^,.\X(/]6^PR=5POJ2#
M7:;Y3.5CG8L$MVBP(I.C%/[5KB0_V* Z/&@]\8J8^[R-"$1H)C#\_;J '67X
MU(NW/;&Q.L;72PO%]KW>R&RB$OIU,)A7K".\X;3(@U-1@*D%MI+YW+>OX-*#
M7],T"JZDT&FRO&._>+M,@W<!@(-@F4"Y8(XM;S&Q(A^+/.BIAI6,SI_=EV]T
M(,E.IB0,,)QS@QI@?-<P@PQP7"XA!" $Z0=G2HL!F-$Y&=:1%/FXCS_U5/.5
MY>(Z0!> ]^8:2O4#70S^+4/X2@HB)PI4$H@0(!V)))2$I+0XZK*4B*(]KX#"
MXZ.'891)2:OC"M>P&CUXT LW8'>P/?SU06^X87GU>;D?]]V^6:ONK8!]$8R_
MY/BX-OZ-"']/GP-E(?%(9)#T)'H2@GR6!KV]C6 N16;='9:5^D1I/,O';TI7
M"-TC@FE:9--4DULCD@Q1N\04SH]?I_.X7=,W9\KNG-"4/S<P"0Z!>?4#*4*2
M[X6(G?]#)<#NXYA@4D)8#-);Z>#L5C'P&<!A$7@E,.#)"6#M.)[["^H 5LEH
MXRF@,,(DF +& Q9,,QE*)V0\OTP)Z-I&";P]M26W^H$B]P[@BXPETR8"31>$
M@FGSZ$$:AD66R:CO UC7(:P+@$^G&#,4>/@*?4!O8 '"R]>9C&$'M[(S:<CZ
MN<NOB(%.XR)O?F61-.W\S/]SG)5"=R0W!YD4GS?%$([X6L0S,=<O'I3W=,<[
M'RCCEZ35^&C2)W2K^P3:J?N!7I9%M)'/9 STU-L%SM!*)U5&T5R<]]UBE71O
M_2%^@#]Q[P^ 6)_XLTX#O!?\L<'AI,_@<$.Z2>=A3(H,L;^!K*]!)&VWW<+S
MM&&>:1%'^/6OP>>#6&I]Q^'& JXJ!G*->)NP ?^D&-A!/J7]C=3? QR>Y&8"
M$C6*3/HFRI=-0'[A3H\<4/A;$0P@Y*HD\> F+.3,,2NL>PB@PWT 8DA&-8,T
M=3 CH#0+.;S=[]IV&*R0[;"S]RV-A^ 71QPB. 7E<D2:S2EL.DOCI9H60=!4
MI%OVR-J#9AZ%$$!=U5(#D3*HDD%OW_!'C&XI@$&>]H-BBKP-_S&#-\S)QP($
M=> >'2X"#FALBG3R9^W>U^[E']/NAT5LF)3C30]E/RV\YOM@8^$*L;''NT"$
M!FJ[DKJ(<XL[;915I8TSI(V58U=_E"L0*+('@L*PB:])X]%&[X\:\,RELS0@
M[4=,T@*^-<!$<ZLBERS< Y>OV$Q26 <MU22OVJ&6P[?K>U:7K7_0_P/&?HLJ
MW&KGAQML*W2;^?KQ5KQGIY-&B&JBS&Y5*/\<U;,!R8?IFMW%((_+X5@9$_;&
M73_<]0AS9_G6Z@*Z:ARUD_+Y%QD6Z+!H)::2;BV'B(AMU-(%@QX^8C+-VM:Q
MF6>L-.$ZH9@J0"DX=61,F23-X3J'<-HH -U$(L%FTOU*)9TD?\=%MUW9$[II
MQYL-&_%O6(2?DW0&]BDHBLB8U#1WSL#6A$"#-P!KH%*^#(2BQ1"^"<-A.A8H
M>72>"[2/Z;90O;4[]%9QG%CHAC^QAQE-R*EN93PW;-O@4 -QUOF**X)O(N;(
MBB61I4%[L+J!4T[0T ]1;,EL"CA@+!"0X)$:#N$*D.(1-U ?IQM!P:8E_ YY
M9_6;Y/N%&YJ-%?Q0EP "G1QJ!+P7C(X!&'CXL7LZ3T>2K ?^&DAT@%]>4%Y=
M*>TTEIV@W,BH4!/4E5^0W<,7G+\57B,1 ;(T46&@X2Y$7F2>^RDW1:)"^UOZ
M=KCP5;[V#1S'+3O\1E5]#1S?PSWM/67W]=[+1>[K!QAZ>[M;+P]7Q!5.U_+C
M#[M'.V]6_\]O8V8U"E()1O>K,KX[4O-\M^U__CSG'/%E!= !6(O<!MV;/P#M
MF?X,KK>"=VF!F>H?Q@)EH8R#CO^>D>-!?_J@:X'R,S0?#<V?4U3*3\="9<_,
M[$^'\-/E97X)=85S/59F/V/.@VFS4L;^#,;'@O%1 >;OT#C;?V+&6;64;G>O
M:E$MJWO- XR%Y2% ^ZX[F@W]>G5^_MOYY4VP><^JQI6Z"H#\^ZL/[Z].\%@W
MYU>_70<GEV?!Z?O+LXN;B_>7UX\\5%MTUE1O+H-XRUN:B$A2W>RP3$N"GRD\
M4 ^U=?IVR57+W3@NV44\8,>SC;G\-L^4@$=D(N%C#1B>A%L5][]Q5WL>_^ ,
MN.=,D/<RFZ8V]0Z7K:@;_BJU4,5B%_"3NK%/_SB_.C^Y[E>C*E*K#-Z1I^;"
M6J(Y6,$?D" JHST>L"F:$Z:3"3I]\4K[P7_O8/>^J<B"6Q$7%.!$WRI<1*^\
M+'R>4,"[,7*W JB*T#JE@9"5B!<%DHC8.;8(3WD15%CM YQ-13:N>SI6<N@%
MGMX/AX!I6:UNNQ_(X9"C _5P4[\KN%P)7[3'H0Z/NTN[GQ0>7;[_U ]N$)E^
M>7]U3B!!3SR V:1 &S!,LW2BV-O.COE)D6,H.$QO92(PG@M?RT4E[ 9/8FR6
M<X1&F,B#OT(DHF!OY3V,R#;X1"F<!5ZHDDDX+X,&B'6X//*3,F@5\;=K80O[
M'$6FRC8!B^OR*Z[6E_>XN\TE7M[26H2AB=CAW6XW&L\P_,H)&\O;LE?W\_6"
M-ZM"V!\32A#V^E],9:B&"A-5LJ!(7/HPTBULV7LRD[\7*$?ZIE;/I2$C7R2^
M7F@;2O>CCOU@+&YE[4L3*3#WY ZRNS\<'](@H]FXLH.BEW)'B^CE),*4'5"N
M1)YFRZ08NC]&%';V 2L^ ^0(85^ "P:/%.:::] _8CDBQ6*:SB2E,HF0DMTQ
MU7P@QR(>>CK'1.6YE"1SF+N'0DLG@8,*#+Q]N&\^2)5[FFA@>\VL  H(7^_F
M"VL6/MF4L8.]@U(1B_".<0$0T*A'P7=T,0#9K[Q*#J>O181=^! 0/_V\_O?<
M)*T5N/!VFJ_=U_K?#>6T+_4ZD+62RLVB-!B!,9,@'^5J&N25CTIK6YL;6I'Z
MC^?;NM=M@3Q8$>Z&WBIR75'UR06Z'C##^ I3X0N67(A5N\>OCMB= 3<4@;7Y
MP.V?H-/C#VYZF1!321@75%:-3B9 XQ!T/A3B +<"$] S.2IBU@O0<A\5BCTJ
M.5OBWP-.&Y5T11 [M/NQTKI%C@-',HF8[9]W*_3K?Y\6"BMPG4AR$VG;L[;?
MU?=P(;94:*E7 DQO-9,R"#ZQC)ZRYK/4)AFK%DX_: #CR8735Y;1+%6=6D3%
MMO?PBH@=>?]6R#VG(_9=.7^L0 =Q4=IRM=DX)7=0K%,N]$/%DDLS; @O,UZ@
MM![.:WGWPR*Z*XN4"_'B2\@F[DF8KP!NX'U<R[#(%(7;_-VQN;1_X)M+ZW\_
MR^]J]^QZN,\]8>[#"M!/QXP%6X+;R)L0E$_#A=F70D?B]^"=X@KEJR*6P>'1
M/I9H]PZ^ U;H\9V59(8E#]S_OGC@=0&2_'8E3&:NZ \E=65H2S)"IT8<9'*:
M20T$1D8$9;90]CK6EX*F,969YC9=_),FQ46$%!NG=[R?VCX@U">L;%P4BYEI
M ZA#FZX48213#0K\RIKDH#V=]!/.180;J?157@;,MH+ K\8W.4K$^G5;NAYV
MI"3VCY%6_# I1_5@)M_C4S+]/$GZV&5(!L$YUG7#^B6-</PW0:&#& W_QX&Y
M))Z:'5[P()3*=<O%W)PM2/&9,E&P;QNF<+H=THC7U84SP,I6,$!?1%G.IO"/
MS@EG:T)52QNJ]V"JLLT75X.NUN/VE]</O'G]>]@-"R6[(\-.<EW0A*GO]1FR
M*JYA>]4Q3H]G9=0H2OO\@KH#<V^ZMNVZIB*E\_%]PMTL*AV9'KVE?H,ENFX4
MAG5&/I,D^ZSD[,0O=9UA!IB6=RMB629VF_Y336&03LGE:5:N=9GRNT75M^DZ
M\+7T^LL:XZ^:J]\Q>HLY-8J8ZX([AK0=E&%%T4/R72+8, %YFL>8Y!YC%U@<
M\V4;A,'#U+U,VT:*.)$DGP>]_9T-V-9<;]3/TB)IJ^U6.X9Z=?<DJV+3FC"C
MI348;6-&.WL(B/.%^'4/,O5X1IU1J:8F0U8$:69(NI8RAL9&R+@9:9-0J-[%
M]X]ZRE:S8[N9I^CZOXD_DPLE7CE/LW<<TDZ1F.; S$2(^-1D(B/<>DR-A.#U
M0ZF:)2,M8+34:[L#FL(?W$*2!D,<!P,4#0N&U.N5RS/61'=;VMS9!^MN'[)T
MK 96'";!#:"-'LJ,6R:"D%FZD>1Z?O6J^2=>*T!3RT0R-&KK&EQK1$D%36")
MH_Q+(MTWO]# ZK$A(=,TJPT:#(U8 #4B7 0GM0JN)#(2PE# WU#L.O>/C7UX
M7=0J92X;ACJP2QUUIF*HDYQIV7_)XJC%+G;L?;BWH<]]=_TV?B+XO0 "HFJ
M*)T@LPFY*(SQ 4=&!I3_P5WS'(.+B&9O4($)+JHE4A+Y4JXR9@(720CK6L_8
MG/UB;,%F12PU2W="2-L:&'L#X]8,FV3,,KD/AD>2FECZLG6]K=_U^:ES\F!Q
M809(<D'-PTP/4'K!E1QQ6KDBC0-X%&WY.?Q<4N#ATP\_KXC/],5;ZE8.Z'J]
M^:I?H\+<<=VR'>(4%?22YJI5$#U3!D</ 7*7W*1(6!D!5D(2&SG16,;11EE>
M084Y/E7Y-72Z;..H6_HX5M7;4@ESUH2AP&DF;U5:(%,$]$VL)=2AZ+-:I;0N
M:J,)6E4*]V@_B(K,\N%6!Z\: BN:2/0QQ:W:?B_-^G;/W/D8]L9^81 W8BI"
MTY98(2.;2CP+=I?LKEP=%2"L%#48K+F6-ZKRK"(!A,:&A7BD*9<RXM?'\RER
M_E"8UHW4)%_,\?:Y92+@1CKU*C1!! 2VTA+%!?<XKKS(,XZY*R3'Y:GYYL16
M91BA!Y>**9ZP[1,4N#DPR"GI?@9=^V;;K#7SQOO>KA7[S5F2XIQAP_]JS3QM
M+!_T:"0777$/<+@+78X95HD8P!.ZZ8H-;TM.]OM6P,3R=FY77GA ZJ0?-!H]
M#]#+"G]3M6JJ'A:\65WE=&DSYQ^LG)Y$"#IJ$[UD-?3CU#BIS:PG-/@-9AGE
MIW0;L NBX?EQ#,(@.?D+@#M,/5>5J&*?H/-S*)@])NP&L<QV31!RY7R="^.;
M)+#.K.W =A+][IK,AR4CZL70S?-8Z%1C2< F$'%@D&X#HT*32C*B9KF4@Z4G
M\ WXL>F8S*RKQ+H!C-, I7-@_MVV![+'JE:8K0X%J\F-"*V%B<S@$,_P*_>1
MR!FGB]G>Q>5'QI KC;.65#)Z)$F3S5#H,4HUB9$N[!=N#2@9-2A6=[LN?6>W
M[91PIU_7>#3)""S-(H\=H+8WS8PW!A22C$/;-#3!_@,?X1;X])AID5Y^TS"5
M6J]^:O="CN@AME#FHS$C Z2Z3(-AQL9O"?2:+N8/#'A<*M$*,ZC!QEV-Z58K
M">/45.A*]N?PU2V9-5U4J4Y99RKZ1=)8\20 (C%TP'!Z1<0.5"9/"IC,>?+&
M1&8CU#_++RLS"TF+F$4S^T:PP!C82:X$SN4QC<?;>MT8FO<&&8F*TP<V"R]%
MPC-9CL1B<],7":V#LBBZ)\KV12T74;;&L1.8Q$:+C6>TV($M\XC\TEO*RV6
MP,Z+B;6"T@$0D/"B6]4< ^-H8=J=B,\5IE)JU2[+@$/]1:4%#',U#-LA;+%5
M.P5_$TKNA6O+V8LEM-)NG:JUA\[H6I".%S7P,&_VNL],Q9Q6;5.:?(G1P5FY
MFTUB+ 1O"D7+[1#65(1%M=K-82?I>G0%+)L&&UTE5!,Q)R,3Y1L(%&#5C*Y&
MC^,(G.]I=Q$ A$(QF53@W[IK7^ XSEP.HUH;73'HA4^,%U])-YS$6<17,LU&
M(C&_6;;*6/-^H*>\N>6LLN6&#N6SS7:R\MTZ9D[$0I5LZ!B_SUI1)S,*Q^-X
MP0,C\FQPY=R3ZBZ@6&X'Y!MB&RH5F6G"\WY- \SD-!8FK=</&Q!<>%XH]= 9
M8)<\%]E0PXK.B6,]Z0'K.+-<@QZZ>[]=C>>_-0YVT7,O>F*D?@87@7Y] ^UW
MZO?"J"8U!%\5;T94W7#<N6&?P%N$:455ZM^'5,#0D.1&(<>F:Q>#0A0>/G"3
MQBBT1X&N>B"9XDIW^.>>>_2VHL#1.D9U5D5#.7PR[E6O7.&=F!&IQPISF98>
M\Z\):.Y8%[()UQ6JHOFZJ*F+F*7^7?XO\GETM/XTK>_,A,)A2W4'^]I\%AFE
MDL?.D>1&8\AU',W\2+-VD694&53LO=9[!1[-5=117PFM';^M:3W=L;32BU1-
M56IJ0<1C;3"*/%!I&98DDX@XK?-W=UE:_-X[QP=6PGJF>YS\@O$E,EV'63JI
M0@VV@$E4R<B.IO0R\SP-BI(@4$D4MT+%^"F."N-D(QQYUL?TB"EF1/JK]Q>M
MAC/4,I-IQ5YZ.ZRT->&= (7GPP >[+.J?)8Y+%$A%X41A<D9JQFLW&RK6CQ0
MB>\9!P#?@;&GV1_;P!0N:9FHW*"\<YUT.VZM!HHK$L609*<OLM9ZJ]*89?2\
M&Z9]ROW@[]J.,6MBGWXL&VJFZ(KF;*7(N:4\TJD0:F%5,FI>&Q88G;PM\^KK
MQGUI'#@F$\\-2E-.K/7&UME6M5&TXX7\>))Z_B/<7P?B8+-?XYRK9/X:.L;S
M%F!+Q;7 F)=X7>Y_6,2 Z,#/%S<&?5)(T!.=ADM#MM$-P,WZ?;I=#T23F(TI
M#"31/&#W._.V2^]4X^)0"'BL*9VQ]"LP?#^D) =<G</Y>(O(4XR"?ZL -CB6
M,V590@C=- 7ZUJYP:6>>!\U:KEZK3SMMNL,D'\#>7 I,/>COXU8L1QA$ZM$,
M8/,/E=3<OS;L#_N?;-2'5<(WTDS[I!A*V!'J'3EZ1S!*%5JH&A)NS5@QE+I&
M^&P3ELN#N\06FZ $2.6#JZ3O7'R620VY;$AL3K+5)J:D<51)7G'JAXL#V&),
M7XP*DW<B71/:WNZ&[U@77=K7HG!>B15.A^OBJ&UEOA6'<)79$F2<1P?3A*8J
M,62"E CJ ]!6KO10H/.8,EY4;M7;4D=J49%,N!"/@?M2VJ1]6TV(:;JWM\'1
MQ88H"9T!8(@>-3Y/AN><A%[1CK9,,&,]$'U!H*^F['M)=J84A!K;#P4"SLY:
MMV8)78EWU7 SP#,!5T4V;Q/(BW!$48M]QA,G 0S6FFF_ABNIYHVV8&^9J>QA
M4AE]!E7SD]_'Q3+ $6?5>FHPD+@<I48RE2?"/44R%G-/9S3V%&^:-07:J?3E
M11F-20<X4,!H0C3M&T0 R:@RG_&>]R(G'NBM(5%553&'SDLU;W:Q:1("[-&P
MR $.QM"?[;P2(I&-MGWR11>:>_3)+&0)Y;9/G"?-N!C8U3PQ)%S@"/C,.)V!
M",WZGOV+R,80+PT#D_MN<@@!)8P)TUK_Q"#)Q1=XD4Q$;!,@4;/4N8&:<]GM
M')_X+9[71(\_>C)>G"M.)Z.4&M+RQB!(Y5+[+[3Y<$K&!E8&I<!Y64"\95^L
MWZ:Y-9U<AA GSO5;72!<LN3'E-<P#^7EDT'*&_$E>*<6.$IX7-/<-@Z Y^6R
M4^?J*'NGIU%Q;8O+'\OQ$.37(=VLZ6&KHNUS1,+#['6,2"P)EM7,^C^AZJ)B
ME)&9YLRCSAQG0'-,X&$&T*5$UE3&"O%YM*:&39<O:FFM+FS0APPAPC>;E?S6
MR\8IDE77&EE+G"W3X2;S,P1<O@XF)Q&<6JG>O*&LT#>Z5<DV^"-M8PZ1N1=;
MN%.O*AXTM-6J'Y6+-1@$C7<@<W*GX00%8T*DT[:P[WW'93TI,;IR^>9(LUE:
MC% \1(5S,MW=",)#QY*26W1Z@_5=S0S(++ H*K$DU"["K=W1#8&9B9-BTB++
M'='G:8[?!-Q&:<F(1U@,+(.L-R\W,2HXCF\3^ZI(CC&;1L*Q'Z'*I)DQAWX;
M\I88_U"5KNM)GNV[09*A&"#\.I[?P8O\9"EG?Y?4[;_!$32'1CP;S*53<[X5
M]T4:2-K6C+D/ZAB\*IT;'61T3L7.,/\]Q$I+<)FOM7$C!P@ >SB6.*7Q\/@-
M6W=\D)AF'Z":X3B#C&78 M2FF5\FYI,EBWT+5P./4RW]JH$9 ,X)Q=(;0.F6
MM\;']TW1G1USYKS (ZU+G,K39*2=[Y^<[MA9148/P._J396EG5-AO 6XHM8!
MU3ZT]1X#RRI-$R[S1#1CT)L>%7 7U64$CWB:=S0%<YL=RH@*LXT:C8#T]\_7
MN$8C-E>QBPJSJ)826KS:2)(AT0@_>T2&3FO$FHK0,)\Y+VA#A6$R[])WVLS[
MIAPJ-_#UZ;.J ?MKW(O)MC$E=@E[6EGWVRV/7A,J"%>)"DCYJM6P#62LY*T5
M^(1])GAO1$8(]^GE#S7")IVI),#G"Y!&F?H/V3PHXCFV.T/+HR64B]H.O '(
M4$M._X%=N/')29I,"T#B$)[!D*;'[&G';8U$%@M0*V?NE-A"5T"F3&\-[:)M
MG!^0I9]Y6@PEQ7BZVD.$%Z=@1ZA/^&H(+UZ95<TI4GU7<6?>[PP>G^-DDA)?
MJEV,*.J+_*S4"E1BVJ!XI2R6B=G3J'R!:GGSM<3Z5Y'J_6\CUK>PZL"J9/TR
ML9V2"ACOW=SGW)[J@:!I4^'-0K7>51V0*+W1UCSSE$A8)TLQ=:/<0+_%TN_<
MGW $7M'K6]A-C?;:/)7N=/BJFJBND *L.*$@.0DN)(LPU>A3C\1$C-AC(+],
M9:*EF0Y/QT^]# Y!*74+G:6.<7;L JV=CHPC2H0924XQ<2AA'*Y>;A256'#Q
M2CT9O?Q:)PR[BD"X(X;TXFAI6' 2*/(.[HYF;LF<!?C#LR.W%.^OGAVY?U[#
M()([F,9)22@%2NB[^8/5)'T^W<6%*GSPGE2M4+'-@.6(*>:!4EPXB5BHDBK$
M3,\%B'=W!H>;NSB78+>G-GH_;WB9-/[(D#6)T5W8Q)N&J") E=R_TVQ!W[!G
MFGAU]1:D+[TF#DYX6!GE-(RHX&;;U\5 FR_"+01BD-Z6R5(^ES99!225E&UP
MXEQ"_JK-/;74MVYU)"F;-@>+THQ;U!5.$U$$7?_0*!KBV/.UE:CNIYFBLKXF
M&/;JR42!_?L[*5D)"U1D4R?&'!(KT)_@T9,Y$!561VC<P<*]G-GGB,[7="KX
MO,\H^C91UL1F_4(-TV>A$5 U0X 63&#SVPNO"8-;14<I7N<H<P%==XN8]VPZ
M56"J)HZYV"27SD F<JA,%U9;&1924R4S0@--3?0&NB M9T7YQ>>N\)8:@_7M
MHJA+!+&2!8EH_*C6M=9_CFB^R$%LKPMZK)X'$;'C5F#N9P,[*&<;[IK"B^10
MRN6$D[TG:&>;ZK8B1QQR%4)A.I6+G"RRG-M&O;L2#"V:&AM"+-MX &.;ME>N
M2W0P_ C-:6['G4T8#]'TIW;BE<VA+3XM,C!&654+11P6QC5 2AQFH KJ\0G*
M'&",L&7@$2@#@AIF4H>O(<]Y#%W*A :43I-"8TE(G )4[>>,U)1_JET!N6LJ
M[-#;;^5H5C16#&.\?RD+2A9!N40AR5/+0Y&8(/,4#L#=U<F@P?H& 4K\?%WH
M*%HE.BK9;*4]*_9[,TJBU V?$N7WE-WU*4F/G*&>[5N1E7/OZ:$(,3M)E#GM
MS-_AN;(/4SU)B%J_HHT38U"YYDBT/)BS]-V;#/UY3GJ6"B(7=4>Z68%K.-Q.
MV78R'JC2(PUO=V>0]SX!AY.H$D0]"+KH\,[3S(Q,P-H<]* WC@;;HXR!+$U4
M2*5695\4RT06C(FY-W'MK"IQ[>\#<1TORTB#MS_,2.,1$<LRO@A8)F>-W0Y>
M(IPK4/;<KAV]J$N/" \['6 &2IB.$M@&BK,B4]0$DL1+'^F&! >)+!>O0E'*
M16SPCXE0,7X*<B1Q??R=%[B/L0"0)IJ[LZY?DAS6.U6XV^*SK;!%_-L\4R*B
M.0" 7Z!47"1A-Y=9X8.<Y,:!2%?A!AN<FFJPIWBD_;V=X)/X+#(!?\W7Q 5S
M+>(\>(?-%4^I.>#'F^#5P>Y.,S3R'<>)CM<Q3K1ZO-O3I=W0@EB $FGL'99A
MWBPX?N0?!>P!QTN!W$2)'$FT%=GV:DDJ*9O.&6^%639U/[+9Q660)KI@7!-:
M3#"5)DDH.JW=X B:7@&"G,2Y41 X-X6_[N0]%G7RSDMO/^L )@] "M!T4'&F
MOGLDQ_LTCG10:*S1U3@:SFLE8.(3<Q>.EXG1ML5"G8*47%!'*NMJ;V'4*/#O
MP7RATK$FYN7NSNK$*7;OF#/@IEAP.W?;Z_4)1216%P]6TC=?,1TPHDU])<H4
MUGJIHJT"Y^ JMMF<96B6)+86O>YM:!GN<L_A7MY@+^;6=\P0#V[:#"&5H/O+
MG,;ZHBF@&W$A$PW>Z]C2X@'I:\*?5C/*\/"K'"AN=^O:UO@N'/1#N=;5IHJ5
MD%&S&Z@Y!+:)P/R%NKUMYKN25 3EP T#YV;8PFN8;<9V+VK&[B0F?M4T8J_2
M$S?V,2]"@I'I<*//Q31YM7FWJ<VQ78;+/!1.>Y6Z-2F3/>,V#J=-UFDY!\'0
M8X99I""E:30Y=I H<Q&\Q)K:YOW:2M<WH:W$T'@^:AW'[P' >JZ) RC<^(\_
M'+Q\4P(65\..\7AZI&MM6F50$B%E2,J,O':U"V_1U[RJ%?JU V<-E[C^J9:
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M$/MTXK6ZQ@"1X7O  Z'E07XQ(C>"I^ P)37'IO$E6(6Q0*A2BO$H=(HQ$%6
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MQE[!:+YY)MV3RZZ]?A+9M84L]149YN]1B96@<G*I80^L]XQ*T K.6)KDUU3
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M M!N@1D9L^_A9:)X[16367#A+#P^3"=MQ%0VQR!=FV*"*"0&[VH$QF3</&2
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M[':?@;@/B3Q<H4Q4MM7!P>X;G(?::8]=&@B"Y?@8ZUV$S;G-$6XL/#<$G>;
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M_L4O\Z6KJ6B85T 1NG8\K7?E-7P%FIC,M/ERH%ILCD*]?:B4QW:M$P,#CK
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MUIK2_]"%IN@F8!5<VZLAR\=I#,29>YR.2R)MO3_R(/BR F1LUNPSKIDM,4<
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M-6J$0R9*C6^X;D@500P)&1$>V0O^O+6YM8TA$0:JZN%5[9QED35U#_3RC@H
M;TF]]&E<4PLW;3>+^W##(O[9[LQ49KP[U?:O?.XM?ED-*02>6]GT#^07TEPQ
M(FBZP_(22#?8WNT%.UL[6T\HJ#CP$H5HX1+!5B13N(>$/ B$;5!K+AZI!%BW
MPCH7E7_U2VWI:BK<Y1U0E. ZF=6;RQK,  VM9AI0N;Q6[,]"W86HG,;V4Q-#
MDZ!@<[@8"JVM)Y'7ZH5(I0H,K),7C.>S __?3-GR"TUTW..W:&DU\-B"(+2E
M4S$S"Z5Q_FKGU7@WM1C_X_ X\Y>KVO+\M0=/;HL38+D*#0NMK6UT&&_ LL5B
MFLNWYI=W6/P=B]E;E=#DZ:9W5P@3 42D]Z1(I]HDW-_:W'VU@U9A >,K(O-X
M;3!NDL'XLHB:W[TYV'RSU?WUUN:V_>XE/=M:L&8_&$FZP)KZ. <N^M<7NR]J
MTS--X*<%@BRJ*# $HM?G[5:P34]Q[WE),[[C!K0M]R*H\W,L12Z;G3/6PK$$
MWI\FV-]YGOK3-9'5F#Y(U3?[>WOO*%M?(Z3"2;S7F:K,Z=5>O>/M]L&2S))8
M\#_G_$= ]_]*%8H1F1!H*R>'X",Y.T6W01ZK:>_^['KQO%GK3@[V1H/^W)WI
MWI*Q6CC['\%:7^UM'FSM+Q]K[6:=]V+1,.$[\>?O*P?N.8B&D'B*KF\Z<]9]
MNM'T@2]G@M-JZY^?9A;,RZ";41\@M.VP.R-V<@:#O$Q,/U_"9HX4-@2CU$<3
MD3-WQ^@WBM"4N *#4CTSRV=F^:.9Y1\U=ZH@!MN+.XR_$3A?5L:S8):667XW
M[6F%ICHO5G13>LJRSJE[Y'YBPAK#RY>97'_>W$>QN1E:0B=B(I_W\S'LY[$H
MFCOY%-7QK:HZOO.0*2DOL2(8_AD7D_CG_P]02P,$%     @ ?4!I43;**0&*
M'@  '<,  !H   !E>&AI8FET,3 V+61I87IF;W)M;V9S+FAT;>U=6W/;MK9^
M/[\".YVSMSTCRY8=QXF=G1G7<5K/-''&=IMSGLY )"2AH0B5(.UH__JS+@ (
M4I(O21K3<?J0RA()@L"ZKV\MO/S'Z].CB_]]?RPFY303[W__^;>3(_%D8W/S
MP\[1YN;KB]?BUXNWOXFG_:V!N"AD;G6I32ZSS<WC=T_$DTE9SO8W-Z^NKOI7
M.WU3C#<OSC9QJ*>;F3%6]=,R??+J)7X#_RJ9OOJOE__8V!"O35)-55Z*I%"R
M5*FHK,['XD.J[$>QL>&N.C*S>:''DU)L;VUOB0^F^*@O)?]>ZC)3K_PX+S?Y
M[Y>;])"70Y/.7[U,]:70Z;^?Z!>CK;VM9'OWQ=-TZ^GVKI0OAL/=@1QMJS0=
M/AON_=\ )KD)E_,]MIQGZM]/ICK?F"A\_O[>]JP\N-)I.=D?;&W]]Y/F=;(8
MPZ6EF>T/\+J93%-XFXU,C<K]G6?P3:D^E1LRT^-\G]X'[A\9>'LW0&(R4^S_
MM$7_'> O&R,YU=E\_U\7>JJL>*>NQ)F9ROQ?/0M[L&%5H4=\H=7_4?Q8^O/*
MS1?&R72N_/P'@UV8]/&GB1[J4@RV^L]>;N+UT5OSE&#IBE?-WQ;7A=]W:,K2
M3/G9=UJ"!#9,%5]]#0:W6H,WIV=OQ>D;<7[\_O#L\.+D])TX?/=:G!W_=GQX
M?BP.?SD[/GY[_.YB87WN\/;1N_Y9V5*/YOR5SE-X=5J/O_WMG[;??AO)]F*B
MK3A7,UE(Y&,A\U2<J4Q)J\3AN%"*F'*MG"CQSY^>;V]O'?AU^,9[1;,-,_HV
MDUB^9+0.@X/UGDA)4DDKS A6Y\7@ /YYMO<"_[=ST!.PLD38<(W.2R.&JKQ2
M*A=O08;)5/RB<E7JQ/;$29[T88W-6,$Z%^)*EQ.A2RML-;0ZU;+0"JZ2HY'.
M-#P2/MLJ292UIK"T8]):H"WXOB/[=&2F,YG/N[%+N$ +NR/6.K!,QY]44I7Z
M4G5AH<1:F [048,6D:K<EG:&Q-[+H@2VZ,#*$8$IF4R$[,K"=(+S^M^GQOSP
MZ_$96 8]$=A%P$B7K B8.=JR!M1#Q$).8@.U3-5T"#SF?O[9R"+%/U[K0B4E
MRO;6C5U1PS33+I"8F%6%K21, -1K.9'@/JBBE#J/-N=X.LO,G,R8VJ!AS;U$
M*W1DA9=-N@L+_L^?=E\</!:^QI<>[!V %5?O1EL?LO#/QW+,A+62KXGIX?K$
M3*>Z+)4B85$HN$C!N\,@HQ%P/5+L"H.2UA['^3[7_]WIAYZXP$T C^P8K.<<
MUBH'^U<YU\0MY\@4:FPP.(!+BM],J[*2&5Q]J7*0!6P25_!"( H^PH5@2*M2
MF*H$"SPS5VS"./M!P!X,81>1R7#A1R:#2RRL]?,OHO-K_=UE*[]QCTL_Z-^?
M;&FNU/9>?V_7+U:J$L-[OT^[B;<V1&/DM[X&@7Z_ O)K$LS>+5CU/@E&=H=@
MGO=W]G =CF\2GYW1[9VB6N\D?Y'2TSFIML)D*K+(4+N5!@5YDE6X8V(((C@W
MI<@TJ$!0>6"TH>F,/\%BW$97]H2=R"Q#E>EO:2UG7X@WA9GR&*,2U/"2BQK&
M.PTXD? Q-T)6Y<04NN1WY-]PRH6:%<KBRT[TU*IL1)H^=ZL$NL,4H$3P]Z;-
M#M.A$%MM>J)2*W59E<K&OG0TPW"M=S#AEA(?1$8K:*MSI'2X\.G::-T_;YG%
M^$4>V(/28-O=$4@W:[#WDO:)[92?5:Y&NKS70,;7HY,?BNO.BNLBDJLL;V:%
MN02S-Y)100 ?)DE1@1 X'<+R$F%9L28Q4IS !:J88M Y!8+**>B\4C*L@UQZ
M-)L^[,ZFLW  $<!;G'+0HFQJ"/@#P_DLZVLB<-LY@VD8BA.5,$UR;< EPHQ!
M?FO%0)*'U=JE^=AZ4*^AZF\DR7-U"1Y:GJ@@RCZ/(I>_R7T::F1"/EU+UD%'
M/]T[@%5-ZX]JG:S*^Q3;UZK^Q\/>27?8.Y;I,Z_E"S4"VQ48)(T(VXKM-;E.
M?+B]-EQW;#948BJ!S4@FP/]FLTPG<@AF-?+ZFEWWC)@BIUS'3H]'I:?=V7XO
MW6LI27$EEZ--/N;F*E/IF Q_M\6SV!8<>@%*)%.PAT2;3$EZEHC;0A:D##*M
M*A0!>"?\.:J @"S8!'8D$Q\P(V=M:BI\ CUS2N@9@^[4E;8**0ZF0"1&%JKS
MN_*R@$%Z GR.'/XU0(9S='%F^+5.0$?,I"WY&W*+>HM^3[0*[5?O\0SP,[N.
M;AE 4=BDT$.O*AJO#0^KY^U_#@3?$\A IBIM"0N"+F586K@QK"RR3?O"R--E
MY6IK=H3K1XJ<571R$S#G4])U7OWI@I2<A?<]; _[5T5^Y!6XM!AGS%KZ/#RC
M=)"GZY\0PITD BS)$%CS'XKRRQ1E')^@)0=ZGL&:(NL191I;;N &Z)R]<_5)
M%0F2H*<5)*E+97$';6F2C\+,2,)?9V+'*#)X F'H]@L%'CY0QDI<F9/96_4M
M<FA-5I6K;_GV**L5(>:[PLOXWTGA)SJ38[4Q!$[YN$%AG7V97<FY?7(G@-ZW
M@[1U34ON=$U+7A<@0614(3,/1/N;9TXC[NL2-BZY2[#D7B39R8JLV'([@D!G
M;%+&F?*@4\'R[,6.7W#J-(B*W(\_U*S0(H4.#UF,&*.NLCT4D/"#P8\R!8[4
M%HR)<@&JEAK.OBE0B@5O= \^3#7^7R:H/.D&S/>!ARE2;9,)L*!:C$0C]@;F
MV8;,N1BP1\UU)@'@YW[HIY:*7PI3S;J1"6"3PT>[W0Y,*9T] LL/MS7U !6_
MV4 %N-L8_\;_@\PL<C7'GUUXG/<B!,L#@:)]B?$"9]J,=%HE;O-<Q-\!^/#7
M&O38P_F![%B$0"(=>'IH9HO78"DS3A%EW8&Q>5IPHBX5W<&UK?>\=S'BA(I#
M+H'1FF123W&GV9?MB4165M'B\U<]S-W YFHB".9;)!P%DTOA X'>\0LYE>Z7
M84FXUBF-,C5 /STRARL:8@3F5PZD 29V'?K$ZW5)5#A3N54Q[3FI)$:>^(#3
MAL!NE/2')UR!&T)RY:/&7%(AP+RKG&,EKWK>>H^=#I"/$T9%2@[#PN.<_=4C
MGPG(C"S**L\TW,X@HX;;@A/Q@X!+)- ORO&2*J>/^$9D?O*-55[_>3710-:1
ML$:I? D, QM"\VQ!3R3NDH4EP>=,)'R \<D9FI@,]P _X3TE;2T%$SEEASP#
M/Z5T!T\$O1=D<-A0R]<O)=RY3P4F<B837+\U!L7-00G-.<DV1 BTG#+HI9R
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MX#*5@70H9 7TF:LQR 8:JJA-&) 9.A^!<>>75TV-^Q[F,.T%#H6M+DKW]N#
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M9U((!=_I*;U X/O2QJX0AEF,2#RN^S<0%N"KHK%PM+OA:)O<O!><N<Q\M5[
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MQD &I5WO\I5OYZI?_R6?^Z;P[/]02P,$%     @ ?4!I42:\IYG8!   8Q@
M !H   !E>&AI8FET,S(Q+6-E<G1I9FEC871I+FAT;>U966\;-Q!^[Z^8R&CB
M -*>.JPC!AK):5/D<&P%09\*[I*2B%#DAN1:5GY]AURM;<56X@0IXAQ^$+2:
MX1S??#-<TJ-[DY?CZ3_'1["P2P''KQ\_>SJ&1BL,WZ3C,)Q,)_#7]/DS: =1
M#%--I.&6*TE$&!Z]:$!C86TQ",/5:A6LTD#I>3@]"9VI=BB4,BR@EC8.1^X7
M_&2$'OXVNM=JP43EY9))"[EFQ#(*I>%R#F\H,V^AU=IHC56QUGR^L)!$201O
ME'[+ST@EM]P*=EC;&875\RCT3D:9HNO#$>5GP.FC!N_%-&:4'O1HK]^.TW[6
M[1]T*.N0@UZO&]/TWQB##%&]6F/L6K!'C267K05S_@?M).AU"CM<<6H7@SB*
M?F]XU</13$F+_C2NK[Y69JX;(WJ.]JPJ!G&"EBP[MRTB^%P.?(J-RE2MGBNA
M]& O\G]#)VG-R)*+]>#!E"^9@1=L!2=J2>2#IL&RM S3?%8I&OZ>88SHQ#^N
MJA1Z:$=PR>J4XL0E<72^X!FWD"9!O)W![6+/$7RFOU'P8Z8MG_&<.$[NC/ZN
M1'M<:E,2]&L5G++<Q0S]J MJ!G;!X)3HC$AF6B_/!5O#'[EUDB2*DCN?V?YI
MF9DJ(P/[Y"$026$_>^@2J#.-TT[4A/&"%!@G=%,GF[J>A?B@":\E=U/@U.(P
M,-CWE#V\+1O_]YS;GZRF^9QJPK[9C9;90BO?0LM^#*TF,)(O:N^EI$P;Y 5J
MJ1EV"#XYV7,<IX3"GTPRRW/3A*<R#YI 8,($61'-(%>Z4-HW%.P[4_?W#I(D
M&H[5LB!R[9_B(;JC"ETOF&;9&G+?A^NFQZ+T87B?3CON#0V\E6HE&)TS5%D0
M>W^O<S"\X_6=8NZO2J(1?[&&$X:H8 DE/%%Z"7'4>@4SI3W8[RHM8 @Z%H5A
MR9:92S[N1L,4R^@WKZM@7MBHX:SKMD$99J5 ISD^"8XIK;A=>+EF[TJNF=OQ
MS'9S.1YA/'%GGUY80VFI<;]&"T?GR"4Y9S41XW[:;GKB.44N,9=E5?0<D2'<
M$8=++[R2,.$.BT(SXP)H.@TB!.!*Q)@(#,\4&)%I^H4S+HG,W>]HD_KW!N\1
MM4I1Q:\*5G'-?(! <!MV=#PY+,FP+3;23&ED?@M)(DAAV*#^,J3<%(*L!USZ
M4OM%PS/'VYR(S0SUXS13UJKEY48?1-5F;W&'M[3VLQ$'7A1:>EV6!NTTV2F-
M@OBJ#,,TF/:C1MJH]>J I9)LEY6/^6^G03_IWS: SY!U>[TO6GG7P4IWBZ\&
M$'HBZ.U(NA>1%(12?),=),4YQ-NO2H+-[(>4J]CVC4;<!/O6CV)XH<[\S()^
M-:TNNF\WY'6BD4OSINK\T)C<R(+KX'P/&3]>;V_'G]UE-VANQG"5UP 1 *,$
MIU!G\YW@XR?__;TVOL+X3S@FI8"_ YAP\OYK],@OQOSHC#D)X+%>$PDG?#XW
M&6.?'B-?/#B7G%+!OE'27[LUOD\4?IYRXUL\I^X&S[W2CQ><S?"0@0<.R\\8
MO*S.?S\O#RI GER<@&X"Y(=B \<\"TST%P=N .62!ZY9_LAS54KK[KMWTB+T
M!]0KQ]^=%\U7CL8?W%47JKJL'V@FB"O)M=OKR\W7[[K1Y1*2X?9;VNM+/G'A
MO?FLKM_]/P(._P-02P,$%     @ ?4!I4<&S.3?HHP$ GN 2 !$   !M>6=N
M+3(P,C P.3,P+FAT;>R]:U=;29(N_/W\"KW,F9GJM6KCO%]<U3Z+,MA-C25L
MD,N#OWA%WD"@"RT)&_CU;^26,&"#"[! VF+7ZL:2]BUW1L033T1F1O[^_TYZ
MW<;G.!QU!OU_KM!5LM+X?R]^__^*XG__V'[36!_XXU[LCQLOAQ'&,32^=,;[
MC0\AC@X;:3CH-3X,AH>=SU 4Y34O!T>GP\[>_KC!""/?'!P^CU;2Q*PO@%%2
M"!ED85),!7CMC?84:+*_[CTGPL3 @12*0BB$8:( S64AP+&@(Q JY:_A.9<A
M,<68PU,%X]$F02QX1C4'3KW)C]T?X]OA&_9'SWNG>_B"^^/QT?-GS[Y\^;+:
MPZ9"6/6#WK/<6F(YOOODW,[)^,JI)V[871T,]YYU^MU./^:N>38>0G^4!L,>
MC+'K\!94%H053)W?),3.UYN4-QA%O[HW^/P,#Y1/+ @M./WZS-% 8-NO?RXV
MCS^;GG%^P6AXT<@$(U>>B#]^?^\K]_S"RQ.IM?;92>Z?\_N=X*L=WGQJ/OKU
MU%'GNA.QE?39_S;?[/C]V(.BTQ^-H>_C^57'HV(/X.C[1D\/7-,IWS7I:H_D
MPPY&7Y^0CW9^U(/?M*AS<M/)E%^2]26U*%"(5ZXY%^K?:8:Y]%;Y.>$;Y9BV
M43V;'#P_U0^.^^/AZ?6*-#WX;;\][T)_[Y\KL5^\WUE!&X@07OS>BV-HY)L4
M\=_'G<__7'DYZ(_1LHOVZ1'VAY]\^^?*.)Z,GY5J\>S%__D__^?W<6?<C2^R
M\13G5O+[L\F/OS^;W-H-PNF+WT/G<V,T/NW&?ZZ$SNBH"Z?/^X-^Q 9T3I[G
M$^-P\K$30NR7'_%X"^%EV/&3YY^,MV/ZYTHG.I4,"SPY;D1,T3B1?.*0$M%@
ME?VT7C9%XRM?6&X?>OG1L?-\#1$K9-1ZU86]E48GX"T#_^O4K0\^OV';GW=Y
M\S@<;'S^^-H>;!TTZ<?7NZ>M@\W3W8/6?G/]W6F3O9<?#]Y]V?KPZJ!YL,&;
M;..L^:$IWO!6=_=L<-;ZL-UK'NR>-GN;9[OM-=(\:'6W/NR2YGIW?_=L\Z1U
MAO<Y>W6P]<J0-^SCZ>X'KW8_O*=;ZYXWU_?D[H$_:ZT??OEXT#ULM4-OM_V.
MX#T[S;,_#G8_;'P.KU]UW.OWZF/[W9=6^^/AUOK>V2[[L]MZ_==!L[?QI<4V
M3C^N;_<^KG</FNUP^+&].[WF+WR6[']L'W5;ZVNTU7LGMM9;![N]]^3CA^8I
MMI7OMO\\;+W&>WYHGK38=K?5Q3:V-\;-'7+RIKWVB6D'G$G$L1@1>X-PA9'2
M%UYHDI@V*ABW\B)!=Q1_?W9%A \IT8T^:MSI2Q3I$+J;_1!/_B>>UI+].\F>
M7DAV0VRUWWW21"2NDBY\9*X0$7VO4>AH8W017:MR--*5%P3_,XCYC#^BB%\>
M#X?99#LC#]W=",.-?EA'RE%+^>^D?/:ME &8T4PAPP(#A:#1%B"5+!07!H5,
M0N1BY451$%5D,'\T$9^3R0L9O\)?1K6$_T["[#)"2P;<I10+SR4MA-6N<";X
M(A'IP3+/C4*GB_U/YR;:MWC_0:B%>ROA\LO"I9I@D,.A"!+E*B2HPCGE"QJY
MX0S-V1.V\N+=8XEV2LR?;\?/L7\<WP[!CSLHX(V3HQ@Z*.]MY/F=?J>_AR(O
M&2^2ZRW7[>R5U'?.PF^>VI[OO>IO'6RP5GOW=.OU)MUEK[J[[>V#C^TL\$/1
M;.-]/KQG6^UNI]7>Y&_X]OYN[Z2[=>!/4&%(D[4ZN[T_#W8/MO&Z/=DZ^'CP
M\?6&:!WLL7R/W?9^[_P:?-;Q1_9>M<[P^-F[K#1X;:N#BK._M7[(6KW6(=Z#
M;:U_1&7Z<W_K]<?4>EGB=E: +Y\41L&6:5*@%0L$;D<+,/@GN0B,.\1N)E=>
MC(?'WW.O9U>9]1#EC.[4Q]$U 4&.FIZ/RA@--:111G;/QQ@&_'-EU.D==7-X
M5/ZV/\P*=(7[KYZ, M[BV=5[3)Y_\=!I&T:#XV'YK8S+GD^U<J(4]]'*\QO%
MD@Z>?^N$_#UUXK!1-BA>&Y^]W/R?J\SFVXM?G/]T]>Y')9:=?\/P<3C.M.3%
M).;2&':=7W=Q[&LSPZ53;>ELKQXY_W[^D&=7.NK\/L?]SJ331ON G?JU&WH1
M1L?#^&+Z^/+@^2W.CYU_S_>X5@Z6LJ2]-3QJ+CR3 (D8I0T$ZV3TYM-F;CZE
M&7?FWOV3^'T\Z5%*"\*^WFAZY(X]>EQJ\]4NFZ99GK_?6;]S;\H4K:5!,@%>
M*&;!D82::XC*G6S9I#<71)FO].85_;Q;;U[I@90,2*$E]YX*[[6U,B0T\P1.
ML*3HM ?4 O: FDT/Q*"%Q*C*$H<]$*0)5( +7B9A+1K7')!MBA!Q+W.TR=>
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M"]$1YBQ+PA@/AJ'JF. ,)8Y3J%6HBNYF3KJ$4;X*-!DFN1!$ O.$Y.@?]2>
M(K4N55N^$;V,3F D1"V$5B89KFAR+*]4DM$M)9UX.XQ]&$-W6=S,G-+R" 2H
M-X9[!4(Y!RY$,,%[;H.1:@E6E<]==98^FL% V%M!N9&""N2[-N9R/%);8X..
M3M<Z5$VY<BZ,IX@%.4J5F@ GEOB@,@_5!NQ2TH9E<RMS6EREC(Y1\YC="K#D
M=+">>RN3C$'I6G4JY5;FHT/$",/! #4RBI#7<D655<9JPK0*55A]N>!N93YR
MM9(J(YT0G%E!@+F\J!8I0^0N" M52:3_'*H_@.J\COTXRKM8+#$E41C?(K%D
ME&@C4DZ0Y<46EC+/!%#+*Z([#RK8"CF6^2B13H&$*)AUIJP=ZI15/J7(M?)!
M+D,EM2>*#D8K*YFFBBHIK-(.X]*@*'.2H(.92]&MVK-4A)5HT(Q:KR1+( AE
M5DJ.46\BN2Q-2DM0A^])>98Y#;3(Y(W2WECM!#<*(B2E\]0CC%@46\Z:JT\!
M'6R"8%)@#HP6ED?C(5*92T\(_"W.H^S[PPOVK^C'0UB61-A\* EQ"1B22@,&
M5452C%H()XH0CLQ$3-Q*K3C5\"ES&EUA6K!@-7,61-#)N1!I),[%(+T6\<EK
M4"6EJH6T*GIA08.(+AH>D6\:]"YY@Q%'EY(I+)=#F0\3\5P)$75($8@@1%H-
M7FOA49]DLKY6G HYE#E53N-*&<JH$A:#%"O!!T5)U(D;(H0S3UZ#*BG5H%CD
MFGOK$]($RIU&=!"0ZY?J:&A5B.;"Y;Z:IR_W!WC6R_639>0A/$_4<9&#1^HA
MG;2!>NGS!$(DE]+ZBJC-0\FT0LYD3MN7>- ^,+ 1PUFB#&A./ _$XA=A_7+.
M_5IR3$B,,>.4#BH2H:0RW%K <%-9+9ECHB($X>FZDCGQRD <BC!Z#TY8 L"#
MCIQQHA/1//B*J$WM2N8U N?SQF82-0=#$Z(!!$_4^9"$ AGE4]>?2LI4!@A&
M1$5!*F&2,HXF23QQUG#T*,N9O,2S\7MGM"R)KCEE2 GGP)S@0*G0%$R,E*)N
MHE?A"0_4JE,EES*GU4TL\""1OPH@0AKB +P,6@7"9 )>E:FF#ZE#U92K2S*2
M0)7E0E"@)G$"-EB9HJ"*NZ6D"LOF5N:T,:=F0GD(V?X%AK2.29>\(38$ZK5>
MUE4%2^I6YL1JE08&%J$F<)&XMTQ*':Q@+!$N3 T_%96KB<Z%/"_<YDWO*;?.
M668H @6C7%4F6EFXQ-=&/PS>YFH,?IEGGPLCDA9<$A6CL(1!1%;B&0D8PH"Q
MIB+:\\"BK9!SF1.W-<1'D1?"!86XX\%(2M'%Q!B"![*<I0J?!D(H(L%*32%9
M+SSZ&4D%D1ZIJ %)357J\#QY_S*G*C]&,R*I3%I+X1-U#ET,(D3>5P^U:3DK
M@BVS?YE3\&(C,SJ !NT%M<8)8I6*+B_$9E0LYQJ5IX$0S$@D"=;D?0$%!.:X
MT\@8DD[,\*B6,V5>5@Y?EIS8?'B)I"EH&:-BG@H9F94,O! J[S]FG5[.26"/
MJ#=+'[. H(PZXQ@-0C!4( 8B!L%<<)P$39ZZ E52J'D)M-&">J:T<!P[6B7!
M-2>@'-5T.;.<2^5-YC03'2,3DZ<1:VI$$,F*X)E'," D&6#+6?MK.;W)?!2(
MQT08E4J:O)1!>V2U,1DJ(2]],FHYES@]GC>9T[JU0&FPGC"7LYL2)<L%#<EZ
MY A&F.4LNK,LCF1.:U.T@5PL$FU>B 31TDB-D8GH@%33URI3"1\RIU2[(L0'
M!YYX)I1T3M/@@2'T"*IB6LXLU[+ S9QJO,00B2<B(>\0BE)'> K!:$:I1!!:
M3MJQ=' SI[4ODGG#F$L)(89I!H0X#HHSHPU3J@I[%L]_9._M/@Q[X./QN'QL
M/[SL=OKYX_34I714#J30$97%2R5\DLYSJA7V0G0L*+,$J;.?%6N%P&=.ZS61
M)WO..9C$49? Q)"D9XD8ETQ(];2""H#/O*84&"Y#8,12*B3CSMEH0 G#>4PF
M5:5@:@T^<RQYJ0/'N)Q8+:S0QAK+E)?!!^$)6%F5Z6I/,+T2O0XQ:2Z2,$+E
M>E(,/Q(1J%-)LB7@K$OO^348%$N((%&,0J/Y40-!.YFTI,['BN#W$TPV) :*
MTN@)DU&DB(0?[TX#)"6D5% 5S[L8QC<GSR>4 &]X#)8)#/XMLYHR3J5SGA%W
MU?@0/]7#B_#A^BV#EKIWOQWW.Y-.ZQ]G@7_MAEZ$T?$POIC> S^>W^#\R/GW
M?(?KLW; *;<R$.:$<)%; Y3GH0*>9,!?*N#%SBWEY:#O\8HAC/'G[<[H\(_3
M/V+?[_=@>'C5IK;CY]@_CJ^&@QY>A%?X\8?.>/_E\6@\Z,7ASW+:'S2H?7H4
MK[;E_*'?G;R,#A>-F$6.H;5,5@CO76(Z*B:MEX[Q2JS\J[6M,AZ&):D5HRD9
M:07GRD&RH*+W&*B;%/VGS86'-!CMYZ ;_]GX]W'G,W3Q^M$W(L6#LY=>IX\R
MPG._-__S(_<)F70N(:$2!XO>)C+ [URQ*!TP#>CRET8@EPY61#8>F7-4U&GM
MN: )G!4DB;RCL22&1K/XLMGL?XZC<;[H&MP;#(\&B'9Q/;KQ3O3'P\ZX\Q!)
MR0>1C8L,_21&I(H%X8*'D(OYY**C20'7I-JR:2(Y]9TCZ/XQZ(>JB"373]'6
M4 5EU6=F(HN1\(2P%K6)%1?)^YWVL(P@3A'L7@\^QV$_GU@1V:CDM) ^2:.=
M@!B-85(J263$"),@RZRX;"X$LK:'E!-QK)*HQA4&FI*J!%8*8;@QR7+-0!A!
M%/+ J9@>(>ZO.CU3,[(;KR)R9HOB,,)'[51>69U7+I"8@-#E$<@CTK,9R889
MCOV5(F$@!4;+ED6B8PK(U4#FU20++YL%I&<SDHVCTCOB2  4!PNY#+R-/ (5
M7D>I*P!DBT//9B02Y&3)2Z.X"-F?&!219"DE!SX((+S:(ID3/9N1;+S0H#6G
MGFLCE'6@B:11Z6 $!_*5.E=6-O.F9[-B XYH82%%9I2(RIHH!-46\H@!L5"%
MF0E?(6PR&I*OVNP?'5\'<M^<L7%R%/TXAG8<]F:5H'T%G>%?T#V.?YQ^_?@O
M?"\8^OW3-_%S_&;D[^M)98M&Y1E\&4<%0)) @J&<!BD4TWGA+$W4V, 2#50L
M?KRVH*)]D+"-<$>99!AD>R:$)%8F1Z@';R!+J0))W!^RG4$_GC9A>!C'KX[_
MGN\\JH;0BFB(LQX4U4)"X@+IEV7),9$("TE2'WFM(0^E(:PB&A*$#S0!4,.X
ML,QD4F'SL%QB@A%%:PUYZE[&.U00[GUD40IFHF,T)NYR:M"82.%):<BB"$6*
MR'UP@=BHA!8.@C9!)@U1>Q.L7'RA/(8;GHF&5'O ,HGDHM324R&$MLGR9$S2
MQ".C5\@$%E]19B^;F@A<1P000YQT+EH,)H*%G)XC5')K4LQ)U5I1:CXPF:K/
M@(/(R\LY:DB2P QGR -2U(*GI*JM*'?*L2^4LUL4_?!)1!-RK0H1!=$)2&#:
M<BF9ULGJ"E"3:NI'51P-<\0P2O$/<"&%L5Q3E8A5%@,*3VO\>.+^Q5D9-4\Y
MGC$B$&Z82,8F)"7&&$4K,/VQ,J%-M2>7>6ZMB@FBTDHH C:F2$PB0C-G-51@
M4OECP'ZM*)V8?/3&.4XX$QR#FP3X.:48HG1+, OQ/K*I7<]U,3#"AV3&VXBN
M1R8+2%\UCXQA5!Q)J  UJ9#KF??DC!GI##4I:$9XB,$(XPDHHI@''[G6RO *
M#,)6R LMB<XD&9RUWN4-H85PQH6DJ&<!=!16JHJ'R#\MIMHW7:,SRDG-C$[6
M&"Z\\X#J$JV4 J@P>6N+A=>9O.2VTT>%&..G$=YQLN;U\N+8LM+1#><MDM)4
M)1<G@W)$QF!#2D(H:76>=VN<!8EPPT*M- OD(Q=%:2! BDYX;W@0P223-\K0
M$+QUAB1?@4E#2Z0T57%/A%DM?=20]\K00CD(1&AEN=*(,Z8"LT0>5FD614[&
M,B,P8@&"O$$P"9KG83RP7""=X!68[_64_#<X:K6BDG*"D0%R/TGS!JN:<6E]
MD$]$6E5QG#922O-*9QZ)@"P6*DBD+,5H-?<56+59U;F4#V[/,UK)$P+ED/!/
MKKI$DG-)$VFHU\8FXU/%%\,MLH8\.(;,2$.D\I(P;O(Z','!&%0&( JHDDC#
MOZ83:PVI'M.>D89$@O$9(8)K9H4 B@$]@H<0D<:8N Y/2D,612A.$4^)9&BR
M0J3$G&3>8>#L@2>B*%M\H51FY*C:%0HL539)R4%+#+LB&$50;XP6S"F?=[9>
M>$6I^#3;JA !H%HR"]1Z(X4##M)Q;1A0:D$I4?%@H@**4A4^(&G4"2S-.U'F
MF )4#!" !BM)X%)56U$6=SYE96).KSQR1)"$*\%-,%$XF?)Z(,8MY[+6CZ?M
M:(2RD6ONC"=><,] !HW1)_?).!=(JO7C:?L7T"FY",X2&87PR;(8/1#K#*6&
MI0H0D<J$-M6N)F5U1.\"QED;!//,,(VRI$HXI9/A%2 B%9H)5V5%D9H)XZ)G
M7#JA46N49]KE+60X(DHPBZ\H]7SL1U&4Y"T)P3K"- ACI&4I,"YDTBH2[2J@
M*!5R/?.>6SNK>I/*YNJLFM-(!(W>>J&Y-H'FS70<B*>A,T]D/O:L*"[WED8;
M(L;#PE/C$&SRU"4IJ*7"5P!GZOG8CZTSQC+A/.2](*A(.H**6H2@#$9(,CB_
M^#JS1+,DJY*+2\S(P+SPW"+&)%0:" P#IA"I\CI6(->R1$I3E00=3Y(G31Q+
M7@MIJ$M6)1!YGID'S2O@G99(::KBGG0DCD3K :P1 D,G,#P1YJ2)GB,;?NI*
MLRAR2D Q4A$&HLU;5CM+T4$@!Y400 BE%U].3\E_,Q^DY8XX04%$+:U$[D<L
M2S3E?28J0/J>DN-,2,FI]BHJG]"D//A$?"26@P[4R0I@X%/R6 JC<.64XKDJ
ME <)+CH03.4)#=38"M"<KWN(_W$\ZO3C:+0SN<7HDK=:[\!>?S :=WQ5DB.4
M*FNI)S8H*ZR75GLO1#0NFD3!5F!JX]_(Y?RTM6YW:[P?A^='*R(?JS4*)6JM
MF$+^$-%4O.,&?Q66AL0JM#O(W UH_CMP1.E"LC0)IX)@ 4 S BHDIV1>LQ>6
M1YJ/9W;SERI&8%9Z1H0VN29F,%81QP,H:A5SJ0+K\.=NF@^S\65""@_4VQ"9
M<"P8)Z1V.B@=G&:A D4U%L;('J9R6_ 4F3JR"XK<0^=Z)Y39/(N12&)(%0IR
M=?J=<7S3^1S#9A^[8:_CNG%M-(KCT1^G33@8#%]V8739BMX>([F'40QO.A[O
M%D=K_=".?K\_Z [VJE/C*'(GD9%H)XT12.P-\P()/0$$P0B\ O7$[R2ZKUFK
MX]%XT(O#[=@MTU"C_<Y1543F M?.6NV<X@*" B0B/&+T;,I- :NP^]=]1-8>
M0H@]&!Y614ZY,']43CN?O# 4Q94,8$2F#><F1;OX<MKLAYCNC(R;_;?#@4<?
MMQU',:= $!G7<XIC<)2?_Z$SWK]ZXZH(- :JDTHI4!D1'9DA&JQ('B$T2I 5
M6!16/3<WJX6? <V.D1AB3M<3:]$L$Y!H/&/<0A4FO5;&S<UJ08RRD3*(DDLI
M$J=.>P&",F&)S*OLEU1DC^?F9I40)C)J'Y6BP@F1K $.@2L, 91@Z.L67T[+
MXN9FE4GF%(V."!5R8C]J(R(H9]'Z.(8&CN3<%D7?QW-N:_)A426;QZ"WTMIP
MB (MP^]+\EO#[Z&<BC=X.8RA,U[;&\8XRSG@D]N^ M_I8J=<-?/M^'G0_=SI
M[UT]Z6&S:M3DK!J_35;MVU-_(JO&H\:HA%()R0C"DD&XT-PE00%4,&6\0A5%
M1[RH:K00@KRP=:H*RHI+K_@3TR-E9$B((B&)"E!@I:.$)IM2Y PF54IJ$Z^.
M9GQCM3\S,\E:D*@97C(F?-+6&_0(PJ )"VK=^7ID26K-J()F9'X@+PVH_$PV
MWE)%'(!$A! 6V9X1U &71$5% Z] _JG6C(?:$RHQRL$2X;E@SMM@#$<@(2I0
MHXB9CHKRDCDRNL@QP5\P[ "& -M(>JZ*Z,V@'P9]#!+BT$'_< M=)<HJG_=F
M\X^M[5EIR7QT=#0<7XQ5[?C8QVX83)Y<'IK^\FHPC!Y&RV42WXX_\]LQ94:O
M1EX_P90-U7G>(KA,F+U6+D9A;')!(^+26"7[J=7WZ:DO29RK$"/Z "E<2KG:
M7G A(H]D5#%5JB\]GQ13?EA4]:WA_VG;#[W]]*-O3OT)^]$A&)F25#IRH;0T
M7N@H73+1*/PU5LA^GH3ZYGMNYQ>\>$2ST^_TCGNU8<S4,##(]"8J#9!'[Y)U
M3 <@U"9"@M=>UX9Q#TV%DUEH:NTQYFD8X+7QF@H1HQ,,F-6.JZ1E+M9CJ"G'
M2*E>Y#AA9Q^&<3L>3:<9O!T.]H;0NV04&YV]_?'^]:<]:"I5SZ[62;*,,O ,
M@ J2#%"EA?&113 @N*C09/&U+S ,W]>NV.@==0>G,>Z,!_YPZVB6JX'?=J'?
M@M[EI:3M+X/V_N!X!/W0WD>$/'_Z>@=!9CP8KO5#7F-ZW,T"V_CW,7;@9M_G
ME_\<\^V6<>JZ3T"T=QIB4$(K#AIL0E<97;*6<%,A'?L;B<?^C.5]7^4O6S91
M]CPK:CN.QL..'\=06L'[?F<Y%TG(%" O,1,B@##,NSPL%#@SQB5*K*V0IMV
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MK;P@Z,N48$\H3_EH;\)N]R8/;@;;<:^<0-<?Y]EV3\P4FF>'[)/D&OO0R$*
M4OA'L\)$ZPL/@2;+D@5'5UXT=[<WU]8;KS=:&^W-ESN_-C9;+U<K9QB_;)R
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MHO$=;/MA3JT 8FQ<'];6>#$;O#COWM=E[[Z<=&Z-&W^'&Z<7@\B>M0Z:GX1
MZ3A)BA 5QA[$N,()C@""P@J",NYXN@-V+/:@<?I!;BPO;+DVI==)UPU_E(,>
MR/+Z@W+,XG@TR:NA#4S* U]3I&\P+)_5/<T/_]+!1^-C&WU\M4$F%I\[HY(U
MYNU@.]#-D=YTSRKLINFF58U<\Z03KI\8WJ#\%_C'M2FRNZ[/J=.X-Z=Q1_NQ
MVSW7FL8OJ ME,G52Z>C'J<J;AXMVX^A!"];=E8WE=ZPRJ,ZHL'1[@WYR(CKA
MG2R"5KH0-,G"16>+"-Q*87WD1-V(D L\R'*RT(:Y5HY+M :?RVK=DVYBDXK=
MOWZ/QU_+L;\J1T01"_.&I:6]C/9A&#&BN&)#EK*DO34\:BX\DP")&*4-!.MD
M].;39GX0I82MH'7[#@8GHW^N;+9>72W3WC_NA<%X>L(U4UK*:;CE+-R=LA5;
MQ^,2RE%VR/:0PN'IY&G9%\/V\^99WLSA/6T>')Y\RHOJ$^.V2(ZF0KB8LY]&
M%8YI$< 99H58>:'EKXR27X7YNF#M7-0O&A,19WWY9JIS1ND\$7J41= 87/3^
M]V-&U^C^345.%W1PJ<I[NJD?+'_^FTH#WVQ+>328L*[GPYCGC7R.WVU4>?%*
MY;N0BTO C0;=X_'-E]REB=^N^;[=[IOZ:\F3_>%%/+@7"S>,<(BL'!_Z'+I?
MX'2T\JS>HG-F;:FWZ*Q@XV^S1>>BK%J^H>3KWWNA<F/$QW^+&\*EUOK&_^8Z
M_.6^?Y-MYQ9AV;%5JT2R^WA-LTKX[&<C&+ZJ] ,LY%VU9J:3'!XM._MH"U]N
M$UW\R">]16?[P"GQ.VW!,5<HNR'U>YV[>, G?B<N)/]W\124H%C7MMN-S4;1
M>/4UO[;9GX1R9878[_S('0WB>D9M?\"H'W$LY2&V-WJ$;3B71/LXNLUQ[#7H
MZKW4K);*0TGE @K*FJ;EJJ@:"1[8F=4QZ QB'ZKR&O]<L2@/&>&G<@%R.>OH
M#^BB4L?&SGZ,4W6NZAOF;20PR*[T.US>;[+2+W*^66:%7Z'QR_L^'(<.FLD_
MJOTBE6Y]7OKQYW$_ECNP5OI-*FX/T^8_-"&])GP=YI>IH]=;2XK?(*B::]9<
M\Z&1@K$;N>9%V)1YVM91G#QF5%U4SR][7A=CC%?%:K_*=-G[=,/Z*K_)4O#H
M_"(3'EVN?V6$VLO /@]O^'<3 VNDO)MX+X48C9I=+3Z[RC(3-;NJV=6\,$/>
MDEWER;C#N(_G=3['ZGI 6>7L16[]F\&HNEG5LONO\-MJO\J2\%NY+/Q6UOQV
MR7W5MRGTFMXN-KU%D<F:WM;T=EZ086Y);\M%,ON#+CYBE"M_4?U;8^/?Q^5.
MMU7UAN82V:KT6U2<*9KE88KF$E.L]%LT>*6;7V&.;FJ.ON0.][MY+C5)7VR2
MCC)3-4FO2?J<,(/3V^:@8;3?>-4=?*EN!C2_:_5)>7Z+:I/R4@[+0<KSJU2?
ME)<"J2XIS\VO+BG/K:])^5([V)J45XN49YGIFI37I'Q>F"%R1>DQMFD\:-S
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M*?D ##[*M5?Z[@F.U?,?K-(!BOL^.+%B.%2!4Q,U\-R2(.0V2$X$SPE&2D<
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MI@#10NV)JY#^G;//D]AO#(YM/]ZIS-^,3!C,>NB-,IF]*)3'+@)XBU$^MQH
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M,M:QF7*LF)"BO5NNQ,IEDL@IPI'RPAGAO7&1K[VBXHJ\ZIIBWO?YO.6'2&L
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MM0-A1:%]-K(&=-5Z"N"."9:(6ZJ122Q[%#AQ1BA'@BA="/P*,EL#_#6AO\E
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MY'O0^'&-ID\(31<!4R"+@BO!O"?< W\T(J3 4O:GTB1_ *8UAE8 0W?+_!_
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M:D<3-AZ9),&*E1@,6.PPXB81+'5DP;!\?O8N^45UO.\V;*27"G6#4>=7\.L
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M,IEOGD[(_,<V$&G6_+###\\\WCWXAS:W/A[O'?SUI4D/V<?.7T#8#RD0].]
MS-OQ/^]./WX()XYRV>S\^V7WP)/#S\>?FV= Y+<.<;.S+78[_["/GT,'R'Z[
M^?DC$/37:>_@"VL>??(X8)XL@76A/>),!60(,<A8;#F(-48BUL9%C$8Q;.13
M[5XQ)7C2+*C(I7>.8$Y,"$QX1P31:XT(%M))QM;^*-[[0OC3#EJ#O30K<U@"
M^X!OK02LO#O< !X[*HJ"O(5%XEMQ\*R%_NV3%3@2$!RRS.:3;"XBZX-'3O (
MAK0+2:F+0H]*1V&UT\X;KC@U"DN*60HL G_4XJ+0_]S8W]EO[+UNO'VWO0][
MU<;!SEYS8M2-E\*KRZ]GX1O>&X^AK)A5B.KGBV]^W)@Y2[6&=98/ZC"KI3",
M:8+A"P06_]HU]_GI\UZW4\BK-HI',CD.CB]8<0L8;T79U-W3?LN&QIO8C6#A
MPIZ\T_7KY88]<H-6:-E^;F/T2PZJY+(*%/^^6=ZM>$5^;\!%QF^4UQK__=?&
ML?T:&R[&;N.D'T]@>R_.&^?1]@,,)A8E7!OOU_?7&T=P^[YMMT_SVT )<LFT
M<YV&K[=@[">YB=(OXUN]V=AX>WZC_!RMS'-:G9D';77+*AU9X/EY3D;]P0C
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M/&LYM.'IR7C6?S!7XYME]E=H]GA@,_<$(6R-X@2UQGHT@:47^6'!AL^J,@;
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MU[ZQM7O<W?Z+!U EC1?10J>RGZ^(3<82SS5+0AC/C%LY47UM/WQN_CO?#_\
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M.A9?;A1<>RF4TLUN"*W:Y]V>Q!$*(.F8DZ/X,&FU"UI#0+3);,-58%6USY4
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M\FGOG[W-/]_1S?5_[G;7=[$=.U^0WG/W2\#/@MC<>B6ZQZ^.-__X2_@26N"
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M.EBL(FS9M%N-3,"YFRI6@\5@]&;Y40:-@Z#I^GB"_[3OQ38,]Z?#/$_P@NW
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M#9D&2C5U=/"[-M1MK;->G$"I^+J:F%]4^$IQ'>P=JM33!RZ"PYO /3<:G')
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MB$L9P8@9(1C\4B+8(R+85-MG9ZPVU")-<[%EB7/146L1E1;;0$/@CF4$6YE
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M7M&&G-/E0_.?H_Z&E6%OPWP6=#"B@7O4-GU;-,>UO5';S]Z=.G%>MT*/>KK
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MELVGX[_[[\YCMQ-L[[#DZ:?BZ5ES25.?(G,&,:49XIA$I#$/2-@4< J"TYR
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MV8_6A"!)0-9%EA/''=+14)3[9-I<0]8P_:820<\YR:C>'<0W]Y%,3^[_/8P
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M+.&LA+-'BI\NX>R!X6SB@@2QDDP@'G$7">)6)N08"PA;*@B.BDN2"CA[J+9
M2Y:"O-08,W(U5/KV-SST9.C]>O4=A!Y*2:KG51VY%$L<N0>.3)_/&L^=9]$@
M8E)$/ 2,#&A(2#&<4C#$2$%STZ!GZ )<MC)Y$B%=LM,?L]-4@F8D#*P,C+ O
M^I<(C6SP(*6#=TXHH^""-^_E&EF%_B4^QI16RIFSW3^,W?O5E;LZV9<'&0\E
M@8MEOGJ>4J+'XN@QT\&/$\&TDQ(IZ1SBR0ED660H<FV5=I$*E>,*^)SL[D65
M^KF\_;ANB-E7WJ]6V&O@TH<2["67/B273C7^ WN8*R*1A>T!+C4)64,%<C%0
M";@J:.ZS2>D#F-X/QZ4OR+H>-28;V=C-"667E;W*2A'/I!&5,/L@,#M]8..P
MH,FJ@!Q/$G&5%-*!661PLDESJ4GV3$BQ,,P^>W6(LMY-B6)+J3&6*/9 *#91
M%K%5.&+C$3&<(\YX0D;:A$@2.AIB(_;ZS7LEULRJH=ALN/>M@=Z3D-([AGNK
M%0_WUJ\NW'LCNOX2AG.?C2'CZU$MW[/Q5W/O\^;YWL:.V*V'1NTGP ' 1/7<
MD]K/S=-=^O7H<F!M[7.5POA.JZT?Q[OUVG$-WE.C6P3@H+G7^GY>._].=NL?
MCO8^UU+UZ!AOK^\+&KG'1B)%L_HB/04KT6-DE2-62T:=O!+1+4QP04D*$,XX
MUD1+JZ3A% M-/8GL<BSNW]NUSZB^^;5:V=C\4+\YF'MN>/;M+YP=H+74.>65
M4-%R;;!UP0'_<J-%9!8FM IU0;;;E8WHAV&@E+VM4$SDVZ+XQ[A:2!&F.6Q9
MTJG82B^V&YTN_.,'^=-N_-5I_LH%0SS\V>A7DO597)Y5_I$?DBO[4_SO3Z,/
MBS_)O_]9<6=%5*%M=>#.ZEFW8</;7#\$@+K;.8W=M\77^0G-7-V@VZND;J=5
MZ</4*S",XM\3VX779+].['?6*C"3OP;-LPHCQ2ST#;-8;\%#<S.]2@UN))73
MPX8_K,24HN_GLBCM\;AMOK 8"O O_#H:?Z7?A24?J2*GC?[AN%)*,39XZWB^
M>9[#A^=/6[8_Z.9/@^W'X< [J7(*TQX^/1^2=RHWX1)A) J&N01*XS0J "<K
MG?'<,AZ=PT52G,:*%4EQQ2]O<LD6>#/<_;O_+K^YJ!H1[-E9M*#.S,.MK78/
M>"HO4'4TY VX[Y5!U_;&%@9M"#[;^ET]7V>UT_VD8\CY)P@3)W)M((&L\PK1
M9*1@1+N0XTRFJ)"RRSAT0=<M^[O1&K0J]N"@&P\R09QT&VW?.+'-''W;:O0+
M LW4 1]WH^T!>11,\'\64(995"IP0D2V$C&%"0!@,9<XL58&S;,R3"2AE$TK
MPUNU3Y?)XF] CNWTL>#Q,757AU/X4/ L0,!'>P+?],^61T%^8I*IP7CVA4F.
MNMS_0%J,>(@:.2TU8I[F/NI4JESWBV$\I^YVYO]%MA<D#>5<1HP3X59:(QS!
M)!E ,D:M"L7VCF"@W-X_W][-TWT 7*\BI8A:D@MU:HH,<08YHK2D2B>F<XR(
MF+>]:T,K!B15U9Y5A@B![RRGZ(Q(+;Z#"R^+UK<C@7-J<]&WZ6?_=Z\(ZV\V
M;-O'H=CR8-/81AL^_Q7;MIUK> $\M3JAD1JCFQO%@'K]2C=C5/ZZDR57!3YM
M]::+A4T&^Z6H%38$JVK1PW:$AA@N['8&!X>5<:I%_I0,Y_7F\@/>_'.M\@%>
M5K'C+WH54 UB]G;G3,J,AZ") $ .!^P+7:Y7.1ET>P.83&:F@T$C%-.%2:Y_
M^UCA"B/8FKND]BV3EO9E:DH7:SVU^;,T-%*BII6S9@?>GA<!QCY/XH B!BN:
M"] \/OQ<=;7,ZAP?;;=[!H->+\;T>M'FZ/@\'X)+IF) 46"+.$L$:183(D!O
M,:28E/#7"I."Q9]_/S_%^-JW\GS]][XFF!/*%;*PI8AK89'FWN5B"5QD[Z0/
M8,62.6V2,M\.3@!.@4-3C$.0?K9][64D\O%CI]?O3:L-ZUTPB@YB@=-%+Y=7
MO-U;>)\#FTK&.#)%\)O"##D)6B'C04D='3 N>_,>SZF* 5O@^I7&:)UA)V&A
MIVIVPO8/KPB-7B$'LU!PL3)I+@K"O"C26<CHC.GS1,9:9;HD*,B![-PN;-\L
M\_) 0"PL0F3*&"N R+R@E/NDC-=@IW(-=@<GQHF1WUW@$CP6<Z'5=_%V?8O6
MSG=PK;Z%JSL )90%8B0"^@([% Q_9$! (*(95V!>6"QS':EY,N$*E&1R OUN
MT"RD_R6-<Z),PF7-7N=F,CRT8*\VFLU[4Z,?'K!4G&T6I#^ZN!W[H," &E8\
M8<0=BYG!!O1N9ZT N./&,IM+"%E0TF64)#!^UY/MOV$4=1A$IM%72Y#;&U[L
MRV@SDV,4G /%)&J!C%0JA\HK6%-,+8TY[H>OR:MF4-[LK,?#?X^^B86Q.^4"
M Q7<OVL/6J= Q[W;W%_K[?; -K^,U>0O]JRU5 > 3[[SH))2S"E.6"'NA<M.
ML( <!?!1RA%F8).L!0.XW;F*/;U1^9$P97B<#)>T=QTPY$MSR>E.I0$7S7A0
M5\Z*J\^;7R9Q,,'!-A_T^O".[EEAK WMZ[>SYC?\W8TG\">LV,C8S:K@J<VJ
M5SZA?ENQ*34RK>>:W?F[=K;T\A\7)GY^9B5:0'5O>_%MI3=P1R/7]=00&JW&
MZ!5O*_&WCR>3U\7<]:67_QRB]I4I%9)B,J^QC^'BX?'7>,=#3!8DS]H53\>,
M"^+BP9D*1K[0.;Z)H1J4&K^S>.KGHPI8*AOR>_[>^K#]M7("P[X><  37.Q>
MPAQG$B7,&LP]X]1Y$[1FH.E@&8B66(\. EGA<*?D<E3!'$_;+,!\L+U&[ULQ
MSNWV#]MMY!/DKS ;<@$RB+\ZE)DXWFM'GF[O[$L=F.&@1TM+).+$YD H84#A
MB1',XUPF4!1.MZN@X_(*5TXZC8+DVI70M:?M"PUC[(T?M(>?@TYTR>4^.9&Y
M(\EHHH1ASKKL>?=*NABY-LD%!>*+Q'N0S#SG[/?V $8W=LE^O#@P 'WY2^SF
MVBKV()8T-*(A5EO?5RX%3V- 7&:#S,M,0]8AZX)76B>+0WCS_E82NL'C"3#6
M+[[(AX;3\FSJFLN(#H .(JT]=NP!$OQJ= "F0.SY_!YXS&+DAQ-C,L0(L"6X
M2\E)[(,+$6PS2B25!?F1<>A"\4N)6 ],;=OK^]8J2IE(R(%. 8BE$M+:.X2U
ML13^WRN6]6.\*&(-1;!MSR!6=KQD8BD\[HN1BPI!BY2$!!3E4@GMN8K")1VU
MA$_CXN12HM6?T@^OGNX++:/G6<$V%.@G28(LT ZBGCMAK'<L>J"?JYG(BPLL
M,*6\CE)9:SF7R3BJ@L7$)(P!&;TJ2> 92*!VNA^=E#XYCH(A%''&(C*:<\2R
M3J&"S!3RYCV?0P(S".(*-0:H8/8HL E:>!>6O%+TPQIJ\D,U.34[8'%=N'R6
M0A5JG1VT+PFB8K"?\ECGT0]]W?0CJCO[5FM0B[U$(02!># >::<%*I(Y@J".
M.#O?2_A_;]9RZE>/A0MK[J*@X/"8>W2\BPM26HQP[N?J8?/<=?V1N^YG88G'
ML#XD^ZW1^+\6@4VOE6IF?<L[#$PM'8WD,I]6 /RC'->(-"$<64$P XW JT0
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M"A_;?P:V"S<,STLFA#/VQEU'>+=XQ"Y?/B>T9Q@[.QKXQ>O&_HZ+6>1O)FK
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M2]=]X+'<124ZENCX](IKB8[W1\>)9NHHF'=*.61E3LA4AB'K+464T0C_IWG
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MV]A+U:/J>75]'Z2+@?7%B.3J>]PDBXQ)$@&L> =K+9F)5\)% P[<DX"%-SP
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MY?S99KO@*&R&1423@#@F'!EO-<(">^M84I2HNX:0/4+2\LK4="A%PY*?Z95
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MBN &<<HQ,DP&E+#AT2C* [%%^L-R<]T#Z9,KH2%L7AS^7!R6#%GR3]*M7SQ
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M8%Z(9 -*K"#@CA]$ =@F02!<](6Z7D0B+ARSA=\]X$>./OUP*9RI[[NZ:YL
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M'N*\[N,/0!@491YC&6X^I[G_SNR1/1)0U;:K'.7*G54T,O!&5Q<#?')1J?,
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MV_(R#] F%$59!7+;3,Q'ZUUTD%[ N:/MID1,#8E6S"PE9CY-ZLV!:PLCTL/
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MGY]> F/HP7?6T=6N]7WODW.\]SD^E@SGK_/3\P28QB?S:.\3]F@8_B LL.U
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M-UZ=N% W([7#G[!/A+C2O=-!K4KG<?%3732 ]>9(II*<)!>14 ,.(E-M6#F
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M0TQ^:7>\-KWQD12?1MRNF"B-?5;Q'=/JW#P[:%OC.YL-5;.-VMW=#EV_O<^
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MW2OR'NPE!M6BU&B25.P.WB)UAD&($,,W5$^%Q;#L0L#OLDF<K$)"M)"H< /
M.MI?,@NB0K(*M^"#0<J4!E.B7G)&<U[K(PKI9N%<A<Y-U -9@%P1&%TLMX5P
MO,3W#!*.!P5'<1%GB4)S;,M7J4VSMH6+@^_$B/5>WXQLB=?\3@YS^BC9=8V9
M^2!%C3#/!F==P,U4:!6_-T<P+(3X"3 'T9$7"!A:/ZI2F51Q5HK%6;@2Z=R0
MM6<768S:8G4,_:S$"KC&%L9;W9$X4"&21'!%^YG,HAG?"0>-Y]C1#B(\MDL!
MSQVD-7:A=$J&S4: ]5'5O5WE2G;4L:LSKZKI\/7IE,RLU=E13@P20Q+WXK*H
M85SKE2K9!CZH(=8@BQC.)@1B2D6AF(=Z]6A;L&9&!X60[TPRFBKNTJL8$](/
M8R)1G!+  OL#')X@O$'*D;&)FLA!O#-19?8D%/A0P;#63PI= *' 3:2XNP)5
ME8HP)-^5"P3Q\E-(Q@=J0Y:7\.Q\WG PA,D%+ 1Y#9*M!-D8Y^7US:W*!4T\
MH7H]C^E9FH'T8++PL:B HE8@-?(\NP AT.3;<N,*]HI2KS%[B2E8D*BJ'.&,
MX;V($=)@P!5/PI"RKI1G<CW-34JH]7HB1R*,KQ2!GF4T*<;$2SF2"'(Q*I4M
M,<-ZF*5^6$\FP7='*)0,=Y3&5?,P6 T7/8"%DG9()8@/9TD6 L+QN,@'?05@
M6>LI$9A/F'<7DKAKJVO,P11R%5A9"KQP_"1INB$<\S@$>T="?$3Y7$04EJ X
M#,*,R3EJ6"7*1'R!+&"G.G9L"@JB'%N;5B@X7C[<C?PZSB5461>@@'@KS5IU
M,QY")4_5V@%S$LD4\**QT ). 6>'LN52@#H!_RK,+\29XHU576UUW6C3P%0'
M>"I7:*/F,A4/KAP_MR> NA5.(W)?P^?*Q%5"7F87PL.E:E&7SBHQ."('5&Q0
M:C6$"+PD2D!/F[2(ZPI:M5!\@$(-6/+_U!I$0S-O:%VU"B$ X!<-' '[=5!S
M=RGV4!D8BSZD9S@:6.]E5\BC&R"SCE'GJ?2Z K0ND:+N6!WF&"E1=0&H9,C\
MA\"3?R+9R<T"JU:,I@*H%$\3:O:T:CHA'Q9,>7PZJD65K]X#%_TD4Z)"EK^+
MLR$P?S8HE+:)4@7.;FJG/\40SY 6U;<S6?M.LS4N4 E*L;%HVADI]/ 1/+Q+
MBY$D05:9X;ED[.>$97K=9(C3BZK&/<O/:(J./JF,*GUDKLQ!+:1>VD4%^6+0
M[Z.@" =%+"7MZ#PJN:$\7R'*\5P H%--UH_C L0(*=:=8\O.S5F29)=2_Y2J
M#YP_GA0R';E#FM"::-#6VE$6%UHPP!-'%HPB=/D =0@*B5!#E]+\]>)=D-O<
MV0U(1]VHQ:XD=[9&M31+Q<U1B$V^<A."O6T:Z\Q.-HU\9VW+DUJ;KH=M/H<M
MS6Y]BQJ*TLTG594VR74[,ZM,T^_8;>O2%I6? 2J[=CN+L$7EYX#*+XFSCDT-
M-L$$6O"$#V_QRCS/[%=BW=)R_PD'TVWTP3JWS3)H#_:NY2M6QWB@V9A;8_5]
MR-(S'5,[;G5&+\#V%CJ1#<$NV[BE&F!1\#^E4OC<8>1UC!9&ZPVCEW<ISVHU
MTBG7W!U#B/-.7MD#5:K[M$FP+=;BRHYAO8G0#(Q;RJ!6=A*/H\&V:+R-:&R!
M+>6W:-RB\6:C\4N7=*RY.M%38_ &E%.>=,>#93"=;G:*U<Y""I*LWVK42.7Q
MA4AQ0LIO3M"QZZ=K,K46/KV6!XK)7E6"WV]VQQ_5=/7SC G!B_&@E[@H!I@3
M)E/"&KEYJC$E3OCJ4DPBK;M#JA:5F$C?S1)5Z4!_[30FN/QF^AT7US?Y+EGG
MHG8&#YVY^V)^AMU6%DTZZU8TN7'YCIBJC%U65<HPLB25/XR4$\&-FBQ31MQ[
MW28S/I/\P(U:;-L(=';"4]L(]$$S*(V[9%#.U?!N"BRL'U8MF$5X^VX7P*EG
M<V3;VE;4V,[$2V.4>(E:4EW,.RIY']=U;F\.IK&MV3Y*=J 1NG[9/FW.6HO%
M2VS<=&YSV[:8W&+R)F#R2\]9Q[EHFV ^W5$;&I<GS]>&-CZ?37%)KTT4?""B
MG4^S[9G>[4PM\K#-<K?6^AMW"%F*WSV3E#%%KW8G>)*4L3:C;R'PF-8=;-(6
M/H\%'[]#GBXI]AEIHOM5\Z)H>G*CZE:<5;D!BQ1-/P^I;]Q21=EJ4W<]UYL+
MK=MSO>NYWLP*6R5UL7,\$N54PM5=V=X#^<C6#_G6M%+W"92H9P=9^QD'9;8:
ML%@%O7Z0?49*]=PN0]A57#6'/(O35+:CC!K#1IZG/GU[7Y)6\[O;R0;V(_@G
MM_%@/:/CM#KU8W!"@:VG;^*!"\JE*C7?!ECP;( YU<^OKNA>4>E5'-!Z$^W]
M6[FMX(PV(T6CI9:MIQ8_Z 0ML;3$TA++(HD =PXW/3VQ+%SJ^K#CZ1:O)QDW
MZGTWSA@X'N6+[TYG#&Q,_>YM&? +C4L<M:_>66Y.XL[U*N#QE)7?3,/K!%H5
M^*ONK.8[H'K>QVD<@)<E_=48L/>;Z76,^3>5.>5B]@"=<8'OC&E8@[0QD+4Y
MW9+R\T%5VHRER"98OVJBSO0SN(A$GLN19:,AF==N)T#3BTWA6&>Z.!AE#FX*
M7;Q[4!27A;HCC+Q.<[/R+"555!7Q8^((U=#%YL"9R6'#OUEVQ[Q6?=XHN&\,
M$KYY>*D:L0BTA5.+U'CAQKT+'=*"@X36&8W?C1+"6C2NT?@FX3$K@>Y&1*[[
M-U3M%-3SX'7C"8"3<\2B>K9CB\@WHH'*GY%M* [22$V97&_$_0:8E54#4R<F
M9%6KEQ-BNQ0G:M9#SD:S1]5,O'KRU4X]03?+)T;8%G* WM0H==0]9#N%1><5
MKA.<OV#C$NWS> +9QSP[RVEOO6&-$]S^RF@N?:Q[,>A59987$L( BXLX&Q0X
MP&Y0=K-<JEL#.1"P,6AMT,</?K,, U2]&8-M)R:PU9-<FX/:KDUIJWK%Q#VE
M>^*_:@8O'$YC^BCHD44\'A@+V)76$P-!K4R+:D KW@LLZ$*)Y%2<964L;Y^X
M"-FBP/:O<H@M]K>!1<'9TC/9K0,'1(*>VD,U5>FV.+14AN;4DL?;*4 YE5-G
M5?<;1  UY9F+OO1DI^.Q<..^/(TAASO5(V'1# ?$@HI<T4P)GU27-*;AU>Q=
M#114DQ^!-2,4)^;=[4H.-&>BNAS8BNC; /1,*)NFT?&J+4K 5;,:9=>>YO7U
M@R3#F%C(%^#R-"DR[;__R[<LX\U''(A\<+"C'<#*-*NC?07M_BPN<- MB  Y
M"196O@\[ADU^&2M0N-^O2FA]K'O_X#--\XUV4!0#6.+'$51F/4$NP'PS@]4L
M.L\]>/&4#.KF\3VX1[#X05V2YA4BT<<LP6FU:ZXWC59.QROO5RN72 J858CQ
M1VI\-'X1 OJC),KRLAH,KLA0RI31)&NJ5*UT*)'%>U-,S+2NZ+ Q;+8>LR[G
MKC>XPNCV7E:@7H.C@.'RG7H(>'PA.9><!2U^:><#KN:QHG%; K<"ID/KJ<^5
M:B7GFLO9H3^%AG9(3V;8TA"G+,M@V"@9%[XI<<ZU%,VX^3@%TE<STT<CPB<(
M[RB;&(JK;"#)S1MC;"<.N\PR8$0)!6M]2E9W- T57!RJG4NFP^."#8JB.F3)
M'&X Y X.\Y97[:;I *X!P8DS,^%N>&Q/K=@T]/\=.3RB&"='*TU2J8<XJ6N2
MC[4=O28Z>KGS.WHMP>6(,^)RZ],'#%MI5+Y/'=WDKVVW]IWCD/.T?*W;C\'"
M9C-?*<KL">IK_OPTP/'"I40\R5S@@Z3^>P_P/,D*.4IY5Q*^FL2A?8Z+G^O-
MN4^0 ZDIW*$ #I>.IR"/V$TU-;O2>W+8T])&X)2IS!M'!L^O#VG.$431@QV!
M0D PRS/5'?&UU)3P*H (79NU:'#*$?#$LNP7K__XX_+RLE,(UCG++OZ(?_T_
MGK'_^\<N*$Z C<4?@I_1_ ].2_J''P2!9?\!RS8=ES@!@,* -YOF'[WA6:J;
MQL\?"![#M8U.M^S]U\')_N$/;_?'IZ^[1R<')[LG!__LXQ\?ZM_W#KZ\_7#\
MY<6?$SJ@HA%OMQ8C,P6$AK+A7W_0/V\!]H/B^U*R::=25.)"NISS?E;9,6@-
M12BZ0<PB 8'8OK-&2OP%--)U9YQD+N-\"P_(LT1I9%+IYTCT3\X5Y[H*9N]R
M_X(F@Y$^.F;XVBW[>PH<GX#%DQ_TK;X,,)M!D^\#,8I?8.@I)1PU<Y ?>*CC
M[\=*?_4]F-6HR6BB@DXEDI3*C3Y3M-DKGC26.&@RC&'6'\%,>RF="I'T*(!0
MVJ^+YG9!?_\\0*O6M*EN.B_%*WFKZ7#UURNT#"J#8"KY#5YW(0UCZ;4%7@*J
M0PZK!JU_FD%^VE'"&);(D@&R);06=M!U(J0KHA@ 0Q(C;-Q9=&^7*.='!X-B
M6*3RAMI1" M0^%V935)4AR-)K=8_*&HG<2Z77ADSE\A/$VD[@275B\N&2V7B
M%&,9,L3H.-]1JRL*_+48]-"UC4X,F5B8]7J#% R14BUCTK>S@]P8#D?Z<^8@
MT"V(H_R; )\"?4GP+VX?GU?$@.4@$B(PR&K/3:&B1/ X6,\.KH=B3UGIZ,*0
MJV!Q(7U2N0#!6_E^JC,<0V8Q]^C3-<L]2&$GTMK$  0<7X.H%L.QG6MPTIHA
M7VGSIL/Y]RK-$ZFY"V=[*:0##M=3X81R1B.R@"V,=U[$'# N35 84X"CC-;1
M E98!ZLI*$3BHN8*^+1<-?K%%6A9;?)7_;:O+3X5B)PJWB+1=DP5@ [X(6!_
M[2% JKC&A%A6E'H=Y58V*^!(-^[+V'L&9C>N=\YQK+,O_:;9TY(]'* !G0*Q
MU;)Q<^01.HW?*E>3TOHD*'LQ+TKEA^H-DC+656P,W=%CM@G 0WR2^"'Q#BTJ
MB<^ 4\FPC%D#R""6!'*B&%1(Z;:I?.*-J-YQ3AD@R+N!],^\3;(!&E;Y!;"O
M0OLR+$#MZFA[8SOL/TJJW!"N+!N;4RXNR5ZQQ3O^T6MZW"IO%-AU7 H^V46^
M.HXQ-QTUQ]:DB!CM3;G)&WP 904LM*/M<N6L@YO[RLTK7>U(!G&J<E?"QGI0
MYEU4@@26C'O%L^]H^SV\/59A#VFY9A6L8-6E2&L6,)9X<8V5$R0'_ (6W(R5
M*J;38#GXTBF-XJ<8L;)FM+:"([H .&! DO7EH_%A7/23;!25%8 CZ@3672X<
M2U<A\.]4Q5P*EL<A\N00(".1"B2"U"Z @U]S&5P_<P7,,?Z,$$/)!QE@EE)S
M6?>"O%TJ3K7W D-@$F@H,=#K*8,=E9P8:DG\$V5WF4W?L+/<TEL'YH0#TUN)
M ],QG]B!^32V],?=SR?:P8&F:XKJ#L9J^9W]"PZYQ;_@KK][P9SK7O@ *G=2
M!Q-A!PLY%M9*<?HX0+]2*?G:*%#Z-@'!)-.FI.RG<6]Z8_.Q^!'P=XZL2!O,
MV?*0.9L!:->8<E=MDLF=J2B^TD)08,LT)S0A1TK&US269U+*<-I>K&+IH+\,
MP&"NG7BCCT&B?BUI%UYU!H\KRJ:NLR,U=20D#"^#<AWS6B:_!3TM @NUMAJ/
M:[<"^N^UMQWM+>UGJ5#V 3YE?.D_<.',I[T;B8C1TSYWM+_R(8#C<WQV5H"V
MHKVL(NE[(@*91M.RCFR_ZFAPB.]$F(,Z-_S_[5UI4R-'$OTK'1.Q87!(&AT#
MC,81C@#!V'B!P8"]NQ]+4DGTN-6MZ .0?_WF58<N$!A&Q\A?S$BM[JJLRLR7
M69FO@WK-!V\LJ[#7$U&A2QZP3YPM5I/ !.T6I->:.$>=.R&0: L6F X#CQV4
M*<E,S@%[:O#V89IPA!SC0PRTL]/",HS0C LCMR'^ 6-97G[LL83_*68_@O,1
MX(%N\ N /43M)3##G8JOG6?PO_Z855Y**GOG(JD$]4^U9KES5ZY6#ZH'Y>.C
MH]T21B[#5 ]"Q.S%$$_&HTCWY>5/!)5(>>S> PP$H71/11DG3N"7D>8B%HOP
M_>S&>+V8>[$4ZXE7Z6+J63"LPCMZ.SC3^B]^!8]7J]A5 X7PD<:KNP#)LB+#
M.(2S3V%NR]0G#4K;9 $,C/>GC&7IH/]8:<#&Q6J-4Y1A1+DM+&')<IY(1+[%
MU>A@1,]10T]K?VHV8L3(HTOG\W=A/TFY$JM+<O8LDU4(N<6QJ]F/\1U87&B/
METE"A*R/U JX2H&<SN1#2JIAY9_-*<"]3'I$Q5ZNT(B&L&]XFR24J(1+BKBG
M[D =\,<0NE!Q/4+FV!8T6*ER0176F%).CU(9,.D<[1V$@#@@O.5H_1(8C+B>
MQA.KY79K>^QV#XL^:$I0_T ^]R/',/>W"80UY>0>]2<KVF#:0_ JI> 0LV3Z
M(?A5JRB_%0.W\TX^?K=+[A@&<P>_PQ>YX58X%)UI.9]-O@6K2BD 'W/?K3#M
M%*'QU^A,L#"EA;L'GG\:P222$'8+?P*V:*C2G!W,F;H'QWY'.56X /Z*#!(B
M@P?3"\Z":O5#\Z!>0L6_#(<ZN,'&E,QE2,XO@O_HJ(=AWV4$P]]YYUWV;I>=
M5@"6*LC5@/-S";AJ+/;3MRKJF1U/ (0J@>V8O1N)Q8LB-A&9R1^CY0KS@O.5
MUE9AB)G"O,"$4L6DR/L':_# ;"22*#3/-X^%-3*93<:#P>=4%7CD!,XY)NE@
M@MVS5JJ0*CHQ-F-R8O.+EH2*BURAU;"0H@:RJZ6)2U0VT_K:EZK13TO.2GME
MZ*E&\_*$A?>'^+:F'AU; 4L^<D/"Y)P&^,*&]?D.@4I.I_8+0\/9NY\R%@!%
M(IH_V&UZ'F:9;.J1/ "!0H>L:S6#K*T_->A98;]*@GMR>MZ*BUF_=/*$[E(U
M=S'FP-SB/*'%AO$ P 8PD*$*\7,L<+SFQTQ;!<3F9ZKS%Q5YT@$+R.PW@$Y9
MEXMA:1S74FM<HL2Z].]8:#)O#G(>A4-B4X.8''=_JE&P9*I@)WXMNE2)BT.)
M9"A#,Y2ODT,Q9<\DY-\*V))U+V6*7IC%09T8.@YUEU=Z$DK+92S$Q)KD6MW<
M#(=#"QPE'=YZ:CC4="@EF<<X=/\:V$60&9>\$>#<57"K%>7)O$5U71=S@(F?
M:5T,I 3?!SY9CE]?'*20I_\=_-4-^"OPD1FXUQ69Q*/@Y#2FRAHT-?M/P)(6
MF-H.;,,D. J3C Y'M $G$C"WCDY-I%R2[E.V>D5[F(#Q=J^MY>B;>WBR(35)
M4$B7.A5SJ ,_83!$F_G7 J;ML,2DB8)!X [N%EAE"[ILXJ-(3O\2LDER(*!R
M-T[C#VF0>!>3R(#%B+0S27*.(@T+[0A5 >< ZQ)+/S&/QS\*5Z"= XSX8AJ)
MV$U*@-S2U#H(AD3STLSS8Z#+*0XN!21F1LX&Y#$AXLJA8*A^642$:^'2 $8V
MK-U@LHY!$)P;JM8.*D:..!Y;&/C8$\E(>O*61[+A5C%E3,:/NQ;*(ETD5 X=
MCZ636J"1< %89!!H!O*C;6;PHN=5G;T?IH!4<9/C5K>F%"=IH(S-2!%DP46;
M!GR?=9<F2[#!#>(S1><"_0X[N<-'WD4.(\X"AV-RJENWQ"4T8T>;TE+;-PL'
M:R.*1YYN8CKN<T&QZ+P+/$B97H*98&=\8 ?^ EHXY<T2_<-]F&D3<>3D7V37
M\ .XAV7,!Z+S1#>D[E5J_85#%ECL'HDL0LY'FG6GX9TK&%K#'UJ'-I'XXQFK
M/ D,G"??.N>53QX\XTC4A1QR)"J-6;39Q*IB40 L-0<00Y==L.53IFV33L,I
M+%B@4].=1IJ#0A*NM,!@W9M-S;V\/G7OX'7K4^> D^_ZT/3C.KS'?0W*D&N'
M<P\*L14#G"AU6:Y^#9)[:SVU6W!WJ%^"E]TF182)-\R%4#@(ON.K%"UR($Q5
MFN[7?NV&)!?FE^F_4@O7BA9S2T<S"$]U[P *8R4(VUB43<\8\()+"L%V9T4'
M\7BOB/C*R)0(W@<956)1T[*[7G45TC[)5U+ ZAA,/*&60:@S&!)6*XZ3^E!7
MZY;KSFT,S^V/["2I%3GV6CG1\9G::]L_[3DD["OG)LB5KK$+=MZ-7?5N5\XT
MS5C@3_TPI$(C K4#A$_:U*'SX[G3>ZJ(S!39.3^.EUEA>?WNME;:@6\^MAS1
M(9VL@8[OPC2)N?_]6:6!]WH5*@(1"?=E?]#>\ 6;8X,M=[;:DL 8G(\4!![&
M,\9,.%A@,6)F&,)74M0N3N8OFXA7;@8E?YB<$L;$8:PC^FO(*\@(?OJ!XQL*
MC8SL!BIK'"2I]KN.,7\<C:@\C4@3P(1GQ4#2#+&=O<VG8^FUP@,*++5SE<Z2
M-H4)\D9@$-G6PK%%ZR(A LB+YP6J$@[53-:.E;0]-JU >Y4!<APG&,]@7.YL
M*YJ;":?EUGCL8\F<4E"CL!T<5@N6D))5ID*3C5""3T"*XZZ:NOF<N]A,A[U-
MR:M%-;$N5W?43)D&K9OI6O?TS9Z_6%]B-)Z4$'VUUZ\]7]5..0[S338%*:Z[
M(:*JUE[8+U*Y<3[&O37AN3" [! 0F0Q9Q+':[G=>F)FA"1^@3/?SKXQ;?&:.
M5OR:4 I0V*_;.74!Q51MP1TWX"C1"3G"P#$I^.0A*+V"Q>3 "2V<P TRW2.+
M^@:EI]=E/*2<6(PHA"T(B^ "\04E>XC/F"//Y@O%N2J[X-$D=\LNKH'6<G3U
MV5!N/7N]R<5D>OP;\2BW83ND1 K[PR@<A+G)(H*%5(,$K9+)[<9]:<U1;1X+
MY=Z0RTOYOA=WJ>YR9@%)RG)G@_+1D(^2(T S<NAM\$(PT&F?.JK0?2'3J2D&
M2GS,:\JH?1(?)(XQ;6*3 BN-675;A-T;SZ.RW1QH90J;%//:W"81\=U@7A,I
M7*GIQOLF0S@ W[8UYJOX4-OSEG@T 0:[2^1*H%ET<&?^52(NCX1;Y^*@L?<O
M,ZP\@4T=W"5"FW&/(^!OY#/F"9J:!&FJQU;2570Z.)SB<?-)FG"Y&(9,[37<
M)<37\]16F=P5&79=84L$4I[ LT$"F G$["21,DG/E2$/@7W9+JQ?\L4[<_.R
M1:*!T3 FGTX(#PP4Z)'B]* 7-Z 3*V(YFE@'DX!!)I[_4D,**A$=X/0P61Q!
MX)+B%#DWRR4& 5G@##=S1MYWJJ64H 3VG@$:0,MO8+T:I\-YPA+-WC,E&Q[1
M-[3IJ-HFH,0807W$'IP(MU6I#$[,$7U(<-0F'^PTS9AL[&+G3*VQBM]+&2;V
M0@N(J+=$T=F9&=^Y2N&;AH5.5(!#]:W@YL(X'!2#X.3H].;XT#W7 !F16&:
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M-._J<\LC6W;8&RU+%HMP_"T]F_PMV3=AA)''OS:/A;/DU%$('<T/,>N38]Y
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M;M79&K8:WEJ8^SW+[#6".5TCB:ML)>1?.'>>70\LY5PC+E,7HEB46%;#5<=
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M?(*GM=A ?>%Z8<"<2RI\,*8<,:&LC>>/A9%UZNZ4VX%D6B^T>E:_>?90<&C
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MC5Z/?1A/QHLQS)]-T_O%+/YQ-ILDG"9>_OMBO+@<"9^XU9D2''R,2 J*>&>
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M7;X(HMSZ<KS*#DWOE.=4*Q.;W'X]!-Q!7#K54Y*/R:4^1FM(IVT7O:^++HU
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M) 7\0](,:/0@" 2E-=6"<F@:2.Q$]CU$#'U)M2MBJ&.NVJ'!-UC//OOQI*R
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M:#;<=J#5K% MTKJ)Z/>IORI27*IL%%B_S:;Q*A2,AL=$$TE)8U)@:2FC#)E
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M!VM3Z/7,5/X(?@Y__]/_ U!+ P04    " !]0&E1H[1>$#]0  !P4P, %0
M &UY9VXM,C R,# Y,S!?9&5F+GAM;.R]:W-C-Y(F_'U^A5_OUQ=MW"\3T[-1
M%]OKC;*KHJK<O?.)D0 2*HXELI:DRJ[^]9N@J!M%2H<\!Z0DN\-3HPL%/,A\
M &0"F8G_^)]_G)U^\P5G\_%T\O=OQ=_XM]_@)$WS>'+R]V]__?@#\]_^S__\
MMW_[C_^/L?_S\OV;;UY/T_D93A;?O)HA+#!_\_MX\>F;?V:<__9-F4W/OOGG
M=/;;^ LP]I_+/WHU_?QU-C[YM/A&<LG7?SO[=PQ&%!D2 RDXTR8;Y@L6!LDE
M[Y( 4<+_?_+O7'O,"CBS C+37FH&3AFF(<KL$+@P9MGHZ7CRV[_7?R+,\1L:
MW&2^_/;OWWY:+#[_^W??_?[[[W_[(\Y._S:=G7PG.5??77[ZV]7'_[CS^=_5
M\M,BA/#=\K=7'YV/-WV0FA7?_9^?WWQ(G_ ,V'@R7\ D77= W>?%U1_>1&.^
MN_@E?70^_O?Y\N_?3!,LENIY< C?;/U$_8Y=?HS5'S$AF1)_^V.>O_W/?_OF
MFPO)P2S-IJ?X'LLWJR]_??_37:3CR>*[/#[[;O69[^#TE! O6UA\_8Q__W8^
M/OM\BI<_^S3#LA7]Y9 K*%/A_(_:VG>],7TB(+-T'I'13W%2"3X@QDVM]\=\
MU1;+6.#\=#$@XKMM#XIW>@;C(05\I^D!T"X;8F=X%G$V)-1;[=[ >0ER'6%M
M\HR61<A_2].S[Y;@7DV_= %U]O5DPNI2RH/BR]XO_O!&KZ3>\61<5XPW].WJ
MKVL?N_:/?RQPDC%_^\TX__W;<0K&8Y !2Y ZE0Q>H0M!8/96A1)'=Y#L-G[J
M:C+'3%_,IZ?C7'>7EW!:%\X/GQ 7\_V$\V"K TAN-^1K8HU@>4*?>4E&)ZV\
M -#%RN!*,.C-:+<Q#"OS=S"CS?X3+L8).BSQ^RC@=A<'T,8]8UI3C0J*Z(W>
M6XU:QN1#5D4Y9RR9 FA\!]5L'5UO/7U8T+_5%)M/RUO:C)8VPG"39$OS;?33
M92QKNL%DLD[1<IF =&/(8'02+2\Q)RS;ILV6CNJ@+H=U.DVW^CVMYM?T:FD\
MA8BGRY^.SN?L!.#SZ*I1D@/^1%_.1UQI39P!,E S,JUT8-ZGP R0=>NU\#*4
MC;O-<J<I,(_+[6;5PW=57=_AZ6)^^9.E AD7*PON?VR'<J&Q_0?W'K_@Y!Q_
M(-N>!+F805K\DTS^5^?SQ?0,9]__D4[/J[?P8CY'^B]_A#]&0DBRRXMBT0JR
MT8-$LN=Y9 C1E(22IH]N,?H]L-X6SS6E7\PN!;6R'O8T+ZI/-"A;%M/#ZN>"
M)S3&;[^9SC+._OXM[TNIU<2;G+R:SA?S%Y/\_1^?ZTR=OXCSY0!&.CNO;!:L
M<)Z8+CXSB$$Q]"%(&80H(K<@T(/(GCQ=AI7]77*(ON2HN-Z6'Z?37-%]P-F7
M<<+YA^EI'BG#4Y8"F(@Y,RU1LF *9R8F(R#P(DUHP8KMD Y/AX'U-VTB_ :T
M>(]SI 8_$:S7M.*=3C_7.;$:_*AD!X Y,6F\8SH&FA$0$\M&&9HC$GAIM.'<
M@^JYD6,X%=SEA^S+CY?G<UH?Y_-7T[,XGBS-NKH=DBP(8[4 QWEE[;V8S8!^
MNC0"7WVJ7_XT>7$V/9\0\[?\R9LQQ/'I>/%5C)"#-1HM2PB<!$BR"PXBC5H#
METK2NMR$:0<:WW/C[&.DQ5WVJ[[L_X"G]*N3'W%"T$Y)B"_R&6FN"G Q_H*7
M<S3EH'5!P4RN=I_%Q'Q2@LQ CCY&E4N*3;R23O">&_<:*.4N=?00]M;-H8^L
MLT*YX)A%1]8E5X&%R!5+VKOD94DAV%96UDT@SXT.O01]5_%F,"_LITDB3_'-
M=#X?(0897:6A(/M.IZA92$ZR8J,7 H3DWC3UNZZQ/!]/:T_Y-C"2?IE.IK=1
MK<AX17")G ?A*L')=M,^6>:S=&3T2^E+2$#L;T& !Y$]>3H,*_L&-L1/DR\X
M7]0!7\#[:;+ &?UDY%))6JO(  F<YMG4RWI@,0@53!)>&=F"$]L '9X* ^MN
MVD#P#5SN2QR7ADI./H%6P(RTY.$5Q!JJ089N1&X$AE"4:,.#6SB>G_KW%W.#
M/>+MXA/.MHYXA)*,'N]L/3JF=="2O>*3\8R3$1,=2@T&FE@(]\)Z;IP84 D-
M=HKMP(1-!C&256Q#9CJ+PKP22!8N=[D4G@MO<NWUIR'&,*)OX$9>&[F7-U'C
MR3F!O+YD?8EE.L.+SWV$/W#^_1\D#^I_/('9UZ6!1:-+]0YKNG2<K_9!+G3,
M/M%BF,G7TCE*Y@6MB-'K)#@'45P3KZ3AF)Z\.?M8]-V,R@1Y-;5>XH3TLZAG
M?!%,O2N5LC#M0#%(A3-0G'.=LHJBR?73%CS/A$+]Y-S@7.3=;$HHENZZ!ZV=
M(7<=,] 0=4HL*C3,<6=C$K8&'K?0^#6$)Z_D/:5Y5Z^VM]6"B^M%Z\5B,1O'
M\P7$4_PXW;(.*6%5 8\L:D_KD+*&7*_HF< 4?9 %5&JB_IV1/GF6M-7-73*Y
M0<DTXMP# G(6P4:F1=8L!$[8 N<N*O 0-L<6#TF4YT6"G61Z5\&^KX*_A]F$
M^#9_A[,/GV"&+V$^3O7F>WQZOL!\9<Q#3&2\V\*P9,.TE.24R2A8"CEKEZ(*
MKLE]<$=\3YX4+?1PERZA,5U&EA>3<JD^G^'D\QE@H23/B@Z2)R6-XTTNU1[
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M=RN+LS>$/Q]O]M=  _/U+O"1)@.+ANH9CT#F$.1"-A<&YFS01:.VRG2IDS^
MT?'DN3&0E!L8G5VLJHL@W"@2,9$&ZK63M9BO(L=?+T^D@DI&E.R:'$)W1GBH
M?+W#&:)ME/-8LOJN)\-5I*90L3XEZ6@RR.J!\<("VLRDS%*%)$1*C9><8T?
M-U+YUG5H+]$W.'"^C>@5;9<GT]GX7\N0RE4X91>$+4/B'X9XG,CXOLJ\EQN#
M:>(XG%%%:"]U9JBC(5<N)@8\.^:S@&B]M\C#<^+* U'RAZ?*+@IHDCHQ^SR=
M$;#;1WV7E4JS30#*,H<%:0FUR#SPP)3GF=;3X&.;^ZE[41W3V!U&C7=2*(;2
M08.(L)_/)^,T_@RG+Z>3?(G)*ZOK,S@LR !,<^]9?3J5"1%E=+R6M%<M>+$)
MS+.C0V^)-U@F?OWPD;SR^?GL*[EE/TZ_X&Q2QW\Y6L>=JWD<QBNBJ$B& 6AD
MY/!!,,EG,N-;T.%>5,^.%\/IH,&U\Z\?KA&].,%)NG-[=%G\/KK@"I(NHZH2
M<);%HH!!0JYLR!9LDZ6C*\!G2)L&FFEPP+8E\K&:8-*9K'0-J8BA, U<L5!D
MK,]D.6<Q*<7;Y'!NA?2\O=^!5-%@F:FO4\_&:8%Y,\;-/UT1O OVEOYQ'_!'
MRBD?B AW*E(<6(M-ZIST&(--12D%P#BDQ+1&SD(6@<GZ&(P7WD7?9!-\? Q\
M*&O]$1)P%^4U2J^XJMD2I-6\,*N=8#KZQ*(UD7$R"" 'R;UJ4P[P"L+AK:7#
MJ6[#IKB'W!LE:=T=&W?&>AH=*X"FOB&(#$H&9H.(.=DLA6I3S:#U8O$$>-%/
M&X<H,7U_VF\=P]HX8))_AL7J][5P\DV/89GJ.RYCS#"_+WJP419X6[B-$\(/
M*.NUW/!"#IP)1ECILLY%A9(R+5E*R)BL2?A ;GA;X(=,$_?@T1J3&?G5OM8=
MJ:%K22_C]$WR!8UOXD\>-$W\_JC>:[5]&$].3G'U_=?7L,"[V3;OIZ>G]5VK
MU8>N0CTR1ZV%#*P(U$PK4]^Z"LNGBX5QX)-I4\;O &-[[/&[NW!XMX#OPU/C
M:(GL?KD9.\MJ_2O:]S/A"X0T%?(DA(K%J#]3(ONCX\5>Z>^[*/4 F8';A/@+
M[<XK(7W\'4^_X,_3R>+3IE1'"3I:1=*20=-4KT_%!B$M2^!5#%(F)YHD-PP^
MDK\8O>]*W(8L!TW6OSV@U6#^"V'V\??IQT^SZ?G)IQ_&7S;(?22]2CJ 8S$I
M3@+VBGETAIEH@U=2YG"8+-D!QO+7#-AW!K0BS,$S'3<.Z</XC]60/N)DPX@,
M&.3U?3K!763:1=K=7.),!,R2AUJBL\E)W_!#^6L&## #AJ3+@#'SG?+&A%&J
MUJ5F/M5 A42\\R%H9@%=?5C/R,0?.AYZG%EXCY5H@ZOE+F7,H=;,J_I$VP1$
M,*% 3$QY&\C^2;0+1$M&D+>"0W8Y@3SF2OG0 /XZ=QA8R4>M<(:1H^>T_"*2
M#:YI!6.^B,30*++%M><"FX17/^(*9\<AP=[%SW;1X.,[3;@:T4@D(5,0FN7B
M)<U;@2PJ8U@*UH')9!'8)B\G#C6 /RE1CZ+_QW@N<#T2#X9+Z0O#5-_\<T$R
MGZ5G BPW.5D@<_>1^$);AO 7EP_)@4?HX5\/!(NW'GU@D=>L=O)P6+19,!$5
M:!&=T^*QG&UM'L%?7#X@ PY25(GDHE**WK LZ!_-K2$3GUQ.69]_#A&5MK%M
M3N#QZAH\"G+UU$D#][Q[W+D5I0A;"G.YGKUZ74\4$KF+T91L@U0Z'RVVXA%7
M0>CC5K=1SF.I@G!/"'! 7118R8P1=>DTP*+WCB6CE>91N=(F#?$IYX7L1('N
M>2&[J.*Q1>-WP?Y77D@+(@P9EK^/%A\;$RW/P&TM?B/H'YVL8P%$9JDHB2&H
M;%23P^O'Q\#]\T*.1L!=E-<V+X1<8!.K2R&R(^\X 8D@:V2)<R/ 8):NV;[X
M-./_=U'=]KR07>1^L+P0*8(MR\2HJ!73UI)1Z0RG <;B70[<JR9O8CV+O)">
MO.BGC4/DA5SYL3\O2PLL3?>],C8V-]0[EZ(#OK4L!QE$B$8$7ZS3Y#B%Z)-T
MW): *D8=1P\B[2V__5^QO*^Y-K+L\&:E3:;(G,%&875QTFLNG4>$C"10+)LE
MVN^IRHU-_@*S^H;L%^R16=2MX3:ROA__FM1]IJV#_K-%>&T%;2L>K M9$:N-
MR;A9ZG>ZZ+>E7/7Q$DYADO##)\3%C[/I^>?QY.2'\81^-H;3#PM8++M_!9^K
MH&Z<:Q!BK[00C--RR70,P "S8_59Z8S.I)2:G"7V!=XK!.KE^9S:F<]?3<\B
M=55;?C6=+*CGVA5U,Z;5'"XH!7%\.EY\O:'#GR:?SQ<?<78V"MP4;F)]C=L9
MIB7/#+1?'@\%&T/)$,-#?!\2T.%W[X/R[U:\U#%TV, F?#.=G%0<]?3Z^LY!
M2QEE)H$8Q1/9-;ZPJ*1F3@FR=(3.DC?)%=Z(YD_"JN$TTL!YO);(UTTRN3@Z
MY"[(5)QE1H,C*H-BP23+;/9>0)3)\";/-78!=ZA3_:-29W M/98S_AL#N_KR
M?XUI?9VE3U_?X!<\71[M%,V+Q"19".1::ULO28R+##'Z$IV/KDV%[6[PCG7V
M/SPKMM-N*.VT7,)NFL-W\;Y>;A&=P+8\\]\)[7$.^5NH?1NSFNGLZ$3CBG"6
MD%GVCB8>7S[1RQ5S-E?4U@?9Y/CM$1#L@3/\1\>O7535DE=+YV&^E("Z+ "9
MZ@O/-2<CJDQ6@S8L.)() 359.1L!F^1_W8/IB&;[\-K<QIN>JFA1CWG=R;RJ
M4RYH(BB'#);W7D$:YGVQ3!@ U 5*;/,TQ#9 S]8<&D0##4*L-^%:S84NR%I:
M.]NA'<>T&4:%'7C10_X-=IA[$'(GO76<("6,3"LDA,%()H0-2D=IBVWBVQ^:
M&0_8)(<FQBYB/P AOO_C,]:KTGH^M=KNG)9D@0E=BQN2^24TLJ"6IU-:HC76
M.7D08MR%=G@#9"A%/L"/GEK8:G2TOC:^^N&T7)V$O9C/<5DG[O*4O%]=P$'Z
M;7.YUVOT:W=_R7L=(>227-!*IRB\K>\XYV1$-N ?,(4[(AC(7;GHXL6M+E:P
M\MO)^QI_.B/#BS[PRW0RN_QVF>5^?2RJ.,\H=:"].R/-'TX$US&R&- 7LN*-
M:I,H.^@H>J<5+3%LRD)508JDC*<1:+)7P0FR5Z-F"KPE9\0XGIM$=&U%=$3O
M[^!\NY/[,XB:6ESV70MD$SIK*P*?&==HF4ZUV$/TFI44<\B@:*EI4NWN?EA_
M9B8-J+"6!U*_X&(IJJN;[E&*F+@E*X3,&L^T@\RB=IK%E$T&CZ)14.%V2']F
M&@VDJ 9G$D/(Z.+$1NE2"J\.6(%E*"89V%K;.A -/A2575O&]1W!P6^H'P\M
M#ZK\)W:G;<%R;]"S:*J <ZW+(%)D!B 6\+* ;)( _D3NM ]+G?TNOG=1X='O
M([N _>OB>W"U][J8W$=G1R=:U IU=&2WTO[!-$^!@:1OK<VFD$4B&R4A/0*"
M#7/Q?3A^[:*J UU\B]7!IW99>I$D*X7^(1>(Q*$R,$6KN2_6&R^:E!.X!]-C
MO_C>29L=+K[W446#PXU-T.3E&\FE:.T!F'$N,6VE9;XXP;S/:%Q1RON#A4?(
M/R=+]E'%@8-H9$@R*&X8U/@AS9<O:2]SA*45TJ/+NDF$Q!,.HAF:)?NHHL&Q
MQ)9,CI=?K^Y[C5-1NY(9)%_+/FK/ K>6<2*P0NN%5&T*=SZ$[,_MD0VKN,,Q
MZ\9-<1> +1VP!Q$>J:3(L)KMQIN>:FE1Q>%!H"F"" 4BR\YFIH4*+$24# */
M&82!"(=<F8X<L'-LVNRBC0'ILDQ1W()NM<5"Y!($"A:<H'%[,L0 E&080LWG
MAN)P+7!G2_+HO=T<WH 96"?3)@)MX/]<%P6\HK:61.1:!;#>$S*M=&"Q1-I)
MLT\.#;A@FM1TO@OESVV5]%1-@P*UMQ&]@@6>3&?C?]VD<Q>$+>V0AR$>QQ#I
MJ\Q[N3&8)AJ8'AV0$AS,X!T#EQ2MK$8SG[5A4IH<34K!FR;G+,?BR@/&Q^&I
MLHL"6L0+3R?X]>*5X!_.)_FRJ!%94H >@;GE>^C>T=J)Q;,HG4 :,*VH;6*$
M-\(YO$DRM.+6XX/[2[U%M;'I[/.4#"2\_>KS"ERNA6J,*PQB/0;T*=!VNMQ8
M4R@E*:URDU3M>U$].V8,IX,6B\7Y9)S&G^'TY?2:M&!*TD"8K/0UGL0*YFWA
M9* 7+.BSMZE)&,\F,,^.#KTEWN! [-</'V=+._PKV=X_3K_@;%+'?UDQD;;%
MJ RP#+(P752A[1(L*\)$(7-PRC4I>'HOJF?'B^%TT,!5^?7#-:(7Y'NG5:W]
M.\L9%SQXD1S+7M)R%A-6G(%QXZ&:5UGE)D6+N@)\AK1IH)F[#-*'R4YZ]0DF
M)SB^?GEC6K:<]PR=G[1[SVTRE'I*8"U'2=1*MZGD^E:!-KIXX[(,D@M(,<NX
MI3YA+UGLPH%WL^EGG"V^OCN%R0(FN99B_5PA_(*+?31[;WN]]=4=[9H65$J>
MIK</MJ:A%N.]2R($%T*RP(L9=<4]E&SWKWW:H=6F<NY0"15(OIZ8[A6W&D"'
M+&ASM$*F#%!2O%?:_0JBWM?RJLY!G\3*79IOJH5[Q[*F#DT<QQP2)JET!!ZR
MX0:]%-P$4"+<JXY[1C647E[CYQFF\7(YJTF]DWF?RK5[]M146UU'N*:X&.N:
M%85+T=2T)K(S2W:@8@ MH[Q_U>HVUEUT^.-TFG\?GU)?^:?:W<F89NK%C<(^
MBKJON=[:Z(QU3>39(^W5R14IH\ZH8A&9QY(35]Y*B*..J >2Z_[;Q,.-MI1Q
MATTB@J6U)T1"K'4ULY62!2UD$Y1S1=PGZ7Y[Q#T-?S@_.X/9UVFY_$R/A6B?
M;EKJI-O8UK041 F W$* I+FR/@0@+U@75ZMLIWNUM+7#?I[P96MOKK*OR+ZP
M!46I%PG M-2:U1MLEI6/]#^#4C2YX+V#I*^3?]G@^^GIZ0_3V>\PRZ.HN+"I
MNHE%6::A:$8,BTP$IX0/T9HV_OP&+(=WW?OI>MU3[RO>!M<#EY!&:*F_7!_@
MH<V^ADT8%H.QS*MJ/5NI432Y'+H$<#S=[JV-+=K=290-#O0O<="8<'PR>74^
MF^$D??TX@\G\=&F._4CB>3.=S^NQ4[&>R"PATW#KPY41=6:Y**]=C>[U34*M
MNT-\/K086!T-[@"N" P9>?3H6:HO<FGA,_,<.8M*&$LZL"8UW<^&>P;ULL55
M\%#,UMJ S#LI:%S6L4A&!2.?QAD-7)"#VF)<6_ <*M5\V$UL".$^EN3OJP+P
ME\](?+AH]^*).FVC"=PD%DTB444AF <+S%J78ZK%;E63+?%>5,=_NK2'VM>I
M-)CX&VRC*RRK8-4N8%J&X=U"<YR(NP&UM<Z#WJ)NKO\<9-2&MGR94F*ZQ,!B
M], B%$=X:%LT3;R@ ^C]@>BY0ZE]%PD/':+_>@PGD^E\,4Z7=Z4IH_$I%V:@
MT+*&W-: +5L?84Y!^AR+63,5MH3EWVGZ\!9M#SE/!Q-2 ]_UQ>GIV\4GG%T2
M\O*%X8).!\S,8'TZ.Q$Y@XJ%*0<B:A'K SXMINIF.$]1W0,*>.M,'3".X,$C
MP/&_,+\XFY[3$-[CY^EL@1GFZQ]M>=*Z$X#V9[#[RV/]=%:30YR]+5I'G7D&
MM(*L0<%1!)Z5?/AT=B<H/5;X]2:O?2'D3GMM%).:D[-;7 V_K/$QUBN9G @>
M3:>5?FL7O9/E*P?PS?@+WA'BC[-Z;A"T-N!I1>)H:\H3+<'!TH0,R<4@!3AO
M7(L5[R%@AUO[!M3QG?SX(:7?HN#&=GPO4CH_.S\E^ZW.L=EB%7,V0B%4JK4J
M41?)M!*<>4[F&W<);-*%@VSS0-?.4)\[@X;04(OR'-L1_X*+D98$#T)@"I=5
M]GEFP>>:9UD*!B3BVS:OQ=X+Z[ES95?)-S@A_FFR$NMFA-__D4[/\WAR<G62
M; UH:SS6%%Q/:Z,G4]&+R)2-UGLEM$Z-,M%V _HLN--4.TVR7S=LIW=1DF49
MC2'?4@:KZG4:9]%$SX \#Y"1(U]_7GDH#G6!]TR8,[@FM@:0#\<76A#O8D2+
M!;SF+'&!3".)(::"3,60K5)(NVJC9/N'P3U+KO36PEVFF%Z'>=<W%1O#MD9"
M!="H'1,E<J:=01:M!E:2\%8$HO)Z=O06A^^!CEI?[S70\>#R>RP7?0]LC2^_
M_@S_/9V].H7YQ;%VP5+D,E67%]H9;7T8OI9G]\)$6R!RY9H$1NR(\]"7@</S
M8S<3II>>FM1BN!?N-=A?X.RR[$T7R&T+>NR,^5@5/AIR83?>#:;(1\+!X&S@
MLF2&B4>"K@2+(A26A"E!! "$)NG=CX9[#U8,>=S4VT5_0]^5_C1Y-YLFG,_?
MXQQK$=(7D_RZ%@V=+C,__CE>?+H]I*M"&,:*%%QDW.9 WH-0)*3E*WS.)R.4
M=>OO&FT]:-\/P3$R?QOK=GIHQ1SV /O.1%/(;2+S@DE?_8J8:IDWS*Q@=$8E
M#=DU\>YVP/CL;+)6^FEP/GD/U(USK0O<IJ]L/(:]\,%W-EKIOSO/!E/>8>]*
M-L).&HO(5C*0H49/J,(\2EK?2^(*9190FM12>11<>^C)C4=*M5UT-K2]]>Z<
MMG*88WXS3C6)ME;/_(CITV1Z.CVY+N[AN,H^H6,J94'B0,%\M(9%'I-QLGB]
M'@.PQ;KJUM\1*N*WU-FTK<!;U'4[GR^F9SA[CQ=))/-/X\^7T-#Y&$TT3-$,
M85J351>!*Z9\?0Y.HX^I3>WI[9B>)U^&5D:#[>GC##*>P>RW2SS"6H5>.:8S
M%++V=68QD*<158JJ:)]E:4*.=2#/FQ&]Q+[5,CY,T.3-2)3IY#!QDMWZ;!D:
MN<>HUZ(AN3!9FDANNX^:!^V5TIRV PU:>F_,?=&0.X]_%UV_2&EVCC=K;N^C
MO0VM]-;'0\C6)"PSV.!"3D%P;64$0ZMG\0*TL-('/;H?8S^9[5\+8VM;#>37
MH?(%-UEE%%A,D=KI[&.(!@$2)D5$A0U2[%?PXFY[/1:1[8TUD&:7:9]**=K)
M)%60&J2*TF?DD!5)UUNWB90]Y_.;Z>3D(\[.:I6_?41XZ^][2VT[FO6R7$0P
M+2+Y9SQK9T6HIXXN^1RBLYC=:!NN?66S_XS=T,J@<NHR2Y/(A0MO,D\UNCX4
MR9TT  2R +>C^S'N*[-?8%8+^WWI4P+KWO8&E>/]:-=K*Y$X"Y&O< ,Z+>MM
M*I^SAU)(PJ&,[FVYGQE>F_QI,E_,SNM9_)NK* V'9#,(#<Q$%9E&G<@[D,BD
MX,IPD%IBDT"#+7CZ>ANWF_T9%K4"Z=?7L,"1!I6D1G*0E5;D!P$P'VKQ?2_)
MD^;6>=?$[]@.Z? >R! L6/<T!A)Y@R.*.KZWY=4,\WCQ Z2Z]WW]&?X8GYV?
MO9S.9M/?QY.35_"9?K/X.@HQ1Q>,9F38D9N<203@A&?&%(,EDZW2YDIZ%Y#/
M@S#-U-+@].+V^%_1FORU/@^T3!@;&6T*80G,!"^8=HJ(GEQFQ5A>K/(V8),T
MA/M /0^*#";V!G=\M[']@'@)"W+T5DHF/"S3L)!%DC\K10KRQXV(ILD3U%OP
M/$<B["?L!ID#2UCS^7FM#/MJ.K\(>[U<TUZ0X38YN:AC?9&AIWU!E9-@O&A/
M$J@AZU!,+5(  6LUP=PD"V4WF,^(,6U4TR"EX*;%/W(I61,$,B=S+8WD# NE
MU!N=HL@'DY;(WL0$N>/V/G42["W6 7,!-H_OQ61R#J?O9N/)\@66=_"U_G14
M,N>$SK.@) U6T,H6(=*(DP*.4AIOVZT0#X!['I087 UWJ6*'I<KRU<D/GV<(
M^>WD'S ;US.6]^17B9')'#.'Q P:8+J^6 N9'"MON/:J@ VB20Q'5X#/D3(#
MJ>,N;5P+/_?7R?D<\Z4;]6IZ=C9>K$RH=SA+]!6<X"AJ)[GSA?%H.-.QIDF9
MD%A)09B28TPQ'<KI[83X>1#K, J[RS3?KTC5;4G\]/+M^Q].I]/9#7@@-!J4
MCO1=PSQI-:6M-M+.:SR8X'QT92T\=EO5J@?[>MI,:"'0N_H.0YBGBY4=]4\<
MGWRJ=2*^X(R@_32A7^!\45? D>*N6,VQUG?*Y(YA+?+$ TO1*BZ*#Z":G")W
MQ/>TN=)2&1N.S'H?N]X>^T7\=RRI5J?A+,I2\W')L/(&.5.\5M'WSAES@&N&
M@U:];6^1["[:QY(.>WOK6X;3THKF4RF:I>1)+%#33K++S)A<K,\(*34Y3+T+
MY5@5;GLK=STHL)^0&YRFWT:TBG+K@JEE#L0F4,=)=.BKL'OUWT/:AV)"(G<I
M>7 ,4%JF)?T3@I;DAV,V@?ML8I--XG ,>"#]X! $V$7(#13_'K],3[_4&[[;
M]W\70:I&A%*\J>6E D%R9/A&(,-7"9T#^*!R:')'?R^JPUN/_14W;27U!M?T
M]5':M^7&T?R2^$;4 B)*,70BU^%F!CD"30&O=0P^Z=3DK82-:)Z+2=!?U TN
M5&]>RKR8Y%^F$[C^R?*9$DC+I(8KNCX,MZ7!L"/>X]@2 VAZO1CS =348,/9
M%;;5JD3-"TL*EY4O:<$U1C$K)*V%&8+136J3/@I6/6"?')]4NVAGZ$3(%X0I
M+W%-5[?))S-< KTJ1Q^*HSV3I5B+IB:21E19$4P,*G"P]&^GT\^'>CJ\1=)4
M3]-60FY@K-R\^%FRGSKDT8;$E,.:5X5DELE:>D5FYWC@*F&3L)]U(,_%1.DE
MX :A/C?QK"SQ+HA:&B!W(1W'QNBGJGOTWD/.#2R(#<B"DBEJQ1DM9+0(@5.T
M"$&JA4@%@5(\\^:3_HCG%*T5OXMX&RC\S722ESF0.(LP^>UM*4A;4<6WO*-;
M;429=K)BG&9%FDACY@0W)O+,>0[>""]#;/(B4R=TA[<0^JKQ[F77P#H8T!B8
MSQ;7SU)]2$C&T'AZ,1$X1NZY8=9A8EH+0:/5AB7-=<J@<Q9=3BVH@QN$H._6
MR; 5P5,W X81[8"1FDM *QR_3N:?,8W+&//E%M4!U ZF0#>];T-S6"M@($U-
M6XEYP(WA?G!)NZA,44RFZI%(89GG&9A4T4KO5%*&/U'=;[$##JGZ7:3;2.7U
MY>0$\TL/5$89ZJNCK-;3( \T1.9K_HDOVJ&6Q9MU-[^_OF]#.-SN/J!N-FB[
MAV 'WLW?U[.,55DOAR!X8"'4A#--_8/"^L(<Y\83?7VG=^@[:?>JU^>P:^\G
MP@$#[J] 7)85[0!CZ+WY1O^'WXWWU,"Z#GN(;^ %^"8<K64HM PP]#6+P]47
MJ0K1,F>,L59B@4X5\1^'%N_95X=5XBY2&UAY/Y.DSL[/+M=V*YSS'FEMMXY\
MP42K"M9%2B=7GVKUME/5R4[JN]7S8??*O64_'4)P V^*JZ3L2R#9U/+/B15=
MJXB59&@X7#%K3 1/WXI.^:W=-'BSYR>HP;T%=XCG:F\FQUW6;9Z6FS\=J/3*
M_8T/6H=EAW&L%65!7FI1("?02ITU]UH:I;),0F078Q[M-:)=]+%\XOBRO9XU
MTK:VU5O:W5"N"=>ZZ*-5$(4UFH,%;Z!('[WE@DNE1UWP#B'+_2LQ/=!B,[EV
MJ-"4G/22EB*58]"A</*/R/D&'X(J$8O;*MU^U9JVM=ICU7BHR692[O;(M-4Y
M1FO)RZTOB7DPHJ#-!G4B&ONM8NZY+KPC8>%LAADFN>:#32<?%M/TVZ?I*6T,
M\^__[WFM"+.'L#NUVUOBNZ-?$[ORRF7E9(FE:!TRQ"2]0UI)2@SH]&C7<0PM
M^_W7E!U:/X@>NE2#(R<D)X-"8M!<%1^DY>@R%]HGDW,G;?1;=[KT,$3UN+WZ
M.8B>=JHVITDM010),3BM. 3/E;;<HXG&.4R=-#9P%;IEA>.W9=G/FZN,*,4+
M:I\Y*\%[ID40+&24#+DP"62I+Q@UB?O?A*;OY?&55)?-?O@$,YR_.%]\FL[&
M_\(\RJ!$*#55W#I%SH"O!^31$D01G _1R/5'B(89Z_VPCA#BWIL)ZS?& PJ^
M0=S8;73O8/9VMKQ!R?^ T_.:X;T$/+*U$B28Q'B P'0(@04LB65NC:]/WZHV
M67#=X#T_F@RBB 8A*)O(_/9\,5_06CV>G(QD=+GPG!CJ&G.K14T&0<,L-](F
M,E1SFS>I'\#U_ C23_0-LB5N[-1WUKAHL9;6]LS37L^TDL!J[!4S@ER8%(S
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M&)9,0)-U%#(WN>_?@N=8R^X07-CL^?43>8,S^^]+P5HB$J_PO:<MYV+TYR2
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M .8W_6.>BO*-6*_<^&W$/K?CQE?NPFEXU1@)2BLO0,O.ZNBC;2FH3 4O;;T
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M!9E1%ZX5?-2_T#()4,_ZH >QMN.-P1 <F3NVX)6*7H"O#7I:V:JBUPCU0[M
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MU0FSN%!V5,D_Q\VQ4Q@/=D7LI* >.ZXOMW*;4,3G]UH"6Z;YG10+G@@?Q2B
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M5QPCRED@I%LVH^/"YC:MO- 59%I9\,-#I:YSWJ(.B.W8;"C@1J:MEY@9/2_
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M40='B&,_-'EN)3=G$PFD2*]*XB",:!@3'*.^R5E.B)[; '^1P:/2';24[YU
MY50/6'I[H^ Z^BYL)Z13Y3ZQ!&RD+">GI+]6/A-+5#HRE]BVT(_$/J2KM)"?
MTB>3WNKEY=_/LE@HK *1R! 2XFOB2BB!.,(2>E2R1'@)BCSA<JC:+6YNAZU:
MI0M ZQO26E$W=CH!K1TC#0?8R"Q4*0I+3?<O^>OUG1PP%LL.E2&IYH3$2>G%
MSOI=2K%\ZHR[Q&9-E<D[O:S20JITX-O2P?]1E0LW%80_K?/\:M6J-YREN;G)
MH']=W7XI]ZVT1E?*%/GV?,8\)1DD L<0^8)!YLMR!13[*$D"[CG=4QQ+T;GY
M6:UZWTM3_WN] G0_89HPQ<3S5N#D2I;5XHJ.JN#3]K\=2\ZA5T?FUZNW'R_
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MB- 8ZN4A@IP'G&/J1T0ZI8(97,.YT?'&0*B[&>;:Q OP3E.QR1*9KL!Z)<L
M-<>T_X/WJQTQOVIOC4S9Q@*P->@"'.JYVD3MJEXN2\Z5HIQ4K[6EFKF;C\$[
M_<D%J"%H^OI*][4)J=(/-T"4B2T&+ $P5O\,FO]_<"6G3?X_%L9[F?]'$]0C
M[?\O&B'^N*39NY3>KG2+*7^_$NLOYGX^U_-5;J:R.G:>*BP2DWD944(ADGX,
M2>(E>K8(A:0^]Y%G=4+M*GANU+]1'8B-[@""EOH.2>5=.J";S,>$=62.WB*Z
M5;O$$]2*@UKSTQ<=SD/8(5O_2$A/E*3_X#O<TA\4E0%_'2@C?P^T.A/QN[0W
M7?[]'E:^2+O?Y_ES;IQ<Z]>L/!+=)!M3,8D8E02&2<@APGX"28 $C+GD2>S'
MBDFG[/I'Y,R-TNLMDXV>9V:"W,?5S@\? *V1F;H/4#UO@1R%8?A+'_NB7N&.
MQU%[#U_I./[UGGL*7$\\FGOTTN>JN).9.<S.Y)U<Y>E3?:>^F20)8G$@!60A
M-Y%#?@0Q2B3T0B_!4:0_5E95GYPESXTU6HJ#M='<9 +?JEY6"73< +#N!,N%
M_1C0CDPQEU=O/X++HLA2]EB4&Z>%]@-I5K+-X/=<G1$:=,EL+7S:I; K)GM+
M7.<&^GHQ3[(NHE<6@TY5:@KE-=4^'NFRV;DQ&S<[47(BB@+J^0KZ)# %.K27
M0ST601&(*/8PXIX7N+DZ_969&[.USSG,A><+L'OE_*+<']ON5IAO[FRU@2T,
M@.:M?;</ZPR:G8_6=UV]K#/ZW=85FZ8W1_?7-F:TNX,]@Y8E+_<W1SVN&@+6
M8?V_,_29V$D\'[E]3W* -GOL.C8EXZZ4Z99?S.I6S^_-M9S[]>.J6%#N41P0
M'T9E&$ 02H@5BF!$DRBF2<Q%:!4&8"MP;A1\*9ZH?C% HRQXJ+0MRQ;7Y:9!
M)I>I5%5:-E-#=GV?<I#>ZR:+DI'?7OW]XSL]P3ELE]GTC<5&Y,"(CTR3FP*4
MX$H!H_ 6]DT >:GSP$ Z[#<.#.A$^XQ;8->[P-;O,Z"E[D-M-#K U+G!:-/.
M=!N+#E:]V%!T>>[,&A&?3&'03REE94IGDV?O,3-KM@4-%,6Q2J# ILI,B$-(
M<!A"%8D@""*DO(3WJA%Q3.+<F'RK&5AO@K2691W<9:V]LP=\&G8[-W=0,$<F
MZ6V$6ZGL!=BH6R4:K10>H6K$*6Q&J1IQ5.CK5(TXA<'1JA$G'YPDNK3,6)[X
M$HL@1%"I,GN62=E,L-2]$&'&8Q1QY'2XT4.'N7'3.0&-O?/(V_>8'8F-W \C
MT]HX73!V(.GXR>OMU9AS *E=TGOWIGH>\N2YU&O]BH$WAY,H^?^Y>]?FQG$E
M6_2O(.)$G.D=8>SA R2!.9]<KYXZ45U5M\JU=\SM#PH\;4[+DD>4J]OSZR_
MAT0]2 $42'/N3$1ONRP2F0OB8@+(7*F0()+ C,84HE13(@N1@G$<A2I08:)2
M)^F)LZ/,C?EJ\P MC77LVG4>1\LSF6O1&?O\I;3O!C0 C7'"VXN!UQ.6LP--
M>YK2Y^O)R4GOAZ\]):F.7G9]#G#,PH G7#_MJ8*(JQ@RHM=HE 8L2*-$96X'
MN5T#S>W1;^RJQ4*'GCT<H>EZKC <H\G.#.I2HIM1&C?TXS#.)O_16*^T@7_>
MX^[-^8[/7ZDU7"O3;%_>K1]IOEH$"2-A(@(8485,8_$ ,B%"&$0JQ3A.,TR<
M>GEV#30_-MAIW>XL!;]7M@[M WR,K2TW7(_8Z-PP!*SA.L =2(RB^WL\UNOH
M_'9XW*GKV_7Y@=LJ1JQ$+T/T]^6!&M&[]?V&/GZ3YM9Z7;)7L]I_IMI&#A?8
MK!DRDL!81 PBQ1#$*I!088IH*.,DB)73[LI@4^;&,*5"#-CLS#3'=\:7&_UO
MM3=MU;O6!ZG#H9.'*;3<;IED8L;>=2EUG_86@J_-G.P<:6GIM3]XX2#0?>/E
M:CB][K\,MV;:;9BK43O9C;G^CH-508^SXS[+[1>ER7TA:!HKBAADS*B<$T'T
M3QF',HZC*"$X#%.G+H,]8SFQY@3R*V]/<FD!/<H*_>UEDU,!?I4KN<UY8=8I
M_.^5(/7#>JEGP+5G3,],V'&C)WQ')K]#: _T(FZ MM=L16N+;SK2<+TJBUZ"
MR[.R:.=P4RN+7O+[C++HQ4N&BD!))3>;6JE.3_&735E<(/Y!E\_RJ]R4\8NF
M(B0EPS%4*B80R2B$3,;Z/YD*$2%)*F,GB0"[8><6R^VL;N2*G^@&_#067Z^*
M;SD1=DSD']Z126F/;*UHK&W6W^.JUDB TFR@[:Z4CGT*1[D Y5= RFKDB86D
M7- X%91RNGIHN\U2]>BKV1K/.5V:QGLB+X_/ZEA-#U2>GVF/O[!E?E\>I+V3
M!=_DI=S[@O"(J(P%,!4TUFO50&DN4RF4-$IQ%F2(QMBM)^>U)LV-YVJ/-+\U
M/I4M.TNGVNO6I[U?8+US[ :(O6NN/3ZOGET[@IQVSD8FS]UT[=P![_?3M5_2
MMEP"7UK3]<YBN@8T%O6%L-_NHU=;-7&+4E\HGO8Q]79G-R8O-MO%=RY7=).O
M?ZR*)\G+RH-ZLQQ3DB4L9%"$9B-1H!A2&IG,_Y#+)&(4Q=*&G'M'F1O?-H8Z
MGCST(]E/A-[P&7NKSAH::X:R<KV'=/3U+<+1OQV33?\ D_"'E8\-)=A]V(_
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M'7B0D"M)*8%,+\8@0ED*,4U"F)JM%QI2GD1.E5DCV#@W1CZ7F?+N60*J].A
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MDN_;EZ!_R9=EI/HK+?:?-_]PEY<EI<V_^6,W*VQ]LEG_@).REY7OQVQE=]'
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MM&>'>A"HEKL2_J :>T.BMA0<F J,K2.D95OBXG47XL*0TVY V/E_LO=@>=E
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MAC7_XIJ\Y6]N[;CU=69L9-JUZ-)V VK?7O1?*Q&X6FCPNW9S*7=_!N_T7VY
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MI2=2-%59XM:=RFK8N7&'MGK[WW*C_TTXAGAV*%N&;MZQ&SLD,P:#VN(J?>+
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M<"H3F'*3H6[$ZU@4Q3#)HE3%&489MGKZ;0><&Q$<V N,P6!G\>4O_3#,;:,
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M_;6(J"!)AIG>;O$4HD!*2'"@=U]9K+=A,F5$.BUBQC%S;KSTOKY%SPN@:I\
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MI^=E^2+EAWPEN?YB&%54O5[>+K4EFW99S34K:_N^ZF]J$TJ=92J,%.(PI%)
MQ$0,LXP*F$K)48RD5'8:!AYMFMLZU;0&C'D.E_Z>>L<BL&)ZS$<F3NT0:#T"
ME4N@]0FT3H%;(^J\<VM_1M,X5G77D&P$3_WF$-,Q??]-%/I1#9MA/><KB\$O
MMKV!(YZ:FBZ^Q"\V!V$HGE_M-CFN5YM%<T?<#$:9!1E/E( !EQBB1&$CD9K!
MA&<LQ$E"2&HUQ1V]>6X356.<'=T=X]0_V5SE_<A31AOI<9'PK>GCK+<]2V/]
M3&=9K']ZO20^?NDDP_VL+^V@/?^!8?OSKQHCN5I)4947J0YZU[?;S6.YRO]7
MB@5*$TF8(##&)C(WHWH;SDW5-I:D/*"*<[OQ:-?<W ;ISEJP-N;> +HS%?RV
MKHP_'_L^!&Z[O;8_$$<>ZWO\OM?XU;:"O;'^=M!VH/C<+5]H<=*=L9WWKW?!
MED\-O8DQ)XE2?*0K<YZX;F:N6 :8"2[TO%ZI9P0Q9('^,:42$Y0)%3"G(AJG
MFYD;D[16 MF8"7ZCG4,EDXK!\XTCF9Q!V/;ZXUK<1K_9:"!K+?2X9+ #P>_M
MP\F6)KY8Z//V^,Z@]]/^EAMWV\U:[RY,LM$B3&(:DA1!$K+0J&$I2/3:'R),
M%5-AP"1V"D6_T-[<:.)HP5'N;?6XXN@B/GS),1#'-UIS=*P==]%Q I:Q5QW=
M)M]\V7'"?YMUQZG'!G),':/RJ5SMBTP=U)AJQ:)?/N4%+;@1%N6;_&>E'KV(
ME,Q4& 8PID3S#DDSF$5ZV\-8',<I4YP([G;[>)4]\[N(;$/N>A3_P4KR\J&H
M]DET RC_GVV^SMUO*Z_K24MF&[UW)N*]IEM,<?!SQ=5VXOXO-V#G#=B[XY$8
M?:#JE3:O,FA:4O6!W1'E>GGI,$+^J)0T[Y)_%+Q\DO?TUS?-4[4=6]W0W7-C
MPWJ1IBJ)!&4P"!#6JSX2P(RA% I*J(BI.8NB+NL_^Z;GMA2\?7Y>E;_R)Q.(
MO#+_T\/W>27AAOXR 7?:&3<N=>@$.^(<!]J167)G-*BM!MIL8.P^JEWR5:YX
M7Z:G,R6ZX^63_QQ:GY3LW%%YS6P#WG!EL:HF3J00_55'] >^E,7JH C)9[VC
M_F,CG]8+$H28$DXA#4SUCR CD"580AZS6.C?R0 /*R;KP[JYD6&W0%&C1V B
M#B[7*C*?ZKI9%R\"/XRGH'+5,8/2[Y? CFG?K&M')N,WZ=7A!:9\HC]*,2DO
M!KY-X2B?V)XM$N6UD6%SR!>Y,?7/OZ[*GWKE+=Z]_+4V$8A_5(DRA]M7DF99
MFJ04<BF4*4*2Z DB"""G',D@Q3A,H\6FW-"EW01AW[03^^\,&(\GM.6 :]/U
M^K>VW60!_K8U^7]Y\6_ZO\8#0"_O9*_M%3O&'@?KD>G8P&RL!E^[,/_5PKPS
M?I0# W?$?%*H0^N3\J,[*J_);\ ;KBVK=#&A<'TNH[ 6V2(9%1RG"BJ29*94
MFR:^,$-0<$EY$C/,I)4:G'?+YK8J[@IVV21/KWNSI]WDTOQWNQVSODEGCDR\
M$_?C%;6D/&$^3LFI:XU[H\I4GC ]7\#*5P,CR;^<;7TO0E,($VK\10^A#^43
MS8L%3F@2,!;!E 8Q1)PED(0RA8GD$@=1Q/2LX57#98"1<YLMNGI)M86N5#]&
M3UJR_AOWS\@3@$O7^)<9N0*[2;5"AM@Y+\&/*Y!V5NVXIJVA8O9F3V':,6]_
M3S?RP0225H8UH8D(BY0*FD*>H!0BF5%(9)C!2"C!.::2$4?Y^DM-SHV%]Q:O
M!]*P!<QVI.H7O)$IT@FW ;+SME#X%9J_V.K$TO*V*!R+R5L_.5#/N"P>3 EB
M4XRUE>):I!(IF:82QH3&IF!.I/=#DL!$,9D$>GV8,B>]GE.-S(T_7E<I_ZO@
M2[I>YRK7^T +E3)[=.U(Y%K,1J:-:^%R%QGNP<.KF/"I=J85#>[Q]$@<N.^S
MPQCA?;EZ+DU@C'GG=W-9T]SGU'FD@I*,\ B2R(A\QDC_S404L92$$0MD0E*G
M@LJ]K<V-(W;& E86HKY4+<J-ZZU(/\)V]. -MY%Y8@]95:5];^D(22=6F/CD
MBOX&)R4-*]]?LX?=0^[%^.Y7U(2;?W]Y8N5RD<DD%$F$H.*,042# #+$ AB&
MF-$DXXF(K$(/C]X\-WIHC .U=?8%]@[AZA__5X$P\EBW]-^I:-Y)7Z\HDW?X
MOLD*XYUTHUL*[_0'/$MU?I-/M0;=5[E2Y>J):KOOV#)_J"5:]*C$<2)32#*1
M0H2PR4D/D)[@*9%1@&C"G'+$!MHQMV&]4X(\J=&Y:GT!SWMG0+GSQI,ZYX6N
MLULT3- A(U/,KB]V%H..R6!O\TTC2EW)=LJGYUWL\8G/3BW3:8?V)!*=%TR9
MASRG'5[6TIR6KYNX*$,C[:R_K"N>K\W]X"MQY^9?M$,YEPN6I6E ].XK3(V6
MIV (4I8%4.$,*X8$0F*:8@MN=L^-V]N:XG)OODFLDWIC5RK#Z'DIP&^B7"[I
M:FU^!E6NL&.J\%1?"D]W?M-W]=AQ(-<70-B5..AX?Z+(08L J""804F#87TV
MBU(%CJ;/ZT;2;W]X*RTPL/FAFA2E9LS-B[D,W=P655V#9V/*AWS-EZ4)#[^7
MOS;O-+#_O9"1DD3&' 8<4U. .X2$4PY%HC*1I4Q2G+D)5-@W/K=9J;7]IA*"
MW%3GC#O[;\ 7Z:CY[]01=I/(6/"./!/T(@OVMH,?QGI0F>]Q2S $-;\:%P[M
M3RQXX8[,L?K%@'?X*P/[5V$R)]I2C.]W-4T_2=GDO&I^720XCD,I!,2IXA E
M0D*:H QB'D51AD,1)NFU-6&M+)D;Z?U5B!7]NP!*2O#;<VVFXSI[>*]8WLE.
M@?78%[?G*L76CNS*P]Z O2] .P/VWHQ;.=8)T+'+R-H9\^8U99TPLRDPZ_;"
M*].^]7JFRB#<*64L*",4TTS ()(A1#A((>-<<V:(4Y8P$5&N7%+TSC?EQ((3
MI.3=FS8&9DX?XVA':W[0&9FWNCG-)J&N,A3\MC/U_%0Q/#'Y+!ZC9!D?M_8V
M*<-GO3Z;_WO^B2N9X=W+.[HTY[/?'Z7<_+XJM\]Y\5"G-45)DD5<;Q/#,)40
MQ8Q"BCF#.(BE2D-,T]CI!-2FT;FMF;J#@KV QFY0&0Y:RX?EGUGU@2._>$)V
M0J89#NIPUK% :13^Z6OW;9C( HFSG&3S[("*0Y6PXA_K]5:*#]M5?8F4EZ*6
M6CP^<]N?R)G]:%,"HGK'5_UU?=0?-9O5]2+$ F,6QY#I90]$5&0P(RF'220#
MFM)8Q+'5Z=>(-LZ-^\RBM"QJ/5>05]Z"[;/^C6S/X$VUS/;8ODVQU[_31FQ6
M.=^T8K!@6^2-0HIL*[74__!L_'8HG#/2EZ.?96?2Y6-?X50=4GL(:A=![6,K
M1-O\"=\=7M]T;GA,U9U=+9[ZA:V[U7'@#+K:H6;2VW?Y1#64WK;KW8HMC=LI
MO<671FIZNF),XV)W4)QIY*:&[7KN5@^T:')[C()HN<Q%?:]7B*_:KG:DW:E&
M290NO^O?U$F)N^P2G%*BL@1!'@L"490RF 6I@EA%2(E <$6=A#Z]6#6WM4/7
MJ1MPX%:U#N@Z9I8,.]? WK?!24%^^MENZS5Y[XV\#)BJXYQW;UZ!]KF]\V/8
MI/L_KUB^WB#Z??G0V\.=3-[[[6IEYI5=ZJ4($BGC!"J](80HH1@2%NHMH>2,
M,I7@2#G%8)]O:FZ<W)@'EGN+_]WU^N\LK+;W>S[ &OT";V>D9L &M%$R+B^B
MX??V[6QK$U^O7?+Z^/[LXA/N*50?BTV^>?G^*)=+$^)%BY<%0RA!$9,P1HDY
M\$XRF,6$0D)XPE,1:H9 MGE4QZ^?&QW4%H+*1-#8:)]2=0*^?@JX'I21A[T3
M'DXI5N?=OB+/ZL1+)TNV.N]0-^.JYU,#0__EPU.57O!LBML7#W\4579!70.B
M%::.$I)PIB*H)WEEJN @2'F(H- 08AFRD":Q4]R^1:-S&]J-S6!G-.A8?86$
MN%4'V*T$?,,Z]NGH]8BZAZ0[0.0UGMRFW6F#P1V0.(KD=GEVJ'Q44[YA5Z"&
MO]37MVF:D2P0"12I-&I_7$(:I:'^$<<<<1JFU&I%<;&EN3%0IT9)Q]1A%^7G
MX;6C&B^@C<PO _$:(!=U 0N_*E'G&IM8'.J"S\>:4)<>&"JA__<MY^6V>NG7
M55GHO_+ZW.-KN<SY2_W_?:9 K'"84!-\PW&F-R280:H"# D5 8H12A%WH@]7
M ^;&*M\DK^Z:=CZ 0R=<M?,=N\..;L8$>606TJ:?!_<&U(:#'\V?HR1P#$7/
MKZ:^HPT3*^L/0^A87W_@>P8$]?RI_>/;)5U]R.E#4:XW.;^OXT5VM=43GF1(
MPH!G7._:A("4(04%CC*2TM"$[EB'YUQJ;6ZTMK,7B)W!8%-;[! Q<1'D?O[R
M#MW(9+5';6\K:(R]K'TU #Z'T!&?,$X4!-+W)?R'I^ -6UAZPS NOF2Z@ I;
M?PY"(ZP?&GA(UMZE=>[7OI9U#>/=;4U&!&9<;TD3+HS^:$0A02F'/%8ASB*.
M*7%:6-HT.C?6W=E\>(W=FCTX^L"J RP/R3S#.O8AV?6(NA^2.4#D]9#,IMUI
M#\D<D#@Z)'-Y]APO=3OUL_[;?_Q+^QO]/Z/Y\1__\G]02P,$%     @ ?4!I
M4?.( //^?@  B\\% !4   !M>6=N+3(P,C P.3,P7W!R92YX;6SDO5EW6TF2
M)OA>OR(F^W4LP_>E3E?UT1(1'6<4(8VDJ.R>%QQ?S"5T@H *(!5B_OHQ!W<2
M)+%<QW5EY8F42)"ZUY;/S<W,S<W^^__X=C+[X2LN5]/%_-_^PO_*_O(#SM,B
M3^>?_NTO?WS\&=Q?_L>__\N__/?_"^!_O7S_YH?7BW1V@O/3'UXM,9QB_N'/
MZ>GG'_Z6<?7W'\IR<?+#WQ;+OT^_!H!_7_^C5XLOY\OII\^G/P@FV/V?+O\5
MO>9%^ 1!< 9*9PVN8(&0;'(V\<"+_[\__2M3#K,,# P/&903"H*5&E2((EL,
MC&N]?NAL.O_[O]8_8ECA#\3<?+7^]M_^\OGT],N__OCCGW_^^==O<3G[ZV+Y
MZ4?!F/SQZK?_<OGKWQ[\_I]R_=O<>__C^J?7O[J:;OI%>BS_\7_]]N9#^HPG
M :;SU6F8I_J"U?1?5^L/WRQ2.%W+_%FZ?GCT-^IW</5K4#\"+D#ROWY;Y;_\
M^[_\\,.%.):+&;['\D/]^X_WO]YYY0EI)^2_IL7)C_7'/[Y:$!B(T/4_/#W_
M@O_VE]7TY,L,KS[[O,3R;W\Y.?\TAZI1YB6KK_MO%__PQYNW?EGBBH"RYO(-
M?7#Y[^M;=J4 OYWB/.,%3U?/GRW2G5^:58DNKO_E+$2<K3^=9)Q.UD]]$5>G
MRY!.)UX*JX,U(!$C*.4%>!$B))5,D E%T>XNPY7@%5&\5L *TU\_+;[^2 _^
ML0JA?K&6!C!^*?[_]N"E%[+9C_JK5?>1?G=B4XC9J4P+Q08@B@TX90H4SUD1
MD1FNT@#$WW[G7=IO:_;%,OVP6&9<DO&X>FE8I@=:O@O<R]_X\4M8TH,@?9[.
M\M6_KE9D"+V=+@:0WX5RB-R__$!<%UPN,;^YT,VCS*TY.R63BNO?/$3O+XCH
M7 G_>18^310BQV(R^*2(^^0X!&0%DC6.*U3:Y3* XN^\="O-BWXUO[\$1U;]
M%63_W[.PI"?.SM_CE\7R=")+06260Q+>@Y)90(PQ019$/?<)$Q\"!(^\?BLX
MR'[A,(14.P'&.UQ.%_FG>7Y-?MC$\Q"$90FDR@94#N1"14524<*BM1YY&')3
MN//RK4"A^@?%_A+M!!(?EV&^FE;!7\+:R%R*3 J*U.0V1TU;G76TU?$D9+).
MEF"'=!7NO7\K8.C^@7&07$?&QD_ST^GI^<_3&?Y^=A)Q.7'1"Y<* DHD7'.>
M(6;Z5C@E699::50#8.+^>[?"@ND7"P?)L0L,O,=/TRJ$^>GOX00GP22BGYQ?
M(Q-%WJY&WL()2(D+HX2W"<U@.+C[[JVP8'O'P@'R[ (/KTA6RS#[E2+K;_\/
MGD\8059E6T@:0H(2Y"%'K@7(D$+*,MB4V6" N/?RK1#A>D?$(1(=&1*OSI95
M4C]/5RG,_C>&Y94;Y%22)7$%Z,@?IJTN0_ Z0M;,N\2C$&F05,DC[]\*&+Y?
M8 PBUT[<RQLF?J9/5A/%I$^627*)K05E.4(H18-BO-#>&*)G8D#O\M[KM\M)
ML7ZA,818NT+&1?QTP81$98/QY!@IAQ0]*0G.*P<Y,A-E(H,HY.#8N$7 =NCX
M#E*6AXFV"T?CUWE:+"EN6HO_ VD!7RW.:*<\?[7(.+%>6Z4].<X:/:A ?E/4
MD79*;:WR.F09A[ B6Y"R'68Z3G8.+>XNT/,Q?/LUD_BF97IQ9'89?TDGC>3&
MD85,Y%S%1#&X*0ERX5I'XZWWP^'F$2*V0TS'^=#A1-P%5E[D3#I87?[U9CI'
M/K&I.&&9!^E$)G.9+'A7 MA8I-,ENNSR8#C90,!V&.DX/3J,:'O"QROZ\NWR
MX^+/^41QBUD:3ENH(3?<,X28/(7N69>$R42T86ATW+Q^.VQTG"$=0JP](6.]
M7;Y=OELNOD[G"2="L. 2R<4K+@CACD$PY' 5:TR()9#/A4/#XQX-VV&D^\SI
M  +N"2CO%JO3,/O_IE_63I66:&+@!H3GA79+;RO<'7'!$A/<69&&B'8>IV [
MD'2?4CU8N&-GT2H/2PQKNKWPQ:.S@(H,H?(J4QSO:K%!=CQ)ID7Q X#B]CNW
M@T''>=2]!3BRXFLYW^S=Y\7\ZG3(6^64L@Y$-A842YYH9PI8S@Q5%CJD(<[C
M[[]W.P!TG"\]2) C@^ #IK,E 9B+^'%Z.L,)5R$42T+@M*>!DLI#=(Y#*5$%
M6RB*,GP $-Q_[W8U6QUG1@\2Y,@@^+@,M7CZP_E)7,PF)2*G2"B!51Y!T0X&
M0=@ ACM?9.#DWPQ1K77GI=NIO^/4Y_XB[,0 _/0M?0[S3[@^%TZ"9^V4AI T
M8=<$!.?H#Q.4E"(9KL00-3B;WKT=$CI.:!XLT"Y"ALLSP(O:H0ILTL'9:F(Y
MVLRR V]R  I_$ADUF8 ++XO0.=+'PYVW;Z1A.X!TG[\<0,!= .77.3V-Q#']
MBJ_#:;AD:^)()E&Z!)E'#2H%#I%%V@*#R=84;U(<+@FQF8;M@-)]$G,  7<!
ME%J&MGP53O'38GD^L8:V2$(V!,_K#DE[93"%8,]-M$DX5%X/AH\[K]X.%MWG
M+_<79Q=H^' 29K.79ZOI'%>K28P^H&09F)&A1LT<O/44.BM,1211N!NNOO/.
MJ[=#0_>9ROW%V04:?CK!Y2?:!']9+OX\_?QJ<?(ES,\G4BN?!"8PK(;165 8
M'6($K1,CZT8<BB&244^0L!TZND]1'B[>+E#RX3/.9E?41]0Z(,DA*D8>M<H%
M?#*1%)LP^IS+,#5^#]^\'28ZSE<>*,PNH$"$G]1"D47Z^X?/)+?5V[/3>F&Y
MQN 3+2S7*CB0/G-0T?M:ED9\:>3%AN)\'#!(>8*2[:#2<69S8&'O#1WB)2[N
M@.>___A IF_H@WTOD,\SSE>8Z8O58C;-M4O RS"K%^!IG>#IZBX'V]XN?_:I
M@UP]WXWV ^^EGZW@4PA?)NLST5KK][;\/)W3RZ9A]FYQ<>'H&G:\U'-1$2$X
M33$*=PQBK"<BVOG"= IETT*\6H<EK.(:!Y?OO%B,.#M=77UR?U7N0MR^-NCJ
M'2]6*Y+M-:LNB.PX5T0*,Z!0<G"&_'&.6I)I=<%ONN!^.*MWR1CGSGLS3%R9
MH@%D/N*N=9?ZR_C]F@F6G?:9!8K>-=E/+CVX3%MOEBR*J*V6:D/H,Q1P[E$S
M+GX.4>]&I!PBZPX \RJL/K^8Y_K73_]Y-OT:9L3,ZL7IJ[!<GM/>^Q]A=H83
M;65R]1HXQD +BCPUB%PZR,H[EZPT3FW(M!T.H*VHZP%0!Z%@T5HE'>#LM[#\
M.YZ&.,/+LXLI7@EM8D125D@%1:5"K# 'Y$P&T$(P;X5-'F,+=#U!TSCM/=IA
M:BCQCXBDZOQ.WBWQ2YCFG[Y]J?[H3]_2[*Q&")<??PS?;MAR,66;7#7M(=0[
M(1I"H,C$1Z6TS%F'^^>+#]WK'=\Y3A>0X5'34M0=V*)?YU^)ZL7R_'<DVJV+
MVB')1T7R  *SX,B 0I!>)Y/1(]^0XSG<^-PF8IQ&(>VLS=X"[@ <+U*JMX)6
M[S$A[;UD,8F)*Z 'G:6C_15D) Z4XL25$V0OLS'"2,V#WU"V,H C_011XS03
M:0>>P130 9AN&\N)\9[I4GOF2(LD%%/O)THDVKDH*3OATX;&$H>#YS81XW0;
M:0>6O07< 3C>GG[&Y0W*5[=@3M%G]M(&L$C>F(HV@2L1(;' 1"H^;&QF=CA4
M'B=IG-8D[8 SD/ [@-$=V4QB,E$)J<$P3S)AM2&L\-5*)G+%K'5.-#$R=Z@8
MIVM)PRUI;Q'OCX_%:9@-M <MON#R]/S=+) XYKGF%+[4#&IUSI+3MG#4D+4F
MS]W&#-'R""I[EFT.Y+@U";V?(JJ'V'N0!.%@DN_ RKPE3D*M(7R#887O:^?J
MM^6/%:[%-4%+WGP6'$2QOII,K%**P)(+2 ;3LM@DP?PD53U$XX/@:#C9=P"D
M39FHWQ?S=&E<DW;&6"X@<"R@$H6,3FL!)26IM>-:A@VWTMOD F_(ZB% 'P1*
M TJ_ RS]2DJ8?YH2-Q<B(KMZG:?Z9;'(?TYGLXF124:?$(3,C'A2#((R#&20
M/$>7%<L;^F$,D>!YGK@>8O=!<#6X)CI US7=S))@%--@5>U@R'G--^0(Q8:D
M1%T@;7SJG5#2.&@?!"5[2;0#)*R#Q4M@WQA+'Y5%C[GF%_2Z%@DH-$R079(2
M<^+1-<D<;Z2FA_A\&&?G8%EW )@+^B>H&+(8'6A4M5HM$-6&_D@*!5D[X5RC
M=/'Z]3U$X0,66NPDS0[B[C?3$*>SM8=%L=^ZLO'S8D9"7]4X\/3\6C0Y)&]"
MY& 2>?%*ICI\02; Y"67,4EA-O27/1PEVQ(X;CS>O."KB9XZL$&W^'J0"\.<
MO2L6BM.T_4HA(=;%:%DPV:2"16VX&#4HXKHJ"FL#@<=Q=H@^.D#6U0G=NW!>
M(\FKO&BAF%&&$,$X=* 4Q8T^DF>7C&;6:<3LFQ2);2:G&T0=I.Q'SD8/D'P?
M^%F>T5L?R(B\!&Y+;=S*34Y \:"&F$P"(X5*Q3CKS8:> (- :#-%X^Y][5 T
M@/P[ -+=Q.@5/U?7WB<LD2/ &*V#C"0CPQ"\)Y94#C:3>U B;W*X\319XZ:E
M&T%J0$UT@*NK2ZZO%B>1?,ZJFU>+>66/F*EW8*89EY>W:.YQJK//CHPO2%DD
MJ"(E.%<[E3N5M?<"'6MR'65_DL?-;3?"XY$TV %6*UM57'^;GGY^=;8Z79S@
M\@%/OOC,LW-0!%I0404(4M<Q38H5B<(U2E5M0]RX.?!&^!M<*QT@;8._$%3.
MA?-ZB=<K(!>!DUTG/U3I1.LD*N=%D[.5/1VU9CGR1B@Z4.(=),'^F"\Q+3[-
MI__ 6J3W$N=8IJ>K293:9I4%,"\*$2_((;"F4,2""5D="Z6:'*D\0D\W;GZ[
M],,0FNC "+V^?&T=YG""Q,@MX=6R&ND<2TQZT"63395&0S 4% ?EN&*6EIYM
MDMIZAJYNG/YV !M2,QT [<UB_NDC+D]>8R2?D-6Q#CF =F2Z*5[)X(369-,]
M2B.BB)MF @ZPS]TBHAL_O6&*=%^9=X"71R+@6V>81I%D5+* A3M0%$^ RQ0$
MZZ1\$=IZ$9J<\SQ+63<>>#MD#:N='N!6C\EO6]@;3D1F14NDL)4%,K2\#FCV
MFL2FBA7"&14WM;0:J"YA(TG=..<- 3:,/CI UBTF)L*C%[%HBE:XJ4W>$GCF
M.+A@A;?.)YLWS&\8-+X;M[#EV">#.TF\@_BNMFV:GIZL&Q3,\W6*+5562BC$
M=G'@4JH!JA<0-%<@E"3X,YZ%:9(<>(*F<4MBC@*FH332@25Z0D()>5"FD'-8
M*(Y0ME[U0Q5!IF*49YH5V:2RZL JF<';L!T56@/IHP-DW>HV=]%-)3/CF10"
M<DX*% NT1K*D/[C@*+(7PC0YMKE/R-C-M891\ :3M+>T.T#+BYS7Y69A]BY,
M\Z_S5^'+E#;06VQ-6$%CR:&#4FI!LR)E^RPC!1,V%5I95HDF::?G21N[>J\)
MH@;62 \82^GLY&Q6&RNN0XG:-76)GW&^FG[%BY3:F\6J)M+>EH_AVT1;1RYA
M;=\OLJR#!!W$6.^TQL1T= P3;]/2;3<ZQ\U[MD)?0UUU ,7W>!JF<\P_A>6<
M?,?5+79?8YFF*4FO1*LC!2AH="9'4AF(UAB0WID8E);&-2GU>YZT<;.DC0 W
ML$8ZP-A#04VD-BS)("#%.O'2DZVF16(A$86N<!/8IEF1+5SZ<?.AC3!TH,0[
MR#7\-ITOEE?#2G!5*W4XZL(TH,]US++B%-CJ",ZJ@F1;0W%-$'.?D''3FXWP
M<I"TN[0PM#-?MK"KTY!(.:>GRVD\6]^&_KBH"=M:M+.8T1,_77-=F,B9NPA9
M:0\*N8;@> )96%(V"^[$AE&%+:S2/N2/FSP]FB5KKMD.K-]S&9Z)22YPC [0
ML5*[7R4(NA1@D2)J9I/*HDD*XSG"MDMI##YU<ZP,_N'*&0QL1YY?\&ZMC\]X
M.DUA=I>9H889W'W%428;/,'5,<<<Y*3)G2^< "3Q8MRO4\63R;)!QD+N/VM2
MP7N,,0=/SOZ@A<APW596UEQAH.7CI=3 $E.IV."4;)V9W6_FRK@C$';!RQ/Y
MVL/T,9@;V-Z270MUM2B7Q2+TT\&LV"./;V7!MN%F(.MUD>^Z?N$U .MU?.]0
M@A6$/<4# Z]CK58V1>O"?:/>!X_0<W@X<?G C]6IG'"AF/2"N#/U0A.W 2C^
MJ;./7 Y2,65<DQJ;NV2,:X>&T/Q#WWYO,8\8<ZZ6I[797SY+IV^7'W#Y=9KP
MQ;?I:I)19LV\!N-(E\HG2P;8E5KZ$V.=?Q>VRI/2\V]!A+Z[#X_'".ADH]I#
MF8L!)=L',M:1P04'J]>+DS"=3Q"5*]H4B*I>M]71U/XV#H303'&?K2[;.'6[
MP.,A%>-@9!C%/D3)@5(>>[[%;_2L=#8+R]?3\&F^6%'4\1%7M83G-SR)N)R$
M)#PKJ5:HBCIVE24RKDJ1<2V:655EEY_S4+9ZT^BP.%23BU9B'1LC[\@G/PD)
MS]8A:2WRHE^K7UY)ZY(GQ8UV0@>(0410Q45PR!1)*YEB(HDKBJV@LN4+QZDT
M:(28%D+N(BM^N253B(&_TI>K"9-**52$^I I4I2*(D5'CIL.KJ!3W(DVCOI#
M4L8N53G86QE(RAW@Y#U^Q?D9_DQ2VG25^;JW9VW-1O_5&X43SD6(HM3[K;5'
MGQ<((;$(&*(N"87AODE)RAZT=N(7[PF/!]4!;775 1ROK^^\HKV[FOG+J50W
M_055MDZ:S*$PVKO)#F<(T4M BD6%\)P7WJ1O]+.4=6+4AH':L'KH %B5C[>E
M]J6][3Q\6,SR1&J6LN !>*SGW0(%N82%@8ZICAEB1>@F*9['21K7:@VL^P<Y
MYT$4T0&DWI-:B( ZPO,U6>;98CWRX5)8DY)M"$B^J-#.7HPR=R$FR+4-:D81
M6&FT23Y!U;@VJBVPAE-'!]C:OJW1B^4RT*?K,X!7G^N7O\Y?G-3F@6_+<YV0
M^ 19,%JA@82!G-]"LO8V1)*2"DQ(0?M'$Y0>B;]QJY+;XKU'B'2P<C[@NOKG
M%YP3*S6>?Y%/**"O C^=?L4K>Y"R5ZH@![WN,VXP@4N2DYO,T,4H<TE-6@9N
M1]ZXQ<UM<=M 01W [KZH)L8:+JVW8+#.**S]4'QD$I)R-CE1DO=-.HG<)V3<
M&N?VON3>0N^@U.]:.C=W2298KX7;"GE._J]*48%/5D QT7$>N&"NR06S#;2,
M?:>G342[IZP[@,OOB_GB+A>7P+\YD4?&/+=U,9%OJUPRX+*P%% )X8I/@59:
M"_ \2]G8MW4&A=*P>NA@\ZICO%?K5@(7[%R73MM4DE(R0D#++]I$AQJ@1\_K
M4&_NI&XT4FLS0>,F1@;6^X99Z@<KH0LP7=!]Y<CEY%)0,H 6AB+O@@BTQ"B(
MB,@T1^^+;'*QXAX=XZ8^6D-G?Y'OCAA_@9@Y?JH5B,,UN7I41A,4Y!8Z:^HA
M1JA=Q66]D>2 D9L7+0H5=)/2X*?)&M<]:HNH 172@4EZG!%NDD:,%',87^^Z
M\0).<J3X@=E<"LN%-3D3/PQ4S1REMJ :1@T=..(W(<356>QT?D9,W51@O\2R
M6.)UAU1<_?2-Y$?JF\[#\GSM@CYR6XUQ%;-+MLZ'KMTPHP#'R79'IQ)G+/#2
MIJ]M0Y[&OF8]J//?B^Z[60;$XN4ROFPU73/&,=3^TD'43M,V2 BI, B2,:92
MEI$W.5!]A)ZQ;VTW@-]A,N]@1WZW7!#5ZR2,"TI9S35@KI>-5$H0)=:^B-;$
MQ(W%-MUR;T@8^_+TH #94[(=F)/?\?3&N&YULUMR(TMP"%'5SM&UTWCTT0''
M%)T7)<C4!#H[4SIN.\JATU]-]=2!<;K#X(0Q%S @@QA,!,5S+19GQ(MGS$89
M7&@S[? .%>,VG6P)H)WDVX&5NFK-] Z7ZSNS+\-JFFK-R71V=HKY.E *,5%@
M9 I@J?//A*!@640.R>>L;*K]=YI45FQ)W\C-&@9&5 NE=&"(GF%K8EC1*9<:
MC->10TX'\/5N2U%>L"2%MJS)&?,S=(V;I6^"A=WPMI-B^L?9.AGX>KI*L\7J
M;'GK[#[Y:%R0 FHU!@4=*D+4WH MB(F6K(Z^2:YB3WJWP^7W<AO@&$KK )M_
MP^FGSW7=?L5E^(2_G]7;6&_+FN5;[2KNKT ;5*;8)T(H19%D.7D5D@5PQA2O
M5+"T$EM <S]RN[:8PR!I<72U?J=-2>XTF5W[_G?X&:@WR<.W'*-%R3.\#=]G
MZ2+.6,]'>-"Z]QK'OF3F<J3@P[OU1"#R!)1*P(K S*ST2K1NN;0-G<.&M<*I
MPDRLG4#)Z5$QD(OB> 8> D<I30JYR;'\[F'M,?HK#8Z3IV/>783?P1[\6//K
M.FHRS.J@R?^YF%5S_4N8SBN#;^<?,)TM+_KD+:<K^M%K^G;^B;:8Z2+?-,SV
M+D:N"\1ZXU89\G^"I;U$L^RL9X6STN8R7R.&.KD#> 0\=P&)CI?&^H!PL20O
M9WXQT3>=?UR&^8KD7M$PS^OO9A?8R/_G[*+RZUH*C)7"),4$Q@M/KI6T$$P.
M$)+WB2L1&YT"MV&GDT+B$9?%$>'0P:+8(( K5O;JX.NS#PF3!.88V007*$Q&
M3>QK940T,6C6Y)QG8#XZ*8(^PC(8$P =G!$\P?Y6[.K,<Y06H<18+ZNZ BZB
M!,&SBHKVQY33D?$^&+[;U_F,B^_!%=Q%@>X3#$]2S58*J4&@XW4BB8;(T8*P
MF)AU'GEL<I7R"9HZ*?D9%XD[*>8[ZD5^.Z&TH0M]BVS98\WN&Z?+GN-N^'S9
M$VWS>73D@BH$H7QM"ET<1%;;*/#$M<N<2];D0'LKZ@;N^IN5X"*I D$D02O2
M>/#99G"IEE*5DD*;B;8]=?T='A7/] #>1>@=!#G7U%](I!KBQ;RNVW5WT^AL
M+"$&\ I)+H["MN@<[?!2:U2F6/JN*8(V4=4)H/90]V/(.5CV'0#I'@^7#2T5
M#VBEBV C3Z!0DV0XUZ"US@45&AO:U ]MHJ83X!RN[?MGZ >+O@/\W)KB<-FK
M-/(2K4(.5HK:4\%*\#XQLM$HLI+:^'8#V>]0,O*Y]N':?7Q@QAZB[@ KC\S3
MO6(F86':(R3./2A!(8GG*@,W2:H2*'9034I=GZ1JW#.5X3$TG IZP-/S$W(O
M&=,^)!)4 J-XJ<$H;?P4VX)D2$(S2KK0Y*AO:PK'/:1H@+,FJND <_>'Y%YR
M(8Q(N7;X8T62K!@6\*G>(366J1!0HV^2--U,SKBY_N'1-(#0.X#.AA+,XC#H
M8@*%(2'6\?$%8K:6=G%,0C'FM6X;J+WILBOZ(-'9?E+N B>#3![EL3!:<Q&8
M$IJ$&&K=HN804Y&88E:.-TJ9'6VF[#&KI7<"49M9LKMH=&\<?UE7Q)  EJ?#
MH?G7U>H,\^V2F_\(LS.\*OC%]0D%.0=K!4\\(A?21A!!(+D$CNRZUP*<JZ:
MN1)<D\UT=U([L9H#HK2=ICJPK#?%+:N/BT="H36G\3ZG[Y&6[6IZBI<]PR]$
M\Q[3XM-\_92UE":94^#M8^U4*VMK&I,@*FV@*&&M4"25-AV-6S/620W5,#CO
M"@4=K(J[U<'*RQQB\O6BOB3)<@:A3C7212HN Z\7'?HHS3YFQ\9#\+:_?/<&
MQU=<QL41BDRO3OLW>C$7,ZTG+F)8^_&.!6+8UD9+P;,:ZD?F4V:!-6G(<B#=
MG=03#0/!8^JP XLVD+\=HG#6JDS(L@94%@IJ:UX0T7HE*]>V2=;PB!'4,3L/
M=1!![:+1 R.HG^:WB]^.?(LOK#[_/%O\V>CVWO73CW)K;S,OPU<?7;_HNKS$
M&E&8DPJ\JA>D,9EZ&V0]Y]Y(ZUQ4IG71T0.B!G#VZC/?+1=?IR2^E^=_D.Q_
MG5\W*'^13J=?+^[)7/<JR"J7*#4846<4>DW&O_9?9+%([41!9IN46.Y.:B=)
MHT.QM,&!;*FS#C;LNRYR-)GL,S?@T'I0@=6I#*6./(VF*&Y31-M'"-*NVW=C
ME3\9HNPB_P[ <R>>K\'X/$UG>(>ECXM=I9EEM.B#J+=B%:B(M%Z%U: S0R^0
MO)?0) QNP<S(W<>/"^71T=#!BGB-].8T#9?7^UZ<5!?Y'Q<I6RY="MYR"":Z
MVC>#O'"-'!)JQYG5PO,FU]F>H&E<4SL^8!9MM#?V!'F*P:K8[L\'$,78+!T"
MK>(:@VD-0<<(R3C&*#0L4K#G8I0GGC^NL>L&3$-IH -K=BV:-QA6^+ZV[GE;
M2&IUTO3I[=5QQ9\A]YIA2*"3RZ!DO;#)>('"14S"&*7;S-3=E=!Q3U6Z@>I1
M]-P!CF^:4;R>KKXL5NL3H[=ES=YJ(E3.4J0,3)G:IC;4L2G"@E9>%DO_9[Y)
ME/TD5>.>PW2'T.$TV,6]VD<.]57!P"Q#X+8. M#,@S>5F>"%X,9%WJC\8O\2
MBV;G,-U!< "==6 *27K+:N1?X\7?O\Y?7Q)R:W+%1(A<@D@U26;8Q?6^8,G9
M5:BB1&-JMZH60-R*NG&/5[K#Y? :'=5$KMWGASS5!E/K8H]_8":.+N=?K":E
MJ"QBT!!3++6-N 2?.0E21<^L#<:(LE5,L_4KQQT;T0W\&NII[/#Y:ECZSV&Z
M7-<5/3HO?>)3R$+Y LZL._D:!UX5!4R6@%BX"=EL!;_MWSGN4(F^\-=(4UWN
MTS<SM2\*Y6YRMGYMO@-DG30HY32XF$EZBH68T;N4&DUKW9;$<<=8= /9QKH=
MVVP^9.O=$K^$Z=6<]I^^7=:-//J+%ZX*RR6SPNJ426UHJ_"F]I?V$%E1QN3(
MQ/WV\EMOZ7L1-&Z2O!58GM[&VVNNBSC\(3\O4EJ<D:4@.X'3K^L[44B.LY4Z
M0K2<7=R)"L$&2%S;J'2=)=\D*M^&N'%S[HVQV4Q+G6)O72MZP])J(KT(,1 R
M;)2UDU>4%+198C$(9GDV298F8VJ?)VW<!/IHN#M(0YVBK@Z@G],_(N]FH@P7
M,GH-O([A59(<FI@I5.,I>Q\\!C1-ZFZ?I&K<5/AH6-M7+YW"[(ZC8 7YR2HI
M*)S7A/TZ+"L%@G&V&):*$$TF6 W@Z#5+>(\&M+TUTRG2KH;8IW7'[=/+,R(F
MI2VL3N1B.=:Y7PR\J\T+K \V:D-\-REMW)*^<9/:XVZH!^GJ4!!^;)BRN7)3
MWX7SB^X*GBB/Q8/@K";ALP<?;0%NLB,[SI"D>=Q(XI*R<7/:HX<1^^BGRQPA
M,;0\(SJF(4YGZX351/.$M7P8A.$.5/$<8E$"C*% O00FBSM2=O A<>.FLL>$
MW2%:ZA)Y->U>1?6WZ>GG5V>KT\4)+J\8/)\HC-'&H( B=%,OH$4(63-P')V)
M,7*7CV3XGJ1SW#SU:'@<3G<=0'/[HO>)=R)(06++ZS/):!Q$;04(;W34R?E&
M8ZBV)W'<-,OQK\*TT%P'@T$>X:Q&^*O'!"FD8$BK3J C%Y@)"]Y(66_.HK;*
MN>*:1,B[D]I))YXC7?T;2F<=6$KR>J]:L:3_/)LND7C-9Y4MO(S#7$S1LCHK
M6VE7VZE$<+I.+E&I*)U,\-@D__PL95U>$1P,&HN6>NHB:?. I1=?PW168["?
M%\L/888W0P-?8SR=2(\L<5K(B2M^,?_7Y;J:O909(^T$LDD0LR.=75[W.QHL
M!]1A'R!=+A)B7OU,DJ[\O)CGW\)I9>G\;?DM+/^.ZY87-VQ.N \J:&;(#R_D
M*D=9765NP15)+G-2*;4Y/MF9TB[]RF9 ;:K'#C;R[>4YL9%;CH%VBN0$U- .
M@F*2_'.CG2[.*GW,CA(;2!SWM._(T&RDN7Y#GI^G\S!/FP7I;/":Y =)IGJ6
MC@*B+\1AL**H6 S#)IO\[J1VTI3Q2"'/4#KKP%)>^2SO<=T@_^/B8_A6LUZ?
M+X965\=E\RT?F;./B;"#'#,M[23!2Y9IS0L;"OHDVF31]R6XRP!I," ]XHDV
MU6H_YXR7[!);C]2Z7^=N-PA\8HN@(+%N(<K1)I5L F=MADP..2M2>26:5#,>
M1'67@55C.!]!OUV$6>_QR^7Z?5O>3.=(?[TB.J:GD^R#E847,#IH4*7N9<E*
M""4(@2KXE)L8W4<IZC)L:@7#8?32!<2VE]Q$$$L:48$)=?F8VH&+<P=1YF"S
M\HGY)BG/[4GL,D!J!<)&FNL@0/JI%$SDPO_T+:TOL;TGM+]=-XVI_Z^=5K^&
MV8570W*<)EH+]0<OYOGN![=^<Z*X*#(7#8E;1LZ_2+0PC8/L<I0^!25EDT.C
M!KQTTH=\Z!!K;*UW$(,=Q.Q%W_^')0R7]Y-NB_5"U!.O"Q:M,CA/AD<Y0_M4
M]C7M7+2,G-D'-W2'61/'9;.3GNE#+Y>.L=+!%G*8V2C".6YC@)R0M.&XHFW9
M(L7"4B6#)HK8I%=7^VVA?6OUKG"^DR:[F4YU(,LU.>.U)GQEVO.LT75$G8-4
MM+9&^2#:C%AK#]YF5=:]@G<'3?8[&.!E6$U7B_+NUL/N$KW=!(!-CQF@U?^S
MU W4T__M\E.87[8*O)DJ<-%,]?;+WY;+ "[,;@8.7&,QALB32A&$J0V*8I3@
M71'@K8LE9QXT:W)39Q#J#VZY>0@1KZ>K-%NLSI;XD33ZDI[[]XE4(A3K$!PM
M95"TS"$XI0"]-L$(CZS1$*"!&1GW1./XR'[0HW-,8 P6-K8VNN](+*DFR88Q
MOM>/:V.$-U/;E3'VK!C.4$(LKN9Z#;D((B9(01F="X^>-REIZL(8KU7V]H[*
MZ/4?II_FTS)-87YZ>8%L/0OI0I4WZRL7A=Y[1R$DDN1BYA#(L:(_O$J>)]^H
M9O$0HO\9C.PNB+UO9(^F\ [R<+_CG[>X62[F]&6ZD.6:M_.+/V_QQRTZ(0)(
M[P-YZC*1IZX#Z.Q\5@D+;].-9%="QSTL'A_$317;IR?P'K_B_ SWV?6O_ND
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MAX>[#QXU7$#[-)5'#EES-,QZJ<#P0/I'<K=H'TN06<C"H>:6CY'".C1DO;#
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M";F?G..G:&X_]28,9 5E9M8#K_-GR14KX#5/H++3JJB0-&MR6_X!>L;UB =
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M=RUB2_ETL"4_%+USRT+R)0'R5!L>^011DF?!N?4Z:<%+>)Z(=X^D23,X-<7
MCNF4?01R,*Z^K[?W99@OGR.I(G,B&( 5"4'E&F.5O.IW':3A47!L4J1Z=%*E
MV5GGJ#@[5#2C@VU5S+1:R%I5?O545Q]_J_[L9CK.UM@N\G#?D*\V^XFXSH9?
MA6$78;HXC\EPAI@!1:Q3=)R'D!1Q.&)B+%N6M'[*RVM(W[BGI\\!UUZ$V_%6
M+4/.B;L$GM=$NV:YCMU9[1&1>608=)-.&\=LU<W.8'O8JO<1R)'6\\UTF%;$
MC^X&PI;(F!.@B1^@HM$0LT1@.=G,B\,DF@1:1V_4S<YCN]FH]Q'-H%![]C3,
M1TRS:9WSM'K7K+S&Z>Q;;>,UFR]FI4XE2_37K^O-0LQW;PUN72D\ILO?*'0^
M4V*G+7_;9( R/=$K72 %2>;5<0:.I0#!!6FQ".U"DYJV83- CU[NWE+VE0S.
MBPR2,:+)6ENG!%5_)14)F+,)N2@30I/=?B\JN\K^[(.2N\:WG6RZ.*6^=WD;
M'?]EC6?YORX7JX%ZYU)J%$A1(<HZ"<L("YX5#U)F'@HSF;$FH?N!]';5$6)P
M. XLKPXBG0>T[J&%GI.'[:.ROLYP#*1W!)PHR>MV3J><,&IOF]PNW)/.KKHY
M-+"*@\CG=#L0_C$C'V<Y"1<7/U]O&EQLGY9=M;BHDGGSQZ<MEZFQ1WHT7<_D
M@0[+OT8=%*U,(3$!/& !59MU>I88<&X*DE2B-TUNZ@SK<1[9@V4SZ*N05GO)
M/0BL-7FI( 6U5:MC4EQ+PY1H4CDT"/5=>:C[H.JN+7Y^6?99RG&3!J[KQ>EB
M];Q#;.H#3QK "NY"XU#30Z];;ZY:VEV_["->U$+_5[/%<ITYCUN9\\4U(HWT
M!H724"QCA$BK(6KZ,LAH58E<\38W,8XC^^A9@+N^??NX87'3DDJ'[,AWXL0P
M(VN'+ 4.E01NH^*K6=&ZB44\DNZ19YP^'U)_F2[XC/(^):MY>/?:1Y_7S((V
M[%![)#J]"T6YJ,!*0?NJUP:\LPI$\G7+M[4,Z>79T:TV$_?*:]U=]?LJ77R6
MR'.YZC*\I5HE:%6/2-BJBZ7DM0^U<L"]8*44SU5HT[K[:-)/VIKN@]='&J,]
MA]2[2* ^M>:/2(R=I.7F/OB?TPDQNQX)/L  H:1;S;"5J?*?B0 A$"M02(H"
M0G(\-LGN#[R.<1.N'>M 2SQTIA#7A3<X_S%)>#\_SBY6CUR%IO4$\LNT7G19
ME_>LY'3#BB"SSM%4L3!-M@$%^7@R0?0LNMJ?RI0FA<_-5C1N.K@+)1D3(Z?D
MD _1!7C')S=STI^ET^^1J"ZQF&A< NOJ?;K(:B\]"BLMLSHKC#&U&9;<M[N^
M55"Y^.WGK_66UU,1SKVPOABGP0E,H'*]$582@Y+KC=F0HQ"M^PX?MX*3=M[W
M0>^^CDL;#'1PUEQ+@=^';[CJO!JREBE:!)YK7^C(.3AI)+BLG:&-SG/;1/^W
MB>BFS_%SXN!N%ZU#A=(1H#;M60T&ESBK^N@0E(D1/)++Q"0Z[M%F[]JTC;Q%
MQKB@.ER<#^#B -Z.W<_X\U^SSU]GEXLPS9])SGCE^KZ>S#'1WYW5@_'IXO)B
M&:;+]?G@[]-4#\1_K*XK;#KRJF081Q,AHK>@@JGZI3.0MBDGK2A%NJ<\P0'I
MZ0-7A\!A-JYL>H(C3@]<<%8QVN@8)%;K>JS$VN(I0:WG2<6(%)7?&XR'4C-N
MSJD%%)]%+F,#\<'[69__HG7]I(\7/W"SKJ**BL9'( #5=8D((3MBK48?N;+,
ML1T;ON_^TG&S-$/!JA67._"WUBXG_?)Z=H)ABBFOP,=<;Z[J!#Y8#J(V*\R.
M:]O&@[]%13=-WD=TX0\72P>8.IQQ-\N>YCO*JZSV+,L PF>Y<7P51P@\JL)U
M0B;;C=09>#'C^GU'8.N^<2EC"KH#L-_:&];GLYN= '/@)7@#,B)Q-F@'008&
M)@LNA3$JM1D"]2!%'8QA&14LLQ:2ZP""]QV+?OSTYU5<I:T(CFG@,A=2\"2(
M18)#D=6MRSD@-NF1^2A5(^_QO4%Q. F.'9!<5:C4SG>_KFFSH*12D3QS"";4
MJD.1($2501977.1),2EVBD1V>=NX(4@W4&LCG0ZLWXI/K\-RDQ]-P@6'M904
M78WQ+,2<"@BIBY?!2IN;5+[=HF)DR/43P1PDEIXPM5$X%S J01:8&1'6TY*=
M5A8R:E%;@BH,38XA[M#10=QPF$0?PL8![.UD@_LWTJ%ZA[/08U]C6EG.MY,?
M>$]&2/*0& L<3/$9E#"1](E5QNE ?B9WN..@Q;U?W0E>#I'R/;M6(Y;W!:@_
MYI/9_//LB?59P;BF31IDLL3*9!TY )8B=UJ7DL9HTL(#(+73R\=UW1N!:GBV
MCPBKQ7QY_GFRK![ [],\^3')E^%B9;13"<0A"AV\Y0(4)PWQK+;8$%9P$6AU
M;)?9[?2"K3V,OKJ[?SU(P;CMS<;UC(812V^X^H_)\NNJPJIJT]?)]\^S-]/E
M9/ESHY^V#JR)I5 (D36Y"?56K)8>"MDAS&AS"KMT/SL,<8_3-L[N.! *'L/4
M@"(9>W-\/_OE%'=CBTU&$XJ54)10=7B# 9_)^@N4626',@JSTQ;XX"LZPL>0
M$IT-SMX. K8G[?E#YOS=]> 'Y9)43#O(LE! $X('9PQ"R((<BE3[]C;ITW@\
MZ>-V<^PCW?#, #AER%\U'#K+>5+_)%S\,AT32]%.A0*:K$ M8B"#(A')VV4Q
MD),;BFHS/:;=FCH__!H8GD-IQ\!8.66U67WX)RZ6UQVT^;G523DE*.9,FC;>
M@K5<D3DPZ+BP"HUH<^-ER$5T?A37J6(<BX9>-"$^O?9X=^UO_OX^F:]^>;WR
M\U!BP&2(^=YQBES(672>R^HL&I3<L]#FT&6P%71^1O@,.O#L..A  7:Z/TLA
MT@]2<UQK_.)S[9.X_?-ZK>S];/F?N+RY7;O=J^'<L)*-LP$21@,J>08Q\@"L
MN*A+S,R:)LKQ+*L;.9\WKN+TAY\7K5373UK_T8?E5YQ__AJF5XQ";;VW*@!J
MCZ"T""1*02Q#RUQ$[W1LTC]LM!6/'/>_5.4;$F<O62'7F_[;V7SSK?I[_)PE
MX71($9P3B;BC%<2, ;@,$F61QF.;N9+/NLR=5,_\K^H]-Z(ZT+>C<RV_9%B"
M9C8HK@ QU &<)4.07D%RV6/A4AG;I/IH\)7LI#7VA6K-N+CH0#&V.I>_"M\G
MRZM<XD>"P?P'5KU_>[F\G&,=!!:F"<^5S,XRI4!$S2N[$5Q&!<7R4N_KR=RF
M(^S>E.X$;/="@=U6KJ?4:&HK;KOJ2#=XRZE'WM&L^=2NZ^JC#57 Y(LE\'J5
M!"AO+$0K-3AT5@NTTHB7V(;J4".P"6NV)HY\W)J]5[(M*4D!0J DY\LPB#Q)
ML/1M=,Y@;M."M\UR3KI!U3ZX'LSY& X='7@@ W)A[92=9RZTK,O.J5;!^]HR
M47L.A6=G$FJ&,G6N'NN5G.CQ^(#P;*<Q!V!E]+'@0[%A55^]^/WJA,B%K+!D
M R)X#XKK6JX=,W"-(I<238FZ1WVYO8P3/3+O5UF.0$D/V\JC ]:WSG+>_(WS
M-"$6G NG1!") RE^)%N0<RT:\+3"8HKAUEG1IIO%WJ2>Z-%X0ZRWE?;^>/9K
M/$_Q2_4BN[#ZQ.>"DQKSU[O&-W4"-RH>;(HQ1PDQN PJ8(8078+BBG4HK9&^
MKVK;75=VHB?B_>X-PV+I1:C7K[ZE88%%C1Y0UX;RJC9/Y'PUR9Z9H()#W]<1
MP5%Q2']GVOVJSW%8.3(.>3/M0V$V6W&]97 5C E,7&D)/NC:0L-%LAF2 0]%
MAD06Q<<N _=?5G*B)]']*LQQ6.DA'!E.)G=&55]YM'_,)PFKO,I&7LA#<L)Z
MB*+.\Q-%@2\608M(LM*"%=ME6+__4D]Z-E,G&>06J/K7T;MSYS5G/"APEI5Z
M-5-#(&K :$?VB$>G2Y>ATX[K>S&9Z"8P'T<K]\+<J?B,#]Y&O3<I^2A[)'<6
M>;)0="01:O*F(V8+IC:;8>0L&#-.^#7<&E],SKL+M1P)>Z>P2S[%FJO5[\8=
M;F+(JAC0*)&"797(Y0D.HLLL,RZ]Q'%N,@^ZS!>3I#\)Y6R'P%/0SV/3M8_[
M&<[9XKR [*6J';8HU"[" )=%,1.T#JKTZ-L>M>H7<V30A?9V@\\7H,R[A@?%
M66NRD4"VSH$BQX/"@ZP!!6<&Z7^?VET [R0D/85#B5-0T!:8>S'E5%O)Z<?M
ME+11E<1!%VM!&5W/>.K%J6A\2,H6E;H\#]QQ?2_FT.,4%+(%YD[I5L?'3W\V
MN\UQS[.;W>)X:AU]W-ZHDPT<JCJ%J/8RM%Z#=V3EF0Z5F4DG[5I8KI<R1)SK
MXIDQ"5+AB;9%IB'Z6,"0G?#.)ZGN]L7\WR'BXZ"WW1#Q?3#0091R>R"9ET)8
M(0-D)B)M=<G6?G(,HK;2F=IYP31) >P_@_ $QHCOA81'9Q#N(Y8.,'4XXQZ9
MNR.8RB)D"274>ZM:DS_F2@0L3G&7M71BG.S4B<\@W M;SS&#<!]!=P#VQ\>'
M:5FKES@#6[N)*T[;4:C-HDG_O6;),][F</+X 7"G-8MP+]#L-0!N'PEV ,>#
M \YWU_T(-!-8:C^"Q,@.K(?!D_L$25IE72T]Z*P!\;N]FG&?P/3B8SR'9P;
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MP<6[>C-RJP.U4#'[J, (1QMUB &<YPC<N!2+C86U:0V\,X4C5RH/"ZLV<ND
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M/S8_J!\B6;[_^W_^/U!+ 0(4 Q0    ( 'U :5&_)[7D3T0  +7F 0 :
M          "  0    !E>&AI8FET,3 Q+61I87IE;7!L;WEM+FAT;5!+ 0(4
M Q0    ( 'U :5%$;^=@UB@  ,H0 0 :              "  8=$  !E>&AI
M8FET,3 R+61I87IP<W5A9W)E+FAT;5!+ 0(4 Q0    ( 'U :5'F1&/ZTB<
M $T2 0 :              "  95M  !E>&AI8FET,3 S+61I87IR<W5A9W)E
M+FAT;5!+ 0(4 Q0    ( 'U :5'=R)N1W3,  +M^ 0 :              "
M 9^5  !E>&AI8FET,3 T+61I87IP97)F;W)M+FAT;5!+ 0(4 Q0    ( 'U
M:5'1Q-XIU3,  -YZ 0 :              "  ;3)  !E>&AI8FET,3 U+61I
M87IT:6UE>&)A+FAT;5!+ 0(4 Q0    ( 'U :5$VRBD!BAX  !W#   :
M          "  <']  !E>&AI8FET,3 V+61I87IF;W)M;V9S+FAT;5!+ 0(4
M Q0    ( 'U :5&D +8G" @  )XH   :              "  8,< 0!E>&AI
M8FET,S$Q+6-E<G1I9FEC871I+FAT;5!+ 0(4 Q0    ( 'U :5%2,![S"0@
M *XH   :              "  <,D 0!E>&AI8FET,S$R+6-E<G1I9FEC871I
M+FAT;5!+ 0(4 Q0    ( 'U :5$FO*>9V 0  &,8   :              "
M 00M 0!E>&AI8FET,S(Q+6-E<G1I9FEC871I+FAT;5!+ 0(4 Q0    ( 'U
M:5'!LSDWZ*,! )[@$@ 1              "  10R 0!M>6=N+3(P,C P.3,P
M+FAT;5!+ 0(4 Q0    ( 'U :5&U(N%&B1   %^N   1              "
M 2O6 @!M>6=N+3(P,C P.3,P+GAS9%!+ 0(4 Q0    ( 'U :5&DN:)H@"8
M .F4 0 5              "  >/F @!M>6=N+3(P,C P.3,P7V-A;"YX;6Q0
M2P$"% ,4    " !]0&E1H[1>$#]0  !P4P, %0              @ &6#0,
M;7EG;BTR,#(P,#DS,%]D968N>&UL4$L! A0#%     @ ?4!I42IQ47I'X0
M44$) !4              ( !"%X# &UY9VXM,C R,# Y,S!?;&%B+GAM;%!+
M 0(4 Q0    ( 'U :5'SB #S_GX  (O/!0 5              "  8(_! !M
J>6=N+3(P,C P.3,P7W!R92YX;6Q02P4&      \ #P 2!   L[X$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
